,mnppid,edbirthd,edsex,edheight,edweight,edversi,edmaanam,edsympmws,edsympuws,edsympknoch,edsympfrak,edsympleist,edsympmued,edsympschwae,edsympbakt,edsympnfunk,edsympande,edecog,eddusa,edprottyp,edprotg,ediss,edcrabkritc,edcrabkritr,edcrabkrita,edcrabkritb,edmikrogl,edalbugem,edkofscore,edcovmedca,edcovmedreg,edcovmedmol,edcovmednir,edmmtyp,edcrabkrits,edcrabkritli,edcrabkritm,edrisklightch,edriskmprot,edriskbone,edmikroserlevel,edalbuserlevel,m1tm_regimen,m2tm_regimen,m3tm_regimen,pttm_regimen,pttmstart,pttmendeong,pttmendefin,m1tmstart,m1tmendeong,m1tmendefin,m2tmstart,m2tmendeong,m2tmendefin,m3tmstart,m3tmendeong,m3tmendefin
0,1429,6/15/1945,Male,178,99,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,98,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,V-X,V-X,Other,3/23/2015,7/2/2015,7/2/2015,10/9/2016,12/2/2016,12/2/2016,12/12/2016,3/25/2017,3/25/2017,9/3/2017,9/26/2018,9/26/2018
1,2447,6/15/1951,Male,189,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,7,ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,V-X,V-X,POM-X,LEV-X,1/9/2015,9/17/2015,9/17/2015,5/23/2016,1/6/2017,1/6/2017,7/2/2017,11/23/2017,11/23/2017,6/25/2018,6/17/2019,6/17/2019
2,5149,6/15/1934,Male,179,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,Other,V-X,V-X,LEV-X,3/29/2015,6/13/2015,6/13/2015,10/29/2015,7/22/2016,7/22/2016,6/25/2017,9/18/2017,9/18/2017,11/27/2017,6/1/2018,6/1/2018
3,6733,6/15/1931,Female,145,76,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/30/2015,10/28/2015,10/28/2015, , , , , , , , , 
4,9821,6/15/1951,Female,173,74,Compulsory health insurance CHI,Yes, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,89,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,V-X,EMP-X,V-X,4/13/2015,10/16/2015,10/16/2015,12/16/2016,6/9/2017,6/9/2017,3/14/2018,4/26/2019,4/26/2019,9/20/2019,6/25/2020,6/25/2020
5,5109,6/15/1956,Male,183,101,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,0,III: one or more criteria are fulfilled,IgG,"87,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,V-X,R-X,LEV-X,2/27/2015,8/3/2015,8/3/2015,8/25/2015,7/23/2016,7/23/2016,5/9/2017,9/23/2017,9/23/2017,11/27/2017,9/28/2018,9/28/2018
6,9573,6/15/1935,Male,172,67,Compulsory health insurance CHI,Yes, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"1,36",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/2/2014,3/27/2015,3/27/2015,11/2/2015,8/1/2016,8/1/2016, , , , , , 
7,5183,6/15/1930,Male,168,71,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,",2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/17/2014,1/16/2015,1/16/2015, , , , , , , , , 
8,8222,6/15/1947,Male,172,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,",59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,KYP-X,V-X,8/12/2014,8/28/2015,8/28/2015,9/7/2015,7/3/2016,7/3/2016,7/14/2016,12/22/2016,12/22/2016,5/14/2018,5/19/2021,5/19/2021
9,6317,6/15/1946,Male,181,77,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"64,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,3/30/2015,7/19/2015,7/19/2015,3/3/2016,6/22/2016,6/22/2016, , , , , , 
10,6246,6/15/1938,Female,160,54,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"58,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,3/16/2015,10/4/2015,10/4/2015,6/13/2016,12/4/2016,12/4/2016, , , , , , 
11,6464,6/15/1943,Male,181,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,",16","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,LEV-X,DAR-X,V-X,12/16/2013,2/13/2014,2/13/2014,3/9/2015,4/18/2016,4/18/2016,4/27/2016,7/28/2016,7/28/2016,8/12/2016,9/29/2016,9/29/2016
12,5590,6/15/1934,Female,179,75,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,13,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,EMP-X,DAR-X,POM-X,No CTx, , , ,9/15/2016,7/15/2017,7/15/2017,8/15/2017,6/15/2018,6/15/2018,6/15/2018,4/15/2019,4/15/2019
13,6533,6/15/1944,Male,171,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,",3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,3/12/2012,7/16/2014,7/16/2014,8/19/2014,9/29/2017,9/29/2017,11/5/2020,3/31/2022,10/14/1582, , , 
14,5633,6/15/1948,Female,168,70,Compulsory health insurance CHI,No, , , ,Yes, , , , ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,21,ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,DAR-X,FAR-X,V-X,2/1/2015,5/28/2015,5/28/2015,11/7/2015,7/15/2016,7/15/2016,6/15/2017,2/15/2018,2/15/2018,3/15/2018,10/15/2018,10/15/2018
15,5919,6/15/1942,Male,180,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,10,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,EMP-X,EMP-X,V-X,2/1/2015,5/15/2015,5/15/2015,11/15/2015,6/15/2016,6/15/2016,8/15/2016,12/15/2016,12/15/2016,6/15/2017,1/15/2018,1/15/2018
16,2328,6/15/1939,Male,178,77,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,",6",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/7/2013,3/4/2014,3/4/2014,2/4/2015,6/9/2015,6/9/2015, , , , , , 
17,8732,6/15/1957,Male,187,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,30,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,DAR-X,No CTx, , , ,4/1/2015,8/18/2015,8/18/2015,11/15/2015,9/15/2016,9/15/2016,4/1/2017,1/1/2018,1/1/2018
18,6135,6/15/1951,Male,178,69,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"63,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,3/2/2015,4/12/2015,4/12/2015,11/30/2015,5/22/2016,5/22/2016, , , , , , 
19,4884,6/15/1951,Female,169,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,20,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,R-X,DAR-X,V-X,5/15/2013,8/15/2013,8/15/2013,4/1/2015,12/1/2015,12/1/2015,1/15/2016,5/15/2017,5/15/2017,5/16/2017,1/1/2018,1/1/2018
20,6686,6/15/1944,Male,183,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"24,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,V-X,LEV-X,V-X,3/2/2015,7/2/2015,7/2/2015,5/30/2016,9/11/2016,9/11/2016,6/4/2018,9/16/2018,9/16/2018,6/17/2019,12/1/2019,12/1/2019
21,7590,6/15/1953,Female,164,59,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"54,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,3/30/2015,6/21/2015,6/21/2015,11/9/2015,6/19/2016,6/19/2016,6/27/2016,4/30/2017,4/30/2017, , , 
22,5704,6/15/1940,Male,175,69,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"63,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,3/16/2015,7/19/2015,7/19/2015,6/20/2016,12/11/2016,12/11/2016, , , , , , 
23,8625,6/15/1931,Male,171,83,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,3,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,LEV-X,No CTx,V-X,9/16/2013,1/23/2014,1/23/2014,2/3/2014,4/15/2014,4/15/2014,4/22/2014,4/26/2016,4/26/2016, , , 
24,4684,6/15/1938,Female,158,62,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"48,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,3/9/2015,8/30/2015,8/30/2015,5/30/2016,10/23/2016,10/23/2016,8/14/2017,2/4/2018,2/4/2018, , , 
25,2848,6/15/1952,Female,176,51,Self-Payer,No,Yes, ,Yes, , ,Yes, , ,Yes,Yes,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,R-X,R-X,V-X,7/21/2011,10/8/2011,10/8/2011,10/9/2013,5/19/2014,5/19/2014,1/26/2015,1/5/2016,1/5/2016,1/15/2016,10/7/2016,10/7/2016
26,3813,6/15/1939,Male,165,80,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, ,Yes,Yes, , ,Yes,3,III: one or more criteria are fulfilled,IgG,79,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/29/2015,9/17/2015,9/17/2015, , , , , , , , , 
27,8739,6/15/1937,Male,179,75,Compulsory health insurance CHI,Yes, , , , , , , , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"28,86",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/28/2015,5/5/2015,5/5/2015, , , , , , , , , 
28,7468,6/15/1959,Female,170,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,9,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,V-X,V-X,3/9/2012,6/6/2012,6/6/2012, , , , , , ,4/9/2015,6/23/2015,6/23/2015
29,7162,6/15/1956,Male,182,88,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,12,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,R-X,V-X,R-X,3/23/2015,5/2/2015,5/2/2015,5/25/2015,10/30/2015,10/30/2015,8/6/2016,3/28/2017,3/28/2017,9/8/2017,5/24/2018,5/24/2018
30,2979,6/15/1937,Male,180,83,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"42,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,DAR-X,LEV-X,3/23/2015,9/6/2015,9/6/2015,5/23/2016,10/16/2016,10/16/2016,11/27/2017,5/20/2018,5/20/2018,3/11/2019,5/31/2020,5/31/2020
31,2364,6/15/1938,Male,176,69,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"57,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,R-X,LEV-X,LEV-X,1/16/2012,6/30/2012,6/30/2012,3/23/2015,9/6/2015,9/6/2015,5/9/2016,12/25/2016,12/25/2016,1/9/2017,6/25/2017,6/25/2017
32,8275,6/15/1929,Female,145,51,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,9, ,IgA,"47,7",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/25/2014,2/2/2015,2/2/2015,7/21/2016,7/19/2018,7/19/2018, , , , , , 
33,5242,6/15/1941,Female,162,53,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"18,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,No CTx,V-X,12/9/2013,3/31/2014,3/31/2014,4/5/2014,8/20/2016,8/20/2016,9/27/2016,10/25/2017,10/25/2017, , , 
34,7622,6/15/1936,Male,171,57,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"56,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,EMP-X,No CTx,V-X,10/21/2013,3/28/2014,3/28/2014,1/5/2015,6/5/2015,6/5/2015,5/19/2016,9/30/2016, , , , 
35,4394,6/15/1942,Male,177,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"58,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,R-X,POM-X,V-X,1/30/2012,7/20/2012,7/20/2012,7/21/2014,11/28/2014,11/28/2014,2/12/2015,7/13/2016,7/13/2016,7/21/2016,9/30/2016, 
36,4388,6/15/1953,Male,179,91,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"32,21","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/16/2015,5/12/2015,5/12/2015, , , , , , , , , 
37,7411,6/15/1933,Female,158,53,Private,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"47,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,V-X,V-X,Other,5/28/2013,9/20/2013,9/20/2013,9/30/2013,3/21/2014,3/21/2014,2/5/2015,8/14/2015,8/14/2015,9/26/2016,9/30/2016, 
38,6564,6/15/1936,Male,177,65,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"53,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,LEV-X,LEV-X,V-X,2/20/2012,8/10/2012,8/10/2012,2/3/2014,7/25/2014,7/25/2014,2/26/2015,6/16/2015,6/16/2015,12/14/2015,5/27/2016,5/27/2016
39,8303,6/15/1937,Male,177,73,Private,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"49,4",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,V-X,R-X,V-X,2/7/2011,5/4/2012,5/4/2012,4/29/2013,10/18/2013,10/18/2013,3/4/2015,7/10/2015,7/10/2015,7/23/2015,4/27/2016,4/27/2016
40,7763,6/15/1935,Male,176,66,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"51,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,R-X,No CTx,V-X,2/11/2013,8/23/2013,8/23/2013,2/11/2015,7/29/2015,7/29/2015,2/24/2016,9/30/2016, , , , 
41,6858,6/15/1943,Male,168,78,Compulsory health insurance CHI,Unknown,Yes, , , , , , , ,Yes, ,9,Unknown,IgG,"20,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/27/2014,1/19/2015,1/19/2015, , , , , , , , , 
42,2258,6/15/1983,Female,165,63,Compulsory health insurance CHI,Unknown, ,Yes, , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , ,Ja,V-X,V-X,DAR-X,No CTx, , , ,1/19/2015,4/7/2015,4/7/2015,4/18/2016,10/18/2016,10/18/2016,6/4/2018,9/21/2018,9/21/2018
43,1187,6/15/1959,Male,177,86,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,R-X,DAR-X,Other,2/9/2015,10/26/2015,10/26/2015,2/17/2017,6/20/2017,6/20/2017,12/2/2017,6/25/2018,6/25/2018,6/29/2018,12/15/2019,12/15/2019
44,1146,6/15/1930,Female,167,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,5",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,8/15/2011,1/15/2012,1/15/2012,3/1/2015,10/15/2015,10/15/2015, , , , , , 
45,1139,6/15/1950,Female,160,50,Compulsory health insurance CHI,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"48,01",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,V-X,V-X,12/20/2013,4/17/2014,4/17/2014,1/24/2015,5/15/2015,5/15/2015,5/19/2015,5/26/2015,5/26/2015,6/19/2015,10/5/2015,10/5/2015
46,5398,6/15/1941,Male,180,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"56,31",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,V-X,V-X,Other,10/23/2003,10/26/2003,10/26/2003,2/11/2005,8/29/2005,8/29/2005,8/25/2006,11/6/2006,11/6/2006,11/4/2008,9/10/2009,9/10/2009
47,8504,6/15/1953,Male,183,99,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"9,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,POM-X,V-X,Other,1/14/2015,9/3/2015,9/3/2015,9/10/2015,6/27/2016,6/27/2016,6/28/2017,11/23/2017,11/23/2017,3/18/2018,6/22/2018,6/22/2018
48,1542,6/15/1934,Female,165,70,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,",2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/9/2013,3/24/2015,3/24/2015, , , , , , , , , 
49,1013,6/15/1935,Male,186,73,Private,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,",6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,POM-X,V-X,1/20/2011,4/11/2011,4/11/2011,4/26/2011,8/26/2011,8/26/2011,3/22/2012,8/10/2013,8/10/2013,2/11/2015,4/28/2016,4/28/2016
50,3591,6/15/1947,Male,174,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,641,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,FAR-X,DAR-X,V-X,1/12/2015,3/30/2015,3/30/2015,6/2/2016,12/9/2016,12/9/2016,1/2/2017,2/26/2018,2/26/2018,3/8/2018,2/15/2019,2/15/2019
51,2627,6/15/1942,Female,162,62,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,871,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,1/5/2015,3/23/2015,3/23/2015,3/3/2016,9/12/2016,9/12/2016, , , , , , 
52,8300,6/15/1950,Male,182,80,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgM,540,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,Other,2/17/2015,5/5/2015,5/5/2015,6/22/2016,4/5/2018,4/5/2018,4/23/2018,6/18/2021,6/18/2021, , , 
53,1792,6/15/1948,Female,164,68,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,524,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,FAR-X,No CTx,V-X,2/16/2015,5/4/2015,5/4/2015,9/12/2016,12/15/2016,12/15/2016,12/28/2016,12/27/2017,12/27/2017, , , 
54,1850,6/15/1951,Female,170,59,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,571,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,EMP-X,V-X,3/10/2015,5/26/2015,5/26/2015,5/23/2016,1/11/2018,1/11/2018,1/29/2018,7/12/2021,7/12/2021,8/2/2021,3/31/2022,10/14/1582
55,6318,6/15/1933,Female,152,57,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,No CTx, , , ,10/30/2014,6/30/2015,10/14/1582, , , , , , 
56,4944,6/15/1943,Male,171,75,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"16,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,10/20/2014,1/19/2015,1/19/2015,6/15/2021,3/31/2022,10/14/1582, , , , , , 
57,6251,6/15/1936,Male,177,84,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"60,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,EMP-X,No CTx,V-X,3/11/2015,8/21/2015,8/21/2015,12/4/2015,8/23/2016,8/23/2016,9/2/2016,9/30/2016, , , , 
58,2180,6/15/1954,Male,172,64,Private,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,631,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,2/23/2015,6/15/2015,6/15/2015,5/18/2016,11/16/2016,11/16/2016,11/28/2016,6/22/2017,6/22/2017,7/12/2017,9/18/2017,9/18/2017
59,1575,6/15/1947,Male,172,84,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,526,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,1/22/2015,5/20/2015,5/20/2015,6/6/2016,12/15/2016,12/15/2016, , , , , , 
60,5526,6/15/1933,Female,158,62,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,KYP-X,V-X,V-X,1/1/2015,7/8/2015,7/8/2015,1/5/2017,2/8/2017,2/8/2017,8/28/2017,9/6/2017,9/6/2017,2/2/2018,9/1/2018,9/1/2018
61,6378,6/15/1946,Male,176,84,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"64,8",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,KYP-X,DAR-X,V-X,7/1/2011,10/1/2011,10/1/2011,3/1/2015,5/29/2016,5/29/2016,5/30/2016,8/22/2016,8/22/2016,10/27/2016,12/1/2016,12/1/2016
62,6553,6/15/1935,Female,165,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,V-X,R-X,Other,11/1/2004,5/1/2005,5/1/2005,5/1/2005,6/1/2005,6/1/2005,2/1/2009,4/1/2009,4/1/2009,3/1/2015,11/2/2016,11/2/2016
63,5716,6/15/1938,Female,163,64,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"38,6",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,2/20/2013,5/5/2013,5/5/2013,5/1/2015,8/15/2017,8/15/2017, , , , , , 
64,1623,6/15/1947,Female,159,44,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,8",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,EMP-X,No CTx,V-X,1/1/2015,3/1/2015,3/1/2015,3/10/2015,5/10/2016,5/10/2016,7/2/2020,9/30/2021,10/14/1582, , , 
65,2383,6/15/1947,Female,162,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,602,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/11/2015,7/8/2015,7/8/2015,9/5/2016,12/29/2016,12/29/2016, , , , , , 
66,2515,6/15/1947,Male,170,83,Private,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,592,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,POM-X,V-X,3/24/2015,10/28/2015,10/28/2015,3/14/2016,12/22/2016,12/22/2016,1/13/2017,6/12/2017,6/12/2017,7/5/2017,7/20/2017,7/20/2017
67,9450,6/15/1946,Female,172,73,Private,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,492,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,POM-X,DAR-X,V-X,1/20/2015,5/19/2015,5/19/2015,5/17/2016,12/5/2016,12/5/2016,12/22/2016,3/27/2017,3/27/2017,4/7/2017,12/11/2017,12/11/2017
68,9623,6/15/1945,Female,178,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,509,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,2/11/2014,6/10/2014,6/10/2014,3/16/2015,12/7/2015,12/7/2015,1/14/2016,9/20/2016,9/20/2016,10/7/2016,12/25/2016,12/25/2016
69,2043,6/15/1947,Male,183,87,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"7,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,No CTx,V-X,1/6/2014,5/5/2014,5/5/2014,2/19/2015,2/16/2016,2/16/2016,3/10/2016,9/29/2016,9/29/2016, , , 
70,7347,6/15/1950,Male,178,78,Private,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,531,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,10/23/2013,2/19/2014,2/19/2014,3/30/2015,11/26/2015,11/26/2015,2/4/2016,9/16/2016,9/16/2016,9/30/2016,11/7/2016,11/7/2016
71,8884,6/15/1948,Female,173,65,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,603,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,KYP-X,V-X,1/28/2013,5/27/2013,5/27/2013,4/23/2014,1/14/2015,1/14/2015,2/9/2015,1/4/2016,1/4/2016,1/26/2016,7/15/2016,7/15/2016
72,4977,6/15/1939,Male,184,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"62,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,LEV-X,No CTx,V-X,7/9/2012,10/1/2012,10/1/2012,5/18/2015,10/4/2015,10/4/2015,4/25/2016,9/11/2016,9/11/2016, , , 
73,2468,6/15/1951,Male,157,64,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,41,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,11/22/2014,2/23/2015,2/23/2015,3/14/2015,6/30/2016,10/14/1582, , , , , , 
74,4902,6/15/1942,Female,159,61,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,47,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,KYP-X,No CTx,V-X,2/15/2015,7/11/2015,7/11/2015,11/16/2015,8/11/2016,8/11/2016,9/5/2017,12/31/2017,10/14/1582, , , 
75,8133,6/15/1952,Male,181,79,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,79,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,Other,10/15/2009,12/15/2009,12/15/2009,5/18/2015,12/2/2015,12/2/2015, , , , , , 
76,1826,6/15/1936,Female,162,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"57,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,No CTx,LEV-X,6/17/2013,12/2/2013,12/2/2013,5/25/2015,11/17/2015,11/17/2015,1/4/2016,6/26/2016,6/26/2016, , , 
77,4296,6/15/1939,Female,166,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,59,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/15/2013,8/4/2014,8/4/2014,3/19/2015,6/30/2016,10/14/1582, , , , , , 
78,1004,6/15/1954,Male,182,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"63,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,LEV-X,No CTx,V-X,1/27/2014,5/18/2014,5/18/2014,5/21/2015,10/4/2015,10/4/2015,9/5/2016,2/26/2017,2/26/2017, , , 
79,2772,6/15/1935,Female,160,63,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"37,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,R-X,LEV-X,LEV-X,3/19/2012,9/2/2012,9/2/2012,5/4/2015,10/25/2015,10/25/2015,4/25/2016,7/10/2016,7/10/2016,7/11/2016,12/4/2016,12/4/2016
80,3596,6/15/1940,Male,173,80,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"48,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,LEV-X,No CTx,V-X,2/7/2013,12/31/2013,12/31/2013,5/4/2015,9/6/2015,9/6/2015,5/9/2016,9/25/2016,9/25/2016, , , 
81,3063,6/15/1944,Male,179,80,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,2",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,FAR-X,No CTx,V-X,11/29/2012,1/30/2014,1/30/2014,5/6/2015,11/6/2015,11/6/2015,11/30/2015,12/31/2015, , , , 
82,3122,6/15/1933,Male,178,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,3/19/2012,4/10/2013,4/10/2013,5/12/2015,6/30/2015, , , , , , , 
83,4895,6/15/1947,Female,167,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,7",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,FAR-X,V-X,10/5/2011,10/31/2012,10/31/2012,4/29/2014,12/19/2014,12/19/2014,4/14/2015,10/30/2015,10/30/2015,11/23/2015,12/31/2015, 
84,7205,6/15/1933,Male,175,91,Private,No,Yes, , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,FAR-X,V-X,8/8/2012,9/28/2012,9/28/2012,3/17/2014,11/27/2014,11/27/2014,3/31/2015,11/13/2015,11/13/2015,11/30/2015,12/31/2015, 
85,1212,6/15/1948,Male,178,86,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,FAR-X,No CTx,V-X,3/18/2014,3/31/2015,3/31/2015,6/8/2015,11/27/2015,11/27/2015,11/30/2015,12/31/2015, , , , 
86,9069,6/15/1943,Male,179,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,No CTx,V-X,5/23/2012,6/11/2013,6/11/2013,7/2/2014,2/18/2015,2/18/2015,5/20/2015,11/17/2015,11/17/2015, , , 
87,1917,6/15/1943,Female,167,75,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,POM-X,V-X,2/6/2012,2/20/2013,2/20/2013,7/27/2013,3/5/2014,3/5/2014,8/5/2014,2/13/2015,2/13/2015,6/10/2015,11/6/2015,11/6/2015
88,6100,6/15/1941,Female,153,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"26,6",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,DAR-X,No CTx,V-X,4/7/2010,3/2/2011,3/2/2011,11/27/2013,7/27/2016,7/27/2016,1/27/2021,11/3/2021,11/3/2021, , , 
89,9402,6/15/1955,Male,182,81,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,61,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,V-X,No CTx,V-X,5/15/2012,8/3/2012,8/3/2012,3/17/2015,11/10/2015,11/10/2015,11/11/2015,6/30/2016, , , , 
90,4752,6/15/1942,Male,180,79,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"25,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,LEV-X,LEV-X,V-X,9/9/2013,12/1/2013,12/1/2013,5/25/2015,10/18/2015,10/18/2015,10/26/2015,3/20/2016,3/20/2016,3/27/2017,9/24/2017,9/24/2017
91,9643,6/15/1936,Female,155,60,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"58,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,3/19/2012,9/2/2012,9/2/2012,5/19/2015,10/11/2015,10/11/2015,12/5/2016,5/28/2017,5/28/2017, , , 
92,7563,6/15/1941,Female,175,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,49,ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,3/20/2015,6/30/2016, , , , , , , , , , 
93,8590,6/15/1953,Male,185,89,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"6,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,V-X,NIN-X,V-X,1/18/2015,3/31/2015,3/31/2015,1/11/2017,3/1/2017,3/1/2017,8/11/2017,2/6/2018,2/6/2018,7/10/2019,3/23/2020,3/23/2020
94,5124,6/15/1959,Male,184,86,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"80,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,V-X,KYP-X,V-X,2/23/2015,5/17/2015,5/17/2015,5/18/2015,11/1/2015,11/1/2015,3/27/2017,7/30/2017,7/30/2017,12/6/2018,12/1/2019,12/1/2019
95,7182,6/15/1952,Male,176,103,Private,Unknown, ,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"25,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,R-X,POM-X,V-X,2/22/2010,6/17/2010,6/17/2010,5/28/2012,10/8/2012,10/8/2012,4/25/2014,5/23/2015,5/23/2015,9/19/2015,4/2/2016,4/2/2016
96,9557,6/15/1939,Male,179,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"62,4",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,V-X,V-X,Other,7/13/2009,9/10/2010,9/10/2010,8/8/2011,1/17/2012,1/17/2012,5/6/2013,11/15/2013,11/15/2013,5/18/2015,9/25/2015,9/25/2015
97,9104,6/15/1941,Male,177,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"70,3",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,LEV-X,No CTx,R-X,2/23/2015,5/17/2015,5/17/2015,5/18/2015,9/20/2015,9/20/2015,4/11/2016,9/25/2016,9/25/2016, , , 
98,7541,6/15/1972,Male,170,64,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"4,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,7/15/2013,9/15/2013,9/15/2013,2/24/2015,5/17/2015,5/17/2015, , , , , , 
99,3779,6/15/1957,Female,156,67,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/6/2015,5/5/2015,5/5/2015, , , , , , , , , 
100,3803,6/15/1938,Male,178,81,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"17,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,R-X,No CTx,V-X,3/6/2015,5/19/2015,5/19/2015,3/8/2016,5/19/2016,5/19/2016,5/17/2017,11/29/2017,11/29/2017, , , 
101,3080,6/15/1942,Male,176,70,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,55,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/15/2013,9/6/2014,9/6/2014,4/10/2015,6/30/2016,10/14/1582, , , , , , 
102,4914,6/15/1947,Female,167,73,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"61,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/20/2015,10/16/2015,10/16/2015, , , , , , , , , 
103,7965,6/15/1931,Male,183,88,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,78,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,Other,No CTx,No CTx,Other,2/23/2015,10/19/2015,10/19/2015,11/16/2015,4/14/2016,4/14/2016, , , , , , 
104,2968,6/15/1940,Male,181,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,53,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,11/24/2014,4/16/2015,4/16/2015,4/20/2015,3/29/2016,3/29/2016, , , , , , 
105,5431,6/15/1940,Male,177,67,Compulsory health insurance CHI,Yes, , ,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"53,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,POM-X,V-X,5/23/2011,4/27/2012,4/27/2012,1/6/2014,6/26/2014,6/26/2014,2/24/2015,5/19/2015,5/19/2015,5/23/2015,9/18/2015,9/18/2015
106,1459,6/15/1951,Male,180,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,613,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,DAR-X,KYP-X,No CTx, , , ,12/30/2015,11/15/2016,11/15/2016,11/24/2016,8/15/2017,8/15/2017,9/26/2017,11/28/2018,11/28/2018
107,8383,6/15/1955,Male,185,83,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"6,3",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,V-X,No CTx,V-X,3/16/2015,5/19/2015,5/19/2015,2/27/2018,6/20/2018,6/20/2018,11/7/2018,11/30/2018,11/30/2018, , , 
108,3958,6/15/1949,Male,176,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,7",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,1/19/2015,3/23/2015,3/23/2015,10/25/2016,3/15/2017,3/15/2017,12/5/2017,5/15/2018,5/15/2018,9/25/2018,9/30/2019,10/14/1582
109,3570,6/15/1938,Male,175,66,Private,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"59,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,KYP-X,No CTx,LEV-X,1/2/2013,6/18/2013,6/18/2013,3/30/2015,12/11/2015,12/11/2015,8/18/2016,9/30/2016,10/14/1582, , , 
110,3682,6/15/1956,Male,183,88,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,56,unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,10/13/2013,9/20/2014,9/20/2014,3/9/2015,6/30/2016,10/14/1582, , , , , , 
111,2527,6/15/1942,Female,167,74,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,23,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,7/17/2014,4/28/2015,4/28/2015,4/30/2015,6/30/2016, , , , , , , 
112,4356,6/15/1936,Male,193,93,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,V-X,R-X,V-X,2/1/2009,3/1/2009,3/1/2009,3/14/2013,3/17/2013,3/17/2013,10/17/2013,11/25/2013,11/25/2013,9/22/2014,3/29/2015,3/29/2015
113,5496,6/15/1959,Male,174,78,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,36,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/17/2015,12/31/2015,10/14/1582, , , , , , , , , 
114,2961,6/15/1961,Female,181,80,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,22,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/5/2015,6/16/2015,6/16/2015, , , , , , , , , 
115,8554,6/15/1943,Male,175,96,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,No CTx,Other,9/26/2013,4/5/2014,4/5/2014,6/8/2015,1/31/2017,1/31/2017,11/19/2018,12/31/2018, , , , 
116,2664,6/15/1925,Female,152,78,Compulsory health insurance CHI,No, , , , , , , , ,Yes,Yes,2,III: one or more criteria are fulfilled,IgG,"6,9",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,V-X,V-X,No CTx,V-X,2/15/2013,5/15/2013,5/15/2013,5/15/2015,10/2/2015,10/2/2015,6/7/2017,6/30/2017, , , , 
117,5120,6/15/1960,Female,174,80,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,Other type,"9,2",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/27/2015,8/24/2015,8/24/2015, , , , , , , , , 
118,5749,6/15/1950,Female,168,53,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"99,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/30/2015,4/15/2015,4/15/2015, , , , , , , , , 
119,6416,6/15/1952,Male,172,87,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/12/2014,11/7/2014,11/7/2014,9/29/2016,12/31/2017, , , , , , , 
120,7373,6/15/1935,Male,175,85,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"56,6",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,2/13/2015,3/24/2016,3/24/2016, , , , , , , , , 
121,7303,6/15/1935,Female,160,70,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"14,08",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/13/2015,4/29/2015,4/29/2015,1/25/2016,7/10/2016,7/10/2016, , , , , , 
122,7961,6/15/1930,Male,170,55,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"29,8",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/17/2015,4/22/2015,4/22/2015, , , , , , , , , 
123,7462,6/15/1939,Female,164,52,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"43,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/19/2015,6/19/2015,6/19/2015, , , , , , , , , 
124,8532,6/15/1940,Female,170,69,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"41,3",ISS stage II (neither stage I nor stage III),No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,Other,Other,R-X,V-X,8/27/2014,11/28/2014,11/28/2014,2/4/2015,10/10/2015,10/10/2015,3/9/2016,6/29/2016,6/29/2016,9/21/2016,12/15/2016,12/15/2016
125,3757,6/15/1962,Female,157,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"1,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,R-X,KYP-X,V-X,5/21/2013,8/2/2013,8/2/2013,6/2/2015,12/22/2015,12/22/2015,2/16/2016,5/7/2016,5/7/2016,8/31/2016,11/16/2016,11/16/2016
126,1952,6/15/1942,Female,166,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"63,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,Other,DAR-X,V-X,3/27/2013,10/15/2013,10/15/2013,2/17/2015,2/18/2015,2/18/2015,9/30/2015,1/28/2016,1/28/2016,9/29/2016,10/12/2017,10/12/2017
127,4414,6/15/1955,Male,176,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"63,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,3/30/2015,10/9/2015,10/9/2015,8/23/2016,9/30/2016,10/14/1582, , , , , , 
128,1661,6/15/1949,Female,158,82,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,DAR-X,No CTx,V-X,3/15/2015,9/15/2015,9/15/2015,4/15/2016,9/15/2017,9/15/2017,9/25/2017,11/28/2017,11/28/2017, , , 
129,1475,6/15/1956,Female,157,62,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,55,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,R-X,No CTx,Other,11/15/2012,6/15/2014,6/15/2014,4/15/2015,8/15/2015,8/15/2015,9/8/2015,7/18/2016,7/18/2016, , , 
130,2201,6/15/1941,Male,173,70,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"10,44",ISS stage II (neither stage I nor stage III), , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,No CTx,V-X,8/6/2012,12/3/2012,12/3/2012,10/22/2013,7/21/2014,7/21/2014,8/13/2015,6/30/2016, , , , 
131,5004,6/15/1935,Male,160,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"2,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/2/2015,4/7/2015,4/7/2015, , , , , , , , , 
132,9469,6/15/1952,Female,168,65,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"20,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
133,2314,6/15/1946,Male,179,88,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,33,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,1/15/2015,9/15/2015,9/15/2015,11/19/2015,7/15/2016,7/15/2016, , , , , , 
134,3388,6/15/1962,Male,182,74,Private,Unknown, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"33,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,4/1/2015,6/2/2015,6/2/2015, , , , , , , , , 
135,6846,6/15/1945,Male,167,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,LEV-X,V-X,5/1/2007,9/1/2007,9/1/2007,12/15/2008,2/17/2011,2/17/2011,3/17/2011,4/24/2012,4/24/2012,5/3/2012,11/14/2013,11/14/2013
136,2774,6/15/1953,Female,166,81,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"36,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,V-X,V-X,9/22/2014,11/6/2014,11/6/2014, , , , , , ,11/24/2016,12/15/2016,12/15/2016
137,9828,6/15/1943,Female,163,97,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,29,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/6/2015,12/30/2015,12/30/2015, , , , , , , , , 
138,9738,6/15/1942,Female,168,76,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"59,5",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,LEV-X,R-X,V-X,7/5/2012,11/29/2012,11/29/2012,5/27/2014,9/10/2014,9/10/2014,6/29/2015,7/28/2015,7/28/2015,11/13/2015,3/21/2017,3/21/2017
139,2992,6/15/1939,Male,175,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,91",ISS stage II (neither stage I nor stage III), , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,KYP-X,DAR-X,Other,7/1/2010,11/1/2010,11/1/2010,2/20/2012,5/7/2015,5/7/2015,4/7/2016,8/20/2016,8/20/2016,12/15/2016,2/9/2017,2/9/2017
140,4911,6/15/1950,Male,172,65,Compulsory health insurance CHI,No,Yes, , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,120,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/15/2015,8/15/2015,8/15/2015,9/21/2015,5/23/2016,5/23/2016, , , , , , 
141,2825,6/15/1947,Female,170,89,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,KYP-X,No CTx,V-X,3/30/2015,6/15/2015,6/15/2015, , , ,4/10/2018,3/31/2022, , , , 
142,5658,6/15/1939,Male,172,93,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgD,"9,9",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,11/15/2013,1/15/2015,1/15/2015,1/25/2016,1/15/2017,1/15/2017, , , , , , 
143,2127,6/15/1935,Female,173,81,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,No CTx,V-X,9/15/2012,2/15/2013,2/15/2013,11/27/2014,4/17/2015,4/17/2015,4/30/2015,8/15/2016,8/15/2016, , , 
144,2115,6/15/1948,Male,999,80,Private,No, , , , , , , , , , ,9,Unknown,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,No CTx,V-X,7/15/2012,9/15/2012,9/15/2012,5/15/2014,10/15/2014,10/15/2014,1/15/2015,11/30/2015,11/30/2015, , , 
145,2830,6/15/1936,Female,154,57,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,3/15/2015,1/11/2016,1/11/2016, , , , , , , , , 
146,3534,6/15/1952,Female,158,89,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,KYP-X,No CTx,V-X,3/15/2015,6/15/2015,6/15/2015, , , ,11/16/2020,3/31/2022,10/14/1582, , , 
147,2204,6/15/1936,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,R-X,No CTx, , , ,6/15/2015,4/15/2016,4/15/2016,9/23/2016,3/15/2017,3/15/2017,3/15/2017,4/17/2017,4/17/2017
148,2893,6/15/1938,Male,168,75,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgA,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,R-X,V-X,V-X,3/17/2014,1/15/2015,1/15/2015,6/15/2015,3/14/2016,3/14/2016,3/15/2016,6/15/2016,6/15/2016,9/8/2016,11/15/2016,11/15/2016
149,4400,6/15/1950,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,Other,No CTx,No CTx,No CTx, , , ,1/15/2015,9/15/2015,9/15/2015, , , , , , 
150,5379,6/15/1939,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,6/23/2014,3/30/2015,3/30/2015,8/17/2016,1/15/2017,1/15/2017, , , , , , 
151,5283,6/15/1934,Male,180,90,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,3/15/2015,10/15/2015,10/15/2015, , , , , , , , , 
152,3733,6/15/1945,Male,172,87,Compulsory health insurance CHI,No, , , , ,Yes, , , , ,Yes,9,Unknown,IgG,"30,13",unknown/ISS-Criteria not used for prognostics, , , , ,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,V-X,V-X,7/15/2014,3/30/2015,3/30/2015,8/15/2015,11/18/2015,11/18/2015, , , ,9/19/2016,12/15/2016,12/15/2016
153,6578,6/15/1931,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,POM-X,No CTx,V-X,6/15/2014,3/11/2015,3/11/2015,11/2/2015,3/15/2016,3/15/2016,3/16/2016,7/25/2016,7/25/2016, , , 
154,4860,6/15/1943,Male,173,62,Private,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,3/20/2015,10/15/2015,10/15/2015, , , , , , , , , 
155,4815,6/15/1950,Male,180,80,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgD,"10,9",ISS stage II (neither stage I nor stage III), , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,2/15/2015,1/15/2016,1/15/2016, , , , , , , , , 
156,7897,6/15/1936,Female,160,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"36,6",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,3/30/2015,9/29/2015,9/29/2015,11/26/2015,11/15/2017,11/15/2017, , , , , , 
157,6913,6/15/1955,Male,182,82,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,R-X,3/15/2015,9/25/2015,9/25/2015, , , , , , , , , 
158,5220,6/15/1936,Female,167,70,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,V-X,No CTx,No CTx,R-X,1/15/2015,11/15/2015,11/15/2015,2/24/2016,7/15/2016,7/15/2016, , , , , , 
159,3322,6/15/1951,Female,169,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/15/2015,5/15/2015,5/15/2015, , , , , , , , , 
160,3686,6/15/1935,Male,180,80,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,Other,1/1/2015,11/1/2015,11/1/2015, , , , , , , , , 
161,6385,6/15/1940,Female,169,58,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,51,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,2/15/2015,10/14/2015,10/14/2015,2/27/2017,9/14/2017,9/14/2017, , , , , , 
162,2255,6/15/1951,Male,182,91,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,KYP-X,DAR-X,LEV-X,1/8/2015,10/6/2015,10/6/2015,8/30/2016,1/13/2017,1/13/2017,2/2/2017,8/22/2017,8/22/2017,9/7/2017,2/6/2018,2/6/2018
163,3823,6/15/1948,Female,164,72,Private,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"5,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,2/17/2015,6/16/2015,6/16/2015,8/23/2016,11/29/2016,11/29/2016,12/7/2016,12/21/2016,12/21/2016, , , 
164,2083,6/15/1941,Female,174,63,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,FAR-X,DAR-X,V-X,10/27/2014,2/23/2015,2/23/2015,8/16/2016,11/22/2016,11/22/2016,12/8/2016,3/17/2017,3/17/2017,3/28/2017,8/28/2017,8/28/2017
165,5462,6/15/1942,Male,180,82,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,9/8/2014,3/23/2015,3/23/2015, , , , , , , , , 
166,9859,6/15/1940,Male,171,74,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"7,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,1/12/2015,5/11/2015,5/11/2015,5/26/2015,2/24/2016,2/24/2016, , , , , , 
167,4130,6/15/1939,Male,176,74,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"5,86","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,LEV-X,2/23/2015,8/31/2015,8/31/2015,9/15/2015,7/11/2016,7/11/2016, , , , , , 
168,3486,6/15/1942,Female,163,69,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,Other,V-X,LEV-X,10/22/2014,3/19/2015,3/19/2015,8/22/2016,2/17/2017,2/17/2017,2/27/2017,6/1/2017,6/1/2017,6/15/2017,8/31/2017,8/31/2017
169,7574,6/15/1954,Male,181,59,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"9,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,Other,Other,LEV-X,1/13/2015,9/16/2015,9/16/2015,5/10/2016,1/6/2017,1/6/2017,1/26/2017,4/17/2017,4/17/2017,5/3/2017,6/22/2017,6/22/2017
170,3516,6/15/1951,Female,166,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"6,4",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,2/25/2015,6/24/2015,6/24/2015,4/19/2016,9/27/2016,9/27/2016,10/10/2016,2/21/2017,2/21/2017,3/3/2017,7/12/2017,7/12/2017
171,4552,6/15/1947,Female,170,69,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,LEV-X,1/5/2015,1/18/2016,1/18/2016,8/8/2016,12/7/2016,12/7/2016,1/4/2017,2/6/2017,2/6/2017, , , 
172,1754,6/15/1938,Female,171,69,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,31,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,R-X,Other,V-X,10/15/2012,8/15/2013,8/15/2013,4/15/2015,9/8/2015,9/8/2015,10/7/2015,8/10/2016,8/10/2016,5/11/2017,9/22/2017,9/22/2017
173,6056,6/15/1958,Male,179,88,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,36,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,LEV-X,No CTx,V-X,9/15/2009,12/15/2009,12/15/2009,8/15/2014,5/15/2015,5/15/2015,5/11/2015,11/9/2015,11/9/2015, , , 
174,6177,6/15/1927,Female,165,59,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,V-X,No CTx,Other,2/2/2012,1/5/2013,1/5/2013,2/28/2015,10/1/2015,10/1/2015,11/29/2016,5/7/2017,5/7/2017, , , 
175,8219,6/15/1949,Female,160,67,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,V-X,5/1/2013,9/1/2013,9/1/2013,3/1/2015,7/1/2015,7/1/2015, , , , , , 
176,9159,6/15/1942,Male,175,72,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,52,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,4/25/2014,6/14/2014,6/14/2014,5/14/2015,6/22/2016,6/22/2016, , , , , , 
177,6363,6/15/1951,Male,175,61,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,1/19/2015,4/6/2015,4/6/2015,10/19/2015,9/8/2016,9/8/2016,9/26/2016,1/20/2017,1/20/2017,2/7/2017,6/19/2017,6/19/2017
178,8281,6/15/1944,Female,168,54,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,7",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,V-X,LEV-X,2/19/2015,8/17/2015,8/17/2015,4/20/2016,4/27/2017,4/27/2017,5/15/2017,12/14/2017,12/14/2017,1/3/2018,4/10/2018,4/10/2018
179,9792,6/15/1940,Male,179,100,Private,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,R-X,R-X,V-X,3/23/2013,1/29/2014,1/29/2014,10/29/2015,7/19/2016,7/19/2016,7/23/2016,3/16/2017,3/16/2017,3/31/2017,7/25/2017,7/25/2017
180,5382,6/15/1940,Male,181,80,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"28,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,R-X,NIN-X,V-X,3/13/2015,7/31/2015,7/31/2015,7/29/2016,1/20/2017,1/20/2017,9/27/2017,5/23/2019,5/23/2019,8/14/2019,12/31/2019, 
181,1051,6/15/1970,Female,168,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"21,3",unknown/ISS-Criteria not used for prognostics,Yes,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,2/19/2015,5/4/2015,5/4/2015, , , , , , , , , 
182,8030,6/15/1939,Female,161,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"8,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,POM-X,LEV-X,2/26/2015,8/31/2015,8/31/2015,9/15/2015,12/28/2016,12/28/2016,1/17/2017,8/14/2017,8/14/2017,9/4/2017,11/6/2017,11/6/2017
183,9536,6/15/1951,Male,999,80,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,9",ISS stage II (neither stage I nor stage III), , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,KYP-X,Other,2/8/2005,4/13/2005,4/13/2005,6/6/2006,11/14/2006,11/14/2006,3/2/2015,11/30/2015,11/30/2015,9/5/2016,4/4/2017,4/4/2017
184,6339,6/15/1962,Male,186,80,Private,No, , , , ,Yes,Yes, , ,Yes, ,0,III: one or more criteria are fulfilled,IgG,11,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/1/2015,7/1/2015,7/1/2015,6/1/2018,3/31/2019,10/14/1582, , , , , , 
185,2051,6/15/1935,Male,178,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,Other,2/1/2015,11/1/2015,11/1/2015,11/1/2015,12/31/2017, , , , , , , 
186,3920,6/15/1929,Female,165,77,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,Unknown,IgG,8,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,V-X,DAR-X,V-X,10/23/2012,11/9/2013,11/9/2013,2/15/2015,10/23/2015,10/23/2015,6/25/2017,1/25/2018,1/25/2018,6/13/2018,9/25/2018,9/25/2018
187,9092,6/15/1933,Male,178,71,Compulsory health insurance CHI,No,Yes, , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,44,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,R-X,Other,Other,1/15/2012,9/15/2012,9/15/2012,3/15/2015,7/15/2015,7/15/2015,11/15/2015,7/7/2016,7/7/2016,9/10/2016,12/22/2016,12/22/2016
188,3436,6/15/1940,Male,173,79,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,R-X,FAR-X,V-X,11/2/2012,10/2/2013,10/2/2013,5/23/2014,3/20/2015,3/20/2015,10/29/2015,7/18/2016,7/18/2016,6/15/2017,8/8/2017,8/8/2017
189,6509,6/15/1929,Female,165,59,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,9,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,Other,Other,Other,V-X,10/23/2010,8/19/2011,8/19/2011,12/23/2012,11/2/2013,11/2/2013,10/19/2015,6/4/2016,6/4/2016,6/2/2017,11/22/2017,11/22/2017
190,3704,6/15/1940,Male,184,85,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"35,7",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,Other,R-X,R-X,V-X,3/18/2014,4/25/2014,4/25/2014,1/27/2015,4/28/2015,4/28/2015,12/2/2015,7/5/2016,7/5/2016,9/20/2016,8/14/2019,8/14/2019
191,8382,6/15/1947,Female,158,56,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,39,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,V-X,V-X,Other,11/15/2001,6/15/2002,6/15/2002,10/15/2002,12/15/2002,12/15/2002,12/15/2013,4/15/2014,4/15/2014,5/27/2015,8/18/2015,8/18/2015
192,8018,6/15/1954,Male,160,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,50,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,POM-X,No CTx,R-X,4/20/2014,5/15/2015,5/15/2015,6/10/2015,5/20/2016,5/20/2016,6/2/2016,6/30/2016, , , , 
193,1916,6/15/1942,Female,154,72,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,Other,V-X,V-X,1/13/2015,5/12/2015,5/12/2015,4/11/2016,12/21/2016,12/21/2016,1/5/2017,3/14/2017,3/14/2017,3/23/2017,7/14/2017,7/14/2017
194,4474,6/15/1946,Female,165,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"5,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,FAR-X,NIN-X,V-X,11/16/2014,2/2/2015,2/2/2015,9/5/2016,9/18/2016,9/18/2016,9/20/2016,9/11/2017,9/11/2017,9/25/2017,5/10/2018,5/10/2018
195,2110,6/15/1944,Male,183,104,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"7,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,FAR-X,LEV-X,1/4/2015,9/7/2015,9/7/2015,4/6/2016,12/13/2016,12/13/2016,1/6/2017,8/16/2017,8/16/2017,8/24/2017,5/31/2018,5/31/2018
196,3262,6/15/1941,Female,168,61,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,EMP-X,V-X,10/20/2014,2/16/2015,2/16/2015,5/16/2016,12/21/2016,12/21/2016,1/4/2017,7/18/2017,7/18/2017,8/1/2017,8/28/2017,8/28/2017
197,3804,6/15/1939,Female,163,52,Private,No, , ,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,NIN-X,LEV-X,3/23/2015,9/21/2015,9/21/2015,5/2/2016,9/12/2016,9/12/2016,9/26/2016,5/5/2017,5/5/2017,5/25/2017,12/6/2017,12/6/2017
198,5679,6/15/1947,Male,182,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,No CTx,LEV-X,1/12/2015,9/22/2015,9/22/2015,9/6/2016,3/8/2018,3/8/2018,3/22/2018,7/11/2018,7/11/2018, , , 
199,9538,6/15/1941,Female,173,71,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,10/6/2014,2/2/2015,2/2/2015,4/8/2016,9/19/2017,9/19/2017,9/28/2017,6/6/2018,6/6/2018,6/29/2018,1/17/2019,1/17/2019
200,9328,6/15/1947,Male,183,85,Private,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,591,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,1/27/2015,4/14/2015,4/14/2015,3/15/2016,7/19/2016,7/19/2016,8/3/2016,10/27/2016,10/27/2016, , , 
201,3289,6/15/1938,Male,184,74,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"6,95","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,No CTx,LEV-X,3/17/2015,9/15/2015,9/15/2015,4/5/2016,12/16/2016,12/16/2016,1/6/2017,1/9/2017,1/9/2017, , , 
202,6633,6/15/1941,Male,189,114,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,584,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,FAR-X,DAR-X,V-X,11/25/2014,3/24/2015,3/24/2015,4/28/2016,8/17/2016,8/17/2016,8/30/2016,12/27/2016,12/27/2016,1/16/2017,5/30/2017,5/30/2017
203,2715,6/15/1935,Male,181,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"4,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,1/27/2015,9/23/2015,9/23/2015, , , , , , , , , 
204,3357,6/15/1933,Male,178,84,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,Other,LEV-X,12/1/2014,5/13/2015,5/13/2015,5/16/2016,1/18/2018,1/18/2018,2/5/2018,2/6/2019,2/6/2019,3/4/2019,10/21/2020,10/21/2020
205,6648,6/15/1947,Male,175,81,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"5,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,Other,LEV-X,1/6/2015,8/18/2015,8/18/2015,7/6/2016,12/12/2016,12/12/2016,12/29/2016,8/14/2017,8/14/2017,8/24/2017,9/22/2017,9/22/2017
206,9208,6/15/1939,Female,164,57,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,Other,KYP-X,LEV-X,1/14/2015,10/20/2015,10/20/2015,11/2/2015,4/18/2016,4/18/2016,12/6/2016,2/16/2017,2/16/2017,3/14/2017,8/28/2017,8/28/2017
207,3198,6/15/1944,Male,172,68,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,4",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/17/2015,7/14/2015,7/14/2015, , , , , , , , , 
208,4951,6/15/1939,Male,170,80,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,11,ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/20/2015,6/30/2015, , , , , , , , , , 
209,8664,6/15/1939,Female,158,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,90,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,2/15/2015,10/15/2015,10/15/2015,11/15/2015,6/6/2016,6/6/2016, , , , , , 
210,9820,6/15/1939,Male,170,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,3/15/2015,11/15/2015,11/15/2015,11/15/2015,6/30/2016,6/30/2016, , , , , , 
211,7937,6/15/1937,Male,168,72,Private,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,180,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,DAR-X,No CTx,R-X,3/15/2015,10/15/2015,10/15/2015,10/15/2015,6/27/2016,6/27/2016,2/13/2017,8/29/2017,8/29/2017, , , 
212,5753,6/15/1938,Male,180,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,115,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,3/15/2015,11/20/2015,11/20/2015,12/1/2015,6/22/2016,6/22/2016, , , , , , 
213,6451,6/15/1956,Male,185,89,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,8,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,Other,V-X,Other,5/25/2014,9/21/2014,9/21/2014,6/9/2015,8/12/2015,8/12/2015,10/19/2015,7/15/2016,7/15/2016,6/11/2017,9/12/2017,9/12/2017
214,7065,6/15/1934,Male,169,71,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,235,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie, , , , , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,5/15/2015,9/15/2015,9/15/2015,9/15/2015,4/20/2016,4/20/2016, , , , , , 
215,2682,6/15/1935,Male,185,90,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,21,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,DAR-X,V-X,3/15/2011,1/15/2012,1/15/2012,2/15/2015,7/15/2015,7/15/2015,5/15/2016,4/15/2017,4/15/2017,5/15/2017,1/15/2018,1/15/2018
216,5700,6/15/1942,Female,172,69,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,KYP-X,KYP-X,V-X,11/15/2013,6/15/2014,6/15/2014,5/15/2015,11/15/2015,11/15/2015,1/10/2016,11/15/2016,11/15/2016,8/15/2017,9/15/2018,9/15/2018
217,8939,6/15/1939,Male,186,89,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,34,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,9/15/2010,11/15/2010,11/15/2010,3/15/2015,1/15/2016,1/15/2016,3/15/2016,9/15/2016,9/15/2016,11/15/2016,5/15/2017,5/15/2017
218,3731,6/15/1957,Female,172,74,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,7,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,Other,No CTx,Other,6/23/2012,6/25/2013,6/25/2013,2/23/2015,8/29/2015,8/29/2015,10/29/2015,7/27/2016,7/27/2016, , , 
219,1561,6/15/1939,Female,158,52,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , ,Unknown,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/15/2014,10/15/2014,10/15/2014,1/15/2015,6/29/2016,6/29/2016, , , , , , 
220,1549,6/15/1940,Male,172,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,92,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/15/2014,5/15/2014,5/15/2014,1/15/2015,2/13/2016,2/13/2016, , , , , , 
221,9345,6/15/1938,Male,175,85,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes,Unknown,1,III: one or more criteria are fulfilled,IgG,160,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,10/15/2013,4/15/2014,4/15/2014,1/15/2015,8/15/2015,8/15/2015,10/15/2015,5/19/2016,5/19/2016,12/12/2016,7/19/2017,7/19/2017
222,4428,6/15/1969,Male,188,80,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"4,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,V-X,No CTx,V-X,2/10/2014,5/15/2014,5/15/2014,5/11/2015,10/27/2015,10/27/2015,9/20/2017,12/13/2017,12/13/2017, , , 
223,1375,6/15/1950,Male,167,69,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,8,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,Other,Other,LEV-X,7/23/2013,11/29/2013,11/29/2013,2/14/2015,9/23/2015,9/23/2015,10/24/2015,7/28/2016,7/28/2016,5/26/2017,9/24/2017,9/24/2017
224,9224,6/15/1953,Male,171,76,Private,No, ,Yes, , ,Yes, ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,8,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,FAR-X,V-X,V-X,6/21/2014,12/19/2014,12/19/2014,7/12/2015,5/23/2016,5/23/2016,6/29/2017,12/18/2017,12/18/2017,2/26/2018,5/25/2018,5/25/2018
225,7382,6/15/1940,Female,174,84,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,33,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,V-X,No CTx,Other,2/28/2014,4/13/2015,4/13/2015,4/25/2015,11/20/2015,11/20/2015,11/20/2015,6/30/2016, , , , 
226,7569,6/15/1939,Female,164,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,4",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,Other,5/1/2010,7/1/2011,7/1/2011,2/23/2015,5/15/2016,5/15/2016, , , , , , 
227,8226,6/15/1966,Male,183,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,03","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,V-X,DAR-X,V-X,9/5/2013,12/15/2013,12/15/2013,4/9/2015,11/30/2015,11/30/2015,6/9/2016,9/1/2016,9/1/2016,9/5/2017,6/30/2019,10/14/1582
228,8028,6/15/1933,Female,155,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,133,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/15/2015,6/20/2016,6/20/2016, , , , , , , , , 
229,2740,6/15/1960,Male,186,85,Private,Yes, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,2",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,10/1/2011,12/1/2011,12/1/2011,4/27/2015,6/30/2017, , , , , , , 
230,5566,6/15/1949,Male,182,79,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"28,7",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,2/15/2015,10/15/2015,10/15/2015,7/1/2017,10/1/2017,10/1/2017, , , , , , 
231,6287,6/15/1937,Male,172,69,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"19,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/15/2015,2/15/2016,2/15/2016,10/1/2017,3/31/2019, , , , , , , 
232,9934,6/15/1940,Female,168,59,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,36,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,8/1/2013,5/1/2014,5/1/2014,2/1/2015,9/1/2015,9/1/2015,12/1/2015,12/31/2017, , , , 
233,9764,6/15/1940,Male,180,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"58,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,4/26/2011,10/9/2011,10/9/2011,6/1/2015,11/15/2015,11/15/2015, , , , , , 
234,6020,6/15/1939,Female,167,61,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"18,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,1/14/2013,6/30/2013,6/30/2013,2/16/2015,8/9/2015,8/9/2015,6/27/2016,12/18/2016,12/18/2016, , , 
235,6269,6/15/1946,Male,179,83,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"64,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,LEV-X,No CTx,V-X,7/15/2013,10/6/2013,10/6/2013,6/15/2015,10/4/2015,10/4/2015,5/11/2016,10/30/2016,10/30/2016, , , 
236,2888,6/15/1942,Female,166,60,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"64,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,FAR-X,V-X,1/3/2011,3/27/2011,3/27/2011,1/7/2014,12/29/2014,12/29/2014,1/5/2015,3/29/2015,3/29/2015,11/16/2015,3/6/2016,3/6/2016
237,5355,6/15/1939,Female,162,63,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"72,4",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,No CTx,LEV-X,7/1/2013,12/15/2013,12/15/2013,6/15/2015,10/18/2015,10/18/2015,4/11/2016,10/9/2016,10/9/2016, , , 
238,3650,6/15/1942,Female,171,68,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"44,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,LEV-X,LEV-X,5/29/2012,11/11/2012,11/11/2012,4/20/2015,10/13/2015,10/13/2015,9/19/2016,3/12/2017,3/12/2017,3/5/2018,9/2/2018,9/2/2018
239,9376,6/15/1940,Male,182,80,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"39,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,LEV-X,LEV-X,V-X,2/18/2013,6/23/2013,6/23/2013,6/22/2015,10/25/2015,10/25/2015,6/20/2016,12/11/2016,12/11/2016,2/26/2018,8/19/2018,8/19/2018
240,2624,6/15/1939,Female,159,64,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"46,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,LEV-X,LEV-X,LEV-X,5/25/2009,11/8/2009,11/8/2009,8/13/2012,11/4/2012,11/4/2012,2/23/2015,8/9/2015,8/9/2015,9/26/2016,3/19/2017,3/19/2017
241,5112,6/15/1937,Male,175,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"73,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,6/27/2011,12/18/2011,12/18/2011,2/23/2015,8/9/2015,8/9/2015,4/25/2016,10/16/2016,10/16/2016, , , 
242,7503,6/15/1944,Male,171,69,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"59,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,LEV-X,No CTx,V-X,7/9/2012,11/11/2012,11/11/2012,4/27/2015,9/6/2015,9/6/2015,6/27/2016,12/11/2016,12/11/2016, , , 
243,2617,6/15/1946,Male,180,86,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"22,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,2/21/2013,5/15/2013,5/15/2013,6/29/2015,10/18/2015,10/18/2015, , , , , , 
244,1322,6/15/1937,Female,162,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"73,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,LEV-X,LEV-X,8/1/2008,2/1/2009,2/1/2009,7/2/2012,12/16/2012,12/16/2012,2/23/2015,8/16/2015,8/16/2015,5/2/2016,10/23/2016,10/23/2016
245,4096,6/15/1940,Male,177,75,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"53,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,No CTx,Other,1/27/2014,3/22/2015,3/22/2015,4/7/2015,10/6/2015,10/6/2015,3/27/2017,9/17/2017,9/17/2017, , , 
246,6229,6/15/1951,Male,182,88,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"59,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,V-X,V-X,V-X,7/12/2012,10/3/2012,10/3/2012,4/20/2015,8/23/2015,8/23/2015,3/6/2017,7/2/2017,7/2/2017,3/4/2019,5/26/2019,5/26/2019
247,5602,6/15/1943,Male,172,76,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"34,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,R-X,KYP-X,V-X,3/25/2013,7/28/2013,7/28/2013,2/17/2015,8/2/2015,8/2/2015,5/23/2016,2/28/2017,2/28/2017,3/6/2017,10/15/2017,10/15/2017
248,9370,6/15/1941,Female,169,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"55,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,LEV-X,LEV-X,9/12/2011,3/4/2012,3/4/2012,4/7/2015,10/4/2015,10/4/2015,4/18/2016,10/9/2016,10/9/2016,11/6/2017,4/29/2018,4/29/2018
249,9391,6/15/1942,Male,184,73,Private,No, ,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"7,61","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,2/18/2015,6/17/2015,6/17/2015,9/20/2016,9/20/2016,9/20/2016,10/10/2016,2/14/2017,2/14/2017,2/23/2017,8/7/2017,8/7/2017
250,2698,6/15/1943,Male,180,73,Compulsory health insurance CHI,No,Yes, , ,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,3",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,2/2/2015,6/1/2015,6/1/2015,12/2/2015,6/20/2016,6/20/2016,7/18/2016,10/20/2016,10/20/2016, , , 
251,1408,6/15/1945,Female,172,64,Private,No, ,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,DAR-X,FAR-X,V-X,11/18/2013,3/17/2014,3/17/2014,2/9/2015,4/18/2016,4/18/2016,7/19/2016,9/13/2016,9/13/2016,9/26/2016,3/8/2017,3/8/2017
252,4182,6/15/1950,Male,184,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"7,1",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,8/26/2013,12/23/2013,12/23/2013,3/25/2015,12/10/2015,12/10/2015,1/25/2016,9/23/2016,9/23/2016, , , 
253,3081,6/15/1941,Male,174,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,7",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,4/22/2013,7/15/2013,7/15/2013,5/26/2015,12/14/2015,12/14/2015,2/8/2016,9/21/2016,9/21/2016,10/4/2016,12/22/2016,12/22/2016
254,1114,6/15/1943,Female,167,65,Private,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,11",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,FAR-X,DAR-X,V-X,5/6/2013,9/2/2013,9/2/2013,6/8/2015,6/27/2016,6/27/2016,7/11/2016,2/1/2017,2/1/2017,2/14/2017,6/22/2017,6/22/2017
255,4054,6/15/1943,Female,171,64,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,22",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,Other,V-X,2/11/2013,6/10/2013,6/10/2013,4/27/2015,11/19/2015,11/19/2015,1/18/2016,12/27/2016,12/27/2016,1/13/2017,3/9/2017,3/9/2017
256,5788,6/15/1941,Male,186,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"4,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,5/13/2013,7/29/2013,7/29/2013,6/17/2015,4/8/2016,4/8/2016,5/9/2016,9/23/2016,9/23/2016,10/12/2016,3/15/2017,3/15/2017
257,7148,6/15/1940,Male,180,63,Private,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"5,62",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,POM-X,V-X,6/12/2013,8/28/2013,8/28/2013,4/2/2015,6/20/2016,6/20/2016,9/12/2016,12/6/2016,12/6/2016,12/14/2016,2/21/2017,2/21/2017
258,2415,6/15/1943,Female,164,57,Private,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,4",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,POM-X,V-X,4/10/2012,6/26/2012,6/26/2012,3/11/2014,6/24/2014,6/24/2014,1/20/2015,1/11/2016,1/11/2016,8/30/2016,12/9/2016,12/9/2016
259,7935,6/15/1946,Female,171,61,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,7/16/2013,11/12/2013,11/12/2013,2/26/2015,1/15/2016,1/15/2016,2/10/2016,9/14/2016,9/14/2016,10/6/2016,2/20/2017,2/20/2017
260,9900,6/15/1940,Male,182,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"4,96",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,3/17/2014,7/14/2014,7/14/2014,5/25/2015,3/25/2016,3/25/2016,4/6/2016,12/13/2016,12/13/2016, , , 
261,4729,6/15/1940,Male,181,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,9/23/2013,1/27/2014,1/27/2014,8/6/2015,6/10/2016,6/10/2016,7/12/2016,12/16/2016,12/16/2016,12/27/2016,6/8/2017,6/8/2017
262,4436,6/15/1940,Female,168,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,49",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,2/10/2014,6/9/2014,6/9/2014,4/20/2015,12/17/2015,12/17/2015,1/19/2016,9/19/2016,9/19/2016,10/4/2016,2/13/2017,2/13/2017
263,4548,6/15/1945,Male,175,68,Private,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,85",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,POM-X,V-X,5/28/2012,8/13/2012,8/13/2012,3/24/2014,7/21/2014,7/21/2014,3/19/2015,6/16/2016,6/16/2016,7/5/2016,9/19/2016,9/19/2016
264,8865,6/15/1942,Male,183,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,R-X,DAR-X,V-X,3/16/2015,6/29/2015,6/29/2015,8/1/2016,10/13/2016,10/13/2016,11/2/2016,6/8/2017,6/8/2017,6/23/2017,6/29/2017,6/29/2017
265,3599,6/15/1940,Female,175,59,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"5,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,Other,V-X,5/12/2015,9/15/2015,9/15/2015,10/31/2016,2/14/2017,2/14/2017,3/7/2017,12/21/2017,12/21/2017,1/15/2018,3/30/2018,3/30/2018
266,6997,6/15/1944,Female,163,52,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"5,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,1/13/2015,5/12/2015,5/12/2015,8/15/2016,12/22/2016,12/22/2016,1/4/2017,12/18/2017,12/18/2017,1/10/2018,7/20/2018,7/20/2018
267,8707,6/15/1951,Female,161,53,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,35",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,No CTx,V-X,4/23/2015,8/20/2015,8/20/2015,9/12/2016,12/19/2016,12/19/2016,12/29/2016,12/29/2016,12/29/2016, , , 
268,1603,6/15/1942,Male,179,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,NIN-X,LEV-X,4/9/2015,10/8/2015,10/8/2015,5/3/2016,12/28/2017,12/28/2017,1/4/2018,11/12/2018,11/12/2018,11/22/2018,5/15/2021,5/15/2021
269,6750,6/15/1940,Female,162,53,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,Other,KYP-X,LEV-X,6/10/2015,12/14/2015,12/14/2015,5/25/2016,9/28/2016,9/28/2016,10/11/2016,1/9/2017,1/9/2017,1/19/2017,6/26/2017,6/26/2017
270,3800,6/15/1950,Male,179,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,LEV-X,1/20/2015,8/20/2015,8/20/2015,3/10/2016,6/28/2017,6/28/2017,7/14/2017,3/13/2018,3/13/2018,4/5/2018,4/5/2019,4/5/2019
271,8238,6/15/1939,Male,175,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,04",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,FAR-X,V-X,6/19/2013,10/2/2013,10/2/2013,6/10/2015,4/20/2016,4/20/2016,7/20/2016,11/17/2016,11/17/2016,12/1/2016,5/18/2017,5/18/2017
272,3098,6/15/1944,Male,185,98,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,85",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,3/17/2014,6/30/2014,6/30/2014,1/28/2015,12/22/2015,12/22/2015,2/9/2016,9/19/2016,9/19/2016,10/11/2016,11/24/2016,11/24/2016
273,8007,6/15/1941,Female,172,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,FAR-X,DAR-X,V-X,12/2/2014,6/29/2015,6/29/2015,5/12/2016,11/17/2016,11/17/2016,11/29/2016,12/12/2017,12/12/2017,1/2/2018,6/26/2018,6/26/2018
274,4653,6/15/1948,Male,184,91,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,82",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,1/27/2015,5/12/2015,5/12/2015,10/13/2015,6/27/2016,6/27/2016,7/12/2016,11/3/2016,11/3/2016, , , 
275,2724,6/15/1945,Female,159,63,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,82",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,FAR-X,No CTx,V-X,4/28/2015,9/1/2015,9/1/2015,6/1/2016,11/2/2016,11/2/2016,11/17/2016,11/25/2016,11/25/2016, , , 
276,6297,6/15/1942,Female,164,58,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,R-X,DAR-X,V-X,5/21/2015,9/10/2015,9/10/2015,9/28/2015,7/15/2016,7/15/2016,7/28/2016,2/28/2017,2/28/2017,3/24/2017,9/11/2017,9/11/2017
277,7278,6/15/1943,Female,161,55,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,52",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,R-X,No CTx,V-X,6/8/2015,10/5/2015,10/5/2015,10/26/2015,7/25/2016,7/25/2016,8/8/2016,9/26/2016,9/26/2016, , , 
278,7514,6/15/1940,Male,184,120,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,59",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,Other,Other,LEV-X,6/22/2015,12/17/2015,12/17/2015,1/4/2016,11/22/2016,11/22/2016,12/5/2016,3/13/2017,3/13/2017,3/27/2017,4/21/2017,4/21/2017
279,5439,6/15/1947,Male,174,54,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,28",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,6/1/2012,11/1/2012,11/1/2012,5/12/2015,3/21/2016,3/21/2016,8/23/2016,12/15/2016,12/15/2016,12/29/2016,5/25/2017,5/25/2017
280,7147,6/15/1941,Male,189,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,14",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,No CTx,V-X,3/1/2013,8/1/2013,8/1/2013,6/2/2015,6/17/2016,6/17/2016,7/11/2016,11/17/2016,11/17/2016, , , 
281,6313,6/15/1940,Male,179,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,4/1/2013,9/1/2013,9/1/2013,5/7/2015,3/11/2016,3/11/2016,3/30/2016,9/16/2016,9/16/2016,10/6/2016,12/15/2016,12/15/2016
282,6666,6/15/1956,Male,180,85,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"9,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,V-X,No CTx, , , ,7/12/2014,12/19/2014,12/19/2014,9/9/2016,11/18/2016,11/18/2016,9/19/2017,12/12/2017,12/12/2017
283,6523,6/15/1932,Female,160,50,Private,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,FAR-X,V-X,10/28/2013,5/12/2014,5/12/2014,10/17/2014,6/24/2015,6/24/2015,7/6/2015,11/4/2015,11/4/2015,2/16/2016,2/23/2016,2/23/2016
284,2672,6/15/1957,Female,165,78,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , ,Unknown,1,III: one or more criteria are fulfilled,IgG,"53,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/19/2015,2/22/2015,2/22/2015, , , , , , , , , 
285,5803,6/15/1941,Female,160,64,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"38,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/1/2013,2/1/2014,2/1/2014,2/1/2015,12/1/2015,12/1/2015,12/1/2015,12/31/2017, , , , 
286,9588,6/15/1938,Male,179,84,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"44,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,No CTx,V-X,8/1/2013,12/1/2013,12/1/2013,12/1/2013,8/1/2014,8/1/2014,5/1/2015,12/31/2017, , , , 
287,9894,6/15/1952,Female,165,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,13,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,8/15/2011,3/15/2012,3/15/2012,7/15/2013,5/15/2014,5/15/2014,12/15/2014,5/15/2015,5/15/2015,2/10/2016,11/15/2016,11/15/2016
288,4845,6/15/1949,Female,169,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,30,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,LEV-X,DAR-X,V-X,1/15/2009,11/15/2010,11/15/2010,6/15/2012,2/15/2013,2/15/2013,10/15/2014,4/15/2015,4/15/2015,1/10/2016,3/15/2017,3/15/2017
289,5466,6/15/1948,Male,187,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,18,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,POM-X,DAR-X,V-X,9/15/2011,5/15/2012,5/15/2012,3/15/2013,12/15/2013,12/15/2013,10/15/2014,6/15/2015,6/15/2015,2/20/2016,3/15/2017,3/15/2017
290,6672,6/15/1935,Male,177,92,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,53,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,LEV-X,POM-X,V-X,8/5/2011,7/17/2012,7/17/2012,3/10/2013,6/23/2014,6/23/2014,8/19/2014,1/17/2015,1/17/2015,8/15/2015,2/20/2016,2/20/2016
291,7825,6/15/1940,Male,180,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,29,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,Other,POM-X,V-X,2/25/2011,4/20/2012,4/20/2012,7/13/2013,10/12/2014,10/12/2014,11/25/2014,3/19/2015,3/19/2015,12/20/2015,5/27/2016,5/27/2016
292,7207,6/15/1941,Female,170,57,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,71,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,R-X,KYP-X,No CTx,V-X,9/13/2010,11/10/2011,11/10/2011,9/18/2012,8/22/2014,8/22/2014,1/3/2015,5/24/2015,5/24/2015, , , 
293,6322,6/15/1941,Female,164,61,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"48,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,LEV-X,No CTx,V-X,3/25/2013,7/7/2013,7/7/2013,6/22/2015,10/4/2015,10/4/2015,6/13/2016,10/30/2016,10/30/2016, , , 
294,8637,6/15/1938,Male,178,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"39,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,LEV-X,V-X,4/23/2012,7/15/2012,7/15/2012,6/1/2015,11/15/2015,11/15/2015,5/30/2016,11/20/2016,11/20/2016,12/11/2017,6/3/2018,6/3/2018
295,9249,6/15/1939,Male,180,83,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"63,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,V-X,LEV-X,LEV-X,6/1/2010,12/1/2010,12/1/2010,7/1/2013,1/1/2014,1/1/2014,4/27/2015,8/9/2015,8/9/2015,4/25/2016,9/11/2016,9/11/2016
296,9070,6/15/1947,Male,176,89,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,8,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,Other,POM-X,V-X,5/23/2011,1/9/2012,1/9/2012,3/10/2015,5/22/2015,5/22/2015,9/14/2015,7/8/2016,7/8/2016,3/29/2017,8/30/2017,8/30/2017
297,7838,6/15/1951,Female,164,63,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/1/2015,7/1/2015,7/1/2015, , , , , , , , , 
298,9920,6/15/1939,Female,172,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"56,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,LEV-X,LEV-X,7/8/2013,12/22/2013,12/22/2013,7/28/2014,1/11/2015,1/11/2015,1/19/2015,7/5/2015,7/5/2015,4/18/2016,8/7/2016,8/7/2016
299,8236,6/15/1937,Male,181,76,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"72,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,LEV-X,LEV-X,3/18/2013,9/1/2013,9/1/2013,4/13/2015,10/4/2015,10/4/2015,9/12/2016,3/5/2017,3/5/2017,11/20/2017,5/13/2018,5/13/2018
300,3023,6/15/1943,Male,184,102,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,11",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,FAR-X,V-X,2/10/2014,12/18/2014,12/18/2014,1/13/2015,5/18/2016,5/18/2016,7/4/2016,11/10/2016,11/10/2016,11/25/2016,11/26/2016,11/26/2016
301,7362,6/15/1946,Male,178,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"7,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,2/20/2012,11/26/2013,11/26/2013,12/16/2013,12/15/2014,12/15/2014,1/12/2015,2/5/2016,2/5/2016, , , 
302,9215,6/15/1936,Female,168,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/26/2015,8/26/2015,8/26/2015, , , , , , , , , 
303,5969,6/15/1949,Male,185,92,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"7,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,3/10/2015,9/14/2015,9/14/2015, , , , , , , , , 
304,7176,6/15/1930,Male,182,83,Private,No, ,Yes,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,4/6/2015,10/7/2015,10/7/2015, , , , , , , , , 
305,1514,6/15/1940,Male,174,64,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/25/2015,11/24/2015,11/24/2015, , , , , , , , , 
306,9422,6/15/1937,Female,173,67,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,85",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/23/2015,8/26/2015,8/26/2015, , , , , , , , , 
307,2036,6/15/1941,Female,171,63,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/19/2015,9/22/2015,9/22/2015, , , , , , , , , 
308,9770,6/15/1935,Male,184,63,Private,No, , ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,NIN-X,V-X,1/26/2015,12/21/2015,12/21/2015,7/19/2016,11/25/2016,11/25/2016,12/14/2016,3/20/2017,3/20/2017,4/7/2017,10/25/2017,10/25/2017
309,1587,6/15/1943,Male,176,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"6,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,2/10/2015,9/24/2015,9/24/2015,10/19/2015,3/29/2016,3/29/2016, , , , , , 
310,6688,6/15/1940,Male,170,93,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,FAR-X,EMP-X,V-X,4/6/2015,9/14/2015,9/14/2015,8/10/2016,11/16/2016,11/16/2016,12/9/2016,11/20/2017,11/20/2017,12/4/2017,6/25/2018,6/25/2018
311,9134,6/15/1929,Female,172,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,6/4/2015,10/2/2015,10/2/2015,10/27/2015,11/15/2016,11/15/2016, , , , , , 
312,7263,6/15/1932,Female,171,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,42","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,3/9/2015,9/17/2015,9/17/2015,4/14/2016,2/26/2018,2/26/2018,3/16/2018,9/14/2018,9/14/2018,3/6/2019,9/16/2020,9/16/2020
313,4111,6/15/1941,Male,189,141,Private,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,5",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,1/7/2015,5/12/2015,5/12/2015,2/10/2016,12/20/2016,12/20/2016,1/11/2017,8/25/2017,8/25/2017,9/12/2017,9/14/2017,9/14/2017
314,8567,6/15/1952,Female,170,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,10/15/2013,4/15/2014,4/15/2014,4/15/2015,5/25/2016,5/25/2016,7/12/2016,7/18/2017,7/18/2017,11/13/2017,6/12/2018,6/12/2018
315,3861,6/15/1938,Female,174,63,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"7,4",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,3/31/2015,9/23/2015,9/23/2015,10/12/2015,11/16/2016,11/16/2016, , , , , , 
316,7105,6/15/1932,Male,185,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,FAR-X,DAR-X,V-X,5/25/2015,9/21/2015,9/21/2015,4/21/2016,11/28/2016,11/28/2016,12/15/2016,1/1/2018,1/1/2018,1/15/2018,2/28/2019,2/28/2019
317,7770,6/15/1941,Male,182,75,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,LEV-X,4/28/2015,10/21/2015,10/21/2015,3/30/2016,12/21/2016,12/21/2016, , , , , , 
318,8190,6/15/1940,Female,164,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,16","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/23/2015,9/24/2015,9/24/2015, , , , , , , , , 
319,1498,6/15/1935,Male,182,85,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"6,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,5/6/2015,11/9/2015,11/9/2015, , , , , , , , , 
320,1091,6/15/1929,Male,171,66,Private,No,Yes, ,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,51",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,4/20/2015,10/26/2015,10/26/2015, , , , , , , , , 
321,3143,6/15/1932,Male,175,67,Unknown,No, , ,Yes,Yes, ,Yes,Yes, , ,Unknown,0,III: one or more criteria are fulfilled,IgG,7,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,Other,Other,V-X,V-X,5/9/2011,9/11/2011,9/11/2011,12/12/2014,6/9/2015,6/9/2015,10/12/2015,7/28/2016,7/28/2016,6/16/2017,9/22/2017,9/22/2017
322,5699,6/15/1937,Male,163,59,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/2/2015,9/9/2015,9/9/2015, , , , , , , , , 
323,1054,6/15/1927,Female,168,69,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,R-X,V-X,Other,9/29/2010,2/2/2011,2/2/2011,4/6/2015,6/20/2015,6/20/2015,9/14/2015,7/2/2016,7/2/2016,6/9/2017,4/6/2018,4/6/2018
324,7269,6/15/1929,Male,171,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"49,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/23/2015,7/27/2015,7/27/2015, , , , , , , , , 
325,6485,6/15/1949,Female,170,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,Other,V-X,Other,11/20/2012,3/9/2013,3/9/2013,4/20/2014,11/20/2014,11/20/2014,2/20/2015,3/20/2015,3/20/2015,9/13/2015,7/8/2016,7/8/2016
326,3751,6/15/1941,Male,174,83,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"8,5",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/18/2015,9/2/2015,9/2/2015, , , , , , , , , 
327,8038,6/15/1939,Female,158,52,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,6/13/2015,12/16/2015,12/16/2015, , , , , , , , , 
328,1005,6/15/1940,Male,182,95,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,52",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/12/2015,9/16/2015,9/16/2015, , , , , , , , , 
329,2713,6/15/1932,Female,169,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,5/26/2015,11/25/2015,11/25/2015, , , , , , , , , 
330,8427,6/15/1950,Male,185,92,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,2/26/2014,1/27/2015,1/27/2015,2/24/2015,12/15/2015,12/15/2015, , , , , , 
331,7900,6/15/1945,Male,181,72,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,61","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,6/18/2014,3/23/2015,3/23/2015,4/6/2015,9/30/2021, , , , , , , 
332,8102,6/15/1937,Male,175,86,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,39",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,1/20/2014,2/10/2015,2/10/2015,3/9/2015,9/30/2021, , , , , , , 
333,2987,6/15/1941,Male,183,74,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,42",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,6/19/2013,4/29/2014,4/29/2014,5/22/2014,3/25/2015,3/25/2015,4/13/2015,9/30/2021, , , , 
334,2079,6/15/1941,Female,172,75,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"12,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,Other,V-X,10/21/2013,12/22/2014,12/22/2014,1/5/2015,12/21/2015,12/21/2015,2/4/2016,7/19/2016,7/19/2016,8/11/2016,9/26/2016,9/26/2016
335,1125,6/15/1939,Male,183,103,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,14",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,4/24/2014,2/16/2015,2/16/2015,3/9/2015,5/24/2016,5/24/2016, , , , , , 
336,4743,6/15/1935,Male,174,82,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"7,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,LEV-X,12/2/2013,1/8/2015,1/8/2015,1/28/2015,6/14/2016,6/14/2016,7/7/2016,12/5/2016,12/5/2016,12/19/2016,12/27/2016,12/27/2016
337,6325,6/15/1942,Female,171,56,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,FAR-X,V-X,4/21/2014,2/19/2015,2/19/2015,3/9/2015,11/27/2015,11/27/2015,1/11/2016,9/12/2016,9/12/2016,9/22/2016,6/1/2017,6/1/2017
338,3847,6/15/1944,Female,164,81,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,24",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,KYP-X,V-X,3/2/2015,9/1/2015,9/1/2015,3/11/2016,9/27/2016,9/27/2016,10/12/2016,1/26/2017,1/26/2017,2/9/2017,7/12/2017,7/12/2017
339,6421,6/15/1939,Male,182,75,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"6,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,FAR-X,DAR-X,V-X,5/11/2015,11/9/2015,11/9/2015,8/2/2016,9/21/2016,9/21/2016,9/30/2016,8/31/2017,8/31/2017,9/14/2017,9/18/2017,9/18/2017
340,9225,6/15/1936,Female,162,52,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,55",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,FAR-X,DAR-X,V-X,1/26/2015,1/29/2016,1/29/2016,8/16/2016,11/22/2016,11/22/2016,12/15/2016,11/28/2017,11/28/2017,1/11/2018,1/9/2019,1/9/2019
341,7878,6/15/1940,Male,182,80,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,28",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,5/22/2015,11/23/2015,11/23/2015,4/6/2016,12/13/2016,12/13/2016,1/2/2017,1/26/2017,1/26/2017, , , 
342,9463,6/15/1936,Female,163,52,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,02",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,2/10/2015,12/14/2015,12/14/2015,12/30/2015,8/29/2016,8/29/2016, , , , , , 
343,6060,6/15/1940,Male,177,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"1,01",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,2/12/2011,9/26/2011,9/26/2011,3/9/2015,6/30/2015, , , , , , , 
344,6865,6/15/1945,Female,152,72,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,FAR-X,NIN-X,V-X,1/16/2015,12/17/2015,12/17/2015,9/20/2016,12/29/2016,12/29/2016,1/16/2017,2/26/2018,2/26/2018,3/9/2018,2/28/2019,2/28/2019
345,3921,6/15/1940,Male,181,76,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,66",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,4/9/2015,10/8/2015,10/8/2015,10/27/2015,11/8/2016,11/8/2016, , , , , , 
346,4775,6/15/1930,Male,167,83,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"302,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,12/1/2014,1/19/2015,1/19/2015,2/2/2015,6/30/2015,10/14/1582, , , , , , 
347,7918,6/15/1955,Female,178,92,Compulsory health insurance CHI,Yes,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,2,III: one or more criteria are fulfilled,IgG,"1,01",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,7/25/2013,9/19/2013,9/19/2013,3/2/2015,6/30/2015,10/14/1582, , , , , , 
348,7249,6/15/1936,Female,158,73,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,Unknown,IgG,"26,1",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , ,Nein,V-X,R-X,No CTx,V-X,1/3/2014,4/4/2014,4/4/2014,7/8/2014,8/5/2014,8/5/2014,9/25/2014,2/2/2015,2/2/2015, , , 
349,9475,6/15/1938,Male,178,73,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,91",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,1/20/2014,2/16/2015,2/16/2015,3/4/2015,6/10/2016,6/10/2016,7/6/2016,11/10/2016,11/10/2016,11/22/2016,4/27/2017,4/27/2017
350,8403,6/15/1940,Male,184,92,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,12/16/2013,3/12/2015,3/12/2015,3/25/2015,6/2/2016,6/2/2016,7/13/2016,12/13/2016,12/13/2016, , , 
351,4604,6/15/1938,Male,175,80,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,6/17/2014,1/21/2015,1/21/2015,2/3/2015,1/6/2016,1/6/2016,1/28/2016,9/19/2016,9/19/2016,10/6/2016,2/17/2017,2/17/2017
352,9436,6/15/1941,Male,184,82,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,34,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,V-X,No CTx,V-X,9/1/2010,12/1/2010,12/1/2010,5/1/2013,2/1/2015,2/1/2015,2/1/2015,7/1/2015,7/1/2015, , , 
353,7224,6/15/1936,Male,185,89,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"5,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,9/30/2013,2/17/2015,2/17/2015,2/24/2015,4/20/2016,4/20/2016,5/11/2016,1/10/2017,1/10/2017,2/1/2017,6/22/2017,6/22/2017
354,1273,6/15/1930,Female,166,74,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,45,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,R-X,No CTx,Other,9/1/2011,5/1/2012,5/1/2012,4/1/2013,5/1/2014,5/1/2014,3/1/2015,12/31/2017, , , , 
355,2879,6/15/1942,Male,179,116,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,48",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,4/7/2014,1/20/2015,1/20/2015,2/10/2015,1/12/2016,1/12/2016,2/3/2016,6/15/2016,6/15/2016,6/23/2016,12/5/2016,12/5/2016
356,2844,6/15/1940,Male,168,73,Private,No, , ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,88",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,11/20/2013,12/11/2014,12/11/2014,2/27/2015,1/14/2016,1/14/2016,3/1/2016,8/17/2016,8/17/2016,8/31/2016,2/9/2017,2/9/2017
357,7353,6/15/1937,Female,172,49,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,4/12/2014,3/10/2015,3/10/2015,4/7/2015,1/4/2016,1/4/2016, , , , , , 
358,3845,6/15/1946,Male,172,68,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"43,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,2/5/2015,4/10/2015,4/10/2015,7/6/2015,9/13/2015,9/13/2015, , , , , , 
359,9513,6/15/1935,Female,176,71,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"6,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,LEV-X,7/8/2014,4/17/2015,4/17/2015,5/21/2015,3/14/2016,3/14/2016,4/8/2016,9/22/2016,9/22/2016,10/10/2016,12/5/2016,12/5/2016
360,9844,6/15/1941,Male,179,85,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"2,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,Other,No CTx,V-X,3/2/2015,5/4/2015,5/4/2015,1/16/2014,6/30/2014,6/30/2014,7/30/2014,9/30/2015,9/30/2015, , , 
361,2064,6/15/1934,Female,157,74,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , ,Yes,1,I: fulfilling all 4 criteria,IgG,"13,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie, , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,1/6/2015,4/7/2015,4/7/2015,11/1/2015,3/30/2016,3/30/2016, , , , , , 
362,8970,6/15/1937,Male,180,80,Private,No, , ,Yes, ,Yes,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,IgG,300,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,9/3/2012,2/4/2013,2/4/2013,1/12/2015,6/30/2015, , , , , , , 
363,5591,6/15/1944,Male,175,84,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"185,5",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,11/8/2011,1/13/2012,1/13/2012,3/12/2015,12/31/2017, , , , , , , 
364,1579,6/15/1940,Male,161,58,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,POM-X,V-X,6/15/2013,11/15/2013,11/15/2013,6/14/2014,1/8/2015,1/8/2015,1/21/2015,12/18/2015,12/18/2015,1/19/2016,9/29/2016,9/29/2016
365,5799,6/15/1937,Female,169,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,POM-X,V-X,3/15/2012,8/15/2012,8/15/2012,12/9/2013,1/13/2015,1/13/2015,2/11/2015,12/21/2015,12/21/2015,1/14/2016,9/16/2016,9/16/2016
366,8574,6/15/1934,Male,185,94,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,FAR-X,V-X,10/1/2012,3/1/2013,3/1/2013,4/22/2014,2/25/2015,2/25/2015,3/5/2015,4/6/2016,4/6/2016,7/11/2016,12/29/2016,12/29/2016
367,7471,6/15/1935,Male,185,94,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"11,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,6/15/2013,10/15/2013,10/15/2013,4/27/2015,12/22/2015,12/22/2015,1/27/2016,9/20/2016,9/20/2016,10/12/2016,3/20/2017,3/20/2017
368,7812,6/15/1940,Male,185,84,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"9,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,No CTx,V-X,7/24/2014,3/27/2015,3/27/2015,4/16/2015,4/26/2016,4/26/2016,5/12/2016,9/26/2016,9/26/2016, , , 
369,6740,6/15/1942,Male,170,92,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"4,68",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,POM-X,V-X,3/4/2013,9/5/2013,9/5/2013,9/30/2014,2/19/2015,2/19/2015,3/10/2015,5/11/2015,5/11/2015,9/24/2015,4/12/2016,4/12/2016
370,3922,6/15/1946,Male,192,91,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"90,3",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,V-X,POM-X,V-X,3/15/2010,9/15/2010,9/15/2010,7/10/2012,8/25/2014,8/25/2014,9/22/2014,5/6/2015,5/6/2015,9/28/2015,6/10/2016,6/10/2016
371,5235,6/15/1939,Female,157,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"33,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,V-X,KYP-X,V-X,5/21/2013,10/15/2013,10/15/2013,8/1/2014,2/15/2015,2/15/2015,3/31/2015,6/17/2015,6/17/2015,5/26/2016,6/3/2016,6/3/2016
372,6958,6/15/1946,Male,185,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"18,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,R-X,V-X,5/15/2011,10/15/2011,10/15/2011,11/12/2013,12/2/2014,12/2/2014,12/15/2014,6/1/2015,6/1/2015,9/2/2015,6/29/2016,6/29/2016
373,4757,6/15/1936,Male,185,81,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"30,21",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,POM-X,V-X,6/1/2011,11/1/2011,11/1/2011,1/21/2014,11/5/2014,11/5/2014,11/24/2014,5/30/2015,5/30/2015,9/30/2015,5/31/2016,5/31/2016
374,8926,6/15/1941,Male,179,86,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"8,94",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,POM-X,V-X,5/15/2012,10/15/2012,10/15/2012,2/18/2014,12/8/2014,12/8/2014,1/5/2015,6/4/2015,6/4/2015,9/2/2015,4/19/2016,4/19/2016
375,5555,6/15/1938,Male,182,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"14,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,POM-X,V-X,12/1/2011,4/1/2012,4/1/2012,3/17/2014,11/24/2014,11/24/2014,12/10/2014,3/12/2015,3/12/2015,11/9/2015,6/27/2016,6/27/2016
376,1090,6/15/1942,Male,178,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,POM-X,V-X,10/15/2012,3/15/2013,3/15/2013,6/10/2014,11/25/2014,11/25/2014,12/9/2014,3/25/2015,3/25/2015,9/23/2015,4/11/2016,4/11/2016
377,6912,6/15/1951,Male,184,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"12,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,KYP-X,V-X,9/15/2011,1/15/2012,1/15/2012,8/26/2014,1/7/2015,1/7/2015,10/12/2015,12/20/2016,12/20/2016,1/12/2017,1/18/2017,1/18/2017
378,1001,6/15/1932,Female,170,49,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"10,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,KYP-X,V-X,1/15/2012,5/15/2012,5/15/2012,1/6/2015,10/12/2015,10/12/2015,1/18/2016,9/22/2016,9/22/2016,10/17/2016,3/21/2017,3/21/2017
379,8879,6/15/1943,Female,164,55,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,02","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,KYP-X,V-X,3/15/2013,8/15/2013,8/15/2013,6/23/2015,7/11/2016,7/11/2016,7/25/2016,10/24/2016,10/24/2016,1/3/2017,5/23/2017,5/23/2017
380,9145,6/15/1943,Female,168,61,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"11,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,7/15/2013,3/15/2014,3/15/2014,1/5/2015,11/16/2015,11/16/2015,2/5/2016,9/22/2016,9/22/2016,10/6/2016,3/21/2017,3/21/2017
381,6329,6/15/1957,Male,186,91,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,5/15/2013,8/15/2013,8/15/2013,5/18/2015,3/14/2016,3/14/2016,4/18/2016,8/8/2016,8/8/2016,8/18/2016,1/25/2017,1/25/2017
382,6436,6/15/1939,Female,173,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"7,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,No CTx,V-X,7/15/2011,12/15/2011,12/15/2011,3/24/2014,11/19/2014,11/19/2014,12/8/2014,6/4/2015,6/4/2015, , , 
383,6975,6/15/1942,Male,184,88,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"11,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,No CTx,V-X,10/15/2011,3/15/2012,3/15/2012,9/24/2013,7/23/2014,7/23/2014,8/13/2014,4/21/2015,4/21/2015, , , 
384,2409,6/15/1937,Male,173,78,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,V-X,V-X,LEV-X,4/9/2014,3/6/2015,3/6/2015,10/10/2015,7/23/2016,7/23/2016,5/23/2017,12/12/2017,12/12/2017,1/6/2018,11/20/2018,11/20/2018
385,7787,6/15/1941,Female,171,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,DAR-X,FAR-X,Other,7/20/2015,5/19/2016,5/19/2016,6/20/2017,3/9/2018,3/9/2018,6/9/2018,10/7/2019,10/7/2019,12/17/2019,11/24/2020,11/24/2020
386,8368,6/15/1938,Female,176,79,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,Other,R-X,DAR-X,V-X,10/13/2010,7/9/2011,7/9/2011,7/29/2015,6/2/2016,6/2/2016,10/25/2017,6/9/2018,6/9/2018,12/5/2018,2/24/2020,2/24/2020
387,5748,6/15/1944,Female,170,59,Private,No,Yes,Yes, ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,V-X,Other,FAR-X,Other,10/5/2010,10/9/2011,10/9/2011,7/23/2015,6/29/2016,6/29/2016,6/23/2017,3/10/2018,3/10/2018,3/21/2019,2/12/2020,2/12/2020
388,4613,6/15/1940,Male,180,88,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,R-X,R-X,R-X,4/5/2011,3/8/2012,3/8/2012,9/12/2015,7/29/2016,7/29/2016,3/24/2017,6/28/2017,6/28/2017,8/30/2017,6/16/2018,6/16/2018
389,2256,6/15/1943,Male,182,84,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,Other type,"3,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,KYP-X,V-X,10/5/2015,1/24/2016,1/24/2016,12/11/2017,6/10/2018,6/10/2018,11/25/2019,5/17/2020,5/17/2020,9/14/2020,6/27/2021,6/27/2021
390,6296,6/15/1956,Female,160,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"58,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,10/5/2015,1/10/2016,1/10/2016,12/3/2018,2/17/2019,2/17/2019, , , , , , 
391,5569,6/15/1946,Male,176,72,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"51,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,2/23/2012,5/17/2012,5/17/2012,10/12/2015,1/31/2016,1/31/2016, , , , , , 
392,2804,6/15/1940,Male,180,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"39,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,No CTx,V-X,6/29/2009,9/20/2009,9/20/2009,3/18/2013,8/31/2013,8/31/2013,10/12/2015,5/8/2016,5/8/2016, , , 
393,3820,6/15/1938,Female,159,53,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"57,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,LEV-X,LEV-X,1/14/2013,7/7/2013,7/7/2013,10/5/2015,6/26/2016,6/26/2016,7/11/2016,12/25/2016,12/25/2016,2/19/2018,8/12/2018,8/12/2018
394,5607,6/15/1961,Female,168,70,Private,No, , , , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/15/2015,11/15/2015,11/15/2015, , , , , , , , , 
395,6468,6/15/1935,Female,171,83,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,48,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,DAR-X,NIN-X,V-X,8/15/2015,5/15/2016,5/15/2016,9/15/2016,6/15/2017,6/15/2017,7/15/2017,9/15/2018,9/15/2018,10/15/2018,5/15/2019,5/15/2019
396,3864,6/15/1935,Male,186,79,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,71,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,KYP-X,V-X,9/15/2015,5/15/2016,5/15/2016,9/15/2016,7/15/2017,7/15/2017,8/15/2017,9/15/2018,9/15/2018,2/1/2019,6/15/2019,6/15/2019
397,3343,6/15/1946,Female,158,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,53,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,EMP-X,DAR-X,V-X,3/15/2013,3/15/2014,3/15/2014,7/15/2015,5/15/2016,5/15/2016,6/6/2016,4/15/2017,4/15/2017,5/15/2017,1/15/2018,1/15/2018
398,1525,6/15/1951,Male,179,83,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,80,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,FAR-X,V-X,11/15/2012,2/15/2013,2/15/2013,10/15/2015,8/15/2016,8/15/2016,7/15/2017,1/15/2018,1/15/2018,3/15/2018,12/15/2018,12/15/2018
399,4826,6/15/1948,Female,169,74,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,57,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,10/15/2012,1/15/2013,1/15/2013,9/15/2015,3/15/2016,3/15/2016,4/10/2016,5/15/2017,5/15/2017,6/15/2017,2/15/2018,2/15/2018
400,5589,6/15/1939,Male,179,76,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,53,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,EMP-X,DAR-X,V-X,8/15/2011,8/15/2012,8/15/2012,8/15/2015,7/15/2016,7/15/2016,9/15/2016,8/15/2017,8/15/2017,9/15/2017,2/15/2018,2/15/2018
401,9902,6/15/1945,Male,187,80,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,POM-X,V-X,10/10/2015,7/23/2016,7/23/2016,3/23/2017,6/28/2017,6/28/2017, , , ,7/9/2017,11/23/2017,11/23/2017
402,7482,6/15/1944,Male,160,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,60,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/15/2014,6/20/2014,6/20/2014,10/10/2015,6/30/2016, , , , , , , 
403,7379,6/15/1935,Female,167,60,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"20,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,V-X,DAR-X,V-X,8/9/2015,6/30/2016,6/30/2016,12/20/2016,5/28/2017,5/28/2017,10/23/2017,3/25/2018,3/25/2018,6/20/2019,6/9/2020,6/9/2020
404,2644,6/15/1943,Female,174,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,32,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,R-X,5/20/2013,4/25/2015,4/25/2015,10/11/2015,6/30/2016, , , , , , , 
405,8471,6/15/1941,Male,163,67,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,60,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/15/2013,9/29/2015,9/29/2015,10/15/2015,6/30/2016,10/14/1582, , , , , , 
406,9630,6/15/1946,Female,158,62,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,640,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
407,9698,6/15/1955,Male,190,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,54,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,6/1/2012,8/1/2012,8/1/2012,10/19/2015,6/30/2016, , , , , , , 
408,4956,6/15/1949,Male,183,85,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,43,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,1/1/2013,3/1/2013,3/1/2013,10/9/2015,6/30/2016, , , , , , , 
409,5506,6/15/1941,Male,177,100,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,R-X,Other,7/15/2005,10/15/2012,10/15/2012,12/15/2012,10/1/2013,10/1/2013,8/3/2015,10/23/2015,10/23/2015,9/3/2019,12/31/2019, 
410,7107,6/15/1937,Female,170,64,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,V-X,V-X,Other,3/18/2011,2/6/2012,2/6/2012,7/23/2015,5/13/2016,5/13/2016,9/3/2017,12/4/2017,12/4/2017,2/16/2018,5/30/2018,5/30/2018
411,3929,6/15/1943,Female,165,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,V-X,V-X,POM-X,V-X,9/25/2015,8/3/2016,8/3/2016,5/17/2017,9/19/2017,9/19/2017,10/18/2017,5/26/2018,5/26/2018,6/25/2018,5/7/2019,5/7/2019
412,4257,6/15/1946,Male,182,86,Private,Yes,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,12,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,KYP-X,EMP-X,Other,9/8/2015,7/3/2016,7/3/2016,5/2/2017,3/29/2018,3/29/2018,3/12/2019,2/19/2020,2/19/2020,3/26/2020,3/9/2021,3/9/2021
413,3028,6/15/1951,Male,190,76,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,8,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,Other,V-X,V-X,10/21/2012,9/30/2013,9/30/2013,10/12/2015,7/6/2016,7/6/2016,5/29/2017,9/13/2017,9/13/2017,9/21/2017,7/13/2018,7/13/2018
414,9035,6/15/1956,Male,163,64,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,45,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,12/17/2013,3/1/2014,3/1/2014,10/20/2015,12/31/2015, , , , , , , 
415,4451,6/15/1933,Female,152,57,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,10/30/2014,10/27/2015,10/27/2015, , , , , , , , , 
416,9034,6/15/1944,Female,160,69,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,35,ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/1/2014,6/20/2015,6/20/2015,11/3/2015,6/30/2016,10/14/1582, , , , , , 
417,1305,6/15/1940,Female,166,59,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,70,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,No CTx,No CTx,V-X,10/15/2013,10/2/2014,10/2/2014,10/20/2015,6/30/2016, , , , , , , 
418,4807,6/15/1937,Male,179,75,Compulsory health insurance CHI,Yes, , , , , , , , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,88",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,DAR-X,V-X,3/28/2015,9/29/2015,9/29/2015,8/1/2017,4/18/2018,4/18/2018,12/2/2019,4/6/2020,4/6/2020,5/11/2021,3/31/2022,10/14/1582
419,2671,6/15/1940,Male,174,74,Compulsory health insurance CHI,Yes, , , , , , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgG,5,ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,6/23/2015,9/3/2015,9/3/2015,12/12/2015,8/8/2016,8/8/2016, , , , , , 
420,8023,6/15/1941,Female,170,68,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,DAR-X,V-X,8/29/2015,4/14/2016,4/14/2016,6/19/2016,2/16/2017,2/16/2017,8/17/2017,10/1/2017,10/1/2017,6/25/2018,8/31/2018,8/31/2018
421,2794,6/15/1938,Male,179,89,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,POM-X,NIN-X,Other,9/7/2015,7/25/2016,7/25/2016,8/6/2017,12/5/2017,12/5/2017,5/30/2018,6/24/2019,6/24/2019,6/25/2019,11/23/2019,11/23/2019
422,9405,6/15/1942,Male,178,81,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,5/1/2010,10/1/2010,10/1/2010,2/1/2015,9/1/2015,9/1/2015, , , , , , 
423,2353,6/15/1952,Female,163,69,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"14,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,11/9/2015,1/24/2016,1/24/2016, , , , , , , , , 
424,8791,6/15/1943,Male,190,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,V-X,No CTx,V-X,10/30/2015,7/26/2016,7/26/2016, , , ,7/25/2017,3/31/2018,10/14/1582, , , 
425,5018,6/15/1949,Male,176,98,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"63,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,KYP-X,V-X,9/1/2014,11/1/2014,11/1/2014,10/14/2015,3/4/2016,3/4/2016,3/26/2016,3/23/2017,3/23/2017,3/27/2017,9/14/2017,9/14/2017
426,3372,6/15/1948,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,R-X,KYP-X,V-X,10/20/2009,12/1/2009,12/1/2009,4/1/2012,7/1/2012,7/1/2012,10/26/2015,6/28/2017,6/28/2017,6/29/2017,1/31/2018,1/31/2018
427,5612,6/15/1950,Female,174,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,No CTx,No CTx,No CTx,V-X,11/1/2015,3/18/2016,3/18/2016, , , , , , , , , 
428,8270,6/15/1949,Male,171,101,Private,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"3,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,6/5/2015,8/27/2015,8/27/2015, , , , , , , , , 
429,2020,6/15/1945,Male,172,93,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,4/1/2015,9/1/2015,9/1/2015,12/12/2016,3/31/2017, , , , , , , 
430,8518,6/15/1961,Female,153,73,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,9,III: one or more criteria are fulfilled,IgA,"5,32",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/9/2015,9/5/2015,9/5/2015, , , , , , , , , 
431,4467,6/15/1969,Male,180,79,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,I: fulfilling all 4 criteria,IgG,"2,54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,No CTx,EMP-X,7/16/2015,9/30/2015,9/30/2015,12/13/2019,2/16/2022,2/16/2022,2/21/2022,3/31/2022, , , , 
432,9930,6/15/1942,Male,178,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"58,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,LEV-X,LEV-X,V-X,5/24/2012,8/19/2012,8/19/2012,10/26/2015,2/14/2016,2/14/2016,6/12/2017,12/24/2017,12/24/2017,3/4/2019,11/17/2019,11/17/2019
433,7860,6/15/1961,Female,167,60,Compulsory health insurance CHI,No, , , , ,Yes, , , , ,Yes,9,III: one or more criteria are fulfilled,Other type,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,6/1/2015,8/1/2015,8/1/2015, , , , , , , , , 
434,2947,6/15/1953,Female,999,65,Compulsory health insurance CHI,No, , , , ,Yes, , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"7,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,R-X,No CTx,No CTx,V-X,3/23/2012,6/6/2012,6/6/2012,10/26/2015,9/30/2021,10/14/1582, , , , , , 
435,7405,6/15/1939,Male,181,84,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"54,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,4/20/2009,10/4/2009,10/4/2009,1/14/2013,7/1/2013,7/1/2013,10/5/2015,3/28/2016,3/28/2016, , , 
436,9962,6/15/1935,Female,161,54,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,9/8/2015,11/13/2018,11/13/2018,12/17/2018,1/19/2022,1/19/2022, , , , , , 
437,3306,6/15/1940,Female,160,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"63,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,LEV-X,LEV-X,5/23/2011,11/6/2011,11/6/2011,10/27/2014,10/25/2015,10/25/2015,11/2/2015,4/24/2016,4/24/2016,9/4/2017,2/25/2018,2/25/2018
438,5904,6/15/1943,Female,152,50,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"14,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,DAR-X,V-X,7/8/2013,9/29/2013,9/29/2013,10/19/2015,4/10/2016,4/10/2016,9/4/2017,2/25/2018,2/25/2018,12/3/2018,4/6/2020,4/6/2020
439,3202,6/15/1943,Male,176,70,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"8,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,3/1/2015,6/1/2015,6/1/2015,3/29/2018,12/31/2021,10/14/1582, , , , , , 
440,9602,6/15/1951,Female,999,99,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"2,46",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,7/20/2015,10/11/2015,10/11/2015,3/16/2018,6/25/2018,6/25/2018, , , , , , 
441,4524,6/15/1951,Female,159,60,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,Other type,"999,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/3/2015,9/15/2015,9/15/2015, , , , , , , , , 
442,3530,6/15/1941,Male,184,80,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"47,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,3/9/2015,10/19/2015,10/19/2015,10/26/2015,1/24/2016,1/24/2016, , , , , , 
443,5617,6/15/1939,Male,172,76,Compulsory health insurance CHI,No,Yes,Yes, , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"46,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,10/12/2015,1/31/2016,1/31/2016,11/20/2017,5/13/2018,5/13/2018, , , , , , 
444,9511,6/15/1952,Male,185,75,Private,No, , , , ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"5,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/15/2014,11/15/2014,11/15/2014,8/15/2015,3/31/2017,10/14/1582, , , , , , 
445,5948,6/15/1950,Male,173,97,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,",68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,3/1/2015,6/1/2015,6/1/2015,1/5/2017,2/26/2019,2/26/2019,3/15/2019,12/31/2019,10/14/1582, , , 
446,8357,6/15/1960,Male,175,90,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"7,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/1/2015,12/20/2015,12/20/2015,11/17/2016,12/31/2017, , , , , , , 
447,6346,6/15/1942,Female,170,90,Private,No,Yes, ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,POM-X,KYP-X,Other,12/1/2014,6/1/2015,6/1/2015,8/1/2015,2/15/2016,2/15/2016,2/15/2016,8/24/2016,8/24/2016,2/15/2017,12/31/2017,10/14/1582
448,8393,6/15/1942,Male,167,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,31,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/14/2012,4/16/2013,4/16/2013,9/29/2015,12/31/2015, , , , , , , 
449,2263,6/15/1947,Female,173,70,Private,No,Yes, , , , , , ,Yes, , ,9,I: fulfilling all 4 criteria,IgG,"2,18",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,R-X,POM-X,V-X,V-X,10/14/2011,12/24/2011,12/24/2011,6/1/2013,12/1/2014,12/1/2014,1/1/2015,10/22/2015,10/22/2015,11/1/2015,3/1/2016,3/1/2016
450,1784,6/15/1936,Male,177,81,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"38,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,LEV-X,LEV-X,6/1/2007,12/1/2007,12/1/2007,2/6/2012,4/29/2012,4/29/2012,1/5/2015,10/4/2015,10/4/2015,10/5/2015,3/27/2016,3/27/2016
451,9409,6/15/1955,Female,160,64,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"53,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/19/2015,1/24/2016,1/24/2016, , , , , , , , , 
452,6405,6/15/1939,Male,165,70,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,DAR-X,V-X,1/29/2015,9/17/2015,9/17/2015,10/17/2015,6/24/2018,6/24/2018,7/11/2018,11/15/2018,11/15/2018,12/10/2018,2/26/2020,2/26/2020
453,5922,6/15/1956,Male,172,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"74,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/5/2015,1/3/2016,1/3/2016, , , , , , , , , 
454,7180,6/15/1959,Female,170,57,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,",63","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,V-X,No CTx,V-X,3/3/2012,5/11/2012,5/11/2012,4/9/2015,6/24/2015,6/24/2015,8/30/2016,9/26/2016,9/26/2016, , , 
455,6031,6/15/1939,Male,178,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"22,2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/28/2015,12/31/2015, , , , , , , , , , 
456,5534,6/15/1946,Male,999,79,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"999,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,V-X,POM-X,Other,8/13/2004,9/4/2004,9/4/2004,5/1/2011,7/7/2014,7/7/2014,7/22/2014,9/13/2014,9/13/2014,5/1/2015,7/4/2016,7/4/2016
457,4425,6/15/1940,Male,175,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,42,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,4/15/2013,4/27/2014,4/27/2014,11/10/2015,12/31/2015, , , , , , , 
458,9276,6/15/1949,Male,999,80,Private,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"5,06",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,KYP-X,DAR-X,V-X,5/1/2015,10/1/2015,10/1/2015,8/1/2016,1/26/2017,1/26/2017,2/3/2017,11/2/2017,11/2/2017,11/4/2017,12/31/2017, 
459,6932,6/15/1960,Female,999,99,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,No CTx,No CTx,No CTx,EMP-X,7/24/2015,10/8/2015,10/8/2015, , , , , , , , , 
460,1744,6/15/1939,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,R-X,Other,7/1/1997,10/1/1997,10/1/1997,9/1/2007,1/1/2008,1/1/2008,6/7/2011,7/30/2011,7/30/2011,7/1/2012,10/1/2015,10/1/2015
461,9530,6/15/1943,Male,168,89,Private,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,",43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/18/2015,7/30/2015,7/30/2015, , , , , , , , , 
462,1853,6/15/1939,Male,175,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"2,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,7/16/2012,10/7/2012,10/7/2012,11/9/2015,4/24/2016,4/24/2016, , , , , , 
463,4429,6/15/1943,Female,999,99,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,Other type,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,Other,LEV-X,Other,2/24/2003,5/9/2003,5/9/2003,3/1/2006,4/1/2006,4/1/2006,1/1/2008,9/1/2008,9/1/2008,9/1/2008,3/1/2009,3/1/2009
464,5822,6/15/1944,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,41",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,6/19/2015,10/1/2015,10/1/2015, , , , , , , , , 
465,5187,6/15/1939,Male,175,75,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"3,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,DAR-X,V-X,4/5/2013,7/5/2013,7/5/2013,11/9/2015,2/28/2016,2/28/2016,9/14/2018,9/28/2018,9/28/2018,7/10/2019,7/24/2019,7/24/2019
466,8435,6/15/1941,Male,171,76,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,No CTx,V-X,7/30/2012,10/21/2012,10/21/2012,1/13/2015,10/21/2015,10/21/2015,11/9/2015,4/24/2016,4/24/2016, , , 
467,7502,6/15/1951,Female,168,67,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,9,III: one or more criteria are fulfilled,IgG,"10,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,POM-X,FAR-X,No CTx,V-X,10/11/2013,12/25/2013,12/25/2013,1/11/2015,10/11/2015,10/11/2015,10/19/2015,3/1/2016,3/1/2016, , , 
468,4662,6/15/1946,Male,177,82,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"2,65",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,R-X,V-X,Other,5/3/2004,7/17/2004,7/17/2004,11/26/2007,2/10/2008,2/10/2008,3/17/2010,8/25/2010,8/25/2010,7/4/2011,9/26/2011,9/26/2011
469,8041,6/15/1937,Male,170,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,11/16/2015,5/8/2016,5/8/2016, , , , , , , , , 
470,2960,6/15/1940,Female,170,71,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,",17",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,Other,No CTx,V-X,3/4/2014,8/16/2014,8/16/2014,9/15/2015,5/11/2016,5/11/2016,6/6/2016,6/30/2016, , , , 
471,8181,6/15/1933,Male,185,76,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,53",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,1/27/2014,7/28/2014,7/28/2014,8/1/2015,4/7/2016,4/7/2016, , , , , , 
472,4059,6/15/1949,Female,159,73,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,38",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,9/18/2015,12/17/2015,12/17/2015, , , , , , , , , 
473,6041,6/15/1951,Female,167,74,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/19/2015,1/4/2016,1/4/2016, , , , , , , , , 
474,2945,6/15/1950,Male,185,99,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,"47,9",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,5/27/2014,1/23/2015,1/23/2015,7/30/2015,8/2/2016,8/2/2016, , , , , , 
475,5307,6/15/1957,Male,182,68,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , ,Yes,1,III: one or more criteria are fulfilled,Other type,"2,05",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,Other,DAR-X,V-X,2/6/2015,4/20/2015,4/20/2015,9/28/2015,12/22/2015,12/22/2015,1/19/2016,6/28/2016,6/28/2016,7/1/2016,9/30/2016, 
476,5214,6/15/1939,Male,179,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"64,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,FAR-X,KYP-X,V-X,11/5/2012,1/11/2013,1/11/2013,8/22/2015,3/27/2016,3/27/2016,4/4/2016,8/19/2016,8/19/2016,5/23/2017,8/29/2017,8/29/2017
477,1149,6/15/1945,Female,168,80,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,1",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,No CTx,V-X,4/8/2013,8/2/2013,8/2/2013,8/5/2014,7/15/2015,7/15/2015,7/16/2015,6/30/2016, , , , 
478,1300,6/15/1951,Male,178,94,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgA,",78",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/17/2015,10/29/2015,10/29/2015, , , , , , , , , 
479,2284,6/15/1938,Female,160,58,Private,No, , , , , , ,Yes, , ,Yes,9,III: one or more criteria are fulfilled,IgG,576,ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/10/2015,8/13/2015,8/13/2015, , , , , , , , , 
480,1162,6/15/1932,Female,168,70,Private,No, , , , , , , , ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,Other type,",34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/18/2015,12/31/2015, , , , , , , , , , 
481,2516,6/15/1949,Male,182,88,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgA,56,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,LEV-X,No CTx,V-X,7/15/2015,10/7/2015,10/7/2015,10/4/2016,3/24/2017,3/24/2017,8/17/2017,12/22/2017,12/22/2017, , , 
482,4547,6/15/1952,Female,170,67,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,Other type,",11",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,V-X,POM-X,V-X,1/6/2012,3/24/2012,3/24/2012,8/23/2013,2/27/2014,2/27/2014,4/22/2014,8/26/2014,8/26/2014,7/15/2015,2/11/2017,2/11/2017
483,7718,6/15/1934,Male,175,68,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"3,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,4/29/2013,10/13/2013,10/13/2013,11/16/2015,5/8/2016,5/8/2016, , , , , , 
484,2776,6/15/1956,Female,171,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,KYP-X,No CTx,V-X,11/19/2015,1/3/2016,1/3/2016,11/13/2017,1/14/2018,1/14/2018,11/25/2019,4/18/2021,4/18/2021, , , 
485,8245,6/15/1938,Male,168,52,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,8/27/2015,12/31/2015, , , , , , , , , , 
486,1349,6/15/1936,Female,165,60,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"3,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,9/28/2015,3/30/2016,3/30/2016,6/14/2016,9/29/2016,9/29/2016, , , , , , 
487,9778,6/15/1948,Male,173,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,No CTx,No CTx,No CTx,V-X,9/29/2015,12/31/2015, , , , , , , , , , 
488,5876,6/15/1943,Male,175,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,FAR-X,No CTx,V-X,1/30/2013,9/12/2013,9/12/2013,5/21/2014,1/30/2015,1/30/2015,11/9/2015,12/31/2015, , , , 
489,9277,6/15/1940,Male,185,88,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,No CTx,V-X,8/20/2012,11/11/2012,11/11/2012,11/19/2015,4/10/2016,4/10/2016,8/28/2017,2/11/2018,2/11/2018, , , 
490,3925,6/15/1947,Male,178,89,Private,No,Yes,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,10/1/2014,1/1/2015,1/1/2015,9/1/2015,8/23/2017,8/23/2017,9/11/2017,4/15/2018,4/15/2018, , , 
491,1063,6/15/1936,Female,166,72,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,11/23/2015,4/10/2016,4/10/2016, , , , , , , , , 
492,8498,6/15/1954,Male,183,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,Other,9/30/2015,12/31/2015, , , , , , , , , , 
493,8666,6/15/1933,Male,173,171,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,unbekannt, , , , , , , , ,No CTx,No CTx,No CTx,V-X,7/31/2015,12/31/2015, , , , , , , , , , 
494,5050,6/15/1939,Male,183,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,3/24/2015,5/28/2015,5/28/2015,7/14/2015,12/31/2015, , , , , , , 
495,2680,6/15/1928,Male,177,79,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"44,7",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/6/2015,3/4/2016,3/4/2016, , , , , , , , , 
496,6655,6/15/1939,Male,172,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,23",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/5/2011,8/3/2012,8/3/2012,7/1/2013,12/31/2015,10/14/1582, , , , , , 
497,4810,6/15/1941,Female,163,63,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"39,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,V-X,Other,4/26/2007,3/3/2008,3/3/2008,3/5/2008,7/3/2008,7/3/2008,9/1/2009,11/13/2009,11/13/2009,10/4/2010,1/7/2011,1/7/2011
498,5834,6/15/1941,Female,166,81,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"2,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,11/2/2009,9/20/2010,9/20/2010,9/8/2015,12/31/2015,10/14/1582, , , , , , 
499,2215,6/15/1945,Female,166,81,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/31/2015,12/7/2015,12/7/2015, , , , , , , , , 
500,3990,6/15/1925,Female,160,58,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,28,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,V-X,No CTx,No CTx,V-X,1/8/2014,7/16/2014,7/16/2014,7/17/2015,12/31/2015, , , , , , , 
501,7381,6/15/1934,Male,188,93,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,POM-X,V-X,12/4/2014,3/18/2015,3/18/2015,3/18/2015,9/15/2015,9/15/2015,10/1/2015,12/23/2015,12/23/2015,10/28/2016,11/24/2016,11/24/2016
502,5446,6/15/1925,Male,176,76,Private,No, , , , , , , , ,Yes, ,0,Unknown,Other type,"9,9",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,V-X,LEV-X,LEV-X,Other,5/9/2007,9/12/2007,9/12/2007,4/20/2010,7/23/2010,7/23/2010,5/7/2013,11/21/2013,11/21/2013,4/20/2015,5/19/2015,5/19/2015
503,9264,6/15/1940,Male,180,86,Private,No, , , , , , , , , , ,0,Unknown,IgA,"4,9",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,Other,No CTx,No CTx,Other,1/15/2015,11/15/2015,11/15/2015,1/15/2016,8/15/2016,8/15/2016, , , , , , 
504,1356,6/15/1937,Male,178,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,9/21/2015,2/15/2016,2/15/2016,9/25/2017,2/26/2018,2/26/2018, , , , , , 
505,6772,6/15/1948,Female,163,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,R-X,R-X,No CTx,V-X,7/16/2015,11/15/2015,11/15/2015,11/16/2015,12/15/2015,12/15/2015,1/20/2017,6/15/2019,6/15/2019, , , 
506,1738,6/15/1955,Male,180,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,7/6/2015,9/30/2015,9/30/2015, , , , , , , , , 
507,8875,6/15/1940,Male,179,78,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,77",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,R-X,R-X,Other,5/2/2006,7/6/2006,7/6/2006,5/4/2011,9/24/2012,9/24/2012,5/6/2014,12/22/2014,12/22/2014,5/28/2015,11/1/2015,11/1/2015
508,4364,6/15/1942,Female,156,61,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgA,53,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,V-X,No CTx,LEV-X,7/15/2015,2/15/2016,2/15/2016,6/7/2017,10/20/2017,10/20/2017,12/19/2017,12/31/2017, , , , 
509,3696,6/15/1937,Female,158,67,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,8/25/2009,6/20/2010,6/20/2010,8/3/2015,12/31/2015, , , , , , , 
510,3983,6/15/1930,Female,157,68,Compulsory health insurance CHI,No, , ,Yes,Yes,Unknown,Unknown,Unknown, , , ,2,III: one or more criteria are fulfilled,IgG,"4,13",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,V-X,No CTx,V-X,3/26/2010,10/19/2010,10/19/2010,4/16/2015,6/18/2015,6/18/2015,7/16/2015,12/31/2015, , , , 
511,9080,6/15/1929,Male,175,73,Compulsory health insurance CHI,Yes, ,Yes, , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"1,94",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/27/2014,12/2/2015,12/2/2015, , , , , , , , , 
512,1588,6/15/1943,Male,174,106,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Other type,"9,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,V-X,Other,V-X,Other,4/16/2009,7/6/2009,7/6/2009,8/31/2009,11/12/2009,11/12/2009,1/19/2010,3/1/2010,3/1/2010,4/9/2013,5/28/2014,5/28/2014
513,2526,6/15/1941,Male,176,100,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,09",ISS stage II (neither stage I nor stage III), , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,V-X,V-X,EMP-X,V-X,5/13/2013,9/2/2013,9/2/2013,10/8/2015,10/27/2016,10/27/2016,3/9/2017,1/18/2018,1/18/2018,1/25/2018,2/1/2018,2/1/2018
514,9430,6/15/1942,Male,165,75,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,V-X,No CTx,Other,7/1/1999,10/1/1999,10/1/1999,4/1/2014,12/31/2014,12/31/2014,7/6/2015,12/31/2015,10/14/1582, , , 
515,8522,6/15/1955,Male,180,107,Compulsory health insurance CHI,No,Unknown,Unknown,Yes,Yes,Unknown,Yes,Unknown,Unknown,Unknown,Unknown,1,III: one or more criteria are fulfilled,IgG,"12,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,R-X,V-X,1/13/2014,2/13/2014,2/13/2014, , , , , , ,8/8/2016,1/8/2017,1/8/2017
516,5635,6/15/1936,Female,155,59,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"69,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,V-X,No CTx,V-X,3/4/2014,3/24/2015,3/24/2015,10/27/2015,5/3/2016,5/3/2016,2/20/2017,4/4/2017,4/4/2017, , , 
517,9872,6/15/1942,Male,179,85,Private,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,32",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,LEV-X,No CTx,No CTx,LEV-X,11/23/2015,4/17/2016,4/17/2016,9/25/2017,3/18/2018,3/18/2018, , , , , , 
518,1369,6/15/1944,Female,175,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,35","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,5/10/2010,10/31/2010,10/31/2010,1/14/2013,7/7/2013,7/7/2013,11/30/2015,5/22/2016,5/22/2016, , , 
519,3442,6/15/1942,Male,184,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,83","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,No CTx,No CTx,V-X,10/14/2013,2/23/2014,2/23/2014,11/30/2015,5/22/2016,5/22/2016, , , , , , 
520,4551,6/15/1938,Female,158,57,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Other type,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,12/1/2015,12/23/2015,12/23/2015, , , , , , , , , 
521,9837,6/15/1943,Female,162,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,No CTx,Other,11/1/2003,1/1/2004,1/1/2004,4/1/2010,8/1/2010,8/1/2010,12/22/2011,4/16/2013,4/16/2013, , , 
522,1666,6/15/1952,Female,167,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,12/7/2015,1/24/2016,1/24/2016,8/26/2019,10/27/2019,10/27/2019, , , , , , 
523,7566,6/15/1938,Female,167,80,Compulsory health insurance CHI,No, , , , , , , , ,Yes,Yes,2,III: one or more criteria are fulfilled,IgG,"16,86","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/24/2015,12/31/2015, , , , , , , , , , 
524,2485,6/15/1963,Male,182,115,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,71",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,FAR-X,V-X,R-X,9/19/2009,1/15/2010,1/15/2010,11/15/2013,7/15/2015,7/15/2015,9/15/2015,11/8/2015,11/8/2015,11/9/2015,12/31/2015, 
525,9620,6/15/1942,Male,173,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,65",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,POM-X,No CTx,No CTx,V-X,1/1/2013,1/4/2015,1/4/2015,7/6/2015,12/31/2015, , , , , , , 
526,4783,6/15/1944,Male,172,78,Compulsory health insurance CHI,Unknown,Yes,Yes, , , , , , , , ,9,Unknown,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/15/2015,12/31/2015, , , , , , , , , , 
527,9617,6/15/1936,Female,154,67,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,74",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/5/2015,12/31/2015, , , , , , , , , , 
528,2168,6/15/1943,Female,153,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,R-X,No CTx,V-X,1/1/2012,11/1/2012,11/1/2012,6/1/2013,2/1/2014,2/1/2014,7/27/2015,12/31/2015, , , , 
529,8838,6/15/1945,Male,178,95,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"66,04",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/14/2015,12/2/2015,12/2/2015, , , , , , , , , 
530,3641,6/15/1941,Male,186,86,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"11,7",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,7/22/2014,9/13/2014,9/13/2014,2/27/2015,12/3/2015,12/3/2015, , , , , , 
531,3761,6/15/1943,Female,160,69,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , ,"<3,5 mg/L",Nein,Other,No CTx,No CTx,No CTx, , , ,7/17/2015,11/23/2015,11/23/2015, , , , , , 
532,3033,6/15/1952,Male,175,83,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,5/11/2015,7/23/2015,7/23/2015, , , , , , , , , 
533,4705,6/15/1944,Male,178,80,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,9,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,V-X,V-X,1/29/2010,7/12/2010,7/12/2010,4/4/2012,5/1/2012,5/1/2012,8/16/2012,9/15/2012,9/15/2012,9/15/2012,10/12/2012,10/12/2012
534,6348,6/15/1945,Female,170,85,Private,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/1/2015,10/1/2015,10/1/2015,9/1/2016,5/17/2017,5/17/2017, , , , , , 
535,8779,6/15/1940,Male,171,102,Private,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/1/2015,11/1/2015,11/1/2015,5/1/2016,7/11/2016,7/11/2016, , , , , , 
536,5216,6/15/1952,Male,180,72,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,10/1/2014,1/1/2015,1/1/2015,9/1/2015,4/1/2016,4/1/2016,9/6/2016,3/31/2017, , , , 
537,5696,6/15/1947,Male,180,89,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"61,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,Other,V-X,11/1/2012,6/27/2013,6/27/2013,1/14/2014,6/25/2014,6/25/2014,8/12/2014,10/30/2015,10/30/2015,11/26/2015,12/31/2015, 
538,7746,6/15/1959,Male,183,75,Unknown,No,Yes,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,9,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,V-X,V-X,Other,6/15/2008,1/15/2009,1/15/2009,1/15/2011,9/15/2011,9/15/2011,6/15/2012,3/15/2013,3/15/2013,2/4/2014,9/15/2014,9/15/2014
539,5076,6/15/1968,Female,168,94,Compulsory health insurance CHI,No, , , , , ,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"4,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie, , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,10/26/2015,2/27/2016,2/27/2016,11/23/2016,1/27/2017,1/27/2017,2/2/2017, , , , , 
540,9317,6/15/1936,Male,178,76,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,Unknown,IgA,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,7/5/2013,7/11/2014,7/11/2014,3/13/2015,7/1/2015,7/1/2015, , , , , , 
541,9042,6/15/1936,Male,170,75,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,"999,99",ISS stage II (neither stage I nor stage III), , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,Other,12/1/2009,1/1/2010,1/1/2010,10/27/2015,12/31/2015, , , , , , , 
542,9457,6/15/1938,Female,160,69,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,6/15/2015,7/6/2015,7/6/2015,9/16/2015,6/30/2016,10/14/1582, , , , , , 
543,6827,6/15/1944,Male,169,82,Unknown,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,35",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/15/2015,8/15/2015,8/15/2015, , , , , , , , , 
544,4075,6/15/1941,Male,174,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"8,4",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/26/2013,8/29/2014,8/29/2014,9/9/2015,12/31/2015, , , , , , , 
545,2423,6/15/1942,Male,172,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"9,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,7/25/2013,6/27/2014,6/27/2014,8/19/2015,12/31/2015, , , , , , , 
546,8543,6/15/1940,Male,175,91,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"8,7",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/27/2015,12/31/2015, , , , , , , , , , 
547,3094,6/15/1939,Female,165,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,1",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/14/2013,7/28/2014,7/28/2014,9/30/2015,12/31/2015, , , , , , , 
548,8870,6/15/1949,Female,9,65,Unknown,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,",48",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/22/2015,7/15/2015,7/15/2015, , , , , , , , , 
549,7041,6/15/1942,Female,155,59,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/19/2015,12/31/2015, , , , , , , , , , 
550,5210,6/15/1935,Female,157,63,Compulsory health insurance CHI,No, , , , , ,Yes, , , ,Yes,2,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/10/2015,12/31/2015, , , , , , , , , , 
551,9845,6/15/1945,Male,172,74,Compulsory health insurance CHI,Yes, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"8,4",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,11/2/2015,12/31/2015, , , , , , , , , , 
552,5068,6/15/1958,Male,999,80,Unknown,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,R-X,10/12/2015,12/31/2015, , , , , , , , , , 
553,8208,6/15/1943,Female,165,78,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,"4,16","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/24/2015,12/31/2015, , , , , , , , , , 
554,7720,6/15/1957,Male,185,119,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"9,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,No CTx,No CTx,No CTx,V-X,12/14/2015,2/26/2016,2/26/2016, , , , , , , , , 
555,3254,6/15/1934,Male,188,93,Compulsory health insurance CHI,Yes,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,No CTx,No CTx,V-X,12/14/2015,6/9/2016,6/9/2016,5/6/2019,7/29/2019,7/29/2019, , , , , , 
556,9239,6/15/1950,Male,178,74,Unknown,No,Yes, , , , , , , , ,Yes,2,III: one or more criteria are fulfilled,Other type,"9,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/15/2015,8/15/2015,8/15/2015, , , , , , , , , 
557,2271,6/15/1943,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,No CTx,Other,12/28/2012,1/18/2013,1/18/2013,11/14/2014,3/16/2015,3/16/2015,7/13/2015,1/15/2016,1/15/2016, , , 
558,4153,6/15/1935,Male,176,90,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes,Yes,3,I: fulfilling all 4 criteria,IgA,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,11/16/2015,12/31/2015, , , , , , , , , , 
559,1137,6/15/1943,Male,170,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"1,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/16/2015,4/25/2016,4/25/2016, , , , , , , , , 
560,9887,6/15/1952,Female,175,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,0,I: fulfilling all 4 criteria,IgG,"2,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/14/2015,3/17/2016,3/17/2016, , , , , , , , , 
561,8216,6/15/1944,Male,180,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,0,I: fulfilling all 4 criteria,IgG,"2,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,No CTx,V-X,4/20/2009,6/18/2009,6/18/2009,11/15/2010,1/13/2011,1/13/2011,12/14/2015,1/16/2017,1/16/2017, , , 
562,1559,6/15/1964,Female,163,55,Private,No, , , , , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgA,"2,7",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/1/2015,12/18/2015,12/18/2015, , , , , , , , , 
563,5353,6/15/1960,Male,180,86,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,",3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/30/2015,4/15/2016,4/15/2016, , , , , , , , , 
564,5975,6/15/1933,Male,175,61,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Unbekannt,R-X,No CTx,No CTx,V-X,1/28/2015,5/22/2015,5/22/2015,12/14/2015,12/15/2015,12/15/2015, , , , , , 
565,9752,6/15/1959,Male,175,95,Unknown,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,3,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,R-X,11/11/2015,12/31/2015, , , , , , , , , , 
566,5390,6/15/1951,Female,999,65,Unknown,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"2,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/5/2015,12/31/2015, , , , , , , , , , 
567,9871,6/15/1942,Male,182,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"794,8",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/27/2015,12/31/2015, , , , , , , , , , 
568,5544,6/15/1947,Female,160,102,Compulsory health insurance CHI,Yes,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,250,ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/28/2015,12/10/2015,12/10/2015, , , , , , , , , 
569,9196,6/15/1959,Male,180,103,Unknown,No, , , , ,Yes, , , , ,Yes,1,I: fulfilling all 4 criteria,IgA,"1,16","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,6/15/2014,8/15/2014,8/15/2014,12/15/2014,3/15/2015,3/15/2015, , , , , , 
570,3457,6/15/1959,Male,999,80,Unknown,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,Other,8/15/2003,10/15/2003,10/15/2003,11/27/2015,12/31/2015, , , , , , , 
571,4835,6/15/1965,Male,999,80,Unknown,No, , , , , , , , ,Yes, ,9,III: one or more criteria are fulfilled,IgM,"999,99",unknown/ISS-Criteria not used for prognostics,Yes,Yes,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,V-X,V-X,6/15/2011,8/15/2011,8/15/2011,1/15/2014,4/15/2014,4/15/2014,3/15/2015,3/15/2015,3/15/2015,4/15/2015,6/15/2015,6/15/2015
572,6303,6/15/1963,Male,168,64,Unknown,No, , , , , , , , ,Yes, ,9,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,FAR-X,No CTx,V-X,2/10/2011,3/15/2011,3/15/2011,4/15/2014,11/15/2014,11/15/2014,11/27/2015,12/31/2015, , , , 
573,1345,6/15/1939,Male,175,74,Unknown,No, , , , , , , , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,Other,No CTx, , , ,7/9/2010,8/15/2010,8/15/2010,2/15/2012,2/15/2015,2/15/2015,10/20/2015,12/31/2015, 
574,7066,6/15/1962,Female,999,65,Unknown,No, , ,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,V-X,No CTx,V-X,11/15/2013,2/15/2014,2/15/2014,6/15/2015,9/15/2015,9/15/2015,10/10/2015,12/31/2015,10/14/1582, , , 
575,1058,6/15/1949,Female,159,64,Unknown,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,"3,45",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/15/2015,10/15/2015,10/15/2015, , , , , , , , , 
576,7993,6/15/1957,Female,999,65,Unknown,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,11/15/2014,1/15/2015,1/15/2015,3/15/2015,8/15/2015,8/15/2015, , , , , , 
577,4900,6/15/1950,Male,999,80,Private,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,R-X,R-X,Other,7/15/2007,7/15/2007,7/15/2007,12/15/2008,9/15/2009,9/15/2009,9/15/2009,10/15/2010,10/15/2010,11/15/2010,5/15/2011,5/15/2011
578,6879,6/15/1949,Male,176,75,Unknown,No, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/15/2015,12/31/2015, , , , , , , , , , 
579,3951,6/15/1952,Male,999,80,Unknown,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,KYP-X,V-X,V-X,3/15/2008,5/15/2008,5/15/2008,3/29/2011,9/15/2011,9/15/2011,12/15/2013,11/15/2014,11/15/2014,7/15/2015,9/15/2015,9/15/2015
580,5536,6/15/1954,Male,999,80,Unknown,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,V-X,No CTx,V-X,12/15/2011,2/15/2012,2/15/2012,1/15/2014,5/15/2014,5/15/2014,4/25/2015,7/15/2015,7/15/2015, , , 
581,1412,6/15/1963,Male,999,80,Unknown,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,Other,10/15/2005,1/15/2006,1/15/2006,12/1/2015,12/31/2015, , , , , , , 
582,3706,6/15/1955,Male,183,105,Unknown,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"1,56","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/2/2015,12/31/2015, , , , , , , , , , 
583,4207,6/15/1937,Male,999,80,Unknown,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,3,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,11/17/2015,12/31/2015, , , , , , , , , , 
584,9031,6/15/1937,Male,171,84,Unknown,Yes, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"1,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/15/2015,12/31/2015, , , , , , , , , , 
585,8006,6/15/1954,Male,174,96,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,678,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/10/2015,10/2/2015,10/2/2015, , , , , , , , , 
586,3701,6/15/1954,Male,183,100,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,I: fulfilling all 4 criteria,Other type,50,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/14/2015,12/31/2015,12/31/2015,9/10/2018,6/30/2019,10/14/1582, , , , , , 
587,7290,6/15/1934,Male,158,56,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,11/2/2015,4/29/2016,4/29/2016, , , , , , , , , 
588,4294,6/15/1941,Male,180,72,Private,Yes, , , , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"45,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,11/14/2012,11/29/2013,11/29/2013,10/7/2015,4/12/2016,4/12/2016, , , , , , 
589,3246,6/15/1949,Male,176,85,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"57,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/28/2015,3/4/2016,3/4/2016, , , , , , , , , 
590,5616,6/15/1940,Male,180,80,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/6/2015,12/31/2017, , , , , , , , , , 
591,1904,6/15/1985,Female,175,62,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"6,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,Other,V-X,No CTx,V-X,8/5/2012,11/15/2012,11/15/2012,10/6/2015,10/7/2015,10/7/2015,1/22/2018,3/26/2018,3/26/2018, , , 
592,6952,6/15/1944,Female,159,54,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"4,5",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/3/2014,11/3/2014,11/3/2014,10/10/2015,12/31/2015, , , , , , , 
593,4998,6/15/1936,Male,164,66,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/9/2015,9/2/2015,9/2/2015,9/10/2015,3/31/2022,10/14/1582, , , , , , 
594,1954,6/15/1948,Female,157,43,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/11/2015,12/15/2015,12/15/2015, , , , , , , , , 
595,8314,6/15/1938,Male,170,60,Compulsory health insurance CHI,Yes, , ,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"51,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,V-X,10/22/2015,3/15/2016,3/15/2016, , , , , , , , , 
596,2681,6/15/1939,Male,175,83,Private,Yes, ,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,54,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,3/7/2012,3/22/2013,3/22/2013,9/24/2015,3/31/2016,3/31/2016, , , , , , 
597,2270,6/15/1938,Male,170,68,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"14,5",unknown/ISS-Criteria not used for prognostics,No,9,No,No,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,V-X,12/11/2015,3/15/2016,3/15/2016, , , , , , , , , 
598,3689,6/15/1965,Male,191,104,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,10/9/2015,1/11/2016,1/11/2016,2/12/2019,3/31/2022, , , , , , , 
599,5833,6/15/1957,Male,178,84,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"61,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/16/2015,4/29/2016,4/29/2016, , , , , , , , , 
600,2150,6/15/1938,Female,153,60,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgA,"999,99",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/23/2015,9/28/2015,9/28/2015, , , , , , , , , 
601,6506,6/15/1929,Female,160,56,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"45,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,Other,7/8/2015,3/15/2016,3/15/2016, , , , , , , , , 
602,4745,6/15/1936,Female,168,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,Other,DAR-X,KYP-X,V-X,12/11/2015,12/19/2016,12/19/2016,1/15/2017,3/15/2017,3/15/2017,7/6/2017,11/30/2018,11/30/2018,12/13/2018,9/5/2019,9/5/2019
603,2937,6/15/1947,Male,172,63,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgM,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,11/1/2015,12/31/2015, , , , , , , , , , 
604,9780,6/15/1945,Male,184,71,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,9/16/2015,3/22/2016,3/22/2016,12/8/2016,2/27/2017,2/27/2017,3/7/2017,11/8/2017,11/8/2017,12/1/2017,12/22/2017,12/22/2017
605,3681,6/15/1941,Male,171,79,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/21/2014,5/16/2014,5/16/2014, , , , , , , , , 
606,2038,6/15/1934,Male,182,77,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,R-X,No CTx,V-X,11/15/2011,7/15/2012,7/15/2012,2/12/2014,7/30/2014,7/30/2014,9/4/2015,8/16/2016,8/16/2016, , , 
607,1566,6/15/1940,Male,174,99,Unknown,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"99,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,No CTx, , , ,8/3/2015,12/31/2015, , , , , , , 
608,8562,6/15/1951,Female,169,80,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"8,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,11/9/2015,3/24/2016,3/24/2016,4/11/2016,11/17/2016,11/17/2016, , , , , , 
609,3160,6/15/1949,Male,178,73,Compulsory health insurance CHI,No, ,Yes, ,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,12/1/2015,3/28/2016,3/28/2016,10/6/2016,3/28/2018,3/28/2018,4/19/2018,10/11/2020,10/11/2020,10/22/2020,3/31/2022, 
610,5759,6/15/1950,Female,168,59,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,10/20/2015,4/11/2016,4/11/2016,8/30/2016,1/25/2017,1/25/2017,2/7/2017,9/11/2017,9/11/2017,9/27/2017,3/14/2018,3/14/2018
611,7089,6/15/1944,Male,179,66,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"7,91",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,Other,V-X,11/17/2015,4/5/2016,4/5/2016,4/25/2016,8/31/2017,8/31/2017,9/20/2017,4/10/2018,4/10/2018,5/4/2018,6/14/2018,6/14/2018
612,4704,6/15/1948,Female,172,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,10/19/2015,2/8/2016,2/8/2016,2/22/2016,11/22/2016,11/22/2016, , , , , , 
613,2368,6/15/1950,Male,170,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,No CTx,No CTx, , , ,12/3/2012,3/10/2013,3/10/2013,10/5/2015,12/31/2015, , , , 
614,8302,6/15/1950,Male,183,80,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,192,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/28/2015,12/31/2015, , , , , , , , , , 
615,6575,6/15/1943,Female,162,53,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"53,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,3/6/2015,7/14/2015,7/14/2015,8/20/2015,12/31/2015, , , , , , , 
616,8971,6/15/1930,Female,162,78,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/6/2015,5/21/2016,5/21/2016, , , , , , , , , 
617,6701,6/15/1937,Female,164,57,Compulsory health insurance CHI,Yes, , ,Yes,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"47,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,No CTx,V-X,9/12/2012,3/22/2013,3/22/2013,6/2/2014,12/12/2014,12/12/2014,10/21/2015,9/30/2016, , , , 
618,6677,6/15/1940,Male,176,82,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,FAR-X,V-X,7/3/2013,10/9/2013,10/9/2013,8/19/2015,6/24/2016,6/24/2016,8/15/2016,3/7/2017,3/7/2017,3/21/2017,11/13/2017,11/13/2017
619,2843,6/15/1941,Female,171,78,Private,No, , , , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"62,4",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,V-X,DAR-X,V-X,10/9/2012,8/9/2013,8/9/2013,4/7/2014,9/26/2014,9/26/2014,8/12/2015,1/26/2016,1/26/2016,6/28/2016,9/30/2016, 
620,7026,6/15/1947,Male,175,80,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,EMP-X,POM-X,V-X,3/15/2013,6/15/2013,6/15/2013,3/15/2015,11/15/2015,11/15/2015,1/18/2016,3/15/2016,3/15/2016,3/16/2016,4/26/2016,4/26/2016
621,9168,6/15/1943,Female,168,71,Private,No, , ,Yes,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"66,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,EMP-X,No CTx,V-X,8/20/2013,9/5/2014,9/5/2014,11/4/2015,4/15/2016,4/15/2016,9/14/2016,9/30/2016, , , , 
622,9160,6/15/1937,Female,164,55,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,IgG,"69,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,10/13/2015,3/24/2016,3/24/2016, , , , , , , , , 
623,4898,6/15/1950,Male,178,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"4,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,1/1/2015,3/15/2015,3/15/2015,11/1/2015,12/31/2015, , , , , , , 
624,3425,6/15/1939,Male,178,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,61,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,V-X,No CTx,V-X,9/6/2011,9/21/2012,9/21/2012,5/13/2014,11/21/2014,11/21/2014,11/17/2015,4/8/2016,4/8/2016, , , 
625,1934,6/15/1942,Male,184,69,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,FAR-X,DAR-X,V-X,4/1/2011,9/1/2011,9/1/2011,12/16/2015,9/16/2016,9/16/2016,10/6/2016,9/19/2017,9/19/2017,10/12/2017,3/23/2018,3/23/2018
626,2838,6/15/1946,Female,172,59,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,R-X,No CTx,V-X,2/1/2013,4/30/2013,4/30/2013,1/1/2014,3/31/2014,3/31/2014,10/1/2015,12/31/2015,10/14/1582, , , 
627,8361,6/15/1954,Female,163,64,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"5,3",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,12/21/2015,12/31/2015, , , , , , , , , , 
628,5293,6/15/1953,Male,178,97,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"4,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/21/2015,3/21/2016,3/21/2016, , , , , , , , , 
629,4582,6/15/1942,Male,186,74,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"69,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,R-X,V-X,V-X,6/15/2009,8/15/2009,8/15/2009,12/15/2012,1/15/2014,1/15/2014,9/15/2014,5/15/2015,5/15/2015,9/16/2015,11/26/2015,11/26/2015
630,9115,6/15/1945,Male,183,82,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,41",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,POM-X,V-X,11/1/2012,5/29/2013,5/29/2013,9/21/2015,6/24/2016,6/24/2016,8/2/2016,12/15/2016,12/15/2016,1/2/2017,2/23/2017,2/23/2017
631,3453,6/15/1947,Female,169,59,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,FAR-X,DAR-X,V-X,5/1/2012,9/1/2012,9/1/2012,10/8/2015,9/28/2016,9/28/2016,10/23/2016,2/23/2017,2/23/2017,3/10/2017,3/24/2017,3/24/2017
632,4127,6/15/1937,Male,169,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,3",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/15/2014,5/17/2015,5/17/2015,12/10/2015,12/31/2015, , , , , , , 
633,8759,6/15/1940,Male,185,63,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,52",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,Other,V-X,5/1/2012,9/1/2012,9/1/2012,12/14/2015,6/24/2016,6/24/2016,7/18/2016,9/12/2016,9/12/2016,9/19/2016,12/29/2016,12/29/2016
634,1551,6/15/1938,Female,173,58,Private,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,10/1/2011,3/1/2012,3/1/2012,8/13/2015,6/27/2016,6/27/2016,7/13/2016,12/20/2016,12/20/2016,1/2/2017,3/6/2017,3/6/2017
635,8847,6/15/1946,Female,169,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,NIN-X,V-X,2/1/2012,7/1/2012,7/1/2012,11/19/2015,12/14/2016,12/14/2016,1/4/2017,8/3/2017,8/3/2017,8/27/2017,2/27/2018,2/27/2018
636,9030,6/15/1938,Male,179,88,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,R-X,V-X,2/1/2013,7/1/2013,7/1/2013,9/28/2015,3/18/2016,3/18/2016,4/13/2016,11/16/2016,11/16/2016,12/6/2016,3/7/2017,3/7/2017
637,8129,6/15/1953,Female,168,57,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,28",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,5/1/2012,9/1/2012,9/1/2012,10/29/2015,12/23/2016,12/23/2016,1/13/2017,1/31/2017,1/31/2017, , , 
638,1948,6/15/1940,Male,184,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,18",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,POM-X,V-X,6/1/2013,11/1/2013,11/1/2013,12/7/2015,6/30/2016,6/30/2016,7/18/2016,12/16/2016,12/16/2016,1/9/2017,3/19/2017,3/19/2017
639,5538,6/15/1940,Female,169,81,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,11/24/2015,6/13/2016,6/13/2016,10/6/2016,3/6/2017,3/6/2017,3/17/2017,9/28/2017,9/28/2017,10/11/2017,11/10/2017,11/10/2017
640,1424,6/15/1943,Male,184,97,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,02","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,10/20/2015,2/22/2016,2/22/2016,3/3/2017,2/26/2020,2/26/2020, , , , , , 
641,5372,6/15/1947,Female,164,58,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,NIN-X,V-X,12/8/2015,5/9/2016,5/9/2016,10/25/2016,3/9/2017,3/9/2017,3/23/2017,6/28/2017,6/28/2017,7/13/2017,8/2/2017,8/2/2017
642,3156,6/15/1949,Male,180,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,V-X,V-X,11/23/2015,4/18/2016,4/18/2016,10/14/2016,3/10/2017,3/10/2017,3/17/2017,10/27/2017,10/27/2017,11/9/2017,4/3/2018,4/3/2018
643,4526,6/15/1950,Male,191,84,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,Other,LEV-X,12/7/2015,5/17/2016,5/17/2016,5/27/2016,12/28/2016,12/28/2016,1/9/2017,8/25/2017,8/25/2017,9/7/2017,9/18/2017,9/18/2017
644,9041,6/15/1950,Male,179,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"9,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,10/26/2015,4/19/2016,4/19/2016,5/9/2016,1/12/2017,1/12/2017,2/1/2017,9/13/2017,9/13/2017,9/28/2017,11/7/2017,11/7/2017
645,7145,6/15/1946,Male,181,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,KYP-X,V-X,V-X,8/1/2013,1/1/2014,1/1/2014,10/29/2015,6/27/2016,6/27/2016,7/18/2016,11/14/2016,11/14/2016,11/22/2016,2/2/2017,2/2/2017
646,8203,6/15/1948,Male,173,91,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,EMP-X,V-X,4/1/2012,9/1/2012,9/1/2012,11/30/2015,3/8/2017,3/8/2017,3/22/2017,8/7/2017,8/7/2017,8/24/2017,4/16/2018,4/16/2018
647,1505,6/15/1952,Male,184,83,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,R-X,DAR-X,V-X,5/1/2013,9/1/2013,9/1/2013,12/7/2015,8/11/2016,8/11/2016,12/15/2016,6/28/2017,6/28/2017,7/11/2017,3/15/2018,3/15/2018
648,6629,6/15/1950,Male,172,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,61",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,12/1/2012,5/1/2013,5/1/2013,10/5/2015,3/31/2016,3/31/2016, , , , , , 
649,8782,6/15/1953,Male,181,88,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,44",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,2/1/2013,6/1/2013,6/1/2013,12/17/2015,6/26/2017,6/26/2017,7/10/2017,10/26/2017,10/26/2017,11/16/2017,11/28/2017,11/28/2017
650,4789,6/15/1949,Female,175,58,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"12,96",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,10/20/2015,4/6/2016,4/6/2016,4/22/2016,12/19/2016,12/19/2016,12/29/2016,9/4/2017,9/4/2017,10/4/2017,5/17/2018,5/17/2018
651,5049,6/15/1949,Male,184,68,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,61",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,11/9/2015,3/28/2016,3/28/2016,4/15/2016,8/30/2017,8/30/2017,9/14/2017,4/6/2018,4/6/2018,4/27/2018,1/9/2020,1/9/2020
652,1610,6/15/1946,Female,168,71,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"14,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,Other,V-X,10/8/2015,4/14/2016,4/14/2016,4/26/2016,12/21/2016,12/21/2016,1/9/2017,4/24/2017,4/24/2017,5/11/2017,7/6/2017,7/6/2017
653,6544,6/15/1939,Male,181,74,Private,No,Yes, ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"9,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,R-X,Other,LEV-X,12/28/2015,3/21/2016,3/21/2016,3/31/2016,2/21/2017,2/21/2017,3/3/2017,2/20/2018,2/20/2018,3/8/2018,5/18/2018,5/18/2018
654,1218,6/15/1948,Female,167,64,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,65",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,9/24/2015,1/19/2016,1/19/2016,2/8/2016,10/20/2016,10/20/2016, , , , , , 
655,8370,6/15/1946,Male,174,73,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"12,16","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,10/19/2015,2/12/2016,2/12/2016,4/20/2017,6/28/2019,6/28/2019,7/2/2019,3/31/2022,10/14/1582, , , 
656,1449,6/15/1942,Male,181,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,62",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,KYP-X,FAR-X,V-X,8/1/2012,1/1/2013,1/1/2013,11/4/2015,5/17/2016,5/17/2016,7/20/2016,10/26/2016,10/26/2016,10/27/2016,7/13/2017,7/13/2017
657,1909,6/15/1939,Female,173,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,99",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,KYP-X,V-X,1/1/2012,6/1/2012,6/1/2012,12/1/2015,9/27/2016,9/27/2016,10/11/2016,4/28/2017,4/28/2017,5/15/2017,6/27/2017,6/27/2017
658,6366,6/15/1947,Male,176,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,23",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,POM-X,KYP-X,V-X,4/1/2012,9/1/2012,9/1/2012,11/24/2015,4/19/2016,4/19/2016,4/29/2016,11/14/2016,11/14/2016,12/5/2016,2/23/2017,2/23/2017
659,1630,6/15/1946,Male,172,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,49",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,4/1/2013,9/1/2013,9/1/2013,11/10/2015,9/22/2016,9/22/2016,10/12/2016,6/6/2017,6/6/2017,6/20/2017,2/7/2018,2/7/2018
660,3087,6/15/1938,Female,164,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"53,5",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,R-X,DAR-X,V-X,5/14/2012,11/30/2012,11/30/2012,4/2/2014,10/10/2014,10/10/2014,9/11/2015,8/19/2016,8/19/2016,8/30/2016,9/30/2016, 
661,5628,6/15/1942,Female,170,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"11,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,R-X,KYP-X,V-X,3/1/2013,8/1/2013,8/1/2013,12/14/2015,5/27/2016,5/27/2016,7/14/2016,2/10/2017,2/10/2017,2/20/2017,7/19/2017,7/19/2017
662,1134,6/15/1943,Female,168,62,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"9,15",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,11/1/2012,5/1/2013,5/1/2013,10/24/2015,4/18/2016,4/18/2016, , , , , , 
663,2237,6/15/1947,Female,162,51,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,19",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,EMP-X,DAR-X,LEV-X,10/13/2015,3/21/2016,3/21/2016,3/31/2016,3/13/2017,3/13/2017,3/30/2017,4/10/2018,4/10/2018,4/20/2018,12/5/2018,12/5/2018
664,5443,6/15/1951,Male,186,89,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,07",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,R-X,POM-X,V-X,11/2/2015,4/27/2016,4/27/2016,5/10/2016,12/28/2016,12/28/2016,1/9/2017,8/21/2017,8/21/2017,8/31/2017,11/20/2017,11/20/2017
665,6134,6/15/1940,Male,182,83,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,EMP-X,V-X,9/14/2015,3/28/2016,3/28/2016,4/8/2016,11/13/2017,11/13/2017,12/4/2017,6/18/2018,6/18/2018,7/11/2018,8/30/2018,8/30/2018
666,5666,6/15/1938,Female,165,53,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"5,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,NIN-X,EMP-X,LEV-X,11/19/2015,5/9/2016,5/9/2016,5/31/2016,11/15/2016,11/15/2016,11/24/2016,9/8/2017,9/8/2017,9/19/2017,4/13/2018,4/13/2018
667,8075,6/15/1936,Male,172,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,45",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,EMP-X,V-X,12/6/2015,3/21/2016,3/21/2016,4/5/2016,9/4/2017,9/4/2017,9/27/2017,7/20/2021,7/20/2021,8/10/2021,3/31/2022,10/14/1582
668,6947,6/15/1944,Male,175,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,29",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,11/1/2012,3/1/2013,3/1/2013,9/24/2015,9/16/2016,9/16/2016,10/11/2016,11/17/2016,11/17/2016, , , 
669,8981,6/15/1945,Female,167,54,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,10/1/2013,4/1/2014,4/1/2014,10/22/2015,2/5/2016,2/5/2016, , , , , , 
670,8891,6/15/1949,Male,183,91,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,94",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,8/1/2013,2/1/2014,2/1/2014,11/16/2015,9/13/2016,9/13/2016,10/4/2016,12/5/2016,12/5/2016, , , 
671,5115,6/15/1940,Female,162,51,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,KYP-X,V-X,10/17/2012,4/24/2013,4/24/2013,10/5/2015,2/19/2016,2/19/2016,3/4/2016,11/3/2016,11/3/2016,11/23/2016,4/14/2017,4/14/2017
672,2138,6/15/1946,Female,175,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"12,4",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,R-X,V-X,9/1/2012,2/1/2013,2/1/2013,12/9/2015,9/23/2016,9/23/2016,10/4/2016,10/30/2016,10/30/2016,10/31/2016,4/21/2017,4/21/2017
673,2663,6/15/1950,Male,182,90,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,9,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,12/7/2015,3/21/2016,3/21/2016,9/7/2016,12/29/2016,12/29/2016,1/17/2017,3/29/2018,3/29/2018, , , 
674,6231,6/15/1941,Male,174,52,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,1",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,V-X,V-X,11/3/2015,2/29/2016,2/29/2016,3/14/2016,11/23/2017,11/23/2017,12/18/2017,11/21/2019,11/21/2019,11/28/2019,4/30/2020,4/30/2020
675,6548,6/15/1938,Male,175,75,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,19",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,11/30/2015,3/28/2016,3/28/2016,4/7/2016,5/17/2016,5/17/2016, , , , , , 
676,8571,6/15/1941,Male,179,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,7",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,EMP-X,LEV-X,10/29/2015,2/22/2016,2/22/2016,3/14/2016,9/21/2017,9/21/2017,10/16/2017,4/30/2018,4/30/2018,5/11/2018,5/27/2021,5/27/2021
677,5450,6/15/1946,Male,172,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,EMP-X,DAR-X,NIN-X,V-X,10/22/2015,2/4/2016,2/4/2016,5/22/2017,12/7/2018,12/7/2018,3/21/2019,5/24/2019,5/24/2019,6/28/2019,7/17/2019,7/17/2019
678,3702,6/15/1938,Female,165,55,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,06",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,11/17/2015,5/18/2016,5/18/2016,6/3/2016,9/28/2017,9/28/2017, , , , , , 
679,7153,6/15/1965,Female,177,65,Private,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"6,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,No CTx,V-X,3/24/2014,5/26/2014,5/26/2014,8/8/2017,10/31/2017,10/31/2017,9/11/2018,9/30/2019,10/14/1582, , , 
680,7240,6/15/1937,Male,181,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,I: fulfilling all 4 criteria,IgG,64,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,LEV-X,No CTx,V-X,11/4/2015,8/6/2016,8/6/2016,12/16/2016,6/27/2017,6/27/2017,6/30/2017,10/5/2017,10/5/2017, , , 
681,4708,6/15/1949,Male,182,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,7/1/2012,11/1/2012,11/1/2012,9/22/2015,2/12/2016,2/12/2016, , , , , , 
682,5673,6/15/1935,Female,171,54,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,49",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,8/14/2013,2/19/2014,2/19/2014,10/5/2015,9/21/2016,9/21/2016,10/5/2016,1/20/2017,1/20/2017,2/27/2017,9/11/2017,9/11/2017
683,5410,6/15/1940,Female,164,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,77",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,POM-X,V-X,9/17/2015,3/14/2016,3/14/2016,4/8/2016,12/5/2017,12/5/2017,1/3/2018,7/4/2018,7/4/2018,1/24/2019,12/31/2021, 
684,8700,6/15/1938,Male,174,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,5/1/2013,10/1/2013,10/1/2013,11/17/2015,5/2/2016,5/2/2016, , , , , , 
685,6697,6/15/1944,Female,162,51,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,NIN-X,V-X,3/1/2013,9/1/2013,9/1/2013,11/9/2015,9/20/2016,9/20/2016,10/13/2016,2/1/2017,2/1/2017,2/9/2017,7/20/2017,7/20/2017
686,3408,6/15/1949,Male,180,74,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"9,18","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,EMP-X,DAR-X,LEV-X,12/15/2015,5/23/2016,5/23/2016,6/6/2016,12/20/2017,12/20/2017,1/10/2019,3/7/2019,3/7/2019,3/28/2019,4/18/2019,4/18/2019
687,3592,6/15/1952,Female,170,62,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,Other,V-X,Other,LEV-X,11/12/2015,5/18/2016,5/18/2016,5/31/2016,3/10/2017,3/10/2017,3/27/2017,8/11/2017,8/11/2017,8/24/2017,11/16/2017,11/16/2017
688,1342,6/15/1946,Male,189,81,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,27",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,10/14/2015,4/8/2016,4/8/2016,5/2/2016,12/18/2017,12/18/2017,1/2/2018,8/9/2018,8/9/2018,8/23/2018,9/17/2018,9/17/2018
689,3678,6/15/1939,Male,182,85,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"12,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,DAR-X,V-X,V-X,11/12/2015,3/21/2016,3/21/2016,4/4/2016,11/7/2017,11/7/2017,1/4/2018,7/5/2018,7/5/2018,3/22/2019,3/25/2019,3/25/2019
690,3132,6/15/1942,Male,182,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,91",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,3/1/2013,9/1/2013,9/1/2013,8/26/2015,12/31/2015, , , , , , , 
691,1667,6/15/1946,Male,174,102,Private,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"9,42","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,2/17/2014,8/18/2014,8/18/2014,10/13/2015,12/31/2015, , , , , , , 
692,5842,6/15/1937,Male,189,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"6,99",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,9/1/2013,3/1/2014,3/1/2014,9/21/2015,12/31/2015, , , , , , , 
693,8064,6/15/1938,Female,167,68,Private,No, ,Yes,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,"4,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,LEV-X,DAR-X,V-X,10/15/2015,7/19/2016,7/19/2016,2/15/2017,5/15/2017,5/15/2017,9/19/2017,12/14/2017,12/14/2017,3/20/2018,3/31/2018, 
694,2514,6/15/1932,Female,171,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,42","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,1/1/2012,7/1/2012,7/1/2012,11/6/2015,12/31/2015, , , , , , , 
695,5199,6/15/1945,Female,168,91,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,06","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,8/20/2012,2/19/2013,2/19/2013,12/8/2015,12/31/2015, , , , , , , 
696,8340,6/15/1940,Male,183,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,V-X,4/1/2013,10/1/2013,10/1/2013,9/17/2015,12/31/2015, , , , , , , 
697,8185,6/15/1947,Male,178,74,Private,No, , ,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,61",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,9/11/2013,3/19/2014,3/19/2014,11/4/2015,12/31/2015, , , , , , , 
698,4168,6/15/1951,Male,175,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,36",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/20/2015,12/31/2015, , , , , , , , , , 
699,4841,6/15/1945,Male,180,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,51",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,10/20/2015,12/31/2015, , , , , , , , , , 
700,3539,6/15/1939,Male,169,85,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/29/2015,12/31/2015, , , , , , , , , , 
701,7894,6/15/1942,Female,166,59,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/4/2015,12/31/2015, , , , , , , , , , 
702,8689,6/15/1946,Female,159,54,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,18","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/9/2015,12/31/2015, , , , , , , , , , 
703,6662,6/15/1946,Male,173,89,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,79",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/14/2015,12/31/2015, , , , , , , , , , 
704,2202,6/15/1954,Male,181,82,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,47",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,KYP-X,V-X,10/1/2013,3/1/2014,3/1/2014,9/16/2015,6/23/2016,6/23/2016,7/12/2016,12/29/2016,12/29/2016,1/19/2017,2/7/2017,2/7/2017
705,3055,6/15/1942,Male,174,69,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,94",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,1/7/2014,7/15/2014,7/15/2014,11/16/2015,12/21/2016,12/21/2016,1/2/2017,1/12/2017,1/12/2017, , , 
706,5811,6/15/1946,Male,179,80,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"9,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,9/2/2013,3/13/2014,3/13/2014,10/5/2015,2/2/2016,2/2/2016, , , , , , 
707,3465,6/15/1939,Male,191,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"8,44",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,No CTx,No CTx,V-X,5/12/2014,11/17/2014,11/17/2014,10/19/2015,4/11/2016,4/11/2016, , , , , , 
708,4882,6/15/1938,Female,165,61,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,FAR-X,DAR-X,V-X,3/14/2014,8/29/2014,8/29/2014,8/31/2015,4/19/2016,4/19/2016,7/5/2016,12/20/2016,12/20/2016,1/2/2017,6/8/2017,6/8/2017
709,5776,6/15/1939,Male,174,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,FAR-X,POM-X,V-X,8/5/2014,2/10/2015,2/10/2015,9/28/2015,5/11/2016,5/11/2016,7/4/2016,12/14/2016,12/14/2016,1/2/2017,3/9/2017,3/9/2017
710,3661,6/15/1941,Male,185,76,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,3/27/2014,9/11/2014,9/11/2014,12/1/2015,9/23/2016,9/23/2016,10/4/2016,1/26/2017,1/26/2017,2/7/2017,3/16/2017,3/16/2017
711,3065,6/15/1940,Female,169,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,12/9/2014,5/9/2015,5/9/2015,11/3/2015,6/30/2016,6/30/2016,7/12/2016,11/18/2016,11/18/2016,12/12/2016,5/29/2017,5/29/2017
712,5119,6/15/1945,Female,165,49,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"11,91",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,EMP-X,V-X,10/6/2014,3/30/2015,3/30/2015,12/14/2015,12/8/2016,12/8/2016,1/2/2017,8/3/2017,8/3/2017,8/18/2017,9/7/2017,9/7/2017
713,6037,6/15/1948,Male,172,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,9/28/2015,1/18/2016,1/18/2016,2/9/2016,8/18/2017,8/18/2017,9/11/2017,5/7/2018,5/7/2018,5/17/2018,6/11/2019,6/11/2019
714,1771,6/15/1946,Male,185,79,Private,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,11/5/2015,2/26/2016,2/26/2016,3/17/2016,9/13/2017,9/13/2017,10/5/2017,12/9/2017,12/9/2017, , , 
715,9904,6/15/1950,Male,174,89,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,09",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,11/17/2015,5/18/2016,5/18/2016,6/2/2016,11/16/2017,11/16/2017,12/11/2017,6/25/2018,6/25/2018, , , 
716,2763,6/15/1943,Female,165,54,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,85",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,POM-X,V-X,11/26/2015,3/21/2016,3/21/2016,4/14/2016,10/23/2017,10/23/2017,11/9/2017,2/5/2019,2/5/2019,3/21/2019,12/31/2021, 
717,4243,6/15/1942,Female,159,52,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/23/2015,3/14/2016,3/14/2016, , , , , , , , , 
718,7805,6/15/1940,Male,177,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,EMP-X,DAR-X,V-X,11/23/2015,3/28/2016,3/28/2016,4/8/2016,10/4/2017,10/4/2017,10/19/2017,8/27/2018,8/27/2018,9/18/2018,5/4/2020,5/4/2020
719,8839,6/15/1947,Male,181,78,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,12/8/2015,3/29/2016,3/29/2016,5/9/2016,11/24/2016,11/24/2016, , , , , , 
720,9350,6/15/1945,Male,174,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"8,19",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,LEV-X,11/3/2015,4/25/2016,4/25/2016,5/11/2016,9/4/2017,9/4/2017,9/21/2017,10/11/2017,10/11/2017, , , 
721,6011,6/15/1949,Male,182,71,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"13,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,KYP-X,No CTx,V-X,6/28/2012,11/5/2012,11/5/2012,9/28/2015,1/8/2016,1/8/2016,10/21/2016,6/20/2017,6/20/2017, , , 
722,3487,6/15/1944,Female,165,63,Compulsory health insurance CHI,No, ,Yes, , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,2/10/2014,8/18/2014,8/18/2014,11/16/2015,6/20/2016,6/20/2016,7/26/2016,10/31/2016,10/31/2016,11/18/2016,11/23/2016,11/23/2016
723,8131,6/15/1942,Female,175,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"12,03","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,2/10/2014,9/22/2014,9/22/2014,12/7/2015,9/23/2016,9/23/2016,10/17/2016,5/9/2017,5/9/2017,5/23/2017,6/16/2017,6/16/2017
724,4498,6/15/1940,Female,174,69,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,1/28/2014,6/2/2014,6/2/2014,8/31/2015,4/26/2016,4/26/2016, , , , , , 
725,6766,6/15/1942,Female,169,64,Private,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,2/10/2014,7/22/2014,7/22/2014,9/23/2015,11/24/2016,11/24/2016,12/5/2016,3/6/2017,3/6/2017,3/23/2017,8/1/2017,8/1/2017
726,5181,6/15/1945,Male,176,81,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,R-X,DAR-X,V-X,10/26/2015,4/11/2016,4/11/2016,11/8/2016,11/23/2016,11/23/2016,11/24/2016,7/26/2017,7/26/2017,8/9/2017,8/28/2017,8/28/2017
727,2784,6/15/1946,Male,172,75,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"7,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,NIN-X,DAR-X,NIN-X,V-X,11/17/2015,3/21/2016,3/21/2016,6/23/2017,6/5/2019,6/5/2019,6/27/2019,8/23/2020,8/23/2020,8/31/2020,9/30/2020, 
728,1569,6/15/1948,Female,171,78,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/14/2015,1/8/2016,1/8/2016, , , , , , , , , 
729,4889,6/15/1943,Male,184,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,22",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,DAR-X,V-X,10/6/2015,3/31/2016,3/31/2016,9/19/2016,3/22/2018,3/22/2018,4/6/2018,2/14/2019,2/14/2019,3/22/2019,6/13/2019,6/13/2019
730,8677,6/15/1940,Male,173,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/28/2015,4/20/2016,4/20/2016, , , , , , , , , 
731,8856,6/15/1942,Male,176,84,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,FAR-X,DAR-X,V-X,2/26/2014,8/27/2014,8/27/2014,9/28/2015,6/27/2016,6/27/2016,7/11/2016,12/19/2016,12/19/2016,1/13/2017,1/16/2017,1/16/2017
732,5194,6/15/1939,Female,162,54,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,12/3/2013,4/22/2014,4/22/2014,10/26/2015,12/12/2016,12/12/2016,12/30/2016,8/11/2017,8/11/2017,8/29/2017,8/29/2017,8/29/2017
733,4764,6/15/1936,Male,182,76,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"8,21",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,Other,Other,V-X,8/26/2013,2/4/2014,2/4/2014,11/10/2015,7/12/2016,7/12/2016,11/17/2016,2/6/2017,2/6/2017,2/21/2017,4/10/2017,4/10/2017
734,1538,6/15/1948,Female,168,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,DAR-X,KYP-X,V-X,1/7/2014,5/28/2014,5/28/2014,11/18/2015,5/17/2016,5/17/2016,8/16/2016,12/20/2016,12/20/2016,1/13/2017,6/15/2017,6/15/2017
735,8025,6/15/1941,Male,177,70,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,No CTx,V-X,4/28/2014,10/27/2014,10/27/2014,9/17/2015,6/22/2016,6/22/2016,7/12/2016,12/16/2016,12/16/2016, , , 
736,8508,6/15/1945,Female,170,65,Private,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,POM-X,V-X,10/6/2015,4/19/2016,4/19/2016,5/12/2016,9/28/2017,9/28/2017,10/9/2017,12/6/2018,12/6/2018,12/18/2018,6/30/2019, 
737,4946,6/15/1939,Male,189,81,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"8,82","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,EMP-X,DAR-X,LEV-X,12/14/2015,4/20/2016,4/20/2016,5/13/2016,12/11/2017,12/11/2017,1/3/2018,11/1/2018,11/1/2018,11/16/2018,4/11/2019,4/11/2019
738,6664,6/15/1942,Female,173,63,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,4",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,11/6/2015,3/23/2016,3/23/2016,4/4/2016,1/4/2018,1/4/2018,1/23/2018,2/5/2019,2/5/2019,3/7/2019,12/8/2020,12/8/2020
739,6477,6/15/1951,Male,180,92,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"12,61",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/21/2015,2/3/2016,2/3/2016, , , , , , , , , 
740,4589,6/15/1949,Male,184,76,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,35",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,11/27/2015,7/1/2016,7/1/2016,7/15/2016,9/26/2016,9/26/2016, , , , , , 
741,3299,6/15/1939,Female,169,80,Private,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"54,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,V-X,No CTx,V-X,2/28/2012,9/7/2012,9/7/2012,9/20/2014,11/27/2015,11/27/2015,12/10/2015,5/20/2016,5/20/2016, , , 
742,9680,6/15/1956,Female,169,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"31,6",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,7/15/2015,11/12/2015,11/12/2015, , , , , , , , , 
743,6714,6/15/1942,Female,158,61,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,59,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,Other,2/15/2014,11/15/2014,11/15/2014,12/10/2015,9/19/2016,9/19/2016, , , , , , 
744,5419,6/15/1954,Male,186,172,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"45,3",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,8/14/2015,11/15/2015,11/15/2015,8/8/2017,10/17/2017,10/17/2017, , , , , , 
745,4223,6/15/1951,Male,168,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,12,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,9/18/2015,11/13/2015,11/13/2015, , , , , , , , , 
746,7595,6/15/1958,Male,177,89,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,LEV-X,KYP-X,V-X,10/8/2015,12/3/2015,12/3/2015,7/12/2016,4/5/2017,4/5/2017,5/2/2017,8/9/2017,8/9/2017,9/26/2017,12/31/2017,10/14/1582
747,8022,6/15/1931,Female,158,55,Compulsory health insurance CHI,Yes, ,Yes,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,19,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,LEV-X,11/17/2015,7/5/2016,7/5/2016, , , , , , , , , 
748,8428,6/15/1946,Male,190,103,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,V-X,No CTx,No CTx,No CTx, , , ,8/12/2015,10/9/2015,10/9/2015, , , , , , 
749,6461,6/15/1971,Male,175,97,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,39,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,7/15/2015,9/29/2015,9/29/2015,11/30/2015,2/26/2016,2/26/2016,3/3/2016,5/26/2016,5/26/2016,1/11/2017,3/16/2017,3/16/2017
750,1500,6/15/1951,Female,165,73,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,31,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,7/20/2015,9/29/2015,9/29/2015, , , , , , , , , 
751,7470,6/15/1948,Male,175,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,18,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,7/1/2015,9/3/2015,9/3/2015,9/21/2016,4/26/2017,4/26/2017,6/5/2019,3/31/2022,10/14/1582, , , 
752,1363,6/15/1960,Female,165,57,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,54,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,EMP-X,EMP-X,No CTx,V-X,8/11/2015,11/10/2015,11/10/2015,10/15/2018,8/27/2020,8/27/2020,8/3/2021,3/31/2022,10/14/1582, , , 
753,4471,6/15/1940,Male,170,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,95,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,9/15/2015,2/16/2016,2/16/2016,5/6/2017,9/18/2017,9/18/2017,12/12/2017,3/7/2018,3/7/2018, , , 
754,9147,6/15/1939,Female,168,62,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,8/4/2015,6/27/2016,6/27/2016,7/11/2017,12/19/2017,12/19/2017, , , , , , 
755,6949,6/15/1944,Female,162,75,Compulsory health insurance CHI,No,Unknown,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,135,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,R-X,9/14/2015,6/14/2016,6/14/2016,2/15/2017,9/26/2017,9/26/2017, , , , , , 
756,5328,6/15/1939,Female,165,66,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,150,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/5/2015,5/25/2016,5/25/2016,2/14/2017,9/4/2017,9/4/2017, , , , , , 
757,2096,6/15/1949,Male,172,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,11/3/2015,5/30/2016,5/30/2016,1/12/2017,8/29/2017,8/29/2017, , , , , , 
758,9258,6/15/1945,Male,170,88,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,166,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,11/17/2015,6/29/2016,6/29/2016,7/3/2017,12/7/2017,12/7/2017,5/8/2018,3/31/2019,10/14/1582, , , 
759,5281,6/15/1949,Female,160,72,Private,No,Yes, ,Yes, ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,175,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,11/26/2015,4/19/2016,4/19/2016,3/1/2017,9/5/2017,9/5/2017,3/6/2018,12/12/2018,12/12/2018, , , 
760,3831,6/15/1944,Female,159,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,210,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,12/8/2015,6/14/2016,6/14/2016,2/2/2017,9/12/2017,9/12/2017,1/10/2018,9/30/2019,10/14/1582, , , 
761,5146,6/15/1949,Male,175,82,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,205,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,8/4/2015,6/27/2016,6/27/2016,7/4/2017,12/11/2017,12/11/2017,5/15/2018,12/20/2018,12/20/2018, , , 
762,1568,6/15/1950,Male,175,77,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,135,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/30/2015,6/21/2016,6/21/2016,3/14/2017,9/25/2017,9/25/2017, , , , , , 
763,4678,6/15/1952,Male,178,66,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,220,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,12/22/2015,5/25/2016,5/25/2016,2/27/2017,8/21/2017,8/21/2017, , , , , , 
764,4731,6/15/1949,Male,175,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"27,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/7/2015,9/18/2015,9/18/2015, , , , , , , , , 
765,1940,6/15/1939,Female,158,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"48,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/23/2015,4/25/2017,4/25/2017, , , , , , , , , 
766,1307,6/15/1937,Male,174,77,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,61",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,9/2/2015,10/5/2016,10/5/2016, , , , , , , , , 
767,5911,6/15/1946,Male,179,75,Private,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"5,61",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,R-X,POM-X,V-X,2/17/2014,8/4/2014,8/4/2014,10/29/2014,12/22/2014,12/22/2014,8/26/2015,6/10/2016,6/10/2016,7/18/2016,9/22/2016,9/22/2016
768,4186,6/15/1948,Male,184,87,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,16","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,6/16/2014,10/20/2014,10/20/2014,12/18/2014,9/2/2015,9/2/2015,10/5/2015,6/10/2016,6/10/2016,6/23/2016,12/12/2016,12/12/2016
769,5258,6/15/1944,Male,175,72,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,77",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,11/25/2013,4/14/2014,4/14/2014,12/8/2014,8/17/2015,8/17/2015,9/28/2015,2/8/2016,2/8/2016,2/25/2016,10/14/2016,10/14/2016
770,8802,6/15/1941,Female,174,80,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,01",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,POM-X,V-X,3/11/2013,7/8/2013,7/8/2013,5/12/2014,9/8/2014,9/8/2014,11/24/2014,9/28/2015,9/28/2015,10/26/2015,6/7/2016,6/7/2016
771,2385,6/15/1940,Male,176,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,3",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,KYP-X,V-X,1/20/2014,5/19/2014,5/19/2014,12/29/2014,8/12/2015,8/12/2015,11/2/2015,4/25/2016,4/25/2016,5/18/2016,10/24/2016,10/24/2016
772,7526,6/15/1940,Male,174,59,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"11,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,Other,No CTx,V-X,12/9/2013,10/20/2014,10/20/2014,11/10/2014,7/20/2015,7/20/2015,8/10/2015,12/31/2015, , , , 
773,4535,6/15/1938,Female,167,57,Private,No, , ,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,02",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,Other,V-X,4/7/2014,10/6/2014,10/6/2014,11/10/2014,7/6/2015,7/6/2015,7/27/2015,10/26/2015,10/26/2015,11/16/2015,12/31/2015, 
774,9990,6/15/1944,Male,182,91,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,14",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,3/5/2014,9/10/2014,9/10/2014,12/16/2014,9/25/2015,9/25/2015,11/18/2015,12/31/2015, , , , 
775,4985,6/15/1939,Male,170,67,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,POM-X,V-X,4/14/2014,10/13/2014,10/13/2014,10/27/2014,7/8/2015,7/8/2015,7/20/2015,11/16/2015,11/16/2015,12/21/2015,12/31/2015, 
776,9531,6/15/1929,Male,173,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"19,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/6/2015,11/26/2015,11/26/2015, , , , , , , , , 
777,2135,6/15/1940,Female,166,68,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,73,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,5/22/2018,1/24/2019,1/24/2019,10/26/2021,3/31/2022,10/14/1582, , , , , , 
778,9975,6/15/1953,Male,174,84,Private,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/21/2015,11/3/2015,11/3/2015, , , , , , , , , 
779,1858,6/15/1944,Male,176,81,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,LEV-X,V-X,8/12/2013,11/25/2013,11/25/2013,7/18/2014,11/24/2014,11/24/2014,12/15/2014,10/5/2015,10/5/2015,10/26/2015,12/31/2015, 
780,6142,6/15/1945,Male,185,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,16",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,9/16/2014,12/8/2014,12/8/2014,12/29/2014,7/27/2015,7/27/2015,8/31/2015,5/23/2016,5/23/2016,7/4/2016,11/29/2016,11/29/2016
781,5523,6/15/1940,Female,167,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,05",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,5/6/2014,9/2/2014,9/2/2014,11/24/2014,7/16/2015,7/16/2015,8/10/2015,3/29/2016,3/29/2016,5/19/2016,12/7/2016,12/7/2016
782,7241,6/15/1938,Male,181,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,74",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,FAR-X,V-X,12/2/2013,3/31/2014,3/31/2014,8/18/2014,11/17/2014,11/17/2014,12/8/2014,10/8/2015,10/8/2015,10/8/2015,3/15/2016,3/15/2016
783,4283,6/15/1939,Male,174,75,Private,No, , , , ,Yes, ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,R-X,POM-X,V-X,11/18/2013,3/24/2014,3/24/2014,12/29/2014,7/6/2015,7/6/2015,8/26/2015,6/14/2016,6/14/2016,7/12/2016,9/22/2016,9/22/2016
784,7188,6/15/1942,Male,178,75,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,POM-X,V-X,3/3/2014,6/30/2014,6/30/2014,8/18/2014,11/10/2014,11/10/2014,11/24/2014,10/7/2015,10/7/2015,11/2/2015,6/28/2016,6/28/2016
785,6478,6/15/1946,Male,185,79,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,08",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,POM-X,V-X,7/8/2013,11/4/2013,11/4/2013,6/2/2014,12/4/2014,12/4/2014,12/15/2014,10/14/2015,10/14/2015,11/10/2015,5/20/2016,5/20/2016
786,2488,6/15/1947,Female,171,85,Private,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"9,01",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,Other,V-X,9/16/2013,3/17/2014,3/17/2014,6/16/2014,11/27/2014,11/27/2014,12/29/2014,7/6/2015,7/6/2015,9/21/2015,4/19/2016,4/19/2016
787,6196,6/15/1945,Male,179,72,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,56",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,DAR-X,V-X,1/6/2014,5/5/2014,5/5/2014,10/20/2014,7/13/2015,7/13/2015,8/10/2015,1/29/2016,1/29/2016,8/15/2016,9/26/2016,9/26/2016
788,2443,6/15/1947,Male,174,69,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,38",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,R-X,POM-X,V-X,9/2/2013,3/17/2014,3/17/2014,6/2/2014,12/1/2014,12/1/2014,12/22/2014,11/23/2015,11/23/2015,1/28/2016,9/14/2016,9/14/2016
789,1717,6/15/1938,Female,170,70,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/10/2015,12/31/2015, , , , , , , , , , 
790,5767,6/15/1939,Male,184,79,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,27",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,FAR-X,V-X,3/7/2013,9/12/2013,9/12/2013,4/9/2014,9/24/2014,9/24/2014,12/8/2014,9/14/2015,9/14/2015,10/26/2015,2/10/2016,2/10/2016
791,7478,6/15/1942,Male,181,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,91",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,R-X,Other,V-X,2/11/2013,6/3/2013,6/3/2013,1/20/2014,8/18/2014,8/18/2014,11/13/2014,7/23/2015,7/23/2015,9/22/2015,1/12/2016,1/12/2016
792,9130,6/15/1947,Female,167,64,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,Other,R-X,FAR-X,V-X,8/26/2013,12/16/2013,12/16/2013,5/28/2014,10/16/2014,10/16/2014,11/3/2014,11/5/2015,11/5/2015,11/26/2015,3/21/2016,3/21/2016
793,6333,6/15/1941,Male,179,88,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,29",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,POM-X,V-X,11/4/2013,3/3/2014,3/3/2014,5/12/2014,11/3/2014,11/3/2014,12/8/2014,7/25/2015,7/25/2015,9/1/2015,6/28/2016,6/28/2016
794,7018,6/15/1944,Female,172,68,Private,No, , , , ,Yes, ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,FAR-X,V-X,1/7/2013,5/6/2013,5/6/2013,1/3/2014,11/10/2014,11/10/2014,11/24/2014,7/20/2015,7/20/2015,9/7/2015,2/15/2016,2/15/2016
795,4735,6/15/1945,Male,189,102,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,04",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,6/17/2013,10/21/2013,10/21/2013,9/16/2014,7/20/2015,7/20/2015,8/17/2015,3/30/2016,3/30/2016,5/16/2016,10/18/2016,10/18/2016
796,7070,6/15/1954,Male,184,78,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,FAR-X,No CTx,V-X,1/14/2013,4/15/2013,4/15/2013,11/24/2014,10/26/2015,10/26/2015,11/23/2015,4/19/2016,4/19/2016, , , 
797,7499,6/15/1941,Male,172,84,Private,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,9/3/2013,1/6/2014,1/6/2014,9/29/2014,7/20/2015,7/20/2015,9/21/2015,4/11/2016,4/11/2016,5/24/2016,12/20/2016,12/20/2016
798,8770,6/15/1955,Male,175,85,Private,No, , , , ,Yes, ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"8,53",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,R-X,Other,V-X,3/18/2013,6/3/2013,6/3/2013,8/18/2014,12/8/2014,12/8/2014,12/22/2014,10/19/2015,10/19/2015,11/23/2015,3/21/2016,3/21/2016
799,1885,6/15/1946,Male,174,78,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,25",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,Other,R-X,POM-X,V-X,5/6/2013,11/4/2013,11/4/2013,3/10/2014,10/20/2014,10/20/2014,11/10/2014,10/5/2015,10/5/2015,10/26/2015,6/16/2016,6/16/2016
800,3027,6/15/1945,Male,172,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,36",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,POM-X,DAR-X,V-X,7/29/2013,11/11/2013,11/11/2013,6/2/2014,11/10/2014,11/10/2014,12/3/2015,5/23/2016,5/23/2016,6/23/2016,10/5/2016,10/5/2016
801,7831,6/15/1939,Male,174,82,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,48",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,1/6/2014,6/23/2014,6/23/2014,10/20/2014,8/24/2015,8/24/2015,10/5/2015,5/30/2016,5/30/2016,6/20/2016,8/22/2016,8/22/2016
802,4742,6/15/1948,Male,180,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,09","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,LEV-X,Other,V-X,11/5/2013,3/10/2014,3/10/2014,9/2/2014,7/21/2015,7/21/2015,9/14/2015,12/21/2015,12/21/2015,12/28/2015,3/28/2016,3/28/2016
803,2796,6/15/1942,Male,172,71,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,3/17/2014,9/1/2014,9/1/2014,12/9/2014,10/26/2015,10/26/2015,11/10/2015,6/20/2016,6/20/2016,7/11/2016,9/18/2016,9/18/2016
804,2534,6/15/1944,Male,182,74,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,42",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,Other,R-X,FAR-X,V-X,4/22/2013,8/12/2013,8/12/2013,1/13/2014,9/24/2014,9/24/2014,10/23/2014,9/10/2015,9/10/2015,10/19/2015,3/25/2016,3/25/2016
805,9141,6/15/1946,Female,167,65,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,32,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,R-X,DAR-X,V-X,7/13/2014,7/19/2015,7/19/2015,7/1/2016,2/23/2017,2/23/2017,8/15/2017,2/15/2018,2/15/2018,5/24/2018,9/15/2018,9/15/2018
806,5255,6/15/1944,Male,187,93,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,17,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,Other,3/13/2013,6/25/2014,6/25/2014,3/4/2016,8/18/2016,8/18/2016, , , , , , 
807,3848,6/15/1949,Male,185,91,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,0, ,IgG,38,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,FAR-X,V-X,10/2/2013,11/24/2014,11/24/2014,2/12/2016,11/29/2016,11/29/2016,7/22/2017,10/4/2018,10/4/2018,3/28/2019,6/12/2020,6/12/2020
808,5388,6/15/1944,Male,190,100,Private,No,Yes,Yes, , , , , ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,33,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,No CTx,V-X,9/12/2014,11/24/2015,11/24/2015,4/25/2016,10/6/2016,10/6/2016,1/23/2017,6/12/2017,6/12/2017, , , 
809,3532,6/15/1946,Female,168,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,27,ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,R-X,R-X,V-X,9/23/2012,10/14/2013,10/14/2013,4/28/2016,9/29/2016,9/29/2016,2/28/2017,6/29/2017,6/29/2017,9/12/2017,4/15/2018,4/15/2018
810,9886,6/15/1947,Male,191,92,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,12,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,R-X,POM-X,V-X,4/14/2012,5/24/2013,5/24/2013,5/29/2016,1/9/2017,1/9/2017,6/15/2017,9/29/2017,9/29/2017,12/17/2017,12/5/2018,12/5/2018
811,4268,6/15/1947,Female,169,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,31,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,LEV-X,R-X,V-X,9/12/2013,10/24/2014,10/24/2014,4/19/2016,12/30/2016,12/30/2016,6/27/2017,9/30/2017,9/30/2017,12/11/2017,10/10/2018,10/10/2018
812,8120,6/15/1948,Male,180,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , ,Yes, ,0,III: one or more criteria are fulfilled,IgA,16,ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,V-X,POM-X,V-X,6/26/2012,4/15/2013,4/15/2013,2/12/2016,9/24/2016,9/24/2016,5/17/2017,9/18/2017,9/18/2017,10/18/2017,6/25/2018,6/25/2018
813,6445,6/15/1951,Male,189,78,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,35,ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,V-X,DAR-X,V-X,4/30/2016,9/25/2016,9/25/2016,6/13/2017,10/20/2017,10/20/2017,10/25/2017,4/26/2019,4/26/2019,6/25/2019,11/15/2019,11/15/2019
814,1727,6/15/1938,Female,169,73,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,DAR-X,V-X,V-X,3/5/2016,6/18/2016,6/18/2016,9/15/2016,8/15/2017,8/15/2017,9/15/2017,6/15/2018,6/15/2018,6/15/2018,6/30/2019, 
815,3726,6/15/1953,Male,189,94,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,5,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,KYP-X,V-X,5/20/2016,8/15/2016,8/15/2016,4/15/2019,8/15/2019,8/15/2019,11/15/2019,2/1/2020,2/1/2020,3/1/2020,6/15/2020,6/15/2020
816,9496,6/15/1946,Male,174,82,Compulsory health insurance CHI,No,Yes, , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,KYP-X,V-X,4/28/2016,6/10/2016,6/10/2016,11/15/2018,4/15/2019,4/15/2019,11/15/2019,1/1/2020,1/1/2020,2/1/2020,6/15/2020,6/15/2020
817,6069,6/15/1946,Female,165,64,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,5",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,3/20/2016,11/15/2016,11/15/2016,7/15/2017,10/15/2018,10/15/2018,2/1/2019,6/15/2019,6/15/2019, , , 
818,6016,6/15/1934,Female,175,64,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,5,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,KYP-X,R-X,6/15/2016,5/15/2017,5/15/2017,6/15/2017,3/31/2018,3/31/2018,4/1/2018,11/15/2018,11/15/2018,5/15/2019,6/30/2019,10/14/1582
819,1947,6/15/1941,Male,187,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,5,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,FAR-X,V-X,1/15/2013,4/15/2013,4/15/2013,1/5/2016,4/15/2017,4/15/2017,5/15/2017,1/15/2018,1/15/2018,2/15/2018,10/15/2018,10/15/2018
820,1460,6/15/1937,Female,159,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,DAR-X,DAR-X,V-X,3/15/2014,1/18/2015,1/18/2015,1/25/2015,12/28/2015,12/28/2015,3/15/2016,4/15/2017,4/15/2017,5/15/2017,2/15/2018,2/15/2018
821,8640,6/15/1936,Male,173,65,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,KYP-X,V-X,2/20/2015,10/20/2015,10/20/2015,5/25/2016,3/15/2017,3/15/2017,4/1/2017,2/1/2018,2/1/2018,3/1/2018,1/15/2019,1/15/2019
822,8635,6/15/1941,Male,180,84,Compulsory health insurance CHI,No,Yes, , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"69,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,LEV-X,LEV-X,V-X,6/2/2016,10/9/2016,10/9/2016,3/19/2018,9/9/2018,9/9/2018,3/25/2019,6/28/2020,6/28/2020,2/15/2021,6/6/2021,6/6/2021
823,4570,6/15/1944,Female,148,46,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , ,Yes,1,III: one or more criteria are fulfilled,Other type,"259,7",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,R-X,No CTx,V-X,1/26/2016,10/11/2016,10/11/2016,5/21/2018,11/28/2018,11/28/2018,10/14/2019,12/31/2019, , , , 
824,4920,6/15/1938,Female,168,64,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,LEV-X,LEV-X,3/9/2009,8/23/2009,8/23/2009,4/11/2016,9/25/2016,9/25/2016,11/27/2017,5/20/2018,5/20/2018,9/2/2019,2/23/2020,2/23/2020
825,3015,6/15/1950,Female,155,56,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"1,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/29/2016,7/1/2016,7/1/2016,5/17/2021,10/25/2021,10/25/2021, , , , , , 
826,6669,6/15/1936,Female,174,65,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,"2,87","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/17/2016,8/17/2016,8/17/2016, , , , , , , , , 
827,7217,6/15/1936,Female,160,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,84",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,7/1/2013,12/15/2013,12/15/2013,6/6/2016,11/27/2016,11/27/2016, , , , , , 
828,1015,6/15/1948,Female,165,56,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,30,ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,3/21/2016,12/16/2016,12/16/2016,1/16/2017,4/4/2017,4/4/2017, , , , , , 
829,3454,6/15/1958,Female,168,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,2/4/2016,2/15/2016,2/15/2016, , , , , , , , , 
830,8489,6/15/1944,Female,168,70,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/4/2016,7/17/2016,7/17/2016, , , , , , , , , 
831,2537,6/15/1940,Male,180,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,No CTx,V-X,7/11/2011,10/2/2011,10/2/2011,1/5/2015,4/11/2016,4/11/2016,4/18/2016,9/4/2016,9/4/2016, , , 
832,3165,6/15/1942,Male,176,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,LEV-X,No CTx,V-X,2/4/2013,5/19/2013,5/19/2013,5/9/2016,8/21/2016,8/21/2016,6/26/2017,12/10/2017,12/10/2017, , , 
833,2620,6/15/1942,Female,160,52,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"5,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,6/6/2016,11/27/2016,11/27/2016,3/19/2018,9/9/2018,9/9/2018,11/18/2019,5/17/2020,5/17/2020, , , 
834,1127,6/15/1940,Male,184,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,LEV-X,LEV-X,5/18/2009,11/1/2009,11/1/2009,5/27/2013,11/10/2013,11/10/2013,5/23/2016,11/20/2016,11/20/2016,9/25/2017,3/18/2018,3/18/2018
835,8310,6/15/1943,Female,170,65,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,R-X,No CTx,V-X,1/20/2014,5/4/2014,5/4/2014,4/18/2016,10/9/2016,10/9/2016,3/13/2017,7/23/2017,7/23/2017, , , 
836,1828,6/15/1945,Female,152,54,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"51,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/11/2016,6/6/2016,6/6/2016, , , , , , , , , 
837,2433,6/15/1929,Male,166,68,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,26,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,Other,No CTx,No CTx,Other,4/4/2016,11/24/2016,11/24/2016,9/19/2018,9/30/2018, , , , , , , 
838,8312,6/15/1959,Male,193,115,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,",07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/25/2016,7/30/2016,7/30/2016, , , , , , , , , 
839,6609,6/15/1962,Male,175,70,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"89,53",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,EMP-X,DAR-X,R-X,3/8/2016,5/15/2018,5/15/2018,6/15/2018,10/15/2018,10/15/2018,11/8/2018,4/8/2019,4/8/2019,4/11/2019,8/13/2019,8/13/2019
840,7363,6/15/1941,Male,173,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"6,42","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,DAR-X,LEV-X,6/20/2016,11/13/2016,11/13/2016,12/18/2017,6/17/2018,6/17/2018,9/2/2019,12/22/2019,12/22/2019,8/17/2020,4/25/2021,4/25/2021
841,4288,6/15/1957,Male,183,80,Private,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"3,45",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,5/30/2016,8/28/2016,8/28/2016,9/9/2019,11/17/2019,11/17/2019, , , , , , 
842,1417,6/15/1942,Female,153,50,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"1,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,LEV-X,LEV-X,V-X,4/14/2014,7/27/2014,7/27/2014,5/26/2016,8/21/2016,8/21/2016,9/11/2017,3/4/2018,3/4/2018,9/16/2019,3/8/2020,3/8/2020
843,9213,6/15/1945,Male,182,94,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,13",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,LEV-X,No CTx,No CTx,R-X,8/17/2015,4/10/2016,4/10/2016,4/11/2016,9/25/2016,9/25/2016, , , , , , 
844,8639,6/15/1946,Male,178,75,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"34,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,2/25/2014,4/27/2014,4/27/2014,6/8/2016,10/8/2018,10/8/2018,10/15/2018,1/29/2019,1/29/2019,2/12/2019,6/4/2019,6/4/2019
845,7091,6/15/1943,Female,167,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"6,34",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,11/15/2011,3/16/2012,3/16/2012,6/9/2016,9/21/2016,9/21/2016, , , , , , 
846,6547,6/15/1956,Male,181,82,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"5,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/18/2016,7/31/2016,7/31/2016, , , , , , , , , 
847,9461,6/15/1974,Male,187,97,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgM,"12,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,EMP-X,No CTx,V-X,12/1/2014,1/24/2015,1/24/2015,5/23/2016,11/3/2016,11/3/2016,11/17/2016,3/31/2017, , , , 
848,1297,6/15/1962,Female,171,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"2,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/23/2016,8/14/2016,8/14/2016, , , , , , , , , 
849,2359,6/15/1943,Male,173,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,25",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,LEV-X,DAR-X,V-X,10/10/2013,1/30/2014,1/30/2014,4/4/2016,9/18/2016,9/18/2016,10/23/2017,4/15/2018,4/15/2018,3/25/2019,8/16/2020,8/16/2020
850,2502,6/15/1966,Female,165,95,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"26,69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,DAR-X,DAR-X,V-X,3/21/2011,6/9/2011,6/9/2011,1/18/2016,12/28/2017,12/28/2017,1/18/2018,4/3/2018,4/3/2018,8/10/2020,3/31/2022, 
851,1906,6/15/1959,Male,179,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"3,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,4/11/2016,5/22/2016,5/22/2016,2/22/2021,4/4/2021,4/4/2021, , , , , , 
852,6308,6/15/1936,Male,186,80,Private,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"72,07",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,V-X,POM-X,V-X,11/11/2014,2/24/2015,2/24/2015,3/30/2016,3/22/2018,3/22/2018,5/22/2018,8/14/2018,8/14/2018,3/27/2019,6/22/2019,6/22/2019
853,9335,6/15/1941,Female,161,61,Private,No,Yes, ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,73",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,R-X,DAR-X,V-X,1/22/2014,4/2/2014,4/2/2014,4/14/2016,11/15/2016,11/15/2016,5/25/2017,10/17/2017,10/17/2017,1/10/2018,6/20/2019,6/20/2019
854,2320,6/15/1940,Female,159,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,95",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,LEV-X,2/11/2013,7/28/2013,7/28/2013,5/6/2016,4/13/2017,4/13/2017, , , , , , 
855,7485,6/15/1959,Male,186,90,Private,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"2,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,4/21/2016,6/2/2016,6/2/2016,12/9/2019,2/9/2020,2/9/2020, , , , , , 
856,3397,6/15/1931,Male,170,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"9,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,POM-X,DAR-X,V-X,9/1/2014,12/1/2014,12/1/2014,1/8/2016,4/7/2016,4/7/2016,5/8/2016,6/2/2016,6/2/2016,11/17/2016,11/24/2016,11/24/2016
857,7822,6/15/1953,Female,162,81,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"13,46","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,4/1/2016,6/16/2016,6/16/2016, , , , , , , , , 
858,9021,6/15/1935,Female,160,70,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"14,08",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/4/2015,4/29/2015,4/29/2015,12/21/2015,7/10/2016,7/10/2016, , , , , , 
859,3892,6/15/1928,Male,182,73,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"28,97",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,R-X,POM-X,No CTx,V-X,9/2/2014,11/3/2015,11/3/2015,11/11/2015,6/1/2016,6/1/2016,6/14/2016,12/22/2016,12/22/2016, , , 
860,6371,6/15/1962,Male,191,85,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,39,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/2/2016,6/30/2016, , , , , , , , , , 
861,3828,6/15/1942,Female,162,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,35,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,R-X,5/24/2016,6/30/2016, , , , , , , , , , 
862,6607,6/15/1941,Female,155,60,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,50,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/10/2016,6/30/2016, , , , , , , , , , 
863,5502,6/15/1938,Male,181,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,30,unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,4/20/2016,6/30/2016, , , , , , , , , , 
864,7968,6/15/1940,Male,166,72,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,Other type,940,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,4/14/2016,6/30/2016, , , , , , , , , , 
865,5587,6/15/1944,Female,163,97,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,19,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/23/2016,6/30/2016, , , , , , , , , , 
866,7673,6/15/1956,Male,169,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,29,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/29/2016,6/30/2016, , , , , , , , , , 
867,9364,6/15/1941,Female,159,59,Compulsory health insurance CHI,No, , , ,Yes, ,Yes, , , ,Yes,2,III: one or more criteria are fulfilled,Other type,",24",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,No CTx,V-X,1/21/2014,8/4/2014,8/4/2014,2/29/2016,8/17/2016,8/17/2016,11/30/2016,12/31/2016, , , , 
868,4421,6/15/1949,Male,173,76,Compulsory health insurance CHI,Unknown, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"35,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,KYP-X,DAR-X,No CTx, , , ,3/22/2012,8/17/2012,8/17/2012,3/14/2016,7/18/2017,7/18/2017,2/27/2019,6/30/2019,10/14/1582
869,1621,6/15/1958,Female,162,66,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,4/28/2016,6/9/2016,6/9/2016,11/6/2017,5/13/2018,5/13/2018, , , , , , 
870,8264,6/15/1942,Male,184,100,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,V-X,KYP-X,DAR-X,V-X,9/10/2012,4/9/2013,4/9/2013,4/15/2013,9/3/2014,9/3/2014,4/13/2016,11/10/2016,11/10/2016,1/23/2017,2/13/2017,2/13/2017
871,9098,6/15/1940,Male,170,70,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,1,I: fulfilling all 4 criteria,IgG,"15,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,5/15/2012,9/19/2012,9/19/2012,2/25/2016,5/25/2016,5/25/2016, , , , , , 
872,7372,6/15/1952,Male,185,73,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"29,7",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,KYP-X,POM-X,DAR-X,V-X,8/1/2010,1/1/2011,1/1/2011,4/6/2016,9/8/2016,9/8/2016,9/14/2016,12/7/2016,12/7/2016,12/14/2016,4/10/2019,4/10/2019
873,7700,6/15/1947,Female,153,51,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"3,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/26/2016,12/30/2016,12/30/2016, , , , , , , , , 
874,3090,6/15/1939,Male,178,95,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"5,7",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,POM-X,KYP-X,V-X,4/6/2016,2/21/2017,2/21/2017,9/6/2018,11/20/2019,11/20/2019,11/27/2019,2/1/2021,2/1/2021,2/15/2021,3/31/2022, 
875,2988,6/15/1958,Male,186,99,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"20,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/10/2016,10/17/2016,10/17/2016, , , , , , , , , 
876,9442,6/15/1944,Female,152,77,Private,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,"9,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,DAR-X,NIN-X,V-X,12/2/2015,2/6/2016,2/6/2016,8/13/2018,9/24/2019,9/24/2019,9/30/2019,10/22/2020,10/22/2020,11/11/2020,6/24/2021,6/24/2021
877,3790,6/15/1964,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"5,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,V-X,DAR-X,No CTx,Other,4/1/2004,6/1/2004,6/1/2004,10/1/2015,3/1/2016,3/1/2016,1/24/2019,6/30/2020,10/14/1582, , , 
878,1245,6/15/1942,Male,185,92,Private,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"3,78",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,R-X,DAR-X,V-X,V-X,2/25/2014,5/11/2014,5/11/2014,4/19/2016,10/11/2016,10/11/2016,12/21/2017,1/8/2020,1/8/2020,1/21/2020,7/29/2020,7/29/2020
879,2001,6/15/1948,Male,180,81,Private,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/4/2016,3/20/2016,3/20/2016, , , , , , , , , 
880,6765,6/15/1948,Male,9,80,Private,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,5064,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,DAR-X,No CTx, , , ,5/15/2014,10/15/2014,10/15/2014,10/15/2014,3/15/2016,3/15/2016,6/29/2016,1/8/2018,1/8/2018
881,5800,6/15/1959,Male,167,80,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"3,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,6/1/2012,9/28/2012,9/28/2012,5/2/2016,10/15/2016,10/15/2016, , , , , , 
882,3634,6/15/1936,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,4/15/2015,1/15/2016,1/15/2016, , , , , , , , , 
883,4980,6/15/1950,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,Other,No CTx,No CTx,No CTx, , , ,12/1/2014,1/15/2016,1/15/2016, , , , , , 
884,8636,6/15/1955,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgA,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,KYP-X,No CTx, , , ,6/21/2016,9/15/2016,9/15/2016,3/30/2017,2/1/2018,2/1/2018,2/14/2019,4/3/2020,4/3/2020
885,3376,6/15/1940,Male,180,82,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,1875,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,R-X,2/15/2016,12/10/2018,12/10/2018, , , , , , , , , 
886,3230,6/15/1952,Male,184,84,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,I: fulfilling all 4 criteria,IgG,3500,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,KYP-X,R-X,No CTx, , , ,12/15/2017,12/31/2017,12/31/2017,1/3/2018,5/17/2018,5/17/2018,1/29/2019,4/2/2019,4/2/2019
887,7212,6/15/1960,Male,179,110,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"9,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/16/2016,3/18/2016,3/18/2016, , , , , , , , , 
888,5632,6/15/1954,Male,184,80,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,9",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,V-X,R-X,No CTx,No CTx, , , ,6/30/2016,6/15/2017,6/15/2017,8/15/2017,9/15/2017,9/15/2017, , , 
889,9307,6/15/1940,Male,178,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,4/11/2016,8/15/2016,8/15/2016,2/16/2017,9/30/2019,9/30/2019, , , , , , 
890,2973,6/15/1958,Female,167,57,Compulsory health insurance CHI,Unknown, , , , , , , , ,Yes,Yes,1,III: one or more criteria are fulfilled,IgG,"5,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/1/2016,3/9/2016,3/9/2016, , , , , , , , , 
891,5291,6/15/1937,Female,156,62,Compulsory health insurance CHI,Unknown,Unknown,Unknown,Unknown, ,Yes, , ,Unknown, , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,DAR-X,No CTx,V-X,11/18/2013,12/7/2015,12/7/2015,12/21/2015,6/23/2016,6/23/2016,7/21/2016,9/11/2016,9/11/2016, , , 
892,7783,6/15/1940,Female,169,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,1/13/2014,7/6/2014,7/6/2014,6/20/2016,10/9/2016,10/9/2016, , , , , , 
893,3391,6/15/1936,Female,174,60,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,59",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,DAR-X,LEV-X,LEV-X,6/27/2016,12/18/2016,12/18/2016,8/27/2018,2/17/2019,2/17/2019,3/16/2020,6/14/2020,6/14/2020,6/15/2020,12/6/2020,12/6/2020
894,7072,6/15/1937,Male,180,78,Private,No, , , , ,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,90,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,KYP-X,NIN-X,V-X,9/21/2015,1/22/2016,1/22/2016,9/27/2016,11/30/2016,11/30/2016,12/2/2016,1/31/2017,1/31/2017,2/6/2017,12/21/2017,12/21/2017
895,2260,6/15/1946,Male,166,75,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"7,34",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,EMP-X,KYP-X,No CTx,V-X,1/27/2016,6/6/2016,6/6/2016,3/15/2018,5/9/2019,5/9/2019,6/12/2019,6/30/2019,10/14/1582, , , 
896,2710,6/15/1959,Male,190,92,Private,No,Yes, , , , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,2/18/2013,5/4/2013,5/4/2013,4/18/2016,5/24/2017,5/24/2017,7/26/2017,2/10/2020,2/10/2020, , , 
897,7871,6/15/1950,Male,169,59,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,R-X,R-X,R-X,Other,3/17/2006,6/5/2006,6/5/2006,5/1/2012,8/15/2012,8/15/2012,4/1/2014,7/1/2014,7/1/2014,1/1/2015,8/1/2015,8/1/2015
898,4550,6/15/1937,Female,166,61,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"6,21",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,1/15/2008,7/15/2008,7/15/2008,6/15/2012,12/15/2012,12/15/2012,5/23/2016,10/16/2016,10/16/2016, , , 
899,4227,6/15/1932,Female,160,47,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"36,75",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,V-X,R-X,No CTx,V-X,12/17/2014,4/8/2016,4/8/2016,2/8/2017,9/7/2017,9/7/2017,9/14/2017,10/15/2018,10/15/2018, , , 
900,2487,6/15/1937,Male,178,92,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,0,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,POM-X,V-X,V-X,5/16/2014,9/5/2014,9/5/2014,11/27/2014,12/30/2015,12/30/2015,1/6/2016,12/29/2016,12/29/2016,2/10/2017,9/30/2017,10/14/1582
901,2454,6/15/1974,Male,180,94,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"2,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,Other,KYP-X,V-X,2/1/2013,5/1/2013,5/1/2013,10/1/2014,2/1/2015,2/1/2015,5/1/2016,4/24/2017,4/24/2017,9/8/2017,12/31/2017,10/14/1582
902,5349,6/15/1939,Male,999,80,Private,No, , , , , , , , , , ,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,R-X,NIN-X,V-X,7/1/2012,9/1/2012,9/1/2012,1/1/2014,3/1/2015,3/1/2015,6/30/2016,4/27/2017,4/27/2017,6/1/2017,12/31/2017, 
903,8956,6/15/1942,Male,184,80,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,I: fulfilling all 4 criteria,IgG,"2,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,R-X,R-X,Other,6/5/2008,8/20/2008,8/20/2008,10/1/2011,10/4/2015,10/4/2015,12/1/2015,2/16/2016,2/16/2016,6/10/2016,8/18/2016,8/18/2016
904,9466,6/15/1941,Male,163,84,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,POM-X,DAR-X,V-X,7/17/2013,9/17/2013,9/17/2013,6/1/2016,5/9/2018,5/9/2018,8/24/2018,9/4/2018,9/4/2018,9/26/2018,11/26/2018,11/26/2018
905,8953,6/15/1941,Male,172,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/1/2013,5/1/2014,5/1/2014,4/11/2016,5/31/2016,5/31/2016, , , , , , 
906,4246,6/15/1935,Male,999,99,Private,No, , , , , , , , , , ,9,Unknown,IgG,"9999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,R-X,No CTx,V-X,9/27/2011,2/18/2012,2/18/2012,4/23/2016,6/19/2016,6/19/2016,1/27/2017,12/19/2017,12/19/2017, , , 
907,2834,6/15/1946,Male,178,69,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,"1,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,Other,DAR-X,V-X,9/19/2012,11/25/2012,11/25/2012,6/21/2016,8/31/2016,8/31/2016,11/8/2018,12/19/2018,12/19/2018,1/7/2019,8/26/2021,8/26/2021
908,1223,6/15/1944,Female,170,93,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"36,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X, , , , , , , , , , , , 
909,4861,6/15/1956,Male,190,98,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"7,34",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,R-X,POM-X,KYP-X,V-X,5/23/2013,8/1/2013,8/1/2013,2/1/2015,6/1/2015,6/1/2015,6/30/2016,4/12/2017,4/12/2017,5/1/2017,7/4/2018,7/4/2018
910,6799,6/15/1967,Male,180,92,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"4,23",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/9/2016,8/4/2016,8/4/2016, , , , , , , , , 
911,9915,6/15/1945,Male,188,112,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"98,8",ISS stage II (neither stage I nor stage III), , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,5/13/2016,7/22/2016,7/22/2016, , , , , , , , , 
912,3483,6/15/1935,Male,172,75,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,POM-X,No CTx,V-X,12/30/2015,4/21/2016,4/21/2016,4/22/2016,11/15/2016,11/15/2016,1/15/2017,3/29/2018,3/29/2018, , , 
913,8069,6/15/1954,Male,172,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,73",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,EMP-X,No CTx,No CTx,R-X,3/9/2016,6/6/2016,6/6/2016,11/6/2018,4/10/2019,4/10/2019, , , , , , 
914,4910,6/15/1951,Male,167,80,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"1,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/4/2016,7/18/2016,7/18/2016, , , , , , , , , 
915,5069,6/15/1972,Female,160,62,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,Other type,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,64", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/27/2016,7/9/2016,7/9/2016, , , , , , , , , 
916,9018,6/15/1938,Male,185,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,3",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/11/2016,3/12/2018,3/12/2018, , , , , , , , , 
917,2413,6/15/1938,Female,153,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,2,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No,"1,68", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,V-X,DAR-X,BLEN-X,R-X,2/8/2016,12/26/2016,12/26/2016,1/9/2017,11/15/2018,11/15/2018,6/28/2021,1/31/2022,1/31/2022,2/28/2022,3/31/2022, 
918,5212,6/15/1944,Male,180,94,Private,Yes,Yes,Yes, , , , , , ,Yes, ,9,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,KYP-X,Other,Other,10/4/2006,12/1/2006,12/1/2006,3/24/2012,10/24/2014,10/24/2014,11/6/2014,7/10/2015,7/10/2015,5/30/2016,6/27/2016,6/27/2016
919,1813,6/15/1966,Female,163,73,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,Unknown,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , ,"<3,5 mg/L",Nein,R-X,Other,KYP-X,V-X,4/1/2013,6/1/2013,6/1/2013,12/1/2015,4/8/2016,4/8/2016,6/24/2016,7/14/2016,7/14/2016,7/21/2016,11/10/2016,11/10/2016
920,9574,6/15/1954,Male,178,70,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"4,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,FAR-X,No CTx,V-X,11/1/2013,1/1/2014,1/1/2014,5/3/2016,11/1/2016,11/1/2016,11/28/2016,2/9/2017,2/9/2017, , , 
921,5270,6/15/1952,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"11,1",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,No CTx,No CTx,Other,2/1/2006,7/1/2006,7/1/2006,5/11/2016,8/11/2016,8/11/2016, , , , , , 
922,7529,6/15/1929,Female,160,60,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,04",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/11/2015,3/22/2016,3/22/2016, , , , , , , , , 
923,4762,6/15/1935,Male,173,89,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,Other type,",24",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/15/2016,7/5/2016,7/5/2016,10/22/2016,11/21/2016,11/21/2016, , , , , , 
924,1816,6/15/1938,Male,164,53,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,Other type,",48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,No CTx,No CTx,V-X,5/26/2016,12/15/2016,12/15/2016,4/1/2017,8/13/2017,8/13/2017, , , , , , 
925,2190,6/15/1939,Female,158,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,Unknown,IgG,"1,15",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , ,"<3,5 mg/L", ,V-X,No CTx,No CTx,R-X,2/17/2016,2/26/2016,2/26/2016,3/1/2016,1/18/2017,1/18/2017, , , , , , 
926,6301,6/15/1940,Female,164,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,LEV-X,No CTx,V-X,4/26/2013,3/29/2014,3/29/2014,4/1/2015,6/1/2016,6/1/2016,6/13/2016,12/24/2016,12/24/2016, , , 
927,5890,6/15/1928,Female,160,57,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"10,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,8/16/2013,6/14/2014,6/14/2014,6/2/2016,10/26/2018,10/26/2018,11/20/2018,3/1/2019,3/1/2019, , , 
928,2063,6/15/1931,Male,182,73,Private,No, ,Yes, , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,R-X,No CTx,No CTx,Other,10/2/2014,12/12/2014,12/12/2014,11/18/2015,3/9/2016,3/9/2016, , , , , , 
929,7911,6/15/1933,Female,160,61,Compulsory health insurance CHI,Yes, ,Yes,Yes, , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Nein,R-X,KYP-X,V-X,V-X,4/2/2014,12/3/2014,12/3/2014,2/13/2016,4/20/2017,4/20/2017,11/6/2018,12/4/2018,12/4/2018,1/14/2019,7/11/2019,7/11/2019
930,5092,6/15/1957,Male,999,80,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgD,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,DAR-X,No CTx,V-X,4/1/2011,6/1/2011,6/1/2011,6/9/2016,9/19/2016,9/19/2016,9/19/2019,12/31/2021,10/14/1582, , , 
931,1152,6/15/1949,Female,999,65,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,KYP-X,DAR-X,EMP-X,V-X,10/1/2014,12/1/2014,12/1/2014,5/1/2016,5/16/2017,5/16/2017,6/1/2017,9/30/2017,9/30/2017,10/1/2017,3/1/2018,3/1/2018
932,7465,6/15/1946,Female,172,80,Private,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,",92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/20/2015,7/6/2016,7/6/2016, , , , , , , , , 
933,1129,6/15/1941,Male,175,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"3,53",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,No CTx,No CTx,V-X,4/11/2016,6/13/2016,6/13/2016,6/19/2018,6/30/2019,10/14/1582, , , , , , 
934,8709,6/15/1974,Female,170,101,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"99999999,99",ISS stage II (neither stage I nor stage III), , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,DAR-X,EMP-X,KYP-X,No CTx, , , ,6/9/2016,11/2/2017,11/2/2017,11/16/2017,12/13/2018,12/13/2018,2/27/2019,6/30/2019,10/14/1582
935,9292,6/15/1963,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"4,72",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,EMP-X,6/28/2016,9/26/2016,9/26/2016, , , , , , , , , 
936,8145,6/15/1947,Female,170,54,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , ,Yes,0,III: one or more criteria are fulfilled,IgA,"3,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,9/1/2015,1/1/2016,1/1/2016,9/15/2017,8/7/2018,8/7/2018,11/29/2018,4/9/2019,4/9/2019, , , 
937,7032,6/15/1946,Male,161,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,DAR-X,EMP-X,No CTx, , , ,3/30/2016,9/28/2016,9/28/2016,11/28/2016,5/15/2017,5/15/2017,5/26/2017,7/11/2017,7/11/2017
938,8170,6/15/1946,Female,164,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,57",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,KYP-X,DAR-X,V-X,3/29/2012,6/9/2012,6/9/2012,3/4/2013,1/8/2015,1/8/2015,5/30/2016,12/12/2017,12/12/2017,5/7/2018,10/22/2018,10/22/2018
939,2372,6/15/1940,Male,175,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,4500,ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/10/2016,9/11/2016,9/11/2016, , , , , , , , , 
940,2351,6/15/1959,Female,160,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,96,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/21/2011,6/26/2011,6/26/2011,6/6/2016,12/31/2016, , , , , , , 
941,6649,6/15/1948,Male,170,92,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,54,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/8/2016,8/28/2016,8/28/2016, , , , , , , , , 
942,7323,6/15/1941,Male,178,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,25,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,EMP-X,DAR-X,V-X,6/15/2016,1/2/2018,1/2/2018,11/21/2019,8/25/2020,8/25/2020,9/7/2020,1/25/2021,1/25/2021,2/9/2021,2/23/2021,2/23/2021
943,4339,6/15/1944,Male,185,100,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,45,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,2/1/2016,6/30/2016, , , , , , , , , , 
944,7632,6/15/1936,Female,165,78,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,3234,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,1/15/2016,6/15/2016,6/15/2016, , , , , , , , , 
945,9437,6/15/1945,Female,159,78,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,65,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,EMP-X,No CTx,V-X,6/15/2016,12/15/2016,12/15/2016,6/4/2018,4/2/2020,4/2/2020,4/28/2020,3/31/2022, , , , 
946,5693,6/15/1946,Male,189,79,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,32,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,V-X,DAR-X,V-X,1/15/2013,9/15/2013,9/15/2013,2/15/2016,1/2/2018,1/2/2018,12/6/2018,6/20/2019,6/20/2019,10/29/2019,3/31/2022, 
947,3340,6/15/1932,Male,166,76,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,6/21/2011,9/2/2011,9/2/2011,3/29/2016,6/14/2016,6/14/2016, , , , , , 
948,6166,6/15/1935,Male,175,88,Compulsory health insurance CHI,Yes, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,55,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,EMP-X,No CTx,V-X,5/15/2015,6/15/2016,6/15/2016,7/15/2017,2/13/2019,2/13/2019,10/14/2019,12/31/2019, , , , 
949,2725,6/15/1945,Male,179,83,Compulsory health insurance CHI,Yes,Yes, ,Yes, , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,4/6/2016,11/1/2016,11/1/2016, , , , , , , , , 
950,4101,6/15/1948,Male,176,92,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,0,I: fulfilling all 4 criteria,IgG,37,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,V-X,R-X,EMP-X,V-X,12/1/2011,3/1/2012,3/1/2012,1/15/2016,9/1/2016,9/1/2016,11/15/2018,6/3/2019,6/3/2019,6/4/2019,9/15/2020,9/15/2020
951,3432,6/15/1948,Male,187,94,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,15,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,R-X,KYP-X,V-X,2/15/2016,5/15/2016,5/15/2016,6/15/2016,9/1/2016,9/1/2016,1/8/2018,11/11/2020,11/11/2020,12/7/2020,5/18/2021,5/18/2021
952,3292,6/15/1936,Male,178,69,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,56,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,DAR-X,DAR-X,V-X,6/15/2015,5/1/2016,5/1/2016,8/15/2016,7/1/2017,7/1/2017,8/1/2017,7/18/2018,7/18/2018,7/25/2018,12/12/2018,12/12/2018
953,9455,6/15/1941,Male,173,88,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,18,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,8/1/2015,2/1/2016,2/1/2016, , , , , , , , , 
954,7203,6/15/1960,Female,168,70,Private,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,11,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/1/2016,9/13/2016,9/13/2016, , , , , , , , , 
955,9907,6/15/1953,Male,180,90,Private,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,KYP-X,POM-X,V-X,1/15/2016,4/15/2016,4/15/2016,9/6/2016,8/15/2017,8/15/2017,8/15/2017,6/6/2018,6/6/2018,6/11/2018,3/5/2019,3/5/2019
956,4250,6/15/1949,Female,166,70,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,7",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,4/1/2015,7/1/2015,7/1/2015,5/15/2016,12/13/2016,12/13/2016,2/21/2017,12/31/2017, , , , 
957,7496,6/15/1942,Female,162,60,Private,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"6,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/15/2016,9/15/2016,9/15/2016,1/15/2017,12/20/2017,12/20/2017, , , , , , 
958,2950,6/15/1953,Female,168,52,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,52,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,KYP-X,No CTx,V-X,10/5/2009,1/10/2010,1/10/2010,1/19/2015,3/13/2016,3/13/2016,4/4/2016,12/16/2016,12/16/2016, , , 
959,2762,6/15/1935,Female,166,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,",4",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,5/25/2016,6/30/2016, , , , , , , , , , 
960,9067,6/15/1936,Male,174,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,3/16/2016,10/25/2016,10/25/2016, , , , , , , , , 
961,9164,6/15/1939,Male,172,62,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,105,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/10/2016,9/11/2017,9/11/2017, , , , , , , , , 
962,8419,6/15/1940,Male,168,59,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,3/30/2016,12/12/2016,12/12/2016,7/17/2017,12/12/2017,12/12/2017,5/23/2018,3/31/2019,10/14/1582, , , 
963,6522,6/15/1948,Male,175,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,138,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/16/2016,12/31/2017,10/14/1582, , , , , , , , , 
964,8844,6/15/1942,Female,174,68,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,120,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/31/2016,8/21/2017,8/21/2017, , , , , , , , , 
965,2194,6/15/1945,Male,170,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,155,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/27/2016,1/25/2017,1/25/2017, , , , , , , , , 
966,6671,6/15/1950,Male,172,70,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,145,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,2/16/2016,3/15/2017,3/15/2017,8/14/2017,4/10/2018,4/10/2018, , , , , , 
967,1638,6/15/1943,Female,162,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/14/2016,4/10/2017,4/10/2017,9/18/2017,6/18/2018,6/18/2018, , , , , , 
968,7050,6/15/1943,Female,160,55,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/8/2016,9/18/2017,9/18/2017, , , , , , , , , 
969,9285,6/15/1939,Female,168,65,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,145,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/24/2016,9/20/2017,9/20/2017, , , , , , , , , 
970,2286,6/15/1938,Male,175,71,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,2/9/2016,7/18/2017,7/18/2017,11/21/2017,6/12/2018,6/12/2018, , , , , , 
971,6683,6/15/1947,Male,174,77,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,36,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,Other,R-X,V-X,1/19/2016,4/11/2016,4/11/2016, , , ,6/14/2017,6/17/2017,6/17/2017,8/2/2017,9/10/2017,9/10/2017
972,8653,6/15/1927,Male,180,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,47,ISS stage II (neither stage I nor stage III), , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,R-X,No CTx,Other,10/1/2010,8/1/2011,8/1/2011,2/1/2015,9/1/2015,9/1/2015,11/1/2015,2/1/2016,2/1/2016, , , 
973,6960,6/15/1950,Female,170,65,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/18/2016,6/5/2016,6/5/2016,6/6/2016,9/26/2017,9/26/2017,5/3/2018,12/6/2018,12/6/2018, , , 
974,9359,6/15/1948,Male,175,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,75,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,10/20/2015,1/30/2016,1/30/2016,2/17/2016,1/15/2017,1/15/2017,1/17/2017,5/15/2017,5/15/2017,9/12/2017,2/14/2018,2/14/2018
975,3635,6/15/1952,Male,172,68,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,137,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,2/7/2016,6/12/2016,6/12/2016,6/13/2016,7/19/2017,7/19/2017,10/3/2017,12/31/2017, , , , 
976,2361,6/15/1942,Female,160,52,Compulsory health insurance CHI,Yes, ,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,95,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,2/15/2016,6/21/2016,6/21/2016,6/22/2016,7/4/2017,7/4/2017, , , , , , 
977,9128,6/15/1952,Male,175,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,130,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,R-X,No CTx,R-X,3/20/2016,6/20/2016,6/20/2016,6/22/2016,8/16/2017,8/16/2017,12/18/2017,1/22/2018,1/22/2018, , , 
978,9085,6/15/1936,Male,177,68,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,25,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,DAR-X,EMP-X,V-X,6/1/2015,5/1/2016,5/1/2016,6/1/2016,5/24/2018,5/24/2018,7/11/2018,5/30/2019,5/30/2019,6/4/2019,7/28/2021,7/28/2021
979,6423,6/15/1949,Male,178,77,Private,Yes, ,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"61,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/24/2016,9/30/2016, , , , , , , , , , 
980,3504,6/15/1941,Female,166,63,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"5,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,KYP-X,No CTx,V-X,11/5/2012,5/10/2013,5/10/2013,3/31/2015,9/18/2015,9/18/2015,5/10/2016,9/30/2016,10/14/1582, , , 
981,8337,6/15/1941,Male,171,88,Private,No, , , , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"66,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,1/12/2016,4/29/2016,4/29/2016,5/3/2016,9/30/2016, , , , , , , 
982,2346,6/15/1946,Female,174,76,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"47,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/3/2015,5/13/2016,5/13/2016, , , , , , , , , 
983,1084,6/15/1937,Male,174,67,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,"53,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,V-X,No CTx,LEV-X,6/27/2012,12/14/2012,12/14/2012,3/18/2014,9/5/2014,9/5/2014,3/30/2016,9/16/2016,9/16/2016, , , 
984,7254,6/15/1948,Male,178,81,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"62,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/4/2016,9/30/2016, , , , , , , , , , 
985,1663,6/15/1943,Female,171,69,Private,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"47,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,11/18/2013,10/17/2014,10/17/2014,5/3/2016,9/30/2016, , , , , , , 
986,4155,6/15/1943,Female,173,83,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"9,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,2/13/2013,3/31/2014,3/31/2014,11/5/2014,7/29/2015,7/29/2015,6/24/2016,2/22/2017,2/22/2017,3/14/2017,12/14/2017,12/14/2017
987,9319,6/15/1944,Female,168,80,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"6,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,DAR-X,EMP-X,R-X,2/26/2016,1/19/2017,1/19/2017,8/16/2017,9/20/2018,9/20/2018,10/9/2018,11/13/2019,11/13/2019,12/2/2019,12/31/2019, 
988,7010,6/15/1942,Male,176,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,6,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,POM-X,R-X,5/29/2016,2/28/2017,2/28/2017,9/12/2017,12/20/2018,12/20/2018,1/18/2019,10/11/2019,10/11/2019,11/4/2019,6/29/2020,6/29/2020
989,8221,6/15/1942,Female,169,81,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,1",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,5/22/2012,4/26/2013,4/26/2013,11/12/2014,9/30/2015,9/30/2015,6/15/2016,4/14/2017,4/14/2017,1/16/2018,4/26/2019,4/26/2019
990,9105,6/15/1946,Female,167,86,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,1",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,6/18/2014,3/11/2015,3/11/2015,5/11/2016,4/26/2017,4/26/2017,3/15/2018,8/22/2019,8/22/2019,9/20/2019,8/14/2020,8/14/2020
991,6670,6/15/1947,Male,178,86,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,9",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,FAR-X,No CTx,V-X,2/4/2013,2/28/2014,2/28/2014,3/4/2015,11/12/2015,11/12/2015,6/16/2016,3/31/2017,3/31/2017, , , 
992,2597,6/15/1948,Male,175,87,Private,No, , ,Yes, ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,4",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,EMP-X,V-X,5/9/2012,6/13/2013,6/13/2013,1/14/2015,9/24/2015,9/24/2015,4/12/2016,2/16/2017,2/16/2017,10/12/2017,9/30/2018,9/30/2018
993,8593,6/15/1944,Male,177,83,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"83,2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,2/21/2011,6/5/2011,6/5/2011,4/25/2016,12/2/2016,12/2/2016, , , , , , 
994,2366,6/15/1939,Female,162,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"45,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,LEV-X,No CTx,V-X,1/18/2010,9/26/2010,9/26/2010,11/24/2014,5/1/2016,5/1/2016,7/6/2016,11/21/2016,11/21/2016, , , 
995,2453,6/15/1943,Male,174,89,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,31,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,6/6/2011,1/15/2012,1/15/2012,3/14/2016,10/28/2016,10/28/2016,12/8/2016,12/31/2016, , , , 
996,7870,6/15/1934,Female,163,64,Private,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,6/27/2016,12/18/2016,12/18/2016, , , , , , , , , 
997,5818,6/15/1939,Male,182,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"2,2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,7/12/2015,1/20/2016,1/20/2016,3/15/2016,12/31/2017,10/14/1582,11/9/2016,12/31/2017, , , , 
998,5123,6/15/1934,Male,175,105,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,POM-X,No CTx,V-X,8/7/2015,10/23/2015,10/23/2015,1/4/2016,7/6/2016,7/6/2016,9/7/2016,10/17/2017,10/17/2017, , , 
999,8101,6/15/1933,Female,158,78,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,No CTx,V-X,7/2/2012,11/22/2012,11/22/2012,10/1/2014,6/5/2015,6/5/2015,10/9/2016,12/28/2016,12/28/2016, , , 
1000,3117,6/15/1947,Female,176,80,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"23,8",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,No CTx,V-X,4/20/2009,9/13/2009,9/13/2009,6/3/2013,2/15/2015,2/15/2015,3/7/2016,12/20/2016,12/20/2016, , , 
1001,3740,6/15/1958,Female,156,65,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,4000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/20/2016,12/9/2016,12/9/2016,10/13/2017,12/31/2017, , , , , , , 
1002,2735,6/15/1946,Female,168,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,3800,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,5/3/2016,7/28/2016,7/28/2016,10/19/2016,12/31/2017, , , , , , , 
1003,1563,6/15/1944,Female,166,72,Unknown,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgA,"171,6",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/23/2016,10/1/2016,10/1/2016, , , , , , , , , 
1004,6265,6/15/1935,Female,159,73,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,EMP-X,DAR-X,V-X,5/10/2016,10/13/2016,10/13/2016,2/24/2017,11/22/2017,11/22/2017,11/30/2017,10/30/2018,10/30/2018,11/9/2018,11/28/2020,11/28/2020
1005,5597,6/15/1962,Female,171,63,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,I: fulfilling all 4 criteria,IgG,",57",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,EMP-X,4/18/2016,6/12/2016,6/12/2016, , , , , , , , , 
1006,6760,6/15/1961,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,No CTx,No CTx,No CTx,V-X,6/24/2016,9/22/2016,9/22/2016, , , , , , , , , 
1007,5072,6/15/1957,Male,999,80,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, ,Yes, ,Yes,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/12/2016,7/25/2016,7/25/2016, , , , , , , , , 
1008,2140,6/15/1955,Female,170,56,Unknown,No, ,Yes, , , , , , , ,Yes,1,I: fulfilling all 4 criteria,IgA,1570,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/28/2016,9/28/2016,9/28/2016, , , , , , , , , 
1009,5732,6/15/1950,Female,155,48,Unknown,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,KYP-X,3/15/2016,5/1/2016,5/1/2016,6/6/2016,7/20/2016,7/20/2016, , , , , , 
1010,7987,6/15/1959,Female,167,81,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,1/22/2016,4/8/2016,4/8/2016, , , , , , , , , 
1011,9799,6/15/1941,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,EMP-X,DAR-X,No CTx,V-X,5/13/2015,8/1/2015,8/1/2015,9/13/2017,11/5/2019,11/5/2019,11/15/2019,3/31/2021, , , , 
1012,9330,6/15/1963,Female,173,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/11/2016,4/28/2016,4/28/2016, , , , , , , , , 
1013,4056,6/15/1961,Male,179,78,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"1,3",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,1/14/2013,5/26/2013,5/26/2013,3/29/2016,7/31/2016,7/31/2016,11/28/2016,12/31/2016, , , , 
1014,8455,6/15/1932,Male,176,76,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,KYP-X,V-X,3/29/2011,4/30/2012,4/30/2012,8/10/2015,1/25/2016,1/25/2016,5/9/2016,9/20/2016,9/20/2016,9/28/2016,12/8/2016,12/8/2016
1015,7818,6/15/1940,Male,183,92,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,DAR-X,NIN-X,V-X,4/1/2014,6/1/2015,6/1/2015,11/1/2015,5/1/2016,5/1/2016,6/30/2016,10/12/2016,10/12/2016,6/14/2017,9/30/2017,10/14/1582
1016,1517,6/15/1939,Female,161,49,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"49,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,KYP-X,No CTx,V-X,1/29/2016,6/22/2016,6/22/2016,12/23/2016,2/9/2017,2/9/2017,4/20/2017,5/4/2017,5/4/2017, , , 
1017,7236,6/15/1946,Male,176,87,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"57,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,2/9/2016,4/15/2016,4/15/2016,4/28/2016,9/30/2016,10/14/1582, , , , , , 
1018,7557,6/15/1935,Female,164,50,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes, , , , , , ,3,III: one or more criteria are fulfilled,IgG,"44,97",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,R-X,No CTx,V-X,3/10/2016,6/20/2016,6/20/2016,1/25/2017,3/14/2017,3/14/2017,5/11/2017,6/29/2017,6/29/2017, , , 
1019,1882,6/15/1934,Female,157,52,Compulsory health insurance CHI,Yes, ,Yes,Yes, , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"46,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,5/25/2016,9/30/2016, , , , , , , , , , 
1020,8444,6/15/1949,Female,162,58,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"50,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/1/2016,7/22/2016,7/22/2016, , , , , , , , , 
1021,8902,6/15/1946,Male,179,75,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,89",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,LEV-X,No CTx,V-X,10/12/2009,6/6/2010,6/6/2010,1/26/2015,4/14/2016,4/14/2016,7/26/2016,12/15/2016,12/15/2016, , , 
1022,2137,6/15/1944,Male,177,83,Private,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"40,7",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,7/8/2015,9/9/2015,9/9/2015,4/17/2019,9/30/2020,10/14/1582, , , , , , 
1023,5477,6/15/1966,Male,168,77,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"73,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,R-X,V-X,V-X,5/21/2015,8/15/2015,8/15/2015,5/17/2016,1/10/2017,1/10/2017,1/11/2017,12/15/2017,12/15/2017,1/17/2018,3/20/2018,3/20/2018
1024,6439,6/15/1939,Male,165,70,Unknown,No,Yes,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/27/2016,6/30/2017, , , , , , , , , , 
1025,9710,6/15/1938,Male,999,80,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgA,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,4/12/2016,12/22/2016,12/22/2016, , , , , , , , , 
1026,3062,6/15/1945,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,LEV-X,No CTx, , , ,6/14/2013,6/16/2014,6/16/2014,5/10/2016,11/9/2016,11/9/2016,11/22/2016,12/31/2016, 
1027,6430,6/15/1959,Male,182,78,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/2/2015,2/27/2016,2/27/2016, , , , , , , , , 
1028,2282,6/15/1961,Female,169,80,Unknown,No,Yes,Yes, , , , , , , ,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III), , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,3/11/2016,8/17/2016,8/17/2016, , , , , , , , , 
1029,2690,6/15/1953,Male,192,75,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
1030,7123,6/15/1949,Female,165,82,Compulsory health insurance CHI,Yes,Yes,Yes, ,Yes, ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"3,47",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/5/2014,9/28/2014,9/28/2014,8/15/2016,12/31/2016, , , , , , , 
1031,5363,6/15/1929,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgA,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,R-X,LEV-X,V-X,3/15/2010,5/17/2010,5/17/2010,5/30/2013,1/10/2014,1/10/2014,12/21/2015,4/3/2016,4/3/2016,8/9/2016,12/31/2016, 
1032,6119,6/15/1964,Female,166,62,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,",62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/25/2016,12/31/2016, , , , , , , , , , 
1033,6698,6/15/1950,Female,158,60,Private,Yes, , , , , ,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"1,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
1034,4113,6/15/1949,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"4,14",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,R-X,R-X,V-X,7/2/2012,8/23/2012,8/23/2012,8/15/2013,11/15/2013,11/15/2013,12/9/2013,3/3/2014,3/3/2014,11/7/2014,4/12/2015,4/12/2015
1035,5409,6/15/1946,Male,184,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"12,09",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/23/2016,9/5/2016,9/5/2016, , , , , , , , , 
1036,1136,6/15/1948,Male,192,95,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"16,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,5/11/2016,9/7/2016,9/7/2016,9/30/2016,1/2/2017,1/2/2017, , , , , , 
1037,7966,6/15/1942,Female,159,51,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,04",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,4/25/2016,8/22/2016,8/22/2016,9/1/2016,1/1/2018,1/1/2018,1/22/2018,12/5/2019,12/5/2019, , , 
1038,6963,6/15/1951,Male,184,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,02",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,2/3/2015,6/9/2015,6/9/2015,5/17/2016,10/26/2017,10/26/2017,11/20/2017,6/14/2018,6/14/2018,6/25/2018,6/27/2018,6/27/2018
1039,7914,6/15/1954,Male,178,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"20,2",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/19/2016,3/21/2016,3/21/2016,1/11/2017,6/30/2017,10/14/1582, , , , , , 
1040,4857,6/15/1942,Female,157,56,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
1041,7256,6/15/1951,Male,185,80,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,05",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/25/2016,7/11/2016,7/11/2016, , , , , , , , , 
1042,5171,6/15/1939,Male,175,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,03",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,DAR-X,V-X,4/21/2014,9/29/2014,9/29/2014,5/26/2016,1/31/2018,1/31/2018,2/22/2018,8/23/2018,8/23/2018,2/25/2019,1/20/2021,1/20/2021
1043,2474,6/15/1942,Male,182,90,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"6,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/3/2016,8/17/2016,8/17/2016, , , , , , , , , 
1044,3945,6/15/1941,Male,174,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"9,2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,DAR-X,POM-X,No CTx,V-X,4/18/2016,9/26/2016,9/26/2016,3/14/2018,9/12/2018,9/12/2018,1/31/2019,12/31/2021, , , , 
1045,3077,6/15/1945,Male,182,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,FAR-X,No CTx,V-X,4/7/2014,9/15/2014,9/15/2014,2/8/2016,9/30/2016,9/30/2016,10/18/2016,9/13/2017,9/13/2017, , , 
1046,8074,6/15/1948,Male,163,99,Unknown,No, , , , , ,Yes, , , ,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/20/2016,7/15/2016,7/15/2016, , , , , , , , , 
1047,7154,6/15/1940,Female,171,72,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,1750,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,6/29/2015,5/2/2016,5/2/2016,8/1/2016,12/31/2016, , , , , , , 
1048,4023,6/15/1952,Female,158,81,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,97",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,4/16/2012,8/26/2012,8/26/2012,3/7/2016,12/31/2016, , , , , , , 
1049,1110,6/15/1952,Male,184,107,Unknown,No,Yes, ,Yes, , , , , ,Yes,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,KYP-X,Other,No CTx,V-X,2/26/2016,6/16/2016,6/16/2016,12/2/2016,3/22/2017,3/22/2017,3/22/2017,3/25/2017,3/25/2017, , , 
1050,5578,6/15/1951,Female,169,62,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"44,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,2/5/2013,8/16/2013,8/16/2013,4/20/2016,9/13/2016,9/13/2016, , , , , , 
1051,9485,6/15/1935,Male,168,79,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"1,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,LEV-X,No CTx,V-X,1/20/2014,4/9/2015,4/9/2015,8/24/2015,11/5/2015,11/5/2015,12/8/2015,7/21/2016,7/21/2016, , , 
1052,5237,6/15/1951,Male,181,89,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,LEV-X,No CTx,V-X,12/10/2014,9/7/2015,9/7/2015,4/15/2016,4/20/2017,4/20/2017,11/30/2017,12/31/2017, , , , 
1053,8654,6/15/1940,Male,170,71,Unknown,No,Yes,Yes,Yes,Yes, , , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"7,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/7/2016,12/31/2016, , , , , , , , , , 
1054,3007,6/15/1941,Male,176,92,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/1/2015,5/20/2016,5/20/2016,5/20/2016,6/30/2016, , , , , , , 
1055,9943,6/15/1940,Male,180,78,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,5,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"<3,5 mg/L",Nein,R-X,FAR-X,No CTx,V-X,1/14/2013,1/13/2014,1/13/2014,10/22/2014,9/23/2015,9/23/2015,5/16/2016,8/25/2016,8/25/2016, , , 
1056,6593,6/15/1945,Male,186,91,Private,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,41",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,4/19/2016,8/2/2016,8/2/2016,8/12/2016,6/11/2018,6/11/2018, , , , , , 
1057,4509,6/15/1950,Female,165,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,FAR-X,V-X,1/29/2014,5/7/2014,5/7/2014,6/13/2016,12/23/2016,12/23/2016,1/5/2017,9/18/2017,9/18/2017,9/29/2017,6/27/2018,6/27/2018
1058,4045,6/15/1948,Male,186,74,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Unknown,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,4/7/2016,9/8/2016,9/8/2016,2/16/2018,2/27/2020,2/27/2020, , , , , , 
1059,6850,6/15/1949,Male,175,90,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,92",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/22/2016,7/5/2016,7/5/2016,7/28/2016,3/31/2018,10/14/1582, , , , , , 
1060,3421,6/15/1945,Male,184,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,02",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,5/12/2014,9/1/2014,9/1/2014,4/20/2016,12/14/2016,12/14/2016,12/29/2016,7/24/2017,7/24/2017,8/2/2017,1/18/2018,1/18/2018
1061,8585,6/15/1946,Male,175,81,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,11",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,2/17/2016,8/15/2016,8/15/2016,9/5/2016,2/16/2018,2/16/2018,3/1/2018,11/29/2018,11/29/2018,5/27/2019,6/30/2021,6/30/2021
1062,3778,6/15/1947,Male,187,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgA,"2,91",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,V-X,V-X,5/19/2016,9/1/2016,9/1/2016,9/21/2016,2/13/2018,2/13/2018,2/28/2018,6/20/2021,6/20/2021,7/9/2021,12/21/2021,12/21/2021
1063,7580,6/15/1953,Female,158,69,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"8,9",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,11/15/2013,1/15/2015,1/15/2015,4/15/2016,10/27/2016,10/27/2016, , , , , , 
1064,5061,6/15/1951,Female,166,84,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"4,6",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,LEV-X,KYP-X,Other,3/15/2012,6/15/2012,6/15/2012,11/15/2015,3/15/2016,3/15/2016,5/15/2016,5/15/2016,5/15/2016,1/26/2017,6/30/2017,10/14/1582
1065,6994,6/15/1936,Female,165,60,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"3,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,9/28/2015,3/30/2016,3/30/2016,6/14/2016,8/24/2016,8/24/2016, , , , , , 
1066,2542,6/15/1964,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,",5",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,unbekannt, , , , , , ,"<3,5 mg/L",Ja,V-X,No CTx,No CTx,Other,4/1/2004,6/1/2004,6/1/2004,10/1/2015,3/1/2016,3/1/2016, , , , , , 
1067,1346,6/15/1935,Male,181,83,Compulsory health insurance CHI,Yes, ,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"4,1",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,unbekannt, , , , , , , ,Nein,LEV-X,No CTx,No CTx,V-X,10/15/2009,7/15/2010,7/15/2010,5/15/2016,12/6/2016,12/6/2016, , , , , , 
1068,4504,6/15/1940,Male,179,98,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"39,2",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,POM-X,DAR-X,No CTx, , , ,11/15/2012,10/15/2013,10/15/2013,4/15/2016,11/9/2016,11/9/2016,9/15/2017,12/5/2017,12/5/2017
1069,4546,6/15/1951,Female,169,67,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"7,8",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,unbekannt, , , , , , ,">5,5 mg/L", ,LEV-X,KYP-X,No CTx,V-X,4/15/2012,12/15/2012,12/15/2012,7/15/2015,2/15/2016,2/15/2016,6/15/2016,12/6/2016,12/6/2016, , , 
1070,5424,6/15/1943,Female,164,62,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,09",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,3/1/2016,8/2/2016,8/2/2016, , , , , , , , , 
1071,9491,6/15/1959,Male,179,81,Private,No, , , , ,Yes,Yes, ,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,44",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,5/23/2016,9/5/2016,9/5/2016,2/23/2017,6/26/2019,6/26/2019, , , , , , 
1072,7809,6/15/1943,Female,165,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,51",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/7/2016,8/22/2016,8/22/2016,2/1/2017,6/26/2018,6/26/2018, , , , , , 
1073,7445,6/15/1941,Female,159,52,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,14",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,3/21/2016,7/4/2016,7/4/2016,2/10/2017,12/13/2018,12/13/2018,12/31/2018,1/14/2019,1/14/2019,3/20/2019,11/30/2020,11/30/2020
1074,7814,6/15/1939,Male,184,81,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,28",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,4/11/2016,9/19/2016,9/19/2016,10/4/2016,2/27/2017,2/27/2017,3/9/2017,9/29/2017,9/29/2017,10/12/2017,4/12/2018,4/12/2018
1075,3109,6/15/1959,Male,179,80,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,91",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,DAR-X,V-X,7/2/2013,10/8/2013,10/8/2013,5/25/2016,11/2/2016,11/2/2016,12/1/2016,1/19/2017,1/19/2017,1/31/2017,6/23/2017,6/23/2017
1076,3754,6/15/1945,Male,173,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,92",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,DAR-X,V-X,12/9/2014,3/24/2015,3/24/2015,5/25/2016,10/3/2016,10/3/2016,10/17/2016,2/10/2017,2/10/2017,3/3/2017,7/13/2017,7/13/2017
1077,5489,6/15/1944,Male,183,98,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,9",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,unbekannt, , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,8/15/2014,10/15/2015,10/15/2015,6/15/2016,6/7/2017,6/7/2017, , , , , , 
1078,6077,6/15/1940,Female,160,70,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"5,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,unbekannt, , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,9/15/2014,8/23/2015,8/23/2015,5/25/2016,6/30/2016, , , , , , , 
1079,1431,6/15/1954,Male,185,84,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,3,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,No,No, , , , , ,unbekannt, , , , , , , , ,V-X,No CTx,No CTx,V-X,3/24/2014,5/26/2014,5/26/2014,5/2/2016,6/30/2016, , , , , , , 
1080,4051,6/15/1942,Male,174,66,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,6,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,9/20/2014,5/15/2015,5/15/2015,5/19/2016,6/30/2016, , , , , , , 
1081,7356,6/15/1952,Male,179,90,Compulsory health insurance CHI,No,Yes, , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,Yes, , , , , ,unbekannt, , , , , , , ,Nein,R-X,No CTx,No CTx,V-X,5/10/2015,8/8/2015,8/8/2015,6/20/2016,6/30/2016, , , , , , , 
1082,3934,6/15/1940,Female,158,70,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,2,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,R-X,4/15/2014,4/2/2016,4/2/2016,4/20/2016,6/30/2016, , , , , , , 
1083,3668,6/15/1937,Male,177,69,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,No CTx,No CTx,R-X,7/21/2014,4/20/2016,4/20/2016,5/29/2016,6/30/2016, , , , , , , 
1084,6735,6/15/1952,Female,175,72,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,No,Yes, , , , , ,unbekannt, , , , , , , ,Nein,R-X,No CTx,No CTx,V-X,3/19/2015,7/26/2015,7/26/2015,7/1/2016, , , , , , , , 
1085,1685,6/15/1941,Male,181,90,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,70,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,R-X,2/15/2013,1/20/2015,1/20/2015,6/27/2016,6/30/2016, , , , , , , 
1086,1690,6/15/1947,Male,179,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,2",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,unbekannt, , , , , , , ,Nein,V-X,No CTx,No CTx,V-X,1/2/2014,4/15/2014,4/15/2014,5/19/2016,6/30/2016, , , , , , , 
1087,6332,6/15/1951,Male,157,64,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,41,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,11/22/2014,2/23/2015,2/23/2015,3/14/2015,4/16/2016,4/16/2016, , , , , , 
1088,1111,6/15/1939,Female,166,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,59,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/15/2013,8/4/2014,8/4/2014,3/19/2015,4/11/2016,4/11/2016, , , , , , 
1089,9061,6/15/1944,Male,183,98,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,9",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,8/15/2014,10/15/2015,10/15/2015,6/15/2016,3/14/2017,3/14/2017, , , , , , 
1090,6462,6/15/1943,Male,179,98,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,6",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,unbekannt, , , , , , , , ,KYP-X,V-X,DAR-X,LEV-X,2/15/2015,9/15/2015,9/15/2015,4/15/2016,11/9/2016,11/9/2016,5/2/2017,9/21/2017,9/21/2017,12/14/2017,12/31/2017, 
1091,6962,6/15/1943,Male,175,59,Compulsory health insurance CHI,No, , , ,Yes, ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"8,58",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,LEV-X,V-X,4/13/2016,8/10/2016,8/10/2016,8/22/2016,11/29/2017,11/29/2017,12/11/2017,6/16/2021,6/16/2021,7/12/2021,12/27/2021,12/27/2021
1092,5710,6/15/1939,Female,167,54,Private,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,09",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,POM-X,DAR-X,V-X,5/26/2016,9/8/2016,9/8/2016,1/22/2018,12/17/2019,12/17/2019,1/16/2020,7/26/2020,7/26/2020,8/12/2020,10/14/2020,10/14/2020
1093,1932,6/15/1947,Male,189,85,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,92",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,V-X,V-X,5/5/2016,9/8/2016,9/8/2016,9/21/2016,12/29/2017,12/29/2017,1/15/2018,8/6/2021,8/6/2021,8/27/2021,3/31/2022, 
1094,7792,6/15/1945,Male,168,64,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"5,18",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,DAR-X,V-X,3/31/2016,7/14/2016,7/14/2016,2/19/2018,12/12/2018,12/12/2018,3/1/2019,9/18/2020,9/18/2020,10/12/2020,3/14/2021,3/14/2021
1095,9059,6/15/1946,Male,184,89,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,27",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,FAR-X,EMP-X,V-X,2/6/2014,5/22/2014,5/22/2014,6/13/2016,12/7/2016,12/7/2016,12/19/2016,5/19/2017,5/19/2017,6/5/2017,6/21/2017,6/21/2017
1096,8335,6/15/1958,Male,186,85,Private,No, , , , ,Yes,Yes, ,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,46",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,10/14/2013,1/27/2014,1/27/2014,5/23/2016,6/13/2018,6/13/2018,6/28/2018,3/14/2019,3/14/2019,4/5/2019,9/11/2019,9/11/2019
1097,1008,6/15/1942,Male,176,70,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,55,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/15/2013,9/15/2014,9/15/2014,4/10/2015,4/16/2016,4/16/2016, , , , , , 
1098,2498,6/15/1937,Male,170,80,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"24,24",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,KYP-X,V-X,R-X,R-X,11/30/2015,5/9/2016,5/9/2016,5/25/2016,11/20/2017,11/20/2017,11/30/2017,4/2/2018,4/2/2018,4/16/2018,8/30/2018,8/30/2018
1099,2993,6/15/1940,Female,162,50,Compulsory health insurance CHI,No, , , ,Yes, ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"18,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,KYP-X,DAR-X,V-X,6/13/2014,8/3/2015,8/3/2015,2/2/2016,8/3/2016,8/3/2016,11/10/2016,5/29/2017,5/29/2017,6/20/2017,12/4/2017,12/4/2017
1100,2252,6/15/1937,Female,173,69,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgA,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,NIN-X,DAR-X,V-X,11/23/2015,3/9/2016,3/9/2016,4/4/2016,9/7/2017,9/7/2017,9/22/2017,7/5/2018,7/5/2018,7/25/2018,7/30/2018,7/30/2018
1101,9681,6/15/1951,Male,175,93,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,3/1/2016,5/13/2016,5/13/2016,6/7/2016,11/10/2017,11/10/2017,11/27/2017,12/3/2018,12/3/2018, , , 
1102,2659,6/15/1944,Male,185,72,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,62",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,10/31/2014,11/24/2014,11/24/2014,2/1/2016,5/8/2017,5/8/2017,5/22/2017,11/23/2017,11/23/2017,12/14/2017,7/25/2018,7/25/2018
1103,1372,6/15/1937,Female,167,62,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,27,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,No CTx,V-X,5/30/2016,6/27/2016,6/27/2016,7/20/2016,12/20/2017,12/20/2017,1/4/2018,9/25/2018,9/25/2018, , , 
1104,4720,6/15/1952,Male,176,100,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,6/30/2015,10/20/2015,10/20/2015,11/9/2016,12/19/2017,12/19/2017,1/4/2018,9/11/2018,9/11/2018,5/12/2020,6/20/2020,6/20/2020
1105,2562,6/15/1935,Male,170,110,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"54,64",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,7/21/2015,10/2/2015,10/2/2015,10/26/2015,3/7/2016,3/7/2016,3/18/2016,10/6/2016,10/6/2016,10/25/2016,2/9/2017,2/9/2017
1106,3360,6/15/1934,Female,158,69,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"31,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,V-X,KYP-X,V-X,9/10/2013,10/25/2015,10/25/2015,12/7/2015,1/25/2016,1/25/2016,2/4/2016,9/26/2016,9/26/2016,10/20/2016,1/9/2017,1/9/2017
1107,7464,6/15/1936,Male,183,80,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"11,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,5/10/2016,12/28/2016,12/28/2016,1/12/2017,7/6/2018,7/6/2018,7/26/2018,11/8/2018,11/8/2018, , , 
1108,3594,6/15/1948,Male,173,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,25",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,EMP-X,V-X,5/2/2016,8/8/2016,8/8/2016,8/18/2016,11/23/2017,11/23/2017,12/13/2017,8/14/2018,8/14/2018,8/16/2018,12/6/2018,12/6/2018
1109,3330,6/15/1945,Female,168,59,Compulsory health insurance CHI,No, , , ,Yes,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"34,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,5/11/2016,8/31/2016,8/31/2016,2/14/2018,8/26/2021,8/26/2021,9/7/2021,3/31/2022,10/14/1582, , , 
1110,5259,6/15/1945,Male,173,85,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,3/28/2016,7/11/2016,7/11/2016,7/26/2016,11/27/2017,11/27/2017,12/11/2017,12/21/2017,12/21/2017, , , 
1111,5015,6/15/1949,Female,162,51,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"5,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,No CTx,V-X,3/29/2016,7/12/2016,7/12/2016,8/4/2016,3/5/2018,3/5/2018,3/22/2018,1/31/2019,1/31/2019, , , 
1112,1362,6/15/1948,Female,155,88,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"16,72",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,EMP-X,V-X,9/16/2014,1/14/2015,1/14/2015,1/4/2016,6/5/2017,6/5/2017,6/19/2017,1/24/2018,1/24/2018,2/12/2018,10/29/2018,10/29/2018
1113,5801,6/15/1957,Male,179,81,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"51,09",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,1/2/2014,4/24/2014,4/24/2014,4/25/2016,5/14/2016,5/14/2016,5/17/2016,8/18/2016,8/18/2016, , , 
1114,2100,6/15/1938,Female,171,68,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,37",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,KYP-X,V-X,4/14/2016,9/22/2016,9/22/2016,10/13/2016,11/1/2016,11/1/2016,11/7/2016,2/2/2017,2/2/2017,2/8/2017,4/27/2017,4/27/2017
1115,6450,6/15/1945,Male,177,84,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,72",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,4/28/2016,8/11/2016,8/11/2016,9/1/2016,3/12/2018,3/12/2018,4/4/2018,9/27/2018,9/27/2018, , , 
1116,2752,6/15/1939,Male,184,77,Private,No, ,Yes, , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,R-X,DAR-X,V-X,3/17/2016,8/25/2016,8/25/2016,9/8/2016,5/19/2017,5/19/2017,6/8/2017,12/12/2017,12/12/2017,1/2/2018,8/8/2020,8/8/2020
1117,3637,6/15/1958,Male,188,76,Private,No, , , , ,Yes,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,58",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,4/7/2014,6/30/2014,6/30/2014,5/12/2016,12/19/2016,12/19/2016,1/4/2017,8/22/2017,8/22/2017,9/10/2017,9/11/2017,9/11/2017
1118,2417,6/15/1940,Female,177,64,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,EMP-X,V-X,2/9/2016,7/19/2016,7/19/2016,8/8/2016,1/3/2018,1/3/2018,1/15/2018,9/12/2018,9/12/2018,9/24/2018,1/2/2020,1/2/2020
1119,3492,6/15/1938,Male,189,84,Private,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,71",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,NIN-X,V-X,2/16/2016,7/26/2016,7/26/2016,8/18/2016,1/8/2018,1/8/2018,1/23/2018,8/17/2018,8/17/2018,8/30/2018,4/21/2020,4/21/2020
1120,7982,6/15/1960,Male,172,88,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,95",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,9/16/2013,1/3/2014,1/3/2014,1/7/2016,9/12/2016,9/12/2016,9/26/2016,3/14/2017,3/14/2017,3/30/2017,8/18/2017,8/18/2017
1121,2226,6/15/1950,Male,182,87,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , ,Yes,2,III: one or more criteria are fulfilled,Other type,",15",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,4/14/2016,7/20/2016,7/20/2016,6/7/2018,8/28/2018,8/28/2018, , , , , , 
1122,2428,6/15/1956,Male,170,69,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"1,54",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie, , , , , , ,">5,5 mg/L",Nein,KYP-X,Other,DAR-X,V-X,1/5/2016,4/15/2016,4/15/2016,1/12/2017,3/9/2017,3/9/2017,3/14/2017,3/17/2017,3/17/2017,6/19/2017,7/17/2017,7/17/2017
1123,1171,6/15/1931,Male,167,88,Compulsory health insurance CHI,Yes,Yes,Yes, ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"3,67",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Unknown, , , , , ,unbekannt, , , , , , ,"3,5 - 5,5 mg/L", ,R-X,R-X,R-X,V-X,5/16/2014,8/1/2014,8/1/2014,10/25/2014,7/12/2015,7/12/2015,9/15/2015,2/18/2016,2/18/2016,3/22/2016,5/30/2016,5/30/2016
1124,2550,6/15/1952,Male,177,84,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"38,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/15/2015,4/1/2016,4/1/2016, , , , , , , , , 
1125,4819,6/15/1933,Male,179,80,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"3,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,unbekannt, , , , , , ,"<3,5 mg/L",Nein,R-X,R-X,R-X,V-X,7/1/2013,2/17/2014,2/17/2014,2/12/2016,8/30/2016,8/30/2016,1/16/2018,6/29/2018,6/29/2018,5/14/2019,11/13/2019,11/13/2019
1126,6160,6/15/1942,Male,180,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Unknown,Unknown,Unknown, ,Yes, ,3,III: one or more criteria are fulfilled,IgG,"1,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,unbekannt, , , , , , ,">5,5 mg/L",Nein,R-X,KYP-X,No CTx,V-X,2/24/2015,12/8/2015,12/8/2015,5/18/2016,2/14/2017,2/14/2017,2/23/2017,3/15/2017,3/15/2017, , , 
1127,3428,6/15/1971,Male,193,91,Private,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,unbekannt, , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,No CTx,V-X,9/17/2012,12/8/2012,12/8/2012,3/4/2014,12/15/2015,12/15/2015,2/25/2016,7/29/2016,7/29/2016, , , 
1128,8627,6/15/1959,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"1,96",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,unbekannt, , , , , , , , ,No CTx,No CTx,V-X,Other,8/6/2009,9/3/2009,9/3/2009, , , , , , ,1/15/2014,4/15/2014,4/15/2014
1129,3498,6/15/1949,Female,160,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,2",ISS stage II (neither stage I nor stage III), , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,R-X,V-X,6/15/2002,10/15/2002,10/15/2002,11/15/2013,4/15/2014,4/15/2014,1/30/2015,2/20/2015,2/20/2015,3/23/2015,9/19/2016,9/19/2016
1130,3536,6/15/1944,Male,167,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,36,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,POM-X,DAR-X,V-X,10/1/2010,12/31/2010,12/31/2010,3/8/2016,9/21/2016,9/21/2016,10/14/2016,2/22/2017,2/22/2017,3/6/2017,7/10/2017,7/10/2017
1131,6148,6/15/1933,Male,178,76,Unknown,No,Yes,Yes,Yes,Yes, , , , ,Yes,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/22/2016,8/2/2016,8/2/2016,8/16/2016,9/28/2016,9/28/2016, , , , , , 
1132,1923,6/15/1938,Female,162,51,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"6,99",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,Other,Other,V-X,3/28/2016,7/11/2016,7/11/2016,7/27/2016,4/20/2017,4/20/2017,5/11/2017,8/3/2017,8/3/2017,8/29/2017,10/27/2017,10/27/2017
1133,8959,6/15/1958,Male,175,89,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,3/21/2016,7/4/2016,7/4/2016,8/30/2017,11/6/2019,11/6/2019, , , , , , 
1134,7553,6/15/1939,Female,161,58,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,29",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,KYP-X,No CTx,V-X,4/5/2016,7/12/2016,7/12/2016,8/4/2016,1/19/2017,1/19/2017,2/8/2017,3/30/2017,3/30/2017, , , 
1135,7223,6/15/1937,Male,174,68,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"47,35",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,5/25/2016,9/7/2016,9/7/2016,9/21/2016,12/25/2017,12/25/2017,1/18/2018,7/13/2018,7/13/2018,2/19/2019,12/9/2019,12/9/2019
1136,4724,6/15/1946,Male,184,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"17,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2016,8/24/2016,8/24/2016, , , , , , , , , 
1137,4876,6/15/1935,Male,174,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"31,5",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,10/21/2014,2/10/2015,2/10/2015,4/26/2016,12/16/2016,12/16/2016,1/4/2017,7/20/2017,7/20/2017,8/3/2017,8/24/2017,8/24/2017
1138,1267,6/15/1943,Male,191,82,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"21,79",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,POM-X,DAR-X,V-X,1/8/2016,5/13/2016,5/13/2016,6/6/2016,3/27/2017,3/27/2017,4/6/2017,4/13/2017,4/13/2017,5/3/2017,9/20/2017,9/20/2017
1139,5042,6/15/1948,Male,177,73,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,",38",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,No CTx,No CTx,V-X,2/12/2016,6/14/2016,6/14/2016,3/2/2018,4/30/2019,4/30/2019, , , , , , 
1140,2334,6/15/1956,Male,165,70,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"21,3",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,Other,V-X,No CTx,No CTx, , , ,3/1/2008,5/1/2008,5/1/2008,2/9/2016,6/3/2016,6/3/2016, , , 
1141,8634,6/15/1942,Female,150,50,Unknown,No,Yes,Yes,Yes,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgA,"9,46",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,V-X,V-X,V-X,V-X,3/15/2014,11/15/2014,11/15/2014,11/1/2015,12/1/2015,12/1/2015,3/2/2016,6/2/2016,6/2/2016,6/17/2016,10/2/2016,10/2/2016
1142,6856,6/15/1949,Male,180,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,Other type,"41,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,9/11/2015,12/15/2015,12/15/2015,6/12/2018,9/11/2018,9/11/2018, , , , , , 
1143,9375,6/15/1948,Female,154,57,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,13","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/20/2015,6/1/2016,6/1/2016, , , , , , , , , 
1144,9776,6/15/1941,Male,170,78,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,47","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/5/2016,12/31/2016, , , , , , , , , , 
1145,3227,6/15/1951,Female,166,70,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
1146,8467,6/15/1961,Female,162,75,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"6,83","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/25/2016,11/8/2016,11/8/2016, , , , , , , , , 
1147,1793,6/15/1944,Female,170,87,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"36,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/29/2016,8/25/2016,8/25/2016,1/3/2018,6/30/2018, , , , , , , 
1148,1256,6/15/1958,Female,157,55,Compulsory health insurance CHI,Unknown, , , , , ,Yes,Yes, ,Yes,Yes,1,II: fullfilling neither criteria for I nor criteria for III,Other type,294,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,No CTx,V-X,4/15/2016,7/1/2016,7/1/2016,12/1/2016,3/30/2017,3/30/2017,11/12/2018,12/31/2018, , , , 
1149,1884,6/15/1951,Female,169,55,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/24/2016,10/20/2017,10/20/2017, , , , , , , , , 
1150,9172,6/15/1969,Male,176,72,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,54",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/21/2016,7/14/2016,7/14/2016, , , , , , , , , 
1151,3035,6/15/1945,Female,165,58,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,23",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/12/2016,12/31/2016, , , , , , , , , , 
1152,9608,6/15/1938,Female,168,88,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"3,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/11/2016,12/26/2016,12/26/2016, , , , , , , , , 
1153,8795,6/15/1952,Female,176,95,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"3,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/25/2016,10/31/2016,10/31/2016, , , , , , , , , 
1154,2545,6/15/1941,Female,163,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,62",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/4/2016,12/19/2016,12/19/2016, , , , , , , , , 
1155,5100,6/15/1938,Male,176,67,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,No CTx,No CTx,V-X,1/4/2016,9/29/2016,9/29/2016,12/12/2016,12/31/2016, , , , , , , 
1156,6304,6/15/1942,Male,190,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,13,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,No CTx,Other,7/9/2016,9/23/2016,9/23/2016,2/22/2017,6/22/2017,6/22/2017,10/29/2017,3/15/2018,3/15/2018, , , 
1157,8818,6/15/1954,Male,189,98,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,16,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,V-X,V-X,V-X,8/29/2016,9/30/2016,9/30/2016,10/4/2016,3/31/2017,3/31/2017,8/17/2017,3/29/2018,3/29/2018,3/21/2019,3/23/2020,3/23/2020
1158,7919,6/15/1950,Female,170,66,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,22,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,Other,No CTx,Other,10/14/2015,9/23/2016,9/23/2016,10/6/2016,4/5/2017,4/5/2017,9/20/2017,6/26/2018,6/26/2018, , , 
1159,8465,6/15/1957,Male,172,82,Private,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"4,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/5/2016,12/12/2016,12/12/2016, , , , , , , , , 
1160,4905,6/15/1957,Male,189,78,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,22,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,V-X,R-X,Other,5/12/2015,4/23/2016,4/23/2016,7/23/2016,3/29/2017,3/29/2017,3/31/2017,9/17/2017,9/17/2017,10/29/2017,6/27/2018,6/27/2018
1161,5040,6/15/1955,Male,185,81,Private,Yes, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"7,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,POM-X,EMP-X,KYP-X,V-X,11/15/2012,2/15/2013,2/15/2013,10/15/2014,5/15/2015,5/15/2015,9/26/2016,12/20/2016,12/20/2016,1/10/2017,1/9/2018,1/9/2018
1162,7104,6/15/1955,Male,179,82,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,1,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,9/19/2016,12/16/2016,12/16/2016,11/12/2018,7/2/2020,7/2/2020,7/20/2020,12/31/2020,10/14/1582, , , 
1163,8452,6/15/1945,Male,179,80,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,NIN-X,DAR-X,R-X,9/5/2016,1/10/2018,1/10/2018,1/11/2018,4/20/2018,4/20/2018,4/30/2018,6/28/2018,6/28/2018,7/3/2018,11/27/2019,11/27/2019
1164,4725,6/15/1935,Female,161,56,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,9/5/2016,3/5/2017,3/5/2017,6/25/2018,12/16/2018,12/16/2018,12/30/2019,6/21/2020,6/21/2020, , , 
1165,2704,6/15/1943,Male,177,76,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"5,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,LEV-X,LEV-X,V-X,7/1/2013,11/24/2013,11/24/2013,9/19/2016,1/8/2017,1/8/2017,5/28/2018,12/2/2018,12/2/2018,12/16/2019,6/7/2020,6/7/2020
1166,5186,6/15/1949,Male,185,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,25,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,V-X,V-X,KYP-X,Other,9/12/2015,6/24/2016,6/24/2016,9/7/2016,3/23/2017,3/23/2017,7/15/2017,12/10/2017,12/10/2017,6/25/2018,8/10/2019,8/10/2019
1167,5359,6/15/1958,Female,168,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,35","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/19/2016,10/30/2016,10/30/2016, , , , , , , , , 
1168,7093,6/15/1934,Male,172,75,Compulsory health insurance CHI,Yes,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,76",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,No CTx,No CTx,LEV-X,9/12/2016,3/5/2017,3/5/2017,3/19/2018,3/24/2019,3/24/2019, , , , , , 
1169,7596,6/15/1929,Male,170,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,9/5/2016,2/26/2017,2/26/2017, , , , , , , , , 
1170,7275,6/15/1955,Male,182,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/11/2016,10/12/2016,10/12/2016, , , , , , , , , 
1171,1705,6/15/1957,Female,170,73,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/15/2016,9/25/2016,9/25/2016,3/30/2020,12/31/2021,10/14/1582, , , , , , 
1172,9395,6/15/1940,Female,169,68,Compulsory health insurance CHI,Yes,Yes,Yes, , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,24,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,NIN-X,Other,5/23/2015,6/16/2016,6/16/2016,9/23/2016,3/26/2017,3/26/2017,8/25/2017,9/25/2018,9/25/2018,6/12/2019,2/24/2020,2/24/2020
1173,4945,6/15/1939,Male,176,74,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"3,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,4/15/2013,7/14/2013,7/14/2013,9/5/2016,2/26/2017,2/26/2017, , , , , , 
1174,9911,6/15/1946,Female,169,68,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,26,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,Other,V-X,DAR-X,V-X,3/23/2015,4/19/2016,4/19/2016,9/20/2016,3/26/2017,3/26/2017,6/20/2017,2/23/2018,2/23/2018,6/18/2018,7/9/2019,7/9/2019
1175,3676,6/15/1940,Male,169,69,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"1,66","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,No CTx,No CTx,V-X,2/10/2014,5/25/2014,5/25/2014,9/26/2016,3/19/2017,3/19/2017, , , , , , 
1176,8643,6/15/1942,Female,165,69,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,52,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,4/15/2013,10/15/2013,10/15/2013,8/2/2016,9/13/2017,9/13/2017, , , , , , 
1177,8861,6/15/1935,Male,184,98,Private,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,39,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,LEV-X,No CTx,No CTx,R-X,8/17/2016,5/18/2017,5/18/2017,6/1/2017,11/22/2017,11/22/2017, , , , , , 
1178,4469,6/15/1940,Male,178,91,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,47,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,No CTx,No CTx,V-X,6/28/2017,10/19/2017,10/19/2017,11/30/2017,12/31/2017, , , , , , , 
1179,3323,6/15/1968,Female,159,68,Private,No, ,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/1/2016,12/31/2016, , , , , , , , , , 
1180,8424,6/15/1945,Male,183,85,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,02",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,KYP-X,DAR-X,V-X,8/29/2016,12/22/2016,12/22/2016,1/5/2017,8/28/2017,8/28/2017,9/13/2017,5/17/2018,5/17/2018,5/28/2018,7/15/2021,7/15/2021
1181,7214,6/15/1939,Female,168,80,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,8/22/2016,12/30/2016,12/30/2016,1/19/2018,12/18/2018,12/18/2018,3/27/2019,12/5/2020,12/5/2020,12/22/2020,3/31/2022, 
1182,5493,6/15/1941,Male,192,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,7/20/2016,11/28/2016,11/28/2016,12/21/2016,4/19/2018,4/19/2018,5/15/2018,2/14/2019,2/14/2019,2/21/2019,10/22/2019,10/22/2019
1183,9773,6/15/1953,Male,188,87,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,02",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,POM-X,KYP-X,V-X,8/15/2016,12/19/2016,12/19/2016,8/17/2017,12/14/2018,12/14/2018,4/18/2019,4/29/2020,4/29/2020,11/1/2020,11/29/2021,11/29/2021
1184,2685,6/15/1942,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"3,61",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,EMP-X,DAR-X,Other,7/16/2007,9/15/2007,9/15/2007,1/19/2012,6/16/2016,6/16/2016,7/25/2016,5/9/2018,5/9/2018,5/15/2018,1/9/2019,1/9/2019
1185,2296,6/15/1969,Male,999,80,Private,No, , ,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,8/5/2016,9/30/2016, , , , , , , , , , 
1186,9177,6/15/1940,Female,169,51,Private,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,51",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,NIN-X,No CTx,R-X,9/8/2016,3/8/2017,3/8/2017,3/21/2017,10/1/2018,10/1/2018,10/15/2018,11/23/2018,11/23/2018, , , 
1187,6693,6/15/1947,Female,999,65,Private,No, ,Yes, , , , , ,Yes, , ,9,III: one or more criteria are fulfilled,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,No CTx,No CTx,Other,6/7/2002,8/1/2002,8/1/2002,7/19/2016,10/6/2016,10/6/2016, , , , , , 
1188,8830,6/15/1939,Male,178,74,Private,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,No CTx,Other,4/21/2008,6/16/2008,6/16/2008,1/1/2015,9/16/2015,9/16/2015,8/4/2016,12/5/2016,12/5/2016, , , 
1189,7477,6/15/1952,Male,174,86,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,36,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,KYP-X,R-X,EMP-X,8/1/2016,12/1/2016,12/1/2016,6/1/2017,1/1/2018,1/1/2018,2/1/2018,12/15/2018,12/15/2018,6/15/2019,6/30/2019, 
1190,1499,6/15/1955,Female,164,92,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,48,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,EMP-X,9/15/2016,7/15/2017,7/15/2017,8/15/2017,9/15/2018,9/15/2018,10/1/2018,4/15/2019,4/15/2019, , , 
1191,4683,6/15/1938,Male,188,79,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,39,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,8/15/2016,7/15/2017,7/15/2017,8/15/2017,9/15/2018,9/15/2018,2/1/2019,6/15/2019,6/15/2019, , , 
1192,5343,6/15/1961,Male,172,83,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,47,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,KYP-X,No CTx,EMP-X,7/1/2016,11/1/2016,11/1/2016,6/1/2017,2/1/2018,2/1/2018,3/1/2018,6/15/2019,6/15/2019, , , 
1193,5314,6/15/1942,Female,173,87,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,43,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,R-X,DAR-X,V-X,9/15/2016,8/15/2017,8/15/2017,9/15/2017,9/15/2018,9/15/2018,4/15/2019,7/15/2019,7/15/2019,8/1/2019,2/1/2020,2/1/2020
1194,8787,6/15/1939,Female,167,75,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,55,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,POM-X,FAR-X,R-X,8/15/2016,8/15/2017,8/15/2017,9/15/2017,5/15/2018,5/15/2018,6/15/2018,12/15/2018,12/15/2018,1/15/2019,6/15/2019,6/15/2019
1195,6602,6/15/1950,Male,183,75,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,43,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,EMP-X,8/15/2016,12/15/2016,12/15/2016,7/15/2017,5/15/2018,5/15/2018,6/1/2018,4/15/2019,4/15/2019, , , 
1196,8017,6/15/1940,Female,170,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,53,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,DAR-X,No CTx,V-X,9/15/2016,10/15/2017,10/15/2017,11/15/2017,11/15/2018,11/15/2018,4/15/2019,6/30/2019, , , , 
1197,6634,6/15/1954,Male,187,85,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,63,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,KYP-X,EMP-X,7/15/2016,11/15/2016,11/15/2016,5/15/2019,7/15/2019,7/15/2019,8/1/2019,2/15/2020,2/15/2020,3/1/2020,5/15/2020,5/15/2020
1198,7408,6/15/1935,Female,156,68,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,26,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,DAR-X,KYP-X,V-X,8/15/2016,7/15/2017,7/15/2017,8/15/2017,1/15/2018,1/15/2018,3/15/2018,1/15/2019,1/15/2019,2/1/2019,6/15/2019,6/15/2019
1199,5864,6/15/1941,Female,162,55,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,3",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,3/15/2016,6/28/2016,6/28/2016,8/11/2016,12/9/2016,12/9/2016, , , , , , 
1200,3034,6/15/1929,Female,169,75,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"5,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/21/2015,2/18/2016,2/18/2016,9/21/2016,7/10/2017,7/10/2017, , , , , , 
1201,9355,6/15/1948,Female,165,79,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"4,5",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/26/2016,2/2/2017,2/2/2017, , , , , , , , , 
1202,5022,6/15/1941,Female,165,97,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"7,2",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,3/6/2012,9/27/2012,9/27/2012,11/5/2014,6/19/2015,6/19/2015,8/10/2016,7/4/2017,7/4/2017,3/6/2018,5/14/2019,5/14/2019
1203,2164,6/15/1942,Male,180,76,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"1,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,R-X,No CTx,LEV-X,5/27/2013,11/10/2013,11/10/2013,8/8/2016,1/29/2017,1/29/2017,6/4/2018,8/26/2018,8/26/2018, , , 
1204,5080,6/15/1958,Female,163,64,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"4,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/4/2016,9/14/2016,9/14/2016, , , , , , , , , 
1205,1468,6/15/1939,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,EMP-X,DAR-X,LEV-X,V-X,12/12/2014,11/9/2015,11/9/2015,9/30/2016,6/7/2018,6/7/2018,6/25/2018,12/18/2019,12/18/2019,1/14/2020,6/24/2020,6/24/2020
1206,1704,6/15/1963,Male,999,74,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,7/11/2014,9/26/2014,9/26/2014,9/26/2016,2/21/2019,2/21/2019,3/1/2019,6/4/2019,6/4/2019, , , 
1207,8914,6/15/1945,Female,999,65,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes, , , , , ,9,III: one or more criteria are fulfilled,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,EMP-X,KYP-X,V-X,1/22/2009,4/11/2009,4/11/2009,7/18/2016,10/4/2016,10/4/2016,10/5/2018,3/10/2021,3/10/2021,7/15/2021,12/8/2021,12/8/2021
1208,5734,6/15/1970,Male,999,80,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,Unknown,IgG,"2,9",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,No CTx,No CTx,No CTx,V-X,7/19/2016,10/3/2016,10/3/2016, , , , , , , , , 
1209,8505,6/15/1937,Male,176,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,1230,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/26/2016,12/31/2016, , , , , , , , , , 
1210,9305,6/15/1967,Male,167,107,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/27/2016,2/2/2017,2/2/2017, , , , , , , , , 
1211,3490,6/15/1947,Male,180,92,Private,No, , ,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,62",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,8/25/2016,12/19/2016,12/19/2016,3/27/2017,6/5/2019,6/5/2019,7/29/2021,3/31/2022,10/14/1582, , , 
1212,8535,6/15/1939,Female,162,56,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"13,68",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,9/12/2016,1/19/2017,1/19/2017,2/23/2017,10/30/2018,10/30/2018,11/22/2018,11/26/2020,11/26/2020,12/7/2020,1/27/2021,1/27/2021
1213,8575,6/15/1944,Male,175,82,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,02",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/11/2016,1/3/2017,1/3/2017,3/14/2017,3/20/2019,3/20/2019, , , , , , 
1214,4105,6/15/1939,Male,175,80,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,29",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,Other,DAR-X,V-X,8/30/2016,12/20/2016,12/20/2016,1/9/2017,10/5/2017,10/5/2017,10/19/2017,1/11/2018,1/11/2018,1/29/2018,6/4/2018,6/4/2018
1215,6353,6/15/1938,Female,159,53,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"8,42",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,LEV-X,Other,Other,V-X,8/23/2016,12/29/2016,12/29/2016,1/9/2017,9/11/2017,9/11/2017,9/22/2017,11/8/2017,11/8/2017,11/22/2017,12/18/2017,12/18/2017
1216,8723,6/15/1944,Male,177,85,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,8/3/2016,12/22/2016,12/22/2016,6/5/2018,10/14/2019,10/14/2019,10/24/2019,3/31/2022,10/14/1582, , , 
1217,1971,6/15/1943,Female,168,62,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,54,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,No CTx,No CTx,V-X,8/4/2015,12/11/2015,12/11/2015,9/1/2016,9/30/2016,10/14/1582, , , , , , 
1218,2200,6/15/1940,Male,181,71,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"60,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,EMP-X,No CTx,V-X,5/28/2013,11/15/2013,11/15/2013,9/23/2015,2/26/2016,2/26/2016,8/30/2016,9/30/2016, , , , 
1219,7697,6/15/1939,Female,164,65,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"58,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/6/2016,9/30/2016, , , , , , , , , , 
1220,8538,6/15/1938,Male,172,79,Private,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"62,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/24/2016,9/30/2016, , , , , , , , , , 
1221,6162,6/15/1942,Female,169,62,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"58,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/19/2016,9/30/2016, , , , , , , , , , 
1222,8376,6/15/1955,Female,156,75,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,670,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,FAR-X,No CTx,No CTx,V-X,8/1/2015,6/1/2016,6/1/2016,7/1/2016,7/25/2016,7/25/2016, , , , , , 
1223,5438,6/15/1959,Male,999,80,Private,No,Yes, , , , , , ,Yes, , ,9,Unknown,IgA,"6,17",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,R-X,KYP-X,Other,V-X,1/23/2015,4/7/2015,4/7/2015,7/19/2016,6/16/2017,6/16/2017,6/20/2017,7/13/2017,7/13/2017,7/15/2017,9/8/2017,9/8/2017
1224,1102,6/15/1948,Male,168,68,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,",96",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,Other,V-X,KYP-X,V-X,11/2/2010,1/15/2011,1/15/2011,7/1/2014,3/12/2015,3/12/2015,4/15/2015,7/16/2015,7/16/2015,9/9/2016,2/22/2017,2/22/2017
1225,3137,6/15/1963,Female,151,76,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"2,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,9/21/2016,12/6/2016,12/6/2016, , , , , , , , , 
1226,1646,6/15/1953,Male,172,68,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,8/23/2016,10/15/2016,10/15/2016,5/23/2017,8/13/2018,8/13/2018,10/17/2018,5/15/2019,5/15/2019, , , 
1227,1930,6/15/1941,Male,999,80,Compulsory health insurance CHI,Yes, , , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"1,69",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,DAR-X,No CTx,V-X,9/22/2014,3/4/2015,3/4/2015,8/26/2016,6/26/2017,6/26/2017,5/14/2018,9/30/2021,10/14/1582, , , 
1228,3368,6/15/1952,Female,999,65,Compulsory health insurance CHI,No, , , , , , , ,Yes, ,Yes,9,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,V-X,V-X,6/6/2009,8/20/2009,8/20/2009,7/15/2013,2/1/2014,2/1/2014,3/9/2015,6/3/2015,6/3/2015,6/10/2015,8/2/2015,8/2/2015
1229,8134,6/15/1947,Female,165,72,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,92",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,V-X,V-X,9/12/2016,7/4/2017,7/4/2017,8/8/2017,11/29/2018,11/29/2018,1/8/2019,4/3/2019,4/3/2019,7/2/2019,12/10/2020,12/10/2020
1230,3030,6/15/1958,Male,183,82,Private,No, , ,Yes, ,Yes,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"17,72",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,V-X,V-X,8/29/2016,5/8/2017,5/8/2017,2/15/2018,1/17/2019,1/17/2019,3/1/2019,4/29/2019,4/29/2019,5/29/2019,11/8/2019,11/8/2019
1231,1463,6/15/1941,Male,179,61,Private,No,Yes, ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"11,58",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,8/29/2016,7/19/2017,7/19/2017,2/20/2018,12/30/2019,12/30/2019, , , , , , 
1232,7747,6/15/1944,Female,168,68,Compulsory health insurance CHI,Yes, ,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,",36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,DAR-X,POM-X,V-X,9/27/2016,11/29/2016,11/29/2016,11/1/2017,12/20/2017,12/20/2017,2/23/2018,7/4/2019,7/4/2019,8/13/2019,10/4/2019,10/4/2019
1233,3296,6/15/1957,Male,999,80,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"7,78",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,Other,POM-X,LEV-X,V-X,3/15/2010,3/7/2011,3/7/2011,2/28/2013,1/16/2014,1/16/2014,6/30/2015,12/1/2015,12/1/2015,7/20/2016,10/21/2016,10/21/2016
1234,5190,6/15/1961,Female,999,65,Compulsory health insurance CHI,Unknown, , , , , , , , , ,Yes,9,I: fulfilling all 4 criteria,IgG,"3,4",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,EMP-X,9/20/2016,12/5/2016,12/5/2016, , , , , , , , , 
1235,3669,6/15/1962,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,POM-X,No CTx,No CTx,V-X,8/30/2016,12/29/2016,12/29/2016,12/31/2016,6/30/2017,6/30/2017, , , , , , 
1236,7151,6/15/1949,Male,999,80,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"99999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,1/31/2011,3/25/2011,3/25/2011,8/1/2016,12/31/2020,10/14/1582, , , , , , 
1237,5855,6/15/1943,Male,176,72,Compulsory health insurance CHI,No, , , , ,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"1,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,POM-X,No CTx,V-X,7/14/2011,9/27/2011,9/27/2011,7/1/2015,10/1/2015,10/1/2015,7/27/2016,2/15/2017,2/15/2017, , , 
1238,2813,6/15/1957,Female,999,65,Compulsory health insurance CHI,No, , , , , , , ,Yes, ,Yes,9,III: one or more criteria are fulfilled,IgG,"1,82",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,4/1/2015,7/1/2015,7/1/2015,7/13/2016,11/17/2016,11/17/2016,1/15/2018,12/31/2020,10/14/1582, , , 
1239,6592,6/15/1959,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"4,48",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,EMP-X,8/16/2016,10/31/2016,10/31/2016, , , , , , , , , 
1240,4299,6/15/1953,Male,999,80,Private,No, , , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgA,"2,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,9/13/2016,11/28/2016,11/28/2016, , , , , , , , , 
1241,5170,6/15/1939,Female,171,68,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"59,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/17/2016,9/30/2016, , , , , , , , , , 
1242,5198,6/15/1951,Male,195,89,Private,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,38",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,NIN-X,No CTx,R-X,9/12/2016,12/18/2017,12/18/2017,1/1/2018,3/11/2020,3/11/2020,10/14/2020,3/31/2022, , , , 
1243,5554,6/15/1939,Female,158,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,04",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,NIN-X,V-X,9/13/2016,12/28/2016,12/28/2016,1/18/2017,5/29/2018,5/29/2018,6/21/2018,11/21/2018,11/21/2018,2/21/2019,3/26/2019,3/26/2019
1244,8113,6/15/1968,Male,179,85,Private,No, , ,Yes, ,Yes,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,8/30/2016,3/29/2017,3/29/2017,7/13/2017,6/17/2020,6/17/2020, , , , , , 
1245,7873,6/15/1937,Male,175,81,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"14,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,8/2/2016,9/2/2016,9/2/2016,9/19/2016,5/23/2018,5/23/2018,6/15/2018,1/14/2021,1/14/2021, , , 
1246,6603,6/15/1934,Male,165,102,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"4,85",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,KYP-X,No CTx,Other,4/8/2013,9/1/2014,9/1/2014,5/5/2015,3/22/2016,3/22/2016,9/1/2016,11/23/2016,11/23/2016, , , 
1247,3219,6/15/1950,Female,175,86,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,I: fulfilling all 4 criteria,IgG,"5,68",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,DAR-X,No CTx,V-X,7/31/2014,9/25/2014,9/25/2014,2/7/2015,4/4/2015,4/4/2015,8/17/2016,12/6/2016,12/6/2016, , , 
1248,7430,6/15/1952,Female,169,98,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgA,"1,01",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,9/26/2016,12/8/2016,12/8/2016, , , , , , , , , 
1249,9339,6/15/1939,Female,168,72,Private,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,02",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,EMP-X,No CTx,R-X,8/16/2016,2/5/2018,2/5/2018,2/19/2018,11/23/2020,11/23/2020,12/17/2020,3/31/2022,10/14/1582, , , 
1250,7748,6/15/1942,Male,173,70,Compulsory health insurance CHI,No, ,Yes, ,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"14,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,NIN-X,No CTx,No CTx,V-X,9/19/2016,7/11/2017,7/11/2017,7/31/2017,6/24/2021,6/24/2021, , , , , , 
1251,9498,6/15/1941,Male,171,93,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"5,17",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,8/24/2016,3/23/2017,3/23/2017, , , , , , , , , 
1252,2109,6/15/1944,Female,161,63,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,07",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,9/20/2016,11/25/2016,11/25/2016,1/10/2017,2/10/2017,2/10/2017, , , , , , 
1253,4026,6/15/1943,Male,182,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"9,26",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,No CTx,No CTx,V-X,8/25/2016,7/10/2017,7/10/2017,7/20/2018,12/31/2020,10/14/1582, , , , , , 
1254,6315,6/15/1942,Male,175,63,Private,No,Yes, ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"15,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,9/6/2016,9/27/2017,9/27/2017,10/9/2017,7/16/2018,7/16/2018, , , , , , 
1255,3378,6/15/1945,Male,173,70,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"4,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,LEV-X,9/26/2016,3/19/2017,3/19/2017,12/10/2018,5/13/2019,5/13/2019, , , , , , 
1256,2037,6/15/1941,Female,162,53,Private,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"13,05",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,8/25/2016,8/29/2017,8/29/2017,2/6/2018,9/30/2020,10/14/1582, , , , , , 
1257,9038,6/15/1940,Male,182,79,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"10,4",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/19/2016,7/6/2017,7/6/2017, , , , , , , , , 
1258,3734,6/15/1959,Male,175,90,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"55,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/6/2016,9/26/2016,9/26/2016, , , , , , , , , 
1259,5354,6/15/1951,Male,175,79,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,",12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,NIN-X,No CTx,V-X,1/8/2016,5/3/2016,5/3/2016,5/4/2016,8/31/2016,8/31/2016,1/16/2019,3/31/2022,10/14/1582, , , 
1260,3411,6/15/1949,Female,160,56,Compulsory health insurance CHI,Yes,Yes, , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"17,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,No CTx, , , ,7/7/2016,9/1/2016,9/1/2016, , , , , , 
1261,5941,6/15/1968,Male,173,93,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,",21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/4/2016,9/1/2016,9/1/2016,5/21/2019,3/31/2022,10/14/1582, , , , , , 
1262,6917,6/15/1945,Male,189,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,82",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,NIN-X,POM-X,V-X,8/23/2016,7/6/2017,7/6/2017,2/5/2018,1/2/2020,1/2/2020,2/3/2020,3/24/2020,3/24/2020,4/4/2020,10/2/2020,10/2/2020
1263,5908,6/15/1965,Male,172,85,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"15,62",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,8/16/2016,2/15/2017,2/15/2017,1/22/2018,12/31/2021,10/14/1582, , , , , , 
1264,7917,6/15/1942,Male,163,94,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"43,6",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/13/2016,11/8/2016,11/8/2016, , , , , , , , , 
1265,2297,6/15/1940,Male,178,81,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,63,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,7/28/2014,2/6/2015,2/6/2015,9/19/2016,9/30/2016, , , , , , , 
1266,6187,6/15/1954,Male,181,74,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,9/15/2016,9/30/2016, , , , , , , , , , 
1267,5807,6/15/1943,Female,165,93,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,8/25/2016,6/15/2017,6/15/2017, , , , , , , , , 
1268,7406,6/15/1944,Female,162,67,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,4720,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/28/2016,9/30/2016, , , , , , , , , , 
1269,3478,6/15/1936,Female,165,47,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"31,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
1270,8675,6/15/1934,Female,160,55,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"40,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/5/2016,1/13/2017,1/13/2017, , , , , , , , , 
1271,8375,6/15/1947,Male,176,88,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"18,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/30/2016,11/16/2016,11/16/2016, , , , , , , , , 
1272,2872,6/15/1926,Male,163,61,Private,Yes, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/15/2016,11/21/2016,11/21/2016, , , , , , , , , 
1273,9879,6/15/1934,Male,176,84,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"73,81",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,R-X,V-X,9/20/2012,4/29/2013,4/29/2013,9/16/2013,1/29/2014,1/29/2014,8/25/2015,4/20/2016,4/20/2016,7/13/2016,11/14/2016,11/14/2016
1274,5121,6/15/1952,Male,170,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"31,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,DAR-X,V-X,9/1/2015,3/1/2016,3/1/2016,8/8/2016,5/29/2017,5/29/2017,6/13/2017,11/28/2017,11/28/2017,6/19/2018,7/30/2019,7/30/2019
1275,9311,6/15/1960,Female,166,71,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"35,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,Other,9/22/2016,9/25/2016,9/25/2016, , , , , , , , , 
1276,5084,6/15/1937,Male,176,77,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , ,"<3,5 mg/L", ,POM-X,V-X,KYP-X,R-X,9/4/2015,7/29/2016,7/29/2016,10/5/2017,6/4/2018,6/4/2018,1/28/2019,4/8/2019,4/8/2019,7/15/2019,8/26/2019,8/26/2019
1277,5982,6/15/1937,Female,160,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"11,37",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,KYP-X,V-X,12/22/2015,7/5/2016,7/5/2016,2/27/2017,3/28/2017,3/28/2017,6/20/2017,10/10/2017,10/10/2017,9/11/2018,11/26/2020,11/26/2020
1278,5726,6/15/1941,Male,182,88,Private,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"53,32",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,R-X,DAR-X,No CTx,V-X,11/9/2015,6/27/2016,6/27/2016,7/14/2016,11/24/2016,11/24/2016,1/18/2017,1/18/2017,1/18/2017, , , 
1279,2189,6/15/1949,Male,179,78,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,46,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/27/2016,3/22/2017,3/22/2017,8/17/2017,12/31/2017, , , , , , , 
1280,2234,6/15/1933,Male,180,78,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,31,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,Other,R-X,DAR-X,V-X,2/4/2016,6/8/2016,6/8/2016,12/29/2016,6/8/2017,6/8/2017,10/18/2017,10/20/2017,10/20/2017,6/10/2018,9/21/2018,9/21/2018
1281,9964,6/15/1937,Male,176,83,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,unbekannt, , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,No CTx,V-X,9/18/2015,9/16/2016,9/16/2016,11/4/2016,6/1/2019,6/1/2019,12/4/2019,11/26/2020,11/26/2020, , , 
1282,3563,6/15/1940,Male,162,70,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgA,",02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,R-X,KYP-X,R-X,V-X,5/30/2016,11/17/2016,11/17/2016,3/12/2018,7/22/2018,7/22/2018,3/4/2019,6/26/2019,6/26/2019,6/24/2020,7/13/2020,7/13/2020
1283,8327,6/15/1958,Male,179,84,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"1,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,10/30/2016,1/22/2017,1/22/2017, , , , , , , , , 
1284,3112,6/15/1937,Male,181,79,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"1,9",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,V-X,R-X,No CTx,V-X,11/15/2016,1/10/2017,1/10/2017,1/11/2017,3/2/2017,3/2/2017,6/19/2018,7/17/2018,7/17/2018, , , 
1285,8886,6/15/1938,Male,175,73,Private,Yes,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/31/2016,3/6/2017,3/6/2017, , , , , , , , , 
1286,5492,6/15/1941,Female,168,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"2,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,EMP-X,No CTx,No CTx,V-X,11/8/2016,1/31/2017,1/31/2017,9/16/2020,6/30/2021,10/14/1582, , , , , , 
1287,8469,6/15/1950,Male,9,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes,1,III: one or more criteria are fulfilled,IgA,1,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,10/17/2016,1/3/2017,1/3/2017,3/21/2017,3/31/2017, , , , , , , 
1288,1225,6/15/1956,Male,182,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes,Yes, ,2,I: fulfilling all 4 criteria,IgA,"5,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,12/5/2016,2/5/2017,2/5/2017,7/6/2020,9/6/2020,9/6/2020, , , , , , 
1289,8827,6/15/1965,Male,999,80,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,2,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,No CTx,No CTx,V-X,4/1/2014,6/1/2014,6/1/2014,12/9/2016,2/1/2017,2/1/2017, , , , , , 
1290,2810,6/15/1951,Female,149,44,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Other type,"2,98",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/15/2016,12/31/2016, , , , , , , , , , 
1291,9640,6/15/1939,Female,164,59,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,12/2/2016,5/21/2017,5/21/2017,8/13/2018,2/17/2019,2/17/2019,5/25/2020,11/15/2020,11/15/2020, , , 
1292,5482,6/15/1945,Female,155,48,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,4,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,R-X,No CTx,V-X,12/2/2016,2/3/2017,2/3/2017,2/9/2017,6/7/2017,6/7/2017,7/10/2017,7/24/2017,7/24/2017, , , 
1293,7647,6/15/1944,Male,180,105,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,3,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,24", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/14/2016,6/9/2020,6/9/2020, , , , , , , , , 
1294,5639,6/15/1937,Female,149,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,Other,11/3/2016,1/12/2017,1/12/2017, , , , , , , , , 
1295,5984,6/15/1955,Female,172,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,12/12/2016,1/22/2017,1/22/2017,12/30/2019,3/1/2020,3/1/2020, , , , , , 
1296,2823,6/15/1958,Male,181,85,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"4,21",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/29/2016,4/2/2017,4/2/2017, , , , , , , , , 
1297,5611,6/15/1959,Female,167,74,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,35","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/12/2016,3/5/2017,3/5/2017, , , , , , , , , 
1298,3175,6/15/1936,Female,168,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,41,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,DAR-X,No CTx,R-X,10/15/2016,7/15/2017,7/15/2017,8/15/2017,9/15/2018,9/15/2018,12/15/2018,6/15/2019,6/15/2019, , , 
1299,6653,6/15/1940,Male,177,83,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,R-X,No CTx,R-X,11/15/2016,8/15/2017,8/15/2017,9/15/2017,9/15/2018,9/15/2018,12/15/2018,5/15/2019,5/15/2019, , , 
1300,4052,6/15/1943,Female,174,72,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,25,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,POM-X,R-X,12/15/2015,10/15/2016,10/15/2016,11/15/2016,8/15/2017,8/15/2017,9/15/2017,9/15/2018,9/15/2018,10/15/2018,5/15/2019,5/15/2019
1301,8841,6/15/1936,Female,157,86,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,Unknown,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,V-X,R-X,No CTx,V-X,7/10/2015,10/29/2015,10/29/2015,8/10/2016,11/6/2016,11/6/2016,1/18/2017,12/31/2017,10/14/1582, , , 
1302,9618,6/15/1939,Male,170,60,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"5,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/19/2016,9/18/2017,9/18/2017, , , , , , , , , 
1303,9471,6/15/1942,Male,172,65,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/24/2016,7/19/2017,7/19/2017,1/9/2018,8/12/2018,8/12/2018, , , , , , 
1304,4183,6/15/1950,Male,171,60,Compulsory health insurance CHI,No, ,Yes, , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"12,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/9/2016,8/15/2017,8/15/2017, , , , , , , , , 
1305,4940,6/15/1952,Male,168,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"15,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/18/2016,6/12/2017,6/12/2017, , , , , , , , , 
1306,1089,6/15/1942,Female,165,55,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,R-X,No CTx,V-X,11/28/2016,6/27/2017,6/27/2017,12/4/2017,6/12/2018,6/12/2018,3/5/2019,9/20/2019,9/20/2019, , , 
1307,7255,6/15/1941,Male,174,67,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,LEV-X,No CTx,LEV-X,2/10/2014,8/3/2014,8/3/2014,12/12/2016,5/7/2017,5/7/2017,6/25/2018,12/16/2018,12/16/2018, , , 
1308,1044,6/15/1948,Female,173,73,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, ,Yes, , ,Yes,2,III: one or more criteria are fulfilled,IgG,"9,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/22/2016,9/20/2016,9/20/2016,11/29/2017,9/11/2018,9/11/2018, , , , , , 
1309,1163,6/15/1959,Female,172,68,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/29/2016,2/8/2017,2/8/2017, , , , , , , , , 
1310,1150,6/15/1960,Male,172,65,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"20,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/25/2016,8/18/2016,8/18/2016,11/14/2016,9/12/2017,9/12/2017, , , , , , 
1311,3719,6/15/1952,Female,162,58,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"12,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/7/2016,10/7/2016,10/7/2016,12/5/2016,12/31/2017, , , , , , , 
1312,3195,6/15/1942,Male,168,70,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/28/2016,10/26/2016,10/26/2016,11/28/2016,10/17/2017,10/17/2017, , , , , , 
1313,8242,6/15/1940,Female,165,69,Compulsory health insurance CHI,No, , , ,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"17,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,11/23/2015,9/14/2016,9/14/2016,12/12/2016,7/20/2017,7/20/2017,2/7/2018,10/19/2018,10/19/2018, , , 
1314,1760,6/15/1949,Male,170,64,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/1/2015,9/8/2016,9/8/2016,12/5/2016,9/12/2017,9/12/2017, , , , , , 
1315,8004,6/15/1955,Male,172,66,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/20/2016,10/26/2016,10/26/2016,11/2/2016,12/31/2017, , , , , , , 
1316,8576,6/15/1956,Male,171,65,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"10,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,2/1/2016,10/26/2016,10/26/2016,11/21/2016,8/23/2017,8/23/2017, , , , , , 
1317,8416,6/15/1937,Male,186,94,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes, , ,Yes, ,3,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,8",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/23/2016,12/19/2016,12/19/2016,1/7/2017,3/1/2017,3/1/2017, , , , , , 
1318,9181,6/15/1943,Male,180,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"5,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,LEV-X,V-X,5/19/2014,9/7/2014,9/7/2014,12/12/2016,6/4/2017,6/4/2017,9/24/2018,3/17/2019,3/17/2019,5/11/2020,11/1/2020,11/1/2020
1319,2418,6/15/1950,Female,168,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"25,26",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,10/10/2016,12/22/2016,12/22/2016,5/26/2020,7/16/2020,7/16/2020, , , , , , 
1320,2918,6/15/1961,Male,170,71,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,21,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,11/23/2015,8/26/2016,8/26/2016,10/17/2016,12/19/2017,12/19/2017,6/12/2018,10/18/2018,10/18/2018, , , 
1321,4126,6/15/1944,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgM,"5,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,KYP-X,KYP-X,DAR-X,V-X,6/15/2016,10/15/2016,10/15/2016,11/7/2016,1/31/2017,1/31/2017,4/16/2018,2/4/2019,2/4/2019,2/26/2019,3/29/2019,3/29/2019
1322,4569,6/15/1946,Male,168,88,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgM,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,12/12/2016,1/24/2017,1/24/2017,5/3/2017,7/23/2017,7/23/2017, , , , , , 
1323,8290,6/15/1955,Female,172,73,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , ,Unknown, ,1,III: one or more criteria are fulfilled,IgG,"23,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/17/2016,1/9/2017,1/9/2017, , , , , , , , , 
1324,3008,6/15/1939,Male,178,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,No CTx,No CTx,LEV-X,1/5/2015,6/28/2015,6/28/2015,12/5/2016,4/2/2017,4/2/2017, , , , , , 
1325,8696,6/15/1955,Male,175,77,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"2,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/1/2016,2/5/2017,2/5/2017, , , , , , , , , 
1326,5849,6/15/1941,Male,168,87,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
1327,9969,6/15/1963,Female,170,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgM,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,10/10/2016,10/20/2016,10/20/2016, , , , , , , , , 
1328,5762,6/15/1941,Female,169,72,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,34",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,11/8/2016,3/15/2017,3/15/2017, , , , , , , , , 
1329,9662,6/15/1955,Female,155,40,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"9,89",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,POM-X,Other,2/16/2001,4/24/2001,4/24/2001,5/9/2011,8/1/2011,8/1/2011,12/1/2013,7/3/2014,7/3/2014,10/17/2014,8/23/2016,8/23/2016
1330,8855,6/15/1965,Male,180,135,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"6,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,V-X,KYP-X,V-X,10/1/2012,12/1/2012,12/1/2012,8/20/2014,8/18/2015,8/18/2015,8/20/2015,11/10/2015,11/10/2015,5/18/2016,8/2/2016,8/2/2016
1331,7737,6/15/1933,Male,164,65,Unknown,Yes, , , , , , , , ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/29/2016,12/31/2016, , , , , , , , , , 
1332,4333,6/15/1951,Female,163,65,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, ,Yes, , ,Yes,2,III: one or more criteria are fulfilled,IgG,"10,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,POM-X,FAR-X,No CTx,V-X,10/11/2013,12/28/2013,12/28/2013,12/16/2014,10/2/2015,10/2/2015,10/19/2015,3/8/2016,3/8/2016, , , 
1333,5907,6/15/1951,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,V-X,V-X,R-X,V-X,9/20/2010,11/13/2010,11/13/2010,9/1/2013,1/1/2014,1/1/2014,9/1/2014,11/1/2014,11/1/2014,6/22/2015,7/13/2015,7/13/2015
1334,3380,6/15/1964,Female,165,61,Unknown,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgA,"2,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,No CTx,V-X,1/13/2014,5/8/2014,5/8/2014,7/6/2016,9/9/2016,9/9/2016,10/11/2016,10/11/2016,10/11/2016, , , 
1335,8268,6/15/1964,Male,179,90,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"4,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,12/6/2016,2/27/2017,2/27/2017,3/25/2021,6/30/2021,10/14/1582, , , , , , 
1336,4072,6/15/1957,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,V-X,R-X,R-X,Other,7/11/2007,9/23/2007,9/23/2007,4/18/2011,5/19/2012,5/19/2012,6/19/2012,12/17/2012,12/17/2012,3/23/2015,11/16/2016,11/16/2016
1337,1672,6/15/1929,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,LEV-X,LEV-X,Other,4/23/2001,8/21/2003,8/21/2003,4/1/2004,7/29/2004,7/29/2004,8/4/2004,12/14/2004,12/14/2004,2/13/2006,5/9/2006,5/9/2006
1338,8825,6/15/1960,Male,188,100,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,86","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,EMP-X,12/16/2016,4/3/2017,4/3/2017,6/19/2020,11/30/2021,11/30/2021,12/28/2021,3/31/2022, , , , 
1339,5837,6/15/1962,Female,162,54,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,"5,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,R-X,KYP-X,V-X,6/1/2014,6/28/2014,6/28/2014,5/1/2015,8/1/2015,8/1/2015,10/1/2015,12/16/2015,12/16/2015,7/22/2016,10/1/2016,10/1/2016
1340,2445,6/15/1941,Male,999,80,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgA,"1,83","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,POM-X,DAR-X,V-X,12/20/2010,2/18/2011,2/18/2011,7/28/2014,12/1/2016,12/1/2016,12/13/2016,4/19/2017,4/19/2017,8/29/2017,3/4/2020,3/4/2020
1341,6491,6/15/1955,Male,168,61,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes,Yes,0,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,V-X,KYP-X,V-X,2/21/2013,5/6/2013,5/6/2013,7/10/2014,7/21/2015,7/21/2015,11/20/2015,1/27/2016,1/27/2016,12/29/2016,7/20/2017,7/20/2017
1342,4866,6/15/1954,Female,169,100,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,LEV-X,POM-X,V-X,4/4/2012,6/20/2012,6/20/2012,7/11/2014,12/2/2014,12/2/2014,1/1/2015,3/24/2015,3/24/2015,4/10/2015,6/14/2016,6/14/2016
1343,3811,6/15/1938,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgA,"2,3",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,R-X,V-X,R-X,Other,10/8/2002,12/29/2002,12/29/2002,8/17/2007,11/2/2007,11/2/2007,7/21/2009,11/1/2009,11/1/2009,4/1/2010,7/3/2014,7/3/2014
1344,1182,6/15/1962,Male,190,90,Unknown,No,Yes,Yes, ,Yes, , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgG,",05",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/25/2016,11/30/2016,11/30/2016, , , , , , , , , 
1345,7017,6/15/1954,Female,168,106,Unknown,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,KYP-X,No CTx,No CTx,V-X,1/23/2015,5/1/2015,5/1/2015,7/28/2016,11/4/2016,11/4/2016, , , , , , 
1346,9560,6/15/1948,Male,172,93,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"8,1",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,V-X,DAR-X,No CTx,R-X,10/24/2016,7/26/2017,7/26/2017,1/29/2018,7/19/2018,7/19/2018,3/11/2019,12/31/2019,10/14/1582, , , 
1347,4192,6/15/1947,Male,176,85,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,8/20/2015,1/14/2016,1/14/2016,9/27/2016,8/9/2017,8/9/2017,4/19/2018,5/24/2019,5/24/2019,6/14/2019,12/31/2019, 
1348,4484,6/15/1949,Female,164,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"7,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,R-X,7/23/2014,6/30/2015,6/30/2015,10/18/2016,7/12/2017,7/12/2017,3/27/2018,6/7/2019,6/7/2019,6/28/2019,12/31/2019, 
1349,4397,6/15/1958,Male,184,75,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/17/2016,3/31/2017,3/31/2017,1/22/2018,12/31/2018,10/14/1582, , , , , , 
1350,5335,6/15/1943,Female,165,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,3/3/2015,9/17/2015,9/17/2015,11/23/2016,7/18/2018,7/18/2018,8/6/2018,10/30/2019,10/30/2019,11/21/2019,12/31/2019, 
1351,7376,6/15/1948,Female,160,66,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Unknown, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/27/2016,1/9/2017,1/9/2017, , , , , , , , , 
1352,6776,6/15/1942,Male,180,85,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,3000,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,NIN-X,DAR-X,No CTx,R-X,12/5/2016,8/18/2017,8/18/2017,9/6/2017,11/16/2018,11/16/2018,11/27/2018,5/28/2020,5/28/2020, , , 
1353,6013,6/15/1938,Female,165,69,Private,Yes, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"2,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,NIN-X,DAR-X,V-X,3/30/2016,12/20/2016,12/20/2016,1/3/2017,6/14/2017,6/14/2017,6/19/2017,1/28/2019,1/28/2019,1/29/2019,12/31/2019,10/14/1582
1354,4058,6/15/1937,Female,168,98,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"6,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,8/14/2013,2/12/2015,2/12/2015,10/20/2016,4/1/2019,4/1/2019, , , , , , 
1355,8252,6/15/1957,Male,180,153,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,76",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,DAR-X,No CTx,No CTx,V-X,10/11/2016,6/19/2018,6/19/2018,7/31/2018,6/30/2019,10/14/1582, , , , , , 
1356,3249,6/15/1937,Male,169,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,19",ISS stage II (neither stage I nor stage III), , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,12/19/2016,5/15/2019,5/15/2019, , , , , , , , , 
1357,5356,6/15/1933,Female,160,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,No CTx,No CTx,V-X,10/25/2016,11/30/2016,11/30/2016,12/7/2016,7/26/2017,7/26/2017, , , , , , 
1358,1808,6/15/1934,Male,170,80,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,No CTx,No CTx,V-X,11/22/2016,12/27/2016,12/27/2016,3/1/2017,4/19/2017,4/19/2017, , , , , , 
1359,5796,6/15/1927,Male,170,72,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,",72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Unbekannt,V-X,DAR-X,No CTx,R-X,12/15/2016,1/26/2017,1/26/2017,11/15/2018,3/28/2019,3/28/2019,3/30/2019,9/17/2019,9/17/2019, , , 
1360,7312,6/15/1926,Male,163,61,Private,Yes, , , , , , , , , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,Other type,281,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,7/15/2016,10/28/2016,10/28/2016,11/11/2016,11/24/2016,11/24/2016, , , , , , 
1361,1803,6/15/1938,Male,169,72,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,"9999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,12/7/2016,3/15/2017,3/15/2017,6/5/2019,9/30/2019, , , , , , , 
1362,5108,6/15/1938,Male,176,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"14,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,No,Yes, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Ja,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,11/18/2016,12/1/2017,12/1/2017, , , , , , , , , 
1363,4143,6/15/1944,Male,172,86,Unknown,No, , , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,12/14/2016,12/31/2016, , , , , , , , , , 
1364,1385,6/15/1944,Male,172,83,Unknown,No,Yes,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,5/9/2016,9/15/2016,9/15/2016, , , , , , , , , 
1365,9117,6/15/1933,Female,153,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"111,52",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,R-X,No CTx,No CTx,V-X,12/9/2014,1/29/2015,1/29/2015,2/19/2015,7/11/2017,7/11/2017, , , , , , 
1366,7414,6/15/1946,Female,155,55,Unknown,No, , , , , , , , , , ,0,Unknown,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/2/2017,5/18/2017,5/18/2017, , , , , , , , , 
1367,2323,6/15/1962,Male,181,82,Unknown,No, ,Yes, , , , ,Yes, , ,Yes,9,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/19/2016,11/14/2016,11/14/2016, , , , , , , , , 
1368,8387,6/15/1951,Female,170,80,Unknown,No,Yes, , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/26/2016,1/19/2017,1/19/2017, , , , , , , , , 
1369,1413,6/15/1935,Male,172,80,Unknown,No, , , ,Yes, , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,V-X,No CTx,V-X,4/11/2012,2/1/2013,2/1/2013,7/1/2013,9/30/2016,9/30/2016,10/1/2016,4/6/2017,4/6/2017, , , 
1370,9342,6/15/1949,Female,162,70,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"12,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,EMP-X,12/8/2016,5/2/2017,5/2/2017, , , , , , , , , 
1371,9956,6/15/1933,Male,178,83,Compulsory health insurance CHI,Yes, , , , , , , , , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,IgG,34,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/30/2016,2/2/2017,2/2/2017,8/15/2017,2/12/2018,2/12/2018, , , , , , 
1372,9220,6/15/1964,Male,175,69,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,55,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,KYP-X,DAR-X,V-X,10/13/2015,2/14/2016,2/14/2016,4/15/2016,10/15/2016,10/15/2016,8/1/2017,1/10/2019,1/10/2019,2/5/2019,8/20/2019,8/20/2019
1373,2645,6/15/1931,Female,166,51,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,890,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,1/15/2016,10/14/2016,10/14/2016, , , , , , , , , 
1374,9095,6/15/1958,Male,186,95,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"42,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,POM-X,No CTx,V-X,10/6/2016,12/15/2016,12/15/2016,7/10/2018,7/24/2018,7/24/2018,9/4/2018,10/10/2018,10/10/2018, , , 
1375,6749,6/15/1940,Male,180,105,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,55,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,4/1/2014,8/1/2015,8/1/2015, , , , , , , , , 
1376,5106,6/15/1932,Female,166,75,Compulsory health insurance CHI,Yes, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,53,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,No CTx,No CTx,V-X,4/1/2014,7/1/2015,7/1/2015,10/15/2016,10/15/2017,10/15/2017, , , , , , 
1377,6351,6/15/1933,Female,165,55,Compulsory health insurance CHI,Yes, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,50,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/1/2016,12/1/2016,12/1/2016, , , , , , , , , 
1378,9812,6/15/1956,Male,179,90,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,70,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/1/2016,7/30/2016,7/30/2016, , , , , , , , , 
1379,4334,6/15/1934,Female,167,50,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,1100,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,No CTx,No CTx,V-X,9/1/2015,11/1/2016,11/1/2016,4/19/2018,11/22/2018,11/22/2018, , , , , , 
1380,4811,6/15/1973,Male,187,73,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,0,Unknown,IgA,"28,67",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , ,Nein,KYP-X,No CTx,No CTx,V-X,10/17/2011,12/31/2011,12/31/2011,12/5/2016,3/31/2022,10/14/1582, , , , , , 
1381,3238,6/15/1956,Male,180,89,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,11,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/9/2016,11/17/2017,11/17/2017, , , , , , , , , 
1382,6791,6/15/1940,Female,999,65,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"999,99",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,R-X,11/14/2016,12/31/2016, , , , , , , , , , 
1383,5402,6/15/1942,Female,158,68,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"28,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/5/2016,6/30/2018, , , , , , , , , , 
1384,7156,6/15/1939,Female,160,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgA,"60,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/4/2016,6/30/2018, , , , , , , , , , 
1385,9836,6/15/1951,Female,164,58,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"29,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,11/4/2016,10/1/2018,10/1/2018, , , , , , , , , 
1386,4346,6/15/1964,Female,187,79,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/12/2016,6/30/2018, , , , , , , , , , 
1387,9142,6/15/1947,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,No CTx,No CTx,V-X,2/18/2013,6/30/2013,6/30/2013,11/14/2016,12/31/2016, , , , , , , 
1388,8676,6/15/1945,Male,175,86,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,17",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,POM-X,V-X,11/7/2016,2/8/2017,2/8/2017,2/21/2017,6/5/2018,6/5/2018,6/15/2018,8/27/2018,8/27/2018,3/12/2019,3/22/2019,3/22/2019
1389,1186,6/15/1949,Male,179,85,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,37",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,9/29/2016,1/2/2017,1/2/2017,2/27/2017,11/8/2018,11/8/2018,2/15/2019,9/10/2019,9/10/2019, , , 
1390,9186,6/15/1942,Male,187,65,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,KYP-X,DAR-X,V-X,12/2/2016,12/26/2016,12/26/2016,1/16/2017,10/2/2017,10/2/2017,10/17/2017,5/7/2018,5/7/2018,5/25/2018,11/23/2018,11/23/2018
1391,5655,6/15/1948,Male,189,85,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"21,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,R-X,POM-X,V-X,9/28/2016,1/10/2017,1/10/2017,3/29/2017,11/14/2018,11/14/2018,2/8/2019,7/8/2020,7/8/2020,7/16/2020,12/31/2021, 
1392,1584,6/15/1942,Female,158,54,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,14",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,R-X,10/18/2016,1/26/2017,1/26/2017,2/16/2017,11/28/2018,11/28/2018,3/27/2019,6/30/2021, , , , 
1393,3473,6/15/1949,Male,166,57,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,14",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,KYP-X,R-X,10/17/2016,3/20/2017,3/20/2017,3/27/2017,12/18/2018,12/18/2018,1/7/2019,7/12/2021,7/12/2021,7/23/2021,12/31/2021,10/14/1582
1394,8188,6/15/1951,Male,179,56,Private,No,Yes,Yes, , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,81",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,R-X,11/18/2016,1/23/2017,1/23/2017,1/30/2017,12/13/2018,12/13/2018,2/26/2019,4/9/2019,4/9/2019,4/10/2019,5/13/2019,5/13/2019
1395,2497,6/15/1939,Female,173,59,Compulsory health insurance CHI,No, ,Yes, , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"25,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/30/2016,1/10/2017,1/10/2017,1/19/2017,10/4/2018,10/4/2018, , , , , , 
1396,6048,6/15/1962,Male,179,80,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,V-X,9/15/2016,3/2/2017,3/2/2017,6/14/2018,7/19/2020,7/19/2020,8/14/2020,12/20/2020,12/20/2020,1/15/2021,6/25/2021,6/25/2021
1397,3829,6/15/1930,Male,182,56,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,9",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,R-X,9/6/2016,8/24/2017,8/24/2017,9/7/2017,3/5/2019,3/5/2019,3/13/2019,6/11/2021,6/11/2021,8/2/2021,3/31/2022, 
1398,4800,6/15/1960,Female,156,78,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,R-X,9/6/2016,4/13/2017,4/13/2017,5/26/2017,12/20/2018,12/20/2018,1/11/2019,3/11/2019,3/11/2019, , , 
1399,1540,6/15/1946,Female,155,57,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,99",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,DAR-X,LEV-X,9/7/2016,6/15/2017,6/15/2017,7/10/2017,7/23/2018,7/23/2018,5/13/2019,6/6/2019,6/6/2019,7/4/2019,5/26/2020,5/26/2020
1400,5091,6/15/1942,Male,179,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"20,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,9/8/2016,2/23/2017,2/23/2017,6/29/2017,9/13/2021,9/13/2021,10/5/2021,3/31/2022,10/14/1582, , , 
1401,2089,6/15/1961,Male,180,75,Private,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,42",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,LEV-X,V-X,9/7/2016,1/11/2017,1/11/2017,3/20/2018,1/2/2020,1/2/2020,4/11/2020,1/19/2021,1/19/2021,2/11/2021,7/27/2021,7/27/2021
1402,5630,6/15/1963,Female,165,89,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/7/2016,4/19/2017,4/19/2017,12/12/2019,5/11/2020,5/11/2020, , , , , , 
1403,4148,6/15/1965,Female,161,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,87",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,12/22/2016,4/27/2017,4/27/2017,5/18/2017,7/28/2017,7/28/2017, , , , , , 
1404,6105,6/15/1949,Female,163,68,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,12/8/2016,1/3/2018,1/3/2018,1/25/2018,7/30/2020,7/30/2020,8/15/2020,3/31/2022,10/14/1582, , , 
1405,3159,6/15/1957,Female,170,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,32",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,R-X,12/2/2016,4/5/2017,4/5/2017,7/20/2017,11/13/2018,11/13/2018,1/24/2019,11/21/2020,11/21/2020,12/8/2020,1/1/2021,1/1/2021
1406,9987,6/15/1961,Female,173,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,95",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/6/2016,4/19/2017,4/19/2017, , , , , , , , , 
1407,4152,6/15/1954,Female,156,61,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"9,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,11/15/2016,5/2/2017,5/2/2017,7/2/2018,10/31/2019,10/31/2019,11/18/2019,12/31/2021, , , , 
1408,1961,6/15/1951,Female,173,80,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,22",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/6/2016,7/19/2017,7/19/2017,1/23/2018,11/7/2019,11/7/2019, , , , , , 
1409,8783,6/15/1951,Male,178,83,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,10/6/2016,2/9/2017,2/9/2017,3/12/2018,12/5/2019,12/5/2019,12/23/2019,12/31/2021, , , , 
1410,8651,6/15/1943,Male,168,57,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"29,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/13/2016,7/5/2017,7/5/2017,2/13/2018,12/20/2018,12/20/2018, , , , , , 
1411,1707,6/15/1951,Male,179,98,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"30,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,POM-X,KYP-X,V-X,9/29/2016,3/16/2017,3/16/2017,1/25/2018,12/16/2020,12/16/2020,12/25/2020,9/29/2021,9/29/2021,1/12/2022,3/31/2022,10/14/1582
1412,7417,6/15/1945,Female,163,53,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,33",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,POM-X,DAR-X,V-X,11/28/2016,8/21/2017,8/21/2017,9/13/2017,1/2/2020,1/2/2020,5/25/2020,3/21/2021,3/21/2021,4/6/2021,12/16/2021,12/16/2021
1413,4173,6/15/1943,Male,175,81,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,DAR-X,No CTx,V-X,10/13/2016,7/11/2017,7/11/2017,7/27/2017,5/31/2019,5/31/2019,7/3/2019,3/31/2022,10/14/1582, , , 
1414,3039,6/15/1943,Male,176,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,4,ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,No CTx,LEV-X,10/31/2016,7/12/2017,7/12/2017,1/8/2018,1/2/2020,1/2/2020,2/9/2020,2/1/2021,2/1/2021, , , 
1415,3477,6/15/1959,Male,187,83,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,74",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/1/2016,1/5/2017,1/5/2017, , , , , , , , , 
1416,6207,6/15/1968,Male,184,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,12/7/2016,4/19/2017,4/19/2017,7/4/2017,1/2/2018,1/2/2018,1/17/2018,8/24/2018,8/24/2018, , , 
1417,6463,6/15/1946,Male,178,76,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,12/22/2016,9/19/2017,9/19/2017,2/27/2018,2/20/2019,2/20/2019,7/1/2021,3/31/2022, , , , 
1418,6727,6/15/1964,Male,180,116,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,25",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,11/17/2016,3/30/2017,3/30/2017,7/24/2017,6/25/2020,6/25/2020, , , , , , 
1419,5997,6/15/1951,Female,170,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/15/2016,1/19/2017,1/19/2017,2/12/2018,6/30/2021,10/14/1582, , , , , , 
1420,5330,6/15/1942,Male,181,68,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"18,27","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/3/2016,8/8/2017,8/8/2017,8/31/2017,6/26/2018,6/26/2018, , , , , , 
1421,6654,6/15/1948,Male,181,83,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"21,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,10/20/2016,2/23/2017,2/23/2017,3/13/2018,5/15/2019,5/15/2019,5/29/2019,12/31/2020,10/14/1582, , , 
1422,4836,6/15/1951,Female,172,92,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,64",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/4/2016,4/21/2017,4/21/2017, , , , , , , , , 
1423,1747,6/15/1945,Male,183,78,Private,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,84",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,11/8/2016,7/13/2017,7/13/2017, , , , , , , , , 
1424,8385,6/15/1949,Female,174,63,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,03",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,9/5/2016,5/15/2017,5/15/2017,3/7/2018,3/11/2019,3/11/2019,3/28/2019,5/20/2019,5/20/2019,6/10/2019,6/24/2019,6/24/2019
1425,2326,6/15/1951,Female,160,47,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,9/23/2016,12/12/2017,12/12/2017,12/29/2017,7/20/2018,7/20/2018, , , , , , 
1426,8159,6/15/1948,Male,168,54,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,R-X,No CTx,V-X,10/6/2016,8/23/2017,8/23/2017,3/8/2018,2/11/2019,2/11/2019,3/26/2019,3/27/2019,3/27/2019, , , 
1427,3514,6/15/1945,Male,175,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,R-X,12/6/2016,12/19/2017,12/19/2017,3/15/2018,9/6/2019,9/6/2019,9/23/2019,9/26/2019,9/26/2019, , , 
1428,7310,6/15/1952,Female,159,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,94",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,POM-X,R-X,10/4/2016,2/2/2018,2/2/2018,2/19/2018,5/13/2019,5/13/2019,5/23/2019,6/4/2019,6/4/2019,8/5/2019,9/2/2019,9/2/2019
1429,1644,6/15/1952,Female,159,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,94",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,9/15/2016,3/2/2017,3/2/2017,6/15/2018,3/10/2020,3/10/2020, , , , , , 
1430,3158,6/15/1927,Male,177,68,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,73",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,POM-X,R-X,11/7/2016,1/9/2018,1/9/2018,2/12/2018,8/27/2018,8/27/2018,1/2/2019,1/2/2020,1/2/2020,3/30/2020,4/21/2020,4/21/2020
1431,5169,6/15/1947,Male,175,80,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"19,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,9/16/2016,7/5/2017,7/5/2017,7/20/2017,9/27/2018,9/27/2018, , , , , , 
1432,3648,6/15/1960,Male,168,63,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/8/2016,5/25/2017,5/25/2017, , , , , , , , , 
1433,5665,6/15/1952,Female,163,75,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,59",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,V-X,10/28/2016,4/14/2017,4/14/2017,1/24/2018,12/5/2019,12/5/2019,12/12/2019,12/20/2019,12/20/2019,4/28/2020,7/6/2021,7/6/2021
1434,3128,6/15/1948,Male,189,94,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"15,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,V-X,POM-X,V-X,10/31/2016,7/12/2017,7/12/2017,3/8/2018,9/6/2018,9/6/2018,3/29/2019,5/23/2019,5/23/2019,6/17/2019,4/24/2021,4/24/2021
1435,6854,6/15/1971,Male,180,89,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"6,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/19/2016,1/23/2017,1/23/2017, , , , , , , , , 
1436,3050,6/15/1948,Female,160,45,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"32,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/8/2016,4/13/2017,4/13/2017, , , , , , , , , 
1437,6944,6/15/1944,Male,180,97,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,69",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/14/2016,5/1/2017,5/1/2017,7/16/2018,8/2/2018,8/2/2018, , , , , , 
1438,9216,6/15/1942,Female,161,52,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"11,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,POM-X,R-X,11/7/2016,12/21/2017,12/21/2017,1/8/2018,7/6/2018,7/6/2018,7/30/2018,6/14/2019,6/14/2019,1/1/2020,6/30/2021, 
1439,7400,6/15/1946,Male,186,59,Private,No, , ,Yes, , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"27,43","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,POM-X,R-X,11/10/2016,11/7/2017,11/7/2017,11/20/2017,7/16/2018,7/16/2018,1/7/2019,11/28/2019,11/28/2019,1/30/2020,7/21/2020,7/21/2020
1440,9302,6/15/1946,Female,172,72,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"6,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,10/4/2016,2/7/2017,2/7/2017,1/16/2018,1/15/2019,1/15/2019,3/28/2019,6/19/2021,6/19/2021, , , 
1441,4415,6/15/1949,Female,174,90,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,97",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,11/15/2016,9/14/2017,9/14/2017,10/5/2017,12/14/2018,12/14/2018,3/18/2019,1/2/2020,1/2/2020,2/20/2020,6/10/2021,6/10/2021
1442,9210,6/15/1947,Female,167,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"34,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/8/2016,5/18/2017,5/18/2017, , , , , , , , , 
1443,7508,6/15/1952,Male,180,82,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,9/15/2016,3/2/2017,3/2/2017,9/1/2017,12/23/2019,12/23/2019,4/7/2020,6/21/2021,6/21/2021, , , 
1444,8821,6/15/1954,Male,177,99,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,95",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Unbekannt,KYP-X,POM-X,No CTx,V-X,9/1/2016,5/11/2017,5/11/2017,3/15/2018,1/2/2020,1/2/2020,4/18/2020,9/30/2020, , , , 
1445,7108,6/15/1950,Male,189,96,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,19",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/29/2016,5/16/2017,5/16/2017,5/21/2018,9/30/2020,10/14/1582, , , , , , 
1446,7841,6/15/1957,Female,162,74,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"2,44",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/25/2016,3/31/2017,3/31/2017,5/9/2018,9/30/2020,10/14/1582, , , , , , 
1447,3931,6/15/1951,Female,169,71,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"23,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,11/29/2016,8/10/2017,8/10/2017,8/31/2017,9/30/2020,10/14/1582, , , , , , 
1448,4594,6/15/1944,Male,166,87,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,11",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,9/20/2016,3/1/2018,3/1/2018,3/14/2018,12/17/2019,12/17/2019,8/4/2020,9/30/2020, , , , 
1449,5634,6/15/1950,Female,166,60,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,61",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,LEV-X,11/2/2016,7/19/2017,7/19/2017, , , , , , , , , 
1450,1094,6/15/1944,Female,162,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,18","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/6/2016,6/15/2017,6/15/2017,3/12/2018,12/16/2019,12/16/2019, , , , , , 
1451,2158,6/15/1959,Female,166,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,53",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/18/2016,4/4/2017,4/4/2017,2/26/2018,11/27/2019,11/27/2019, , , , , , 
1452,7890,6/15/1951,Male,185,60,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,58",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,No CTx,V-X,9/26/2016,1/11/2017,1/11/2017,3/24/2017,7/17/2018,7/17/2018,7/30/2018,8/21/2019,8/21/2019, , , 
1453,7564,6/15/1955,Male,182,61,Private,No, ,Yes,Yes,Yes,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,85",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/1/2016,5/18/2017,5/18/2017,8/9/2018,2/28/2020,2/28/2020, , , , , , 
1454,5213,6/15/1955,Male,181,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,96","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/7/2016,2/22/2017,2/22/2017,2/19/2018,3/12/2018,3/12/2018, , , , , , 
1455,7473,6/15/1957,Male,167,71,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,66",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/17/2016,5/4/2017,5/4/2017, , , , , , , , , 
1456,9814,6/15/1945,Male,189,97,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,V-X,V-X,9/29/2016,1/23/2017,1/23/2017,2/8/2017,5/14/2018,5/14/2018,5/24/2018,7/11/2020,7/11/2020,7/18/2020,7/9/2021,7/9/2021
1457,9684,6/15/1944,Female,174,97,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,28",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,9/16/2016,2/6/2017,2/6/2017,2/27/2017,8/14/2017,8/14/2017, , , , , , 
1458,2684,6/15/1969,Female,145,53,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,09",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,10/13/2016,2/6/2017,2/6/2017,3/9/2017,1/2/2020,1/2/2020,5/27/2020,7/27/2020,7/27/2020,8/12/2020,6/30/2021, 
1459,4814,6/15/1963,Female,168,65,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,47",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,9/27/2016,3/23/2017,3/23/2017,7/5/2017,11/14/2019,11/14/2019, , , , , , 
1460,5323,6/15/1943,Male,175,53,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"27,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,12/6/2016,12/22/2016,12/22/2016,1/25/2017,1/8/2019,1/8/2019,3/6/2019,5/16/2019,5/16/2019,5/26/2019,12/9/2019,12/9/2019
1461,8409,6/15/1952,Female,168,51,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,01",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,11/17/2016,12/31/2017, , , , , , , , , , 
1462,3218,6/15/1944,Male,183,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"26,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/19/2016,7/19/2017,7/19/2017, , , , , , , , , 
1463,5549,6/15/1951,Male,184,64,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"27,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/10/2016,6/19/2017,6/19/2017, , , , , , , , , 
1464,4748,6/15/1946,Female,169,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,27",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,12/12/2016,2/28/2017,2/28/2017,3/16/2017,11/15/2018,11/15/2018,12/6/2018,3/31/2022,10/14/1582, , , 
1465,9016,6/15/1942,Female,173,58,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,37",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,NIN-X,V-X,10/4/2016,3/21/2017,3/21/2017,4/24/2018,11/29/2018,11/29/2018,12/17/2018,4/23/2019,4/23/2019,5/20/2019,6/19/2019,6/19/2019
1466,4234,6/15/1951,Male,178,58,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,54",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,11/14/2016,3/9/2017,3/9/2017,3/20/2017,1/14/2019,1/14/2019,3/28/2019,12/31/2021, , , , 
1467,1095,6/15/1946,Male,168,48,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,68",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,EMP-X,V-X,10/11/2016,2/15/2017,2/15/2017,2/27/2017,12/7/2017,12/7/2017,12/11/2017,8/6/2018,8/6/2018,8/16/2018,10/23/2018,10/23/2018
1468,3562,6/15/1951,Female,159,47,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,74",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,KYP-X,NIN-X,LEV-X,10/17/2016,1/11/2017,1/11/2017,1/26/2017,11/9/2017,11/9/2017,11/22/2017,6/7/2018,6/7/2018,6/22/2018,2/27/2019,2/27/2019
1469,8731,6/15/1932,Male,173,88,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"2,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,DAR-X,V-X,9/27/2016,3/14/2017,3/14/2017,3/19/2018,9/17/2018,9/17/2018,1/21/2019,10/28/2020,10/28/2020,11/8/2020,3/31/2022,10/14/1582
1470,6402,6/15/1963,Female,160,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"8,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/14/2016,2/20/2017,2/20/2017,3/14/2017,12/19/2019,12/19/2019, , , , , , 
1471,5056,6/15/1952,Female,155,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"20,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,DAR-X,V-X,10/10/2016,7/19/2017,7/19/2017,7/27/2017,6/25/2018,6/25/2018,7/18/2018,11/29/2018,11/29/2018,12/20/2018,1/3/2019,1/3/2019
1472,9955,6/15/1951,Female,159,61,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,06",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,NIN-X,V-X,11/17/2016,3/14/2017,3/14/2017,3/24/2017,8/24/2018,8/24/2018,9/6/2018,5/16/2019,5/16/2019,7/15/2019,3/24/2020,3/24/2020
1473,2999,6/15/1944,Male,174,83,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,85",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,R-X,12/1/2016,3/14/2017,3/14/2017,3/22/2017,12/20/2018,12/20/2018,3/4/2019,3/2/2020,3/2/2020,4/28/2020,12/6/2020,12/6/2020
1474,4162,6/15/1951,Female,167,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,33",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,DAR-X,R-X,12/2/2016,12/7/2017,12/7/2017,1/1/2018,6/26/2018,6/26/2018,1/7/2019,10/14/2020,10/14/2020,10/29/2020,12/3/2021,12/3/2021
1475,6121,6/15/1963,Female,160,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"18,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/18/2016,12/22/2016,12/22/2016,2/28/2017,8/19/2019,8/19/2019, , , , , , 
1476,7074,6/15/1943,Male,179,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,9/26/2016,1/18/2017,1/18/2017,2/13/2017,7/25/2018,7/25/2018,8/13/2018,9/10/2018,9/10/2018, , , 
1477,5793,6/15/1936,Male,179,85,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"2,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/15/2016,4/20/2017,4/20/2017,4/1/2020,4/14/2020,4/14/2020, , , , , , 
1478,9484,6/15/1945,Male,191,112,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,88",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,9/13/2016,2/22/2017,2/22/2017,3/28/2017,11/14/2018,11/14/2018,2/26/2019,6/27/2020,6/27/2020,7/7/2020,8/18/2021,8/18/2021
1479,5319,6/15/1942,Male,177,59,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"14,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,9/15/2016,2/24/2017,2/24/2017,3/9/2017,11/19/2018,11/19/2018, , , , , , 
1480,6636,6/15/1948,Male,182,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"14,34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,LEV-X,8/22/2016,1/5/2017,1/5/2017,1/17/2017,7/20/2018,7/20/2018,8/1/2018,8/29/2020,8/29/2020,9/7/2020,7/11/2021,7/11/2021
1481,6084,6/15/1948,Female,162,59,Private,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,66",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,9/15/2016,1/16/2017,1/16/2017,3/6/2017,11/7/2018,11/7/2018,1/31/2019,3/14/2019,3/14/2019, , , 
1482,4440,6/15/1947,Male,169,68,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,98",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,9/19/2016,1/4/2017,1/4/2017,1/18/2017,8/16/2018,8/16/2018,9/3/2018,7/1/2021,7/1/2021, , , 
1483,6043,6/15/1957,Female,155,62,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,54",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,V-X,9/1/2016,2/16/2017,2/16/2017,3/8/2018,12/4/2019,12/4/2019,12/30/2019,1/2/2020,1/2/2020,5/29/2020,7/1/2020,7/1/2020
1484,3520,6/15/1946,Male,179,66,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"32,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/11/2016,1/2/2018,1/2/2018,1/18/2018,6/19/2019,6/19/2019, , , , , , 
1485,7628,6/15/1952,Female,161,82,Private,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"7,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,8/24/2016,7/5/2017,7/5/2017,7/19/2017,5/10/2018,5/10/2018,5/23/2018,6/6/2018,6/6/2018, , , 
1486,5421,6/15/1948,Male,174,105,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,07",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,8/25/2016,2/9/2017,2/9/2017,2/13/2018,1/2/2020,1/2/2020,2/19/2020,9/30/2020, , , , 
1487,6375,6/15/1954,Male,177,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/8/2016,1/23/2017,1/23/2017, , , , , , , , , 
1488,6841,6/15/1958,Male,179,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,47",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/24/2016,4/19/2017,4/19/2017, , , , , , , , , 
1489,3598,6/15/1943,Female,159,65,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"31,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,NIN-X,V-X,12/22/2015,6/9/2016,6/9/2016,6/23/2016,12/13/2016,12/13/2016,12/23/2016,8/22/2017,8/22/2017,9/5/2017,9/14/2017,9/14/2017
1490,8213,6/15/1942,Male,190,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"26,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,V-X,V-X,5/25/2016,11/9/2016,11/9/2016,11/29/2016,6/7/2018,6/7/2018,6/27/2018,1/7/2019,1/7/2019,2/28/2019,8/15/2019,8/15/2019
1491,4753,6/15/1944,Male,178,101,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,24",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,2/10/2016,7/27/2016,7/27/2016,8/16/2016,4/19/2018,4/19/2018,5/3/2018,9/30/2020,10/14/1582, , , 
1492,5918,6/15/1930,Male,178,112,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,03",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,R-X,No CTx,V-X,12/9/2015,5/31/2016,5/31/2016,9/9/2016,5/18/2017,5/18/2017,6/8/2017,6/16/2017,6/16/2017, , , 
1493,6650,6/15/1942,Male,184,100,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"7,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,FAR-X,DAR-X,R-X,4/18/2016,10/10/2016,10/10/2016,10/27/2016,3/17/2017,3/17/2017,3/28/2017,4/5/2018,4/5/2018,4/20/2018,12/9/2021,12/9/2021
1494,9324,6/15/1949,Female,173,107,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,38",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,11/5/2015,4/25/2016,4/25/2016,10/13/2016,1/15/2018,1/15/2018,2/1/2018,3/7/2019,3/7/2019,3/25/2019,1/2/2020,1/2/2020
1495,1664,6/15/1942,Female,160,60,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"31,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,8/20/2015,2/8/2016,2/8/2016,6/14/2016,12/12/2016,12/12/2016,1/9/2017,9/18/2017,9/18/2017,10/5/2017,11/27/2017,11/27/2017
1496,7699,6/15/1947,Female,163,51,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,43",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,V-X,V-X,11/23/2015,3/14/2016,3/14/2016,10/10/2016,1/17/2018,1/17/2018,1/25/2018,9/10/2018,9/10/2018,9/24/2018,9/27/2018,9/27/2018
1497,3150,6/15/1938,Male,180,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,1/20/2016,5/23/2016,5/23/2016,10/20/2016,9/3/2018,9/3/2018,9/21/2018,4/29/2019,4/29/2019,2/23/2020,10/10/2020,10/10/2020
1498,5085,6/15/1948,Female,176,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,2/16/2016,6/20/2016,6/20/2016,9/29/2016,6/25/2017,6/25/2017,7/13/2018,8/31/2018,8/31/2018, , , 
1499,4909,6/15/1943,Female,165,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"21,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,V-X,R-X,R-X,5/3/2016,10/24/2016,10/24/2016,11/7/2016,5/22/2018,5/22/2018,6/13/2018,7/17/2018,7/17/2018,3/21/2019,6/19/2019,6/19/2019
1500,3518,6/15/1948,Male,188,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,R-X,DAR-X,V-X,12/21/2015,6/20/2016,6/20/2016,10/17/2016,7/19/2017,7/19/2017,8/9/2017,3/2/2018,3/2/2018,3/20/2018,9/18/2018,9/18/2018
1501,9323,6/15/1945,Female,163,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"26,63","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,R-X,4/4/2016,9/23/2016,9/23/2016,10/12/2016,6/21/2018,6/21/2018,7/9/2018,11/28/2018,11/28/2018,2/21/2019,8/8/2020,8/8/2020
1502,2148,6/15/1951,Female,166,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,3",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,5/20/2016,11/16/2016,11/16/2016,12/8/2016,8/28/2018,8/28/2018,9/18/2018,9/20/2018,9/20/2018, , , 
1503,5745,6/15/1951,Female,174,66,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,75","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,5/6/2016,11/2/2016,11/2/2016,11/21/2016,3/26/2018,3/26/2018,4/19/2018,5/1/2018,5/1/2018, , , 
1504,9205,6/15/1950,Female,160,57,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"9,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,FAR-X,No CTx,R-X,6/2/2016,11/24/2016,11/24/2016,12/21/2016,12/27/2016,12/27/2016,1/2/2017,2/20/2017,2/20/2017, , , 
1505,5200,6/15/1945,Male,177,97,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,37",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,EMP-X,V-X,2/22/2016,8/18/2016,8/18/2016,9/12/2016,3/9/2017,3/9/2017,3/30/2017,11/2/2017,11/2/2017,11/17/2017,6/28/2018,6/28/2018
1506,6377,6/15/1951,Male,181,119,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,11",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,3/10/2016,7/11/2016,7/11/2016,9/29/2016,2/27/2017,2/27/2017,3/7/2017,9/27/2017,9/27/2017,10/17/2017,3/5/2018,3/5/2018
1507,6796,6/15/1946,Male,186,87,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,08",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,Other,V-X,2/24/2016,8/15/2016,8/15/2016,8/24/2016,2/20/2017,2/20/2017,3/2/2017,10/12/2017,10/12/2017,11/2/2017,12/28/2017,12/28/2017
1508,1580,6/15/1946,Male,186,87,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,63",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,KYP-X,DAR-X,V-X,3/30/2016,9/14/2016,9/14/2016,10/10/2016,2/24/2017,2/24/2017,3/10/2017,10/9/2017,10/9/2017,10/23/2017,2/7/2018,2/7/2018
1509,8790,6/15/1947,Female,165,58,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"28,24","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,R-X,R-X,3/30/2016,9/15/2016,9/15/2016,10/6/2016,8/6/2018,8/6/2018,8/16/2018,7/31/2019,7/31/2019,9/5/2019,1/2/2020,1/2/2020
1510,7675,6/15/1944,Female,159,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,75",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,1/7/2016,6/28/2016,6/28/2016,11/3/2016,4/26/2018,4/26/2018, , , , , , 
1511,4676,6/15/1943,Male,175,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"14,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,V-X,No CTx,V-X,5/11/2016,10/31/2016,10/31/2016,11/9/2016,7/19/2018,7/19/2018,8/9/2018,12/31/2020, , , , 
1512,5646,6/15/1951,Female,171,71,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"15,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,V-X,NIN-X,R-X,3/31/2016,9/28/2016,9/28/2016,10/19/2016,2/7/2018,2/7/2018,2/19/2018,7/6/2018,7/6/2018,7/12/2018,8/22/2018,8/22/2018
1513,7292,6/15/1947,Male,172,65,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"14,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,R-X,POM-X,R-X,4/1/2016,9/28/2016,9/28/2016,10/21/2016,11/20/2016,11/20/2016,11/21/2016,6/26/2017,6/26/2017,7/7/2017,11/29/2017,11/29/2017
1514,4536,6/15/1936,Female,163,74,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"3,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/22/2016,6/23/2016,6/23/2016,10/24/2016,7/17/2018,7/17/2018, , , , , , 
1515,2927,6/15/1948,Male,165,53,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,88",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,Other,Other,R-X,5/23/2016,11/7/2016,11/7/2016,11/23/2016,12/11/2016,12/11/2016,12/12/2016,3/21/2017,3/21/2017,4/5/2017,6/22/2017,6/22/2017
1516,8301,6/15/1932,Male,178,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,R-X,POM-X,R-X,4/28/2016,10/17/2016,10/17/2016,10/28/2016,11/23/2016,11/23/2016,11/24/2016,6/15/2017,6/15/2017,7/3/2017,8/29/2017,8/29/2017
1517,6330,6/15/1953,Female,153,53,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,04",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,R-X,5/11/2016,10/28/2016,10/28/2016,11/21/2016,11/22/2018,11/22/2018,1/14/2019,6/11/2019,6/11/2019, , , 
1518,8703,6/15/1946,Male,189,99,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,12",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,4/18/2016,8/18/2016,8/18/2016,11/21/2016,1/4/2018,1/4/2018,1/18/2018,1/14/2020,1/14/2020, , , 
1519,5495,6/15/1952,Female,147,39,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,1",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,R-X,POM-X,V-X,1/21/2016,7/18/2016,7/18/2016,11/21/2016,7/19/2017,7/19/2017,8/3/2017,3/2/2018,3/2/2018,3/19/2018,5/28/2018,5/28/2018
1520,4315,6/15/1945,Male,177,86,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,41",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,V-X,R-X,5/24/2016,11/14/2016,11/14/2016,12/8/2016,10/3/2018,10/3/2018,11/25/2018,2/5/2019,2/5/2019,2/14/2019,2/7/2020,2/7/2020
1521,1183,6/15/1946,Male,196,104,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"30,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,No CTx,V-X,5/31/2016,11/16/2016,11/16/2016,12/1/2016,6/26/2018,6/26/2018,7/6/2018,6/22/2021,6/22/2021, , , 
1522,3367,6/15/1947,Male,173,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,4",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/13/2016,10/31/2016,10/31/2016,11/24/2016,6/13/2018,6/13/2018, , , , , , 
1523,8663,6/15/1943,Male,183,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,KYP-X,POM-X,V-X,6/2/2016,11/17/2016,11/17/2016,12/1/2016,8/14/2018,8/14/2018,8/29/2018,2/12/2019,2/12/2019,3/7/2019,2/26/2020,2/26/2020
1524,8982,6/15/1951,Female,158,87,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,62",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,1/25/2016,5/2/2016,5/2/2016,10/4/2016,3/21/2017,3/21/2017, , , , , , 
1525,2866,6/15/1947,Female,151,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,12/23/2015,4/1/2016,4/1/2016,10/4/2016,6/22/2018,6/22/2018,7/12/2018,12/11/2019,12/11/2019, , , 
1526,4886,6/15/1943,Male,171,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"10,66","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,5/17/2016,8/11/2016,8/11/2016,11/10/2016,3/10/2017,3/10/2017,3/24/2017,9/27/2017,9/27/2017,10/11/2017,4/20/2018,4/20/2018
1527,4450,6/15/1942,Female,161,48,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,LEV-X,V-X,3/29/2016,9/19/2016,9/19/2016,12/14/2016,3/13/2017,3/13/2017,3/21/2017,12/1/2017,12/1/2017,12/26/2017,12/27/2017,12/27/2017
1528,7908,6/15/1944,Male,182,84,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,41",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,R-X,DAR-X,V-X,4/11/2016,9/26/2016,9/26/2016,10/13/2016,3/13/2017,3/13/2017,3/28/2017,10/30/2017,10/30/2017,11/21/2017,4/19/2018,4/19/2018
1529,1497,6/15/1948,Male,165,48,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,41",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,FAR-X,EMP-X,R-X,4/21/2016,10/18/2016,10/18/2016,11/3/2016,3/17/2017,3/17/2017,3/30/2017,3/13/2018,3/13/2018,3/23/2018,12/27/2018,12/27/2018
1530,2647,6/15/1942,Male,181,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,R-X,DAR-X,V-X,6/8/2015,11/30/2015,11/30/2015,12/28/2015,12/8/2016,12/8/2016,1/4/2017,6/22/2017,6/22/2017,7/5/2017,2/15/2018,2/15/2018
1531,2030,6/15/1943,Male,167,53,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,88",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,NIN-X,POM-X,R-X,5/25/2016,11/18/2016,11/18/2016,12/2/2016,11/6/2018,11/6/2018,2/25/2019,5/7/2019,5/7/2019,7/15/2019,1/29/2020,1/29/2020
1532,3024,6/15/1952,Male,188,85,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,62",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,12/7/2015,3/30/2016,3/30/2016,10/4/2016,6/21/2018,6/21/2018,7/16/2018,9/19/2019,9/19/2019, , , 
1533,6349,6/15/1943,Female,162,62,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,KYP-X,No CTx,V-X,3/31/2016,6/23/2016,6/23/2016,9/5/2016,12/30/2016,12/30/2016,1/16/2017,2/16/2017,2/16/2017, , , 
1534,4823,6/15/1942,Male,181,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,V-X,DAR-X,V-X,4/14/2016,10/13/2016,10/13/2016,10/28/2016,2/28/2018,2/28/2018,3/20/2018,9/4/2018,9/4/2018,9/10/2018,9/10/2018,9/10/2018
1535,6261,6/15/1949,Female,172,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,POM-X,R-X,4/28/2016,10/24/2016,10/24/2016,11/17/2016,3/29/2018,3/29/2018,4/16/2018,11/7/2019,11/7/2019,12/16/2019,12/25/2019,12/25/2019
1536,8610,6/15/1944,Male,157,67,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,14",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,V-X,R-X,2/5/2016,7/22/2016,7/22/2016,8/4/2016,5/29/2018,5/29/2018,7/11/2018,1/3/2019,1/3/2019,3/18/2019,5/27/2019,5/27/2019
1537,8733,6/15/1950,Female,168,57,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,12",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,No CTx,V-X,2/24/2016,6/22/2016,6/22/2016,12/2/2016,6/27/2018,6/27/2018,7/9/2018,7/16/2018,7/16/2018, , , 
1538,1615,6/15/1954,Male,167,50,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,3/17/2016,9/5/2016,9/5/2016,9/30/2016,1/23/2018,1/23/2018,2/13/2018,9/10/2018,9/10/2018,9/20/2018,12/1/2019,12/1/2019
1539,1432,6/15/1942,Male,173,107,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,No CTx,V-X,3/17/2016,9/12/2016,9/12/2016,9/26/2016,2/1/2018,2/1/2018,2/26/2018,12/31/2020,10/14/1582, , , 
1540,7727,6/15/1945,Female,167,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,31",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,4/19/2016,10/10/2016,10/10/2016,10/24/2016,3/26/2018,3/26/2018,4/9/2018,12/31/2020, , , , 
1541,1425,6/15/1948,Male,176,79,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,35",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,3/31/2016,6/24/2016,6/24/2016,10/12/2016,7/5/2018,7/5/2018,7/23/2018,8/27/2018,8/27/2018, , , 
1542,3197,6/15/1947,Male,184,95,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,69",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,2/15/2016,5/12/2016,5/12/2016,11/24/2016,2/28/2017,2/28/2017,3/8/2017,9/5/2017,9/5/2017,9/26/2017,4/19/2018,4/19/2018
1543,8437,6/15/1941,Female,157,40,Compulsory health insurance CHI,Yes, ,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"2,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/23/2016,12/31/2016, , , , , , , , , , 
1544,4955,6/15/1949,Male,175,102,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,91",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,R-X,No CTx,V-X,4/19/2016,9/8/2016,9/8/2016,12/5/2016,3/13/2017,3/13/2017,3/28/2017,9/25/2017,9/25/2017, , , 
1545,6010,6/15/1951,Male,170,64,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"17,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,Other,Other,V-X,2/17/2016,8/4/2016,8/4/2016,8/22/2016,1/30/2017,1/30/2017,2/13/2017,5/29/2017,5/29/2017,6/15/2017,8/14/2017,8/14/2017
1546,2940,6/15/1943,Female,161,70,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,R-X,POM-X,V-X,6/18/2015,12/14/2015,12/14/2015,1/4/2016,12/12/2016,12/12/2016,1/9/2017,8/2/2017,8/2/2017,8/17/2017,11/2/2017,11/2/2017
1547,2600,6/15/1942,Male,176,71,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,02",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,KYP-X,V-X,2/25/2016,8/22/2016,8/22/2016,11/11/2016,1/18/2017,1/18/2017,2/7/2017,5/17/2017,5/17/2017,6/2/2017,11/2/2017,11/2/2017
1548,5856,6/15/1948,Male,181,89,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,56",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,2/4/2016,6/9/2016,6/9/2016,11/16/2016,12/21/2017,12/21/2017,1/4/2018,2/8/2018,2/8/2018, , , 
1549,2836,6/15/1950,Male,176,76,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,POM-X,No CTx,V-X,4/25/2016,10/19/2016,10/19/2016,11/10/2016,6/21/2018,6/21/2018,7/12/2018,9/12/2018,9/12/2018, , , 
1550,1893,6/15/1951,Male,177,108,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,POM-X,V-X,5/25/2016,11/17/2016,11/17/2016,12/1/2016,4/9/2018,4/9/2018,5/1/2018,2/18/2019,2/18/2019,3/4/2019,8/21/2019,8/21/2019
1551,8173,6/15/1949,Female,165,65,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,42",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,EMP-X,POM-X,V-X,3/2/2016,6/6/2016,6/6/2016,11/14/2016,12/20/2017,12/20/2017,1/24/2018,5/28/2019,5/28/2019,6/20/2019,6/24/2019,6/24/2019
1552,1326,6/15/1949,Male,175,103,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,13",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,Other,V-X,8/18/2015,12/9/2015,12/9/2015,7/6/2016,12/29/2016,12/29/2016,1/17/2017,8/21/2017,8/21/2017,9/1/2017,9/8/2017,9/8/2017
1553,8580,6/15/1949,Male,175,103,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,06",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,12/28/2015,4/21/2016,4/21/2016,11/14/2016,4/27/2018,4/27/2018,5/14/2018,6/7/2018,6/7/2018, , , 
1554,6918,6/15/1948,Male,183,94,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,68",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,3/14/2016,6/13/2016,6/13/2016,12/23/2016,12/6/2018,12/6/2018,2/21/2019,9/13/2020,9/13/2020,9/24/2020,6/12/2021,6/12/2021
1555,7261,6/15/1940,Female,162,63,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,07",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,No CTx,V-X,4/7/2016,8/3/2016,8/3/2016,10/21/2016,3/1/2018,3/1/2018,3/15/2018,5/4/2020,5/4/2020, , , 
1556,5030,6/15/1951,Male,177,94,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,88",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,5/31/2016,11/16/2016,11/16/2016,12/5/2016,4/18/2018,4/18/2018,5/14/2018,6/14/2020,6/14/2020, , , 
1557,5675,6/15/1951,Female,181,56,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"28,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,V-X,LEV-X,4/18/2016,10/13/2016,10/13/2016,10/25/2016,3/19/2018,3/19/2018,4/12/2018,1/24/2019,1/24/2019,2/15/2019,3/14/2019,3/14/2019
1558,9071,6/15/1944,Male,168,55,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,56",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,2/5/2016,5/11/2016,5/11/2016,10/31/2016,9/13/2018,9/13/2018,9/25/2018,3/31/2022,10/14/1582, , , 
1559,3307,6/15/1947,Male,176,115,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,3",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,7/2/2015,12/29/2015,12/29/2015,7/5/2016,8/23/2017,8/23/2017, , , , , , 
1560,2695,6/15/1952,Male,182,84,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,92",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,DAR-X,R-X,3/29/2016,9/21/2016,9/21/2016,10/6/2016,12/14/2017,12/14/2017,12/27/2017,9/21/2021,9/21/2021,11/9/2021,3/31/2022, 
1561,7823,6/15/1943,Female,166,73,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,I: fulfilling all 4 criteria,IgG,"4,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,NIN-X,V-X,1/18/2016,5/12/2016,5/12/2016,7/27/2016,1/29/2018,1/29/2018,2/9/2018,8/30/2018,8/30/2018,9/18/2018,10/22/2018,10/22/2018
1562,8250,6/15/1948,Male,181,89,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,18",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,NIN-X,V-X,11/20/2015,4/4/2016,4/4/2016,7/7/2016,12/13/2017,12/13/2017,1/2/2018,11/2/2018,11/2/2018,11/15/2018,1/4/2021,1/4/2021
1563,5498,6/15/1947,Male,187,93,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,56",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,LEV-X,5/27/2016,11/14/2016,11/14/2016,11/30/2016,4/5/2018,4/5/2018,4/30/2018,8/10/2018,8/10/2018,9/4/2018,6/14/2019,6/14/2019
1564,9603,6/15/1945,Male,188,89,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"15,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,EMP-X,V-X,10/26/2015,2/23/2016,2/23/2016,7/14/2016,5/7/2018,5/7/2018,5/28/2018,10/8/2018,10/8/2018,3/7/2019,10/14/2019,10/14/2019
1565,8220,6/15/1954,Male,182,78,Private,Unknown,Yes, , ,Yes, ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,No CTx,No CTx, , , ,12/23/2016,5/1/2018,5/1/2018,5/7/2018,6/30/2019, , , , 
1566,2381,6/15/1945,Male,188,89,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"23,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,10/29/2015,2/29/2016,2/29/2016,7/18/2016,6/20/2018,6/20/2018, , , , , , 
1567,7994,6/15/1945,Female,176,92,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"19,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,V-X,V-X,8/24/2015,2/16/2016,2/16/2016,7/12/2016,12/18/2017,12/18/2017,1/3/2018,9/13/2018,9/13/2018,9/25/2018,9/18/2019,9/18/2019
1568,4314,6/15/1933,Female,166,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,11/5/2015,2/29/2016,2/29/2016,7/28/2016,3/12/2018,3/12/2018,3/22/2018,9/20/2018,9/20/2018,3/11/2019,5/7/2019,5/7/2019
1569,5090,6/15/1936,Male,182,82,Private,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"7,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,12/2/2015,5/24/2016,5/24/2016,6/16/2016,12/15/2016,12/15/2016,1/5/2017,8/8/2017,8/8/2017,8/18/2017,8/28/2017,8/28/2017
1570,5606,6/15/1947,Male,180,85,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,36",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,No CTx,V-X,2/4/2016,5/30/2016,5/30/2016,11/11/2016,10/30/2018,10/30/2018,1/2/2019,2/26/2020,2/26/2020, , , 
1571,9725,6/15/1949,Male,182,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,79",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,V-X,V-X,12/8/2015,6/1/2016,6/1/2016,11/23/2016,3/13/2018,3/13/2018,3/30/2018,4/10/2018,4/10/2018,4/24/2018,5/15/2018,5/15/2018
1572,6899,6/15/1946,Female,164,74,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,7",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,6/2/2016,11/30/2016,11/30/2016,12/19/2016,1/5/2017,1/5/2017,1/12/2017,8/10/2017,8/10/2017,8/24/2017,2/12/2018,2/12/2018
1573,9161,6/15/1945,Female,166,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,55",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,FAR-X,DAR-X,R-X,3/29/2016,9/22/2016,9/22/2016,10/10/2016,3/13/2017,3/13/2017,3/27/2017,2/8/2018,2/8/2018,3/1/2018,7/25/2018,7/25/2018
1574,5765,6/15/1942,Male,174,64,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,V-X,Other,V-X,6/6/2016,11/28/2016,11/28/2016,12/8/2016,3/21/2017,3/21/2017,3/29/2017,7/26/2017,7/26/2017,8/3/2017,8/7/2017,8/7/2017
1575,6291,6/15/1947,Female,165,72,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,22",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/18/2016,5/12/2016,5/12/2016,10/27/2016,2/22/2018,2/22/2018,3/8/2018,9/19/2021,9/19/2021, , , 
1576,7088,6/15/1943,Male,175,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,56",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,V-X,R-X,4/4/2016,9/27/2016,9/27/2016,10/24/2016,3/12/2018,3/12/2018,3/26/2018,6/13/2021,6/13/2021,7/2/2021,3/31/2022, 
1577,7589,6/15/1944,Female,172,64,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"32,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,NIN-X,POM-X,R-X,5/27/2016,11/25/2016,11/25/2016,12/12/2016,6/18/2018,6/18/2018,7/12/2018,10/13/2020,10/13/2020,11/7/2020,6/30/2021, 
1578,9562,6/15/1948,Male,188,95,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"34,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,R-X,2/9/2016,7/28/2016,7/28/2016,8/12/2016,12/7/2017,12/7/2017,12/20/2017,3/8/2018,3/8/2018,3/20/2018,7/3/2018,7/3/2018
1579,9136,6/15/1951,Male,187,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,46",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,Other,V-X,12/22/2015,6/8/2016,6/8/2016,7/1/2016,11/17/2017,11/17/2017,1/3/2018,7/30/2018,7/30/2018,8/13/2018,4/23/2019,4/23/2019
1580,8619,6/15/1942,Male,185,103,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,14",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,12/21/2015,6/15/2016,6/15/2016,7/7/2016,2/21/2018,2/21/2018,3/11/2018,12/11/2019,12/11/2019, , , 
1581,8128,6/15/1950,Male,177,77,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,DAR-X,Other,V-X,4/29/2016,10/26/2016,10/26/2016,11/9/2016,5/1/2018,5/1/2018,5/24/2018,7/10/2018,7/10/2018,7/24/2018,5/23/2019,5/23/2019
1582,4131,6/15/1942,Male,185,103,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,05",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,NIN-X,V-X,6/2/2016,11/30/2016,11/30/2016,12/19/2016,3/23/2018,3/23/2018,4/12/2018,7/18/2018,7/18/2018,8/13/2018,9/14/2018,9/14/2018
1583,2581,6/15/1946,Male,175,97,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"13,66","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,8/24/2015,12/21/2015,12/21/2015,7/7/2016,11/3/2016,11/3/2016,11/17/2016,2/22/2017,2/22/2017,3/20/2017,8/1/2017,8/1/2017
1584,2262,6/15/1942,Male,186,115,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,3/25/2015,9/21/2015,9/21/2015,10/14/2015,9/20/2016,9/20/2016,10/10/2016,5/17/2017,5/17/2017,5/30/2017,10/5/2017,10/5/2017
1585,6230,6/15/1949,Female,168,96,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,34",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,12/1/2014,4/2/2015,4/2/2015,10/8/2015,9/15/2016,9/15/2016,10/18/2016,12/6/2016,12/6/2016,1/24/2017,4/20/2017,4/20/2017
1586,2308,6/15/1950,Male,184,62,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,08",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,DAR-X,R-X,3/27/2015,9/10/2015,9/10/2015,10/1/2015,9/15/2016,9/15/2016,10/13/2016,3/7/2017,3/7/2017,3/17/2017,7/21/2017,7/21/2017
1587,6637,6/15/1942,Male,189,83,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,99",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,10/21/2015,1/18/2016,1/18/2016,7/25/2016,12/14/2016,12/14/2016,12/29/2016,2/6/2017,2/6/2017,2/17/2017,3/10/2017,3/10/2017
1588,6902,6/15/1934,Female,177,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"34,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,V-X,POM-X,DAR-X,R-X,2/18/2016,8/18/2016,8/18/2016,9/2/2016,12/13/2016,12/13/2016,12/27/2016,4/13/2017,4/13/2017,4/24/2017,8/28/2017,8/28/2017
1589,9529,6/15/1952,Female,155,58,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,45",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,8/31/2015,2/29/2016,2/29/2016,7/21/2016,11/29/2016,11/29/2016,12/5/2016,3/30/2017,3/30/2017,4/17/2017,5/4/2017,5/4/2017
1590,3293,6/15/1951,Male,188,101,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,POM-X,DAR-X,V-X,8/21/2015,12/18/2015,12/18/2015,4/6/2016,9/30/2016,9/30/2016,10/13/2016,1/23/2017,1/23/2017,2/2/2017,6/5/2017,6/5/2017
1591,7384,6/15/1956,Male,187,100,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"28,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,POM-X,NIN-X,V-X,1/29/2016,5/3/2016,5/3/2016,8/23/2016,11/18/2016,11/18/2016,11/29/2016,3/23/2017,3/23/2017,4/12/2017,5/25/2017,5/25/2017
1592,1795,6/15/1950,Male,184,62,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,43",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,NIN-X,R-X,1/14/2016,7/11/2016,7/11/2016,7/25/2016,12/14/2016,12/14/2016,12/19/2016,4/5/2017,4/5/2017,4/13/2017,11/16/2017,11/16/2017
1593,4019,6/15/1945,Male,178,76,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,18,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,V-X,DAR-X,V-X,12/22/2015,5/7/2016,5/7/2016,3/23/2017,9/20/2017,9/20/2017,2/22/2018,11/29/2018,11/29/2018,6/17/2019,2/25/2020,2/25/2020
1594,2551,6/15/1946,Male,181,99,Compulsory health insurance CHI,No,Yes, , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,26,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,Other,V-X,DAR-X,V-X,3/31/2015,1/29/2016,1/29/2016,3/19/2017,6/30/2017,6/30/2017,10/18/2017,2/23/2018,2/23/2018,6/17/2018,10/10/2019,10/10/2019
1595,2984,6/15/1949,Female,167,72,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,20,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,Other,R-X,DAR-X,V-X,6/2/2015,4/11/2016,4/11/2016,3/22/2017,6/12/2017,6/12/2017,8/2/2017,3/3/2018,3/3/2018,6/4/2019,9/20/2020,9/20/2020
1596,2863,6/15/1947,Female,171,73,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,26,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,Other,FAR-X,No CTx,V-X,5/24/2015,3/2/2016,3/2/2016,3/3/2017,11/27/2017,11/27/2017,3/25/2018,5/1/2019,5/1/2019, , , 
1597,2709,6/15/1943,Male,186,98,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,32,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,Other,KYP-X,EMP-X,V-X,6/2/2015,3/29/2016,3/29/2016,3/13/2017,2/12/2018,2/12/2018,3/19/2019,2/24/2020,2/24/2020,3/18/2020,3/17/2021,3/17/2021
1598,6392,6/15/1949,Male,188,96,Private,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,33,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,Other,V-X,EMP-X,V-X,9/9/2015,6/23/2016,6/23/2016,3/30/2017,3/20/2018,3/20/2018,3/27/2019,1/25/2020,1/25/2020,3/27/2020,3/4/2021,3/4/2021
1599,3601,6/15/1948,Female,165,66,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"29,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,NIN-X,POM-X,No CTx,V-X,1/30/2017,7/17/2017,7/17/2017,1/11/2018,12/6/2018,12/6/2018,2/15/2019,6/30/2021, , , , 
1600,3083,6/15/1951,Female,172,68,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,18,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,Other,KYP-X,FAR-X,V-X,2/2/2016,10/8/2016,10/8/2016,3/11/2017,1/3/2018,1/3/2018,3/20/2018,11/7/2018,11/7/2018,3/19/2019,10/21/2019,10/21/2019
1601,4350,6/15/1949,Female,173,110,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,31",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/2/2017,6/8/2017,6/8/2017,1/22/2019,6/30/2021,10/14/1582, , , , , , 
1602,1113,6/15/1956,Male,188,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"27,02","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/19/2017,5/25/2017,5/25/2017, , , , , , , , , 
1603,5879,6/15/1956,Male,188,60,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/20/2017,5/30/2017,5/30/2017,10/23/2020,5/7/2021,5/7/2021, , , , , , 
1604,8963,6/15/1962,Male,185,88,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,64",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/19/2017,4/20/2017,4/20/2017,11/7/2017,10/2/2019,10/2/2019,11/11/2019,5/25/2020,5/25/2020, , , 
1605,5552,6/15/1943,Female,184,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,35",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,2/29/2016,6/28/2016,6/28/2016,1/3/2017,12/10/2018,12/10/2018,1/15/2019,6/9/2020,6/9/2020,7/2/2020,11/15/2020,11/15/2020
1606,8165,6/15/1949,Female,168,85,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"26,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,NIN-X,POM-X,V-X,8/22/2016,2/20/2017,2/20/2017,3/9/2017,12/6/2018,12/6/2018,2/11/2019,6/25/2020,6/25/2020,7/2/2020,6/26/2021,6/26/2021
1607,5083,6/15/1942,Female,159,53,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"11,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,DAR-X,NIN-X,V-X,3/29/2016,9/19/2016,9/19/2016,2/9/2017,6/20/2018,6/20/2018,7/16/2018,9/15/2020,9/15/2020,10/11/2020,12/3/2021,12/3/2021
1608,3047,6/15/1948,Female,170,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,98",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/4/2016,8/30/2016,8/30/2016,1/24/2017,5/30/2018,5/30/2018,6/11/2018,9/20/2018,9/20/2018, , , 
1609,3236,6/15/1947,Male,175,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,DAR-X,POM-X,V-X,7/12/2016,10/6/2016,10/6/2016,2/15/2017,8/2/2017,8/2/2017,1/4/2018,2/7/2019,2/7/2019,3/20/2019,9/12/2020,9/12/2020
1610,5342,6/15/1952,Male,186,92,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,15,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,Other,Other,No CTx,V-X,2/16/2016,10/22/2016,10/22/2016,3/27/2017,6/30/2017,6/30/2017,11/30/2017,2/5/2019,2/5/2019, , , 
1611,9447,6/15/1963,Male,173,59,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,"31,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/2/2017,4/28/2017,4/28/2017,9/13/2018,9/24/2018,9/24/2018, , , , , , 
1612,5660,6/15/1943,Male,177,66,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"23,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/2/2017,12/19/2017,12/19/2017,3/27/2018,3/20/2019,3/20/2019, , , , , , 
1613,2145,6/15/1967,Female,164,63,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"29,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,3/14/2017,5/25/2017,5/25/2017,7/5/2017,3/31/2022,10/14/1582, , , , , , 
1614,4832,6/15/1944,Female,176,82,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"12,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,POM-X,No CTx,V-X,1/23/2017,10/24/2017,10/24/2017,2/13/2018,11/9/2020,11/9/2020,11/28/2020,8/10/2021,8/10/2021, , , 
1615,5298,6/15/1948,Female,160,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,55",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,NIN-X,POM-X,No CTx,V-X,2/21/2017,8/10/2017,8/10/2017,12/18/2018,1/2/2020,1/2/2020,4/4/2020,8/5/2021,8/5/2021, , , 
1616,6790,6/15/1943,Male,184,87,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,NIN-X,No CTx,R-X,8/16/2016,2/2/2017,2/2/2017,2/16/2017,7/11/2018,7/11/2018,7/31/2018,10/3/2018,10/3/2018, , , 
1617,5144,6/15/1950,Female,173,102,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,33",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,5/27/2016,9/28/2016,9/28/2016,2/21/2017,12/21/2018,12/21/2018,2/11/2019,3/25/2019,3/25/2019, , , 
1618,5829,6/15/1967,Female,161,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,7/18/2016,10/13/2016,10/13/2016,2/2/2017,7/12/2018,7/12/2018,7/30/2018,8/30/2018,8/30/2018, , , 
1619,6560,6/15/1944,Female,166,89,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"11,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,KYP-X,EMP-X,V-X,3/7/2016,8/26/2016,8/26/2016,9/19/2016,3/9/2017,3/9/2017,4/3/2017,10/30/2017,10/30/2017,11/6/2017,12/15/2017,12/15/2017
1620,6948,6/15/1947,Female,159,47,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,6/27/2016,12/12/2016,12/12/2016,1/5/2017,8/27/2018,8/27/2018,9/7/2018,4/18/2019,4/18/2019,7/10/2019,12/16/2019,12/16/2019
1621,2151,6/15/1957,Male,175,87,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"31,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/24/2017,4/28/2017,4/28/2017, , , , , , , , , 
1622,7642,6/15/1955,Male,176,102,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,63",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/28/2017,5/18/2017,5/18/2017, , , , , , , , , 
1623,5135,6/15/1960,Female,160,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,49",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,1/19/2017,4/27/2017,4/27/2017,11/21/2018,9/11/2021,9/11/2021, , , , , , 
1624,9897,6/15/1955,Male,179,103,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,08",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,POM-X,R-X,1/4/2017,4/26/2017,4/26/2017,7/12/2017,1/4/2018,1/4/2018,7/26/2018,11/12/2018,11/12/2018,12/3/2018,6/26/2019,6/26/2019
1625,7711,6/15/1948,Female,166,96,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"17,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/13/2017,8/28/2017,8/28/2017, , , , , , , , , 
1626,6598,6/15/1949,Female,170,74,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"2,21",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,V-X,No CTx,V-X,8/16/2016,2/9/2017,2/9/2017,3/3/2017,10/25/2018,10/25/2018,11/14/2018,6/10/2020,6/10/2020, , , 
1627,6804,6/15/1952,Female,168,72,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,V-X,R-X,V-X,6/9/2016,1/2/2017,1/2/2017,3/28/2017,6/28/2017,6/28/2017,7/12/2017,2/22/2018,2/22/2018,3/4/2019,11/27/2019,11/27/2019
1628,7978,6/15/1948,Male,186,106,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,75","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,DAR-X,V-X,V-X,8/4/2016,2/1/2017,2/1/2017,2/13/2017,5/23/2018,5/23/2018,6/11/2018,12/10/2018,12/10/2018,1/28/2019,3/12/2019,3/12/2019
1629,6732,6/15/1947,Male,181,82,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"33,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,8/15/2016,11/18/2016,11/18/2016,2/28/2017,10/15/2018,10/15/2018,10/24/2018,5/24/2019,5/24/2019,7/10/2019,9/6/2019,9/6/2019
1630,4690,6/15/1942,Male,172,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,24",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,4/4/2016,7/8/2016,7/8/2016,1/25/2017,6/19/2017,6/19/2017,7/2/2018,10/12/2018,10/12/2018,10/23/2018,1/4/2019,1/4/2019
1631,7640,6/15/1950,Male,169,76,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,DAR-X,No CTx,V-X,6/27/2016,12/22/2016,12/22/2016,1/16/2017,11/22/2018,11/22/2018,12/6/2018,12/10/2018,12/10/2018, , , 
1632,1510,6/15/1948,Male,184,79,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,18,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,V-X,DAR-X,V-X,5/7/2015,1/12/2016,1/12/2016,3/22/2017,6/30/2017,6/30/2017,9/10/2017,6/29/2018,6/29/2018,9/20/2019,11/10/2020,11/10/2020
1633,2132,6/15/1951,Male,189,94,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,58",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,NIN-X,LEV-X,2/27/2017,4/9/2018,4/9/2018,4/23/2018,3/20/2019,3/20/2019,5/16/2019,7/8/2019,7/8/2019,8/1/2019,1/2/2020,1/2/2020
1634,8200,6/15/1962,Male,178,87,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,POM-X,NIN-X,V-X,2/20/2017,5/30/2017,5/30/2017,2/27/2018,8/28/2018,8/28/2018,3/27/2019,6/10/2019,6/10/2019,7/17/2019,4/16/2020,4/16/2020
1635,7449,6/15/1962,Female,160,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,56",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/17/2017,5/11/2017,5/11/2017,2/22/2018,12/31/2021,10/14/1582, , , , , , 
1636,3193,6/15/1959,Female,148,48,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/13/2017,5/24/2017,5/24/2017,9/6/2018,9/18/2018,9/18/2018, , , , , , 
1637,3546,6/15/1945,Female,173,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,65",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,No CTx,R-X,1/9/2017,6/18/2018,6/18/2018,7/3/2018,12/18/2018,12/18/2018,1/7/2019,7/21/2021,7/21/2021, , , 
1638,7128,6/15/1947,Male,187,66,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"16,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,2/24/2017,11/14/2017,11/14/2017,11/27/2017,11/14/2018,11/14/2018,2/1/2019,3/14/2019,3/14/2019,4/25/2019,6/28/2021,6/28/2021
1639,8846,6/15/1962,Male,168,64,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"22,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/18/2017,5/18/2017,5/18/2017,2/13/2018,1/29/2019,1/29/2019,2/7/2019,3/22/2019,3/22/2019, , , 
1640,8962,6/15/1953,Male,177,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,61",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,LEV-X,2/20/2017,8/29/2017,8/29/2017,2/26/2018,12/13/2019,12/13/2019, , , , , , 
1641,1745,6/15/1949,Female,174,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"32,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,NIN-X,DAR-X,POM-X,V-X,1/20/2017,10/18/2017,10/18/2017,11/13/2017,12/17/2018,12/17/2018,4/15/2019,1/2/2020,1/2/2020,3/16/2020,7/21/2020,7/21/2020
1642,4055,6/15/1948,Male,192,101,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,R-X,V-X,V-X,1/9/2017,11/15/2017,11/15/2017,1/17/2018,11/29/2019,11/29/2019,12/30/2019,7/25/2020,7/25/2020,8/9/2020,1/31/2021,1/31/2021
1643,6255,6/15/1945,Male,178,104,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,5",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,R-X,V-X,V-X,3/8/2016,6/30/2016,6/30/2016,10/5/2016,3/22/2017,3/22/2017,4/13/2017,10/26/2017,10/26/2017,11/14/2017,5/1/2018,5/1/2018
1644,8338,6/15/1942,Female,182,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,57",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,7/22/2016,1/5/2017,1/5/2017,1/23/2017,11/7/2018,11/7/2018,2/11/2019,1/1/2020,1/1/2020,2/10/2020,8/27/2021,8/27/2021
1645,6770,6/15/1948,Male,165,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"27,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,No CTx,V-X,7/21/2016,1/17/2017,1/17/2017,1/31/2017,7/30/2018,7/30/2018,8/23/2018,8/23/2018,8/23/2018, , , 
1646,7733,6/15/1949,Male,182,72,Private,No, ,Yes,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"28,83","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,3/17/2016,9/5/2016,9/5/2016,1/12/2017,4/19/2018,4/19/2018,5/15/2018,5/28/2018,5/28/2018,6/15/2018,4/29/2019,4/29/2019
1647,8548,6/15/1951,Female,166,78,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,25",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,V-X,No CTx,V-X,5/24/2016,12/22/2016,12/22/2016,1/6/2017,6/21/2018,6/21/2018,7/9/2018,8/2/2018,8/2/2018, , , 
1648,7865,6/15/1947,Female,173,72,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,97",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,5/25/2016,8/24/2016,8/24/2016,3/15/2017,10/25/2018,10/25/2018,3/28/2019,1/13/2022,1/13/2022,2/14/2022,3/31/2022, 
1649,2868,6/15/1950,Female,168,70,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,34",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,No CTx,R-X,8/8/2016,2/2/2017,2/2/2017,2/21/2017,7/23/2018,7/23/2018,8/16/2018,7/12/2021,7/12/2021, , , 
1650,6228,6/15/1950,Male,168,102,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,62",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,7/25/2016,1/18/2017,1/18/2017,1/30/2017,6/6/2018,6/6/2018,6/20/2018,6/27/2018,6/27/2018, , , 
1651,7707,6/15/1957,Male,172,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,120,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,DAR-X,No CTx,V-X,1/23/2017,12/12/2017,12/12/2017,6/18/2018,12/19/2018,12/19/2018,6/3/2019,6/30/2019, , , , 
1652,5738,6/15/1952,Female,160,58,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,175,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/13/2017,11/14/2017,11/14/2017, , , , , , , , , 
1653,8171,6/15/1939,Male,172,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,210,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/20/2017,9/20/2017,9/20/2017, , , , , , , , , 
1654,4146,6/15/1938,Female,162,55,Private,No, , ,Yes, , ,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,250,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/13/2017,12/11/2017,12/11/2017, , , , , , , , , 
1655,3836,6/15/1950,Female,162,60,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/27/2017,11/28/2017,11/28/2017, , , , , , , , , 
1656,6183,6/15/1931,Female,150,51,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"4,4",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,1/17/2017,4/28/2017,4/28/2017,1/8/2018,5/3/2018,5/3/2018, , , , , , 
1657,5503,6/15/1940,Male,168,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,185,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/14/2017,8/14/2017,8/14/2017,5/14/2018,3/31/2019,10/14/1582, , , , , , 
1658,2027,6/15/1943,Female,172,71,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,I: fulfilling all 4 criteria,IgG,"1,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,DAR-X,No CTx,LEV-X,10/21/2010,12/19/2010,12/19/2010,11/7/2016,5/8/2017,5/8/2017,6/11/2018,3/31/2020,3/31/2020, , , 
1659,2737,6/15/1941,Female,161,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,235,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/21/2017,12/31/2017, , , , , , , , , , 
1660,7133,6/15/1944,Female,155,58,Private,No, ,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,195,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,R-X,No CTx,V-X,3/28/2017,10/18/2017,10/18/2017,6/6/2018,8/12/2019,8/12/2019,8/13/2019,12/13/2019,12/13/2019, , , 
1661,3647,6/15/1942,Female,164,73,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,225,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,DAR-X,No CTx,V-X,2/1/2017,10/16/2017,10/16/2017,5/2/2018,12/27/2018,12/27/2018,6/17/2019,2/11/2020,2/11/2020, , , 
1662,2060,6/15/1940,Male,170,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,235,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/20/2017,5/15/2018,5/15/2018, , , , , , , , , 
1663,7840,6/15/1952,Female,173,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,79",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/2/2017,7/25/2017,7/25/2017,1/15/2020,12/31/2020,10/14/1582, , , , , , 
1664,2668,6/15/1949,Male,166,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,26",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,1/4/2017,9/11/2017,9/11/2017,6/11/2018,5/27/2019,5/27/2019,6/3/2019,12/31/2020, , , , 
1665,1955,6/15/1942,Female,162,74,Private,No, , , , , ,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,43",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/23/2017,7/13/2017,7/13/2017, , , , , , , , , 
1666,9965,6/15/1947,Female,167,103,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,1",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,7/28/2016,1/19/2017,1/19/2017,2/14/2017,7/12/2018,7/12/2018,10/3/2018,1/28/2019,1/28/2019,2/21/2019,8/27/2019,8/27/2019
1667,1237,6/15/1949,Female,161,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,NIN-X,V-X,R-X,2/27/2017,2/26/2018,2/26/2018,3/13/2018,1/22/2019,1/22/2019,3/28/2019,12/30/2019,12/30/2019,2/22/2020,2/14/2021,2/14/2021
1668,4431,6/15/1952,Male,173,108,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,36",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,8/10/2016,2/6/2017,2/6/2017,2/16/2017,4/19/2019,4/19/2019,5/6/2019,12/31/2020,10/14/1582, , , 
1669,7603,6/15/1942,Male,168,51,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"29,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,KYP-X,DAR-X,V-X,4/6/2016,7/12/2016,7/12/2016,11/16/2016,3/16/2017,3/16/2017,8/16/2017,6/12/2018,6/12/2018,6/28/2018,12/27/2018,12/27/2018
1670,7434,6/15/1942,Female,178,57,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,35",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/16/2017,6/22/2017,6/22/2017, , , , , , , , , 
1671,6275,6/15/1947,Male,199,91,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,84",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,LEV-X,Other,R-X,9/14/2015,3/10/2016,3/10/2016,3/29/2016,3/14/2017,3/14/2017,4/5/2017,7/31/2017,7/31/2017,8/21/2017,8/24/2017,8/24/2017
1672,7806,6/15/1948,Male,185,89,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,19,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,R-X,NIN-X,V-X,10/12/2016,2/23/2017,2/23/2017,3/30/2017,9/24/2017,9/24/2017,9/30/2017,9/10/2018,9/10/2018,6/5/2019,3/16/2020,3/16/2020
1673,7225,6/15/1949,Male,179,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,42",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,DAR-X,No CTx,V-X,1/10/2017,9/19/2017,9/19/2017,9/27/2018,10/30/2018,10/30/2018,11/20/2018,12/13/2018,12/13/2018, , , 
1674,2876,6/15/1946,Female,162,88,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,47",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,1/2/2017,6/19/2017,6/19/2017,3/9/2018,1/2/2020,1/2/2020,2/17/2020,2/9/2021,2/9/2021, , , 
1675,2218,6/15/1944,Female,161,63,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"11,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/31/2017,7/20/2017,7/20/2017,2/4/2020,4/28/2020,4/28/2020, , , , , , 
1676,8807,6/15/1950,Female,172,75,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,5/31/2016,9/29/2016,9/29/2016,2/9/2017,10/22/2018,10/22/2018,11/2/2018,12/31/2021, , , , 
1677,4718,6/15/1947,Male,175,77,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,72",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,KYP-X,NIN-X,V-X,4/28/2016,10/24/2016,10/24/2016,3/9/2017,12/29/2017,12/29/2017,1/3/2018,8/20/2018,8/20/2018,3/7/2019,7/2/2021,7/2/2021
1678,1839,6/15/1936,Female,165,65,Private,Yes, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"4,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,V-X,LEV-X,V-X,11/28/2013,7/10/2014,7/10/2014,8/19/2014,6/15/2015,6/15/2015,8/18/2015,9/22/2015,9/22/2015,9/24/2015,3/5/2016,3/5/2016
1679,8274,6/15/1958,Male,183,93,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,2,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,R-X,7/25/2016,1/9/2017,1/9/2017,2/2/2017,9/12/2020,9/12/2020,9/28/2020,2/2/2022,2/2/2022,3/2/2022,3/31/2022, 
1680,7703,6/15/1950,Female,172,125,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/16/2017,2/16/2017,2/16/2017, , , , , , , , , 
1681,1185,6/15/1940,Female,153,66,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,1,ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,EMP-X,KYP-X,V-X,11/26/2014,11/10/2015,11/10/2015,11/8/2016,1/24/2017,1/24/2017,7/10/2017,10/4/2017,10/4/2017,11/15/2017,11/22/2017,11/22/2017
1682,2188,6/15/1931,Male,182,84,Private,Yes, ,Yes, ,Yes, , , , , , ,2,I: fulfilling all 4 criteria,Other type,",24",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,V-X,R-X,V-X,4/4/2012,11/28/2012,11/28/2012,1/20/2016,3/16/2016,3/16/2016,3/20/2017,7/17/2017,7/17/2017,3/24/2018,8/17/2018,8/17/2018
1683,2033,6/15/1933,Female,165,65,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,",85",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,No CTx,V-X,10/17/2013,1/2/2014,1/2/2014,9/6/2016,1/30/2017,1/30/2017,2/14/2017,12/31/2020,10/14/1582, , , 
1684,3962,6/15/1941,Male,162,63,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,2,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,R-X,KYP-X,No CTx,V-X,7/14/2016,3/7/2017,3/7/2017,3/8/2017,5/15/2017,5/15/2017,1/8/2018,2/17/2020,2/17/2020, , , 
1685,4749,6/15/1948,Male,166,67,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,18,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,11/29/2016,5/27/2017,5/27/2017,11/30/2017,9/18/2018,9/18/2018, , , , , , 
1686,6818,6/15/1951,Female,170,73,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,NIN-X,V-X,1/23/2017,5/25/2017,5/25/2017,7/20/2017,3/23/2018,3/23/2018,5/26/2018,11/21/2018,11/21/2018,12/4/2018,11/18/2019,11/18/2019
1687,1421,6/15/1955,Male,182,73,Private,No,Yes, ,Yes,Yes,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"4,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,KYP-X,KYP-X,V-X,7/8/2014,9/23/2014,9/23/2014,9/12/2016,1/25/2017,1/25/2017,3/15/2018,10/9/2018,10/9/2018,5/17/2019,7/23/2019,7/23/2019
1688,9766,6/15/1940,Female,158,62,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,350,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,2/8/2016,11/15/2016,11/15/2016,1/17/2017,8/12/2017,8/12/2017, , , , , , 
1689,8103,6/15/1947,Male,175,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,185,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,4/4/2016,12/12/2016,12/12/2016,2/13/2017,9/25/2017,9/25/2017,5/23/2018,12/5/2018,12/5/2018, , , 
1690,4202,6/15/1945,Female,160,66,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,220,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/21/2015,6/13/2016,6/13/2016,2/20/2017,3/15/2018,3/15/2018, , , , , , 
1691,4973,6/15/1942,Male,180,77,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,270,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/23/2015,5/23/2016,5/23/2016,1/24/2017,7/28/2017,7/28/2017, , , , , , 
1692,1531,6/15/1940,Male,169,72,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,186,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/2/2015,6/7/2016,6/7/2016,3/13/2017,12/31/2017, , , , , , , 
1693,8674,6/15/1950,Female,170,63,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"23,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/12/2017,9/19/2017,9/19/2017,5/2/2019,4/4/2020,4/4/2020, , , , , , 
1694,5377,6/15/1949,Male,184,82,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,12",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/26/2017,10/5/2017,10/5/2017,10/17/2017,1/2/2020,1/2/2020,1/16/2020,9/30/2020,10/14/1582, , , 
1695,5299,6/15/1952,Female,155,54,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"32,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,DAR-X,R-X,3/15/2017,12/11/2018,12/11/2018,1/8/2020,7/21/2020,7/21/2020,8/2/2020,12/26/2020,12/26/2020,1/11/2021,8/4/2021,8/4/2021
1696,1864,6/15/1943,Female,165,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,16,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,1/30/2017,8/23/2017,8/23/2017, , , , , , , , , 
1697,4176,6/15/1947,Female,173,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,19",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/23/2017,10/26/2017,10/26/2017, , , , , , , , , 
1698,2010,6/15/1945,Male,184,69,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"16,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,2/9/2017,11/13/2017,11/13/2017,11/30/2017,12/4/2019,12/4/2019, , , , , , 
1699,2429,6/15/1948,Female,165,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,09","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,2/14/2017,11/16/2017,11/16/2017,12/5/2017,1/4/2022,1/4/2022,3/3/2022,3/31/2022, , , , 
1700,8996,6/15/1958,Female,179,70,Private,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"10,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/31/2017,5/17/2017,5/17/2017,2/7/2019,9/30/2020,10/14/1582, , , , , , 
1701,8362,6/15/1943,Female,174,58,Private,No, , , , , , , ,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,1/9/2017,6/26/2017,6/26/2017,10/8/2019,3/31/2022, , , , , , , 
1702,2938,6/15/1952,Male,184,87,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,34",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,V-X,V-X,8/8/2016,1/26/2017,1/26/2017,2/15/2017,8/16/2018,8/16/2018,8/30/2018,8/30/2018,8/30/2018,1/10/2019,9/18/2019,9/18/2019
1703,5846,6/15/1950,Male,187,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,DAR-X,V-X,8/25/2016,2/16/2017,2/16/2017,3/6/2017,7/5/2018,7/5/2018,7/27/2018,9/18/2018,9/18/2018,9/28/2018,5/27/2019,5/27/2019
1704,8906,6/15/1950,Female,171,76,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,64",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,DAR-X,V-X,8/25/2016,2/16/2017,2/16/2017,3/3/2017,7/26/2018,7/26/2018,8/8/2018,7/16/2020,7/16/2020,7/31/2020,9/30/2020,10/14/1582
1705,4531,6/15/1951,Male,175,69,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,51",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,8/9/2016,1/26/2017,1/26/2017,2/8/2017,6/25/2018,6/25/2018,7/17/2018,9/5/2018,9/5/2018,9/28/2018,4/11/2019,4/11/2019
1706,5208,6/15/1948,Male,187,88,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,18,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,3/3/2017,6/29/2017,6/29/2017,8/23/2017,6/25/2018,6/25/2018,3/15/2019,6/20/2020,6/20/2020,7/28/2020,6/17/2021,6/17/2021
1707,6864,6/15/1941,Female,169,64,Private,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"1,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,EMP-X,KYP-X,V-X,9/19/2013,8/7/2014,8/7/2014,3/31/2016,9/22/2016,9/22/2016,11/29/2016,11/22/2018,11/22/2018,12/3/2018,4/24/2020,4/24/2020
1708,3632,6/15/1951,Male,169,77,Private,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,15,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,V-X,KYP-X,NIN-X,V-X,2/28/2017,6/29/2017,6/29/2017,9/25/2017,12/2/2017,12/2/2017,5/9/2018,12/14/2018,12/14/2018,12/21/2018,10/7/2019,10/7/2019
1709,5993,6/15/1950,Female,170,60,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,17,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,DAR-X,KYP-X,V-X,3/25/2017,6/30/2017,6/30/2017,8/13/2017,2/28/2018,2/28/2018,9/13/2018,9/28/2019,9/28/2019,12/16/2019,9/19/2020,9/19/2020
1710,8607,6/15/1952,Female,172,74,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,6/27/2016,12/16/2016,12/16/2016,3/10/2017,9/20/2018,9/20/2018,2/19/2019,5/30/2019,5/30/2019,6/27/2019,4/10/2021,4/10/2021
1711,1699,6/15/1943,Male,171,93,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,53",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,POM-X,V-X,7/20/2016,1/9/2017,1/9/2017,1/26/2017,4/30/2018,4/30/2018,6/10/2018,1/14/2020,1/14/2020,2/6/2020,3/31/2022, 
1712,7321,6/15/1942,Female,160,53,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,12",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,6/23/2016,12/21/2016,12/21/2016,1/4/2017,5/3/2018,5/3/2018,5/22/2018,1/14/2019,1/14/2019,3/15/2019,5/8/2019,5/8/2019
1713,7756,6/15/1952,Female,172,74,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,Other,V-X,1/4/2016,6/20/2016,6/20/2016,10/12/2016,3/29/2017,3/29/2017,4/14/2017,9/4/2017,9/4/2017,9/20/2017,11/7/2017,11/7/2017
1714,7285,6/15/1951,Female,171,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,15,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,FAR-X,KYP-X,V-X,2/5/2017,6/18/2017,6/18/2017,9/13/2017,5/29/2019,5/29/2019,6/29/2019,12/27/2019,12/27/2019,3/30/2020,12/29/2020,12/29/2020
1715,6833,6/15/1950,Female,170,60,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,FAR-X,POM-X,V-X,3/9/2017,9/20/2017,9/20/2017,9/27/2017,3/24/2018,3/24/2018,2/27/2019,6/4/2020,6/4/2020,7/22/2020,6/9/2021,6/9/2021
1716,9644,6/15/1941,Female,168,70,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"4,6",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,V-X,R-X,POM-X,V-X,9/15/2015,1/8/2016,1/8/2016,5/23/2016,8/15/2016,8/15/2016,10/21/2016,12/7/2016,12/7/2016,1/12/2017,5/3/2017,5/3/2017
1717,4824,6/15/1927,Male,170,84,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,I: fulfilling all 4 criteria,IgG,"2,1",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,V-X,V-X,No CTx,V-X,1/2/2017,3/20/2017,3/20/2017,12/7/2017,3/21/2018,3/21/2018,2/6/2020,3/26/2020,3/26/2020, , , 
1718,7059,6/15/1934,Female,160,65,Compulsory health insurance CHI,Yes, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,",06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,V-X,R-X,V-X,8/27/2013,11/26/2013,11/26/2013,12/11/2014,4/14/2015,4/14/2015,4/5/2016,5/31/2016,5/31/2016,1/10/2017,4/25/2017,4/25/2017
1719,6743,6/15/1938,Male,175,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,9/7/2015,1/11/2016,1/11/2016,1/21/2016,5/2/2016,5/2/2016,9/20/2016,12/6/2016,12/6/2016,1/3/2017,4/25/2017,4/25/2017
1720,7898,6/15/1937,Male,183,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Other type,",04",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,DAR-X,EMP-X,V-X,8/4/2008,10/17/2008,10/17/2008,12/3/2013,2/15/2015,2/15/2015,6/20/2016,11/21/2016,11/21/2016,1/2/2017,2/26/2018,2/26/2018
1721,5067,6/15/1945,Male,179,84,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,V-X,NIN-X,Other,1/1/2005,4/1/2005,4/1/2005,11/1/2008,2/1/2009,2/1/2009,4/1/2013,1/6/2014,1/6/2014,3/7/2017,5/16/2018,5/16/2018
1722,8333,6/15/1954,Male,185,90,Private,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,KYP-X,V-X,11/18/2013,1/29/2014,1/29/2014,6/27/2016,11/15/2016,11/15/2016,3/14/2018,2/25/2021,2/25/2021,3/24/2021,4/13/2021,4/13/2021
1723,3558,6/15/1947,Female,168,68,Private,Yes, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,Other,NIN-X,V-X,10/1/2012,12/1/2012,12/1/2012,8/1/2014,12/1/2015,12/1/2015,1/14/2016,5/1/2016,5/1/2016,1/25/2017,11/14/2017,11/14/2017
1724,4978,6/15/1950,Female,167,72,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,16,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/3/2017,6/20/2018,6/20/2018, , , , , , , , , 
1725,2900,6/15/1940,Male,176,75,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"6,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,LEV-X,3/13/2017,9/3/2017,9/3/2017,8/13/2018,12/2/2018,12/2/2018, , , , , , 
1726,8182,6/15/1955,Male,182,79,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/27/2017,5/28/2017,5/28/2017,8/31/2020,1/3/2021,1/3/2021, , , , , , 
1727,3089,6/15/1937,Female,166,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,3/6/2017,8/27/2017,8/27/2017, , , , , , , , , 
1728,3876,6/15/1949,Male,183,86,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,20,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,DAR-X,V-X,2/20/2017,9/18/2017,9/18/2017,3/25/2018,11/7/2018,11/7/2018,12/5/2018,2/5/2020,2/5/2020,3/13/2020,3/15/2021,3/15/2021
1729,5227,6/15/1936,Male,165,81,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/17/2016,2/14/2017,2/14/2017,3/30/2017,10/18/2018,10/18/2018, , , , , , 
1730,3932,6/15/1962,Male,183,81,Private,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,Other type,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,V-X,R-X,POM-X,Other,4/1/1996,5/15/1996,5/15/1996,3/28/2011,11/22/2012,11/22/2012,1/15/2013,4/18/2013,4/18/2013,1/15/2014,2/15/2015,2/15/2015
1731,9114,6/15/1934,Female,156,80,Private,Yes,Yes,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,V-X,R-X,Other,V-X,8/4/2011,6/5/2012,6/5/2012,7/2/2013,11/26/2013,11/26/2013,5/23/2014,9/7/2014,9/7/2014,10/1/2014,1/28/2015,1/28/2015
1732,6132,6/15/1949,Female,161,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,2/27/2017,5/17/2017,5/17/2017,6/6/2017,7/27/2017,7/27/2017, , , , , , 
1733,4681,6/15/1954,Male,173,70,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"2,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,KYP-X,POM-X,V-X,2/8/2014,4/7/2014,4/7/2014,3/3/2017,11/3/2017,11/3/2017,2/12/2018,3/28/2018,3/28/2018,10/3/2018,2/14/2019,2/14/2019
1734,9760,6/15/1967,Male,999,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,9,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,10/8/2014,1/9/2015,1/9/2015,3/31/2017,8/3/2017,8/3/2017,3/1/2018,6/19/2018,6/19/2018,7/30/2018,9/18/2018,9/18/2018
1735,4066,6/15/1964,Male,181,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/27/2017,5/21/2017,5/21/2017, , , , , , , , , 
1736,1038,6/15/1959,Male,185,90,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgA,48,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,2/15/2017,10/15/2017,10/15/2017,12/15/2017,9/15/2018,9/15/2018,2/1/2019,6/15/2019,6/15/2019, , , 
1737,1215,6/15/1954,Female,173,69,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,56,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,3/15/2017,11/15/2017,11/15/2017,12/15/2017,2/15/2019,2/15/2019,3/15/2019,6/15/2019,6/15/2019, , , 
1738,5831,6/15/1938,Female,163,75,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,43,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,1/15/2017,2/15/2018,2/15/2018,3/15/2018,4/15/2019,4/15/2019, , , , , , 
1739,2054,6/15/1941,Male,182,75,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,61,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,3/15/2017,9/15/2017,9/15/2017,10/15/2017,9/15/2018,9/15/2018,12/1/2018,5/15/2019,5/15/2019, , , 
1740,1616,6/15/1944,Male,176,65,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,62,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,KYP-X,R-X,2/15/2016,12/15/2016,12/15/2016,4/15/2017,1/15/2018,1/15/2018,3/15/2018,6/30/2019,10/14/1582,1/2/2019,6/15/2019,6/15/2019
1741,4932,6/15/1940,Female,178,74,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,49,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,KYP-X,R-X,4/15/2016,12/15/2016,12/15/2016,3/15/2017,1/15/2018,1/15/2018,3/15/2018,6/30/2019,10/14/1582,2/1/2019,6/15/2019,6/15/2019
1742,2078,6/15/1938,Male,180,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,37,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,V-X,R-X,3/15/2016,1/15/2017,1/15/2017,2/15/2017,11/15/2017,11/15/2017,12/15/2017,12/15/2018,12/15/2018,5/15/2019,6/30/2019, 
1743,6440,6/15/1944,Female,163,53,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,48",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,3/7/2017,11/8/2017,11/8/2017,11/28/2017,11/21/2018,11/21/2018,10/17/2019,2/26/2020,2/26/2020,3/5/2020,6/28/2020,6/28/2020
1744,9287,6/15/1942,Female,178,57,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,35",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/16/2017,4/18/2017,4/18/2017, , , , , , , , , 
1745,8894,6/15/1966,Male,172,66,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,3/3/2017,5/25/2017,5/25/2017, , , , , , , , , 
1746,9741,6/15/1962,Female,167,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/27/2017,4/20/2017,4/20/2017,3/9/2018,3/31/2022,10/14/1582, , , , , , 
1747,6900,6/15/1946,Male,187,68,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,No CTx,LEV-X,1/4/2017,7/12/2017,7/12/2017,10/18/2017,11/19/2018,11/19/2018,12/13/2018,4/16/2020,4/16/2020, , , 
1748,1823,6/15/1947,Male,199,91,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,84",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,No CTx,R-X,9/14/2015,3/10/2016,3/10/2016,3/29/2016,3/14/2017,3/14/2017,4/5/2017,4/17/2017,4/17/2017, , , 
1749,5029,6/15/1944,Female,169,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,06",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,3/24/2016,9/23/2016,9/23/2016,1/18/2017,5/14/2018,5/14/2018,5/29/2018,6/14/2018,6/14/2018, , , 
1750,1807,6/15/1944,Female,169,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,5",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,3/2/2016,8/26/2016,8/26/2016,3/10/2017,7/30/2018,7/30/2018,8/9/2018,10/2/2020,10/2/2020,10/25/2020,8/2/2021,8/2/2021
1751,7024,6/15/1947,Female,153,40,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"3,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,No CTx,V-X,8/8/2016,2/3/2017,2/3/2017,2/13/2017,9/7/2017,9/7/2017,9/19/2017,10/18/2017,10/18/2017, , , 
1752,4657,6/15/1961,Male,186,62,Private,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"3,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,5/25/2016,9/23/2016,9/23/2016,1/12/2017,6/19/2018,6/19/2018,7/2/2018,2/19/2019,2/19/2019,5/31/2019,10/26/2020,10/26/2020
1753,5513,6/15/1954,Male,182,78,Compulsory health insurance CHI,No, , , ,Yes,Yes, ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"2,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/10/2017,6/12/2017,6/12/2017, , , , , , , , , 
1754,7741,6/15/1962,Male,999,80,Compulsory health insurance CHI,Unknown,Yes,Yes, , ,Yes,Yes, , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,FAR-X,POM-X,V-X,6/15/2013,10/6/2013,10/6/2013,4/4/2015,6/18/2015,6/18/2015,12/9/2015,7/7/2016,7/7/2016,8/17/2016,2/23/2017,2/23/2017
1755,6167,6/15/1947,Male,178,93,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2017,5/22/2017,5/22/2017, , , , , , , , , 
1756,1201,6/15/1956,Female,160,57,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes,Yes, ,1,I: fulfilling all 4 criteria,IgG,"3,17",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,2/13/2017,6/13/2017,6/13/2017, , , , , , , , , 
1757,6755,6/15/1948,Female,158,72,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,2,I: fulfilling all 4 criteria,Other type,258,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,Other,No CTx,V-X,3/6/2017,8/14/2017,8/14/2017,1/16/2019,5/21/2019,5/21/2019,6/3/2019,6/30/2019, , , , 
1758,3903,6/15/1947,Male,171,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,299,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,Other,No CTx,No CTx,LEV-X,2/8/2017,7/6/2017,7/6/2017,8/27/2017,6/30/2019, , , , , , , 
1759,7738,6/15/1934,Male,178,100,Compulsory health insurance CHI,No, , , , , ,Yes, , , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,Other type,146,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,2/2/2017,5/30/2017,5/30/2017, , , , , , , , , 
1760,8253,6/15/1969,Female,167,58,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"3,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,KYP-X,No CTx,V-X,1/16/2015,4/9/2015,4/9/2015,3/22/2017,4/17/2018,4/17/2018,5/7/2021,8/25/2021,8/25/2021, , , 
1761,2197,6/15/1946,Male,178,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,I: fulfilling all 4 criteria,IgG,"48,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,EMP-X,No CTx,V-X,12/3/2013,1/30/2014,1/30/2014,2/10/2017,4/24/2017,4/24/2017,5/10/2017,5/1/2018,5/1/2018, , , 
1762,1506,6/15/1940,Male,167,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,358,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,KYP-X,KYP-X,Other,1/1/2001,2/28/2001,2/28/2001,2/14/2017,5/16/2017,5/16/2017,2/5/2018,4/16/2018,4/16/2018,6/12/2019,6/30/2019,10/14/1582
1763,1023,6/15/1928,Male,172,80,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"24,1",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,No CTx,No CTx,Other,1/2/2017,6/29/2017,6/29/2017,11/2/2017,12/15/2017,12/15/2017, , , , , , 
1764,6063,6/15/1942,Male,172,75,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,Other,1/27/2017,4/21/2017,4/21/2017, , , , , , , , , 
1765,2275,6/15/1952,Male,175,103,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"17,41",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,No CTx,No CTx,V-X,1/24/2017,4/10/2017,4/10/2017,5/16/2017,1/24/2018,1/24/2018, , , , , , 
1766,1359,6/15/1961,Male,168,75,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,16","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/20/2017,5/12/2017,5/12/2017, , , , , , , , , 
1767,1918,6/15/1966,Male,187,85,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , ,Yes,2,III: one or more criteria are fulfilled,Other type,",72",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,2/11/2017,4/25/2017,4/25/2017,6/11/2019,6/26/2019,6/26/2019,7/18/2019,8/1/2019,8/1/2019, , , 
1768,7815,6/15/1942,Female,168,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"19,68",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,6/13/2013,10/16/2013,10/16/2013, , , , , , , , , 
1769,9567,6/15/1951,Male,168,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"7,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,KYP-X,EMP-X,V-X,11/10/2014,2/18/2015,2/18/2015,9/14/2015,9/19/2016,9/19/2016,10/10/2016,3/9/2017,3/9/2017,3/29/2017,5/10/2017,5/10/2017
1770,8896,6/15/1949,Female,159,66,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"6,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,V-X,V-X,9/1/2007,12/1/2007,12/1/2007,1/8/2011,1/12/2012,1/12/2012,2/6/2012,4/3/2012,4/3/2012,1/14/2013,4/25/2013,4/25/2013
1771,4215,6/15/1962,Male,182,84,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/27/2017,5/28/2017,5/28/2017,6/22/2020,5/16/2021,5/16/2021, , , , , , 
1772,6539,6/15/1939,Female,158,61,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,43","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,KYP-X,No CTx,LEV-X,3/1/2017,8/20/2017,8/20/2017,3/4/2019,9/1/2019,9/1/2019,9/21/2020,5/11/2021,5/11/2021, , , 
1773,9337,6/15/1939,Male,181,75,Compulsory health insurance CHI,Yes,Yes,Yes, , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,DAR-X,LEV-X,4/16/2014,10/12/2014,10/12/2014,3/13/2017,9/3/2017,9/3/2017,12/17/2018,6/16/2019,6/16/2019,8/24/2020,12/26/2021,12/26/2021
1774,8299,6/15/1964,Female,165,66,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"4,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,Other,Other,KYP-X,V-X,1/14/2011,3/4/2011,3/4/2011,7/8/2014,12/17/2014,12/17/2014,6/22/2015,2/2/2017,2/2/2017,3/20/2017,5/31/2017,5/31/2017
1775,7985,6/15/1954,Female,156,64,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,"1,4",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,64", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/10/2017,4/14/2017,4/14/2017, , , , , , , , , 
1776,1711,6/15/1941,Female,160,67,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,4,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,3/30/2017,12/4/2017,12/4/2017,1/5/2018,3/26/2018,3/26/2018, , , , , , 
1777,4289,6/15/1953,Female,157,43,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , ,Yes,9,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,DAR-X,V-X,12/2/2013,6/23/2014,6/23/2014,5/29/2015,4/29/2016,4/29/2016,5/30/2016,10/14/2016,10/14/2016,10/26/2016,1/10/2017,1/10/2017
1778,9303,6/15/1930,Female,999,65,Private,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,73",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,LEV-X,V-X,Other,6/1/1999,8/1/1999,8/1/1999,10/5/2010,12/3/2010,12/3/2010,1/9/2012,6/5/2012,6/5/2012,12/11/2012,5/31/2013,5/31/2013
1779,4963,6/15/1938,Male,999,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,9,III: one or more criteria are fulfilled,IgG,"3,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/1/2017,12/21/2017,12/21/2017, , , , , , , , , 
1780,2143,6/15/1947,Male,168,85,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,9,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,Other,10/2/2015,10/12/2015,10/12/2015,2/14/2017,9/25/2017,9/25/2017,10/9/2017,3/24/2018,3/24/2018, , , 
1781,4939,6/15/1943,Female,162,56,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,49,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,12/16/2016,4/18/2018,4/18/2018, , , , , , , , , 
1782,6085,6/15/1950,Male,173,88,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"9999999,99",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,No CTx,No CTx,Other,11/2/2016,12/12/2016,12/12/2016,2/1/2017,3/22/2017,3/22/2017, , , , , , 
1783,1239,6/15/1957,Male,183,102,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,1800,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , ,Unbekannt,No CTx,No CTx,No CTx,V-X,2/13/2017,4/28/2017,4/28/2017, , , , , , , , , 
1784,1763,6/15/1936,Female,164,65,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,3/2/2017,8/27/2017,8/27/2017, , , , , , , , , 
1785,1467,6/15/1940,Male,176,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,LEV-X,LEV-X,DAR-X,V-X,1/6/2014,4/27/2014,4/27/2014,3/27/2017,9/17/2017,9/17/2017,9/24/2018,4/7/2019,4/7/2019,9/23/2019,9/20/2020,9/20/2020
1786,4496,6/15/1935,Male,9,80,Unknown,No,Yes,Yes,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,Other,Other,R-X,Other,3/1/2008,4/1/2008,4/1/2008,1/1/2009,12/1/2009,12/1/2009,5/1/2015,12/1/2015,12/1/2015,10/1/2016,2/1/2017,2/1/2017
1787,5891,6/15/1956,Male,186,110,Compulsory health insurance CHI,No,Yes, , , , , , , , ,Yes,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,unbekannt, , , , , , , , ,R-X,No CTx,No CTx,V-X,2/27/2017,1/30/2018,1/30/2018,11/28/2018,6/12/2019,6/12/2019, , , , , , 
1788,1856,6/15/1963,Male,999,80,Unknown,No,Yes,Yes,Yes,Yes, , , , ,Unknown, ,9,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,POM-X,Other,V-X,11/2/2011,12/1/2011,12/1/2011,6/1/2013,7/1/2014,7/1/2014,9/1/2014,12/1/2014,12/1/2014,7/1/2015,8/1/2015,8/1/2015
1789,9525,6/15/1941,Male,175,82,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes,Yes,Yes, , , , ,Unknown,1,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,10/5/2016,5/23/2017,5/23/2017, , , , , , , , , 
1790,8446,6/15/1948,Female,999,65,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , ,Yes,9,III: one or more criteria are fulfilled,IgD,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,KYP-X,No CTx,V-X,3/3/2014,6/30/2014,6/30/2014,9/19/2016,12/1/2016,12/1/2016,3/1/2017,3/31/2017, , , , 
1791,4770,6/15/1964,Female,999,65,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,I: fulfilling all 4 criteria,IgA,",69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,3/30/2015,6/18/2015,6/18/2015,3/1/2017,12/31/2017, , , , , , , 
1792,1546,6/15/1941,Male,183,92,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"4,66",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,EMP-X,DAR-X,V-X,1/31/2014,9/25/2014,9/25/2014,8/27/2015,3/1/2016,3/1/2016,3/1/2017,12/8/2017,12/8/2017,1/15/2018,1/19/2018,1/19/2018
1793,5143,6/15/1952,Female,999,65,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,R-X,KYP-X,Other,4/4/2006,6/29/2006,6/29/2006,7/22/2009,10/28/2009,10/28/2009,1/1/2014,7/2/2015,7/2/2015,3/13/2017,10/19/2018,10/19/2018
1794,7594,6/15/1948,Male,999,80,Private,Yes, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"5,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,Other,R-X,V-X,7/19/2014,10/8/2014,10/8/2014,3/29/2017,6/14/2017,6/14/2017,1/16/2019,2/4/2019,2/4/2019,2/27/2019,10/6/2019,10/6/2019
1795,3444,6/15/1935,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,3/30/2017,7/16/2017,7/16/2017,7/17/2017,12/31/2017, , , , , , , 
1796,3273,6/15/1947,Female,999,65,Private,No, , ,Yes, , , ,Yes, , ,Yes,9,III: one or more criteria are fulfilled,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,No CTx,No CTx,V-X,2/27/2015,6/8/2015,6/8/2015,3/23/2017,12/31/2017,10/14/1582, , , , , , 
1797,7789,6/15/1934,Male,9,80,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , , ,Yes,1,I: fulfilling all 4 criteria,IgA,"23,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
1798,6309,6/15/1945,Female,168,75,Compulsory health insurance CHI,Yes,Yes, ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,11/29/2016,2/28/2017,2/28/2017,7/24/2017,9/10/2017,9/10/2017, , , , , , 
1799,1619,6/15/1942,Male,163,94,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,R-X,POM-X,V-X,6/13/2016,12/10/2016,12/10/2016,1/10/2017,4/18/2017,4/18/2017,4/19/2017,6/12/2017,6/12/2017,7/13/2017,9/24/2017,9/24/2017
1800,9367,6/15/1960,Male,178,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"58,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/21/2017,7/14/2017,7/14/2017, , , , , , , , , 
1801,3406,6/15/1951,Male,162,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"3,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,2/1/2017,4/19/2017,4/19/2017,9/25/2019,9/13/2021,9/13/2021,10/11/2021,3/31/2022,10/14/1582, , , 
1802,2219,6/15/1942,Male,193,135,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,31",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,POM-X,V-X,6/30/2016,12/22/2016,12/22/2016,1/12/2017,10/10/2018,10/10/2018,1/31/2019,12/10/2019,12/10/2019,12/23/2019,12/23/2019,12/23/2019
1803,1085,6/15/1968,Male,173,107,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,33",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,4/28/2016,8/19/2016,8/19/2016,2/16/2017,9/19/2018,9/19/2018, , , , , , 
1804,5384,6/15/1968,Male,173,95,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,7",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,No CTx,No CTx,V-X,7/18/2016,11/14/2016,11/14/2016,2/2/2017,7/12/2018,7/12/2018, , , , , , 
1805,7367,6/15/1945,Male,187,114,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"4,98",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,DAR-X,No CTx,V-X,5/25/2016,11/16/2016,11/16/2016,3/8/2017,6/13/2019,6/13/2019,7/2/2019,11/29/2021,11/29/2021, , , 
1806,3713,6/15/1944,Male,187,89,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,DAR-X,No CTx,V-X,4/4/2016,7/25/2016,7/25/2016,3/21/2017,1/23/2019,1/23/2019,2/25/2019,3/18/2019,3/18/2019, , , 
1807,1198,6/15/1954,Female,168,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/15/2017,6/26/2017,6/26/2017, , , , , , , , , 
1808,1248,6/15/1946,Male,178,90,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"8,7",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,11/11/2014,10/8/2015,10/8/2015,2/8/2017,8/31/2017,8/31/2017,5/29/2018,5/31/2019,5/31/2019,6/19/2019,12/31/2019, 
1809,9995,6/15/1942,Female,165,74,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,12/9/2015,4/20/2016,4/20/2016,3/10/2017,12/12/2017,12/12/2017,2/8/2018,11/16/2018,11/16/2018,11/22/2018,5/17/2019,5/17/2019
1810,4539,6/15/1944,Female,167,84,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,KYP-X,POM-X,V-X,12/3/2013,12/19/2014,12/19/2014,8/19/2015,3/31/2016,3/31/2016,1/30/2017,9/22/2017,9/22/2017,3/22/2018,11/16/2018,11/16/2018
1811,3029,6/15/1947,Male,175,86,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"5,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,V-X,7/22/2015,1/21/2016,1/21/2016,3/20/2017,3/5/2018,3/5/2018,9/4/2018,8/16/2019,8/16/2019,8/27/2019,12/31/2019, 
1812,5157,6/15/1942,Male,174,89,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,3/21/2017,9/22/2017,9/22/2017,6/13/2018,8/23/2019,8/23/2019,9/5/2019,12/31/2019, , , , 
1813,1805,6/15/1942,Male,168,88,Private,No,Yes,Yes,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,Other type,13,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,EMP-X,KYP-X,KYP-X,V-X,10/9/2012,12/20/2012,12/20/2012,6/2/2017,12/4/2017,12/4/2017,1/8/2018,5/28/2019,5/28/2019,8/4/2021,3/31/2022,10/14/1582
1814,6222,6/15/1935,Female,158,65,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"3,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,5/11/2017,6/7/2018,6/7/2018,9/10/2019,12/31/2019, , , , , , , 
1815,9945,6/15/1932,Male,172,91,Compulsory health insurance CHI,No,Yes, , , ,Yes, ,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"4,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/29/2017,10/27/2017,10/27/2017,8/9/2018,12/31/2019, , , , , , , 
1816,5010,6/15/1950,Male,178,67,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,71,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,DAR-X,EMP-X,Other,4/15/2017,8/22/2017,8/22/2017,8/23/2017,3/25/2018,3/25/2018,9/26/2018,10/22/2019,10/22/2019,12/2/2019,11/27/2020,11/27/2020
1817,5514,6/15/1937,Female,170,76,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, ,Yes, , ,Yes, ,3,III: one or more criteria are fulfilled,IgG,"4,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,DAR-X,No CTx,V-X,3/10/2017,10/10/2017,10/10/2017,3/6/2018,6/13/2019,6/13/2019,6/27/2019,8/22/2019,8/22/2019, , , 
1818,9281,6/15/1940,Male,999,80,Private,No, , , , , , , , ,Yes,Yes,1,I: fulfilling all 4 criteria,IgA,"1,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,No CTx,V-X,4/24/2017,11/22/2017,11/22/2017,8/8/2018,11/7/2018,11/7/2018,1/28/2019,9/13/2019,9/13/2019, , , 
1819,2408,6/15/1949,Male,185,98,Compulsory health insurance CHI,Yes,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,23,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,POM-X,DAR-X,Other,4/12/2017,9/12/2017,9/12/2017,9/21/2017,9/13/2018,9/13/2018,6/12/2019,12/2/2019,12/2/2019,12/19/2019,6/25/2020,6/25/2020
1820,7060,6/15/1940,Male,187,90,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"1,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,EMP-X,KYP-X,No CTx,V-X,6/26/2017,4/24/2018,4/24/2018,5/29/2018,8/5/2019,8/5/2019,9/2/2019,9/3/2019,9/3/2019, , , 
1821,5394,6/15/1945,Female,167,51,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,2/27/2015,5/27/2016,5/27/2016,6/8/2016,2/6/2017,2/6/2017,5/16/2017,6/9/2017,6/9/2017,7/17/2017,1/10/2018,1/10/2018
1822,5750,6/15/1939,Male,178,95,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,V-X,V-X,EMP-X,V-X,7/9/2013,7/7/2014,7/7/2014,6/8/2015,5/30/2016,5/30/2016,5/8/2017,7/17/2017,7/17/2017,8/14/2017,5/3/2021,5/3/2021
1823,5267,6/15/1957,Male,173,60,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,11/24/2015,7/20/2016,7/20/2016,2/2/2017,10/12/2017,10/12/2017,1/4/2018,1/4/2018,1/4/2018, , , 
1824,5906,6/15/1951,Male,184,88,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,EMP-X,EMP-X,Other,4/9/2017,2/28/2018,2/28/2018,3/29/2018,7/20/2018,7/20/2018,9/11/2019,12/18/2020,12/18/2020,12/20/2020,12/2/2021,12/2/2021
1825,7364,6/15/1950,Female,168,72,Compulsory health insurance CHI,Yes, , , ,Yes, ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,21,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,NIN-X,EMP-X,V-X,4/19/2017,9/19/2017,9/19/2017,9/30/2017,6/29/2018,6/29/2018,6/11/2019,2/20/2020,2/20/2020,3/20/2020,6/18/2021,6/18/2021
1826,2032,6/15/1951,Female,170,76,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,35,ISS stage II (neither stage I nor stage III), , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,KYP-X,EMP-X,V-X,6/22/2017,12/29/2017,12/29/2017,3/4/2018,11/28/2018,11/28/2018,11/30/2018,8/8/2019,8/8/2019,9/23/2019,6/15/2020,6/15/2020
1827,2616,6/15/1944,Female,169,65,Compulsory health insurance CHI,Unknown, , ,Yes, ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,"30,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/4/2017,5/24/2017,5/24/2017, , , , , , , , , 
1828,8063,6/15/1960,Male,182,93,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,V-X,POM-X,Other,3/26/2007,6/9/2007,6/9/2007,10/8/2012,1/2/2013,1/2/2013,3/1/2014,6/26/2014,6/26/2014,11/18/2014,3/15/2015,3/15/2015
1829,7751,6/15/1932,Male,177,86,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,1",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,EMP-X,V-X,V-X,2/25/2015,11/11/2015,11/11/2015,11/18/2015,1/6/2017,1/6/2017,1/10/2017,11/15/2017,11/15/2017,1/16/2018,2/5/2018,2/5/2018
1830,1355,6/15/1947,Male,169,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,38,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,EMP-X,DAR-X,R-X,12/1/2012,3/15/2013,3/15/2013,9/12/2016,12/28/2016,12/28/2016,1/30/2017,1/17/2018,1/17/2018,6/25/2018,4/29/2019,4/29/2019
1831,3366,6/15/1952,Male,183,88,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,I: fulfilling all 4 criteria,IgG,20,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,ISA-X,No CTx,V-X,1/16/2017,3/30/2017,3/30/2017,8/8/2019,10/7/2021,10/7/2021,11/18/2021,3/31/2022,10/14/1582, , , 
1832,3544,6/15/1936,Female,166,78,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,24,unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,1/16/2016,4/15/2017,4/15/2017,6/14/2017,6/30/2017, , , , , , , 
1833,2571,6/15/1939,Female,168,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,22,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,1/15/2017,7/28/2017,7/28/2017,12/13/2019,6/30/2020, , , , , , , 
1834,6823,6/15/1939,Male,190,100,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,21,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/24/2017,7/17/2017,7/17/2017, , , , , , , , , 
1835,6926,6/15/1946,Male,170,75,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,34,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,1/15/2013,9/15/2013,9/15/2013,2/15/2016,1/15/2017,1/15/2017, , , , , , 
1836,9997,6/15/1957,Female,165,106,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"42,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie, , , , , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/29/2017,7/10/2017,7/10/2017,10/15/2020,3/31/2022,10/14/1582, , , , , , 
1837,2922,6/15/1936,Female,164,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,15,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,POM-X,No CTx,V-X,1/5/2017,3/30/2017,3/30/2017,4/20/2017,7/15/2019,7/15/2019,7/31/2019,9/20/2019,9/20/2019, , , 
1838,3799,6/15/1946,Female,170,65,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"22,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/6/2017,8/1/2018,8/1/2018, , , , , , , , , 
1839,8630,6/15/1946,Male,178,115,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,57,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,DAR-X,KYP-X,ISA-X,V-X,5/15/2017,5/30/2018,5/30/2018,6/14/2018,3/2/2021,3/2/2021,3/29/2021,6/24/2021,6/24/2021,7/22/2021,10/12/2021,10/12/2021
1840,2317,6/15/1941,Male,179,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,25,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,7/15/2015,10/1/2016,10/1/2016,2/15/2017,12/31/2017, , , , , , , 
1841,8534,6/15/1950,Female,179,82,Compulsory health insurance CHI,No, , , , , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"90,2",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Unknown,Unknown,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,DAR-X,KYP-X,No CTx,V-X,6/15/2017,10/10/2017,10/10/2017,5/28/2020,9/15/2020,9/15/2020,10/6/2020,12/12/2020,12/12/2020, , , 
1842,4076,6/15/1935,Male,170,86,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,30,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,1/15/2017,8/1/2017,8/1/2017, , , , , , , , , 
1843,6559,6/15/1945,Male,172,77,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,27,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,6/9/2017,11/21/2017,11/21/2017,6/3/2019,3/31/2022, , , , , , , 
1844,6877,6/15/1934,Female,160,47,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"55,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
1845,7226,6/15/1959,Female,9,65,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"14,31",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,DAR-X,KYP-X,V-X,10/26/2010,3/11/2011,3/11/2011,3/17/2014,1/16/2017,1/16/2017,4/3/2017,9/11/2017,9/11/2017,10/9/2017,8/27/2019,8/27/2019
1846,9968,6/15/1945,Male,153,60,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,39",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,5/2/2017,2/7/2018,2/7/2018,2/20/2018,6/16/2020,6/16/2020,7/1/2020,2/23/2021,2/23/2021, , , 
1847,2723,6/15/1933,Male,185,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,EMP-X,No CTx,R-X,5/5/2017,7/10/2018,7/10/2018,2/19/2020,12/10/2021,12/10/2021,2/10/2022,3/31/2022, , , , 
1848,5397,6/15/1945,Female,153,60,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgA,"2,2",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,Unknown,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,KYP-X,R-X,POM-X,V-X,4/27/2017,1/5/2018,1/5/2018,3/20/2018,1/31/2019,1/31/2019,2/27/2019,5/29/2019,5/29/2019,6/26/2019,7/29/2019,7/29/2019
1849,1040,6/15/1947,Male,171,90,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,3,ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,5/30/2017,9/12/2017,9/12/2017,9/13/2019,12/30/2019,12/30/2019,1/7/2020,5/1/2020,5/1/2020,5/29/2020,10/2/2020,10/2/2020
1850,4441,6/15/1942,Male,165,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,35",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,No CTx,R-X,6/22/2017,6/15/2018,6/15/2018,2/17/2021,8/2/2021,8/2/2021,8/16/2021,3/31/2022,10/14/1582, , , 
1851,7539,6/15/1949,Male,173,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,4/21/2017,9/29/2017,9/29/2017,3/6/2020,12/2/2021,12/2/2021,1/25/2022,3/31/2022, , , , 
1852,1878,6/15/1947,Female,174,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,19",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,DAR-X,POM-X,V-X,V-X,5/1/2017,9/6/2017,9/6/2017,7/10/2019,1/14/2021,1/14/2021,1/30/2021,9/8/2021,9/8/2021,9/20/2021,10/15/2021,10/15/2021
1853,5909,6/15/1964,Male,160,58,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"15,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,5/26/2017,5/19/2018,5/19/2018,3/21/2022,3/31/2022, , , , , , , 
1854,1604,6/15/1949,Male,176,100,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,6/19/2017,2/23/2018,2/23/2018,3/6/2018,1/2/2020,1/2/2020,5/5/2020,12/31/2020, , , , 
1855,9501,6/15/1967,Male,171,91,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,77",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/1/2017,9/7/2017,9/7/2017,9/30/2019,12/31/2020,10/14/1582, , , , , , 
1856,4169,6/15/1948,Male,182,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"7,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,KYP-X,No CTx,V-X,5/4/2017,1/10/2018,1/10/2018,1/30/2018,7/17/2018,7/17/2018,8/6/2018,6/12/2020,6/12/2020, , , 
1857,7638,6/15/1932,Female,164,45,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/20/2017,4/13/2018,4/13/2018, , , , , , , , , 
1858,1143,6/15/1944,Female,167,50,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,65",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/18/2017,8/22/2017,8/22/2017, , , , , , , , , 
1859,1626,6/15/1934,Female,173,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"17,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/15/2017,9/28/2017,9/28/2017, , , , , , , , , 
1860,8969,6/15/1937,Male,178,76,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/15/2017,10/23/2017,10/23/2017,10/17/2020,12/31/2020,10/14/1582, , , , , , 
1861,4465,6/15/1943,Male,172,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,01",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,6/2/2017,6/13/2018,6/13/2018,12/12/2019,9/30/2020,10/14/1582, , , , , , 
1862,7374,6/15/1942,Male,167,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,01",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,R-X,4/10/2017,1/4/2018,1/4/2018,1/18/2018,1/2/2020,1/2/2020,5/18/2020,12/31/2020, , , , 
1863,5636,6/15/1951,Male,172,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,94",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/3/2017,9/18/2017,9/18/2017, , , , , , , , , 
1864,4396,6/15/1952,Female,172,94,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,24",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,4/14/2017,10/3/2017,10/3/2017,2/6/2018,11/19/2019,11/19/2019,9/11/2020,9/30/2020, , , , 
1865,4236,6/15/1950,Male,175,104,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,4/20/2017,12/14/2017,12/14/2017,12/27/2017,12/31/2020,10/14/1582, , , , , , 
1866,7289,6/15/1948,Female,161,53,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/23/2017,10/6/2017,10/6/2017, , , , , , , , , 
1867,6358,6/15/1947,Female,171,69,Private,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,34",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,POM-X,KYP-X,V-X,6/7/2017,10/5/2017,10/5/2017,1/23/2020,12/26/2020,12/26/2020,1/17/2021,7/29/2021,7/29/2021,8/18/2021,3/31/2022,10/14/1582
1868,1654,6/15/1951,Male,169,50,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,75",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,POM-X,No CTx,V-X,5/9/2017,12/12/2017,12/12/2017,1/4/2018,1/2/2020,1/2/2020,1/10/2020,12/31/2021, , , , 
1869,6176,6/15/1943,Male,177,73,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,39",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/15/2017,10/24/2017,10/24/2017, , , , , , , , , 
1870,7920,6/15/1951,Male,168,81,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,57",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/12/2017,9/26/2017,9/26/2017, , , , , , , , , 
1871,7830,6/15/1942,Male,167,63,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,89",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,DAR-X,No CTx,V-X,5/1/2017,3/20/2018,3/20/2018,5/21/2020,5/14/2021,5/14/2021,3/2/2022,3/31/2022, , , , 
1872,5692,6/15/1943,Male,177,92,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,31",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,5/4/2017,4/27/2018,4/27/2018,6/14/2021,7/12/2021,7/12/2021, , , , , , 
1873,6747,6/15/1945,Female,157,49,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,04",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/12/2017,9/8/2017,9/8/2017, , , , , , , , , 
1874,4003,6/15/1928,Female,173,66,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,8",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,DAR-X,V-X,No CTx,V-X,4/18/2017,8/15/2017,8/15/2017,11/21/2020,9/16/2021,9/16/2021,9/23/2021,3/31/2022, , , , 
1875,4721,6/15/1964,Female,180,111,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,94",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/10/2017,9/26/2017,9/26/2017, , , , , , , , , 
1876,1968,6/15/1942,Male,189,98,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,48",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/19/2017,10/2/2017,10/2/2017,3/6/2019,6/30/2020,6/30/2020, , , , , , 
1877,6795,6/15/1947,Female,163,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/9/2017,8/21/2017,8/21/2017, , , , , , , , , 
1878,7620,6/15/1945,Female,151,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,75",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,4/14/2017,6/26/2020,6/26/2020, , , , , , , , , 
1879,9374,6/15/1944,Male,180,55,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,24",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,LEV-X,4/21/2017,10/25/2017,10/25/2017,11/16/2017,6/6/2019,6/6/2019, , , , , , 
1880,2856,6/15/1945,Female,170,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,05",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/19/2017,10/16/2017,10/16/2017,5/24/2019,9/30/2020,10/14/1582, , , , , , 
1881,8916,6/15/1952,Male,182,89,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,82",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,4/6/2017,12/19/2017,12/19/2017,12/28/2017,4/22/2019,4/22/2019,4/29/2019,5/14/2019,5/14/2019, , , 
1882,4204,6/15/1942,Male,159,63,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"27,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,5/24/2017,1/4/2018,1/4/2018,1/25/2018,9/30/2020,10/14/1582, , , , , , 
1883,6444,6/15/1938,Male,172,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"72,32",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,6/30/2017,12/31/2017, , , , , , , , , , 
1884,5005,6/15/1956,Male,176,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"42,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,R-X,DAR-X,V-X,2/10/2017,5/15/2017,5/15/2017,5/24/2017,7/31/2017,7/31/2017,7/31/2018,1/22/2019,1/22/2019,1/2/2020,6/15/2020,6/15/2020
1885,5709,6/15/1935,Female,158,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"39,4",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,5/8/2017,7/15/2017,7/15/2017,9/30/2020,6/1/2021,6/1/2021, , , , , , 
1886,8516,6/15/1952,Male,179,57,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,75",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,NIN-X,V-X,6/12/2017,9/25/2017,9/25/2017,6/4/2018,12/3/2018,12/3/2018,1/24/2019,5/2/2019,5/2/2019,5/9/2019,6/6/2019,6/6/2019
1887,1903,6/15/1943,Male,188,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,57,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,4/18/2017,12/31/2017, , , , , , , , , , 
1888,5035,6/15/1946,Female,160,47,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics,Yes,Yes,No,No,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,6/30/2017,2/6/2018,2/6/2018, , , , , , , , , 
1889,2746,6/15/1942,Male,173,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"12,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/1/2017,6/7/2018,6/7/2018,12/6/2021,3/31/2022, , , , , , , 
1890,3276,6/15/1952,Female,167,70,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,19",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,R-X,4/13/2017,3/4/2019,3/4/2019,1/23/2020,8/24/2021,8/24/2021, , , , , , 
1891,1074,6/15/1943,Male,179,81,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,6/8/2017,1/10/2019,1/10/2019,3/14/2019,1/2/2020,1/2/2020,5/19/2020,3/31/2022,10/14/1582, , , 
1892,4560,6/15/1943,Male,175,87,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,53",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/5/2017,6/11/2018,6/11/2018,11/30/2020,3/31/2022,10/14/1582, , , , , , 
1893,8363,6/15/1946,Male,178,66,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,4/20/2017,8/3/2017,8/3/2017,2/15/2018,8/15/2018,8/15/2018,9/4/2018,5/13/2019,5/13/2019,2/23/2020,10/6/2020,10/6/2020
1894,8808,6/15/1930,Male,176,69,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,58",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,LEV-X,LEV-X,6/16/2017,11/14/2017,11/14/2017,11/28/2017,12/10/2018,12/10/2018,3/19/2019,7/9/2019,7/9/2019,7/23/2019,12/18/2019,12/18/2019
1895,8746,6/15/1948,Female,164,48,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,91",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,4/11/2017,9/28/2017,9/28/2017,3/13/2018,3/6/2019,3/6/2019, , , , , , 
1896,4553,6/15/1949,Male,189,86,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,25",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,4/26/2017,8/16/2018,8/16/2018,9/4/2018,3/31/2022,10/14/1582, , , , , , 
1897,2936,6/15/1959,Male,167,67,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,22,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/22/2017,5/28/2018,5/28/2018, , , , , , , , , 
1898,9377,6/15/1952,Female,169,91,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,NIN-X,POM-X,V-X,5/8/2017,7/5/2018,7/5/2018,7/19/2018,12/25/2018,12/25/2018,3/28/2019,5/31/2019,5/31/2019,6/13/2019,6/18/2019,6/18/2019
1899,8692,6/15/1944,Female,164,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,54",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/3/2017,8/17/2017,8/17/2017,8/28/2019,6/17/2020,6/17/2020,7/5/2020,12/18/2020,12/18/2020, , , 
1900,3048,6/15/1939,Male,178,75,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,4/18/2017,6/21/2018,6/21/2018,7/11/2018,6/18/2021,6/18/2021, , , , , , 
1901,5746,6/15/1944,Female,167,53,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,88",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/22/2017,11/2/2017,11/2/2017, , , , , , , , , 
1902,7774,6/15/1947,Female,151,51,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/4/2017,9/7/2017,9/7/2017, , , , , , , , , 
1903,4460,6/15/1944,Male,178,70,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/24/2017,6/26/2018,6/26/2018,7/16/2018,6/15/2020,6/15/2020, , , , , , 
1904,8239,6/15/1948,Male,197,74,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,POM-X,No CTx,V-X,5/3/2017,1/4/2018,1/4/2018,1/18/2018,7/5/2018,7/5/2018,1/7/2019,10/9/2019,10/9/2019, , , 
1905,8354,6/15/1942,Female,162,52,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,42",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/22/2017,6/4/2018,6/4/2018, , , , , , , , , 
1906,4439,6/15/1951,Female,174,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,42","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,5/2/2017,8/16/2017,8/16/2017,3/13/2018,6/30/2021,10/14/1582, , , , , , 
1907,3475,6/15/1944,Male,178,70,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"3,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,5/3/2017,6/26/2018,6/26/2018,7/12/2018,8/31/2018,8/31/2018, , , , , , 
1908,5257,6/15/1947,Male,174,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,KYP-X,No CTx,R-X,5/9/2017,1/23/2019,1/23/2019,3/12/2019,11/8/2020,11/8/2020,12/2/2020,3/31/2022,10/14/1582, , , 
1909,1006,6/15/1943,Female,175,76,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"14,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,5/11/2017,6/19/2019,6/19/2019,1/6/2020,7/13/2020,7/13/2020, , , , , , 
1910,3957,6/15/1946,Male,179,58,Private,No, , , , , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,97",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,V-X,V-X,V-X,5/4/2017,6/19/2018,6/19/2018,10/3/2018,3/6/2019,3/6/2019,3/29/2019,9/13/2019,9/13/2019,5/28/2020,12/3/2020,12/3/2020
1911,2833,6/15/1937,Female,999,65,Private,No,Yes,Yes, ,Yes, , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,Other,R-X,Other,6/16/2011,6/19/2011,6/19/2011,7/15/2011,8/15/2011,8/15/2011,8/30/2011,3/25/2012,3/25/2012,6/18/2013,9/3/2015,9/3/2015
1912,2643,6/15/1951,Male,183,76,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,87","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,4/17/2017,4/10/2018,4/10/2018,8/2/2021,3/31/2022,10/14/1582, , , , , , 
1913,6023,6/15/1971,Male,182,84,Private,No, , ,Yes,Yes, , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,4550,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/8/2017,6/30/2017, , , , , , , , , , 
1914,4521,6/15/1945,Female,166,61,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,22",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,NIN-X,KYP-X,V-X,V-X,4/21/2017,9/29/2017,9/29/2017,11/5/2018,6/6/2019,6/6/2019,6/14/2019,7/2/2019,7/2/2019,7/24/2019,1/29/2020,1/29/2020
1915,3915,6/15/1951,Male,179,84,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,5/11/2017,6/27/2018,6/27/2018,7/9/2018,3/31/2022,10/14/1582, , , , , , 
1916,1041,6/15/1947,Female,161,52,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,2",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/14/2017,8/22/2017,8/22/2017,2/20/2018,12/31/2021,10/14/1582, , , , , , 
1917,5622,6/15/1942,Female,158,63,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, ,Yes, , ,2,I: fulfilling all 4 criteria,IgA,"2,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,EMP-X,No CTx,V-X,4/27/2017,8/11/2017,8/11/2017,3/27/2018,1/2/2020,1/2/2020,4/21/2020,6/30/2021,10/14/1582, , , 
1918,3216,6/15/1967,Female,172,106,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,3",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/3/2017,10/11/2017,10/11/2017,2/21/2018,12/31/2021,10/14/1582, , , , , , 
1919,9253,6/15/1944,Female,168,69,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"16,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,5/22/2017,9/4/2017,9/4/2017,2/5/2018,7/28/2020,7/28/2020,8/22/2020,3/4/2021,3/4/2021, , , 
1920,6258,6/15/1959,Female,162,101,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,4772,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,10/5/2015,12/21/2015,12/21/2015,4/13/2017,6/30/2017,10/14/1582, , , , , , 
1921,4336,6/15/1963,Male,183,107,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,82",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,5/16/2017,1/14/2019,1/14/2019,2/27/2019,3/31/2022,10/14/1582, , , , , , 
1922,3748,6/15/1950,Female,167,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,85",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,4/10/2017,11/8/2017,11/8/2017,11/22/2017,4/30/2019,4/30/2019,5/14/2019,6/30/2021,6/30/2021,7/9/2021,3/31/2022, 
1923,1334,6/15/1945,Female,161,66,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"15,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,NIN-X,LEV-X,4/28/2017,10/25/2017,10/25/2017,11/9/2017,10/17/2018,10/17/2018,11/29/2018,11/9/2020,11/9/2020,11/16/2020,9/8/2021,9/8/2021
1924,7976,6/15/1962,Male,175,77,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/19/2017,10/3/2017,10/3/2017, , , , , , , , , 
1925,2298,6/15/1947,Male,188,101,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,09",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,4/10/2017,7/19/2020,7/19/2020,8/5/2020,3/31/2022,10/14/1582, , , , , , 
1926,5442,6/15/1943,Female,175,76,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"22,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/28/2017,12/22/2017,12/22/2017, , , , , , , , , 
1927,6638,6/15/1949,Male,177,78,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,28",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,5/2/2017,1/2/2019,1/2/2019,1/28/2020,3/31/2022,10/14/1582, , , , , , 
1928,1671,6/15/1945,Female,163,49,Private,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"15,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,4/6/2017,9/25/2017,9/25/2017,1/10/2019,3/31/2022,10/14/1582, , , , , , 
1929,1278,6/15/1945,Male,186,65,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,49",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/8/2017,3/19/2018,3/19/2018, , , , , , , , , 
1930,2450,6/15/1946,Female,168,60,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"18,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,V-X,NIN-X,V-X,R-X,6/16/2017,7/5/2018,7/5/2018,5/23/2020,7/16/2020,7/16/2020,7/29/2020,7/19/2021,7/19/2021,8/18/2021,3/31/2022, 
1931,7469,6/15/1938,Male,168,66,Private,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,POM-X,DAR-X,LEV-X,4/4/2017,10/12/2017,10/12/2017,2/8/2018,2/28/2019,2/28/2019,3/26/2019,8/6/2020,8/6/2020,8/27/2020,7/23/2021,7/23/2021
1932,1119,6/15/1945,Female,162,60,Private,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,31",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/30/2017,7/30/2017,7/30/2017,3/9/2022,3/31/2022, , , , , , , 
1933,6051,6/15/1947,Male,170,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,8",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,NIN-X,No CTx,R-X,5/24/2017,2/27/2018,2/27/2018,3/13/2018,11/14/2019,11/14/2019,8/5/2021,3/31/2022, , , , 
1934,3940,6/15/1946,Female,165,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,98",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,No CTx,V-X,5/2/2017,10/10/2017,10/10/2017,2/20/2020,2/12/2021,2/12/2021,10/7/2021,3/31/2022, , , , 
1935,4703,6/15/1929,Male,174,56,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,39",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,DAR-X,V-X,4/14/2017,10/3/2017,10/3/2017,3/22/2018,12/12/2018,12/12/2018,12/27/2018,9/30/2019,9/30/2019,12/5/2019,1/13/2021,1/13/2021
1936,5152,6/15/1945,Female,162,60,Private,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,15",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/8/2017,4/8/2019,4/8/2019,7/16/2019,1/6/2021,1/6/2021, , , , , , 
1937,1398,6/15/1952,Female,169,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,86",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/18/2017,3/20/2018,3/20/2018, , , , , , , , , 
1938,2461,6/15/1947,Female,167,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgA,"1,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,POM-X,No CTx,V-X,5/10/2017,3/14/2018,3/14/2018,3/28/2018,12/11/2018,12/11/2018,1/25/2019,3/20/2019,3/20/2019, , , 
1939,2290,6/15/1944,Male,177,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,6/1/2017,6/13/2018,6/13/2018,6/4/2020,11/15/2021,11/15/2021, , , , , , 
1940,1268,6/15/1970,Male,184,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"2,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,DAR-X,No CTx,V-X,5/13/2013,9/25/2013,9/25/2013, , , ,3/11/2019,3/31/2019, , , , 
1941,3031,6/15/1952,Female,174,58,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,92",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/2/2017,8/14/2018,8/14/2018, , , , , , , , , 
1942,6700,6/15/1948,Female,162,49,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"24,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,NIN-X,No CTx,No CTx,LEV-X,3/30/2017,9/26/2017,9/26/2017,10/17/2017,11/6/2017,11/6/2017, , , , , , 
1943,4359,6/15/1937,Male,163,52,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,6",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/31/2017,12/21/2017,12/21/2017, , , , , , , , , 
1944,6537,6/15/1949,Male,186,86,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,NIN-X,POM-X,No CTx,V-X,6/16/2017,11/24/2017,11/24/2017,1/29/2019,1/2/2020,1/2/2020,5/19/2020,9/14/2021,9/14/2021, , , 
1945,8104,6/15/1946,Female,168,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,POM-X,DAR-X,V-X,4/3/2017,8/15/2018,8/15/2018,8/30/2018,3/6/2019,3/6/2019,3/7/2019,3/19/2019,3/19/2019,5/22/2019,1/23/2021,1/23/2021
1946,5223,6/15/1945,Male,186,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,8",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,DAR-X,No CTx,V-X,5/15/2017,10/30/2017,10/30/2017,7/30/2018,8/23/2021,8/23/2021,9/8/2021,3/31/2022,10/14/1582, , , 
1947,9914,6/15/1947,Male,169,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,89",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,NIN-X,No CTx,No CTx,V-X,5/1/2017,12/14/2017,12/14/2017,12/28/2017,6/11/2018,6/11/2018, , , , , , 
1948,7117,6/15/1943,Male,173,78,Private,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,89",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,EMP-X,V-X,5/8/2017,10/9/2017,10/9/2017,7/9/2019,2/24/2020,2/24/2020,3/3/2020,6/2/2021,6/2/2021,6/14/2021,8/30/2021,8/30/2021
1949,1726,6/15/1932,Female,165,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,LEV-X,5/11/2017,11/13/2017,11/13/2017,11/28/2017,9/5/2019,9/5/2019, , , , , , 
1950,1097,6/15/1945,Male,180,105,Unknown,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,9,III: one or more criteria are fulfilled,IgA,",12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/7/2017,4/26/2017,4/26/2017, , , , , , , , , 
1951,8223,6/15/1949,Female,164,69,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"16,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,6/8/2017,2/2/2018,2/2/2018,2/27/2018,12/31/2021,10/14/1582, , , , , , 
1952,8519,6/15/1947,Male,201,94,Private,No, ,Yes,Yes,Yes, , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,97",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No,"2,31", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,KYP-X,R-X,POM-X,R-X,5/2/2017,11/6/2017,11/6/2017,11/16/2017,5/16/2019,5/16/2019,6/26/2019,6/29/2020,6/29/2020,2/25/2021,12/31/2021, 
1953,1361,6/15/1930,Female,155,60,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,4/13/2017,9/27/2017,9/27/2017,10/4/2018,2/13/2020,2/13/2020,8/13/2021,3/31/2022, , , , 
1954,5422,6/15/1932,Female,152,54,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,89",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,LEV-X,4/20/2017,9/28/2017,9/28/2017,10/12/2017,11/7/2018,11/7/2018, , , , , , 
1955,3104,6/15/1947,Male,201,94,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,81",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,5/8/2017,8/21/2018,8/21/2018, , , , , , , , , 
1956,6532,6/15/1949,Male,178,100,Private,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,85",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,5/1/2017,10/2/2017,10/2/2017,2/14/2018,2/8/2019,2/8/2019,2/15/2019,5/6/2019,5/6/2019,6/25/2019,7/4/2019,7/4/2019
1957,5968,6/15/1944,Female,174,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,64",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,4/20/2017,5/9/2018,5/9/2018,9/6/2020,3/31/2022,10/14/1582, , , , , , 
1958,6936,6/15/1944,Female,174,65,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,69",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/22/2017,11/28/2018,11/28/2018, , , , , , , , , 
1959,7829,6/15/1935,Male,171,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/8/2017,8/22/2018,8/22/2018, , , , , , , , , 
1960,6411,6/15/1944,Female,179,83,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,06",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,5/18/2017,2/27/2018,2/27/2018,3/16/2018,12/31/2021,10/14/1582, , , , , , 
1961,8110,6/15/1950,Male,178,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,29",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/21/2017,10/4/2017,10/4/2017, , , , , , , , , 
1962,5861,6/15/1948,Female,168,76,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,4/10/2017,9/29/2017,9/29/2017,3/5/2018,9/25/2019,9/25/2019, , , , , , 
1963,9448,6/15/1942,Female,160,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,15",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,POM-X,No CTx,V-X,5/11/2017,10/19/2017,10/19/2017,5/16/2019,11/20/2020,11/20/2020,12/13/2020,7/20/2021,7/20/2021, , , 
1964,6837,6/15/1942,Female,162,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,V-X,DAR-X,LEV-X,5/29/2017,10/17/2017,10/17/2017,11/6/2017,12/11/2018,12/11/2018,1/24/2019,4/23/2019,4/23/2019,5/27/2019,6/30/2020,10/14/1582
1965,8684,6/15/1937,Male,176,86,Unknown,No, , , , , , , , , , ,9,Unknown,IgA,",93",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,6/20/2017,6/30/2017, , , , , , , , , , 
1966,6383,6/15/1952,Female,170,58,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"29,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,DAR-X,No CTx,V-X,4/26/2017,10/11/2017,10/11/2017,5/6/2020,11/17/2020,11/17/2020,11/24/2020,7/9/2021,7/9/2021, , , 
1967,9103,6/15/1953,Male,175,97,Unknown,No,Yes,Yes,Yes, , , , , ,Yes, ,9,III: one or more criteria are fulfilled,IgG,"3,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/13/2017,6/30/2017,10/14/1582, , , , , , , , , 
1968,9650,6/15/1944,Male,165,61,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,21",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/12/2017,8/16/2018,8/16/2018,2/28/2019,2/21/2020,2/21/2020,3/2/2021,6/30/2021, , , , 
1969,1086,6/15/1951,Male,187,117,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,03","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,4/17/2017,9/25/2017,9/25/2017,3/10/2022,3/31/2022, , , , , , , 
1970,9419,6/15/1929,Male,180,63,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,84",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,POM-X,V-X,4/14/2017,9/29/2017,9/29/2017,4/3/2018,5/23/2019,5/23/2019,6/28/2019,7/13/2019,7/13/2019,7/23/2019,11/28/2020,11/28/2020
1971,3604,6/15/1944,Male,178,90,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/1/2017,10/9/2017,10/9/2017,12/9/2019,6/23/2021,6/23/2021, , , , , , 
1972,8934,6/15/1950,Female,163,51,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,92",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,KYP-X,R-X,4/4/2017,1/24/2018,1/24/2018,2/7/2018,9/30/2020,9/30/2020,10/8/2020,6/18/2021,6/18/2021,7/12/2021,8/29/2021,8/29/2021
1973,3605,6/15/1950,Female,174,99,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,5",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,3/30/2017,9/21/2017,9/21/2017,2/20/2018,1/2/2020,1/2/2020,4/21/2020,11/28/2020,11/28/2020,12/9/2020,8/30/2021,8/30/2021
1974,4338,6/15/1946,Male,164,72,Private,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,76",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,4/14/2017,10/3/2017,10/3/2017,2/2/2018,2/8/2018,2/8/2018,3/5/2018,3/12/2020,3/12/2020,5/20/2020,8/10/2020,8/10/2020
1975,5868,6/15/1952,Female,165,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,47",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,5/17/2017,11/9/2017,11/9/2017, , , , , , , , , 
1976,8036,6/15/1960,Female,170,68,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,III: one or more criteria are fulfilled,Other type,2112,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,3/21/2017,5/19/2017,5/19/2017,5/30/2017,12/31/2017, , , , , , , 
1977,2007,6/15/1953,Female,178,71,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,6900,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/8/2017,6/18/2017,6/18/2017, , , , , , , , , 
1978,5095,6/15/1935,Female,165,75,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,I: fulfilling all 4 criteria,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,1/15/2016,10/15/2016,10/15/2016,5/15/2017,8/3/2021,8/3/2021,9/7/2021,3/31/2022, , , , 
1979,1317,6/15/1958,Male,183,78,Unknown,No, , ,Yes, ,Yes,Yes, , ,Yes,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,4/5/2017,6/30/2017, , , , , , , , , , 
1980,2446,6/15/1944,Female,165,77,Unknown,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"1,21","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/14/2017,6/30/2017, , , , , , , , , , 
1981,5079,6/15/1948,Female,160,82,Unknown,No, , , , , ,Yes, , ,Yes,Yes,9,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/19/2017,6/30/2017, , , , , , , , , , 
1982,1315,6/15/1929,Female,164,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,31,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,POM-X,No CTx,V-X,8/15/2013,2/1/2014,2/1/2014,8/3/2015,1/8/2017,1/8/2017,2/15/2017,7/1/2018,7/1/2018, , , 
1983,3412,6/15/2014,Male,180,86,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,48,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,POM-X,No CTx,V-X,4/1/2015,8/1/2015,8/1/2015,8/1/2016,12/15/2016,12/15/2016,1/8/2017,2/13/2017,2/13/2017, , , 
1984,1014,6/15/1961,Male,178,84,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/11/2017,6/21/2017,6/21/2017, , , , , , , , , 
1985,3200,6/15/1952,Female,168,80,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"42,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,No CTx,No CTx,V-X,9/21/2010,11/23/2010,11/23/2010,3/21/2017,7/21/2017,7/21/2017, , , , , , 
1986,3884,6/15/1957,Male,202,117,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,65,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,KYP-X,V-X,9/8/2014,10/31/2014,10/31/2014,3/23/2017,9/14/2017,9/14/2017,4/10/2018,5/29/2018,5/29/2018,6/5/2018,9/26/2018,9/26/2018
1987,5009,6/15/1956,Male,186,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,Other type,",4",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,KYP-X,NIN-X,V-X,11/5/2013,12/23/2013,12/23/2013,9/19/2016,1/4/2017,1/4/2017,3/23/2017,11/16/2017,11/16/2017,11/30/2017,2/24/2018,2/24/2018
1988,9875,6/15/1963,Female,161,69,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"52,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,3/16/2017,5/18/2017,5/18/2017,4/20/2021,3/31/2022,10/14/1582, , , , , , 
1989,7135,6/15/1954,Male,186,91,Private,No, , , , ,Yes, ,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,Other type,"1,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,KYP-X,POM-X,V-X,3/9/2017,5/11/2017,5/11/2017,6/12/2018,10/11/2018,10/11/2018,10/24/2018,12/15/2018,12/15/2018,1/8/2019,11/4/2019,11/4/2019
1990,6194,6/15/1954,Male,177,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,KYP-X,V-X,7/7/2014,10/16/2014,10/16/2014,11/11/2015,1/22/2016,1/22/2016,5/3/2016,3/8/2017,3/8/2017,3/21/2017,7/4/2017,7/4/2017
1991,3085,6/15/1936,Male,175,69,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,3",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,6/19/2017,12/10/2017,12/10/2017, , , , , , , , , 
1992,2015,6/15/1960,Female,168,81,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"4,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,6/8/2017,8/13/2017,8/13/2017,9/20/2021,11/7/2021,11/7/2021, , , , , , 
1993,4518,6/15/1935,Male,181,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,LEV-X,DAR-X,LEV-X,6/12/2017,11/26/2017,11/26/2017,3/11/2019,12/15/2019,12/15/2019,12/16/2019,6/14/2020,6/14/2020,3/15/2021,9/26/2021,9/26/2021
1994,6045,6/15/1956,Male,999,80,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"3,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,4/12/2010,6/28/2010,6/28/2010,7/9/2013,2/19/2014,2/19/2014,4/13/2016,6/28/2017,6/28/2017, , , 
1995,2932,6/15/1943,Female,149,85,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"5,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/13/2017,4/21/2017,4/21/2017, , , , , , , , , 
1996,9064,6/15/1954,Female,172,83,Unknown,No, , ,Yes, , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgA,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , ,Nein,No CTx,No CTx,No CTx,V-X,2/27/2017,5/19/2017,5/19/2017, , , , , , , , , 
1997,9817,6/15/1945,Male,178,77,Private,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,",11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,R-X,POM-X,V-X,5/25/2011,7/18/2011,7/18/2011,6/11/2015,7/22/2015,7/22/2015,3/7/2016,5/3/2016,5/3/2016,8/16/2016,1/3/2017,1/3/2017
1998,9896,6/15/1934,Female,999,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,Unknown,IgG,"6,83",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/17/2017,6/11/2017,6/11/2017, , , , , , , , , 
1999,1160,6/15/1939,Female,163,71,Unknown,Unknown,Yes,Yes,Yes,Yes, , , ,Yes,Yes, ,9,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/23/2017,8/3/2017,8/3/2017, , , , , , , , , 
2000,7112,6/15/1946,Male,163,87,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"2,58",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/12/2016,6/29/2017,6/29/2017, , , , , , , , , 
2001,2875,6/15/1941,Female,162,64,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"2,01",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/23/2017,6/27/2017,6/27/2017, , , , , , , , , 
2002,4481,6/15/1954,Female,167,82,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"3,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,LEV-X,V-X,8/3/2015,10/20/2015,10/20/2015,10/31/2016,4/19/2017,4/19/2017,5/9/2017,6/13/2017,6/13/2017,6/29/2017,8/22/2017,8/22/2017
2003,5366,6/15/1949,Male,174,69,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,0,I: fulfilling all 4 criteria,IgG,"2,7",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/12/2016,1/1/2017,1/1/2017, , , , , , , , , 
2004,5511,6/15/1935,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"2,09","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,V-X,Other,3/19/2007,6/3/2007,6/3/2007,12/7/2011,5/29/2012,5/29/2012,6/3/2013,10/14/2013,10/14/2013,4/10/2014,10/14/2014,10/14/2014
2005,5456,6/15/1944,Female,165,54,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/23/2017,4/24/2017,4/24/2017, , , , , , , , , 
2006,5994,6/15/1961,Male,179,101,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,6/21/2017,6/30/2017,6/30/2017, , , , , , , , , 
2007,8701,6/15/1964,Female,999,65,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"9,4",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Ja,R-X,POM-X,POM-X,V-X,1/23/2012,4/15/2012,4/15/2012,8/31/2015,11/22/2015,11/22/2015,10/18/2016,5/30/2017,5/30/2017,6/20/2017,9/11/2017,9/11/2017
2008,4292,6/15/1960,Male,173,83,Private,No,Yes, , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"11,2",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,POM-X,NIN-X,Other,8/1/2012,3/1/2013,3/1/2013,5/18/2015,7/9/2015,7/9/2015,5/11/2017,9/29/2017,9/29/2017,11/21/2017,3/22/2018,3/22/2018
2009,5592,6/15/1945,Female,168,65,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,135,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/23/2017,3/20/2018,3/20/2018, , , , , , , , , 
2010,4343,6/15/1949,Female,165,60,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,210,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/25/2017,5/22/2018,5/22/2018, , , , , , , , , 
2011,8237,6/15/1952,Female,162,58,Private,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,135,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/20/2017,1/3/2018,1/3/2018, , , , , , , , , 
2012,7657,6/15/1942,Male,167,60,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,155,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/10/2017,12/5/2017,12/5/2017, , , , , , , , , 
2013,7998,6/15/1950,Female,164,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/6/2017,11/14/2017,11/14/2017, , , , , , , , , 
2014,2952,6/15/1949,Female,165,62,Compulsory health insurance CHI,No, ,Yes, ,Yes,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,168,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/26/2017,12/13/2017,12/13/2017, , , , , , , , , 
2015,2244,6/15/1939,Male,174,100,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,Other,R-X,Other,10/18/2005,1/9/2006,1/9/2006,11/27/2009,2/18/2010,2/18/2010,4/3/2013,5/10/2017,5/10/2017,6/1/2017,12/31/2017, 
2016,6199,6/15/1952,Male,176,81,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,Other,11/3/2008,2/1/2009,2/1/2009,6/27/2017,9/28/2017,9/28/2017,1/11/2019,1/14/2019,1/14/2019, , , 
2017,3652,6/15/1948,Male,170,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,R-X,No CTx,R-X,4/24/2017,6/2/2017,6/2/2017,6/19/2017,4/17/2018,4/17/2018,12/12/2018,5/6/2019,5/6/2019, , , 
2018,7690,6/15/1946,Male,167,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,165,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,3/15/2017,5/17/2017,5/17/2017,6/6/2017,12/12/2017,12/12/2017, , , , , , 
2019,9119,6/15/1951,Female,167,62,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,210,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,1/23/2017,5/24/2017,5/24/2017,5/29/2017,12/19/2017,12/19/2017, , , , , , 
2020,5427,6/15/1967,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"3,54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,KYP-X,V-X,8/1/2013,10/23/2013,10/23/2013,6/1/2017,8/29/2017,8/29/2017,10/16/2018,2/10/2020,2/10/2020,3/5/2020,2/18/2021,2/18/2021
2021,8341,6/15/1947,Male,178,101,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,8/28/2012,10/29/2012,10/29/2012,6/1/2017,12/31/2017,10/14/1582, , , , , , 
2022,6054,6/15/1935,Male,170,73,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"4,34",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,LEV-X,POM-X,V-X,1/21/2011,9/30/2011,9/30/2011,5/5/2015,7/8/2015,7/8/2015,10/20/2015,1/4/2016,1/4/2016,7/21/2016,8/18/2016,8/18/2016
2023,9079,6/15/1963,Male,185,77,Private,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"5,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,Other,KYP-X,V-X,11/27/2013,2/18/2014,2/18/2014,2/15/2016,5/24/2016,5/24/2016,6/14/2016,8/18/2016,8/18/2016,8/26/2016,11/16/2016,11/16/2016
2024,7425,6/15/1953,Male,176,69,Private,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,",13","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/1/2017,8/23/2017,8/23/2017, , , , , , , , , 
2025,9624,6/15/1953,Male,174,77,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,",74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,DAR-X,DAR-X,V-X,1/14/2013,4/7/2013,4/7/2013,6/10/2015,9/1/2015,9/1/2015,6/13/2017,2/15/2019,2/15/2019,2/18/2019,6/18/2019,6/18/2019
2026,4165,6/15/1937,Female,166,63,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"5,1",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,R-X,POM-X,FAR-X,V-X,1/19/2009,5/7/2009,5/7/2009,11/30/2012,6/13/2013,6/13/2013,11/24/2014,8/16/2015,8/16/2015,10/19/2015,3/14/2016,3/14/2016
2027,6612,6/15/1935,Female,155,66,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"3,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,Other,10/24/2016,3/3/2017,3/3/2017,6/1/2017,6/8/2017,6/8/2017, , , , , , 
2028,5954,6/15/1956,Female,169,75,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,10/15/2008,12/15/2009,12/15/2009,6/1/2012,8/1/2017,8/1/2017, , , , , , 
2029,4354,6/15/1935,Female,999,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"2,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/23/2012,3/29/2012,3/29/2012,2/8/2017,6/15/2017,6/15/2017, , , , , , 
2030,5211,6/15/1958,Male,185,88,Private,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,10/2/2016,11/8/2016,11/8/2016,2/16/2017,6/21/2017,6/21/2017, , , , , , 
2031,1957,6/15/1937,Female,164,64,Compulsory health insurance CHI,No,Yes, , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"66,5",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,V-X,V-X,11/9/2010,4/14/2011,4/14/2011,6/19/2012,2/26/2013,2/26/2013,12/22/2014,5/24/2015,5/24/2015,8/13/2015,1/1/2016,1/1/2016
2032,3670,6/15/1942,Female,164,54,Unknown,No, , , , , , , , , , ,1,Unknown,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,DAR-X,No CTx,V-X,12/3/2012,3/30/2013,3/30/2013,5/10/2016,7/15/2016,7/15/2016,2/6/2017,3/15/2017,3/15/2017, , , 
2033,8624,6/15/1940,Female,163,62,Unknown,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"3,29",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/11/2016,6/30/2017,10/14/1582, , , , , , , , , 
2034,1490,6/15/1944,Male,181,90,Private,No,Yes,Yes, , ,Yes, ,Yes, ,Yes, ,1,Unknown,IgG,"4,86",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,2/15/2017,7/6/2017,7/6/2017,1/9/2019,12/31/2019,10/14/1582, , , , , , 
2035,6319,6/15/1938,Male,178,74,Compulsory health insurance CHI,No, , , ,Yes,Yes, ,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,IgA,"6,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/17/2017,7/17/2018,7/17/2018, , , , , , , , , 
2036,2011,6/15/1931,Female,150,69,Compulsory health insurance CHI,Yes, , , , ,Yes, ,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,IgG,"8,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,4/26/2017,11/14/2017,11/14/2017, , , , , , , , , 
2037,9890,6/15/1939,Male,183,82,Compulsory health insurance CHI,Yes, ,Yes, , ,Yes, ,Yes, , , ,3,Unknown,IgG,"4,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/21/2017,5/26/2017,5/26/2017, , , , , , , , , 
2038,5318,6/15/1962,Male,179,108,Private,No,Yes,Yes,Yes,Yes,Unknown,Unknown,Unknown, , ,Unknown,0,III: one or more criteria are fulfilled,IgG,"2,04","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,2/7/2012,3/31/2012,3/31/2012,5/31/2017,8/16/2017,8/16/2017, , , , , , 
2039,2933,6/15/1954,Male,186,92,Unknown,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,4,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,Other,KYP-X,No CTx,V-X,2/19/2013,5/15/2013,5/15/2013,12/12/2013,1/18/2016,1/18/2016,7/11/2016,12/13/2016,12/13/2016, , , 
2040,1484,6/15/1922,Female,165,56,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,R-X,No CTx,No CTx, , , ,5/3/2011,11/15/2011,11/15/2011,2/27/2017,4/28/2017,4/28/2017, , , 
2041,4616,6/15/1940,Female,167,80,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"3,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,9/15/2011,12/3/2011,12/3/2011,2/1/2017,7/7/2017,7/7/2017, , , , , , 
2042,9794,6/15/1934,Male,178,78,Unknown,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,5/11/2017,8/3/2017,8/3/2017, , , , , , , , , 
2043,2811,6/15/1972,Male,170,63,Unknown,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,Other,1/15/2014,3/11/2014,3/11/2014, , , , , , , , , 
2044,3576,6/15/1966,Male,174,86,Unknown,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Other type,",66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,V-X,V-X,No CTx,R-X,3/27/2012,9/27/2012,9/27/2012,4/25/2013,6/12/2013,6/12/2013,8/12/2014,12/19/2014,12/19/2014, , , 
2045,1071,6/15/1935,Male,178,85,Unknown,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,73",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,EMP-X,KYP-X,No CTx,V-X,2/25/2016,7/19/2016,7/19/2016,8/2/2016,9/9/2016,9/9/2016,9/16/2016,11/22/2016,11/22/2016, , , 
2046,9446,6/15/1960,Male,175,50,Compulsory health insurance CHI,Unknown,Yes, ,Yes,Yes,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"58,6",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,Other,4/10/2017,7/28/2017,7/28/2017, , , , , , , , , 
2047,2239,6/15/1950,Female,167,65,Unknown,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,EMP-X,6/15/2016,9/5/2016,9/5/2016, , , , , , , , , 
2048,1133,6/15/1939,Male,180,64,Unknown,Yes, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,Other,No CTx,No CTx,V-X,12/13/2011,8/30/2012,8/30/2012,7/7/2014,4/10/2017,4/10/2017, , , , , , 
2049,9087,6/15/1969,Male,168,69,Unknown,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgD,"49,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/19/2016,6/15/2016,6/15/2016, , , , , , , , , 
2050,1371,6/15/1957,Female,164,60,Unknown,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,KYP-X,DAR-X,V-X,1/15/2010,2/15/2010,2/15/2010,1/15/2013,4/15/2013,4/15/2013,3/15/2016,1/6/2017,1/6/2017,1/7/2017,2/28/2017,2/28/2017
2051,1857,6/15/1957,Female,180,110,Unknown,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,V-X,11/17/2016,4/12/2017,4/12/2017, , , , , , , , , 
2052,6190,6/15/1949,Female,162,60,Unknown,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"2,7",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,KYP-X,No CTx,Other,8/3/2007,10/1/2007,10/1/2007,8/2/2011,11/11/2011,11/11/2011,3/17/2016,4/1/2017,4/1/2017, , , 
2053,3148,6/15/1943,Male,189,99,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,34,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,No CTx,Other,7/2/2017,9/9/2017,9/9/2017,9/23/2017,6/27/2018,6/27/2018,8/7/2018,9/7/2018,9/7/2018, , , 
2054,1714,6/15/1945,Male,180,100,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,39,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,V-X,EMP-X,Other,11/3/2016,3/29/2017,3/29/2017,9/9/2017,6/29/2018,6/29/2018,3/14/2019,2/29/2020,2/29/2020,3/14/2020,11/16/2020,11/16/2020
2055,6418,6/15/1942,Male,152,49,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes, ,Yes, ,Yes,1,III: one or more criteria are fulfilled,IgG,"8,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,6/13/2017,8/22/2017,8/22/2017,10/12/2017,3/5/2018,3/5/2018, , , , , , 
2056,3101,6/15/1944,Male,187,90,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,NIN-X,V-X,V-X,7/4/2016,4/13/2017,4/13/2017,9/2/2017,5/5/2019,5/5/2019,6/27/2019,6/25/2020,6/25/2020,7/23/2020,8/26/2021,8/26/2021
2057,6009,6/15/1943,Male,185,95,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,22,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Ja,V-X,V-X,FAR-X,V-X,4/28/2016,2/22/2017,2/22/2017,9/19/2017,12/22/2017,12/22/2017,6/5/2018,5/6/2019,5/6/2019,6/28/2019,12/19/2019,12/19/2019
2058,3314,6/15/1941,Male,192,94,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , ,Yes, , ,0,III: one or more criteria are fulfilled,IgA,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,Other,KYP-X,EMP-X,V-X,2/13/2016,12/15/2016,12/15/2016,7/15/2017,3/18/2018,3/18/2018,3/7/2019,3/2/2020,3/2/2020,3/31/2020,3/16/2021,3/16/2021
2059,3822,6/15/1946,Female,169,80,Private,No,Yes,Yes,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,DAR-X,V-X,5/2/2016,1/30/2017,1/30/2017,8/30/2017,6/16/2018,6/16/2018,5/22/2019,6/29/2020,6/29/2020,7/16/2020,12/2/2020,12/2/2020
2060,6595,6/15/1963,Male,183,110,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,2,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,DAR-X,No CTx,V-X,10/28/2011,1/15/2012,1/15/2012,9/4/2017,11/16/2017,11/16/2017,1/14/2019,12/3/2020,12/3/2020, , , 
2061,7183,6/15/1947,Female,173,75,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,DAR-X,DAR-X,Other,7/10/2016,2/3/2017,2/3/2017,9/11/2017,9/3/2018,9/3/2018,6/14/2019,6/13/2020,6/13/2020,7/22/2020,8/19/2021,8/19/2021
2062,3485,6/15/1938,Male,181,64,Compulsory health insurance CHI,Yes, ,Yes,Yes,Yes,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/17/2017,9/28/2017,9/28/2017, , , , , , , , , 
2063,6213,6/15/1930,Female,150,50,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,7/25/2017,1/9/2018,1/9/2018, , , , , , , , , 
2064,2998,6/15/1937,Male,172,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"1,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,R-X,No CTx,V-X,7/5/2010,8/27/2010,8/27/2010,4/11/2013,7/18/2013,7/18/2013,6/29/2015,10/13/2015,10/13/2015, , , 
2065,5517,6/15/1937,Female,157,50,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"49,46",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,KYP-X,No CTx,V-X,7/3/2017,1/31/2018,1/31/2018,9/23/2019,11/7/2019,11/7/2019,12/2/2020,3/31/2022,10/14/1582, , , 
2066,7674,6/15/1958,Male,180,70,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"63,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/28/2017,12/12/2017,12/12/2017, , , , , , , , , 
2067,4462,6/15/1965,Male,182,92,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"29,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/29/2017,12/14/2017,12/14/2017, , , , , , , , , 
2068,2144,6/15/1931,Male,9,80,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"11,23",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,R-X,9/2/2017,12/31/2017, , , , , , , , , , 
2069,8305,6/15/1979,Male,173,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"13,13",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,No CTx,No CTx,No CTx,V-X,7/12/2017,9/8/2017,9/8/2017, , , , , , , , , 
2070,1132,6/15/1959,Male,180,80,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,"3,6",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,R-X,V-X,8/11/2017,11/15/2017,11/15/2017,11/15/2017,1/9/2018,1/9/2018, , , ,10/16/2018,4/15/2019,4/15/2019
2071,3051,6/15/1938,Male,172,66,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,LEV-X,POM-X,LEV-X,9/18/2017,3/11/2018,3/11/2018,6/17/2019,12/8/2019,12/8/2019,12/16/2019,6/7/2020,6/7/2020,2/22/2021,5/30/2021,5/30/2021
2072,3344,6/15/1960,Female,173,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/21/2017,11/22/2017,11/22/2017,9/20/2021,12/31/2021,10/14/1582, , , , , , 
2073,4270,6/15/1959,Male,179,91,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,9/1/2017,10/15/2017,10/15/2017,8/2/2021,12/31/2021, , , , , , , 
2074,6414,6/15/1946,Male,176,75,Private,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/4/2017,10/15/2017,10/15/2017,12/6/2021,12/31/2021, , , , , , , 
2075,4544,6/15/1940,Male,180,80,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, , , ,0,I: fulfilling all 4 criteria,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , ,Nein,R-X,No CTx,No CTx,LEV-X,8/1/2017,1/15/2018,1/15/2018,3/26/2018,6/30/2018, , , , , , , 
2076,9908,6/15/1947,Male,178,76,Private,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,7/10/2017,12/31/2017, , , , , , , , , , 
2077,9616,6/15/1942,Male,176,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,LEV-X,7/10/2017,12/31/2017, , , , , , , , , , 
2078,9426,6/15/1966,Male,182,88,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,45",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/18/2017,12/10/2017,12/10/2017, , , , , , , , , 
2079,9008,6/15/1937,Female,168,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,9/18/2017,3/11/2018,3/11/2018,3/4/2019,8/25/2019,8/25/2019, , , , , , 
2080,5752,6/15/1950,Male,166,98,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,1458,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,No CTx,No CTx,V-X,7/4/2017,12/15/2017,12/15/2017,7/1/2018,4/1/2019,4/1/2019, , , , , , 
2081,1233,6/15/1942,Male,183,106,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,218,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,DAR-X,No CTx,No CTx,V-X,11/11/2014,1/2/2015,1/2/2015,8/30/2017,6/30/2019,10/14/1582, , , , , , 
2082,6813,6/15/1938,Male,181,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,3378,unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,DAR-X,EMP-X,KYP-X,V-X,12/30/2014,2/21/2015,2/21/2015,8/9/2017,3/14/2018,3/14/2018,3/22/2018,10/17/2018,10/17/2018,10/30/2018,5/9/2019,5/9/2019
2083,3123,6/15/1957,Male,170,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"14,63",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,V-X,No CTx,No CTx,No CTx, , , ,7/6/2018,10/1/2018,10/1/2018, , , , , , 
2084,9932,6/15/1938,Male,166,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,POM-X,Other,No CTx,V-X,7/10/2017,2/6/2018,2/6/2018,10/5/2018,2/26/2019,2/26/2019,3/25/2019,6/30/2019, , , , 
2085,1730,6/15/1954,Male,178,72,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,DAR-X,EMP-X,DAR-X,No CTx, , , ,9/13/2017,10/25/2017,10/25/2017,11/2/2017,11/7/2018,11/7/2018,12/12/2018,6/30/2019, 
2086,7438,6/15/1944,Female,163,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,64",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,8/7/2017,1/22/2018,1/22/2018,2/24/2020,3/10/2021,3/10/2021, , , , , , 
2087,5702,6/15/1948,Male,179,77,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,34",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/17/2017,1/4/2018,1/4/2018, , , , , , , , , 
2088,4756,6/15/1944,Male,187,62,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,66",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,8/22/2017,5/1/2018,5/1/2018,7/3/2019,8/26/2020,8/26/2020,9/7/2020,7/22/2021,7/22/2021, , , 
2089,6748,6/15/1945,Male,180,55,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"34,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/21/2017,11/17/2017,11/17/2017, , , , , , , , , 
2090,5905,6/15/1952,Female,171,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,18",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,R-X,8/8/2017,6/20/2019,6/20/2019,10/14/2019,10/6/2020,10/6/2020, , , , , , 
2091,6170,6/15/1945,Male,178,81,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"15,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/17/2017,1/9/2018,1/9/2018, , , , , , , , , 
2092,2206,6/15/1952,Male,181,84,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"21,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,7/24/2017,6/12/2019,6/12/2019,1/13/2020,1/5/2021,1/5/2021, , , , , , 
2093,7119,6/15/1942,Male,183,83,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,08",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/16/2017,3/14/2018,3/14/2018, , , , , , , , , 
2094,4241,6/15/1942,Male,170,77,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,16",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/30/2017,9/22/2017,9/22/2017, , , , , , , , , 
2095,9838,6/15/1943,Male,183,86,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"20,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,6/22/2017,6/20/2019,6/20/2019,10/11/2019,1/2/2020,1/2/2020,5/23/2020,5/23/2021,5/23/2021, , , 
2096,3867,6/15/1942,Male,170,51,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,69",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,6/26/2017,4/9/2020,4/9/2020, , , , , , , , , 
2097,8502,6/15/1942,Male,196,74,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/15/2017,10/12/2017,10/12/2017,1/29/2020,3/31/2022,10/14/1582, , , , , , 
2098,6580,6/15/1947,Female,169,69,Compulsory health insurance CHI,No, , , , , , , ,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"18,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,V-X,No CTx,LEV-X,7/3/2017,1/24/2018,1/24/2018,1/30/2018,6/4/2019,6/4/2019,6/14/2019,6/19/2019,6/19/2019, , , 
2099,9692,6/15/1952,Female,174,79,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,52",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/7/2017,5/22/2018,5/22/2018, , , , , , , , , 
2100,2986,6/15/1950,Female,164,60,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,8/1/2017,10/15/2017,10/15/2017,3/20/2018,6/30/2018, , , , , , , 
2101,9942,6/15/1949,Male,182,82,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,LEV-X,9/1/2017,2/15/2018,2/15/2018,3/18/2018,6/30/2018, , , , , , , 
2102,2196,6/15/1951,Male,182,79,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,01",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/7/2017,10/20/2017,10/20/2017, , , , , , , , , 
2103,7125,6/15/1947,Female,160,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,25",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/25/2017,11/8/2017,11/8/2017, , , , , , , , , 
2104,1173,6/15/1953,Female,164,58,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,9/4/2017,2/19/2018,2/19/2018,4/4/2019,1/2/2020,1/2/2020,4/5/2020,9/30/2020, , , , 
2105,1117,6/15/1951,Female,166,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/12/2017,3/27/2018,3/27/2018, , , , , , , , , 
2106,8400,6/15/1953,Female,164,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/28/2017,12/11/2017,12/11/2017,3/6/2018,9/30/2020,10/14/1582, , , , , , 
2107,4537,6/15/1944,Female,166,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,13",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/17/2017,5/23/2018,5/23/2018, , , , , , , , , 
2108,2050,6/15/1944,Male,186,83,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/28/2017,9/4/2018,9/4/2018, , , , , , , , , 
2109,4926,6/15/1951,Female,166,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"7,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/27/2017,6/7/2018,6/7/2018,7/31/2018,9/17/2018,9/17/2018, , , , , , 
2110,8115,6/15/1947,Male,175,58,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,77",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,8/18/2017,9/4/2018,9/4/2018,9/20/2018,10/18/2019,10/18/2019, , , , , , 
2111,6210,6/15/1948,Female,166,56,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,67",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,NIN-X,No CTx,No CTx,R-X,8/15/2017,8/18/2018,8/18/2018,1/4/2022,3/31/2022, , , , , , , 
2112,5640,6/15/1948,Male,177,77,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,64",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,7/17/2017,12/22/2017,12/22/2017,1/30/2018,3/5/2021,3/5/2021,3/16/2021,3/31/2022,10/14/1582, , , 
2113,4402,6/15/1951,Male,187,124,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,48",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,R-X,POM-X,LEV-X,7/10/2017,12/21/2017,12/21/2017,1/24/2018,7/25/2018,7/25/2018,3/4/2019,4/11/2019,4/11/2019,8/21/2019,8/28/2020,8/28/2020
2114,3043,6/15/1951,Female,161,66,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,52",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,V-X,R-X,6/1/2017,3/2/2018,3/2/2018,3/12/2018,12/5/2018,12/5/2018,2/19/2019,12/30/2019,12/30/2019,2/22/2020,2/14/2021,2/14/2021
2115,6088,6/15/1946,Female,174,92,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,76",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/21/2017,12/4/2017,12/4/2017, , , , , , , , , 
2116,3705,6/15/1950,Female,162,61,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,72",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,6/19/2017,10/16/2017,10/16/2017,11/26/2019,7/26/2021,7/26/2021,8/11/2021,3/31/2022, , , , 
2117,2994,6/15/1948,Female,155,57,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"9,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/18/2017,6/20/2018,6/20/2018, , , , , , , , , 
2118,5857,6/15/1945,Male,180,120,Compulsory health insurance CHI,No, , , , , ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"12,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,R-X,No CTx,LEV-X,8/28/2017,8/14/2018,8/14/2018,8/23/2018,11/12/2018,11/12/2018,11/26/2018,8/9/2021,8/9/2021, , , 
2119,5963,6/15/1951,Female,164,51,Private,No, , , , , ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"22,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,LEV-X,8/14/2017,12/19/2017,12/19/2017,1/9/2018,6/22/2018,6/22/2018, , , , , , 
2120,2440,6/15/1952,Female,164,86,Compulsory health insurance CHI,No, , ,Yes,Yes, , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,47",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,R-X,V-X,7/6/2017,2/14/2018,2/14/2018,2/27/2018,3/18/2019,3/18/2019,3/25/2019,6/3/2019,6/3/2019,7/17/2019,12/31/2021, 
2121,6665,6/15/1952,Female,170,77,Private,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/22/2017,10/19/2017,10/19/2017, , , , , , , , , 
2122,8691,6/15/1927,Female,161,49,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,DAR-X,V-X,No CTx,V-X,7/4/2017,10/31/2017,10/31/2017,4/22/2020,7/19/2021,7/19/2021,8/13/2021,3/31/2022, , , , 
2123,6074,6/15/1948,Female,162,51,Private,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"23,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,No CTx,LEV-X,6/13/2017,1/10/2018,1/10/2018,2/7/2018,1/28/2019,1/28/2019,2/4/2019,3/31/2022, , , , 
2124,4217,6/15/1950,Male,202,74,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,8/25/2017,12/17/2018,12/17/2018, , , , , , , , , 
2125,9340,6/15/1927,Female,161,49,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"27,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/27/2017,11/9/2017,11/9/2017, , , , , , , , , 
2126,2288,6/15/1949,Female,173,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"10,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,POM-X,NIN-X,LEV-X,6/5/2017,8/15/2018,8/15/2018,9/10/2018,11/13/2018,11/13/2018,12/4/2018,8/14/2019,8/14/2019,8/20/2019,9/25/2019,9/25/2019
2127,3968,6/15/1949,Male,189,130,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"24,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,DAR-X,EMP-X,POM-X,R-X,9/19/2017,3/8/2018,3/8/2018,3/20/2018,4/2/2019,4/2/2019,6/25/2019,12/4/2019,12/4/2019,12/30/2019,12/31/2021, 
2128,5684,6/15/1951,Female,173,95,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,14",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/12/2017,10/25/2017,10/25/2017,9/22/2020,12/15/2021,12/15/2021, , , , , , 
2129,5215,6/15/1941,Male,180,88,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,14",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,No CTx,R-X,8/22/2017,12/21/2017,12/21/2017,1/23/2018,12/1/2020,12/1/2020,12/15/2020,7/19/2021,7/19/2021, , , 
2130,9746,6/15/1943,Male,173,70,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,POM-X,No CTx,LEV-X,9/19/2017,6/25/2018,6/25/2018,7/20/2018,7/13/2021,7/13/2021,7/20/2021,3/31/2022, , , , 
2131,2549,6/15/1943,Female,179,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"26,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,9/7/2017,12/20/2017,12/20/2017,1/10/2018,8/21/2019,8/21/2019, , , , , , 
2132,4719,6/15/1944,Male,180,87,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,83",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,R-X,6/26/2017,3/9/2018,3/9/2018,3/27/2018,9/24/2018,9/24/2018, , , , , , 
2133,1031,6/15/1951,Male,171,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,72",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/1/2017,9/5/2018,9/5/2018, , , , , , , , , 
2134,2727,6/15/1946,Male,172,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,8/14/2017,8/30/2018,8/30/2018, , , , , , , , , 
2135,2618,6/15/1952,Female,161,79,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"18,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,6/7/2017,2/8/2018,2/8/2018,2/20/2018,12/31/2020,10/14/1582, , , , , , 
2136,9326,6/15/1946,Male,180,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgA,"1,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,7/3/2017,12/11/2017,12/11/2017,1/8/2019,12/31/2020, , , , , , , 
2137,5453,6/15/1949,Male,183,103,Private,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,77",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,6/30/2017,12/31/2020, , , , , , , , , , 
2138,7375,6/15/1943,Male,185,90,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,6/1/2017,12/19/2017,12/19/2017, , , , , , , , , 
2139,4224,6/15/1949,Male,175,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,93",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/28/2017,1/30/2018,1/30/2018, , , , , , , , , 
2140,2503,6/15/1970,Female,163,77,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,8",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/4/2017,12/20/2017,12/20/2017, , , , , , , , , 
2141,1145,6/15/1944,Male,187,95,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,32",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,LEV-X,8/31/2017,10/15/2018,10/15/2018,11/5/2018,5/3/2019,5/3/2019,5/13/2019,5/27/2019,5/27/2019, , , 
2142,2941,6/15/1952,Female,161,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"20,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/31/2017,12/31/2020, , , , , , , , , , 
2143,2088,6/15/1952,Female,161,79,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"14,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,6/2/2017,12/6/2018,12/6/2018,6/20/2019,6/12/2020,6/12/2020, , , , , , 
2144,1207,6/15/1950,Male,201,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/10/2017,5/19/2020,5/19/2020, , , , , , , , , 
2145,3777,6/15/1942,Female,173,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,86",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/8/2017,9/21/2017,9/21/2017, , , , , , , , , 
2146,6817,6/15/1950,Female,166,71,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"6,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,6/5/2017,5/29/2018,5/29/2018,1/19/2022,3/31/2022,10/14/1582, , , , , , 
2147,6542,6/15/1968,Male,173,109,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,59",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/3/2017,9/2/2017,9/2/2017,2/10/2021,3/31/2022,10/14/1582, , , , , , 
2148,6456,6/15/1968,Male,173,109,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,49",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/14/2017,1/18/2018,1/18/2018, , , , , , , , , 
2149,1226,6/15/1951,Female,165,81,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"14,83","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,POM-X,V-X,V-X,8/18/2017,4/27/2018,4/27/2018,9/16/2019,1/2/2020,1/2/2020,1/28/2020,3/30/2020,3/30/2020,4/7/2020,3/30/2021,3/30/2021
2150,9833,6/15/1950,Male,168,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,41",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,V-X,LEV-X,V-X,7/6/2017,9/6/2018,9/6/2018,9/19/2018,1/2/2020,1/2/2020,1/11/2020,1/3/2021,1/3/2021,7/28/2021,11/17/2021,11/17/2021
2151,3581,6/15/1951,Female,174,61,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,92",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/25/2017,9/18/2018,9/18/2018, , , , , , , , , 
2152,2268,6/15/1945,Male,178,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,47",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/20/2017,11/28/2017,11/28/2017, , , , , , , , , 
2153,6387,6/15/1944,Male,167,75,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"24,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,V-X,POM-X,KYP-X,R-X,6/6/2017,7/11/2018,7/11/2018,12/2/2019,11/24/2020,11/24/2020,7/19/2021,2/17/2022,2/17/2022,2/21/2022,3/31/2022,10/14/1582
2154,7424,6/15/1942,Female,162,55,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,92",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,8/24/2017,8/30/2018,8/30/2018,11/29/2020,3/31/2022, , , , , , , 
2155,5768,6/15/1942,Female,162,55,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"2,29",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,8/15/2017,4/24/2018,4/24/2018,8/15/2019,1/2/2020,1/2/2020,4/16/2020,6/29/2021,6/29/2021, , , 
2156,3687,6/15/1945,Male,161,47,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,35",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,R-X,POM-X,R-X,9/8/2017,7/20/2018,7/20/2018,8/9/2018,1/2/2019,1/2/2019,1/26/2020,2/2/2020,2/2/2020,4/7/2020,8/3/2020,8/3/2020
2157,4798,6/15/1952,Male,165,64,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"19,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/19/2017,10/16/2018,10/16/2018,2/16/2020,12/31/2021, , , , , , , 
2158,1785,6/15/1952,Male,165,64,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"11,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,6/20/2017,8/2/2018,8/2/2018,8/14/2018,2/25/2019,2/25/2019,3/15/2019,4/1/2019,4/1/2019,4/8/2019,11/7/2020,11/7/2020
2159,8183,6/15/1929,Male,172,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,11",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,7/27/2017,11/9/2017,11/9/2017,3/25/2019,11/20/2020,11/20/2020,12/9/2020,6/7/2021,6/7/2021, , , 
2160,7139,6/15/1965,Male,170,71,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"15,34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/7/2017,9/20/2017,9/20/2017,4/24/2018,6/22/2020,6/22/2020, , , , , , 
2161,3807,6/15/1943,Male,179,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/17/2017,9/16/2017,9/16/2017,2/28/2022,3/31/2022, , , , , , , 
2162,9408,6/15/1943,Female,159,60,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"13,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,POM-X,LEV-X,R-X,6/1/2017,1/18/2019,1/18/2019,3/6/2019,6/27/2019,6/27/2019,7/16/2019,2/25/2020,2/25/2020,6/10/2020,1/6/2021,1/6/2021
2163,7883,6/15/1943,Male,179,60,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"1,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/6/2017,9/5/2017,9/5/2017, , , , , , , , , 
2164,7760,6/15/1943,Female,160,79,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,96",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,DAR-X,R-X,9/4/2017,11/5/2018,11/5/2018,1/8/2019,4/10/2019,4/10/2019,4/22/2019,8/14/2019,8/14/2019,9/12/2019,9/13/2019,9/13/2019
2165,2673,6/15/1944,Male,183,85,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,41",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,8/18/2017,9/5/2019,9/5/2019,2/23/2020,2/15/2021,2/15/2021, , , , , , 
2166,7515,6/15/1951,Male,176,59,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,56",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,LEV-X,7/6/2017,6/22/2018,6/22/2018,7/17/2018,1/14/2019,1/14/2019,1/22/2019,2/7/2019,2/7/2019, , , 
2167,3619,6/15/1943,Male,187,86,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,44",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,V-X,NIN-X,POM-X,R-X,8/14/2017,10/25/2019,10/25/2019,2/9/2020,6/24/2020,6/24/2020,7/6/2020,6/29/2021,6/29/2021,7/8/2021,3/31/2022, 
2168,3859,6/15/1947,Male,180,106,Private,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/30/2017,7/6/2018,7/6/2018,2/10/2022,3/31/2022,10/14/1582, , , , , , 
2169,2903,6/15/1944,Male,192,120,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"18,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,7/10/2017,7/30/2019,7/30/2019,1/22/2020,9/4/2021,9/4/2021, , , , , , 
2170,5490,6/15/1954,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"14,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L", ,V-X,R-X,KYP-X,V-X,12/12/2013,3/14/2014,3/14/2014,8/1/2017,10/29/2017,10/29/2017,5/14/2019,10/4/2019,10/4/2019,10/8/2019,6/17/2020,6/17/2020
2171,4167,6/15/1965,Male,178,73,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/13/2017,11/10/2017,11/10/2017,12/17/2018,12/31/2018, , , , , , , 
2172,6883,6/15/1957,Male,165,79,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes,Yes, ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,2,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/4/2017,12/1/2017,12/1/2017,4/17/2019,6/30/2019, , , , , , , 
2173,8961,6/15/1943,Female,157,61,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"35,4",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,9/11/2017,12/4/2017,12/4/2017,5/5/2019,6/30/2019, , , , , , , 
2174,1214,6/15/1941,Male,173,120,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"31,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/29/2017,5/1/2018,5/1/2018,6/13/2018,7/25/2018,7/25/2018, , , , , , 
2175,3832,6/15/1947,Female,163,77,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,87","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,8/31/2016,1/5/2017,1/5/2017,6/29/2017,12/31/2020,10/14/1582, , , , , , 
2176,8747,6/15/1950,Male,184,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,No CTx,No CTx,LEV-X,12/10/2016,5/25/2017,5/25/2017,9/10/2017,4/4/2018,4/4/2018, , , , , , 
2177,2676,6/15/1949,Male,176,72,Private,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,LEV-X,No CTx,No CTx,V-X,11/3/2016,3/10/2017,3/10/2017,7/20/2017,4/2/2018,4/2/2018, , , , , , 
2178,4864,6/15/1945,Female,178,79,Private,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,19",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/31/2016,1/9/2017,1/9/2017,7/5/2017,12/31/2020,10/14/1582, , , , , , 
2179,3434,6/15/1936,Male,174,82,Private,Yes, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"2,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/18/2017,12/8/2017,12/8/2017, , , , , , , , , 
2180,2482,6/15/1950,Male,178,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"15,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,9/6/2016,2/28/2017,2/28/2017,8/21/2017,7/13/2020,7/13/2020,8/5/2020,12/31/2020,10/14/1582, , , 
2181,8816,6/15/1960,Female,174,100,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,DAR-X,EMP-X,V-X,1/19/2017,4/27/2017,4/27/2017,9/14/2017,6/26/2018,6/26/2018,7/9/2018,8/11/2020,8/11/2020,8/26/2020,12/31/2020,10/14/1582
2182,3316,6/15/1959,Male,174,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,56",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,No CTx,No CTx,V-X,1/16/2017,5/18/2017,5/18/2017,8/1/2017,12/31/2020,10/14/1582, , , , , , 
2183,1768,6/15/1949,Female,162,66,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,43",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,6/23/2016,12/15/2016,12/15/2016,7/4/2017,12/31/2020,10/14/1582, , , , , , 
2184,5819,6/15/1948,Male,184,92,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,53",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,V-X,NIN-X,R-X,2/20/2017,8/18/2017,8/18/2017,9/11/2017,12/18/2018,12/18/2018,2/7/2019,1/31/2020,1/31/2020,11/4/2020,12/31/2020, 
2185,2086,6/15/1943,Male,166,74,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,06",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,11/11/2016,5/12/2017,5/12/2017,8/2/2017,10/3/2018,10/3/2018,2/27/2019,3/7/2019,3/7/2019, , , 
2186,4733,6/15/1946,Male,999,80,Private,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,No CTx,No CTx,No CTx,R-X,8/15/2017,12/31/2017, , , , , , , , , , 
2187,2389,6/15/1948,Male,172,50,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,12",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/26/2017,11/26/2017,11/26/2017, , , , , , , , , 
2188,7268,6/15/1945,Male,180,123,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,7/21/2017,10/6/2017,10/6/2017,12/9/2019,7/2/2021,7/2/2021, , , , , , 
2189,8977,6/15/1946,Female,155,55,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"22,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,NIN-X,POM-X,No CTx,V-X,8/16/2017,6/26/2018,6/26/2018,7/16/2018,7/16/2018,7/16/2018,1/29/2019,12/31/2021, , , , 
2190,2376,6/15/1951,Female,171,78,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,49",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,NIN-X,V-X,No CTx,V-X,8/29/2017,12/18/2017,12/18/2017,1/4/2018,4/19/2019,4/19/2019,7/30/2019,9/29/2019,9/29/2019, , , 
2191,1553,6/15/1943,Male,166,61,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"11,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,6/27/2017,9/12/2017,9/12/2017,3/2/2018,3/31/2022,10/14/1582, , , , , , 
2192,5249,6/15/1948,Male,177,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,72",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,6/29/2017,6/22/2018,6/22/2018,10/19/2021,3/31/2022,10/14/1582, , , , , , 
2193,6956,6/15/1947,Male,186,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,95",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/29/2017,11/4/2020,11/4/2020,11/19/2020,6/30/2021,10/14/1582, , , , , , 
2194,9313,6/15/1951,Male,175,57,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,14",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,8/18/2017,8/11/2018,8/11/2018, , , , , , , , , 
2195,5852,6/15/1949,Male,171,104,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,16",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,V-X,No CTx,V-X,7/25/2017,11/20/2017,11/20/2017,3/28/2019,2/2/2022,2/2/2022,2/21/2022,3/31/2022, , , , 
2196,4712,6/15/1945,Male,189,131,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"31,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,8/15/2016,2/13/2017,2/13/2017,7/3/2017,11/29/2018,11/29/2018,1/8/2019,10/7/2021,10/7/2021, , , 
2197,3184,6/15/1948,Male,182,78,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,96",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,V-X,9/5/2016,2/21/2017,2/21/2017,7/3/2017,7/18/2018,7/18/2018,1/15/2019,6/13/2019,6/13/2019, , , 
2198,9195,6/15/1949,Male,169,75,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,07",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,R-X,POM-X,LEV-X,2/16/2017,8/3/2017,8/3/2017,8/18/2017,11/29/2018,11/29/2018,3/11/2019,10/29/2019,10/29/2019,12/2/2019,6/29/2021,6/29/2021
2199,3545,6/15/1947,Female,169,72,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"21,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,DAR-X,No CTx,V-X,7/28/2016,1/16/2017,1/16/2017,8/1/2017,9/8/2017,9/8/2017,9/29/2017,8/28/2018,8/28/2018, , , 
2200,2177,6/15/1965,Female,166,58,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,94",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,10/13/2016,3/1/2017,3/1/2017,8/9/2017,11/28/2018,11/28/2018,1/23/2019,3/31/2022,10/14/1582, , , 
2201,8769,6/15/1934,Male,183,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,41",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,DAR-X,POM-X,V-X,2/24/2016,7/6/2016,7/6/2016,10/10/2016,12/18/2017,12/18/2017,1/8/2018,6/4/2019,6/4/2019,6/27/2019,7/15/2019,7/15/2019
2202,9631,6/15/1961,Male,164,59,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,12",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,12/22/2016,4/14/2017,4/14/2017,9/1/2017,10/23/2018,10/23/2018,1/31/2019,3/18/2019,3/18/2019, , , 
2203,1977,6/15/1949,Female,169,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,24",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,POM-X,No CTx,R-X,3/17/2017,8/31/2017,8/31/2017,9/12/2017,10/4/2018,10/4/2018,1/31/2019,2/20/2019,2/20/2019, , , 
2204,9798,6/15/1963,Male,172,61,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,06",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/7/2017,3/31/2022, , , , , , , , , , 
2205,7299,6/15/1948,Male,189,67,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"8,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,8/17/2017,3/6/2018,3/6/2018,3/22/2018,1/2/2020,1/2/2020, , , , , , 
2206,4787,6/15/1931,Female,162,50,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"16,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/11/2017,11/24/2017,11/24/2017, , , , , , , , , 
2207,9360,6/15/1947,Male,185,87,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,46",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/28/2016,1/27/2017,1/27/2017,8/11/2017,3/22/2018,3/22/2018, , , , , , 
2208,2227,6/15/1931,Female,162,50,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,"15,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/11/2017,11/6/2017,11/6/2017,4/26/2019,6/30/2020,10/14/1582, , , , , , 
2209,4194,6/15/1946,Female,167,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,84",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,12/29/2016,6/28/2017,6/28/2017,9/25/2017,7/18/2019,7/18/2019,2/20/2020,7/30/2020,7/30/2020,8/8/2020,7/5/2021,7/5/2021
2210,5036,6/15/1948,Male,171,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,V-X,No CTx,V-X,9/20/2016,3/9/2017,3/9/2017,7/4/2017,11/26/2018,11/26/2018,1/9/2020,12/31/2021,10/14/1582, , , 
2211,2566,6/15/1942,Male,173,79,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,95","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,R-X,No CTx,R-X,2/2/2017,7/25/2017,7/25/2017,8/14/2017,12/13/2018,12/13/2018,3/8/2020,3/1/2021,3/1/2021, , , 
2212,2484,6/15/1942,Male,173,79,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,5,ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,POM-X,R-X,1/13/2017,7/14/2017,7/14/2017,8/3/2017,2/25/2019,2/25/2019,3/14/2019,1/2/2020,1/2/2020,2/2/2020,7/29/2021,7/29/2021
2213,8210,6/15/1949,Male,178,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"13,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,POM-X,V-X,11/17/2016,5/15/2017,5/15/2017,9/12/2017,3/11/2019,3/11/2019,3/25/2019,1/2/2020,1/2/2020,1/4/2020,9/26/2020,9/26/2020
2214,3431,6/15/1945,Female,165,90,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,22",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/17/2017,1/24/2018,1/24/2018,2/9/2018,12/17/2019,12/17/2019, , , , , , 
2215,2473,6/15/1952,Female,164,64,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,72",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,POM-X,V-X,9/26/2016,1/27/2017,1/27/2017,8/3/2017,3/14/2019,3/14/2019,3/29/2019,12/16/2019,12/16/2019,3/11/2020,1/3/2021,1/3/2021
2216,4640,6/15/1932,Male,182,122,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"3,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,EMP-X,DAR-X,EMP-X,V-X,9/30/2016,2/2/2017,2/2/2017,7/5/2017,4/1/2019,4/1/2019,6/3/2019,1/10/2021,1/10/2021,2/2/2021,3/31/2022,10/14/1582
2217,7143,6/15/1963,Male,172,105,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"23,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/15/2017,12/28/2017,12/28/2017,11/12/2019,12/10/2020,12/10/2020, , , , , , 
2218,2780,6/15/1960,Female,165,77,Compulsory health insurance CHI,Unknown, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,6/14/2017,6/26/2018,6/26/2018,10/14/2021,3/31/2022,10/14/1582, , , , , , 
2219,3271,6/15/1948,Male,177,85,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,91",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/7/2017,2/14/2018,2/14/2018,2/28/2018,6/30/2021,10/14/1582, , , , , , 
2220,8099,6/15/1952,Male,180,79,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,45",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,7/11/2017,10/24/2017,10/24/2017,6/22/2018,7/24/2019,7/24/2019,9/4/2019,3/31/2022, , , , 
2221,2832,6/15/1952,Male,180,79,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,3",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/13/2017,10/11/2017,10/11/2017,8/24/2021,3/31/2022,10/14/1582, , , , , , 
2222,2272,6/15/1951,Female,171,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,56",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/30/2017,12/12/2018,12/12/2018, , , , , , , , , 
2223,3044,6/15/1943,Female,178,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,91",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/28/2017,12/11/2017,12/11/2017,1/30/2020,3/31/2022,10/14/1582, , , , , , 
2224,7324,6/15/1939,Female,165,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,92",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/28/2017,12/20/2017,12/20/2017, , , , , , , , , 
2225,9399,6/15/1943,Male,169,76,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,84",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/27/2016,3/17/2017,3/17/2017,7/4/2017,3/11/2020,3/11/2020, , , , , , 
2226,7009,6/15/1942,Male,184,119,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,V-X,DAR-X,V-X,11/2/2016,2/2/2017,2/2/2017,9/8/2017,1/1/2019,1/1/2019,2/19/2019,2/26/2019,2/26/2019,4/17/2019,4/20/2021,4/20/2021
2227,5586,6/15/1947,Male,187,83,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,1",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,11/23/2016,5/15/2017,5/15/2017,9/12/2017,6/10/2019,6/10/2019,3/3/2020,6/28/2020,6/28/2020,7/24/2020,9/14/2020,9/14/2020
2228,6720,6/15/1946,Female,164,101,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,54",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,11/16/2016,5/12/2017,5/12/2017,9/18/2017,7/2/2021,7/2/2021, , , , , , 
2229,3609,6/15/1936,Male,171,58,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,9",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,V-X,10/6/2016,2/9/2017,2/9/2017,7/18/2017,3/6/2018,3/6/2018,3/4/2019,6/23/2020,6/23/2020,7/6/2020,9/26/2020,9/26/2020
2230,3812,6/15/1937,Female,163,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,39",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,12/19/2016,5/3/2017,5/3/2017,7/20/2017,7/27/2018,7/27/2018,6/9/2020,6/30/2021,10/14/1582, , , 
2231,9717,6/15/1943,Male,179,85,Private,No, , ,Yes,Yes, , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"7,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,V-X,KYP-X,NIN-X,LEV-X,7/12/2016,1/10/2017,1/10/2017,1/30/2017,7/28/2017,7/28/2017,11/30/2017,6/22/2018,6/22/2018,7/5/2018,12/5/2019,12/5/2019
2232,2890,6/15/1955,Female,171,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,07",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/28/2016,5/25/2017,5/25/2017,8/10/2017,12/5/2019,12/5/2019, , , , , , 
2233,5245,6/15/1928,Female,167,94,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,2/2/2017,5/25/2017,5/25/2017,9/7/2017,10/23/2019,10/23/2019,8/18/2020,9/30/2020, , , , 
2234,9493,6/15/1947,Male,181,85,Compulsory health insurance CHI,No, , ,Yes,Yes, , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"26,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,12/22/2016,5/11/2017,5/11/2017,9/4/2017,3/5/2018,3/5/2018,3/19/2018,9/30/2020,10/14/1582, , , 
2235,4320,6/15/1952,Male,173,81,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,29",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,10/4/2016,2/13/2017,2/13/2017,8/31/2017,12/16/2019,12/16/2019, , , , , , 
2236,4358,6/15/1949,Male,176,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"29,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,9/16/2016,3/13/2017,3/13/2017,7/18/2017,11/21/2019,11/21/2019,5/4/2020,9/30/2020, , , , 
2237,8097,6/15/1947,Male,178,62,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,21",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,1/17/2017,7/7/2017,7/7/2017,7/27/2017,6/18/2019,6/18/2019, , , , , , 
2238,5046,6/15/1942,Male,189,91,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,I: fulfilling all 4 criteria,IgG,"4,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,2/13/2017,8/1/2017,8/1/2017,8/15/2017,1/2/2020,1/2/2020,4/7/2020,9/30/2020,10/14/1582, , , 
2239,9273,6/15/1944,Male,172,73,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,69",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,R-X,3/21/2017,9/8/2017,9/8/2017,9/20/2017,4/18/2019,4/18/2019,6/27/2019,9/12/2020,9/12/2020,9/21/2020,9/30/2020, 
2240,2248,6/15/1946,Male,182,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"15,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,9/12/2016,3/3/2017,3/3/2017,7/4/2017,5/6/2019,5/6/2019,6/18/2019,7/22/2020,7/22/2020,7/30/2020,6/10/2021,6/10/2021
2241,4788,6/15/1932,Male,171,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,45",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,No CTx,No CTx,V-X,10/31/2016,1/24/2017,1/24/2017,7/3/2017,6/19/2019,6/19/2019, , , , , , 
2242,2839,6/15/1948,Male,183,88,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"14,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,EMP-X,POM-X,DAR-X,V-X,12/19/2016,3/14/2017,3/14/2017,8/1/2017,6/25/2019,6/25/2019,2/3/2020,5/26/2020,5/26/2020,6/3/2020,9/28/2020,9/28/2020
2243,6978,6/15/1942,Male,183,90,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,79",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,10/27/2016,2/16/2017,2/16/2017,8/11/2017,2/20/2019,2/20/2019,3/28/2019,1/2/2020,1/2/2020,2/7/2020,5/5/2020,5/5/2020
2244,6415,6/15/1951,Male,183,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,12/22/2016,6/9/2017,6/9/2017,8/31/2017,8/1/2020,8/1/2020,8/27/2020,3/31/2022, , , , 
2245,4666,6/15/1946,Male,170,72,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,05",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,DAR-X,NIN-X,V-X,10/27/2016,4/14/2017,4/14/2017,9/4/2017,5/27/2019,5/27/2019,7/3/2019,7/16/2020,7/16/2020,7/23/2020,6/2/2021,6/2/2021
2246,4444,6/15/1940,Female,156,50,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"1,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,R-X,POM-X,Other,11/27/2006,2/24/2007,2/24/2007,7/1/2009,11/30/2009,11/30/2009,5/3/2012,8/28/2017,8/28/2017,9/6/2017,10/9/2017,10/9/2017
2247,5723,6/15/1958,Male,183,68,Private,No,Yes,Yes, , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,45",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/11/2017,9/14/2017,9/14/2017, , , , , , , , , 
2248,4448,6/15/1947,Male,186,100,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,11/17/2016,3/16/2017,3/16/2017,7/10/2017,12/6/2018,12/6/2018,1/3/2019,2/11/2019,2/11/2019, , , 
2249,8292,6/15/1958,Female,163,90,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,49",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,11/17/2016,3/13/2017,3/13/2017,8/2/2017,1/2/2020,1/2/2020,4/6/2020,6/30/2021, , , , 
2250,5347,6/15/1960,Male,178,83,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"11,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,EMP-X,DAR-X,R-X,V-X,2/27/2017,6/21/2017,6/21/2017,9/4/2017,9/9/2019,9/9/2019,9/12/2019,9/18/2019,9/18/2019,4/20/2020,8/17/2021,8/17/2021
2251,2955,6/15/1945,Male,179,84,Private,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,13",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/15/2016,2/10/2017,2/10/2017,8/31/2017,11/20/2018,11/20/2018,3/13/2019,3/31/2022,10/14/1582, , , 
2252,1550,6/15/1945,Male,182,89,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"11,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/24/2016,4/10/2017,4/10/2017,9/6/2017,8/30/2018,8/30/2018, , , , , , 
2253,2795,6/15/1946,Female,155,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,R-X,2/28/2017,8/22/2017,8/22/2017,9/7/2017,10/11/2018,10/11/2018,2/1/2019,6/30/2021, , , , 
2254,6441,6/15/1946,Male,202,112,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,9/19/2016,3/10/2017,3/10/2017,8/2/2017,11/7/2018,11/7/2018,1/16/2019,7/4/2020,7/4/2020,7/23/2020,6/30/2021,10/14/1582
2255,1560,6/15/1944,Female,172,69,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,6/27/2016,12/12/2016,12/12/2016,7/11/2017,12/18/2018,12/18/2018,2/11/2019,2/21/2019,2/21/2019, , , 
2256,4077,6/15/1943,Male,183,99,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,79",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,Other,R-X,1/26/2017,7/28/2017,7/28/2017,8/10/2017,12/20/2017,12/20/2017,1/9/2018,8/10/2018,8/10/2018,8/31/2018,10/17/2018,10/17/2018
2257,6149,6/15/1944,Female,172,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,11/21/2016,5/19/2017,5/19/2017,8/2/2017,1/30/2019,1/30/2019,2/7/2019,10/29/2019,10/29/2019,11/19/2019,12/9/2019,12/9/2019
2258,7036,6/15/1949,Male,180,87,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,71",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,12/28/2016,6/23/2017,6/23/2017,9/19/2017,11/24/2021,11/24/2021, , , , , , 
2259,7354,6/15/1945,Male,181,75,Private,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"11,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,LEV-X,V-X,DAR-X,V-X,12/12/2016,6/7/2017,6/7/2017,7/3/2017,2/20/2018,2/20/2018,3/12/2018,7/27/2018,7/27/2018,8/7/2018,10/19/2018,10/19/2018
2260,2082,6/15/1942,Male,178,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,2/10/2017,6/21/2017,6/21/2017,9/1/2017,7/5/2021,7/5/2021,8/4/2021,3/31/2022,10/14/1582, , , 
2261,3152,6/15/1948,Male,182,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"19,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,8/8/2016,1/26/2017,1/26/2017,8/31/2017,11/20/2018,11/20/2018,12/14/2018,4/29/2019,4/29/2019,7/3/2019,5/2/2021,5/2/2021
2262,1521,6/15/1945,Female,173,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"3,4",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,8/9/2016,12/27/2016,12/27/2016,7/4/2017,1/12/2021,1/12/2021,1/27/2021,3/31/2022,10/14/1582, , , 
2263,6574,6/15/1944,Female,169,69,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,59",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,R-X,LEV-X,V-X,10/28/2016,4/17/2017,4/17/2017,9/7/2017,3/8/2019,3/8/2019,3/25/2019,5/16/2019,5/16/2019,7/11/2019,9/18/2019,9/18/2019
2264,2732,6/15/1943,Female,167,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,LEV-X,1/17/2017,7/11/2017,7/11/2017,8/7/2017,7/10/2018,7/10/2018, , , , , , 
2265,2829,6/15/1943,Male,166,65,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,1/18/2016,7/14/2016,7/14/2016,8/4/2017,6/18/2019,6/18/2019, , , , , , 
2266,5687,6/15/1950,Female,172,104,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,35",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,Other,V-X,11/17/2016,5/15/2017,5/15/2017,8/14/2017,3/8/2018,3/8/2018,3/21/2018,11/8/2018,11/8/2018,11/21/2018,12/19/2018,12/19/2018
2267,9935,6/15/1945,Male,186,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,29",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,POM-X,R-X,2/27/2017,8/21/2017,8/21/2017,9/1/2017,12/27/2018,12/27/2018,1/3/2019,11/19/2020,11/19/2020,12/5/2020,8/10/2021,8/10/2021
2268,8367,6/15/1951,Male,174,60,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"20,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,POM-X,V-X,V-X,12/8/2016,6/6/2017,6/6/2017,8/24/2017,11/26/2018,11/26/2018,12/18/2018,2/13/2020,2/13/2020,8/4/2021,12/20/2021,12/20/2021
2269,4273,6/15/1941,Female,154,91,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,1600,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,9/25/2017,2/21/2018,2/21/2018,3/12/2018,4/3/2018,4/3/2018, , , , , , 
2270,6530,6/15/1948,Female,170,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,Other type,177,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/5/2014,4/21/2014,4/21/2014,9/18/2017,10/11/2018,10/11/2018, , , , , , 
2271,3206,6/15/1938,Female,159,73,Self-Payer,Yes, , , , , , , , ,Yes, ,3,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/25/2017,1/31/2018,1/31/2018,2/7/2018,4/3/2018,4/3/2018, , , , , , 
2272,9232,6/15/1942,Male,184,86,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"22,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,12/1/2016,5/24/2017,5/24/2017,8/15/2017,8/4/2021,8/4/2021,9/2/2021,3/31/2022,10/14/1582, , , 
2273,3985,6/15/1944,Female,166,49,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,33",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,10/18/2016,2/21/2017,2/21/2017,8/9/2017,7/25/2020,7/25/2020,8/2/2020,12/6/2021,12/6/2021, , , 
2274,3899,6/15/1935,Male,178,79,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"39,58",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , , ,R-X,No CTx,No CTx,V-X,4/9/2013,8/30/2013,8/30/2013,9/30/2013,8/9/2017,8/9/2017, , , , , , 
2275,8717,6/15/1950,Female,166,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"25,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,10/28/2016,2/16/2017,2/16/2017,8/4/2017,12/31/2021,10/14/1582, , , , , , 
2276,5758,6/15/1950,Female,169,58,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,36",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,KYP-X,DAR-X,V-X,10/4/2016,3/23/2017,3/23/2017,8/1/2017,6/12/2019,6/12/2019,4/30/2021,8/26/2021,8/26/2021,9/10/2021,3/31/2022,10/14/1582
2277,8462,6/15/1945,Male,181,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,61",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,NIN-X,V-X,12/22/2016,3/23/2017,3/23/2017,8/2/2017,1/31/2018,1/31/2018,2/14/2018,1/5/2021,1/5/2021,1/25/2021,3/31/2022, 
2278,6724,6/15/1948,Male,172,69,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,62",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,NIN-X,V-X,9/15/2016,1/23/2017,1/23/2017,8/7/2017,6/26/2018,6/26/2018,7/16/2018,11/15/2018,11/15/2018,4/2/2019,3/16/2020,3/16/2020
2279,3825,6/15/1949,Female,168,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"9,41","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,EMP-X,DAR-X,POM-X,V-X,9/23/2016,3/21/2017,3/21/2017,9/28/2017,4/4/2019,4/4/2019,4/22/2019,7/2/2021,7/2/2021,7/21/2021,3/31/2022, 
2280,4903,6/15/1950,Male,187,111,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"20,03",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,7/19/2016,1/16/2017,1/16/2017,7/3/2017,6/13/2019,6/13/2019, , , , , , 
2281,3694,6/15/1943,Male,180,117,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"28,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,6/17/2016,12/5/2016,12/5/2016,7/10/2017,12/9/2019,12/9/2019, , , , , , 
2282,3040,6/15/1931,Female,166,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,45",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,12/9/2016,3/14/2017,3/14/2017,8/10/2017,12/18/2019,12/18/2019,8/18/2020,9/30/2020, , , , 
2283,2384,6/15/1949,Male,189,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,NIN-X,V-X,8/22/2016,2/13/2017,2/13/2017,8/18/2017,2/16/2018,2/16/2018,2/27/2018,10/11/2018,10/11/2018,1/4/2019,2/26/2019,2/26/2019
2284,3163,6/15/1948,Male,184,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,93",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,No CTx,No CTx,V-X,10/6/2016,4/3/2017,4/3/2017,8/21/2017,3/31/2022,10/14/1582, , , , , , 
2285,9807,6/15/1931,Male,169,50,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes, , , , ,Yes,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,88",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/3/2017,9/3/2017,9/3/2017,9/11/2017,7/8/2018,7/8/2018, , , , , , 
2286,8767,6/15/1942,Female,169,65,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,04",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,10/4/2016,3/29/2017,3/29/2017,9/6/2017,10/10/2018,10/10/2018, , , , , , 
2287,3567,6/15/1944,Male,185,81,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,4,ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,EMP-X,DAR-X,EMP-X,V-X,10/31/2016,4/20/2017,4/20/2017,7/3/2017,10/4/2018,10/4/2018,2/18/2019,3/12/2020,3/12/2020,4/24/2020,3/8/2021,3/8/2021
2288,7298,6/15/1942,Male,164,70,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,66",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,7/14/2016,12/29/2016,12/29/2016,7/3/2017,12/17/2018,12/17/2018,3/13/2019,5/6/2019,5/6/2019,7/16/2019,7/25/2020,7/25/2020
2289,4139,6/15/1928,Female,165,79,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,KYP-X,DAR-X,DAR-X,V-X,11/7/2016,5/8/2017,5/8/2017,8/3/2017,12/17/2018,12/17/2018,1/14/2019,5/1/2019,5/1/2019,5/8/2019,12/9/2019,12/9/2019
2290,3277,6/15/1943,Male,171,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,11/21/2016,4/3/2017,4/3/2017,8/14/2017,7/4/2018,7/4/2018,1/30/2019,2/27/2019,2/27/2019, , , 
2291,9386,6/15/1956,Male,177,77,Private,No, ,Yes, , , ,Yes,Yes, , , ,9,III: one or more criteria are fulfilled,IgG,"4,45",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,DAR-X,POM-X,V-X,6/15/2016,9/24/2016,9/24/2016,10/12/2016,1/20/2017,1/20/2017,9/27/2017,12/15/2017,12/15/2017,12/16/2017,3/3/2018,3/3/2018
2292,1277,6/15/1972,Male,170,75,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"24,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,EMP-X,POM-X,No CTx,V-X,10/20/2016,2/24/2017,2/24/2017,9/1/2017,6/28/2018,6/28/2018,7/17/2018,9/9/2018,9/9/2018, , , 
2293,2432,6/15/1950,Male,179,79,Private,No, , , , , , , , , ,Yes,0,Unknown,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,DAR-X,DAR-X,V-X,3/13/2017,4/16/2018,4/16/2018,8/27/2018,9/25/2018,9/25/2018,10/15/2018,2/5/2019,2/5/2019,2/26/2019,7/9/2019,7/9/2019
2294,4579,6/15/1947,Male,175,73,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,Unknown,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,No CTx,No CTx,V-X,5/22/2017,1/24/2018,1/24/2018,10/19/2020,12/31/2020, , , , , , , 
2295,9600,6/15/1934,Female,184,76,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,43",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,8/31/2016,3/1/2017,3/1/2017,9/1/2017,6/7/2019,6/7/2019,8/29/2019,3/12/2020,3/12/2020, , , 
2296,7186,6/15/1942,Female,152,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,03",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,R-X,2/20/2017,8/15/2017,8/15/2017,8/31/2017,12/4/2018,12/4/2018,3/8/2019,1/2/2020,1/2/2020,5/12/2020,10/4/2020,10/4/2020
2297,9207,6/15/1952,Female,177,84,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,88",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,NIN-X,DAR-X,R-X,1/26/2017,7/13/2017,7/13/2017,8/7/2017,12/10/2018,12/10/2018,1/14/2019,12/16/2020,12/16/2020,1/4/2021,2/16/2022,2/16/2022
2298,2731,6/15/1948,Female,158,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,LEV-X,KYP-X,NIN-X,V-X,3/8/2016,8/25/2016,8/25/2016,2/7/2017,8/8/2017,8/8/2017,8/24/2017,3/27/2018,3/27/2018,4/11/2018,9/12/2018,9/12/2018
2299,7523,6/15/1950,Male,179,84,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"15,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,POM-X,R-X,12/22/2016,6/22/2017,6/22/2017,7/3/2017,11/15/2018,11/15/2018,3/14/2019,9/25/2020,9/25/2020,10/5/2020,3/31/2022, 
2300,1003,6/15/1937,Male,180,97,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"4,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Unbekannt,DAR-X,No CTx,No CTx,V-X,6/20/2017,4/26/2018,4/26/2018,9/11/2019,5/20/2020,5/20/2020, , , , , , 
2301,5425,6/15/1966,Male,184,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,6",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/21/2017,11/11/2017,11/11/2017, , , , , , , , , 
2302,3882,6/15/1967,Male,176,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,27",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,10/7/2016,1/3/2017,1/3/2017,8/4/2017,11/3/2020,11/3/2020,11/19/2020,3/31/2022,10/14/1582, , , 
2303,8908,6/15/1950,Male,166,98,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,No CTx,No CTx,No CTx, , , ,7/4/2017,9/15/2017,9/15/2017, , , , , , 
2304,2370,6/15/1954,Male,181,64,Private,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"17,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/16/2017,4/18/2017,4/18/2017,9/11/2017,6/14/2019,6/14/2019,6/21/2019,5/31/2020,5/31/2020, , , 
2305,6267,6/15/1938,Female,168,66,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"4,35",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,1/16/2017,8/15/2017,8/15/2017,8/28/2017,3/29/2020,3/29/2020,4/8/2020,3/31/2022,10/14/1582, , , 
2306,4008,6/15/1949,Male,173,76,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,V-X,KYP-X,DAR-X,No CTx, , , ,3/22/2012,8/25/2012,8/25/2012,7/3/2017,7/24/2017,7/24/2017,2/27/2019,6/17/2020,6/17/2020
2307,6861,6/15/1961,Male,182,88,Private,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,R-X,KYP-X,No CTx,V-X,6/29/2015,10/1/2015,10/1/2015,10/10/2015,1/5/2016,1/5/2016,1/14/2016,2/27/2016,2/27/2016, , , 
2308,5296,6/15/1946,Male,161,73,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Unbekannt,R-X,DAR-X,No CTx,V-X,6/1/2014,11/1/2014,11/1/2014,12/1/2015,11/1/2016,11/1/2016,11/28/2016,7/11/2017,7/11/2017, , , 
2309,5990,6/15/1942,Male,183,105,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,0,I: fulfilling all 4 criteria,IgA,"999,99",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Unbekannt,No CTx,DAR-X,No CTx,V-X,11/11/2014,1/2/2015,1/2/2015, , , ,8/30/2017,3/31/2021,10/14/1582, , , 
2310,8941,6/15/1945,Female,163,69,Private,No, , , ,Yes, , , , , ,Yes,2,III: one or more criteria are fulfilled,IgA,",45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,DAR-X,KYP-X,V-X,12/1/2016,5/23/2017,5/23/2017,9/3/2017,11/24/2017,11/24/2017,12/5/2017,9/5/2018,9/5/2018,9/25/2018,2/15/2019,2/15/2019
2311,2686,6/15/1935,Male,178,98,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,NIN-X,No CTx,V-X,9/23/2013,11/21/2014,11/21/2014,1/13/2015,9/1/2017,9/1/2017,9/27/2017,12/31/2017, , , , 
2312,5376,6/15/1952,Male,170,86,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"2,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,No,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,V-X,V-X,V-X,Other,8/16/2000,12/1/2000,12/1/2000,7/10/2014,11/24/2014,11/24/2014,11/9/2016,12/2/2016,12/2/2016,9/1/2017,1/12/2018,1/12/2018
2313,6502,6/15/1938,Male,181,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,DAR-X,EMP-X,V-X,12/30/2014,2/21/2015,2/21/2015,3/1/2015,11/1/2016,11/1/2016,8/4/2017,2/15/2018,2/15/2018,3/22/2018,10/17/2018,10/17/2018
2314,6065,6/15/1938,Male,166,74,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgD,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,POM-X,Other,V-X,6/21/2017,9/7/2017,9/7/2017,1/4/2018,2/6/2018,2/6/2018,3/9/2018,1/25/2019,1/25/2019,3/25/2019,10/30/2019,10/30/2019
2315,8499,6/15/1954,Male,178,70,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , , , ,No CTx,DAR-X,EMP-X,V-X,5/1/2014,8/1/2014,8/1/2014, , , ,9/13/2017,10/25/2017,10/25/2017,11/2/2017,10/23/2018,10/23/2018
2316,8858,6/15/1942,Female,181,82,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes,Yes, , ,1,I: fulfilling all 4 criteria,IgG,"4,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L", ,EMP-X,NIN-X,No CTx,V-X,1/24/2017,6/6/2017,6/6/2017,9/14/2017,11/16/2017,11/16/2017,12/7/2017,12/18/2017,12/18/2017, , , 
2317,7498,6/15/1958,Male,173,90,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,Unknown,IgA,"1,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom, , , , , , ,"<3,5 mg/L",Nein,R-X,V-X,KYP-X,V-X,5/18/2010,8/9/2010,8/9/2010,12/7/2012,9/17/2014,9/17/2014,10/7/2014,12/16/2014,12/16/2014,2/10/2016,3/4/2016,3/4/2016
2318,2959,6/15/1949,Male,197,105,Private,No, , , , , , , , , , ,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,R-X,DAR-X,No CTx,V-X,2/10/2014,4/16/2014,4/16/2014,5/19/2015,8/2/2017,8/2/2017,9/14/2017,10/19/2020,10/19/2020, , , 
2319,4381,6/15/1966,Male,185,94,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"4,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,KYP-X,POM-X,V-X,7/16/2012,10/4/2012,10/4/2012,9/22/2014,1/27/2016,1/27/2016,3/21/2016,6/17/2016,6/17/2016,7/11/2016,7/14/2016,7/14/2016
2320,1258,6/15/1956,Female,168,75,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,145,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,Other,V-X,8/1/2013,10/9/2013,10/9/2013,9/1/2017,1/18/2018,1/18/2018,7/15/2019,11/12/2020,11/12/2020,1/13/2021,11/10/2021,11/10/2021
2321,6008,6/15/1953,Female,173,64,Private,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,R-X,DAR-X,EMP-X,11/27/2015,3/22/2016,3/22/2016,9/26/2017,7/9/2018,7/9/2018,7/13/2018,4/1/2019,4/1/2019,5/13/2019,8/31/2020,8/31/2020
2322,1801,6/15/1951,Female,164,51,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,3/9/2017,8/28/2017,8/28/2017,9/11/2017,11/22/2018,11/22/2018,1/7/2019,3/31/2022,10/14/1582, , , 
2323,9387,6/15/1950,Male,189,97,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,66","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,LEV-X,2/21/2017,8/17/2017,8/17/2017,9/12/2017,12/10/2018,12/10/2018,1/24/2019,5/31/2019,5/31/2019, , , 
2324,1379,6/15/1942,Male,184,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,82",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Ja,EMP-X,KYP-X,DAR-X,V-X,10/17/2016,4/13/2017,4/13/2017,9/13/2017,12/19/2018,12/19/2018,3/8/2019,11/22/2019,11/22/2019,12/5/2019,12/13/2019,12/13/2019
2325,7229,6/15/1964,Male,999,80,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,KYP-X,POM-X,DAR-X,V-X,11/24/2014,4/8/2015,4/8/2015,9/12/2017,5/8/2018,5/8/2018,5/15/2018,1/31/2020,1/31/2020,2/15/2020,10/26/2020,10/26/2020
2326,2232,6/15/1966,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"99999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,No CTx,No CTx,V-X,10/6/2015,12/28/2015,12/28/2015,9/4/2017,3/31/2019,10/14/1582, , , , , , 
2327,9214,6/15/1962,Male,176,80,Private,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"25,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,1/8/2016,7/5/2016,7/5/2016,9/13/2016,8/18/2017,8/18/2017,9/5/2017,6/30/2021,10/14/1582, , , 
2328,5463,6/15/1934,Male,196,129,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,EMP-X,V-X,11/8/2016,3/13/2017,3/13/2017,8/10/2017,1/8/2019,1/8/2019,3/26/2019,10/11/2021,10/11/2021,11/25/2021,3/31/2022, 
2329,2901,6/15/1958,Female,999,65,Compulsory health insurance CHI,No, , , , , , ,Yes, , ,Yes,9,III: one or more criteria are fulfilled,Other type,"27,53",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,KYP-X,No CTx,No CTx,V-X,8/1/2016,10/23/2016,10/23/2016,9/13/2017,12/31/2017,10/14/1582, , , , , , 
2330,9982,6/15/1940,Male,174,92,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz, , , , , , , , ,No CTx,No CTx,No CTx,R-X,9/4/2017,12/31/2017, , , , , , , , , , 
2331,6803,6/15/1972,Male,179,74,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,24",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,DAR-X,NIN-X,V-X,1/28/2016,4/25/2016,4/25/2016,10/24/2016,9/25/2017,9/25/2017,10/19/2017,1/31/2019,1/31/2019,3/11/2019,10/26/2020,10/26/2020
2332,2161,6/15/1966,Female,165,49,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/12/2016,2/2/2017,2/2/2017,7/5/2017,12/18/2019,12/18/2019, , , , , , 
2333,1548,6/15/1944,Female,187,114,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,67",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,9/22/2016,1/16/2017,1/16/2017,7/3/2017,2/14/2019,2/14/2019,3/25/2019,5/14/2019,5/14/2019,7/5/2019,12/23/2019,12/23/2019
2334,5847,6/15/1945,Male,173,104,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,19",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,10/15/2015,3/1/2016,3/1/2016,8/19/2016,7/24/2017,7/24/2017,8/17/2017,2/21/2018,2/21/2018, , , 
2335,2870,6/15/1949,Female,170,62,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,145,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/28/2017,12/31/2017, , , , , , , , , , 
2336,8034,6/15/1945,Male,175,78,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,165,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/26/2017,3/13/2018,3/13/2018,9/3/2018,3/31/2019,10/14/1582, , , , , , 
2337,5141,6/15/1949,Male,168,72,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,155,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/31/2017,5/23/2018,5/23/2018,2/5/2019,9/15/2019,9/15/2019, , , , , , 
2338,6494,6/15/1955,Female,162,68,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,185,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,DAR-X,R-X,No CTx,V-X,9/19/2017,6/5/2018,6/5/2018,2/20/2019,7/24/2019,7/24/2019,8/13/2019,12/12/2019,12/12/2019, , , 
2339,8308,6/15/1952,Female,160,58,Private,No, ,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/25/2017,12/31/2017, , , , , , , , , , 
2340,5826,6/15/1953,Male,184,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,DAR-X,V-X,5/1/2011,11/1/2011,11/1/2011,3/12/2015,8/23/2017,8/23/2017,9/6/2017,11/2/2017,11/2/2017,11/7/2017,2/20/2018,2/20/2018
2341,2953,6/15/1959,Male,173,72,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,1",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,DAR-X,V-X,8/3/2012,12/13/2012,12/13/2012,10/13/2016,8/29/2017,8/29/2017,9/7/2017,6/29/2018,6/29/2018,7/19/2018,2/21/2019,2/21/2019
2342,1236,6/15/1956,Female,167,81,Private,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,1",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,Other,V-X,1/2/2013,4/18/2013,4/18/2013,2/2/2016,6/14/2017,6/14/2017,7/20/2017,11/13/2017,11/13/2017,11/30/2017,2/5/2018,2/5/2018
2343,1504,6/15/1958,Male,194,95,Private,No, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"7,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,EMP-X,No CTx,V-X,4/24/2012,8/29/2012,8/29/2012,6/2/2016,7/26/2017,7/26/2017,8/30/2017,6/11/2018,6/11/2018, , , 
2344,1911,6/15/1959,Female,167,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"6,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,8/15/2013,12/17/2013,12/17/2013,9/8/2016,6/28/2017,6/28/2017,7/13/2017,3/21/2018,3/21/2018,4/11/2018,7/11/2018,7/11/2018
2345,1046,6/15/1943,Male,180,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,KYP-X,DAR-X,POM-X,R-X,2/3/2016,11/10/2016,11/10/2016,12/7/2016,7/13/2017,7/13/2017,8/17/2017,1/18/2018,1/18/2018,2/6/2018,4/10/2018,4/10/2018
2346,7648,6/15/1951,Male,172,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,9",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,5/2/2012,9/13/2012,9/13/2012,11/12/2015,7/26/2016,7/26/2016,8/10/2016,6/21/2017,6/21/2017,7/20/2017,2/12/2018,2/12/2018
2347,3146,6/15/1955,Male,184,110,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"4,16","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,9/11/2017,1/25/2018,1/25/2018, , , , , , , , , 
2348,4067,6/15/1978,Male,184,67,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/21/2017,12/20/2017,12/20/2017, , , , , , , , , 
2349,5560,6/15/1956,Female,179,108,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,"6,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/21/2017,12/14/2017,12/14/2017, , , , , , , , , 
2350,8001,6/15/1958,Female,166,56,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,67",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,EMP-X,V-X,6/27/2012,10/24/2012,10/24/2012,4/13/2017,9/7/2017,9/7/2017,9/21/2017,3/8/2018,3/8/2018,3/21/2018,10/11/2018,10/11/2018
2351,1782,6/15/1958,Male,177,77,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,64",ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,2/4/2016,7/14/2016,7/14/2016,1/1/2018,2/6/2021,2/6/2021,2/16/2021,3/31/2022,10/14/1582, , , 
2352,8441,6/15/1958,Male,187,124,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,48",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,V-X,KYP-X,DAR-X,LEV-X,3/12/2015,10/29/2015,10/29/2015,1/5/2016,6/15/2017,6/15/2017,7/19/2017,1/17/2018,1/17/2018,1/30/2018,12/4/2018,12/4/2018
2353,7218,6/15/1944,Male,177,55,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,97",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,DAR-X,V-X,6/23/2017,6/25/2018,6/25/2018,7/5/2018,12/30/2019,12/30/2019,1/16/2020,11/1/2020,11/1/2020,11/19/2020,6/18/2021,6/18/2021
2354,9572,6/15/1947,Male,180,80,Compulsory health insurance CHI,Unknown, , ,Yes, , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics, , , , ,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , ,Nein,R-X,No CTx,No CTx,LEV-X,8/1/2017,1/15/2018,1/15/2018,3/28/2018,6/30/2018, , , , , , , 
2355,7779,6/15/1952,Female,163,63,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,86","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/31/2017,11/27/2017,11/27/2017,2/7/2020,4/28/2021,4/28/2021, , , , , , 
2356,9451,6/15/1956,Female,161,66,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,52",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,KYP-X,EMP-X,DAR-X,R-X,8/27/2015,3/16/2017,3/16/2017,4/6/2017,8/3/2017,8/3/2017,8/16/2017,5/31/2018,5/31/2018,6/18/2018,11/26/2018,11/26/2018
2357,2969,6/15/1947,Female,165,66,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/1/2017,9/28/2020,9/28/2020, , , , , , , , , 
2358,6130,6/15/1948,Male,184,78,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,32",ISS stage II (neither stage I nor stage III), , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,R-X,POM-X,No CTx,LEV-X,8/24/2017,8/29/2018,8/29/2018,9/24/2018,7/11/2020,7/11/2020,8/1/2020,1/9/2021,1/9/2021, , , 
2359,8850,6/15/1947,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , , , ,KYP-X,DAR-X,No CTx,Other,6/15/2002,8/15/2002,8/15/2002,7/19/2016,10/4/2016,10/4/2016,12/2/2019,12/31/2019, , , , 
2360,8240,6/15/1933,Male,180,90,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,17,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,KYP-X,V-X,KYP-X,Other,8/3/2017,12/3/2018,12/3/2018,9/23/2019,6/24/2020,6/24/2020,7/21/2020,9/11/2021,9/11/2021,9/20/2021,3/31/2022,10/14/1582
2361,6202,6/15/1940,Male,189,92,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,12,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,V-X,Other,7/14/2017,2/25/2018,2/25/2018,6/20/2019,9/20/2020,9/20/2020,10/25/2020,8/26/2021,8/26/2021,9/10/2021,3/31/2022,10/14/1582
2362,2157,6/15/1941,Male,174,78,Private,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/5/2017,12/31/2017, , , , , , , , , , 
2363,9682,6/15/1943,Male,178,103,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"923,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/13/2017,12/18/2017,12/18/2017,12/3/2019,3/31/2020, , , , , , , 
2364,7899,6/15/1932,Male,172,80,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Unknown,Unknown,Unknown, , , ,2,III: one or more criteria are fulfilled,IgG,440,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)", , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,LEV-X,No CTx,No CTx,V-X,7/10/2017,11/22/2017,11/22/2017,1/8/2018,4/2/2018,4/2/2018, , , , , , 
2365,8161,6/15/1961,Male,196,90,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,Unknown,IgG,18368,ISS stage II (neither stage I nor stage III), , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,POM-X,V-X,4/26/2016,7/14/2016,7/14/2016,9/22/2017,8/27/2018,8/27/2018,9/19/2018,4/3/2019,4/3/2019,6/17/2019,10/15/2020,10/15/2020
2366,4363,6/15/1946,Male,170,77,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgA,"52,3",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/4/2017,11/15/2017,11/15/2017, , , , , , , , , 
2367,4913,6/15/1933,Female,165,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,9634,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,7/19/2017,8/10/2017,8/10/2017,8/23/2017,12/31/2017,10/14/1582, , , , , , 
2368,6517,6/15/1953,Male,181,81,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,55,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/29/2017,12/31/2017, , , , , , , , , , 
2369,4948,6/15/1940,Female,154,72,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,28,unknown/ISS-Criteria not used for prognostics, , , , ,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch), , , , , , , , ,R-X,No CTx,No CTx,V-X,11/23/2015,8/24/2016,8/24/2016,9/29/2017,12/31/2017, , , , , , , 
2370,3976,6/15/1950,Male,173,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,7000,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,EMP-X,V-X,10/13/2016,1/12/2017,1/12/2017,9/10/2018,10/15/2018,10/15/2018,10/24/2018,1/30/2020,1/30/2020,2/10/2020,3/31/2020, 
2371,3379,6/15/1961,Male,182,64,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,I: fulfilling all 4 criteria,IgD,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/4/2017,2/27/2017,2/27/2017, , , , , , , , , 
2372,4654,6/15/1937,Male,176,100,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,IgG,4307,unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,R-X,V-X,No CTx,V-X,2/10/2014,6/13/2014,6/13/2014,10/15/2014,5/15/2015,5/15/2015,9/6/2017,8/31/2018,8/31/2018, , , 
2373,9443,6/15/1950,Male,190,86,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , ,Yes,Yes, ,0,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics, , , , ,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/11/2017,11/23/2017,11/23/2017, , , , , , , , , 
2374,6852,6/15/1970,Female,165,59,Compulsory health insurance CHI,No,Yes, , ,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,5600,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/25/2017,9/30/2017, , , , , , , , , , 
2375,6156,6/15/1943,Female,168,67,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,6520,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/11/2017,9/30/2017, , , , , , , , , , 
2376,5209,6/15/1943,Female,163,77,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,52,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch), , , , , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,8/15/2017,2/15/2018,2/15/2018,3/15/2018,10/15/2018,10/15/2018,3/15/2019,6/15/2019,6/15/2019, , , 
2377,5848,6/15/1939,Male,172,70,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,No,No,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,R-X,10/23/2017,11/6/2018,11/6/2018,9/21/2021,11/18/2021,11/18/2021, , , , , , 
2378,8325,6/15/1952,Female,177,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,Yes,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , , , ,R-X,DAR-X,No CTx,V-X,1/7/2016,3/17/2016,3/17/2016,7/14/2017,9/9/2021,9/9/2021,1/31/2022,3/31/2022,10/14/1582, , , 
2379,4679,6/15/1964,Female,169,79,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes,Yes, ,1,I: fulfilling all 4 criteria,IgG,"46,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/4/2017,11/21/2017,11/21/2017, , , , , , , , , 
2380,8225,6/15/1939,Female,165,77,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/8/2014,7/21/2015,7/21/2015,8/23/2016,1/19/2018,1/19/2018, , , , , , 
2381,8629,6/15/1936,Male,170,54,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"51,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/13/2017,3/31/2019, , , , , , , , , , 
2382,3395,6/15/1933,Male,182,113,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"37,7",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,Other,KYP-X,V-X,2/28/2017,10/4/2017,10/4/2017,10/17/2017,2/28/2018,2/28/2018,2/28/2018,5/16/2018,5/16/2018,6/7/2018,7/13/2018,7/13/2018
2383,5458,6/15/1936,Female,171,55,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,R-X,NIN-X,No CTx,Other,6/23/2015,11/8/2015,11/8/2015,9/1/2017,2/15/2018,2/15/2018,2/26/2019,8/28/2019,8/28/2019, , , 
2384,1333,6/15/1931,Female,160,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,2,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/17/2017,10/2/2018,10/2/2018,1/21/2019,4/2/2019,4/2/2019, , , , , , 
2385,8604,6/15/1932,Female,164,56,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,10/12/2015,5/12/2016,5/12/2016,12/13/2017,2/9/2018,2/9/2018, , , , , , 
2386,6988,6/15/1944,Male,172,63,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"1,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,R-X,NIN-X,No CTx,V-X,9/15/2016,8/10/2017,8/10/2017,12/8/2017,6/1/2018,6/1/2018,11/15/2018,12/5/2018,12/5/2018, , , 
2387,7029,6/15/1954,Female,176,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"4,4",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L",Ja,DAR-X,KYP-X,EMP-X,V-X,10/2/2017,12/15/2017,12/15/2017,9/9/2019,2/19/2021,2/19/2021,3/10/2021,7/8/2021,7/8/2021,7/9/2021,8/16/2021,8/16/2021
2388,9876,6/15/1929,Male,178,70,Private,No, , , , ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,",9",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Nein,V-X,No CTx,No CTx,V-X,10/19/2017,1/25/2018,1/25/2018,4/10/2018,4/25/2018,4/25/2018, , , , , , 
2389,2837,6/15/1930,Female,157,46,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"1,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/30/2017,2/1/2018,2/1/2018, , , , , , , , , 
2390,9263,6/15/1939,Male,174,69,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"3,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,R-X,V-X,9/20/2016,12/2/2016,12/2/2016,12/4/2017,3/30/2018,3/30/2018,9/10/2018,10/18/2018,10/18/2018,3/4/2020,10/15/2020,10/15/2020
2391,8864,6/15/1935,Female,158,53,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,9,III: one or more criteria are fulfilled,Other type,"1,8",unknown/ISS-Criteria not used for prognostics,No,Yes,9,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , , ,R-X,V-X,KYP-X,V-X,6/18/2014,3/15/2015,3/15/2015,1/28/2016,11/15/2016,11/15/2016,1/1/2017,4/30/2017,4/30/2017,5/1/2017,10/20/2017,10/20/2017
2392,3389,6/15/1940,Male,180,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,V-X,R-X,V-X,1/17/2014,5/15/2014,5/15/2014,11/1/2014,2/9/2015,2/9/2015,5/27/2015,9/2/2015,9/2/2015,1/7/2016,4/27/2016,4/27/2016
2393,7876,6/15/1936,Male,180,96,Private,No, , ,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"2,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,DAR-X,V-X,1/8/2017,4/15/2018,4/15/2018,12/3/2018,1/16/2019,1/16/2019,7/15/2019,9/30/2020,9/30/2020,10/28/2020,11/10/2021,11/10/2021
2394,7728,6/15/1930,Female,158,53,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,V-X,Other,R-X,LEV-X,1/12/2009,10/9/2017,10/9/2017,10/23/2017,12/4/2017,12/4/2017,1/11/2018,5/31/2018,5/31/2018,6/29/2018,12/3/2018,12/3/2018
2395,8536,6/15/1946,Female,160,67,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,36,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,KYP-X,V-X,Other,7/23/2017,11/12/2017,11/12/2017,12/10/2017,9/5/2018,9/5/2018,5/24/2019,2/12/2020,2/12/2020,3/23/2020,2/27/2021,2/27/2021
2396,8744,6/15/1952,Female,170,82,Compulsory health insurance CHI,Unknown, , ,Yes, , , ,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgA,"8,79",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/12/2017,11/10/2017,11/10/2017, , , , , , , , , 
2397,7958,6/15/1950,Female,168,70,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,2769,unknown/ISS-Criteria not used for prognostics,No,9,No,No,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Unbekannt, , , , , ,R-X,No CTx,No CTx,V-X,11/14/2016,1/17/2017,1/17/2017,12/27/2017,12/27/2017,12/27/2017, , , , , , 
2398,6594,6/15/1941,Female,168,99,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,4799,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,No CTx,No CTx,V-X,3/3/2015,7/15/2015,7/15/2015,11/23/2017,12/31/2017, , , , , , , 
2399,1501,6/15/1926,Male,180,97,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,Unknown,IgG,3008,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,R-X,R-X,Other,9/1/2009,6/15/2010,6/15/2010,1/3/2012,6/1/2012,6/1/2012,4/12/2014,9/5/2014,9/5/2014,5/23/2016,11/8/2017,11/8/2017
2400,6645,6/15/1946,Male,178,80,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,Unknown,IgG,2000,unknown/ISS-Criteria not used for prognostics,Yes,No,9,No,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,8/23/2016,9/21/2016,9/21/2016, , , , , , , , , 
2401,6059,6/15/1949,Male,180,79,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,FAR-X,NIN-X,Other,12/22/2016,5/15/2017,5/15/2017,12/21/2017,9/25/2018,9/25/2018,9/18/2019,9/13/2020,9/13/2020,9/27/2020,8/26/2021,8/26/2021
2402,6482,6/15/1936,Male,178,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, ,Unknown, ,1,III: one or more criteria are fulfilled,IgG,"2,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/19/2017,3/31/2019, , , , , , , , , , 
2403,5924,6/15/1952,Female,167,71,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,33,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,FAR-X,EMP-X,Other,10/27/2016,3/15/2017,3/15/2017,10/15/2017,11/13/2018,11/13/2018,6/24/2019,3/19/2020,3/19/2020,3/30/2020,11/25/2020,11/25/2020
2404,8167,6/15/1959,Male,175,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,21",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/9/2017,1/4/2018,1/4/2018, , , , , , , , , 
2405,7413,6/15/1939,Female,160,50,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,2800,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/22/2017,9/2/2019,9/2/2019, , , , , , , , , 
2406,6591,6/15/1960,Male,180,80,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,4794,unknown/ISS-Criteria not used for prognostics,9,9,9,9,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,V-X,DAR-X,V-X,4/1/2010,6/1/2010,6/1/2010,12/1/2013,11/24/2017,11/24/2017,5/15/2018,6/26/2018,6/26/2018,1/7/2020,11/2/2020,11/2/2020
2407,3399,6/15/1934,Female,165,65,Compulsory health insurance CHI,No, , , , , , , , , , ,2,Unknown,IgG,1199,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,unbekannt,Nein,Unbekannt,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,10/10/2017,12/31/2017, , , , , , , , , , 
2408,8836,6/15/1943,Male,178,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,2654,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Unbekannt,POM-X,No CTx,No CTx,R-X,7/1/2015,5/13/2019,5/13/2019,10/28/2019,4/23/2021,4/23/2021, , , , , , 
2409,3417,6/15/1945,Male,193,103,Private,No, ,Yes,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,14",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,V-X,No CTx,V-X,11/9/2017,7/19/2018,7/19/2018,2/27/2020,2/10/2022,2/10/2022,3/17/2022,3/31/2022, , , , 
2410,9282,6/15/1947,Male,184,81,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,7",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,R-X,11/22/2017,12/28/2018,12/28/2018,8/26/2020,4/15/2021,4/15/2021, , , , , , 
2411,1750,6/15/1935,Male,177,70,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,61",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,11/2/2017,3/6/2018,3/6/2018,3/21/2018,10/23/2019,10/23/2019,12/27/2019,12/28/2019,12/28/2019, , , 
2412,3394,6/15/1945,Male,186,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"13,96","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/27/2017,4/2/2018,4/2/2018, , , , , , , , , 
2413,3105,6/15/1946,Female,165,74,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/28/2017,4/3/2018,4/3/2018, , , , , , , , , 
2414,9809,6/15/1951,Male,171,68,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,25",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/13/2017,4/30/2018,4/30/2018,2/27/2019,5/11/2021,5/11/2021, , , , , , 
2415,1772,6/15/1944,Male,177,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/29/2017,3/14/2019,3/14/2019,9/20/2021,3/31/2022,10/14/1582, , , , , , 
2416,7044,6/15/1953,Male,180,84,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"23,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,R-X,POM-X,No CTx,LEV-X,11/10/2017,11/9/2018,11/9/2018,11/26/2018,1/2/2020,1/2/2020,6/10/2020,6/30/2021, , , , 
2417,4164,6/15/1945,Male,180,109,Private,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"33,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/23/2017,12/20/2018,12/20/2018, , , , , , , , , 
2418,8229,6/15/1952,Male,183,64,Private,No, , , , , ,Yes, ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,15",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,R-X,11/10/2017,3/19/2018,3/19/2018,3/23/2018,12/5/2018,12/5/2018,1/31/2019,12/2/2019,12/2/2019,12/30/2019,1/2/2020,1/2/2020
2419,8445,6/15/1946,Male,186,95,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,39,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,Other,4/15/2014,5/23/2015,5/23/2015,11/23/2017,4/24/2019,4/24/2019, , , , , , 
2420,2531,6/15/1946,Female,172,53,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"21,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/3/2017,2/27/2018,2/27/2018,3/6/2018,5/6/2020,5/6/2020, , , , , , 
2421,5792,6/15/1949,Male,172,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,43",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/9/2017,2/27/2018,2/27/2018,1/18/2020,6/30/2020,10/14/1582, , , , , , 
2422,2411,6/15/1953,Female,164,83,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,62",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/28/2017,5/9/2018,5/9/2018, , , , , , , , , 
2423,6326,6/15/1945,Male,171,80,Private,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"22,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,KYP-X,NIN-X,No CTx,V-X,11/14/2017,2/27/2018,2/27/2018,3/8/2018,12/2/2019,12/2/2019,12/16/2019,7/19/2021,7/19/2021, , , 
2424,8408,6/15/1951,Male,187,91,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,13",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/28/2017,4/3/2018,4/3/2018,9/1/2020,3/16/2021,3/16/2021, , , , , , 
2425,9233,6/15/1951,Female,163,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,R-X,POM-X,No CTx,V-X,11/29/2017,3/13/2018,3/13/2018,3/26/2018,1/2/2020,1/2/2020,6/3/2020,3/31/2022, , , , 
2426,9694,6/15/1950,Male,189,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,4",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,11/8/2017,1/3/2019,1/3/2019,7/17/2020,1/22/2021,1/22/2021, , , , , , 
2427,1106,6/15/1947,Male,172,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"12,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,11/20/2017,11/8/2018,11/8/2018,2/15/2019,9/13/2019,9/13/2019, , , , , , 
2428,8763,6/15/1962,Male,175,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/21/2017,1/21/2018,1/21/2018, , , , , , , , , 
2429,4827,6/15/1932,Male,178,78,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/19/2017,9/30/2018, , , , , , , , , , 
2430,7385,6/15/1949,Male,182,79,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,Unknown,IgG,2811,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,1/3/2017,4/10/2017,4/10/2017, , , , , , , , , 
2431,9963,6/15/1958,Female,165,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,2754,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/13/2017,1/15/2018,1/15/2018, , , , , , , , , 
2432,9332,6/15/1938,Male,180,96,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , ,Yes,2,III: one or more criteria are fulfilled,IgG,3848,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/14/2017,6/29/2020,6/29/2020, , , , , , , , , 
2433,3302,6/15/1954,Male,180,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,3132,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/26/2017,12/31/2017,10/14/1582, , , , , , , , , 
2434,8088,6/15/1940,Male,172,74,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,633,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,LEV-X,No CTx,V-X,4/1/2016,11/15/2016,11/15/2016,1/20/2017,2/1/2018,2/1/2018,4/23/2018,5/29/2018,5/29/2018, , , 
2435,3305,6/15/1936,Female,165,70,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,Unknown,IgG,497,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/12/2017,6/6/2018,6/6/2018, , , , , , , , , 
2436,8501,6/15/1951,Male,171,84,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/2/2017,4/19/2018,4/19/2018, , , , , , , , , 
2437,9832,6/15/1944,Female,161,66,Private,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,72",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/8/2017,11/21/2018,11/21/2018, , , , , , , , , 
2438,7457,6/15/1943,Male,186,83,Compulsory health insurance CHI,Yes, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,40,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,FAR-X,EMP-X,Other,9/2/2014,8/26/2015,8/26/2015,10/12/2017,6/13/2018,6/13/2018,3/20/2019,11/25/2020,11/25/2020,12/17/2020,8/28/2021,8/28/2021
2439,1736,6/15/1933,Female,167,58,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,69",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/7/2017,3/13/2018,3/13/2018, , , , , , , , , 
2440,8304,6/15/1950,Female,164,64,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"22,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,11/2/2017,10/26/2018,10/26/2018, , , , , , , , , 
2441,5619,6/15/1953,Male,180,87,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,02",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,11/10/2017,1/4/2018,1/4/2018,12/17/2020,3/31/2022,10/14/1582, , , , , , 
2442,1669,6/15/1950,Female,164,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"28,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/1/2017,10/27/2018,10/27/2018, , , , , , , , , 
2443,9165,6/15/1949,Female,185,87,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"20,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/8/2017,11/1/2018,11/1/2018, , , , , , , , , 
2444,8968,6/15/1931,Female,176,56,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,"17,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,11/3/2017,1/3/2018,1/3/2018,7/19/2021,3/31/2022,10/14/1582, , , , , , 
2445,5897,6/15/1944,Male,191,93,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,27,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,DAR-X,Other,6/13/2013,8/23/2014,8/23/2014,11/23/2017,12/28/2017,12/28/2017,6/18/2018,10/4/2019,10/4/2019,12/19/2019,11/16/2020,11/16/2020
2446,7984,6/15/1953,Male,177,58,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,55",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/6/2017,10/30/2018,10/30/2018, , , , , , , , , 
2447,5620,6/15/1935,Male,189,87,Compulsory health insurance CHI,Yes,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,39,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,Other,4/23/2014,3/20/2015,3/20/2015,10/14/2017,12/31/2017, , , , , , , 
2448,1993,6/15/1946,Male,176,99,Private,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,19,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,KYP-X,V-X,10/15/2017,6/23/2018,6/23/2018,9/17/2018,6/9/2019,6/9/2019,6/26/2019,3/20/2020,3/20/2020,3/25/2020,9/27/2020,9/27/2020
2449,9502,6/15/1949,Male,170,66,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,V-X,R-X,10/29/2017,1/12/2018,1/12/2018,3/13/2018,10/16/2018,10/16/2018,6/27/2019,6/20/2020,6/20/2020,7/16/2020,5/23/2021,5/23/2021
2450,3645,6/15/1946,Female,152,80,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,39",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/23/2017,3/29/2018,3/29/2018, , , , , , , , , 
2451,5625,6/15/1948,Male,186,87,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,15",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/21/2017,3/8/2018,3/8/2018,3/22/2018,12/27/2019,12/27/2019, , , , , , 
2452,4931,6/15/1964,Male,180,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,94",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/7/2017,3/13/2018,3/13/2018, , , , , , , , , 
2453,6616,6/15/1947,Male,199,79,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/2/2017,6/19/2019,6/19/2019, , , , , , , , , 
2454,3320,6/15/1951,Female,155,49,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"25,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/2/2017,1/7/2019,1/7/2019, , , , , , , , , 
2455,7554,6/15/1946,Male,201,108,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,21","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/3/2017,7/25/2018,7/25/2018, , , , , , , , , 
2456,9248,6/15/1950,Male,174,103,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,82",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/6/2017,8/22/2018,8/22/2018, , , , , , , , , 
2457,8649,6/15/1950,Male,184,113,Private,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,58",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/15/2017,2/16/2018,2/16/2018,2/22/2018,9/26/2019,9/26/2019, , , , , , 
2458,2274,6/15/1946,Male,173,76,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"10,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/6/2017,11/28/2018,11/28/2018, , , , , , , , , 
2459,1665,6/15/1948,Male,185,79,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,32,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,EMP-X,KYP-X,V-X,10/30/2017,3/17/2018,3/17/2018,11/23/2018,11/27/2019,11/27/2019,3/20/2020,2/9/2021,2/9/2021,3/26/2021,3/31/2022,10/14/1582
2460,1197,6/15/1948,Male,176,80,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,KYP-X,V-X,12/5/2017,9/3/2018,9/3/2018,9/23/2019,7/20/2020,7/20/2020,9/3/2020,8/23/2021,8/23/2021,9/20/2021,3/31/2022,10/14/1582
2461,8515,6/15/1938,Female,166,67,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,LEV-X,DAR-X,KYP-X,No CTx, , , ,10/23/2017,2/23/2018,2/23/2018,3/15/2018,12/15/2018,12/15/2018,9/20/2019,6/29/2020,6/29/2020
2462,1184,6/15/1946,Male,167,81,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"1,5",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/29/2017,1/18/2018,1/18/2018,11/13/2019,6/25/2020,6/25/2020, , , , , , 
2463,3789,6/15/1931,Male,176,80,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,34,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,NIN-X,KYP-X,No CTx, , , ,10/23/2017,2/19/2018,2/19/2018,3/27/2018,12/28/2018,12/28/2018,5/22/2019,3/10/2020,3/10/2020
2464,2400,6/15/1948,Male,179,62,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"76,81",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,KYP-X,V-X,11/13/2017,2/1/2018,2/1/2018,8/28/2019,2/12/2020,2/12/2020,2/26/2020,6/4/2020,6/4/2020,2/24/2021,5/19/2021,5/19/2021
2465,9758,6/15/1936,Female,163,62,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"20,07",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,POM-X,V-X,10/25/2017,3/6/2018,3/6/2018,1/24/2019,5/2/2019,5/2/2019,6/26/2019,8/5/2019,8/5/2019,11/28/2019,1/14/2021,1/14/2021
2466,2250,6/15/1960,Female,165,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/4/2017,2/4/2018,2/4/2018,3/8/2021,12/31/2021,10/14/1582, , , , , , 
2467,4074,6/15/1958,Male,184,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"5,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,12/4/2017,2/4/2018,2/4/2018,2/22/2021,4/11/2021,4/11/2021, , , , , , 
2468,2122,6/15/1937,Male,175,52,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,6",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,R-X,DAR-X,V-X,9/9/2013,12/15/2013,12/15/2013,5/1/2017,8/19/2017,8/19/2017,4/17/2019,9/20/2019,9/20/2019,7/27/2020,3/31/2022,10/14/1582
2469,4556,6/15/1950,Female,152,62,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,61",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,LEV-X,11/2/2017,3/15/2018,3/15/2018,3/27/2018,12/30/2019,12/30/2019,2/11/2020,3/31/2022, , , , 
2470,5473,6/15/1948,Male,179,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"3,14",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,NIN-X,No CTx,No CTx,V-X,11/7/2017,11/13/2018,11/13/2018,2/10/2022,3/31/2022, , , , , , , 
2471,4727,6/15/1946,Male,168,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"31,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,R-X,POM-X,No CTx,V-X,11/2/2017,2/15/2018,2/15/2018,2/26/2018,12/18/2018,12/18/2018,2/7/2019,3/19/2019,3/19/2019, , , 
2472,8139,6/15/1951,Male,192,133,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,65",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,V-X,No CTx,V-X,11/2/2017,2/21/2018,2/21/2018,2/27/2018,10/14/2019,10/14/2019,10/24/2019,10/16/2020,10/16/2020, , , 
2473,7365,6/15/1949,Female,167,84,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,17,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/2/2017,2/15/2018,2/15/2018, , , , , , , , , 
2474,6185,6/15/1944,Male,182,94,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,05",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/6/2017,10/30/2018,10/30/2018, , , , , , , , , 
2475,9247,6/15/1943,Female,158,59,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"30,04","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/7/2017,3/13/2018,3/13/2018, , , , , , , , , 
2476,5332,6/15/1951,Male,182,92,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"21,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,11/15/2017,11/8/2018,11/8/2018, , , , , , , , , 
2477,6798,6/15/1951,Male,168,91,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"11,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,R-X,POM-X,LEV-X,11/3/2017,6/19/2018,6/19/2018,7/4/2018,10/4/2018,10/4/2018,10/25/2018,1/28/2019,1/28/2019,3/11/2019,6/21/2020,6/21/2020
2478,7322,6/15/1941,Female,168,68,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"7,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,V-X,11/2/2017,4/19/2018,4/19/2018,3/9/2020,3/2/2021,3/2/2021, , , , , , 
2479,8096,6/15/1951,Female,174,71,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"30,95","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,11/8/2017,7/12/2018,7/12/2018,12/19/2019,5/16/2020,5/16/2020, , , , , , 
2480,6365,6/15/1950,Male,172,74,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,18",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/2/2017,11/8/2018,11/8/2018,3/24/2021,3/31/2022,10/14/1582, , , , , , 
2481,7006,6/15/1948,Male,159,57,Private,No,Yes, ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,22",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,11/3/2017,11/8/2018,11/8/2018,3/28/2019,2/7/2022,2/7/2022,3/7/2022,3/31/2022, , , , 
2482,4781,6/15/1948,Female,171,73,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,91",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,R-X,11/17/2017,12/11/2018,12/11/2018,1/10/2019,1/1/2020,1/1/2020,2/17/2020,11/17/2020,11/17/2020,11/27/2020,2/26/2021,2/26/2021
2483,6676,6/15/1943,Female,165,98,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"16,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/2/2017,8/7/2018,8/7/2018, , , , , , , , , 
2484,6914,6/15/1945,Female,173,64,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,14",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/10/2017,8/9/2018,8/9/2018,10/15/2019,10/7/2020,10/7/2020, , , , , , 
2485,7467,6/15/1950,Female,155,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,41",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/3/2017,1/25/2018,1/25/2018,1/25/2018,11/28/2018,11/28/2018,1/31/2019,3/14/2019,3/14/2019, , , 
2486,5814,6/15/1950,Female,168,76,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,56","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,11/14/2017,10/4/2018,10/4/2018,11/27/2020,3/31/2022,10/14/1582, , , , , , 
2487,1552,6/15/1940,Male,170,75,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,Unknown,Other type,6440,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Unbekannt, , , , , ,R-X,R-X,R-X,V-X,2/1/2010,6/1/2010,6/1/2010,4/15/2013,5/13/2013,5/13/2013,4/3/2014,9/24/2014,9/24/2014,6/3/2015,9/11/2017,9/11/2017
2488,9394,6/15/1949,Female,168,54,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,3992,unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,DAR-X,KYP-X,LEV-X,V-X,11/6/2015,2/1/2016,2/1/2016,10/9/2017,8/30/2018,8/30/2018,10/30/2018,1/2/2019,1/2/2019,2/28/2019,4/4/2019,4/4/2019
2489,5659,6/15/1960,Male,188,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,167,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/9/2017,3/26/2018,3/26/2018, , , , , , , , , 
2490,7824,6/15/1943,Female,160,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/18/2017,3/21/2018,3/21/2018,3/10/2020,3/31/2021,10/14/1582, , , , , , 
2491,3611,6/15/1962,Male,179,90,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"2,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/7/2017,1/21/2018,1/21/2018, , , , , , , , , 
2492,4607,6/15/1938,Male,181,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,12/11/2017,6/3/2018,6/3/2018, , , , , , , , , 
2493,6480,6/15/1958,Male,167,51,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,11/27/2017,2/21/2018,2/21/2018,3/8/2018,12/16/2019,12/16/2019,2/19/2020,2/16/2021,2/16/2021,3/12/2021,4/19/2021,4/19/2021
2494,3310,6/15/1962,Female,165,62,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"15,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,DAR-X,DAR-X,V-X,11/16/2017,2/28/2018,2/28/2018,3/2/2018,8/31/2018,8/31/2018,1/14/2019,11/26/2019,11/26/2019,5/1/2020,10/28/2020,10/28/2020
2495,8260,6/15/1945,Female,161,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"24,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,LEV-X,11/13/2017,2/27/2018,2/27/2018,3/12/2018,8/28/2019,8/28/2019,3/9/2020,7/25/2021,7/25/2021, , , 
2496,1894,6/15/1933,Male,188,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,6",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,11/8/2017,10/1/2018,10/1/2018,1/14/2019,2/5/2022,2/5/2022,3/14/2022,3/31/2022, , , , 
2497,6035,6/15/1952,Male,179,82,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,74",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,11/24/2017,3/30/2018,3/30/2018,7/15/2019,10/13/2020,10/13/2020,11/2/2020,10/7/2021,10/7/2021, , , 
2498,8988,6/15/1947,Male,175,79,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,6",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/6/2017,11/12/2018,11/12/2018, , , , , , , , , 
2499,1524,6/15/1944,Male,176,80,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/7/2017,11/13/2018,11/13/2018, , , , , , , , , 
2500,4950,6/15/1966,Female,164,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,3,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/9/2017,3/8/2018,3/8/2018,2/15/2022,3/31/2022, , , , , , , 
2501,7053,6/15/1946,Male,173,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,27","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/3/2017,7/4/2018,7/4/2018, , , , , , , , , 
2502,2585,6/15/1951,Male,170,74,Private,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"21,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/7/2017,10/3/2018,10/3/2018, , , , , , , , , 
2503,1189,6/15/1943,Male,174,57,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,95",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,11/1/2017,10/25/2018,10/25/2018, , , , , , , , , 
2504,5151,6/15/1947,Female,173,60,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"13,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,R-X,POM-X,No CTx,LEV-X,11/13/2017,2/27/2018,2/27/2018,3/9/2018,12/6/2018,12/6/2018,3/4/2019,12/31/2020, , , , 
2505,2683,6/15/1950,Female,164,48,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/9/2017,11/22/2018,11/22/2018, , , , , , , , , 
2506,2003,6/15/1948,Female,158,45,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,6",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,11/2/2017,12/3/2018,12/3/2018,7/21/2020,12/31/2020,10/14/1582, , , , , , 
2507,8313,6/15/1947,Male,189,115,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,14",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/3/2017,4/20/2018,4/20/2018,8/7/2019,12/31/2020,10/14/1582, , , , , , 
2508,6848,6/15/1945,Female,165,73,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,4",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/8/2017,2/20/2018,2/20/2018,3/26/2018,12/31/2020,10/14/1582, , , , , , 
2509,5564,6/15/1950,Male,177,93,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"2,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,">5,5 mg/L", ,R-X,KYP-X,R-X,V-X,10/15/2012,3/26/2013,3/26/2013,10/7/2013,10/13/2014,10/13/2014,5/11/2017,10/19/2017,10/19/2017,3/28/2018,10/25/2018,10/25/2018
2510,3270,6/15/1933,Female,157,74,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"27,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/6/2014,3/10/2015,3/10/2015,3/21/2017,6/20/2018,6/20/2018, , , , , , 
2511,6112,6/15/1945,Male,191,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,V-X,NIN-X,EMP-X,R-X,11/22/2017,6/12/2019,6/12/2019,5/31/2020,12/28/2020,12/28/2020,1/10/2021,4/1/2021,4/1/2021,9/7/2021,3/31/2022,10/14/1582
2512,6455,6/15/1944,Male,173,78,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"13,02","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,11/27/2017,3/14/2018,3/14/2018,3/21/2018,3/31/2022,10/14/1582, , , , , , 
2513,4001,6/15/1948,Male,174,96,Private,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,49",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/16/2017,11/29/2018,11/29/2018, , , , , , , , , 
2514,4233,6/15/1948,Female,161,58,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"24,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/13/2017,7/23/2018,7/23/2018, , , , , , , , , 
2515,5669,6/15/1937,Male,176,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,9",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/27/2017,6/25/2018,6/25/2018, , , , , , , , , 
2516,9075,6/15/1943,Male,161,59,Private,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,POM-X,No CTx,V-X,11/16/2017,3/22/2018,3/22/2018,7/5/2019,1/6/2021,1/6/2021,2/1/2021,8/17/2021,8/17/2021, , , 
2517,6384,6/15/1951,Female,169,80,Private,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,R-X,11/2/2017,11/6/2018,11/6/2018,4/29/2021,6/17/2021,6/17/2021, , , , , , 
2518,6729,6/15/1951,Male,182,116,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"24,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,KYP-X,NIN-X,No CTx,R-X,11/2/2017,3/7/2018,3/7/2018,3/22/2018,7/21/2021,7/21/2021,8/17/2021,3/31/2022, , , , 
2519,3765,6/15/1944,Male,173,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"34,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,11/6/2017,3/3/2020,3/3/2020, , , , , , , , , 
2520,3679,6/15/1951,Female,166,50,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,7",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,11/2/2017,8/15/2020,8/15/2020,8/27/2020,3/24/2021,3/24/2021, , , , , , 
2521,5960,6/15/1933,Male,180,68,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,34",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/16/2017,4/5/2018,4/5/2018, , , , , , , , , 
2522,1002,6/15/1949,Male,168,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"33,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/13/2017,3/19/2018,3/19/2018,6/12/2019,3/31/2022,10/14/1582, , , , , , 
2523,4577,6/15/1952,Male,189,98,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/9/2017,3/27/2018,3/27/2018,12/16/2021,3/31/2022, , , , , , , 
2524,2283,6/15/1945,Female,152,64,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,91",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,NIN-X,V-X,11/6/2017,2/5/2018,2/5/2018,3/27/2018,3/11/2019,3/11/2019,3/25/2019,11/11/2019,11/11/2019,11/27/2019,7/22/2020,7/22/2020
2525,6931,6/15/1949,Male,180,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,65",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,11/10/2017,5/22/2018,5/22/2018,2/15/2021,7/7/2021,7/7/2021,7/20/2021,8/12/2021,8/12/2021, , , 
2526,5885,6/15/1948,Male,184,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,51",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/13/2017,12/31/2017, , , , , , , , , , 
2527,1384,6/15/1951,Female,151,59,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,91",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,V-X,V-X,11/14/2017,2/23/2018,2/23/2018,3/14/2018,3/8/2019,3/8/2019,3/22/2019,12/4/2019,12/4/2019,12/5/2019,7/2/2020,7/2/2020
2528,2163,6/15/1944,Male,193,75,Private,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"22,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,11/2/2017,12/17/2018,12/17/2018,10/6/2021,3/31/2022, , , , , , , 
2529,4185,6/15/1951,Female,153,57,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/3/2017,4/20/2018,4/20/2018,3/24/2022,3/31/2022, , , , , , , 
2530,3188,6/15/1950,Male,176,80,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,27",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/28/2017,11/15/2018,11/15/2018, , , , , , , , , 
2531,3108,6/15/1948,Male,184,88,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,21",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/2/2017,3/1/2018,3/1/2018, , , , , , , , , 
2532,6890,6/15/1937,Female,164,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"6,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,10/5/2017,3/25/2018,3/25/2018, , , , , , , , , 
2533,7345,6/15/1961,Male,178,81,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/26/2017,12/31/2017,12/31/2017, , , , , , , , , 
2534,1734,6/15/1942,Female,157,55,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,IgG,"5,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,V-X,DAR-X,V-X,5/5/2015,8/6/2015,8/6/2015,8/16/2017,7/18/2019,7/18/2019,7/26/2019,5/22/2020,5/22/2020,5/26/2020,6/2/2020,6/2/2020
2535,2904,6/15/1940,Female,168,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Unbekannt,Ja, , , , , ,KYP-X,DAR-X,No CTx,V-X,5/6/2014,6/27/2014,6/27/2014,7/25/2017,3/15/2019,3/15/2019,4/29/2019,6/30/2019,10/14/1582, , , 
2536,3115,6/15/1934,Male,175,72,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,12/11/2017,6/3/2018,6/3/2018, , , , , , , , , 
2537,1692,6/15/1942,Male,179,93,Private,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"2,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,EMP-X,No CTx,R-X,9/2/2015,4/13/2016,4/13/2016,4/20/2016,10/13/2017,10/13/2017,11/16/2017,3/31/2022,10/14/1582, , , 
2538,3164,6/15/1944,Female,160,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,8/22/2017,12/31/2017, , , , , , , , , , 
2539,1526,6/15/1938,Female,170,72,Private,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,1/28/2014,6/2/2016,6/2/2016,7/10/2017,12/31/2017, , , , , , , 
2540,2885,6/15/1940,Male,192,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"1,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,1/23/2017,12/10/2017,12/10/2017,12/28/2017,12/31/2017, , , , , , , 
2541,6680,6/15/1949,Male,177,72,Compulsory health insurance CHI,Yes,Yes,Yes, , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,V-X,No CTx,No CTx,R-X,4/17/2014,12/20/2017,12/20/2017,1/2/2018, , , , , , , , 
2542,6566,6/15/1952,Male,168,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,9,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,R-X,DAR-X,No CTx,V-X,9/1/2015,2/1/2016,2/1/2016,3/1/2016,8/1/2017,8/1/2017,8/31/2017,2/19/2018,2/19/2018, , , 
2543,2818,6/15/1935,Male,189,78,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,8",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,R-X,9/23/2016,12/20/2016,12/20/2016,9/22/2017,12/31/2017, , , , , , , 
2544,8214,6/15/1946,Female,160,89,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"2,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,R-X,DAR-X,No CTx,V-X,2/25/2011,5/14/2011,5/14/2011,10/7/2015,10/10/2017,10/10/2017,11/2/2017,12/31/2017, , , , 
2545,4737,6/15/1960,Female,186,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,",7",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/4/2015,9/28/2015,9/28/2015,8/20/2017,12/31/2017, , , , , , , 
2546,5971,6/15/1943,Male,168,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Ja,No CTx,No CTx,No CTx,R-X,10/13/2017,12/31/2017, , , , , , , , , , 
2547,6337,6/15/1971,Male,186,96,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/28/2017,3/29/2018,3/29/2018, , , , , , , , , 
2548,2538,6/15/1936,Male,161,90,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"16,6",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , , ,R-X,No CTx,No CTx,V-X,11/13/2017,4/4/2018,4/4/2018,4/11/2018,12/16/2019,12/16/2019, , , , , , 
2549,4833,6/15/1958,Female,170,64,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"5,55",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,R-X,V-X,R-X,Other,6/1/2003,8/1/2003,8/1/2003,9/27/2007,12/19/2007,12/19/2007,1/15/2014,11/19/2014,11/19/2014,11/20/2014,1/1/2016,1/1/2016
2550,1495,6/15/1943,Male,185,90,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"2,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,11/3/2005,1/6/2006,1/6/2006,12/1/2017,12/31/2017, , , , , , , 
2551,2963,6/15/1960,Female,170,65,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/6/2017,6/11/2018,6/11/2018, , , , , , , , , 
2552,6635,6/15/1955,Male,167,62,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/17/2017,6/25/2018,6/25/2018, , , , , , , , , 
2553,9831,6/15/1942,Male,170,62,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/12/2017,5/14/2018,5/14/2018, , , , , , , , , 
2554,7331,6/15/1957,Male,168,58,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/19/2017,12/31/2017, , , , , , , , , , 
2555,9565,6/15/1940,Female,160,62,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"3,6",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/27/2017,7/25/2018,7/25/2018,1/30/2019,6/30/2019,10/14/1582, , , , , , 
2556,8463,6/15/1938,Female,155,52,Compulsory health insurance CHI,Yes,Yes, , , , , , , , ,Yes,2,III: one or more criteria are fulfilled,IgA,"4,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Ja,R-X,R-X,DAR-X,V-X,10/3/2017,4/11/2018,4/11/2018,6/14/2018,12/2/2018,12/2/2018,2/17/2020,4/5/2020,4/5/2020,5/28/2020,6/1/2021,6/1/2021
2557,6173,6/15/1941,Female,162,98,Compulsory health insurance CHI,No,Yes, , , , , , , , ,Yes,2,I: fulfilling all 4 criteria,IgG,"3,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,NIN-X,R-X,No CTx,V-X,9/25/2017,4/19/2018,4/19/2018,5/16/2018,8/3/2018,8/3/2018,9/3/2018,11/7/2018,11/7/2018, , , 
2558,1590,6/15/1957,Female,165,78,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , ,Yes,2,III: one or more criteria are fulfilled,IgG,"7,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/27/2017,9/29/2017,9/29/2017, , , , , , , , , 
2559,6040,6/15/1954,Male,173,82,Compulsory health insurance CHI,Yes,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,4,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/16/2017,2/6/2018,2/6/2018, , , , , , , , , 
2560,5304,6/15/1945,Female,150,70,Private,Yes, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,07",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , ,Ja,R-X,R-X,DAR-X,V-X,12/4/2017,9/17/2018,9/17/2018,3/4/2019,10/2/2019,10/2/2019,5/20/2020,7/20/2020,7/20/2020,7/20/2020,8/17/2020,8/17/2020
2561,5312,6/15/1947,Female,166,76,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,",66",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , , ,R-X,V-X,POM-X,V-X,3/1/2010,5/17/2010,5/17/2010,8/26/2013,8/25/2014,8/25/2014,9/22/2014,5/11/2015,5/11/2015,8/17/2015,10/26/2015,10/26/2015
2562,9101,6/15/1946,Female,170,82,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,78,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/28/2017,6/30/2019, , , , , , , , , , 
2563,6773,6/15/1972,Female,169,65,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"2,3",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/11/2017,12/21/2017,12/21/2017, , , , , , , , , 
2564,3989,6/15/1940,Female,172,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,",57",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,DAR-X,V-X,11/5/2011,9/25/2012,9/25/2012,8/2/2013,6/27/2016,6/27/2016,1/19/2017,11/12/2018,11/12/2018,12/3/2018,4/16/2019,4/16/2019
2565,1921,6/15/1944,Male,175,75,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,5,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,POM-X,V-X,5/15/2011,7/15/2011,7/15/2011,11/15/2011,1/15/2012,1/15/2012,1/15/2013,1/15/2014,1/15/2014,3/15/2016,6/15/2016,6/15/2016
2566,6863,6/15/1950,Male,179,69,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"1,38",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/13/2017,3/31/2018, , , , , , , , , , 
2567,9400,6/15/1945,Female,165,71,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,71","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/28/2017,2/10/2018,2/10/2018,7/20/2018,6/22/2021,6/22/2021, , , , , , 
2568,3329,6/15/1964,Female,171,70,Compulsory health insurance CHI,Yes, , ,Yes,Yes, ,Yes, , ,Yes, ,1,I: fulfilling all 4 criteria,IgG,"3,97",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/13/2017,1/6/2018,1/6/2018, , , , , , , , , 
2569,7455,6/15/1950,Male,184,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,11/20/2017,6/10/2018,6/10/2018, , , , , , , , , 
2570,5160,6/15/1949,Male,178,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,10/25/2017,6/10/2018,6/10/2018, , , , , , , , , 
2571,1373,6/15/1953,Male,180,84,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,11/2/2017,5/10/2018,5/10/2018, , , , , , , , , 
2572,1461,6/15/1935,Male,170,81,Private,No, , , , , , ,Yes, , , ,9,III: one or more criteria are fulfilled,IgA,"7,58",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,R-X,LEV-X,DAR-X,Other,12/1/2009,12/1/2010,12/1/2010,3/25/2013,2/27/2014,2/27/2014,8/1/2015,9/1/2016,9/1/2016,12/1/2017,12/31/2017, 
2573,3054,6/15/1952,Female,160,58,Compulsory health insurance CHI,No,Yes, , ,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/14/2017,6/12/2018,6/12/2018, , , , , , , , , 
2574,9242,6/15/1957,Male,168,73,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/24/2017,4/18/2018,4/18/2018, , , , , , , , , 
2575,9468,6/15/1952,Male,178,78,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,10/4/2017,5/20/2018,5/20/2018, , , , , , , , , 
2576,2379,6/15/1948,Male,183,90,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,R-X,No CTx,No CTx,LEV-X,9/24/2017,2/3/2018,2/3/2018,6/10/2018,6/30/2018, , , , , , , 
2577,8201,6/15/1950,Male,182,81,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,11/11/2017,5/14/2018,5/14/2018, , , , , , , , , 
2578,7127,6/15/1948,Male,178,78,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,KYP-X,Other,V-X,5/15/2011,11/15/2011,11/15/2011,1/15/2017,5/15/2017,5/15/2017,12/3/2019,2/24/2021,2/24/2021,4/13/2021,7/27/2021,7/27/2021
2579,7781,6/15/1945,Female,155,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"67,1",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,1/20/2014,4/14/2014,4/14/2014, , , , , , , , , 
2580,5567,6/15/1941,Male,165,69,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,2,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,6/21/2017,11/6/2020,11/6/2020, , , , , , , , , 
2581,3435,6/15/1948,Male,184,92,Compulsory health insurance CHI,No, ,Yes, ,Unknown,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,11/4/2017,6/10/2018,6/10/2018, , , , , , , , , 
2582,3775,6/15/1950,Male,178,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,LEV-X,10/6/2017,2/15/2018,2/15/2018,3/13/2018,6/30/2018, , , , , , , 
2583,5546,6/15/1941,Male,178,76,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,R-X,12/1/2017,1/17/2018,1/17/2018, , , , , , , , , 
2584,6674,6/15/1962,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,170,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Unbekannt,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,5/15/2017,8/15/2017,8/15/2017, , , , , , , , , 
2585,7064,6/15/1947,Male,187,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,54",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,NIN-X,V-X,4/7/2016,9/26/2016,9/26/2016,3/22/2017,11/8/2017,11/8/2017,1/3/2018,9/6/2018,9/6/2018,9/20/2018,9/24/2018,9/24/2018
2586,6921,6/15/1943,Male,175,83,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,76",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,V-X,V-X,6/21/2016,9/15/2016,9/15/2016,4/17/2017,12/27/2017,12/27/2017,1/8/2018,7/31/2018,7/31/2018,8/22/2018,9/27/2018,9/27/2018
2587,7283,6/15/1965,Male,180,75,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"60,2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/18/2017,2/22/2018,2/22/2018,5/4/2021,3/31/2022, , , , , , , 
2588,8278,6/15/1957,Male,999,80,Private,Yes,Yes, , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,11/28/2017,3/7/2018,3/7/2018, , , , , , , , , 
2589,3233,6/15/1946,Male,177,77,Self-Payer,No,Yes,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"36,3",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,9/15/2017,11/7/2017,11/7/2017, , , , , , , , , 
2590,2523,6/15/1961,Female,160,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"18,6",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,9/12/2017,12/1/2017,12/1/2017, , , , , , , , , 
2591,3913,6/15/1948,Female,180,163,Compulsory health insurance CHI,No, ,Yes,Yes, ,Unknown,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"27,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,12/15/2017,3/15/2018,3/15/2018,3/20/2018,6/14/2018,6/14/2018,6/21/2018,7/4/2019,7/4/2019, , , 
2592,9231,6/15/1962,Male,175,90,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"7,2",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,KYP-X,NIN-X,NIN-X,V-X,9/6/2016,11/8/2016,11/8/2016,12/12/2017,8/16/2018,8/16/2018,6/9/2020,11/3/2020,11/3/2020,1/29/2021,6/16/2021,6/16/2021
2593,6703,6/15/1965,Female,149,57,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"60,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/18/2014,12/22/2014,12/22/2014,12/7/2017,11/3/2020,11/3/2020, , , , , , 
2594,4240,6/15/1937,Female,168,75,Compulsory health insurance CHI,Yes, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,57,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Ja,R-X,DAR-X,POM-X,V-X,12/18/2017,10/16/2018,10/16/2018,6/25/2019,1/15/2020,1/15/2020,1/28/2020,6/9/2020,6/9/2020,6/23/2020,3/31/2022, 
2595,7540,6/15/1950,Female,162,62,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,61",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/17/2017,8/17/2017,8/17/2017,11/6/2017,8/2/2021,8/2/2021, , , , , , 
2596,8334,6/15/1931,Female,164,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,DAR-X,POM-X,NIN-X,R-X,5/1/2017,10/20/2017,10/20/2017,11/7/2017,6/5/2019,6/5/2019,6/13/2019,7/18/2019,7/18/2019,8/6/2019,7/29/2020,7/29/2020
2597,7882,6/15/1947,Male,177,103,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,KYP-X,DAR-X,V-X,V-X,3/8/2017,8/31/2017,8/31/2017,11/9/2017,6/11/2019,6/11/2019,6/20/2019,9/6/2021,9/6/2021,9/20/2021,3/31/2022, 
2598,7869,6/15/1940,Female,165,78,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,31,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,12/4/2017,5/28/2018,5/28/2018,6/4/2018,3/31/2022, , , , , , , 
2599,6286,6/15/1954,Female,150,70,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,2",unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,9/13/2017,12/31/2017, , , , , , , , , , 
2600,8957,6/15/1944,Male,178,88,Compulsory health insurance CHI,Yes,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,57,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,9/8/2017,10/2/2018,10/2/2018,12/18/2019,5/19/2021,5/19/2021,6/28/2021,9/15/2021,9/15/2021, , , 
2601,8837,6/15/1936,Female,169,86,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,54,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,9/12/2017,12/31/2017, , , , , , , , , , 
2602,6252,6/15/1951,Female,166,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,18,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,11/21/2017,10/2/2018,10/2/2018, , , , , , , , , 
2603,7952,6/15/1945,Male,180,95,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,52,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/11/2017,11/21/2017,11/21/2017, , , , , , , , , 
2604,5740,6/15/1943,Female,161,79,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,",44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/18/2016,12/1/2016,12/1/2016,12/1/2017,8/15/2018,8/15/2018, , , , , , 
2605,5928,6/15/1949,Male,183,93,Private,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,83",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,5/22/2017,8/23/2017,8/23/2017,11/9/2017,3/15/2018,3/15/2018,4/6/2018,2/7/2019,2/7/2019,3/25/2019,5/1/2019,5/1/2019
2606,4376,6/15/1957,Male,174,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"8,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,NIN-X,R-X,9/16/2016,3/6/2017,3/6/2017,3/21/2017,12/13/2017,12/13/2017,1/10/2018,8/6/2018,8/6/2018,8/16/2018,8/24/2018,8/24/2018
2607,1770,6/15/1943,Male,172,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,57",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,NIN-X,R-X,5/8/2017,10/31/2017,10/31/2017,11/13/2017,10/18/2018,10/18/2018,1/16/2019,4/10/2019,4/10/2019,5/21/2019,6/14/2019,6/14/2019
2608,1576,6/15/1951,Female,165,69,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,94",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,4/4/2017,7/10/2017,7/10/2017,11/7/2017,6/17/2020,6/17/2020, , , , , , 
2609,9093,6/15/1951,Male,172,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,29",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,3/10/2017,6/9/2017,6/9/2017,11/6/2017,6/10/2019,6/10/2019,6/18/2019,3/31/2022,10/14/1582, , , 
2610,9315,6/15/1960,Female,161,87,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,64",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,V-X,R-X,5/8/2017,10/24/2017,10/24/2017,11/9/2017,7/18/2018,7/18/2018,2/11/2019,3/6/2021,3/6/2021,3/21/2021,11/18/2021,11/18/2021
2611,6951,6/15/1972,Female,175,104,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,3/13/2017,6/15/2017,6/15/2017,11/2/2017,6/21/2018,6/21/2018,1/22/2019,3/6/2019,3/6/2019, , , 
2612,8496,6/15/1936,Female,150,50,Compulsory health insurance CHI,Yes, , ,Yes,Yes,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"3,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L", ,R-X,V-X,DAR-X,V-X,7/11/2016,8/11/2016,8/11/2016,10/7/2017,2/4/2018,2/4/2018,6/5/2020,7/31/2020,7/31/2020,11/1/2021,3/31/2022,10/14/1582
2613,8899,6/15/1949,Male,183,75,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,43",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,Other,R-X,5/17/2016,11/4/2016,11/4/2016,11/25/2016,11/6/2017,11/6/2017,11/21/2017,6/15/2018,6/15/2018,7/3/2018,12/17/2018,12/17/2018
2614,6454,6/15/1946,Male,183,103,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,I: fulfilling all 4 criteria,IgA,"1,61",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,NIN-X,V-X,12/6/2016,5/25/2017,5/25/2017,5/30/2017,6/27/2017,6/27/2017,11/6/2017,6/7/2018,6/7/2018,6/18/2018,6/5/2021,6/5/2021
2615,3016,6/15/1928,Female,162,70,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/2/2017,7/3/2017,7/3/2017,11/6/2017,12/31/2020,10/14/1582, , , , , , 
2616,6289,6/15/1931,Male,162,54,Private,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,64",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,V-X,2/7/2017,5/5/2017,5/5/2017,11/9/2017,12/11/2018,12/11/2018,1/1/2019,5/13/2019,5/13/2019,5/30/2019,10/25/2020,10/25/2020
2617,3126,6/15/1952,Male,165,94,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,49",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,R-X,4/17/2017,10/11/2017,10/11/2017,11/2/2017,1/28/2019,1/28/2019,3/4/2019,12/31/2020, , , , 
2618,1216,6/15/1931,Male,178,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,2/20/2017,6/22/2017,6/22/2017,11/1/2017,5/26/2020,5/26/2020, , , , , , 
2619,5558,6/15/1951,Female,153,60,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,11,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,5/12/2017,8/7/2017,8/7/2017,11/10/2017,5/11/2018,5/11/2018,5/28/2018,12/23/2019,12/23/2019, , , 
2620,9712,6/15/1946,Male,188,81,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"2,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,5/9/2017,11/6/2017,11/6/2017,11/23/2017,1/25/2018,1/25/2018,2/15/2018,5/24/2019,5/24/2019, , , 
2621,5142,6/15/1949,Male,171,63,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,36",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,2/10/2017,6/14/2017,6/14/2017,11/13/2017,6/3/2019,6/3/2019,6/27/2019,7/24/2019,7/24/2019,8/13/2019,9/20/2020,9/20/2020
2622,2401,6/15/1951,Male,167,87,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,V-X,DAR-X,V-X,R-X,3/2/2016,8/25/2016,8/25/2016,9/15/2016,3/9/2017,3/9/2017,3/23/2017,11/10/2017,11/10/2017,1/2/2018,2/5/2018,2/5/2018
2623,7729,6/15/1951,Male,180,96,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,15900,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,8/7/2017,1/29/2018,1/29/2018,6/25/2018,12/1/2018,12/1/2018,12/10/2018,3/1/2019,3/1/2019,4/15/2019,6/30/2019,10/14/1582
2624,2785,6/15/1953,Male,183,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"33,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,POM-X,V-X,3/4/2016,6/23/2016,6/23/2016,11/11/2016,10/16/2017,10/16/2017,11/2/2017,12/18/2018,12/18/2018,3/25/2019,7/10/2020,7/10/2020
2625,7031,6/15/1947,Female,181,62,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,8/23/2016,11/21/2016,11/21/2016,4/17/2017,10/13/2017,10/13/2017,11/2/2017,5/22/2018,5/22/2018,6/7/2018,3/4/2020,3/4/2020
2626,1647,6/15/1948,Female,179,82,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,57",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,5/3/2017,10/27/2017,10/27/2017,11/22/2017,12/31/2021,10/14/1582, , , , , , 
2627,5688,6/15/1951,Female,167,68,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"24,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,KYP-X,POM-X,V-X,4/25/2017,8/25/2017,8/25/2017,11/8/2017,12/4/2018,12/4/2018,3/11/2019,2/11/2020,2/11/2020,2/26/2020,6/9/2020,6/9/2020
2628,6311,6/15/1944,Female,169,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,35",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/28/2016,4/28/2017,4/28/2017,11/6/2017,12/30/2019,12/30/2019, , , , , , 
2629,9110,6/15/1949,Male,165,94,Private,Yes,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,4,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,12/11/2017,2/23/2018,2/23/2018,6/30/2021,3/31/2022,10/14/1582, , , , , , 
2630,1210,6/15/1958,Male,185,56,Compulsory health insurance CHI,No,Yes,Unknown,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,21",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,11/22/2017,2/13/2018,2/13/2018,3/6/2018,5/29/2019,5/29/2019,6/12/2019,3/31/2022, , , , 
2631,6508,6/15/1948,Male,161,49,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,06",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,2/2/2017,6/8/2017,6/8/2017,11/10/2017,3/16/2018,3/16/2018,3/26/2018,2/18/2019,2/18/2019,3/22/2019,7/20/2020,7/20/2020
2632,8151,6/15/1948,Male,172,61,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"11,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,No,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,KYP-X,DAR-X,EMP-X,V-X,3/7/2017,6/28/2017,6/28/2017,11/2/2017,5/2/2019,5/2/2019,7/3/2019,10/21/2020,10/21/2020,11/8/2020,1/27/2021,1/27/2021
2633,4219,6/15/1943,Male,172,63,Private,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,KYP-X,NIN-X,V-X,8/25/2016,2/20/2017,2/20/2017,5/10/2017,10/30/2017,10/30/2017,11/21/2017,6/11/2018,6/11/2018,7/2/2018,9/24/2018,9/24/2018
2634,5859,6/15/1949,Female,154,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,1/25/2016,4/20/2016,4/20/2016,11/14/2016,10/26/2017,10/26/2017,11/8/2017,5/9/2018,5/9/2018,5/24/2018,9/12/2018,9/12/2018
2635,4213,6/15/1952,Male,179,104,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,EMP-X,DAR-X,R-X,10/10/2016,4/10/2017,4/10/2017,5/2/2017,10/27/2017,10/27/2017,11/13/2017,9/4/2018,9/4/2018,9/14/2018,6/30/2019,10/14/1582
2636,4022,6/15/1933,Female,179,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"8,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,KYP-X,NIN-X,V-X,V-X,2/15/2016,6/6/2016,6/6/2016,11/7/2016,10/19/2017,10/19/2017,11/2/2017,9/6/2018,9/6/2018,9/28/2018,9/30/2018, 
2637,1837,6/15/1947,Male,177,74,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,68",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,2/29/2016,7/1/2016,7/1/2016,11/14/2016,10/16/2017,10/16/2017,11/2/2017,6/26/2020,6/26/2020,7/3/2020,2/28/2021,2/28/2021
2638,8687,6/15/1953,Male,188,132,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"21,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,KYP-X,DAR-X,POM-X,V-X,2/9/2016,5/9/2016,5/9/2016,11/17/2016,10/23/2017,10/23/2017,11/14/2018,3/5/2019,3/5/2019,3/27/2019,7/20/2020,7/20/2020
2639,6014,6/15/1953,Male,186,84,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,04","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,4/27/2017,10/26/2017,10/26/2017,11/15/2017,6/30/2021,10/14/1582, , , , , , 
2640,9802,6/15/1952,Female,165,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,45",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,V-X,POM-X,V-X,4/28/2017,7/27/2017,7/27/2017,11/1/2017,12/30/2019,12/30/2019,1/3/2020,11/10/2020,11/10/2020,11/17/2020,1/20/2021,1/20/2021
2641,3189,6/15/1942,Female,162,61,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgA,"2,97",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,4/27/2017,7/31/2017,7/31/2017,11/1/2017,7/27/2021,7/27/2021, , , , , , 
2642,3724,6/15/1944,Male,177,82,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"18,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,R-X,NIN-X,Other,V-X,1/25/2016,5/23/2016,5/23/2016,11/4/2016,4/27/2017,4/27/2017,5/18/2017,11/15/2017,11/15/2017,1/2/2018,2/23/2018,2/23/2018
2643,4017,6/15/1955,Male,197,98,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"9,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,DAR-X,No CTx,R-X,10/31/2016,4/21/2017,4/21/2017,5/17/2017,11/3/2017,11/3/2017,11/16/2017,8/8/2018,8/8/2018, , , 
2644,4029,6/15/1951,Female,160,45,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"17,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,9/29/2016,1/9/2017,1/9/2017,5/1/2017,10/24/2017,10/24/2017,11/13/2017,7/2/2018,7/2/2018,7/20/2018,12/27/2018,12/27/2018
2645,8355,6/15/1933,Male,187,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,DAR-X,KYP-X,NIN-X,V-X,1/23/2017,4/17/2017,4/17/2017,11/2/2017,5/3/2018,5/3/2018,5/22/2018,10/23/2018,10/23/2018,11/6/2018,5/13/2019,5/13/2019
2646,4809,6/15/1928,Male,178,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,19",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/11/2017,4/11/2017,4/11/2017,11/6/2017,3/25/2020,3/25/2020, , , , , , 
2647,7152,6/15/1943,Female,155,42,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,64",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,No CTx,R-X,5/12/2017,10/30/2017,10/30/2017,11/22/2017,4/4/2018,4/4/2018,4/30/2018,8/6/2018,8/6/2018, , , 
2648,3413,6/15/1940,Male,172,57,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,5315,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No, , , , , ,unbekannt,Nein,Ja,Unbekannt, , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,10/26/2017,6/11/2018,6/11/2018,9/5/2018,12/15/2018,12/15/2018, , , , , , 
2649,8276,6/15/1961,Male,181,88,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"999,99",unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/5/2017,12/31/2017, , , , , , , , , , 
2650,8086,6/15/1955,Female,176,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,8090,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L", ,R-X,POM-X,KYP-X,V-X,7/25/2013,9/19/2013,9/19/2013,3/15/2015,10/15/2016,10/15/2016,11/15/2016,6/6/2017,6/6/2017,6/7/2017,12/4/2017,12/4/2017
2651,1410,6/15/1938,Male,181,90,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Unknown,Unknown,Unknown, , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , , ,EMP-X,DAR-X,No CTx,V-X,3/15/2016,10/15/2016,10/15/2016,12/18/2017,7/12/2018,7/12/2018,7/25/2018,8/23/2018,8/23/2018, , , 
2652,3612,6/15/1955,Female,166,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"8,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,DAR-X,KYP-X,NIN-X,V-X,2/10/2017,8/3/2017,8/3/2017,11/2/2017,5/3/2018,5/3/2018,5/24/2018,12/5/2018,12/5/2018,12/28/2018,4/14/2020,4/14/2020
2653,7198,6/15/1952,Male,173,64,Private,No, , ,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,KYP-X,No CTx,R-X,9/19/2016,3/10/2017,3/10/2017,4/5/2017,2/21/2018,2/21/2018,3/5/2018,9/27/2018,9/27/2018, , , 
2654,5350,6/15/1958,Male,999,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,Other type,"999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/6/2017,12/1/2017,12/1/2017,12/4/2017,3/8/2018,3/8/2018, , , , , , 
2655,7608,6/15/1937,Female,168,84,Private,No, , , , , , , , , , ,9,Unknown,IgA,340,unknown/ISS-Criteria not used for prognostics,9,9,9,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , , ,V-X,R-X,EMP-X,V-X,3/8/2011,4/8/2011,4/8/2011,4/21/2011,8/1/2011,8/1/2011,2/18/2017,7/15/2017,7/15/2017,8/10/2017,1/16/2018,1/16/2018
2656,9685,6/15/1954,Male,180,70,Private,No,Yes,Yes,Yes,Yes, , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,2297,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/3/2016,8/15/2016,8/15/2016,12/10/2021,3/31/2022, , , , , , , 
2657,7671,6/15/1942,Female,159,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,59,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/2/2017,12/31/2017, , , , , , , , , , 
2658,6631,6/15/1974,Female,170,101,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,9,No,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , , , ,R-X,DAR-X,EMP-X,V-X,7/1/2013,10/1/2013,10/1/2013,7/1/2015,1/1/2016,1/1/2016,6/9/2016,11/2/2017,11/2/2017,11/16/2017,12/13/2018,12/13/2018
2659,9393,6/15/1951,Male,178,94,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,EMP-X,EMP-X,No CTx,V-X,4/1/2014,10/1/2014,10/1/2014,12/21/2017,5/24/2018,5/24/2018,8/20/2020,3/31/2021, , , , 
2660,3494,6/15/1949,Female,165,80,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,DAR-X,DAR-X,No CTx,V-X,1/5/2014,3/2/2014,3/2/2014,7/26/2017,7/2/2018,7/2/2018,8/3/2020,3/31/2021,10/14/1582, , , 
2661,9978,6/15/1961,Male,184,97,Private,No,Yes, , , ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"2,52",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , ,Nein,KYP-X,No CTx,No CTx,V-X,11/28/2017,1/19/2018,1/19/2018,2/19/2018,5/15/2018,5/15/2018, , , , , , 
2662,8014,6/15/1963,Female,159,93,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/1/2017,11/15/2017,11/15/2017, , , , , , , , , 
2663,7833,6/15/1936,Male,177,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,51,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,LEV-X,No CTx,No CTx,R-X,11/24/2016,4/20/2017,4/20/2017,12/7/2017,12/31/2017, , , , , , , 
2664,7325,6/15/1979,Female,172,63,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,5020,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/2/2017,9/27/2017,9/27/2017, , , , , , , , , 
2665,7800,6/15/1967,Female,170,69,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,48,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/15/2016,12/1/2016,12/1/2016, , , , , , , , , 
2666,8179,6/15/1945,Male,174,110,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,74",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,EMP-X,V-X,2/2/2017,5/1/2017,5/1/2017,11/1/2017,12/10/2018,12/10/2018,7/12/2019,10/8/2020,10/8/2020,10/24/2020,1/12/2022,1/12/2022
2667,8606,6/15/1950,Male,175,95,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , , , , , ,0,I: fulfilling all 4 criteria,IgA,15,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , , ,Nein,DAR-X,No CTx,No CTx,R-X,8/1/2017,12/1/2017,12/1/2017,11/23/2020,3/31/2022, , , , , , , 
2668,1485,6/15/1943,Female,161,92,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,57",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,NIN-X,R-X,4/26/2017,10/24/2017,10/24/2017,11/6/2017,3/19/2018,3/19/2018,4/3/2018,12/13/2018,12/13/2018,3/14/2019,12/31/2021, 
2669,3941,6/15/1930,Female,165,77,Compulsory health insurance CHI,No, ,Yes, ,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,51,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,R-X,7/15/2017,3/12/2020,3/12/2020, , , , , , , , , 
2670,3517,6/15/1949,Male,176,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,88",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,NIN-X,V-X,2/20/2017,5/16/2017,5/16/2017,11/10/2017,3/1/2019,3/1/2019,3/21/2019,4/11/2019,4/11/2019,5/31/2019,3/27/2021,3/27/2021
2671,4851,6/15/1939,Male,180,74,Compulsory health insurance CHI,No,Yes, , , , , ,Yes, , ,Yes,1,I: fulfilling all 4 criteria,Other type,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/15/2017,10/15/2021,10/15/2021, , , , , , , , , 
2672,8851,6/15/1947,Male,171,75,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"16,06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,4/5/2017,7/7/2017,7/7/2017,11/2/2017,3/31/2022, , , , , , , 
2673,6993,6/15/1959,Male,179,90,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,50,ISS stage II (neither stage I nor stage III),No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Ja,KYP-X,KYP-X,No CTx,V-X,8/15/2016,12/15/2016,12/15/2016,8/13/2019,9/10/2019,9/10/2019,10/29/2020,3/31/2022, , , , 
2674,2313,6/15/1935,Female,164,61,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"11,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,NIN-X,No CTx,No CTx,V-X,5/23/2017,8/15/2017,8/15/2017,11/9/2017,12/18/2020,12/18/2020, , , , , , 
2675,4103,6/15/1946,Female,158,58,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,POM-X,NIN-X,V-X,1/26/2017,4/27/2017,4/27/2017,11/3/2017,6/22/2018,6/22/2018,1/25/2019,4/25/2019,4/25/2019,6/3/2019,11/20/2019,11/20/2019
2676,5647,6/15/1939,Male,170,65,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , ,Yes,2,III: one or more criteria are fulfilled,IgA,38,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/15/2017,12/31/2018,10/14/1582, , , , , , , , , 
2677,3100,6/15/1951,Male,173,86,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,24,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,EMP-X,DAR-X,POM-X,V-X,4/15/2016,8/15/2016,8/15/2016,11/15/2017,5/31/2018,5/31/2018,6/25/2018,8/6/2018,8/6/2018,8/9/2018,11/1/2018,11/1/2018
2678,3531,6/15/1943,Male,178,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,07",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,V-X,POM-X,V-X,1/19/2017,7/13/2017,7/13/2017,11/13/2017,6/28/2018,6/28/2018,3/25/2019,6/20/2019,6/20/2019,7/24/2019,3/23/2020,3/23/2020
2679,1310,6/15/1928,Female,166,66,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,NIN-X,POM-X,R-X,4/24/2017,10/9/2017,10/9/2017,11/1/2017,6/20/2018,6/20/2018,4/1/2019,1/2/2020,1/2/2020,2/6/2020,6/18/2020,6/18/2020
2680,5882,6/15/1930,Female,167,55,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,20,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,9/15/2017,12/31/2017, , , , , , , , , , 
2681,8801,6/15/1932,Female,165,66,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,0,I: fulfilling all 4 criteria,IgG,"2,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,EMP-X,DAR-X,NIN-X,V-X,3/7/2017,7/4/2017,7/4/2017,11/8/2017,6/18/2019,6/18/2019,1/23/2020,10/19/2020,10/19/2020,10/26/2020,1/7/2021,1/7/2021
2682,9749,6/15/1952,Male,194,100,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,25",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/31/2016,4/20/2017,4/20/2017,11/20/2017,9/10/2019,9/10/2019, , , , , , 
2683,9096,6/15/1941,Male,178,78,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"99999999,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/21/2016,12/14/2016,12/14/2016,12/22/2017,2/18/2018,2/18/2018, , , , , , 
2684,1586,6/15/1952,Male,194,100,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,6",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,3/2/2017,8/24/2017,8/24/2017,11/2/2017,5/17/2021,5/17/2021,6/2/2021,3/31/2022,10/14/1582, , , 
2685,2970,6/15/1947,Male,176,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,49",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,5/2/2017,10/23/2017,10/23/2017,11/2/2017,5/3/2020,5/3/2020, , , , , , 
2686,2099,6/15/1944,Male,166,72,Private,No, , ,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,67",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/4/2017,7/26/2017,7/26/2017,11/6/2017,12/31/2020,10/14/1582, , , , , , 
2687,7083,6/15/1945,Male,165,100,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,22","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,POM-X,No CTx,V-X,5/8/2017,8/7/2017,8/7/2017,11/16/2017,12/10/2018,12/10/2018,3/20/2019,12/31/2020, , , , 
2688,9716,6/15/1946,Male,169,77,Compulsory health insurance CHI,Yes,Yes,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"2,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,10/16/2012,1/7/2013,1/7/2013,12/28/2017,4/12/2018,4/12/2018,9/21/2020,3/31/2022, , , , 
2689,9929,6/15/1938,Male,176,62,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,47",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,5/8/2017,8/7/2017,8/7/2017,11/8/2017,12/31/2020,10/14/1582, , , , , , 
2690,4151,6/15/1947,Female,161,68,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,I: fulfilling all 4 criteria,IgG,"2,71",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,DAR-X,R-X,V-X,3/1/2017,5/29/2017,5/29/2017,11/15/2017,12/27/2018,12/27/2018,2/13/2019,4/26/2019,4/26/2019,5/6/2019,11/22/2020,11/22/2020
2691,2654,6/15/1953,Male,201,102,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,32",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,No CTx,V-X,1/27/2017,5/3/2017,5/3/2017,11/2/2017,3/15/2018,3/15/2018,3/27/2018,6/9/2020,6/9/2020, , , 
2692,6624,6/15/1963,Female,163,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,18",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,R-X,V-X,2/16/2017,5/17/2017,5/17/2017,11/8/2017,5/30/2019,5/30/2019,6/27/2019,1/2/2020,1/2/2020,3/15/2020,9/30/2020, 
2693,5809,6/15/1971,Male,184,96,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,9",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/14/2017,5/19/2017,5/19/2017,11/6/2017,6/6/2020,6/6/2020, , , , , , 
2694,2422,6/15/1949,Female,169,53,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"12,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,EMP-X,V-X,DAR-X,V-X,4/19/2017,8/21/2017,8/21/2017,11/9/2017,6/17/2019,6/17/2019,1/4/2020,4/28/2020,4/28/2020,5/6/2020,1/22/2021,1/22/2021
2695,2406,6/15/1957,Female,999,65,Compulsory health insurance CHI,No,Yes, , ,Yes, , , ,Yes, , ,9,III: one or more criteria are fulfilled,IgA,"2,58",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/22/2017,12/31/2017, , , , , , , , , , 
2696,6968,6/15/1941,Male,180,109,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,56",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,NIN-X,V-X,4/25/2016,10/20/2016,10/20/2016,3/23/2017,12/12/2017,12/12/2017,1/10/2018,7/26/2018,7/26/2018,8/6/2018,1/7/2019,1/7/2019
2697,5062,6/15/1953,Male,181,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"28,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/2/2017,8/30/2017,8/30/2017,11/8/2017,12/19/2019,12/19/2019, , , , , , 
2698,6475,6/15/1978,Male,999,102,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,28",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/1/2017,12/31/2017, , , , , , , , , , 
2699,6808,6/15/1972,Female,169,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,82",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,KYP-X,No CTx,V-X,2/28/2017,5/25/2017,5/25/2017,11/9/2017,12/6/2018,12/6/2018,3/13/2019,3/31/2022,10/14/1582, , , 
2700,4667,6/15/1930,Female,175,54,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,4/10/2017,7/13/2017,7/13/2017,11/9/2017,2/26/2020,2/26/2020,3/12/2020,3/31/2022, , , , 
2701,8555,6/15/1941,Male,183,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,01",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,3/14/2017,6/13/2017,6/13/2017,11/14/2017,6/13/2019,6/13/2019,6/27/2019,7/10/2019,7/10/2019,7/31/2019,12/30/2019,12/30/2019
2702,2533,6/15/1950,Male,186,92,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,49",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,5/5/2017,10/27/2017,10/27/2017,11/17/2017,4/16/2019,4/16/2019, , , , , , 
2703,6354,6/15/1949,Female,164,62,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"3,49",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,V-X,R-X,5/30/2016,11/14/2016,11/14/2016,11/29/2016,11/13/2017,11/13/2017,12/1/2017,10/16/2018,10/16/2018,2/4/2019,3/18/2019,3/18/2019
2704,7481,6/15/1943,Female,174,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/24/2017,10/9/2017,10/9/2017,11/3/2017,6/5/2019,6/5/2019, , , , , , 
2705,9848,6/15/1953,Female,169,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,NIN-X,DAR-X,No CTx,V-X,4/20/2017,7/25/2017,7/25/2017,11/8/2017,11/28/2018,11/28/2018,3/7/2019,12/31/2020,10/14/1582, , , 
2706,5469,6/15/1955,Female,169,70,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"27,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,NIN-X,DAR-X,No CTx,V-X,9/29/2016,1/23/2017,1/23/2017,5/29/2017,12/11/2017,12/11/2017,1/11/2018,12/31/2020,10/14/1582, , , 
2707,7827,6/15/1940,Male,180,86,Compulsory health insurance CHI,Yes, , , , , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,6,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,3/5/2014,11/1/2014,11/1/2014,12/15/2016,11/15/2017,11/15/2017,12/15/2017,3/31/2022,10/14/1582, , , 
2708,3680,6/15/1951,Female,167,72,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,58,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Nein,DAR-X,No CTx,No CTx,V-X,8/1/2015,12/1/2015,12/1/2015,8/1/2017,3/31/2022,10/14/1582, , , , , , 
2709,4133,6/15/1949,Female,166,67,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,20,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/1/2017,12/1/2017,12/1/2017, , , , , , , , , 
2710,9043,6/15/1951,Male,178,94,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,7280,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Nein,EMP-X,No CTx,No CTx,V-X,4/10/2014,7/23/2014,7/23/2014,12/21/2017,6/24/2018,6/24/2018, , , , , , 
2711,1107,6/15/1961,Male,184,97,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,2520,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Nein,KYP-X,No CTx,No CTx,V-X,11/28/2017,1/19/2018,1/19/2018,2/19/2018,5/15/2018,5/15/2018, , , , , , 
2712,8384,6/15/1960,Female,162,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,1125,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
2713,7555,6/15/1957,Female,163,59,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,DAR-X,No CTx,V-X,6/1/2017,10/1/2017,10/1/2017,3/1/2019,6/15/2019,6/15/2019,9/1/2021,9/30/2021, , , , 
2714,6980,6/15/1945,Male,177,73,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,9/25/2017,12/29/2017,12/29/2017, , , , , , , , , 
2715,7957,6/15/1939,Female,170,79,Compulsory health insurance CHI,Yes,Yes,Yes, , , , , , , , ,1,Unknown,IgM,19,unknown/ISS-Criteria not used for prognostics,No,No,No,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L", ,R-X,DAR-X,V-X,V-X,2/7/2013,11/25/2013,11/25/2013,8/4/2014,5/28/2015,5/28/2015,8/10/2016,1/3/2018,1/3/2018,3/8/2018,6/18/2018,6/18/2018
2716,4751,6/15/1945,Male,180,78,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,45,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,V-X,V-X,DAR-X,V-X,6/13/2017,10/14/2017,10/14/2017,3/17/2018,7/11/2019,7/11/2019,9/26/2019,1/22/2020,1/22/2020,3/4/2020,3/11/2021,3/11/2021
2717,6965,6/15/1941,Male,185,86,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,NIN-X,V-X,R-X,4/2/2017,2/10/2018,2/10/2018,2/16/2018,11/7/2018,11/7/2018,6/25/2019,6/20/2020,6/20/2020,7/25/2020,6/3/2021,6/3/2021
2718,3969,6/15/1957,Male,178,81,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,3/8/2018,4/22/2018,4/22/2018,12/6/2021,12/31/2021, , , , , , , 
2719,7403,6/15/1956,Female,168,54,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Other type,",5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/9/2018,5/26/2018,5/26/2018,1/11/2022,3/31/2022,10/14/1582, , , , , , 
2720,9563,6/15/1950,Male,176,68,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/22/2018,3/15/2018,3/15/2018,4/26/2018,10/8/2018,10/8/2018,2/18/2019,6/30/2020,10/14/1582, , , 
2721,4156,6/15/1937,Male,180,87,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,40,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,V-X,V-X,DAR-X,Other,11/10/2016,7/23/2017,7/23/2017,3/16/2018,7/18/2018,7/18/2018,6/12/2019,6/20/2020,6/20/2020,7/19/2020,6/9/2021,6/9/2021
2722,3061,6/15/1947,Female,170,60,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"9,39","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,3/8/2018,1/3/2019,1/3/2019, , , , , , , , , 
2723,8766,6/15/1946,Male,168,51,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,79",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,3/2/2018,11/7/2018,11/7/2018,1/13/2022,3/31/2022, , , , , , , 
2724,7043,6/15/1952,Male,162,70,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"22,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,3/5/2018,1/30/2019,1/30/2019,2/28/2019,5/1/2019,5/1/2019,7/10/2019,1/22/2021,1/22/2021, , , 
2725,6118,6/15/1946,Male,189,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,55",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/2/2018,2/23/2019,2/23/2019, , , , , , , , , 
2726,7439,6/15/1948,Male,179,119,Compulsory health insurance CHI,No, , ,Unknown, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,97",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,EMP-X,POM-X,R-X,3/2/2018,10/9/2018,10/9/2018,10/23/2018,3/13/2019,3/13/2019,5/6/2019,12/30/2019,12/30/2019,2/22/2020,10/7/2020,10/7/2020
2727,3410,6/15/1948,Female,159,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,42",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/28/2018,4/3/2019,4/3/2019,8/4/2021,3/31/2022,10/14/1582, , , , , , 
2728,4080,6/15/1949,Male,172,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,43",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,3/14/2018,8/29/2018,8/29/2018,5/21/2020,5/14/2021,5/14/2021, , , , , , 
2729,5755,6/15/1953,Female,174,82,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,96",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/6/2018,8/22/2018,8/22/2018, , , , , , , , , 
2730,3496,6/15/1944,Female,165,87,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,04",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/1/2018,3/7/2019,3/7/2019,8/18/2021,3/31/2022,10/14/1582, , , , , , 
2731,9254,6/15/1935,Female,173,108,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/5/2018,8/20/2018,8/20/2018, , , , , , , , , 
2732,1855,6/15/1938,Male,181,94,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,32",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/8/2018,8/23/2018,8/23/2018, , , , , , , , , 
2733,3215,6/15/1946,Male,183,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,86",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/8/2018,5/31/2018,5/31/2018, , , , , , , , , 
2734,7645,6/15/1953,Male,179,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"26,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,No CTx,No CTx,V-X,3/20/2018,11/28/2018,11/28/2018,5/19/2020,11/24/2020,11/24/2020, , , , , , 
2735,3711,6/15/1930,Female,162,68,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"2,85",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,3/15/2018,7/19/2018,7/19/2018,3/6/2020,3/31/2022,10/14/1582, , , , , , 
2736,2767,6/15/1950,Female,157,80,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"31,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,NIN-X,DAR-X,No CTx,V-X,3/8/2018,11/15/2018,11/15/2018,2/25/2020,1/4/2022,1/4/2022,3/17/2022,3/31/2022, , , , 
2737,1382,6/15/1947,Male,156,83,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,41",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,NIN-X,No CTx,No CTx,V-X,3/1/2018,11/8/2018,11/8/2018,2/14/2019,6/30/2021,10/14/1582, , , , , , 
2738,9144,6/15/1953,Female,169,51,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"14,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,3/8/2018,10/13/2020,10/13/2020,10/23/2020,3/31/2022,10/14/1582, , , , , , 
2739,6212,6/15/1951,Female,170,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L", ,DAR-X,KYP-X,EMP-X,V-X,3/23/2018,7/27/2018,7/27/2018,3/3/2020,7/7/2020,7/7/2020,7/24/2020,9/20/2021,9/20/2021,10/5/2021,3/31/2022,10/14/1582
2740,1188,6/15/1948,Male,175,52,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,84",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/23/2018,9/7/2018,9/7/2018, , , , , , , , , 
2741,3628,6/15/1944,Male,169,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,Other,3/7/2018,10/3/2018,10/3/2018, , , , , , , , , 
2742,5173,6/15/1948,Female,164,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,3/5/2018,7/24/2018,7/24/2018,8/8/2019,5/21/2021,5/21/2021,6/16/2021,3/31/2022, , , , 
2743,6712,6/15/1943,Female,168,89,Private,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,3,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,POM-X,R-X,3/15/2018,1/3/2019,1/3/2019,1/18/2019,6/27/2020,6/27/2020,7/8/2020,9/25/2020,9/25/2020,10/10/2020,5/24/2021,5/24/2021
2744,1260,6/15/1943,Male,176,61,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,18",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/13/2018,7/19/2018,7/19/2018, , , , , , , , , 
2745,3979,6/15/1943,Female,164,65,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,67",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/15/2018,3/8/2019,3/8/2019, , , , , , , , , 
2746,3827,6/15/1952,Male,202,90,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,53",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/2/2018,2/23/2019,2/23/2019, , , , , , , , , 
2747,2174,6/15/1951,Male,198,92,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,8",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,3/2/2018,9/13/2018,9/13/2018, , , , , , , , , 
2748,4558,6/15/1932,Male,180,74,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,"25,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,NIN-X,No CTx,V-X,3/8/2018,8/23/2018,8/23/2018,7/31/2019,9/19/2019,9/19/2019,4/1/2020,11/4/2021,11/4/2021, , , 
2749,9413,6/15/1943,Female,159,75,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,59",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,R-X,3/28/2018,3/21/2019,3/21/2019,10/7/2020,12/9/2021,12/9/2021,1/18/2022,3/31/2022, , , , 
2750,3347,6/15/1950,Male,170,64,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,55",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/8/2018,1/3/2019,1/3/2019,12/7/2020,2/22/2021,2/22/2021, , , , , , 
2751,2721,6/15/1956,Male,182,88,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,09",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,3/28/2018,8/1/2018,8/1/2018,5/27/2019,12/14/2021,12/14/2021,1/19/2022,3/31/2022, , , , 
2752,1980,6/15/1952,Male,170,50,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,03",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,No CTx,V-X,3/23/2018,9/4/2018,9/4/2018,4/14/2020,12/3/2020,12/3/2020,12/18/2020,12/31/2020, , , , 
2753,7853,6/15/1946,Male,182,82,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,56",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/1/2018,9/18/2018,9/18/2018, , , , , , , , , 
2754,4316,6/15/1946,Female,164,75,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"23,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/5/2018,2/26/2019,2/26/2019, , , , , , , , , 
2755,6941,6/15/1949,Female,152,51,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,51",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/1/2018,9/27/2018,9/27/2018, , , , , , , , , 
2756,6599,6/15/1973,Female,167,67,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,17",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,3/7/2018,8/22/2018,8/22/2018,3/18/2019,1/12/2022,1/12/2022,2/17/2022,3/31/2022, , , , 
2757,5706,6/15/1943,Male,169,70,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"22,61","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,V-X,No CTx,LEV-X,3/9/2018,8/17/2018,8/17/2018,6/19/2021,8/2/2021,8/2/2021,8/23/2021,3/31/2022, , , , 
2758,8964,6/15/1936,Female,173,83,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,73",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/19/2018,7/23/2018,7/23/2018,6/10/2020,3/31/2022,10/14/1582, , , , , , 
2759,2374,6/15/1949,Male,170,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,3,ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/12/2018,3/28/2018,3/28/2018, , , , , , , , , 
2760,1543,6/15/1939,Female,160,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,4",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/19/2018,7/6/2018,7/6/2018, , , , , , , , , 
2761,6990,6/15/1943,Male,174,94,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,16",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/1/2018,9/1/2018,9/1/2018, , , , , , , , , 
2762,2463,6/15/1943,Male,177,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"14,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,3/1/2018,7/11/2019,7/11/2019,1/21/2020,1/1/2021,1/1/2021, , , , , , 
2763,5690,6/15/1931,Female,164,71,Private,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,3/1/2018,1/2/2019,1/2/2019,1/24/2020,3/31/2022,10/14/1582, , , , , , 
2764,2582,6/15/1943,Male,170,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,61",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/8/2018,5/8/2018,5/8/2018, , , , , , , , , 
2765,4461,6/15/1959,Female,171,94,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,8",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/21/2018,6/13/2018,6/13/2018,3/15/2019,9/30/2020,10/14/1582, , , , , , 
2766,2301,6/15/1953,Female,171,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,38",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,3/1/2018,9/18/2018,9/18/2018, , , , , , , , , 
2767,9517,6/15/1954,Male,186,128,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,32",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/8/2018,1/3/2019,1/3/2019,12/19/2019,5/16/2020,5/16/2020, , , , , , 
2768,1255,6/15/1953,Female,173,111,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"19,27","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/13/2018,3/27/2019,3/27/2019, , , , , , , , , 
2769,9082,6/15/1948,Male,185,133,Private,No, , , , ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,35",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,DAR-X,R-X,8/14/2017,2/8/2018,2/8/2018,3/2/2018,8/17/2018,8/17/2018,1/29/2019,7/18/2020,7/18/2020,7/27/2020,11/24/2021,11/24/2021
2770,6707,6/15/1952,Female,164,66,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,79",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,NIN-X,R-X,1/23/2017,7/21/2017,7/21/2017,3/16/2018,7/27/2018,7/27/2018,3/28/2019,12/23/2020,12/23/2020,1/5/2021,7/22/2021,7/22/2021
2771,8695,6/15/1932,Female,160,44,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,25",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,POM-X,No CTx,V-X,6/23/2017,9/14/2017,9/14/2017,3/5/2018,6/13/2019,6/13/2019,7/17/2019,5/6/2020,5/6/2020, , , 
2772,2412,6/15/1950,Male,175,100,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,61","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,8/14/2017,2/9/2018,2/9/2018,3/7/2018,2/27/2021,2/27/2021,3/15/2021,3/31/2022,10/14/1582, , , 
2773,9583,6/15/1933,Female,178,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"13,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,EMP-X,KYP-X,No CTx,V-X,6/1/2017,8/24/2017,8/24/2017,3/1/2018,12/18/2019,12/18/2019,7/20/2021,3/31/2022,10/14/1582, , , 
2774,9378,6/15/1952,Male,165,58,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"20,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,8/28/2017,2/15/2018,2/15/2018,3/8/2018,1/14/2019,1/14/2019,4/5/2021,3/31/2022, , , , 
2775,8168,6/15/1948,Male,183,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,5,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,4/25/2017,10/17/2017,10/17/2017,3/8/2018,3/18/2020,3/18/2020,5/15/2020,12/29/2020,12/29/2020, , , 
2776,3833,6/15/1950,Male,189,89,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"11,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,4/13/2017,10/11/2017,10/11/2017,3/16/2018,9/14/2018,9/14/2018,1/25/2019,2/25/2019,2/25/2019, , , 
2777,1073,6/15/1948,Male,189,112,Private,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,77",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,POM-X,No CTx,V-X,7/13/2017,11/2/2017,11/2/2017,3/2/2018,1/2/2020,1/2/2020,4/17/2020,12/3/2020,12/3/2020, , , 
2778,7284,6/15/1946,Female,165,95,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,75",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,No CTx,R-X,8/23/2017,2/8/2018,2/8/2018,3/6/2018,9/3/2018,9/3/2018,3/25/2019,1/2/2020,1/2/2020, , , 
2779,4922,6/15/1952,Male,174,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/29/2017,12/4/2017,12/4/2017,2/22/2018,9/30/2020,10/14/1582, , , , , , 
2780,4013,6/15/1950,Female,165,49,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,23",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/10/2017,2/5/2018,2/5/2018,3/1/2018,4/15/2020,4/15/2020, , , , , , 
2781,7839,6/15/1945,Female,161,48,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgD,"15,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,8/14/2017,2/7/2018,2/7/2018,3/5/2018,10/24/2018,10/24/2018, , , , , , 
2782,9180,6/15/1948,Male,180,109,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"14,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,4/5/2017,9/26/2017,9/26/2017,3/8/2018,8/27/2019,8/27/2019,7/27/2020,9/30/2020, , , , 
2783,7579,6/15/1943,Male,168,85,Compulsory health insurance CHI,No, , , ,Yes, , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgA,20,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,V-X,Other,3/3/2016,2/19/2017,2/19/2017,2/24/2018,7/11/2018,7/11/2018,9/12/2019,11/24/2020,11/24/2020,12/11/2020,11/13/2021,11/13/2021
2784,2439,6/15/1939,Male,172,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,4",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/8/2018,3/22/2018,3/22/2018,6/1/2019,3/31/2022,10/14/1582, , , , , , 
2785,6223,6/15/1957,Male,182,75,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"2,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,3/5/2018,5/6/2018,5/6/2018,8/23/2021,9/12/2021,9/12/2021, , , , , , 
2786,6169,6/15/1950,Female,162,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,1",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Nein,R-X,DAR-X,KYP-X,V-X,11/2/2015,1/7/2016,1/7/2016,1/18/2016,3/28/2016,3/28/2016,1/15/2018,10/8/2018,10/8/2018,12/4/2018,4/17/2019,4/17/2019
2787,9421,6/15/1953,Male,184,78,Compulsory health insurance CHI,No,Yes, ,Yes, , , , ,Yes, , ,2,I: fulfilling all 4 criteria,IgA,"2,79",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/13/2017,3/5/2018,3/5/2018,3/20/2018,4/17/2019,4/17/2019, , , , , , 
2788,3205,6/15/1946,Male,167,49,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,5/22/2017,11/20/2017,11/20/2017,3/1/2018,2/18/2019,2/18/2019, , , , , , 
2789,4793,6/15/1945,Male,175,61,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,95",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,No CTx,R-X,9/13/2017,3/5/2018,3/5/2018,3/26/2018,9/10/2018,9/10/2018,1/14/2019,8/16/2021,8/16/2021, , , 
2790,7646,6/15/1953,Male,187,61,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,64",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,POM-X,R-X,8/21/2017,2/12/2018,2/12/2018,3/6/2018,1/2/2019,1/2/2019,1/21/2020,4/2/2020,4/2/2020,4/9/2020,12/31/2020, 
2791,5065,6/15/1944,Male,201,109,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,02",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/24/2017,11/20/2017,11/20/2017,3/7/2018,12/31/2020,10/14/1582, , , , , , 
2792,9700,6/15/1933,Female,160,82,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,8/28/2017,2/12/2018,2/12/2018,3/5/2018,12/31/2020,10/14/1582, , , , , , 
2793,4174,6/15/1948,Male,163,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,68",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,8/29/2017,2/14/2018,2/14/2018,3/2/2018,6/15/2018,6/15/2018, , , , , , 
2794,6507,6/15/1950,Female,167,75,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"32,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/30/2016,3/23/2017,3/23/2017,3/8/2018,12/31/2021,10/14/1582, , , , , , 
2795,7197,6/15/1951,Female,156,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,17","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,V-X,9/12/2017,12/19/2017,12/19/2017,3/1/2018,4/15/2019,4/15/2019,6/19/2019,1/26/2022,1/26/2022,2/15/2022,3/31/2022, 
2796,3371,6/15/1946,Female,163,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,91",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,5/18/2017,8/21/2017,8/21/2017,3/2/2018,6/30/2021,10/14/1582, , , , , , 
2797,1443,6/15/1946,Female,175,106,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,46",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,V-X,R-X,9/25/2017,3/13/2018,3/13/2018,3/26/2018,11/6/2018,11/6/2018,11/26/2018,4/4/2019,4/4/2019,5/24/2019,1/1/2020,1/1/2020
2798,1655,6/15/1952,Female,154,43,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,LEV-X,8/29/2017,2/19/2018,2/19/2018,2/26/2018,3/7/2021,3/7/2021,3/16/2021,3/31/2022,10/14/1582, , , 
2799,4377,6/15/1932,Female,165,60,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,5426,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,R-X,DAR-X,No CTx,V-X,3/1/2013,1/31/2014,1/31/2014,7/8/2014,6/27/2017,6/27/2017,2/20/2018,10/4/2018,10/4/2018, , , 
2800,1962,6/15/1951,Male,168,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,1610,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,EMP-X,No CTx,V-X,5/4/2016,7/18/2016,7/18/2016,2/16/2018,4/8/2021,4/8/2021,5/14/2021,3/31/2022, , , , 
2801,2826,6/15/1944,Female,164,42,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/19/2018,6/19/2018,6/19/2018, , , , , , , , , 
2802,5461,6/15/1940,Male,182,79,Compulsory health insurance CHI,No, , , , ,Yes, , , , ,Yes,2,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Nein,Unbekannt, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,3/28/2018,8/27/2018,8/27/2018,11/11/2019,12/31/2021, , , , , , , 
2803,7929,6/15/1944,Male,174,81,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,25",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,DAR-X,KYP-X,V-X,9/11/2017,12/6/2017,12/6/2017,3/5/2018,9/3/2018,9/3/2018,3/15/2019,3/10/2022,3/10/2022,3/21/2022,3/31/2022,10/14/1582
2804,4545,6/15/1931,Male,169,92,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,Unknown,IgM,4462,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/8/2018,2/5/2018,2/5/2018, , , , , , , , , 
2805,2025,6/15/1949,Male,179,62,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,07",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,1/23/2017,4/20/2017,4/20/2017,3/8/2018,9/6/2018,9/6/2018,1/18/2019,5/14/2019,5/14/2019,5/28/2019,6/27/2019,6/27/2019
2806,5769,6/15/1953,Female,154,55,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"11,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,V-X,No CTx,V-X,5/11/2017,11/3/2017,11/3/2017,3/1/2018,12/2/2021,12/2/2021,1/13/2022,3/31/2022, , , , 
2807,8381,6/15/1938,Male,167,67,Private,Yes,Yes,Yes,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"34,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/6/2018,12/17/2018,12/17/2018, , , , , , , , , 
2808,1998,6/15/1952,Male,168,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"12,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,NIN-X,DAR-X,R-X,9/4/2017,3/5/2018,3/5/2018,3/19/2018,9/3/2018,9/3/2018,1/31/2019,4/4/2019,4/4/2019,7/11/2019,9/12/2019,9/12/2019
2809,3221,6/15/1952,Male,180,107,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,95",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,8/15/2017,2/12/2018,2/12/2018,3/1/2018,4/16/2019,4/16/2019,4/25/2019,1/2/2020,1/2/2020,2/27/2020,3/31/2022, 
2810,3949,6/15/1950,Male,177,87,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,57",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,3/15/2017,9/6/2017,9/6/2017,9/10/2018,1/25/2019,1/25/2019,3/22/2019,3/30/2019,3/30/2019, , , 
2811,2964,6/15/1940,Female,166,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,5/9/2017,8/7/2017,8/7/2017,3/14/2018,3/6/2019,3/6/2019,3/26/2019,3/31/2022, , , , 
2812,5058,6/15/1949,Male,179,88,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,85",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,8/9/2017,11/6/2017,11/6/2017,2/22/2018,5/20/2019,5/20/2019,7/4/2019,7/5/2020,7/5/2020,7/18/2020,2/13/2021,2/13/2021
2813,7358,6/15/1947,Female,174,71,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,LEV-X,8/24/2017,2/15/2018,2/15/2018,3/2/2018,12/30/2019,12/30/2019,1/8/2020,12/21/2020,12/21/2020,1/4/2021,12/31/2021, 
2814,8641,6/15/1939,Male,180,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , ,Nein,V-X,R-X,No CTx,V-X,2/7/2018,4/9/2018,4/9/2018,4/16/2018,4/24/2019,4/24/2019,9/14/2020,9/30/2021, , , , 
2815,8013,6/15/1948,Male,182,57,Private,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,3/29/2017,9/19/2017,9/19/2017,3/12/2018,5/23/2019,5/23/2019,6/27/2019,10/8/2019,10/8/2019,11/7/2019,8/12/2021,8/12/2021
2816,9790,6/15/1948,Female,176,63,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,94",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,LEV-X,V-X,9/7/2017,12/11/2017,12/11/2017,3/12/2018,2/28/2021,2/28/2021,3/9/2021,8/6/2021,8/6/2021,8/27/2021,1/5/2022,1/5/2022
2817,4064,6/15/1949,Male,181,89,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/8/2017,12/4/2017,12/4/2017,3/1/2018,10/10/2019,10/10/2019, , , , , , 
2818,3013,6/15/1947,Female,167,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"13,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,R-X,POM-X,LEV-X,3/13/2017,9/5/2017,9/5/2017,3/14/2018,4/3/2019,4/3/2019,6/24/2019,7/13/2019,7/13/2019,7/23/2019,10/17/2019,10/17/2019
2819,7476,6/15/1950,Male,171,102,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,7/14/2017,11/17/2017,11/17/2017,3/7/2018,8/30/2020,8/30/2020,9/11/2020,12/7/2021,12/7/2021,2/3/2022,3/31/2022, 
2820,2707,6/15/1944,Female,156,65,Private,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"13,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,6/30/2017,9/28/2017,9/28/2017,3/15/2018,8/5/2020,8/5/2020,8/24/2020,6/9/2021,6/9/2021, , , 
2821,9022,6/15/1951,Male,177,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,89",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,5/8/2017,9/11/2017,9/11/2017,3/8/2018,1/2/2020,1/2/2020,6/6/2020,2/10/2021,2/10/2021,3/2/2021,12/13/2021,12/13/2021
2822,3348,6/15/1953,Female,172,98,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,54",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/15/2018,5/28/2018,5/28/2018, , , , , , , , , 
2823,1802,6/15/1945,Male,187,132,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"13,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/28/2017,12/25/2017,12/25/2017,3/2/2018,12/20/2020,12/20/2020, , , , , , 
2824,6529,6/15/1955,Female,168,73,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/2/2018,2/5/2018,2/5/2018, , , , , , , , , 
2825,7511,6/15/1948,Male,178,90,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,Unknown,Other type,94,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,1/30/2018,4/16/2018,4/16/2018, , , , , , , , , 
2826,5256,6/15/1936,Female,168,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,LEV-X,3/15/2018,9/9/2018,9/9/2018,2/10/2020,5/30/2021,5/30/2021,11/8/2021,12/31/2021, , , , 
2827,2093,6/15/1943,Female,163,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"7,75","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,Other,No CTx,No CTx,V-X,2/19/2018,5/4/2018,5/4/2018,4/14/2020,9/14/2020,9/14/2020, , , , , , 
2828,3624,6/15/1963,Male,186,76,Private,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/5/2018,3/23/2018,3/23/2018, , , , , , , , , 
2829,7542,6/15/1943,Male,181,78,Private,No, , , , ,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"4,44",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/8/2018,3/2/2018,3/2/2018,8/5/2021,3/31/2022, , , , , , , 
2830,2047,6/15/1960,Male,179,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"5,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,3/26/2018,5/27/2018,5/27/2018,11/22/2021,12/31/2021, , , , , , , 
2831,3987,6/15/1946,Female,175,87,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"5,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/5/2018,3/15/2018,3/15/2018, , , , , , , , , 
2832,4997,6/15/1950,Male,180,80,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgM,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,3/8/2018,6/30/2018, , , , , , , , , , 
2833,1684,6/15/1949,Male,178,76,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgM,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,2/21/2018,6/30/2018, , , , , , , , , , 
2834,8343,6/15/1951,Male,184,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgM,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,2/20/2018,6/30/2018, , , , , , , , , , 
2835,9149,6/15/1962,Male,178,88,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,3/1/2018,4/15/2018,4/15/2018,5/25/2021,7/25/2021,7/25/2021, , , , , , 
2836,2615,6/15/1936,Male,175,98,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"20,5",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/19/2018,3/30/2018,3/30/2018, , , , , , , , , 
2837,5967,6/15/1941,Female,158,55,Private,No, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,1799,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,1/30/2018,6/10/2018,6/10/2018, , , , , , , , , 
2838,1733,6/15/1950,Male,180,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,Other,6/19/2018,7/15/2018,7/15/2018, , , , , , , , , 
2839,2510,6/15/1943,Female,160,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,1587,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,Other,2/15/2018,7/15/2018,7/15/2018, , , , , , , , , 
2840,1065,6/15/1943,Male,165,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,1556,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,R-X,4/26/2018,6/30/2019, , , , , , , , , , 
2841,1092,6/15/1941,Female,157,73,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,2,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/16/2018,3/26/2018,3/26/2018, , , , , , , , , 
2842,9540,6/15/1940,Male,183,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"999,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/31/2018,2/21/2018,2/21/2018, , , , , , , , , 
2843,8065,6/15/1941,Male,178,108,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/9/2018,4/12/2018,4/12/2018, , , , , , , , , 
2844,5203,6/15/1940,Male,173,84,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, ,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"1,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/31/2018,12/17/2018,12/17/2018,1/21/2019,2/10/2019,2/10/2019, , , , , , 
2845,8544,6/15/1949,Female,165,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/22/2018,6/1/2018,6/1/2018,10/6/2021,3/31/2022,10/14/1582, , , , , , 
2846,6198,6/15/1940,Male,162,51,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"2,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/10/2018,3/29/2018,3/29/2018, , , , , , , , , 
2847,7636,6/15/1947,Male,175,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,7",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/21/2018,4/13/2018,4/13/2018, , , , , , , , , 
2848,4677,6/15/1935,Male,180,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"1,3",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/9/2018,8/17/2018,8/17/2018,8/29/2018,7/30/2019,7/30/2019, , , , , , 
2849,5854,6/15/1938,Female,162,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"34,2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/12/2018,3/27/2018,3/27/2018, , , , , , , , , 
2850,8478,6/15/1949,Male,178,77,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"3,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/26/2018,3/31/2018, , , , , , , , , , 
2851,8448,6/15/1940,Male,185,90,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,42,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,R-X,V-X,KYP-X,V-X,9/2/2016,1/23/2017,1/23/2017,3/3/2018,12/6/2018,12/6/2018,12/21/2018,4/26/2019,4/26/2019,9/24/2019,6/24/2020,6/24/2020
2852,6585,6/15/1937,Female,165,65,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,1,Unknown,IgG,"11,8",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/8/2018,2/5/2018,2/5/2018, , , , , , , , , 
2853,2253,6/15/1963,Female,173,82,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,1298,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/11/2017,6/9/2017,6/9/2017, , , , , , , , , 
2854,1083,6/15/1948,Female,160,62,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,No CTx,V-X,3/6/2017,6/8/2017,6/8/2017,5/22/2018,12/14/2018,12/14/2018,6/6/2019,12/31/2019,10/14/1582, , , 
2855,2129,6/15/1940,Male,174,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"43,7",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/16/2018,3/31/2018, , , , , , , , , , 
2856,5945,6/15/1937,Male,176,88,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"30,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/16/2018,3/31/2018, , , , , , , , , , 
2857,7578,6/15/1940,Male,172,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,999,unknown/ISS-Criteria not used for prognostics,9,9,Yes,Yes,Unknown,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,R-X,EMP-X,No CTx,Other,5/15/2007,6/15/2007,6/15/2007,3/15/2010,3/6/2018,3/6/2018,3/7/2018,5/16/2018,5/16/2018, , , 
2858,1148,6/15/1941,Male,183,95,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,41,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,V-X,V-X,LEV-X,V-X,6/10/2014,3/23/2015,3/23/2015,2/10/2018,6/13/2018,6/13/2018,6/27/2018,6/19/2019,6/19/2019,6/26/2019,3/13/2020,3/13/2020
2859,1253,6/15/1936,Male,167,84,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgA,",25",ISS stage II (neither stage I nor stage III),No,9,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,DAR-X,LEV-X,R-X,3/20/2017,9/7/2017,9/7/2017,9/18/2017,2/19/2018,2/19/2018,2/20/2018,3/29/2018,3/29/2018,4/25/2018,11/8/2018,11/8/2018
2860,3730,6/15/1941,Male,170,96,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgA,"13,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,1/22/2018,11/27/2018,11/27/2018,12/4/2018,6/4/2019,6/4/2019, , , , , , 
2861,6891,6/15/1937,Male,173,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"28,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Unbekannt,KYP-X,DAR-X,No CTx,R-X,7/22/2015,1/8/2018,1/8/2018,1/10/2018,6/17/2018,6/17/2018,7/3/2018,1/24/2019,1/24/2019, , , 
2862,4309,6/15/1947,Male,174,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,17,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/26/2018,9/4/2018,9/4/2018,1/22/2019,6/30/2019,10/14/1582, , , , , , 
2863,9676,6/15/1936,Female,162,47,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"3,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/3/2018,7/25/2018,7/25/2018,2/15/2019,2/25/2019,2/25/2019, , , , , , 
2864,3816,6/15/1946,Female,167,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgA,1048,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,R-X,6/3/2016,3/15/2017,3/15/2017,1/9/2018,10/11/2021,10/11/2021, , , , , , 
2865,7326,6/15/1941,Female,164,54,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgM,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,10/17/2017,1/10/2018,1/10/2018,2/12/2018,2/26/2018,2/26/2018, , , , , , 
2866,1492,6/15/1958,Female,165,65,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,6",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/3/2018,3/9/2018,3/9/2018, , , , , , , , , 
2867,5378,6/15/1953,Male,172,92,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/12/2018,1/22/2018,1/22/2018, , , , , , , , , 
2868,6367,6/15/1946,Male,172,84,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L", ,EMP-X,No CTx,No CTx,V-X,11/4/2013,1/23/2014,1/23/2014,1/31/2018,3/31/2021,10/14/1582, , , , , , 
2869,2230,6/15/1955,Male,185,111,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,3649,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,EMP-X,DAR-X,No CTx,V-X,11/16/2015,1/7/2016,1/7/2016,3/15/2018,8/1/2018,8/1/2018,9/15/2018,9/15/2018,9/15/2018, , , 
2870,5914,6/15/1936,Female,167,60,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,37,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,12/11/2017,1/22/2018,1/22/2018,1/29/2018,2/14/2018,2/14/2018, , , , , , 
2871,1329,6/15/1948,Male,192,88,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,28,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,R-X,No CTx,V-X,2/12/2018,7/30/2018,7/30/2018,8/9/2018,3/15/2019,3/15/2019,3/29/2019,3/31/2022, , , , 
2872,5252,6/15/1940,Female,159,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,27,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,V-X,DAR-X,No CTx,V-X,1/9/2018,3/13/2018,3/13/2018,3/20/2018,2/28/2019,2/28/2019,3/14/2019,6/30/2020,10/14/1582, , , 
2873,4603,6/15/1939,Female,162,77,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,12500,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,V-X,No CTx,No CTx,V-X,1/23/2018,3/28/2018,3/28/2018,4/4/2018,3/31/2022, , , , , , , 
2874,1383,6/15/1938,Male,173,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,20,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,DAR-X,DAR-X,No CTx,V-X,4/15/2014,10/15/2015,10/15/2015,2/8/2018,5/30/2018,5/30/2018,6/13/2018,3/31/2022,10/14/1582, , , 
2875,1508,6/15/1960,Male,180,85,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,21,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,V-X,DAR-X,POM-X,V-X,6/15/2011,12/15/2011,12/15/2011,1/19/2018,7/23/2018,7/23/2018,8/6/2018,10/23/2018,10/23/2018,12/14/2018,3/5/2019,3/5/2019
2876,9659,6/15/1940,Male,167,77,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,KYP-X,KYP-X,KYP-X,Other,8/1/2000,12/1/2000,12/1/2000,2/5/2018,3/20/2018,3/20/2018,6/12/2019,11/5/2019,11/5/2019,2/16/2021,3/31/2021, 
2877,8931,6/15/1958,Male,190,85,Private,Unknown, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,No CTx,No CTx,No CTx, , , ,3/26/2018,5/16/2018,5/16/2018, , , , , , 
2878,6836,6/15/1943,Male,165,74,Compulsory health insurance CHI,Unknown,Yes, , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),9,9,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,R-X,2/20/2018,5/24/2019,5/24/2019, , , , , , , , , 
2879,3994,6/15/1946,Female,156,61,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,8/1/2014,11/1/2014,11/1/2014,3/26/2018,2/5/2019,2/5/2019, , , , , , 
2880,9371,6/15/1946,Male,166,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,EMP-X,KYP-X,No CTx,V-X,2/19/2016,6/6/2016,6/6/2016,3/15/2018,5/9/2018,5/9/2018,6/12/2019,10/24/2019,10/24/2019, , , 
2881,8524,6/15/1942,Female,168,69,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/6/2015,4/14/2015,4/14/2015,2/9/2017,2/28/2018,2/28/2018,3/15/2018,5/27/2020,5/27/2020, , , 
2882,6521,6/15/1948,Male,177,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"22,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,6/8/2016,10/6/2016,10/6/2016,5/23/2017,3/8/2018,3/8/2018,3/20/2018,11/23/2021,11/23/2021, , , 
2883,1178,6/15/1950,Male,180,85,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,9,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,R-X,1/10/2018,3/28/2018,3/28/2018,12/10/2019,3/31/2021, , , , , , , 
2884,7500,6/15/1943,Female,160,71,Compulsory health insurance CHI,Unknown, , , , , ,Yes,Yes,Yes, , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,Yes,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,Other,2/15/2018,5/15/2018,5/15/2018, , , , , , , , , 
2885,5583,6/15/1948,Male,177,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,7/8/2014,10/21/2014,10/21/2014,6/28/2016,3/16/2017,3/16/2017,5/25/2017,2/26/2018,2/26/2018,3/7/2018,8/16/2018,8/16/2018
2886,3801,6/15/1941,Female,166,74,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,69",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,12/9/2015,4/6/2016,4/6/2016,12/20/2016,2/26/2018,2/26/2018,3/13/2018,2/4/2019,2/4/2019,3/8/2019,9/6/2021,9/6/2021
2887,7030,6/15/1941,Male,176,85,Private,Unknown, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,EMP-X,DAR-X,V-X,6/1/2013,8/1/2013,8/1/2013,3/9/2017,1/20/2018,1/20/2018,1/25/2018,3/6/2018,3/6/2018,9/10/2018,3/31/2021,10/14/1582
2888,6050,6/15/1955,Male,185,90,Private,Yes,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,23,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/19/2018,6/15/2018,6/15/2018,4/5/2021,4/10/2021,4/10/2021, , , , , , 
2889,8118,6/15/1942,Male,184,100,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,No,Yes,No,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,KYP-X,DAR-X,V-X,9/10/2012,4/9/2013,4/9/2013,4/15/2013,9/3/2014,9/3/2014,4/13/2016,11/23/2017,11/23/2017,1/23/2018,2/13/2018,2/13/2018
2890,6604,6/15/1941,Male,167,86,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/20/2018,6/30/2018, , , , , , , , , , 
2891,3190,6/15/1941,Female,158,55,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"9,9",ISS stage II (neither stage I nor stage III),9,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Nein,R-X,No CTx,No CTx,V-X,1/23/2018,3/21/2018,3/21/2018,3/27/2018,4/20/2018,4/20/2018, , , , , , 
2892,8726,6/15/1952,Female,168,69,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"16,95","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,1/27/2016,5/11/2016,5/11/2016,2/8/2017,2/27/2018,2/27/2018,3/8/2018,9/4/2018,9/4/2018,1/23/2019,4/12/2020,4/12/2020
2893,7339,6/15/1941,Female,166,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,95",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,11/4/2015,3/29/2016,3/29/2016,11/22/2016,3/1/2018,3/1/2018,3/12/2018,11/15/2020,11/15/2020,11/25/2020,6/3/2021,6/3/2021
2894,4979,6/15/1941,Female,168,72,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,03",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,NIN-X,V-X,1/11/2016,4/15/2016,4/15/2016,11/17/2016,8/10/2017,8/10/2017,8/28/2017,2/16/2018,2/16/2018,3/1/2018,9/10/2018,9/10/2018
2895,7309,6/15/1949,Male,169,58,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"15,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,6/8/2016,10/27/2016,10/27/2016,4/5/2017,3/15/2018,3/15/2018,3/27/2018,3/31/2022,10/14/1582, , , 
2896,3980,6/15/1952,Male,172,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,8/17/2016,11/24/2016,11/24/2016,1/3/2017,2/20/2018,2/20/2018,3/12/2018,8/27/2021,8/27/2021,9/3/2021,3/31/2022, 
2897,9490,6/15/1955,Male,187,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"27,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,V-X,5/6/2015,9/24/2015,9/24/2015,5/5/2016,7/12/2017,7/12/2017,7/27/2017,2/20/2018,2/20/2018,3/8/2018,8/15/2018,8/15/2018
2898,6880,6/15/1945,Male,184,92,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,2/11/2016,11/18/2016,11/18/2016,12/7/2016,2/19/2018,2/19/2018,3/19/2018,3/31/2022,10/14/1582, , , 
2899,1209,6/15/1950,Female,167,58,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,KYP-X,NIN-X,V-X,8/16/2016,11/29/2016,11/29/2016,1/13/2017,7/26/2017,7/26/2017,8/10/2017,2/26/2018,2/26/2018,3/14/2018,11/15/2019,11/15/2019
2900,2605,6/15/1942,Male,182,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,11/10/2015,2/24/2016,2/24/2016,3/9/2017,2/20/2018,2/20/2018,3/28/2018,9/26/2018,9/26/2018,2/22/2019,5/6/2019,5/6/2019
2901,7683,6/15/1948,Male,179,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"14,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,3/4/2016,6/28/2016,6/28/2016,5/11/2017,2/26/2018,2/26/2018,3/6/2018,7/4/2018,7/4/2018,7/16/2018,9/17/2019,9/17/2019
2902,7185,6/15/1946,Male,177,69,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,62",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,1/27/2016,5/19/2016,5/19/2016,11/29/2016,8/10/2017,8/10/2017,8/29/2017,2/20/2018,2/20/2018,3/14/2018,8/27/2018,8/27/2018
2903,6125,6/15/1945,Male,181,80,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,55",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,KYP-X,V-X,4/11/2016,8/22/2016,8/22/2016,3/9/2017,2/22/2018,2/22/2018,3/12/2018,11/29/2018,11/29/2018,12/20/2018,2/19/2019,2/19/2019
2904,6364,6/15/1944,Male,175,89,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"14,39",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,3/5/2015,7/21/2015,7/21/2015,4/5/2017,2/9/2018,2/9/2018,3/19/2018,10/1/2018,10/1/2018,10/17/2018,11/29/2018,11/29/2018
2905,9993,6/15/1942,Male,178,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"9,11",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,7/2/2015,11/19/2015,11/19/2015,9/13/2016,5/11/2017,5/11/2017,6/15/2017,3/13/2018,3/13/2018,3/28/2018,9/3/2018,9/3/2018
2906,9301,6/15/1940,Male,182,86,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,1/7/2016,4/12/2016,4/12/2016,7/18/2017,2/16/2018,2/16/2018,3/6/2018,8/24/2020,8/24/2020,8/31/2020,9/30/2020, 
2907,8568,6/15/1950,Male,165,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Unknown, ,1,III: one or more criteria are fulfilled,IgA,",2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , , ,Ja,V-X,No CTx,No CTx,R-X,2/7/2018,6/20/2019,6/20/2019,8/5/2019,12/31/2019, , , , , , , 
2908,4078,6/15/1938,Male,175,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,3",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,R-X,KYP-X,NIN-X,V-X,3/2/2016,7/12/2016,7/12/2016,6/28/2017,2/27/2018,2/27/2018,3/13/2018,7/5/2018,7/5/2018,7/25/2018,8/2/2018,8/2/2018
2909,9683,6/15/1960,Male,186,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,1/16/2018,4/4/2018,4/4/2018, , , , , , , , , 
2910,7359,6/15/1945,Male,189,91,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,POM-X,R-X,5/18/2016,3/15/2017,3/15/2017,4/5/2017,3/9/2018,3/9/2018,3/21/2018,5/28/2019,5/28/2019,6/26/2019,7/22/2019,7/22/2019
2911,7137,6/15/1944,Male,175,82,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"9,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,4/21/2015,8/11/2015,8/11/2015,5/16/2017,3/8/2018,3/8/2018,3/29/2018,2/25/2019,2/25/2019,3/14/2019,3/14/2019,3/14/2019
2912,3924,6/15/1938,Male,191,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"5,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,4/5/2016,10/27/2016,10/27/2016,11/10/2016,7/19/2017,7/19/2017,8/14/2017,2/23/2018,2/23/2018,3/7/2018,8/9/2018,8/9/2018
2913,4596,6/15/1941,Male,179,81,Private,No, , , , , , , , , ,Yes,1,I: fulfilling all 4 criteria,IgG,18,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , , ,Nein,R-X,No CTx,No CTx,V-X,3/19/2018,7/4/2018,7/4/2018,8/1/2018,3/31/2022, , , , , , , 
2914,4417,6/15/1943,Male,178,71,Private,No,Yes,Yes, , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,11,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,V-X,V-X,R-X,3/15/2018,6/30/2019,6/30/2019,7/1/2019,5/1/2021,5/1/2021,5/1/2021,11/30/2021,11/30/2021,12/1/2021,12/31/2021, 
2915,6811,6/15/1944,Male,185,93,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"7,38",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,No CTx,V-X,4/14/2016,8/19/2016,8/19/2016,8/10/2017,2/26/2018,2/26/2018,3/13/2018,12/16/2020,12/16/2020, , , 
2916,5988,6/15/1949,Male,180,79,Compulsory health insurance CHI,No, ,Yes, , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,35,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/15/2018,6/1/2018,6/1/2018,10/1/2019,9/30/2021,10/14/1582, , , , , , 
2917,5241,6/15/1941,Male,179,86,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"8,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,No CTx,V-X,11/18/2015,3/17/2016,3/17/2016,6/21/2017,2/27/2018,2/27/2018,3/1/2018,6/30/2021,10/14/1582, , , 
2918,1628,6/15/1941,Female,162,71,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,4/10/2015,8/19/2015,8/19/2015,9/1/2016,6/28/2017,6/28/2017,7/6/2017,3/5/2018,3/5/2018,3/22/2018,8/15/2018,8/15/2018
2919,3377,6/15/1950,Male,169,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,1",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,NIN-X,V-X,10/28/2015,3/10/2016,3/10/2016,7/12/2017,2/14/2018,2/14/2018,3/1/2018,1/8/2019,1/8/2019,3/7/2019,11/5/2020,11/5/2020
2920,5205,6/15/1948,Male,180,72,Private,No, ,Yes, ,Yes,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"6,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,KYP-X,DAR-X,V-X,1/26/2016,9/28/2016,9/28/2016,10/17/2016,7/13/2017,7/13/2017,8/2/2017,3/8/2018,3/8/2018,3/19/2018,6/18/2019,6/18/2019
2921,7933,6/15/1939,Male,179,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,42",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,NIN-X,V-X,10/14/2015,3/4/2016,3/4/2016,7/11/2017,3/15/2018,3/15/2018,3/29/2018,1/30/2019,1/30/2019,2/8/2019,10/11/2020,10/11/2020
2922,7627,6/15/1941,Male,175,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,R-X,3/15/2016,4/20/2017,4/20/2017,5/10/2017,3/12/2018,3/12/2018,3/20/2018,10/2/2018,10/2/2018,2/26/2019,8/21/2019,8/21/2019
2923,1527,6/15/1953,Female,170,88,Compulsory health insurance CHI,No,Yes,Yes,Unknown, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,2092,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,V-X,No CTx,No CTx,V-X,4/23/2018,6/12/2018,6/12/2018,4/14/2021,8/16/2021,8/16/2021, , , , , , 
2924,9260,6/15/1957,Female,168,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgA,1170,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,R-X,DAR-X,V-X,9/2/2013,11/11/2013,11/11/2013,2/9/2017,3/20/2017,3/20/2017,6/14/2018,12/17/2020,12/17/2020,1/25/2021,4/26/2021,4/26/2021
2925,1454,6/15/1944,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/3/2017,1/14/2018,1/14/2018, , , , , , , , , 
2926,2404,6/15/1940,Female,162,66,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgM,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,2/16/2015,8/15/2015,8/15/2015,7/24/2017,1/14/2018,1/14/2018, , , , , , 
2927,6987,6/15/1957,Female,167,46,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,V-X,4/24/2018,7/11/2018,7/11/2018, , , , , , , , , 
2928,2254,6/15/1938,Male,174,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L", ,V-X,DAR-X,No CTx,V-X,4/30/2018,11/19/2018,11/19/2018,9/25/2020,1/18/2021,1/18/2021,7/26/2021,3/31/2022,10/14/1582, , , 
2929,7338,6/15/1947,Male,186,90,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"3,34",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Ja,V-X,R-X,POM-X,R-X,10/22/2015,4/5/2016,4/5/2016,9/14/2016,10/19/2016,10/19/2016,1/4/2018,2/1/2018,2/1/2018,8/7/2018,9/3/2018,9/3/2018
2930,1246,6/15/1954,Male,172,76,Private,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"4,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,V-X,DAR-X,V-X,2/2/2015,3/26/2015,3/26/2015,5/28/2018,12/27/2018,12/27/2018,1/7/2020,9/1/2020,9/1/2020,11/30/2020,3/31/2022,10/14/1582
2931,5315,6/15/1948,Female,158,58,Private,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"2,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Nein,DAR-X,EMP-X,DAR-X,V-X,6/5/2018,1/10/2019,1/10/2019,1/22/2019,1/7/2020,1/7/2020,2/25/2020,4/13/2020,4/13/2020,4/14/2020,9/15/2020,9/15/2020
2932,8209,6/15/1953,Male,180,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/29/2018,10/30/2018,10/30/2018, , , , , , , , , 
2933,4953,6/15/1944,Female,164,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,8110,ISS stage II (neither stage I nor stage III),No,9,Yes,No,Unknown,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/22/2018,8/15/2018,8/15/2018, , , , , , , , , 
2934,5437,6/15/1938,Male,168,60,Private,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,3,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Nein,KYP-X,No CTx,No CTx,V-X,11/17/2016,2/9/2017,2/9/2017,5/24/2018,7/6/2018,7/6/2018, , , , , , 
2935,2899,6/15/1943,Female,168,104,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,5640,ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,10/31/2016,7/24/2017,7/24/2017,4/23/2018,3/31/2021, , , , , , , 
2936,8269,6/15/1942,Male,171,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,DAR-X,V-X,4/12/2018,7/16/2018,7/16/2018,12/18/2018,10/22/2019,10/22/2019,11/5/2019,5/14/2020,5/14/2020,5/19/2021,3/31/2022,10/14/1582
2937,2962,6/15/1944,Male,170,64,Private,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,7",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,6/25/2018,10/19/2018,10/19/2018,3/8/2019,11/25/2021,11/25/2021,12/9/2021,12/16/2021,12/16/2021, , , 
2938,2080,6/15/1949,Female,169,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,6",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L",Ja,R-X,POM-X,KYP-X,V-X,3/30/2015,5/15/2015,5/15/2015,6/4/2018,12/17/2018,12/17/2018,7/22/2019,10/19/2020,10/19/2020,1/19/2022,3/31/2022,10/14/1582
2939,5114,6/15/1951,Female,168,135,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,POM-X,V-X,3/14/2016,9/23/2016,9/23/2016,11/18/2016,6/26/2017,6/26/2017,6/4/2018,6/12/2018,6/12/2018,7/1/2018,7/30/2018,7/30/2018
2940,5780,6/15/1938,Male,170,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,Unknown,IgA,1323,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,6/5/2018,9/27/2018,9/27/2018,10/2/2018,11/13/2018,11/13/2018, , , , , , 
2941,4642,6/15/1943,Male,176,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,3/5/2018,9/30/2018, , , , , , , , , , 
2942,5414,6/15/1935,Female,162,67,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,999,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,V-X,POM-X,No CTx,R-X,5/15/2018,7/15/2018,7/15/2018,8/15/2018,10/4/2018,10/4/2018,11/27/2018,4/24/2019,4/24/2019, , , 
2943,7842,6/15/1932,Male,177,74,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,7/8/2016,4/10/2018,4/10/2018,4/17/2018,6/30/2019, , , , , , , 
2944,4212,6/15/1954,Male,180,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,3708,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/21/2017,7/18/2017,7/18/2017, , , , , , , , , 
2945,1451,6/15/1951,Female,180,95,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,LEV-X,KYP-X,V-X,6/4/2012,8/9/2012,8/9/2012,3/14/2014,9/2/2015,9/2/2015,10/7/2015,4/12/2016,4/12/2016,4/11/2018,6/21/2018,6/21/2018
2946,6920,6/15/1969,Female,170,72,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,245,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/18/2018,7/3/2018,7/3/2018, , , , , , , , , 
2947,4489,6/15/1957,Female,165,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"224,5",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Ja,Unbekannt,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,6/4/2018,8/20/2018,8/20/2018, , , , , , , , , 
2948,8000,6/15/1945,Male,180,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"18,21",unknown/ISS-Criteria not used for prognostics,No,Yes,No,9,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , , ,No CTx,No CTx,No CTx,Other,4/26/2018,6/30/2019, , , , , , , , , , 
2949,8211,6/15/1972,Male,183,95,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/25/2018,9/17/2018,9/17/2018, , , , , , , , , 
2950,3064,6/15/1942,Female,164,58,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"61,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/7/2018,11/12/2018,11/12/2018,5/8/2019,9/5/2019,9/5/2019, , , , , , 
2951,8750,6/15/1964,Male,172,77,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,Unknown,IgG,"34,14",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/14/2018,10/1/2018,10/1/2018, , , , , , , , , 
2952,8997,6/15/1949,Male,182,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,2957,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,R-X,EMP-X,KYP-X,V-X,11/18/2013,1/9/2014,1/9/2014,9/24/2015,4/27/2018,4/27/2018,5/9/2018,1/9/2019,1/9/2019,1/30/2019,6/19/2019,6/19/2019
2953,8572,6/15/1948,Female,162,63,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"14,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,4/9/2018,6/5/2019,6/5/2019, , , , , , , , , 
2954,7863,6/15/1943,Male,186,94,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"24,56","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/30/2018,6/19/2019,6/19/2019, , , , , , , , , 
2955,6497,6/15/1947,Female,156,54,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"2,73",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,2/11/2018,4/3/2019,4/3/2019,3/10/2022,3/31/2022, , , , , , , 
2956,8107,6/15/1948,Female,165,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,07",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/16/2018,12/31/2021, , , , , , , , , , 
2957,6093,6/15/1937,Female,157,51,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"40,69",ISS stage II (neither stage I nor stage III),No,No,No,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/29/2018,9/10/2018,9/10/2018, , , , , , , , , 
2958,4525,6/15/1944,Male,175,79,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"33,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/1/2018,5/25/2019,5/25/2019, , , , , , , , , 
2959,3537,6/15/1940,Female,158,47,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes, ,Yes, , ,Yes,2,III: one or more criteria are fulfilled,IgA,"17,24","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,6/11/2018,12/3/2018,12/3/2018,7/31/2019,7/13/2020,7/13/2020, , , , , , 
2960,4261,6/15/1943,Female,174,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,56",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,5/7/2018,12/19/2018,12/19/2018,8/21/2019,12/23/2019,12/23/2019,3/5/2020,1/27/2021,1/27/2021, , , 
2961,4308,6/15/1946,Female,169,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,99",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/4/2018,11/14/2018,11/14/2018,2/8/2019,3/31/2022,10/14/1582, , , , , , 
2962,9150,6/15/1949,Male,175,90,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"18,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,5/10/2018,6/30/2021, , , , , , , , , , 
2963,8881,6/15/1952,Male,179,72,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"23,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,9,9,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,4/12/2018,4/18/2019,4/18/2019,1/19/2022,3/31/2022,10/14/1582, , , , , , 
2964,6957,6/15/1947,Female,160,50,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,1,I: fulfilling all 4 criteria,IgG,"4,12",ISS stage II (neither stage I nor stage III),9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/9/2018,5/8/2019,5/8/2019, , , , , , , , , 
2965,1761,6/15/1949,Male,180,76,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,45,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,1/26/2018,5/29/2018,5/29/2018,6/9/2018,10/4/2018,10/4/2018,12/12/2018,2/20/2020,2/20/2020,3/17/2020,11/20/2020,11/20/2020
2966,5454,6/15/1949,Female,171,87,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,71",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/5/2018,6/5/2018,6/5/2018, , , , , , , , , 
2967,3984,6/15/1946,Male,160,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,5/7/2018,4/30/2019,4/30/2019,11/9/2021,3/31/2022, , , , , , , 
2968,1109,6/15/1953,Female,169,52,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,23",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,KYP-X,POM-X,V-X,5/8/2018,1/17/2019,1/17/2019,3/3/2020,11/2/2020,11/2/2020,11/17/2020,3/14/2022,3/14/2022,3/23/2022,3/31/2022, 
2969,8890,6/15/1973,Female,181,91,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,28",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/7/2018,9/3/2018,9/3/2018,10/20/2021,3/31/2022,10/14/1582, , , , , , 
2970,2845,6/15/1946,Female,150,69,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,31",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/3/2018,4/9/2019,4/9/2019, , , , , , , , , 
2971,6873,6/15/1943,Female,160,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,54",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/20/2018,2/13/2019,2/13/2019, , , , , , , , , 
2972,4196,6/15/1945,Male,166,89,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"29,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/14/2018,9/19/2019,9/19/2019, , , , , , , , , 
2973,7259,6/15/1950,Male,196,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,96","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/9/2018,2/6/2019,2/6/2019, , , , , , , , , 
2974,8487,6/15/1943,Female,160,92,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,24",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/28/2018,1/15/2019,1/15/2019, , , , , , , , , 
2975,9568,6/15/1953,Male,175,80,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,0,I: fulfilling all 4 criteria,IgG,3770,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/11/2018,8/2/2018,8/2/2018, , , , , , , , , 
2976,2862,6/15/1943,Male,167,52,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,65",ISS stage II (neither stage I nor stage III),9,No,9,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/13/2018,12/10/2018,12/10/2018,3/22/2021,7/26/2021,7/26/2021, , , , , , 
2977,8955,6/15/1956,Male,177,54,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/1/2018,10/5/2018,10/5/2018,2/21/2022,3/31/2022, , , , , , , 
2978,1261,6/15/1950,Female,184,110,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,82",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,No CTx,V-X,5/16/2018,10/31/2018,10/31/2018,5/18/2020,5/11/2021,5/11/2021,9/23/2021,3/31/2022,10/14/1582, , , 
2979,3538,6/15/1946,Female,161,65,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,34",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/8/2018,9/11/2018,9/11/2018,2/16/2022,3/31/2022, , , , , , , 
2980,4685,6/15/1950,Male,187,90,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,39,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,EMP-X,DAR-X,V-X,4/24/2018,7/10/2019,7/10/2019,9/17/2019,12/27/2019,12/27/2019,3/31/2020,11/20/2020,11/20/2020,12/30/2020,11/25/2021,11/25/2021
2981,6152,6/15/1943,Male,176,64,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,46",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,4/24/2018,10/9/2018,10/9/2018,5/14/2020,5/7/2021,5/7/2021, , , , , , 
2982,4741,6/15/1946,Female,167,94,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,53",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/10/2018,8/23/2018,8/23/2018, , , , , , , , , 
2983,6782,6/15/1939,Female,174,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"12,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Ja,V-X,DAR-X,No CTx,V-X,5/22/2018,11/6/2018,11/6/2018,1/29/2020,7/14/2020,7/14/2020,6/8/2021,12/31/2021,10/14/1582, , , 
2984,4210,6/15/1947,Male,166,91,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,59",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,V-X,No CTx,V-X,5/30/2018,9/26/2018,9/26/2018,1/31/2020,11/29/2021,11/29/2021,1/13/2022,3/31/2022, , , , 
2985,7265,6/15/1953,Female,179,102,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"21,54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L", ,NIN-X,POM-X,No CTx,V-X,5/4/2018,11/29/2018,11/29/2018,2/1/2020,1/4/2022,1/4/2022,1/19/2022,3/31/2022, , , , 
2986,8198,6/15/1931,Male,175,80,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"27,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,6/15/2018,6/8/2019,6/8/2019, , , , , , , , , 
2987,5751,6/15/1947,Male,178,66,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,66",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,V-X,4/27/2018,7/20/2018,7/20/2018,12/27/2019,6/4/2020,6/4/2020, , , , , , 
2988,3993,6/15/1944,Female,168,72,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,5/3/2018,2/27/2019,2/27/2019, , , , , , , , , 
2989,5044,6/15/1943,Male,169,97,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"28,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/20/2018,10/17/2018,10/17/2018,8/18/2021,3/31/2022,10/14/1582, , , , , , 
2990,5447,6/15/1949,Female,172,52,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,43",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,5/7/2018,6/20/2019,6/20/2019, , , , , , , , , 
2991,4502,6/15/1953,Female,150,68,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,49",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,4/2/2018,12/13/2018,12/13/2018, , , , , , , , , 
2992,8212,6/15/1952,Male,178,59,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"17,54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/10/2018,9/6/2018,9/6/2018,10/28/2019,5/11/2020,5/11/2020, , , , , , 
2993,1481,6/15/1947,Male,181,103,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,02",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,4/20/2018,12/29/2018,12/29/2018,10/28/2020,9/10/2021,9/10/2021, , , , , , 
2994,9007,6/15/1944,Female,164,69,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,12",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/11/2018,8/21/2019,8/21/2019, , , , , , , , , 
2995,1374,6/15/1945,Female,160,62,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,91",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,No CTx,V-X,6/5/2018,12/21/2018,12/21/2018,1/8/2020,7/7/2021,7/7/2021,8/10/2021,3/31/2022,10/14/1582, , , 
2996,4032,6/15/1951,Male,174,81,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,6",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,4/6/2018,1/23/2019,1/23/2019,8/17/2021,3/31/2022,10/14/1582, , , , , , 
2997,5099,6/15/1953,Female,158,55,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"22,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/4/2018,6/26/2019,6/26/2019, , , , , , , , , 
2998,6140,6/15/1945,Male,174,70,Private,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,56",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/18/2018,6/13/2019,6/13/2019, , , , , , , , , 
2999,1583,6/15/1943,Male,180,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,15",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,5/23/2018,9/19/2019,9/19/2019,2/21/2022,3/31/2022, , , , , , , 
3000,5966,6/15/1952,Male,181,90,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,44",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/11/2018,5/17/2019,5/17/2019,10/12/2021,3/31/2022, , , , , , , 
3001,6514,6/15/1946,Male,174,74,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"28,03","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,V-X,NIN-X,V-X,5/1/2018,8/22/2019,8/22/2019,1/10/2020,2/2/2020,2/2/2020,4/16/2020,1/4/2021,1/4/2021,1/11/2021,7/20/2021,7/20/2021
3002,8730,6/15/1943,Female,151,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,EMP-X,V-X,POM-X,V-X,6/11/2018,2/11/2019,2/11/2019,2/21/2019,1/2/2020,1/2/2020,1/26/2020,11/13/2020,11/13/2020,11/26/2020,3/31/2022, 
3003,6495,6/15/1947,Female,174,110,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,66",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/13/2018,8/28/2018,8/28/2018, , , , , , , , , 
3004,4107,6/15/1943,Female,163,100,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,49",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/26/2018,6/19/2019,6/19/2019,11/17/2021,3/31/2022, , , , , , , 
3005,7440,6/15/1943,Female,163,100,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,62",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/23/2018,10/29/2018,10/29/2018, , , , , , , , , 
3006,3235,6/15/1950,Male,181,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"18,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/4/2018,10/25/2018,10/25/2018, , , , , , , , , 
3007,8972,6/15/1947,Male,175,82,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,61","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/10/2018,11/28/2018,11/28/2018,7/23/2019,12/31/2020,10/14/1582, , , , , , 
3008,5468,6/15/1945,Male,182,97,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/26/2018,12/31/2020, , , , , , , , , , 
3009,7282,6/15/1945,Male,182,97,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,55",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,4/12/2018,4/5/2019,4/5/2019, , , , , , , , , 
3010,2380,6/15/1955,Male,175,80,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Ja, , , , , ,No CTx,R-X,No CTx,V-X,7/1/2017,10/31/2017,10/31/2017, , , ,7/13/2018,4/15/2019,4/15/2019, , , 
3011,8053,6/15/1939,Male,185,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"128,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , , ,R-X,KYP-X,DAR-X,V-X,4/16/2018,10/11/2018,10/11/2018,6/27/2019,6/30/2021,6/30/2021,7/1/2021,2/17/2022,2/17/2022,3/23/2022,3/31/2022, 
3012,2912,6/15/1939,Female,160,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/15/2016,5/31/2017,5/31/2017,1/2/2018,6/30/2018,6/30/2018, , , , , , 
3013,2191,6/15/1938,Male,177,73,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,Other,1/6/2016,1/20/2017,1/20/2017,2/1/2018,6/30/2018,6/30/2018, , , , , , 
3014,8191,6/15/1947,Male,178,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,4/13/2018,8/29/2018,8/29/2018,2/5/2019,8/24/2020,8/24/2020,9/10/2020,6/30/2021, , , , 
3015,9905,6/15/1951,Male,175,56,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"29,57","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/12/2018,6/5/2019,6/5/2019,2/11/2022,3/31/2022, , , , , , , 
3016,3991,6/15/1943,Male,168,83,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,86",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/25/2018,9/7/2018,9/7/2018,2/8/2021,2/2/2022,2/2/2022,2/17/2022,3/31/2022, , , , 
3017,5866,6/15/1944,Female,159,56,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/1/2015,10/15/2016,10/15/2016,2/1/2018,6/30/2018,6/30/2018, , , , , , 
3018,7659,6/15/1943,Male,162,64,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,58",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,10/10/2017,1/16/2018,1/16/2018,5/8/2018,2/28/2019,2/28/2019,3/14/2019,11/29/2019,11/29/2019,12/25/2019,12/27/2019,12/27/2019
3019,8466,6/15/1938,Male,164,58,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"21,33",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/11/2018,11/20/2018,11/20/2018, , , , , , , , , 
3020,7020,6/15/1972,Female,165,72,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"6,87","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,V-X,V-X,8/7/2017,10/30/2017,10/30/2017,5/3/2018,6/1/2019,6/1/2019,6/5/2019,9/2/2021,9/2/2021,9/15/2021,10/30/2021,10/30/2021
3021,4391,6/15/1948,Female,160,100,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,Unknown,IgG,"5,1",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,DAR-X,No CTx,No CTx,V-X,1/9/2018,3/5/2018,3/5/2018,12/9/2019,3/31/2022,10/14/1582, , , , , , 
3022,9587,6/15/1947,Female,167,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,47",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,KYP-X,NIN-X,No CTx,R-X,11/20/2017,5/17/2018,5/17/2018,6/11/2018,1/28/2020,1/28/2020,3/11/2020,6/30/2020, , , , 
3023,2293,6/15/1948,Male,173,75,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, ,Yes, ,1,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/6/2018,6/1/2018,6/1/2018, , , , , , , , , 
3024,1791,6/15/1946,Female,156,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,28",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,V-X,8/30/2017,2/28/2018,2/28/2018,6/4/2018,10/15/2019,10/15/2019,12/23/2019,12/3/2020,12/3/2020,12/22/2020,12/31/2020, 
3025,8542,6/15/1938,Male,180,97,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"48,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/15/2018,10/22/2018,10/22/2018,4/1/2019,9/30/2021, , , , , , , 
3026,5280,6/15/1960,Male,170,100,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgA,"13,93",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,KYP-X,No CTx,No CTx,V-X,11/24/2017,3/20/2018,3/20/2018,3/22/2021,7/13/2021,7/13/2021, , , , , , 
3027,8540,6/15/1967,Female,160,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"6,67",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/26/2017,1/9/2018,1/9/2018, , , , , , , , , 
3028,6189,6/15/1931,Female,162,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"53,91",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,4/10/2018,8/7/2018,8/7/2018, , , , , , , , , 
3029,3020,6/15/1935,Female,162,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"32,07",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,V-X,DAR-X,No CTx,V-X,3/9/2015,8/31/2015,8/31/2015,1/5/2017,2/16/2017,2/16/2017,3/21/2017,10/8/2018,10/8/2018, , , 
3030,1951,6/15/1954,Male,184,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"22,6",unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,DAR-X,No CTx,No CTx,V-X,12/27/2016,2/23/2017,2/23/2017,12/7/2020,3/31/2022,3/31/2022, , , , , , 
3031,5224,6/15/1937,Male,178,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/2/2016,5/15/2016,5/15/2016,11/1/2017,6/30/2018,6/30/2018, , , , , , 
3032,6940,6/15/1963,Female,168,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"83,14",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Nein, , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,7/4/2013,9/16/2013,9/16/2013,2/25/2014,8/6/2018,8/6/2018, , , , , , 
3033,4117,6/15/1939,Female,175,89,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,05",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,6/5/2017,11/30/2017,11/30/2017,6/11/2018,1/20/2020,1/20/2020,11/10/2020,3/2/2022,3/2/2022,3/23/2022,3/31/2022, 
3034,3982,6/15/1932,Male,173,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , , ,V-X,No CTx,No CTx,V-X,4/12/2010,9/20/2010,9/20/2010,4/17/2018,8/7/2018,8/7/2018, , , , , , 
3035,6460,6/15/1943,Female,165,62,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,LEV-X,2/1/2016,9/30/2016,9/30/2016,12/1/2017,5/31/2018,5/31/2018, , , , , , 
3036,5011,6/15/1948,Female,163,48,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"12,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/8/2017,11/27/2017,11/27/2017,5/23/2018,8/14/2019,8/14/2019, , , , , , 
3037,8973,6/15/1944,Female,164,71,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"13,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,V-X,NIN-X,V-X,7/13/2017,1/11/2018,1/11/2018,6/6/2018,10/16/2019,10/16/2019,11/19/2019,6/23/2020,6/23/2020,7/16/2020,11/5/2020,11/5/2020
3038,5126,6/15/1937,Male,173,77,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,LEV-X,6/4/2018,12/9/2018,12/9/2018,3/30/2020,12/31/2021,10/14/1582, , , , , , 
3039,8616,6/15/1945,Male,182,86,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/2/2018,5/15/2018,5/15/2018, , , , , , , , , 
3040,1797,6/15/1950,Male,181,104,Private,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,71",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/4/2017,3/23/2018,3/23/2018,4/4/2018,4/2/2020,4/2/2020, , , , , , 
3041,5232,6/15/1957,Female,163,66,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/16/2018,6/30/2018,6/30/2018, , , , , , , , , 
3042,6815,6/15/1937,Male,166,72,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,2,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/9/2018,6/1/2018,6/1/2018, , , , , , , , , 
3043,9246,6/15/1948,Female,159,68,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,V-X,8/17/2017,2/12/2018,2/12/2018,4/26/2018,1/2/2020,1/2/2020,2/14/2020,3/18/2022,3/18/2022,3/30/2022,3/31/2022, 
3044,8484,6/15/1936,Female,168,72,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"35,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,KYP-X,DAR-X,No CTx,V-X,5/15/2018,10/17/2018,10/17/2018,5/17/2019,11/12/2019,11/12/2019,6/10/2020,8/19/2020,8/19/2020, , , 
3045,3018,6/15/1944,Male,171,76,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,V-X,8/14/2017,2/2/2018,2/2/2018,4/16/2018,4/23/2019,4/23/2019,1/6/2020,2/16/2021,2/16/2021,3/11/2021,8/11/2021,8/11/2021
3046,4427,6/15/1940,Male,178,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/1/2015,6/30/2016,6/30/2016,1/2/2018,6/30/2018,6/30/2018, , , , , , 
3047,7851,6/15/1951,Male,186,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,64",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,7/24/2017,1/11/2018,1/11/2018,5/23/2018,1/28/2019,1/28/2019,3/14/2019,6/29/2020,6/29/2020,8/24/2020,10/18/2020,10/18/2020
3048,6120,6/15/1928,Female,166,52,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/7/2017,12/7/2017,12/7/2017,5/3/2018,12/18/2019,12/18/2019, , , , , , 
3049,1653,6/15/1937,Female,163,55,Private,Yes, , , , ,Yes, ,Yes, , ,Yes,1,I: fulfilling all 4 criteria,IgG,"1,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L", ,V-X,No CTx,No CTx,V-X,5/2/2018,1/29/2019,1/29/2019,9/10/2019,12/17/2019,12/17/2019, , , , , , 
3050,6569,6/15/1943,Male,176,74,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,57,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/2/2018,1/30/2019,1/30/2019,6/18/2019,8/3/2021,8/3/2021, , , , , , 
3051,3125,6/15/1937,Female,169,56,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes,Yes, ,Yes,1,III: one or more criteria are fulfilled,IgA,"6,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,3/14/2018,9/1/2018,9/1/2018,3/11/2019,4/15/2019,4/15/2019,4/23/2019,6/30/2019,10/14/1582, , , 
3052,6888,6/15/1948,Male,176,78,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,4/1/2018,6/30/2018, , , , , , , , , , 
3053,6091,6/15/1950,Male,182,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,3/10/2018,6/30/2018, , , , , , , , , , 
3054,9649,6/15/1946,Male,184,82,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/10/2018,6/30/2018, , , , , , , , , , 
3055,8823,6/15/1960,Male,169,73,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/29/2018,9/24/2018,9/24/2018, , , , , , , , , 
3056,2574,6/15/1933,Female,166,62,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"22,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,10/16/2017,1/11/2018,1/11/2018,5/16/2018,11/24/2021,11/24/2021,12/14/2021,3/31/2022, , , , 
3057,8207,6/15/1933,Male,176,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/6/2017,11/28/2017,11/28/2017,4/23/2018,7/15/2019,7/15/2019, , , , , , 
3058,2822,6/15/1938,Male,170,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"35,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,6/16/2018,4/15/2020,4/15/2020,12/16/2020,3/31/2022,10/14/1582, , , , , , 
3059,1660,6/15/1951,Male,175,93,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,64",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,KYP-X,R-X,10/4/2017,3/30/2018,3/30/2018,4/16/2018,11/22/2019,11/22/2019,12/3/2019,11/25/2020,11/25/2020,7/26/2021,12/16/2021,12/16/2021
3060,7907,6/15/1950,Male,175,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,29",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,9/18/2017,12/22/2017,12/22/2017,5/17/2018,11/7/2019,11/7/2019,12/12/2019,12/31/2021, , , , 
3061,4082,6/15/1953,Male,168,64,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"18,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,6/16/2017,9/22/2017,9/22/2017,4/10/2018,1/19/2022,1/19/2022,2/10/2022,3/31/2022, , , , 
3062,2471,6/15/1948,Male,187,127,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,36",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/23/2017,9/18/2017,9/18/2017,4/25/2018,3/11/2020,3/11/2020, , , , , , 
3063,5676,6/15/1948,Female,163,60,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/4/2018,1/29/2019,1/29/2019, , , , , , , , , 
3064,5345,6/15/1942,Female,154,57,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"45,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/2/2018,3/31/2022,10/14/1582, , , , , , , , , 
3065,1840,6/15/1939,Male,183,95,Private,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,239,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,4/23/2018,1/23/2019,1/23/2019, , , , , , , , , 
3066,7480,6/15/1941,Female,167,70,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,2/6/2018,6/13/2018,6/13/2018, , , , , , , , , 
3067,5041,6/15/1938,Male,170,70,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/2/2018,6/15/2018,6/15/2018, , , , , , , , , 
3068,5662,6/15/1946,Male,170,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,0,I: fulfilling all 4 criteria,IgG,1300,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/8/2017,7/24/2017,7/24/2017, , , , , , , , , 
3069,8399,6/15/1944,Male,177,85,Private,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/1/2016,5/7/2017,5/7/2017,2/5/2018,6/30/2018,6/30/2018, , , , , , 
3070,8552,6/15/1938,Male,175,72,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/16/2018,6/30/2018,6/30/2018, , , , , , , , , 
3071,5609,6/15/1947,Female,157,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,4/1/2015,12/31/2015,12/31/2015,9/1/2017,2/28/2018,2/28/2018, , , , , , 
3072,4409,6/15/1949,Female,162,53,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"8,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,8/1/2017,10/30/2017,10/30/2017,5/30/2018,7/6/2020,7/6/2020,7/14/2020,1/13/2022,1/13/2022,1/19/2022,3/31/2022, 
3073,1532,6/15/1966,Female,169,56,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,86",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,6/29/2017,12/26/2017,12/26/2017,5/30/2018,5/6/2021,5/6/2021,5/21/2021,11/13/2021,11/13/2021, , , 
3074,4650,6/15/1952,Male,169,55,Private,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,48",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,9/18/2017,12/14/2017,12/14/2017,4/13/2018,1/3/2022,1/3/2022,2/17/2022,3/31/2022, , , , 
3075,3401,6/15/1945,Male,180,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,22",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,No CTx,V-X,11/8/2017,5/3/2018,5/3/2018,5/29/2018,4/14/2021,4/14/2021,5/10/2021,3/31/2022,10/14/1582, , , 
3076,5088,6/15/1938,Female,160,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,0,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,8/1/2015,1/31/2016,1/31/2016,9/10/2017,2/25/2018,2/25/2018, , , , , , 
3077,4419,6/15/1948,Male,182,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,13",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/13/2017,6/13/2017,6/13/2017, , , , , , , , , 
3078,9543,6/15/1960,Male,178,78,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/5/2018,7/15/2018,7/15/2018, , , , , , , , , 
3079,9291,6/15/1941,Male,175,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,Other,2/1/2016,2/15/2017,2/15/2017,3/19/2018,7/13/2018,7/13/2018, , , , , , 
3080,8398,6/15/1959,Male,184,89,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,Other,9/1/2015,11/30/2016,11/30/2016,3/26/2018,7/13/2018,7/13/2018, , , , , , 
3081,9077,6/15/1938,Female,160,66,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"999,99",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/2/2018,7/13/2018,7/13/2018, , , , , , , , , 
3082,9757,6/15/1935,Female,158,54,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"999,99",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,LEV-X,4/3/2018,7/13/2018,7/13/2018, , , , , , , , , 
3083,3930,6/15/1937,Female,155,65,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Unknown,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Ja, , , , ,Nein,KYP-X,DAR-X,POM-X,R-X,5/18/2018,11/7/2018,11/7/2018,5/21/2019,11/27/2019,11/27/2019,12/1/2020,5/12/2021,5/12/2021,7/28/2021,10/4/2021,10/4/2021
3084,9257,6/15/1978,Male,182,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"25,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/16/2018,8/7/2018,8/7/2018, , , , , , , , , 
3085,3630,6/15/1937,Female,160,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,2311,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
3086,3263,6/15/1950,Male,170,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgD,"1,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,9,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , ,Nein,KYP-X,No CTx,No CTx,V-X,6/1/2013,9/15/2013,9/15/2013,6/11/2018,10/8/2018,10/8/2018, , , , , , 
3087,2221,6/15/1946,Female,156,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,104,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Nein,DAR-X,No CTx,No CTx,V-X,8/12/2014,1/13/2015,1/13/2015,3/26/2018,6/30/2019,10/14/1582, , , , , , 
3088,2594,6/15/1940,Male,176,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,Other,6/1/2015,6/15/2016,6/15/2016,10/16/2017,4/1/2018,4/1/2018, , , , , , 
3089,8949,6/15/1941,Male,172,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,2489,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , , ,Nein,R-X,POM-X,No CTx,R-X,4/15/2017,8/28/2017,8/28/2017,4/20/2018,9/11/2018,9/11/2018,9/12/2018,11/7/2018,11/7/2018, , , 
3090,9266,6/15/1958,Male,190,84,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,5610,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,3/26/2018,6/15/2018,6/15/2018, , , , , , , , , 
3091,3900,6/15/1941,Male,175,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,DAR-X,ISA-X,No CTx,V-X,6/11/2018,8/23/2018,8/23/2018,2/11/2020,11/30/2021,11/30/2021,1/10/2022,3/31/2022,10/14/1582, , , 
3092,5974,6/15/1940,Female,165,68,Compulsory health insurance CHI,Yes,Unknown,Yes, , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,401,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,R-X,6/19/2018,6/30/2020, , , , , , , , , , 
3093,9343,6/15/1947,Male,176,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,5/4/2018,6/30/2018, , , , , , , , , , 
3094,8888,6/15/1933,Female,170,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,66,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/18/2018,9/30/2019,10/14/1582, , , , , , , , , 
3095,2494,6/15/1939,Male,172,89,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,4/15/2013,6/15/2013,6/15/2013,6/20/2018,6/30/2019, , , , , , , 
3096,9102,6/15/1954,Female,170,70,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"1,03",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,R-X,No CTx,No CTx,V-X,9/15/2015,11/15/2015,11/15/2015,7/11/2018,3/31/2019, , , , , , , 
3097,7790,6/15/1961,Male,175,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/22/2018,8/5/2018,8/5/2018, , , , , , , , , 
3098,2765,6/15/1947,Male,178,80,Private,No, ,Yes, , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,4/4/2018,6/30/2018, , , , , , , , , , 
3099,5401,6/15/1939,Female,167,65,Private,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,6/25/2018,3/31/2019, , , , , , , , , , 
3100,8073,6/15/1950,Male,175,72,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"2,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/27/2018,11/20/2018,11/20/2018, , , , , , , , , 
3101,9173,6/15/1959,Female,168,89,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , , ,V-X,R-X,KYP-X,V-X,3/8/2010,2/7/2011,2/7/2011,5/2/2013,12/23/2013,12/23/2013,1/16/2014,6/21/2015,6/21/2015,3/26/2018,3/26/2019,3/26/2019
3102,9486,6/15/1931,Male,176,77,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"3,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/29/2018,2/25/2019,2/25/2019, , , , , , , , , 
3103,1986,6/15/1956,Female,165,74,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,80,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2018,8/13/2018,8/13/2018, , , , , , , , , 
3104,6696,6/15/1949,Male,175,85,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,14,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , ,Ja,KYP-X,ISA-X,No CTx,V-X,7/6/2017,9/18/2017,9/18/2017,2/24/2021,12/1/2021,12/1/2021,12/13/2021,3/31/2022, , , , 
3105,3510,6/15/1928,Female,152,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,39",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,8/8/2017,11/6/2017,11/6/2017,5/9/2018,11/4/2021,11/4/2021,12/13/2021,3/31/2022, , , , 
3106,4645,6/15/1934,Male,175,77,Private,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,DAR-X,LEV-X,No CTx,LEV-X,6/5/2018,12/2/2018,12/2/2018,2/24/2020,3/14/2021,3/14/2021,7/5/2021,12/26/2021,12/26/2021, , , 
3107,6959,6/15/1940,Female,158,70,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,",02",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , , ,Nein,R-X,DAR-X,V-X,V-X,2/8/2018,6/23/2018,6/23/2018,3/11/2019,2/2/2020,2/2/2020,2/24/2020,11/3/2020,11/3/2020,11/6/2020,12/31/2020, 
3108,8647,6/15/1943,Female,168,52,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/29/2017,11/28/2017,11/28/2017,4/2/2018,12/31/2021,10/14/1582, , , , , , 
3109,4960,6/15/1946,Female,156,49,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,64",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,3/28/2017,9/22/2017,9/22/2017,4/5/2018,5/8/2019,5/8/2019,5/16/2019,11/12/2020,11/12/2020,12/2/2020,3/24/2021,3/24/2021
3110,4231,6/15/1954,Female,162,73,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"49,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/5/2015,8/24/2015,8/24/2015,2/7/2018,6/30/2018,10/14/1582, , , , , , 
3111,3141,6/15/1937,Female,160,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,25,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,9/25/2017,6/21/2018,6/21/2018, , , , , , , , , 
3112,5877,6/15/1937,Female,164,92,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Nein,Nein, , , , , ,KYP-X,No CTx,No CTx,V-X,3/15/2018,8/30/2018,8/30/2018,11/12/2018,6/30/2019,10/14/1582, , , , , , 
3113,9708,6/15/1947,Female,158,50,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , , ,DAR-X,No CTx,No CTx,V-X,11/25/2013,2/13/2014,2/13/2014,6/27/2018,12/31/2019, , , , , , , 
3114,2889,6/15/1945,Male,160,73,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,2/1/2017,4/29/2017,4/29/2017, , , , , , , , , 
3115,9803,6/15/1942,Male,173,65,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,44,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,6/25/2018,10/24/2018,10/24/2018, , , , , , , , , 
3116,5180,6/15/1937,Female,165,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,50,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Nein,R-X,No CTx,No CTx,V-X,6/26/2018,4/12/2019,4/12/2019,3/30/2022,3/31/2022, , , , , , , 
3117,3996,6/15/1942,Male,170,87,Compulsory health insurance CHI,Yes, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,9166,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/30/2018,6/30/2018, , , , , , , , , , 
3118,2448,6/15/1942,Male,170,65,Compulsory health insurance CHI,Yes, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,64,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Ja,V-X,EMP-X,DAR-X,V-X,6/4/2018,12/3/2018,12/3/2018,12/10/2018,5/13/2019,5/13/2019,5/20/2019,8/12/2019,8/12/2019,9/2/2019,11/16/2020,11/16/2020
3119,3264,6/15/1951,Male,175,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,6/15/2018,5/2/2019,5/2/2019,8/26/2021,10/13/2021,10/13/2021, , , , , , 
3120,5302,6/15/1937,Female,165,75,Compulsory health insurance CHI,Yes,Yes, , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,38,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,5/29/2018,10/1/2018,10/1/2018, , , , , , , , , 
3121,1959,6/15/1943,Male,183,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,57,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Ja,DAR-X,No CTx,No CTx,V-X,5/2/2018,5/28/2019,5/28/2019,3/1/2022,3/31/2022, , , , , , , 
3122,1871,6/15/1936,Female,168,67,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,Other type,5772,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/12/2018,8/12/2018,8/12/2018, , , , , , , , , 
3123,2501,6/15/1950,Male,174,69,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,18,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Ja,No CTx,No CTx,No CTx,V-X,4/10/2018,5/2/2019,5/2/2019, , , , , , , , , 
3124,2743,6/15/1952,Female,168,56,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,2855,ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/20/2018,6/22/2018,6/22/2018, , , , , , , , , 
3125,9551,6/15/1936,Female,160,90,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,24,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , ,Nein,R-X,No CTx,No CTx,V-X,4/25/2018,2/6/2019,2/6/2019,12/6/2019,3/31/2022, , , , , , , 
3126,8871,6/15/1964,Male,178,95,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,Other type,404,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,4/3/2018,7/19/2018,7/19/2018, , , , , , , , , 
3127,4694,6/15/1940,Female,157,62,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,12896,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Ja,No CTx,No CTx,No CTx,V-X,4/19/2018,4/30/2018,4/30/2018, , , , , , , , , 
3128,8826,6/15/1956,Female,165,58,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes,Yes, ,Yes, ,0,Unknown,IgG,2890,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/5/2018,12/22/2018,12/22/2018,4/10/2019,6/30/2019, , , , , , , 
3129,9970,6/15/1958,Male,165,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/17/2018,9/13/2018,9/13/2018, , , , , , , , , 
3130,9546,6/15/1952,Female,160,78,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , ,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,4134,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,No,Yes,9,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,KYP-X,DAR-X,V-X,5/4/2018,6/7/2018,6/7/2018,7/2/2018,9/10/2018,9/10/2018,6/18/2020,9/18/2020,9/18/2020,3/2/2021,3/31/2021, 
3131,6759,6/15/1973,Male,180,78,Private,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,4/30/2018,5/3/2018,5/3/2018, , , , , , , , , 
3132,2880,6/15/1966,Female,176,66,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,KYP-X,DAR-X,LEV-X,V-X,5/23/2018,8/12/2019,8/12/2019,9/3/2019,11/27/2019,11/27/2019,12/11/2019,1/3/2020,1/3/2020,1/9/2020,1/10/2020,1/10/2020
3133,8631,6/15/1934,Female,155,56,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,6/12/2018,6/30/2019, , , , , , , , , , 
3134,3780,6/15/1954,Male,9,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Unknown,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Ja, , , , ,Nein,DAR-X,No CTx,No CTx,V-X,6/27/2018,10/16/2018,10/16/2018,9/11/2019,12/31/2019,10/14/1582, , , , , , 
3135,8433,6/15/1930,Male,169,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,Other type,128,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , , ,Nein,R-X,No CTx,No CTx,V-X,4/5/2018,6/20/2019,6/20/2019,12/10/2021,3/31/2022, , , , , , , 
3136,1694,6/15/1950,Male,168,64,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,596,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,R-X,4/23/2018,9/30/2018, , , , , , , , , , 
3137,4062,6/15/1958,Male,165,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,2357,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,V-X,No CTx,No CTx,V-X,4/17/2018,9/30/2018,9/30/2018,2/21/2019,4/1/2019,4/1/2019, , , , , , 
3138,2842,6/15/1952,Female,160,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,4134,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,R-X,4/18/2018,9/18/2018,9/18/2018, , , , , , , , , 
3139,7451,6/15/1973,Male,180,78,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,422,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/3/2018,10/15/2018,10/15/2018, , , , , , , , , 
3140,3365,6/15/1966,Female,176,66,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,3207,unknown/ISS-Criteria not used for prognostics,No,No,Yes,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,6/13/2018,8/15/2018,8/15/2018, , , , , , , , , 
3141,6131,6/15/1931,Female,162,71,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,9",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,5/28/2018,12/14/2018,12/14/2018, , , , , , , , , 
3142,6520,6/15/1941,Male,171,104,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"47,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/25/2018,1/7/2019,1/7/2019, , , , , , , , , 
3143,5320,6/15/1940,Male,174,98,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"18,66",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
3144,7866,6/15/1956,Male,173,118,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"16,87","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
3145,5603,6/15/1948,Male,168,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"45,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/26/2018,1/8/2019,1/8/2019, , , , , , , , , 
3146,7868,6/15/1950,Male,178,73,Private,No,Yes, ,Yes,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,",6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,3/14/2018,6/6/2018,6/6/2018, , , , , , , , , 
3147,1824,6/15/1949,Female,157,73,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,4258,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/12/2018,5/18/2018,5/18/2018, , , , , , , , , 
3148,7444,6/15/1951,Male,180,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,84",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/10/2018,10/26/2018,10/26/2018,6/20/2019,12/31/2020, , , , , , , 
3149,4643,6/15/1951,Male,171,103,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,6,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,5/14/2018,11/21/2018,11/21/2018, , , , , , , , , 
3150,9504,6/15/1953,Male,195,75,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,9",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,5/9/2018,11/14/2018,11/14/2018,2/28/2019,7/8/2019,7/8/2019,8/1/2019,12/31/2020, , , , 
3151,2892,6/15/1951,Female,167,58,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"23,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,LEV-X,4/20/2018,10/17/2018,10/17/2018,1/18/2020,12/31/2020, , , , , , , 
3152,2159,6/15/1949,Male,177,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,45",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/8/2018,11/21/2018,11/21/2018, , , , , , , , , 
3153,6967,6/15/1946,Female,157,54,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/2/2018,8/16/2018,8/16/2018, , , , , , , , , 
3154,5266,6/15/1947,Female,164,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,51",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,No CTx,LEV-X,11/17/2017,5/15/2018,5/15/2018,6/4/2018,11/22/2019,11/22/2019,12/12/2019,1/2/2020,1/2/2020, , , 
3155,7591,6/15/1955,Male,165,60,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,85,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/22/2018,11/5/2018,11/5/2018,6/4/2019,6/30/2019, , , , , , , 
3156,9953,6/15/1949,Male,168,67,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,55,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,2/19/2018,4/3/2019,4/3/2019,9/23/2019,11/24/2020,11/24/2020,6/15/2021,12/6/2021,12/6/2021, , , 
3157,4027,6/15/1935,Female,167,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,115,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/2/2018,12/31/2018, , , , , , , , , , 
3158,2783,6/15/1937,Female,165,50,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,DAR-X,R-X,No CTx,R-X,4/17/2018,12/9/2018,12/9/2018,5/20/2019,11/25/2019,11/25/2019,6/15/2020,12/31/2020, , , , 
3159,5667,6/15/1955,Male,170,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,95,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/5/2018,12/20/2018,12/20/2018,6/4/2019,3/9/2020,3/9/2020, , , , , , 
3160,2907,6/15/1952,Male,170,79,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,98",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,No CTx,R-X,10/17/2017,4/16/2018,4/16/2018,4/26/2018,8/26/2019,8/26/2019,9/9/2019,7/16/2020,7/16/2020, , , 
3161,7055,6/15/1944,Male,170,85,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,R-X,12/12/2017,6/1/2018,6/1/2018,6/14/2018,8/27/2019,8/27/2019,9/9/2019,6/16/2020,6/16/2020,7/3/2020,12/31/2020, 
3162,1535,6/15/1943,Female,167,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"31,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,R-X,No CTx,V-X,4/17/2017,10/6/2017,10/6/2017,4/3/2018,1/13/2020,1/13/2020,2/21/2020,12/31/2020, , , , 
3163,6168,6/15/1947,Female,164,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,25",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,LEV-X,11/30/2017,6/1/2018,6/1/2018,6/18/2018,12/11/2018,12/11/2018,6/19/2019,7/12/2020,7/12/2020,7/24/2020,12/31/2020, 
3164,6094,6/15/1950,Female,158,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,62",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/8/2017,12/4/2017,12/4/2017,4/2/2018,12/31/2020,10/14/1582, , , , , , 
3165,1869,6/15/1946,Male,189,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,7/21/2016,1/5/2017,1/5/2017,6/20/2017,6/5/2018,6/5/2018,6/19/2018,4/16/2019,4/16/2019, , , 
3166,8056,6/15/1944,Female,172,57,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,LEV-X,4/2/2018,9/10/2018,9/10/2018,7/21/2021,9/30/2021,9/30/2021, , , , , , 
3167,4311,6/15/1949,Female,168,53,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,37",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/2/2018,7/16/2018,7/16/2018, , , , , , , , , 
3168,9109,6/15/1950,Female,170,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,39",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,4/23/2018,8/29/2018,8/29/2018, , , , , , , , , 
3169,5327,6/15/1932,Female,166,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,49",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/13/2018,8/22/2018,8/22/2018,1/28/2019,8/5/2021,8/5/2021, , , , , , 
3170,6259,6/15/1950,Male,170,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,95,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/16/2018,11/30/2018,11/30/2018, , , , , , , , , 
3171,2325,6/15/1949,Female,168,53,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,38",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/30/2018,8/13/2018,8/13/2018,10/8/2021,3/31/2022, , , , , , , 
3172,2388,6/15/1943,Male,175,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,08",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,6/4/2018,6/10/2019,6/10/2019,8/25/2021,3/31/2022, , , , , , , 
3173,2269,6/15/1936,Male,178,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,63",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/28/2018,10/10/2018,10/10/2018,3/10/2020,7/11/2021,7/11/2021, , , , , , 
3174,9639,6/15/1953,Male,174,51,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"23,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,8/31/2017,2/22/2018,2/22/2018,6/6/2018,5/22/2019,5/22/2019,6/10/2019,1/2/2020,1/2/2020,4/6/2020,12/31/2021, 
3175,2307,6/15/1933,Male,170,65,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/25/2018,12/24/2018,12/24/2018,6/17/2019,12/3/2019,12/3/2019, , , , , , 
3176,8169,6/15/1953,Female,174,51,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,4/21/2017,10/12/2017,10/12/2017,4/26/2018,9/10/2020,9/10/2020,9/23/2020,3/31/2022,10/14/1582, , , 
3177,7235,6/15/1950,Male,183,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"20,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/25/2017,4/24/2018,4/24/2018,5/16/2018,10/22/2019,10/22/2019, , , , , , 
3178,5650,6/15/1953,Male,174,51,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"32,56","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,DAR-X,V-X,6/22/2017,12/13/2017,12/13/2017,5/28/2018,1/2/2020,1/2/2020,4/2/2020,9/18/2020,9/18/2020,10/5/2020,10/27/2021,10/27/2021
3179,3500,6/15/1945,Male,168,69,Private,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,150,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/22/2018,12/20/2018,12/20/2018, , , , , , , , , 
3180,5878,6/15/1946,Female,189,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,38",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/8/2018,10/23/2018,10/23/2018,2/11/2019,3/31/2022,10/14/1582, , , , , , 
3181,7764,6/15/1934,Female,174,95,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/1/2018,10/4/2018,10/4/2018, , , , , , , , , 
3182,4188,6/15/1950,Male,168,69,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,97",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/4/2018,5/14/2019,5/14/2019, , , , , , , , , 
3183,3672,6/15/1944,Male,185,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,05",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,5/10/2018,4/16/2019,4/16/2019,3/1/2022,3/31/2022, , , , , , , 
3184,6581,6/15/1952,Male,177,106,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,05",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/5/2018,3/13/2019,3/13/2019, , , , , , , , , 
3185,4091,6/15/1947,Male,183,65,Private,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,6/26/2017,12/11/2017,12/11/2017,4/2/2018,12/18/2018,12/18/2018,2/15/2019,12/23/2019,12/23/2019,6/3/2020,3/24/2021,3/24/2021
3186,3540,6/15/1943,Male,188,128,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,67",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,DAR-X,V-X,12/29/2016,7/1/2017,7/1/2017,7/13/2017,6/22/2018,6/22/2018,7/10/2018,1/9/2021,1/9/2021,1/30/2021,8/9/2021,8/9/2021
3187,2786,6/15/1945,Male,165,96,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"25,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/2/2017,5/2/2018,5/2/2018,5/10/2018,4/17/2019,4/17/2019,4/1/2020,4/16/2020,4/16/2020, , , 
3188,2699,6/15/1945,Male,165,96,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"15,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,9/22/2017,3/22/2018,3/22/2018,4/10/2018,5/21/2019,5/21/2019,4/22/2020,3/31/2022,10/14/1582, , , 
3189,8715,6/15/1947,Female,161,76,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,9/21/2017,3/15/2018,3/15/2018,6/5/2018,9/17/2019,9/17/2019,5/6/2020,4/20/2021,4/20/2021, , , 
3190,4479,6/15/1952,Male,181,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"11,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/14/2017,12/12/2017,12/12/2017,5/29/2018,9/30/2021,10/14/1582, , , , , , 
3191,6678,6/15/1946,Male,177,58,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,36",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/12/2018,8/9/2018,8/9/2018,2/24/2022,3/31/2022,10/14/1582, , , , , , 
3192,8980,6/15/1947,Female,167,77,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,65",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/13/2018,8/13/2018,8/13/2018,1/27/2022,3/31/2022,10/14/1582, , , , , , 
3193,7391,6/15/1946,Female,171,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,73",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/12/2018,4/5/2019,4/5/2019, , , , , , , , , 
3194,9882,6/15/1947,Female,163,45,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,1",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/25/2018,9/17/2018,9/17/2018,2/26/2020,3/31/2022,10/14/1582, , , , , , 
3195,1682,6/15/1952,Female,168,96,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,33",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,10/9/2017,4/5/2018,4/5/2018,4/30/2018,1/2/2019,1/2/2019,2/7/2020,9/21/2020,9/21/2020,10/7/2020,2/9/2021,2/9/2021
3196,8740,6/15/1948,Male,182,116,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,41",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,11/9/2017,5/7/2018,5/7/2018,5/31/2018,1/2/2019,1/2/2019,2/1/2020,3/24/2022,3/24/2022,3/29/2022,3/31/2022, 
3197,9020,6/15/1945,Male,179,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,V-X,V-X,10/12/2017,4/11/2018,4/11/2018,5/4/2018,5/6/2019,5/6/2019,5/23/2019,1/2/2020,1/2/2020,1/5/2020,12/28/2020,12/28/2020
3198,5240,6/15/1948,Male,178,91,Private,No, ,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,11",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,4/27/2017,10/12/2017,10/12/2017,4/5/2018,4/23/2019,4/23/2019,7/5/2019,6/30/2021, , , , 
3199,6382,6/15/1943,Female,163,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,15",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,V-X,R-X,11/28/2017,5/29/2018,5/29/2018,6/12/2018,6/14/2019,6/14/2019,6/23/2019,1/2/2020,1/2/2020,1/3/2020,12/26/2020,12/26/2020
3200,2390,6/15/1947,Male,171,59,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,69",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,9/5/2017,2/22/2018,2/22/2018,5/30/2018,1/2/2020,1/2/2020,2/2/2020,6/25/2020,6/25/2020, , , 
3201,2111,6/15/1929,Male,172,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,57",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,V-X,8/24/2017,11/20/2017,11/20/2017,5/1/2018,7/19/2018,7/19/2018,8/2/2018,12/13/2018,12/13/2018,3/25/2019,1/2/2020,1/2/2020
3202,6938,6/15/1961,Male,188,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,NIN-X,V-X,3/28/2017,6/29/2017,6/29/2017,9/25/2017,3/21/2018,3/21/2018,4/11/2018,7/2/2018,7/2/2018,7/18/2018,8/30/2018,8/30/2018
3203,8819,6/15/1929,Female,168,60,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"29,75","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,10/25/2016,2/28/2017,2/28/2017,6/9/2017,5/22/2018,5/22/2018,6/4/2018,12/3/2018,12/3/2018,1/3/2019,3/1/2019,3/1/2019
3204,8490,6/15/1950,Female,168,77,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,18,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/1/2018,4/26/2018,4/26/2018, , , , , , , , , 
3205,6233,6/15/1950,Male,181,96,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,29,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,POM-X,V-X,4/17/2018,6/18/2018,6/18/2018,6/23/2020,5/24/2021,5/24/2021,6/8/2021,11/16/2021,11/16/2021,11/23/2021,2/2/2022,2/2/2022
3206,5289,6/15/1962,Male,180,88,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"42,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/13/2018,6/4/2018,6/4/2018, , , , , , , , , 
3207,9440,6/15/1954,Female,164,83,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,27,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,R-X,DAR-X,V-X,4/9/2015,10/20/2015,10/20/2015, , , ,1/9/2019,4/14/2020,4/14/2020,2/9/2022,3/31/2022, 
3208,3201,6/15/1939,Male,172,68,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/22/2018,10/11/2018,10/11/2018, , , , , , , , , 
3209,3673,6/15/1957,Male,171,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,5,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,V-X,2/9/2018,4/26/2018,4/26/2018, , , , , , , , , 
3210,7401,6/15/1942,Female,155,55,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,43",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/27/2018,7/8/2019,7/8/2019, , , , , , , , , 
3211,1601,6/15/1942,Male,169,65,Compulsory health insurance CHI,No,Yes,Yes,Unknown,Yes,Unknown,Unknown,Unknown, , ,Yes,9,III: one or more criteria are fulfilled,IgG,"5,46",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,10/7/2016,2/3/2017,2/3/2017,2/15/2017,3/15/2018,3/15/2018, , , , , , 
3212,3684,6/15/1952,Female,160,98,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"32,82",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/8/2018,7/10/2018,7/10/2018, , , , , , , , , 
3213,7858,6/15/1938,Male,180,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"55,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,6/10/2018,8/26/2019,8/26/2019,9/16/2019,7/13/2020,7/13/2020,7/28/2020,12/31/2020,10/14/1582, , , 
3214,3153,6/15/1937,Male,165,62,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"2,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/4/2018,6/30/2018, , , , , , , , , , 
3215,4688,6/15/1966,Female,170,82,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"3,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/11/2018,6/30/2018, , , , , , , , , , 
3216,4568,6/15/1943,Male,176,69,Self-Payer,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,3,III: one or more criteria are fulfilled,IgA,"7,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,Other,6/19/2018,2/28/2019,2/28/2019,3/25/2019,3/31/2019, , , , , , , 
3217,4854,6/15/1970,Male,182,91,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"6,2",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/28/2018,8/24/2018,8/24/2018, , , , , , , , , 
3218,2760,6/15/1959,Female,168,91,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,11,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Ja,DAR-X,KYP-X,No CTx,V-X,4/1/2015,7/1/2015,7/1/2015,3/13/2018,3/17/2019,3/17/2019,3/18/2019,3/31/2019,10/14/1582, , , 
3219,7295,6/15/1981,Female,165,50,Self-Payer,Unknown,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,"33,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/12/2018,6/30/2018, , , , , , , , , , 
3220,6601,6/15/1956,Male,176,84,Private,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"1,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,Other,No CTx,V-X,3/21/2017,9/8/2017,9/8/2017,6/13/2018,8/9/2018,8/9/2018,8/16/2018,8/19/2018,8/19/2018, , , 
3221,3529,6/15/1959,Male,181,115,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,1",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/6/2018,4/27/2018,4/27/2018, , , , , , , , , 
3222,4375,6/15/1949,Male,181,80,Private,No,Yes, ,Yes,Yes,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"36,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,3/1/2018,8/31/2019,8/31/2019,9/1/2019,10/1/2020,10/1/2020, , , , , , 
3223,3381,6/15/1954,Female,167,62,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,0,III: one or more criteria are fulfilled,IgA,"9,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,6/1/2018,9/1/2018,9/1/2018,9/1/2019,10/1/2021,10/1/2021,10/1/2021,12/31/2021, , , , 
3224,4885,6/15/1953,Female,169,74,Private,No,Yes, ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"24,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/1/2017,7/1/2017,7/1/2017,6/1/2018,10/1/2021,10/1/2021, , , , , , 
3225,1683,6/15/1939,Female,165,56,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"1,33",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Nein,R-X,R-X,No CTx,V-X,9/7/2015,5/18/2016,5/18/2016,10/11/2016,12/18/2016,12/18/2016,8/13/2018,11/15/2019,11/15/2019, , , 
3226,1879,6/15/1941,Male,190,97,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,2,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Nein,DAR-X,KYP-X,No CTx,V-X,7/17/2016,9/17/2016,9/17/2016,9/5/2018,7/20/2020,7/20/2020,8/20/2020,9/21/2020,9/21/2020, , , 
3227,6551,6/15/1943,Male,180,83,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/1/2015,11/30/2015,11/30/2015,7/9/2018,9/30/2018, , , , , , , 
3228,5996,6/15/1940,Male,176,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,POM-X,No CTx,No CTx,Other,6/1/2015,5/31/2016,5/31/2016,7/9/2018,9/30/2018, , , , , , , 
3229,1302,6/15/1962,Male,181,88,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,9/13/2018,10/28/2018,10/28/2018,9/27/2021,11/7/2021,11/7/2021, , , , , , 
3230,2084,6/15/1939,Female,163,68,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,11/1/2014,6/30/2015,6/30/2015,7/9/2018,9/30/2018,10/14/1582, , , , , , 
3231,3446,6/15/1936,Female,157,64,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/1/2015,3/31/2016,3/31/2016,7/16/2018,9/30/2018,10/14/1582, , , , , , 
3232,8551,6/15/1942,Male,183,76,Private,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"2,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,KYP-X,R-X,No CTx,V-X,8/1/2016,11/3/2016,11/3/2016,9/24/2018,2/11/2019,2/11/2019,4/1/2019,6/30/2019, , , , 
3233,6254,6/15/1947,Male,178,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,9",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/24/2018,2/21/2019,2/21/2019, , , , , , , , , 
3234,2278,6/15/1957,Male,190,103,Private,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"19,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/22/2018,4/16/2018,4/16/2018, , , , , , , , , 
3235,7418,6/15/1938,Male,178,84,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,Unknown,IgA,"1,5",unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,7/5/2018,3/25/2019,3/25/2019,8/20/2019,5/26/2020,5/26/2020, , , , , , 
3236,5593,6/15/1938,Male,168,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/30/2018,12/31/2018,12/31/2018, , , , , , , , , 
3237,6359,6/15/1952,Male,173,100,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,",4",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Ja,Unbekannt,Unbekannt, , , , , ,R-X,No CTx,No CTx,V-X,8/14/2018,10/16/2018,10/16/2018,11/23/2018,2/6/2019,2/6/2019, , , , , , 
3238,6344,6/15/1938,Female,168,45,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,8",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,8/6/2018,4/2/2019,4/2/2019, , , , , , , , , 
3239,5239,6/15/1946,Male,178,88,Compulsory health insurance CHI,Yes, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,35,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,V-X,EMP-X,NIN-X,V-X,4/23/2016,4/9/2017,4/9/2017,9/19/2018,11/13/2019,11/13/2019,12/18/2019,9/16/2020,9/16/2020,11/3/2020,9/4/2021,9/4/2021
3240,2041,6/15/1944,Female,167,74,Compulsory health insurance CHI,Yes, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,32,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,KYP-X,DAR-X,KYP-X,V-X,9/3/2018,7/11/2019,7/11/2019,9/13/2019,3/24/2020,3/24/2020,7/25/2020,8/30/2021,8/30/2021,9/18/2021,3/31/2022,10/14/1582
3241,1786,6/15/1941,Male,180,80,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"8,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,DAR-X,NIN-X,V-X,8/6/2018,11/8/2018,11/8/2018,10/1/2019,12/19/2019,12/19/2019,10/8/2020,2/16/2022,2/16/2022,2/18/2022,3/31/2022,10/14/1582
3242,2081,6/15/1955,Female,162,78,Private,No, ,Yes, , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"2,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/2/2018,9/28/2018,9/28/2018, , , , , , , , , 
3243,2716,6/15/1968,Male,178,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"5,8",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/6/2018,1/21/2019,1/21/2019,12/20/2019,9/30/2020, , , , , , , 
3244,4392,6/15/1950,Male,181,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,",5",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/3/2018,4/30/2019,4/30/2019, , , , , , , , , 
3245,2107,6/15/1937,Female,160,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"4,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,LEV-X,No CTx,No CTx,LEV-X,3/26/2015,8/6/2015,8/6/2015,9/6/2018,10/8/2019,10/8/2019, , , , , , 
3246,8365,6/15/1958,Male,187,121,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , ,Yes,1,Unknown,IgG,293,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/5/2018,10/19/2018,10/19/2018, , , , , , , , , 
3247,4583,6/15/1940,Female,153,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgA,"1,24","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/3/2018,12/4/2018,12/4/2018,10/8/2020,11/26/2020,11/26/2020, , , , , , 
3248,2077,6/15/1955,Male,182,102,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,DAR-X,KYP-X,V-X,6/19/2018,7/20/2018,7/20/2018,4/9/2019,8/26/2019,8/26/2019,7/7/2020,1/6/2021,1/6/2021,1/26/2021,3/31/2021,10/14/1582
3249,1130,6/15/1963,Male,188,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,5148,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,7/31/2018,11/27/2018,11/27/2018,3/12/2019,4/26/2019,4/26/2019, , , , , , 
3250,8475,6/15/1945,Male,173,77,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,69",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/19/2018,12/19/2018,12/19/2018, , , , , , , , , 
3251,4754,6/15/1952,Female,175,68,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,09",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/30/2018,8/23/2019,8/23/2019, , , , , , , , , 
3252,2231,6/15/1946,Female,166,57,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"28,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,7/12/2018,12/21/2018,12/21/2018,12/23/2019,1/2/2020,1/2/2020,5/17/2020,3/31/2022, , , , 
3253,7082,6/15/1953,Female,167,101,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,69",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,7/9/2018,11/7/2018,11/7/2018,2/14/2019,4/22/2020,4/22/2020,5/21/2020,12/22/2020,12/22/2020, , , 
3254,7877,6/15/1947,Female,162,62,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,83",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,R-X,8/17/2018,3/11/2019,3/11/2019,3/25/2019,1/2/2020,1/2/2020,6/2/2020,12/29/2021,12/29/2021, , , 
3255,3170,6/15/1953,Male,170,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,22",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,8/7/2018,12/20/2019,12/20/2019,3/1/2021,1/4/2022,1/4/2022,1/19/2022,3/31/2022, , , , 
3256,7686,6/15/1946,Male,187,87,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,56",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,7/18/2018,6/3/2019,6/3/2019,6/17/2019,3/10/2020,3/10/2020, , , , , , 
3257,5648,6/15/1947,Male,167,60,Compulsory health insurance CHI,No, , , , , , , ,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,88",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,R-X,8/29/2018,12/4/2019,12/4/2019,1/27/2022,3/31/2022, , , , , , , 
3258,8058,6/15/1943,Male,196,91,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,25",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/14/2018,8/20/2019,8/20/2019, , , , , , , , , 
3259,6103,6/15/1947,Male,185,85,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,05",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/12/2018,12/18/2018,12/18/2018,4/8/2019,3/31/2022,10/14/1582, , , , , , 
3260,7348,6/15/1947,Male,167,60,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,38",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/6/2018,4/28/2020,4/28/2020, , , , , , , , , 
3261,4619,6/15/1953,Female,166,80,Private,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"30,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,7/2/2018,11/8/2018,11/8/2018,1/24/2020,8/4/2021,8/4/2021,8/23/2021,3/31/2022, , , , 
3262,5672,6/15/1941,Male,178,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/1/2014,2/14/2015,2/14/2015,7/13/2018,9/30/2018, , , , , , , 
3263,5499,6/15/1953,Male,184,94,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"4,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/25/2018,2/20/2019,2/20/2019, , , , , , , , , 
3264,2718,6/15/1945,Male,182,69,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,9",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,8/23/2018,6/18/2019,6/18/2019,10/4/2021,3/31/2022,10/14/1582, , , , , , 
3265,3971,6/15/1947,Female,169,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"15,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/22/2018,12/27/2018,12/27/2018,10/29/2019,9/9/2021,9/9/2021, , , , , , 
3266,9362,6/15/1940,Male,179,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,04",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/17/2018,3/13/2019,3/13/2019,12/3/2019,3/31/2022,10/14/1582, , , , , , 
3267,1670,6/15/1949,Male,172,93,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,54",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/23/2018,6/7/2020,6/7/2020, , , , , , , , , 
3268,5412,6/15/1937,Female,162,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,10/1/2016,3/31/2017,3/31/2017,7/16/2018,9/30/2018,10/14/1582, , , , , , 
3269,3005,6/15/1953,Male,184,94,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,8/27/2018,12/19/2018,12/19/2018,1/17/2019,3/4/2022,3/4/2022,3/16/2022,3/31/2022, , , , 
3270,8194,6/15/1953,Male,178,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,98",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/6/2018,12/5/2019,12/5/2019, , , , , , , , , 
3271,4693,6/15/1953,Male,202,119,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,59",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,7/10/2018,11/7/2018,11/7/2018, , , , , , , , , 
3272,6710,6/15/1935,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,LEV-X,3/1/2016,11/30/2016,11/30/2016,7/23/2018,9/30/2018, , , , , , , 
3273,8143,6/15/1946,Female,165,58,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,9/10/2018,2/14/2019,2/14/2019,11/8/2019,4/16/2020,4/16/2020, , , , , , 
3274,2378,6/15/1942,Male,179,73,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,12/1/2015,4/15/2016,4/15/2016,7/31/2018,9/30/2018,10/14/1582, , , , , , 
3275,8136,6/15/1946,Female,165,58,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"18,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/10/2018,4/23/2020,4/23/2020, , , , , , , , , 
3276,1775,6/15/1943,Male,168,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,17",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/20/2018,10/20/2018,10/20/2018, , , , , , , , , 
3277,3114,6/15/1950,Male,176,68,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,77",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,7/6/2018,8/15/2020,8/15/2020,8/23/2020,12/31/2021,10/14/1582, , , , , , 
3278,7350,6/15/1947,Male,181,91,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"16,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/24/2018,11/8/2018,11/8/2018,11/5/2019,12/31/2021,10/14/1582, , , , , , 
3279,2816,6/15/1947,Male,181,91,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"20,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/25/2018,1/22/2019,1/22/2019, , , , , , , , , 
3280,7190,6/15/1939,Female,159,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/1/2015,12/31/2015,12/31/2015,8/3/2018,9/30/2018, , , , , , , 
3281,1265,6/15/1946,Female,174,80,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,37",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/3/2018,6/26/2019,6/26/2019, , , , , , , , , 
3282,9385,6/15/1947,Female,166,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,26",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,DAR-X,No CTx,V-X,7/18/2018,2/25/2019,2/25/2019,3/28/2019,1/15/2020,1/15/2020,1/29/2020,6/30/2021,10/14/1582, , , 
3283,1985,6/15/1944,Female,164,75,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,7/1/2016,12/31/2017,12/31/2017,8/6/2018,9/30/2018,10/14/1582, , , , , , 
3284,1244,6/15/1944,Female,167,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/17/2018,8/10/2019,8/10/2019,3/19/2021,3/31/2022,10/14/1582, , , , , , 
3285,2208,6/15/1938,Female,155,52,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,LEV-X,2/1/2016,10/31/2016,10/31/2016,8/8/2018,9/30/2018, , , , , , , 
3286,3358,6/15/1947,Male,179,76,Private,No, , , , ,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgM,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,5/1/2015,12/16/2015,12/16/2015,8/20/2018,9/30/2018,10/14/1582, , , , , , 
3287,3815,6/15/1936,Female,161,66,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/1/2015,6/30/2016,6/30/2016,8/27/2018,9/30/2018,10/14/1582, , , , , , 
3288,2165,6/15/1946,Male,181,75,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,5/16/2015,5/31/2016,5/31/2016,8/30/2018,9/30/2018,10/14/1582, , , , , , 
3289,3956,6/15/1948,Female,165,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/1/2016,9/30/2016,9/30/2016,9/3/2018,9/30/2018,10/14/1582, , , , , , 
3290,9636,6/15/1943,Male,167,69,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"15,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/16/2018,7/11/2019,7/11/2019, , , , , , , , , 
3291,1180,6/15/1948,Male,173,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,03",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/13/2018,1/30/2019,1/30/2019,2/7/2020,3/31/2022,10/14/1582, , , , , , 
3292,4005,6/15/1943,Male,167,69,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"13,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,POM-X,V-X,No CTx,R-X,8/30/2018,12/22/2020,12/22/2020,1/3/2021,8/17/2021,8/17/2021,8/29/2021,3/31/2022, , , , 
3293,8231,6/15/1946,Male,188,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"30,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/24/2018,11/20/2018,11/20/2018, , , , , , , , , 
3294,9187,6/15/1965,Female,158,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,51",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/21/2018,12/19/2018,12/19/2018,7/8/2020,3/31/2022,10/14/1582, , , , , , 
3295,7959,6/15/1965,Female,164,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,9",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/27/2018,10/27/2018,10/27/2018,2/21/2022,3/31/2022, , , , , , , 
3296,2898,6/15/1951,Female,160,64,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"7,88","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/21/2018,9/14/2019,9/14/2019, , , , , , , , , 
3297,2608,6/15/1952,Female,163,49,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,07",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/5/2018,1/2/2019,1/2/2019,9/8/2021,3/31/2022,10/14/1582, , , , , , 
3298,4732,6/15/1948,Female,163,82,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,76",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L",Ja,R-X,POM-X,DAR-X,LEV-X,8/2/2018,12/17/2018,12/17/2018,8/9/2019,11/27/2019,11/27/2019,1/6/2020,2/2/2020,2/2/2020,4/22/2020,3/31/2022,10/14/1582
3299,1235,6/15/1944,Male,178,54,Private,No, ,Yes,Yes, ,Yes, , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,95",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,No CTx,LEV-X,7/16/2018,12/18/2018,12/18/2018,4/27/2021,8/3/2021,8/3/2021,9/13/2021,3/31/2022,10/14/1582, , , 
3300,3547,6/15/1946,Female,168,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"24,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/16/2018,1/16/2019,1/16/2019,2/25/2020,3/31/2022,10/14/1582, , , , , , 
3301,1804,6/15/1949,Male,175,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,LEV-X,7/12/2018,1/10/2019,1/10/2019,8/31/2020,11/28/2020,11/28/2020,12/6/2020,5/22/2021,5/22/2021,5/29/2021,9/8/2021,9/8/2021
3302,6969,6/15/1952,Male,181,93,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,7/25/2018,12/17/2018,12/17/2018,3/18/2019,2/16/2021,2/16/2021,9/21/2021,9/30/2021,9/30/2021, , , 
3303,9558,6/15/1948,Male,186,84,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"2,74",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,8/30/2018,2/6/2019,2/6/2019,1/29/2020,11/2/2021,11/2/2021,11/23/2021,3/31/2022, , , , 
3304,9250,6/15/1945,Female,166,77,Private,No, ,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"34,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/10/2018,12/20/2018,12/20/2018, , , , , , , , , 
3305,1205,6/15/1946,Male,175,97,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"3,79",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,POM-X,No CTx,V-X,7/23/2018,7/29/2019,7/29/2019,10/3/2020,1/4/2022,1/4/2022,1/17/2022,3/31/2022, , , , 
3306,6150,6/15/1946,Female,170,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"5,34",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/3/2018,12/11/2018,12/11/2018,12/11/2020,3/31/2022,10/14/1582, , , , , , 
3307,4949,6/15/1943,Male,188,69,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/9/2018,5/28/2019,5/28/2019,10/16/2019,10/8/2020,10/8/2020, , , , , , 
3308,5531,6/15/1947,Male,184,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"11,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/13/2018,12/31/2020, , , , , , , , , , 
3309,9919,6/15/1942,Male,180,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,92",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/20/2018,12/31/2020, , , , , , , , , , 
3310,5789,6/15/1939,Male,172,75,Compulsory health insurance CHI,Yes,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,3316,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/19/2018,2/7/2019,2/7/2019, , , , , , , , , 
3311,6126,6/15/1950,Male,177,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,7/9/2018,9/10/2020,9/10/2020,10/5/2020,12/31/2020, , , , , , , 
3312,4254,6/15/1944,Male,172,90,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,2328,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Ja, , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,9/24/2018,2/25/2019,2/25/2019,4/29/2019,10/9/2019,10/9/2019, , , , , , 
3313,9748,6/15/1953,Male,185,127,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"17,82","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/16/2018,12/31/2020, , , , , , , , , , 
3314,3877,6/15/1943,Male,180,79,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,12",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/6/2018,12/31/2020, , , , , , , , , , 
3315,6012,6/15/1945,Female,176,92,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"7,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/30/2018,12/13/2018,12/13/2018, , , , , , , , , 
3316,3484,6/15/1947,Male,184,86,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,87",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,9/6/2018,12/20/2018,12/20/2018,11/10/2021,12/29/2021,12/29/2021,1/18/2022,3/31/2022,10/14/1582, , , 
3317,7581,6/15/1953,Male,171,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,25",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/26/2018,11/8/2018,11/8/2018, , , , , , , , , 
3318,1079,6/15/1944,Male,181,79,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,22",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/3/2018,8/27/2019,8/27/2019, , , , , , , , , 
3319,1100,6/15/1956,Male,175,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,999,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/13/2018,10/25/2018,10/25/2018, , , , , , , , , 
3320,5951,6/15/1952,Male,173,83,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,94",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,7/19/2018,11/14/2018,11/14/2018,1/24/2020,10/4/2021,10/4/2021,10/27/2021,3/31/2022,10/14/1582, , , 
3321,6971,6/15/1948,Female,174,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,11",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,7/30/2018,4/24/2019,4/24/2019,8/23/2019,2/4/2021,2/4/2021,2/13/2021,5/17/2021,5/17/2021, , , 
3322,4478,6/15/1948,Female,165,62,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"14,21","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/30/2018,3/14/2019,3/14/2019,8/7/2019,7/30/2021,7/30/2021, , , , , , 
3323,6394,6/15/1947,Female,173,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,86",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/30/2018,9/29/2018,9/29/2018, , , , , , , , , 
3324,5023,6/15/1933,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,R-X,8/20/2018,9/30/2021,9/30/2021, , , , , , , , , 
3325,8479,6/15/1934,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgM,"9,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,9/6/2018,12/31/2018, , , , , , , , , , 
3326,5775,6/15/1948,Female,165,71,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,83",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/30/2018,7/23/2019,7/23/2019, , , , , , , , , 
3327,5038,6/15/1933,Male,999,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"28,85",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,V-X,No CTx,No CTx,V-X,9/27/2018,10/4/2018,10/4/2018,5/23/2019,9/30/2019, , , , , , , 
3328,6843,6/15/1940,Female,161,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/14/2018,11/14/2018,11/14/2018,3/9/2022,3/31/2022, , , , , , , 
3329,6498,6/15/1944,Female,168,64,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"6,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/30/2018,7/11/2019,7/11/2019, , , , , , , , , 
3330,7678,6/15/1948,Male,999,80,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,8/9/2018,5/23/2019,5/23/2019, , , , , , , , , 
3331,3427,6/15/1946,Female,163,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,Other,8/10/2018,3/8/2019,3/8/2019, , , , , , , , , 
3332,6155,6/15/1943,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,9/4/2018,4/12/2019,4/12/2019,9/30/2019,6/19/2020,6/19/2020, , , , , , 
3333,4635,6/15/1949,Male,173,71,Private,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,8/30/2018,12/27/2018,12/27/2018,5/28/2021,8/20/2021,8/20/2021,9/9/2021,3/31/2022, , , , 
3334,9420,6/15/1951,Female,176,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,05",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,7/30/2018,12/18/2018,12/18/2018, , , , , , , , , 
3335,9295,6/15/1951,Male,172,87,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,4",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,7/5/2018,10/31/2018,10/31/2018, , , , , , , , , 
3336,1689,6/15/1940,Male,176,72,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/1/2015,4/15/2016,4/15/2016,9/3/2018,9/30/2018, , , , , , , 
3337,3272,6/15/1955,Male,168,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,130,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/1/2018,5/13/2019,5/13/2019, , , , , , , , , 
3338,5731,6/15/1948,Male,168,70,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,155,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,DAR-X,R-X,No CTx,V-X,7/18/2018,12/19/2018,12/19/2018,6/4/2019,12/10/2019,12/10/2019,3/16/2020,12/15/2020,12/15/2020, , , 
3339,7588,6/15/1942,Female,162,55,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,220,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/7/2018,5/6/2019,5/6/2019,3/2/2020,11/12/2020,11/12/2020, , , , , , 
3340,1873,6/15/1941,Female,165,67,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,145,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/23/2018,7/15/2019,7/15/2019,2/5/2020,10/15/2020,10/15/2020, , , , , , 
3341,5823,6/15/1939,Female,162,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,160,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/4/2018,4/9/2019,4/9/2019, , , , , , , , , 
3342,1913,6/15/1940,Male,170,66,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,180,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/19/2018,12/31/2018, , , , , , , , , , 
3343,9651,6/15/1937,Male,169,68,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,9/18/2018,4/8/2019,4/8/2019,8/5/2019,11/13/2019,11/13/2019, , , , , , 
3344,1891,6/15/1938,Female,162,60,Private,No, ,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,155,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,R-X,9/24/2018,4/16/2019,4/16/2019,8/12/2019,11/12/2019,11/12/2019, , , , , , 
3345,5595,6/15/1947,Female,167,52,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"23,35","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/13/2018,8/6/2019,8/6/2019,10/19/2021,3/31/2022,10/14/1582, , , , , , 
3346,7653,6/15/1958,Male,176,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,18",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/3/2018,10/3/2018,10/3/2018, , , , , , , , , 
3347,4492,6/15/1952,Male,182,91,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,09",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,8/20/2018,12/18/2018,12/18/2018,3/26/2019,5/3/2019,5/3/2019,5/20/2019,12/31/2021, , , , 
3348,7702,6/15/1953,Female,162,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,51",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/5/2018,10/3/2018,10/3/2018,11/17/2020,3/31/2022,10/14/1582, , , , , , 
3349,8598,6/15/1953,Male,180,96,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"17,34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,7/27/2018,1/28/2019,1/28/2019,2/6/2019,8/14/2019,8/14/2019, , , , , , 
3350,8873,6/15/1950,Female,161,91,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"17,82","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/30/2018,11/21/2018,11/21/2018, , , , , , , , , 
3351,4329,6/15/1950,Female,181,119,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/5/2018,12/3/2019,12/3/2019, , , , , , , , , 
3352,5272,6/15/1953,Male,184,90,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,NIN-X,POM-X,DAR-X,V-X,7/3/2018,3/6/2019,3/6/2019,11/14/2019,5/18/2020,5/18/2020,6/6/2020,8/5/2020,8/5/2020,8/15/2020,9/30/2020, 
3353,6887,6/15/1944,Male,186,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/20/2018,2/6/2019,2/6/2019,12/23/2019,9/30/2020,10/14/1582, , , , , , 
3354,6217,6/15/1949,Female,170,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/26/2018,4/4/2019,4/4/2019, , , , , , , , , 
3355,1928,6/15/1951,Male,181,64,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,83",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/23/2018,4/17/2019,4/17/2019, , , , , , , , , 
3356,9788,6/15/1945,Male,179,83,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,65",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,7/3/2018,3/13/2019,3/13/2019, , , , , , , , , 
3357,1845,6/15/1948,Female,163,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,34,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,7/13/2018,12/28/2018,12/28/2018,5/20/2020,9/30/2020, , , , , , , 
3358,9406,6/15/1945,Female,164,66,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,43",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,No CTx,V-X,8/15/2017,2/8/2018,2/8/2018,7/3/2018,10/13/2021,10/13/2021,12/7/2021,3/31/2022, , , , 
3359,4622,6/15/1960,Female,169,70,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Unknown,Unknown,Unknown,Unknown, , ,0,III: one or more criteria are fulfilled,IgG,1816,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/2/2017,12/18/2017,12/18/2017, , , , , , , , , 
3360,7252,6/15/1972,Female,164,82,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,08",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/25/2018,4/30/2018,4/30/2018,9/11/2018,3/11/2019,3/11/2019,3/19/2019,3/31/2022,10/14/1582, , , 
3361,1658,6/15/1948,Female,153,63,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,1",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/13/2018,6/12/2018,6/12/2018,9/3/2018,6/22/2020,6/22/2020, , , , , , 
3362,4917,6/15/1947,Male,152,53,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,96",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,No CTx,V-X,12/21/2017,3/26/2018,3/26/2018,7/4/2018,10/11/2019,10/11/2019,11/11/2019,1/11/2020,1/11/2020, , , 
3363,3049,6/15/1952,Female,166,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,13",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,R-X,8/20/2018,8/13/2019,8/13/2019,10/8/2021,3/31/2022, , , , , , , 
3364,5683,6/15/1960,Female,166,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,36",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,7/14/2017,12/28/2017,12/28/2017,7/18/2018,12/4/2019,12/4/2019,12/27/2019,12/27/2019,12/27/2019, , , 
3365,2243,6/15/1948,Female,160,57,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/5/2018,7/11/2019,7/11/2019, , , , , , , , , 
3366,9006,6/15/1947,Female,162,51,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,63","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/20/2018,3/18/2019,3/18/2019,2/16/2022,3/31/2022,10/14/1582, , , , , , 
3367,6871,6/15/1940,Male,190,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/31/2018,10/15/2018,10/15/2018,1/10/2019,8/20/2019,8/20/2019, , , , , , 
3368,4108,6/15/1932,Male,187,93,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"17,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,8/10/2017,2/8/2018,2/8/2018,9/6/2018,11/16/2021,11/16/2021,1/14/2022,3/31/2022,10/14/1582, , , 
3369,3797,6/15/1953,Male,184,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,47",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/5/2018,6/28/2019,6/28/2019, , , , , , , , , 
3370,3341,6/15/1945,Female,167,62,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"7,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,V-X,No CTx,V-X,6/8/2017,12/1/2017,12/1/2017,7/9/2018,4/9/2021,4/9/2021,7/19/2021,3/31/2022, , , , 
3371,6691,6/15/1949,Female,174,77,Private,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"26,22","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,8/23/2018,8/16/2019,8/16/2019,3/14/2022,3/31/2022, , , , , , , 
3372,5449,6/15/1951,Male,176,96,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,65",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/13/2018,9/12/2018,9/12/2018, , , , , , , , , 
3373,3883,6/15/1932,Male,180,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,34",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,POM-X,No CTx,V-X,8/30/2018,2/20/2019,2/20/2019,1/3/2020,8/13/2020,8/13/2020,8/21/2020,12/31/2021, , , , 
3374,6324,6/15/1962,Female,167,64,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"15,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,7/9/2018,11/8/2018,11/8/2018,4/10/2019,8/20/2019,8/20/2019,9/5/2019,4/20/2020,4/20/2020, , , 
3375,8473,6/15/1965,Male,169,61,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgA,6946,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,R-X,KYP-X,V-X,8/4/2009,10/18/2009,10/18/2009,9/15/2013,3/15/2015,3/15/2015,4/15/2015,3/15/2016,3/15/2016,8/15/2016,10/31/2016,10/31/2016
3376,3046,6/15/1953,Female,161,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,12",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/20/2017,1/18/2018,1/18/2018,7/5/2018,2/19/2020,2/19/2020, , , , , , 
3377,7768,6/15/1944,Female,166,51,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,69",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,KYP-X,V-X,11/3/2017,4/23/2018,4/23/2018,8/29/2018,7/28/2020,7/28/2020,8/16/2020,2/12/2021,2/12/2021,3/8/2021,7/17/2021,7/17/2021
3378,2598,6/15/1947,Female,171,108,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,87",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,9/5/2017,12/4/2017,12/4/2017,7/2/2018,2/20/2021,2/20/2021,2/27/2021,3/31/2022,10/14/1582, , , 
3379,7587,6/15/1946,Female,159,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,54",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,7/14/2017,1/9/2018,1/9/2018,7/31/2018,7/22/2019,7/22/2019,4/24/2020,12/26/2020,12/26/2020,1/18/2021,8/4/2021,8/4/2021
3380,1159,6/15/1946,Female,167,63,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,18",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/23/2018,8/13/2018,8/13/2018,9/6/2018,12/31/2020,10/14/1582, , , , , , 
3381,8987,6/15/1946,Female,184,114,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,46",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,8/23/2017,2/7/2018,2/7/2018,8/17/2018,6/6/2019,6/6/2019,8/26/2019,3/31/2022, , , , 
3382,5407,6/15/1947,Female,165,80,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,41",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,R-X,V-X,V-X,1/10/2018,7/9/2018,7/9/2018,7/19/2018,2/14/2019,2/14/2019,3/19/2019,6/3/2019,6/3/2019,8/12/2019,6/30/2020,6/30/2020
3383,5920,6/15/1953,Female,156,46,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,84",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,10/23/2017,4/23/2018,4/23/2018,7/4/2018,9/27/2018,9/27/2018,4/26/2019,6/7/2019,6/7/2019, , , 
3384,6323,6/15/1943,Female,165,84,Private,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,72",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,NIN-X,R-X,1/25/2018,7/16/2018,7/16/2018,7/27/2018,3/30/2019,3/30/2019,4/1/2019,9/6/2020,9/6/2020,9/21/2020,3/31/2022, 
3385,5806,6/15/1962,Male,173,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/16/2018,9/17/2018,9/17/2018, , , , , , , , , 
3386,2703,6/15/1942,Male,181,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"20,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/29/2017,2/22/2018,2/22/2018,8/14/2018,3/26/2021,3/26/2021,4/21/2021,3/31/2022,10/14/1582, , , 
3387,7618,6/15/1946,Male,185,86,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,Unknown,IgA,1169,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/27/2018,10/8/2018,10/8/2018, , , , , , , , , 
3388,3653,6/15/1950,Female,176,68,Private,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,86",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,1/11/2018,4/19/2018,4/19/2018,8/8/2018,1/2/2020,1/2/2020,3/13/2020,10/11/2020,10/11/2020,10/19/2020,6/24/2021,6/24/2021
3389,8565,6/15/1966,Female,173,62,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,46",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,10/27/2017,4/20/2018,4/20/2018,7/19/2018,2/10/2022,2/10/2022,3/10/2022,3/31/2022, , , , 
3390,2669,6/15/1948,Female,180,82,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,06",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/24/2017,4/12/2018,4/12/2018,7/27/2018,12/31/2021,10/14/1582, , , , , , 
3391,9091,6/15/1948,Female,165,60,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,2699,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,V-X,V-X,KYP-X,R-X,1/15/2014,4/15/2014,4/15/2014,5/5/2014,9/25/2014,9/25/2014,8/20/2018,1/14/2019,1/14/2019,5/11/2021,7/22/2021,7/22/2021
3392,9076,6/15/1941,Female,150,50,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgA,"22,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,Yes,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,V-X,R-X,Other,8/31/2011,1/19/2012,1/19/2012,8/22/2013,12/20/2013,12/20/2013,3/8/2017,9/20/2017,9/20/2017,8/14/2018,1/1/2019,1/1/2019
3393,7276,6/15/1938,Female,160,64,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgM,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/1/2014,10/15/2014,10/15/2014,9/11/2018,9/30/2018, , , , , , , 
3394,9775,6/15/1940,Female,164,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,POM-X,No CTx,No CTx,Other,2/1/2015,1/31/2016,1/31/2016,9/17/2018,9/30/2018, , , , , , , 
3395,3580,6/15/1944,Male,176,73,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,12/15/2015,7/31/2016,7/31/2016,9/25/2018,9/30/2018, , , , , , , 
3396,2601,6/15/1934,Female,158,56,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,LEV-X,10/1/2016,6/30/2017,6/30/2017,9/27/2018,9/30/2018, , , , , , , 
3397,3909,6/15/1935,Female,165,54,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,"4,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,8/21/2018,10/16/2018,10/16/2018,6/28/2019,6/30/2020,10/14/1582, , , , , , 
3398,1043,6/15/1941,Male,176,81,Compulsory health insurance CHI,Yes,Yes, ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,R-X,7/3/2018,12/31/2018, , , , , , , , , , 
3399,1562,6/15/1938,Male,176,80,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"5,86",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/10/2018,10/11/2018,10/11/2018, , , , , , , , , 
3400,2590,6/15/1963,Female,168,67,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/14/2018,11/20/2018,11/20/2018,12/13/2018,1/26/2019,1/26/2019, , , , , , 
3401,8454,6/15/1933,Female,165,55,Compulsory health insurance CHI,Yes, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,7650,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,7/17/2018,10/28/2018,10/28/2018, , , , , , , , , 
3402,4982,6/15/1934,Female,155,56,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,5668,unknown/ISS-Criteria not used for prognostics,No,No,Yes,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,7/12/2018,6/30/2019, , , , , , , , , , 
3403,8123,6/15/1931,Male,170,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgE,356,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,9/21/2018,4/5/2019,4/5/2019, , , , , , , , , 
3404,3911,6/15/1949,Female,165,70,Private,No, , ,Unknown, ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,6350,unknown/ISS-Criteria not used for prognostics,No,No,Yes,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Nein,DAR-X,No CTx,No CTx,V-X,12/16/2013,2/28/2014,2/28/2014,7/3/2018,10/15/2018,10/15/2018, , , , , , 
3405,1423,6/15/1947,Female,166,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,52,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,R-X,KYP-X,POM-X,DAR-X,9/15/2018,5/15/2019,5/15/2019,9/1/2019,2/1/2020,2/1/2020,3/1/2020,5/15/2020,5/15/2020,6/15/2020,6/30/2020, 
3406,6708,6/15/1939,Female,170,70,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"1,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,8/11/2018,6/7/2019,6/7/2019,6/24/2019,12/31/2019, , , , , , , 
3407,7210,6/15/1967,Male,190,93,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/27/2018,12/30/2018,12/30/2018, , , , , , , , , 
3408,4341,6/15/1946,Female,162,60,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,V-X,KYP-X,V-X,3/29/2012,7/10/2012,7/10/2012,3/4/2013,1/8/2014,1/8/2014,4/23/2014,10/20/2014,10/20/2014,5/30/2016,12/18/2017,12/18/2017
3409,9754,6/15/1958,Male,165,58,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"44,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/13/2018,12/31/2018, , , , , , , , , , 
3410,1673,6/15/1952,Female,165,62,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/13/2018,12/2/2018,12/2/2018, , , , , , , , , 
3411,4047,6/15/1951,Female,168,73,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/18/2018,11/20/2018,11/20/2018, , , , , , , , , 
3412,4230,6/15/1938,Male,185,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,4800,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,No,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,8/10/2018,12/18/2018,12/18/2018,7/1/2020,9/2/2020,9/2/2020, , , , , , 
3413,4085,6/15/1950,Female,170,83,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgD,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,DAR-X,KYP-X,V-X,6/24/2013,9/12/2013,9/12/2013,12/11/2015,5/20/2017,5/20/2017,6/21/2017,7/5/2017,7/5/2017,6/11/2018,9/17/2019,9/17/2019
3414,6357,6/15/1957,Male,180,153,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,KYP-X,DAR-X,No CTx, , , ,10/11/2016,1/9/2017,1/9/2017,1/10/2017,6/25/2018,6/25/2018,7/31/2018,12/8/2019,12/8/2019
3415,8459,6/15/1954,Male,183,80,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,7/5/2015,9/18/2015,9/18/2015,9/10/2018,8/17/2020,8/17/2020,9/28/2020,12/10/2020,12/10/2020, , , 
3416,6568,6/15/1941,Male,175,99,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"3,5",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,KYP-X,KYP-X,No CTx,R-X,9/9/2015,1/31/2018,1/31/2018,7/4/2018,11/1/2018,11/1/2018,3/25/2019,10/3/2019,10/3/2019, , , 
3417,6526,6/15/1957,Male,170,85,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,No CTx,No CTx,No CTx, , , ,7/6/2018,9/7/2018,9/7/2018, , , , , , 
3418,2462,6/15/1933,Female,165,55,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,7/17/2018,10/19/2018,10/19/2018, , , , , , , , , 
3419,8965,6/15/1931,Male,170,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),9,Yes,9,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,8/14/2018,4/2/2019,4/2/2019, , , , , , , , , 
3420,8785,6/15/1959,Female,165,114,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/25/2018,12/27/2018,12/27/2018, , , , , , , , , 
3421,1657,6/15/1945,Male,170,88,Compulsory health insurance CHI,Unknown,Yes, , ,Yes, , , , , , ,9,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,1/1/2018,4/30/2018,4/30/2018, , , , , , , , , 
3422,1406,6/15/1950,Male,178,88,Private,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,46,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/3/2018,11/15/2018,11/15/2018, , , , , , , , , 
3423,5645,6/15/1965,Male,186,94,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,24,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/23/2018,11/5/2019,11/5/2019, , , , , , , , , 
3424,5481,6/15/1950,Male,174,99,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/7/2018,12/14/2018,12/14/2018,3/23/2021,3/31/2022, , , , , , , 
3425,7250,6/15/1944,Female,168,77,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,Other type,7412,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,DAR-X,No CTx,No CTx,V-X,9/26/2018,2/7/2019,2/7/2019,2/18/2019,3/31/2022,10/14/1582, , , , , , 
3426,3703,6/15/1941,Female,151,62,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , ,Yes,Yes,1,Unknown,IgG,"64,7",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,8/13/2018,4/26/2019,4/26/2019,1/6/2020,4/17/2020,4/17/2020,5/21/2020,11/19/2020,11/19/2020, , , 
3427,4954,6/15/1945,Female,167,61,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,55,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,DAR-X,No CTx,V-X,8/17/2016,10/25/2016,10/25/2016,7/12/2018,10/24/2018,10/24/2018,12/11/2018,2/8/2019,2/8/2019, , , 
3428,9198,6/15/1941,Male,178,72,Compulsory health insurance CHI,No, ,Yes, , , , , , ,Yes, ,3,III: one or more criteria are fulfilled,IgG,67,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , , , ,V-X,R-X,No CTx,V-X,7/2/2018,8/20/2018,8/20/2018,8/21/2018,10/24/2018,10/24/2018,11/9/2018,2/8/2019,2/8/2019, , , 
3429,9271,6/15/1941,Female,160,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/10/2018,9/30/2018,10/14/1582, , , , , , , , , 
3430,7835,6/15/1941,Male,168,78,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"4,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/14/2009,3/23/2009,3/23/2009,6/28/2010,4/1/2014,4/1/2014,8/1/2018,3/31/2022, , , , 
3431,2559,6/15/1936,Male,158,64,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/3/2018,2/8/2019,2/8/2019, , , , , , , , , 
3432,7826,6/15/1942,Male,173,65,Private,No, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,24,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,7/24/2018,10/24/2018,10/24/2018, , , , , , , , , 
3433,8936,6/15/1967,Male,178,83,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/16/2018,1/14/2019,1/14/2019,1/15/2020,9/15/2020,9/15/2020, , , , , , 
3434,6109,6/15/1929,Male,170,80,Compulsory health insurance CHI,Yes,Yes,Yes, ,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,6200,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L",Nein,DAR-X,NIN-X,No CTx,V-X,8/27/2018,3/15/2019,3/15/2019,9/2/2019,6/3/2020,6/3/2020,3/1/2021,6/30/2021, , , , 
3435,9116,6/15/1954,Male,172,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, ,Yes,Yes,2,III: one or more criteria are fulfilled,IgG,2413,ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/12/2018,11/26/2018,11/26/2018,2/11/2020,8/5/2020,8/5/2020, , , , , , 
3436,9510,6/15/1962,Female,174,82,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,9/10/2018,12/5/2018,12/5/2018,6/24/2019,1/8/2021,1/8/2021,2/8/2021,3/31/2021,10/14/1582, , , 
3437,8905,6/15/1960,Female,165,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"54,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/11/2018,11/23/2018,11/23/2018, , , , , , , , , 
3438,2646,6/15/1954,Female,164,83,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,4",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,V-X,DAR-X,No CTx,V-X,4/1/2013,5/30/2013,5/30/2013,9/4/2018,10/30/2018,10/30/2018,1/25/2022,3/31/2022,10/14/1582, , , 
3439,1755,6/15/1939,Male,170,72,Private,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,70,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,9/18/2018,5/5/2020,5/5/2020,6/1/2020,12/7/2020,12/7/2020, , , , , , 
3440,8109,6/15/1973,Female,167,168,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"4,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/18/2018,11/8/2018,11/8/2018, , , , , , , , , 
3441,8601,6/15/1952,Male,189,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"1,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,Other,No CTx,No CTx,V-X,9/7/2018,2/4/2019,2/4/2019,5/17/2019,6/30/2019, , , , , , , 
3442,3966,6/15/1946,Male,198,73,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,02",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,LEV-X,2/19/2018,8/20/2018,8/20/2018,9/10/2018,7/7/2020,7/7/2020, , , , , , 
3443,1895,6/15/1947,Male,153,62,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,87",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,V-X,V-X,2/8/2018,7/30/2018,7/30/2018,8/8/2018,10/25/2019,10/25/2019,11/22/2019,1/1/2020,1/1/2020,2/20/2020,6/4/2020,6/4/2020
3444,7655,6/15/1947,Female,153,62,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,47",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,12/18/2017,6/11/2018,6/11/2018,7/6/2018,3/26/2019,3/26/2019,4/5/2019,7/23/2020,7/23/2020,8/8/2020,10/2/2020,10/2/2020
3445,8364,6/15/1951,Female,166,98,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"21,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,No CTx,V-X,10/3/2017,3/26/2018,3/26/2018,8/22/2018,8/15/2019,8/15/2019,9/17/2019,2/25/2021,2/25/2021, , , 
3446,3414,6/15/1954,Male,183,80,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,97",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,11/3/2016,3/7/2017,3/7/2017,8/22/2017,7/30/2018,7/30/2018,8/17/2018,1/28/2019,1/28/2019,2/21/2019,6/6/2019,6/6/2019
3447,8457,6/15/1952,Female,176,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,V-X,POM-X,V-X,5/16/2017,8/21/2017,8/21/2017,1/31/2018,7/23/2018,7/23/2018,8/15/2018,1/23/2019,1/23/2019,2/28/2019,6/21/2021,6/21/2021
3448,1935,6/15/1959,Female,170,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , ,Yes,1,I: fulfilling all 4 criteria,Other type,1067,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,9/17/2018,6/20/2019,6/20/2019, , , , , , , , , 
3449,1611,6/15/1947,Male,184,95,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,Other type,5555,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,DAR-X,No CTx,No CTx,V-X,9/25/2018,12/20/2018,12/20/2018,2/6/2019,2/20/2019,2/20/2019, , , , , , 
3450,8431,6/15/1949,Male,186,116,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,V-X,NIN-X,V-X,12/28/2017,6/21/2018,6/21/2018,8/31/2018,1/2/2020,1/2/2020,2/8/2020,1/25/2021,1/25/2021,2/9/2021,6/4/2021,6/4/2021
3451,1999,6/15/1934,Male,172,82,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"20,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,POM-X,V-X,1/11/2017,5/4/2017,5/4/2017,10/20/2017,9/27/2018,9/27/2018,10/8/2018,6/10/2019,6/10/2019,3/20/2020,10/3/2020,10/3/2020
3452,9992,6/15/1950,Female,163,54,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,POM-X,V-X,8/25/2016,12/20/2016,12/20/2016,7/20/2017,6/26/2018,6/26/2018,7/13/2018,12/12/2020,12/12/2020,12/23/2020,4/10/2021,4/10/2021
3453,1018,6/15/1952,Male,178,106,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,52",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,V-X,8/17/2017,2/15/2018,2/15/2018,7/30/2018,3/8/2019,3/8/2019,3/29/2019,7/5/2020,7/5/2020,7/27/2020,6/30/2021,10/14/1582
3454,2579,6/15/1933,Female,171,71,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,16",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,12/14/2017,6/5/2018,6/5/2018,8/16/2018,5/16/2019,5/16/2019,6/13/2019,3/31/2022,10/14/1582, , , 
3455,2304,6/15/1935,Female,163,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"14,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/5/2017,1/1/2018,1/1/2018,7/17/2018,8/23/2021,8/23/2021, , , , , , 
3456,7394,6/15/1946,Female,162,69,Private,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"11,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,V-X,V-X,1/5/2018,7/2/2018,7/2/2018,7/27/2018,5/20/2019,5/20/2019,6/3/2019,12/9/2019,12/9/2019,1/16/2020,8/18/2020,8/18/2020
3457,1642,6/15/1946,Female,162,69,Private,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"24,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,1/11/2018,7/3/2018,7/3/2018,7/25/2018,11/28/2018,11/28/2018,6/27/2019,7/23/2020,7/23/2020,8/15/2020,12/31/2020, 
3458,4369,6/15/1931,Male,187,93,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"32,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,EMP-X,No CTx,R-X,8/7/2017,1/25/2018,1/25/2018,2/19/2018,8/13/2018,8/13/2018,9/3/2018,12/31/2020,10/14/1582, , , 
3459,6197,6/15/1949,Male,167,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,V-X,V-X,10/19/2016,2/14/2017,2/14/2017,9/4/2017,8/8/2018,8/8/2018,8/24/2018,10/7/2019,10/7/2019,12/12/2019,12/4/2020,12/4/2020
3460,6582,6/15/1943,Female,158,62,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,"24,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,8/28/2017,2/21/2018,2/21/2018,7/26/2018,12/27/2018,12/27/2018,1/16/2019,3/31/2022,10/14/1582, , , 
3461,7934,6/15/1946,Male,176,52,Private,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"29,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/6/2017,2/12/2018,2/12/2018,7/10/2018,6/30/2021,10/14/1582, , , , , , 
3462,5965,6/15/1968,Male,178,89,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,EMP-X,DAR-X,R-X,6/19/2017,12/18/2017,12/18/2017,1/11/2018,7/5/2018,7/5/2018,7/18/2018,8/9/2020,8/9/2020,8/23/2020,8/18/2021,8/18/2021
3463,6047,6/15/1947,Male,187,77,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"14,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,6/13/2017,9/12/2017,9/12/2017,3/1/2018,8/30/2018,8/30/2018,9/25/2018,1/22/2019,1/22/2019,2/4/2019,10/6/2020,10/6/2020
3464,8849,6/15/1953,Female,157,50,Private,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,1/2/2018,4/3/2018,4/3/2018,8/13/2018,9/14/2021,9/14/2021,10/5/2021,3/31/2022,10/14/1582, , , 
3465,9223,6/15/1953,Female,157,50,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,11/28/2017,3/6/2018,3/6/2018,8/24/2018,7/31/2020,7/31/2020,8/16/2020,11/30/2020,11/30/2020,12/16/2020,7/12/2021,7/12/2021
3466,8080,6/15/1945,Female,158,45,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,EMP-X,V-X,R-X,8/11/2017,2/1/2018,2/1/2018,2/14/2018,8/1/2018,8/1/2018,8/23/2018,1/30/2019,1/30/2019,3/4/2019,3/11/2020,3/11/2020
3467,3157,6/15/1945,Female,174,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"23,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,3/15/2017,6/7/2017,6/7/2017,1/9/2018,7/9/2018,7/9/2018,8/2/2018,7/26/2019,7/26/2019, , , 
3468,8440,6/15/1949,Male,184,108,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,01",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,10/31/2017,1/30/2018,1/30/2018,8/29/2018,4/2/2019,4/2/2019,4/17/2019,11/12/2019,11/12/2019,12/23/2019,9/30/2020, 
3469,8771,6/15/1949,Female,161,65,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/13/2017,5/7/2018,5/7/2018,8/15/2018,1/12/2021,1/12/2021, , , , , , 
3470,1716,6/15/1951,Female,171,95,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"22,66","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,EMP-X,No CTx,R-X,7/3/2017,12/28/2017,12/28/2017,1/15/2018,7/5/2018,7/5/2018,7/24/2018,12/18/2019,12/18/2019, , , 
3471,4422,6/15/1943,Male,191,108,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"30,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,V-X,V-X,10/19/2016,1/11/2017,1/11/2017,8/11/2017,7/16/2018,7/16/2018,7/30/2018,2/27/2019,2/27/2019,3/12/2019,5/17/2019,5/17/2019
3472,5830,6/15/1950,Male,181,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,08",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,V-X,9/4/2017,2/21/2018,2/21/2018,8/24/2018,5/7/2019,5/7/2019,5/10/2019,5/29/2019,5/29/2019,7/4/2019,12/11/2019,12/11/2019
3473,7663,6/15/1950,Male,181,80,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,13",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,9/1/2017,2/27/2018,2/27/2018,9/4/2018,11/30/2021,11/30/2021,2/10/2022,3/31/2022, , , , 
3474,9921,6/15/1954,Male,180,90,Private,No,Yes, , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"1,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , , , ,V-X,DAR-X,No CTx,R-X,9/15/2018,5/24/2020,5/24/2020,5/25/2020,7/23/2020,7/23/2020,7/27/2020,9/30/2020,10/14/1582, , , 
3475,7811,6/15/1950,Male,181,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,51",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,11/20/2017,5/14/2018,5/14/2018,7/27/2018,12/27/2018,12/27/2018,2/27/2019,6/18/2021,6/18/2021, , , 
3476,1554,6/15/1942,Female,160,66,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,86",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,11/29/2016,3/28/2017,3/28/2017,6/21/2017,6/6/2018,6/6/2018,7/2/2018,2/25/2020,2/25/2020,3/9/2020,7/5/2021,7/5/2021
3477,8693,6/15/1938,Female,166,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,49",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,10/5/2017,3/22/2018,3/22/2018,7/27/2018,12/27/2018,12/27/2018,3/5/2019,3/7/2019,3/7/2019, , , 
3478,1752,6/15/1949,Male,181,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,91",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,9/1/2017,12/4/2017,12/4/2017,7/4/2018,10/30/2019,10/30/2019,11/28/2019,12/3/2019,12/3/2019, , , 
3479,1759,6/15/1946,Female,158,60,Private,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"14,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,EMP-X,V-X,R-X,7/24/2017,1/15/2018,1/15/2018,2/1/2018,7/23/2018,7/23/2018,8/7/2018,1/9/2019,1/9/2019,2/13/2019,11/26/2019,11/26/2019
3480,1486,6/15/1947,Male,184,126,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,56",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,EMP-X,V-X,7/14/2017,1/3/2018,1/3/2018,7/3/2018,12/19/2018,12/19/2018,2/4/2019,12/5/2019,12/5/2019,12/23/2019,1/2/2020,1/2/2020
3481,7846,6/15/1947,Male,184,126,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,85",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,NIN-X,V-X,8/4/2017,1/23/2018,1/23/2018,7/25/2018,12/20/2018,12/20/2018,3/7/2019,3/20/2019,3/20/2019,4/1/2019,7/15/2021,7/15/2021
3482,8958,6/15/1947,Female,161,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,02",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,DAR-X,No CTx,V-X,7/25/2017,1/23/2018,1/23/2018,8/1/2018,3/3/2022,3/3/2022,3/16/2022,3/31/2022, , , , 
3483,4644,6/15/1945,Female,169,54,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,NIN-X,V-X,4/17/2017,7/17/2017,7/17/2017,1/15/2018,7/2/2018,7/2/2018,7/13/2018,12/27/2018,12/27/2018,1/31/2019,12/31/2021, 
3484,4821,6/15/1945,Female,169,54,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"15,87","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,3/14/2017,6/16/2017,6/16/2017,12/21/2017,6/18/2018,6/18/2018,7/11/2018,4/24/2019,4/24/2019, , , 
3485,3782,6/15/1946,Female,160,70,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/22/2017,2/27/2018,2/27/2018,9/20/2018,12/31/2021,10/14/1582, , , , , , 
3486,1679,6/15/1946,Female,171,100,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,27",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/15/2017,2/13/2018,2/13/2018,8/31/2018,5/30/2019,5/30/2019,6/12/2019,6/25/2019,6/25/2019, , , 
3487,1877,6/15/1950,Male,180,116,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"19,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,12/1/2016,4/6/2017,4/6/2017,8/4/2017,7/16/2018,7/16/2018,8/9/2018,4/20/2019,4/20/2019,4/22/2019,9/18/2019,9/18/2019
3488,7676,6/15/1944,Female,166,56,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,POM-X,DAR-X,V-X,6/12/2017,12/1/2017,12/1/2017,7/9/2018,5/14/2019,5/14/2019,7/23/2019,12/9/2019,12/9/2019,1/21/2020,5/25/2021,5/25/2021
3489,3179,6/15/1947,Male,184,101,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"19,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,DAR-X,V-X,11/21/2017,2/27/2018,2/27/2018,7/11/2018,12/27/2018,12/27/2018,2/20/2019,10/10/2020,10/10/2020,10/27/2020,12/10/2021,12/10/2021
3490,1124,6/15/1931,Female,163,65,Private,No,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,8",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,DAR-X,V-X,11/24/2016,3/23/2017,3/23/2017,7/21/2017,6/28/2018,6/28/2018,7/24/2018,1/10/2019,1/10/2019,2/18/2019,3/5/2021,3/5/2021
3491,5763,6/15/1945,Male,183,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,09","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,10/3/2017,3/26/2018,3/26/2018,7/31/2018,3/12/2020,3/12/2020,4/13/2020,6/30/2021, , , , 
3492,3355,6/15/1951,Male,178,81,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"18,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,KYP-X,V-X,10/20/2017,1/15/2018,1/15/2018,7/23/2018,12/12/2018,12/12/2018,3/29/2019,5/1/2019,5/1/2019,7/9/2019,6/27/2020,6/27/2020
3493,8154,6/15/1950,Female,160,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"5,95","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,No CTx,V-X,12/23/2016,3/17/2017,3/17/2017,8/7/2017,7/19/2018,7/19/2018,8/6/2018,3/13/2020,3/13/2020, , , 
3494,4014,6/15/1953,Female,169,82,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,DAR-X,V-X,8/25/2017,2/12/2018,2/12/2018,7/31/2018,8/14/2019,8/14/2019,8/16/2019,7/29/2020,7/29/2020,8/11/2020,7/15/2021,7/15/2021
3495,2357,6/15/1943,Male,172,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,POM-X,V-X,12/19/2016,3/24/2017,3/24/2017,8/10/2017,7/12/2018,7/12/2018,8/2/2018,5/23/2019,5/23/2019,2/9/2020,6/30/2021, 
3496,1788,6/15/1944,Female,151,57,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,V-X,No CTx,V-X,12/29/2017,6/28/2018,6/28/2018,9/18/2018,8/25/2021,8/25/2021,9/14/2021,11/14/2021,11/14/2021, , , 
3497,5953,6/15/1955,Female,154,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,V-X,R-X,V-X,7/28/2017,10/26/2017,10/26/2017,2/20/2018,8/16/2018,8/16/2018,9/3/2018,3/6/2019,3/6/2019,5/18/2020,9/13/2021,9/13/2021
3498,3577,6/15/1941,Male,168,71,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,8",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,10/17/2018,7/28/2020,7/28/2020,8/4/2020,3/10/2021,3/10/2021, , , , , , 
3499,9633,6/15/1950,Female,159,60,Compulsory health insurance CHI,Yes, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"4,5",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/10/2018,3/16/2019,3/16/2019, , , , , , , , , 
3500,7304,6/15/1946,Male,188,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"12,2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No,"2,11", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,3/2/2015,10/10/2015,10/10/2015,12/13/2018,3/23/2020,3/23/2020,3/30/2020,12/31/2020,10/14/1582, , , 
3501,6046,6/15/1943,Male,180,87,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,EMP-X,NIN-X,V-X,4/5/2017,5/23/2018,5/23/2018,12/14/2018,7/10/2019,7/10/2019,9/27/2019,8/28/2020,8/28/2020,11/3/2020,12/5/2021,12/5/2021
3502,4587,6/15/1944,Male,185,90,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,32,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,No CTx,V-X,2/15/2017,12/6/2017,12/6/2017,11/7/2018,12/2/2019,12/2/2019,12/19/2019,11/27/2020,11/27/2020, , , 
3503,5880,6/15/1949,Female,171,80,Private,No,Yes, , , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,37,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,V-X,V-X,10/18/2018,11/17/2019,11/17/2019,12/20/2019,11/13/2020,11/13/2020,12/12/2020,11/23/2021,11/23/2021,12/16/2021,3/31/2022, 
3504,3791,6/15/1966,Female,167,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/19/2018,12/31/2018, , , , , , , , , , 
3505,2363,6/15/1938,Male,174,66,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"2,4",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,6/11/2015,7/22/2015,7/22/2015,11/15/2018,6/19/2019,6/19/2019,8/2/2019,6/2/2020,6/2/2020, , , 
3506,9169,6/15/1951,Male,178,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,6672,unknown/ISS-Criteria not used for prognostics,Yes,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L", ,R-X,R-X,No CTx,V-X,10/9/2018,12/14/2018,12/14/2018,8/23/2019,10/15/2019,10/15/2019,9/16/2021,3/31/2022, , , , 
3507,7422,6/15/1949,Female,163,55,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , ,Yes,9,Unknown,IgM,1071,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,10/2/2018,3/4/2019,3/4/2019, , , , , , , , , 
3508,1177,6/15/1939,Male,186,86,Compulsory health insurance CHI,No, , , , , , , , ,Yes,Yes,9,III: one or more criteria are fulfilled,IgA,5144,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/2/2018,1/24/2019,1/24/2019, , , , , , , , , 
3509,2738,6/15/1950,Male,168,89,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,9,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,11/29/2018,1/7/2019,1/7/2019,2/7/2022,3/31/2022, , , , , , , 
3510,3092,6/15/1937,Male,174,68,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,4666,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,DAR-X,DAR-X,R-X,V-X,10/8/2018,3/7/2019,3/7/2019,3/27/2019,12/12/2019,12/12/2019,3/20/2020,3/20/2020,3/20/2020,4/22/2020,3/31/2021,10/14/1582
3511,8257,6/15/1947,Male,180,84,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"5,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,DAR-X,EMP-X,R-X,11/28/2018,6/12/2019,6/12/2019,6/19/2019,9/1/2020,9/1/2020,9/14/2020,3/22/2021,3/22/2021,3/29/2021,1/13/2022,1/13/2022
3512,4137,6/15/1960,Female,176,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,9,Unknown,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,KYP-X,R-X,DAR-X,V-X,1/21/2016,4/14/2016,4/14/2016,11/6/2018,6/20/2019,6/20/2019,9/5/2019,6/4/2020,6/4/2020,6/15/2020,6/14/2021,6/14/2021
3513,4175,6/15/1940,Female,165,70,Private,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,POM-X,V-X,1/5/2015,8/28/2015,8/28/2015,10/24/2018,9/12/2019,9/12/2019,9/16/2019,10/13/2020,10/13/2020,3/23/2021,9/2/2021,9/2/2021
3514,9162,6/15/1956,Male,170,68,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,9,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,12/1/2017,2/1/2018,2/1/2018,5/9/2019,11/12/2019,11/12/2019, , , , , , 
3515,1509,6/15/1942,Male,173,67,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"49,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,12/20/2018,5/7/2019,5/7/2019,3/3/2020,5/11/2021,5/11/2021,6/22/2021,3/31/2022,10/14/1582, , , 
3516,1544,6/15/1939,Female,165,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"24,63",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,11/14/2018,5/8/2019,5/8/2019,2/17/2020,3/19/2020,3/19/2020, , , , , , 
3517,1612,6/15/1946,Female,175,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"19,14",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,EMP-X,POM-X,DAR-X,11/12/2018,7/1/2019,7/1/2019,7/10/2019,8/22/2019,8/22/2019,9/11/2019,4/16/2020,4/16/2020,4/24/2020,5/27/2020,5/27/2020
3518,1695,6/15/1930,Female,156,75,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"115,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/20/2018,2/12/2019,2/12/2019, , , , , , , , , 
3519,3938,6/15/1940,Male,178,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"99999999,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/22/2016,3/19/2017,3/19/2017,10/15/2018,3/31/2019,3/31/2019, , , , , , 
3520,8960,6/15/1959,Male,181,79,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"24,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/1/2018,3/1/2019,3/1/2019,9/1/2020,6/30/2021,10/14/1582, , , , , , 
3521,4118,6/15/1938,Female,163,75,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,IgG,",6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/26/2018,3/31/2022,10/14/1582, , , , , , , , , 
3522,8105,6/15/1944,Female,166,68,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"31,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,KYP-X,V-X,6/1/2017,10/1/2017,10/1/2017,12/1/2018,5/1/2020,5/1/2020,5/1/2020,6/1/2021,6/1/2021,6/2/2021,6/30/2021,10/14/1582
3523,8757,6/15/1955,Male,178,82,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/1/2018,11/1/2018,11/1/2018, , , , , , , , , 
3524,3662,6/15/1940,Female,159,54,Private,No,Yes,Yes, ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,39,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/1/2018,4/1/2020,4/1/2020, , , , , , , , , 
3525,7940,6/15/1939,Female,159,56,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Nein,V-X,No CTx,No CTx,V-X,12/7/2012,7/14/2013,7/14/2013,11/7/2018,1/25/2019,1/25/2019, , , , , , 
3526,2311,6/15/1943,Male,182,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,465,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L", ,NIN-X,No CTx,No CTx,V-X,6/24/2015,9/11/2015,9/11/2015,1/22/2019,4/12/2019,4/12/2019, , , , , , 
3527,2568,6/15/1948,Male,189,88,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,56,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,KYP-X,No CTx,V-X,9/23/2017,12/19/2017,12/19/2017,11/15/2018,1/9/2020,1/9/2020,3/30/2020,12/12/2020,12/12/2020, , , 
3528,6709,6/15/1956,Male,164,96,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"3,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"<3,5 mg/L", ,DAR-X,KYP-X,No CTx,V-X,6/10/2014,7/29/2014,7/29/2014,10/15/2018,10/12/2020,10/12/2020,1/12/2021,3/31/2022,10/14/1582, , , 
3529,4590,6/15/1951,Male,176,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,3,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/9/2018,1/14/2019,1/14/2019, , , , , , , , , 
3530,5134,6/15/1958,Female,176,130,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"2,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,8/6/2018,11/5/2018,11/5/2018, , , , , , , , , 
3531,3180,6/15/1934,Female,155,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/8/2018,5/13/2019,5/13/2019,7/26/2021,9/30/2021, , , , , , , 
3532,7955,6/15/1949,Female,168,68,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"4,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/12/2012,1/4/2013,1/4/2013,11/26/2018,3/17/2019,3/17/2019, , , , , , 
3533,1048,6/15/1952,Male,170,82,Private,No, ,Yes, , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"2,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/19/2018,4/5/2019,4/5/2019, , , , , , , , , 
3534,9850,6/15/1950,Female,153,152,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,11/13/2018,2/5/2019,2/5/2019, , , , , , , , , 
3535,6343,6/15/1944,Male,184,103,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/7/2017,12/28/2018,12/28/2018, , , , , , , , , 
3536,1228,6/15/1942,Female,158,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,7",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,11/6/2018,3/25/2020,3/25/2020, , , , , , , , , 
3537,7992,6/15/1937,Male,170,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"3,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/24/2018,5/5/2021,5/5/2021, , , , , , , , , 
3538,8617,6/15/1928,Male,160,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,",4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,12/18/2018,4/30/2019,4/30/2019,2/13/2020,12/31/2021,10/14/1582, , , , , , 
3539,3212,6/15/1931,Female,148,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,6",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,2/7/2018,11/26/2018,11/26/2018, , , , , , , , , 
3540,9241,6/15/1951,Male,187,113,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Other type,147,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/18/2018,3/11/2019,3/11/2019, , , , , , , , , 
3541,8295,6/15/1951,Female,160,75,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,R-X,KYP-X,Other,6/15/2002,8/15/2002,8/15/2002,10/15/2006,3/15/2007,3/15/2007,1/21/2016,9/16/2016,9/16/2016,12/8/2016,7/13/2018,7/13/2018
3542,6279,6/15/1940,Female,173,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,DAR-X,No CTx,Other,10/17/2016,3/13/2017,3/13/2017,12/12/2018,12/11/2019,12/11/2019,10/14/2020,3/31/2021,10/14/1582, , , 
3543,2087,6/15/1944,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/17/2016,10/31/2017,10/31/2017,10/8/2018,6/9/2019,6/9/2019, , , , , , 
3544,8126,6/15/1944,Female,172,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,NIN-X,No CTx,V-X,12/7/2018,3/7/2019,3/7/2019,5/18/2020,5/16/2021,5/16/2021,11/15/2021,12/31/2021, , , , 
3545,7011,6/15/1935,Male,180,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,12/3/2018,6/2/2019,6/2/2019,5/18/2020,11/8/2020,11/8/2020, , , , , , 
3546,5841,6/15/1959,Male,175,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"2,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,12/10/2018,4/7/2019,4/7/2019,7/19/2021,8/29/2021,8/29/2021, , , , , , 
3547,9888,6/15/1939,Female,158,62,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/19/2018,5/7/2019,5/7/2019, , , , , , , , , 
3548,4286,6/15/1961,Male,168,71,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"6,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,12/17/2018,1/27/2019,1/27/2019,3/15/2021,12/31/2021,10/14/1582, , , , , , 
3549,1480,6/15/1949,Female,160,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,52,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/1/2016,12/31/2016,12/31/2016,10/1/2018,3/17/2019,3/17/2019, , , , , , 
3550,8822,6/15/1949,Male,176,67,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes,Yes, , , ,2,Unknown,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,10/1/2014,12/28/2014,12/28/2014,10/19/2018,12/30/2019,12/30/2019,2/12/2020,12/31/2020,10/14/1582, , , 
3551,5736,6/15/1956,Male,183,90,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/27/2018,2/10/2019,2/10/2019, , , , , , , , , 
3552,5052,6/15/1934,Female,162,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,12/27/2018,6/23/2019,6/23/2019,9/21/2020,3/21/2021,3/21/2021, , , , , , 
3553,7519,6/15/1939,Male,168,65,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/26/2018,6/17/2019,6/17/2019,3/3/2020,4/5/2020,4/5/2020, , , , , , 
3554,2623,6/15/1950,Male,170,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,150,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/15/2018,9/20/2019,9/20/2019,6/1/2020,10/12/2020,10/12/2020, , , , , , 
3555,9049,6/15/1941,Male,172,79,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,5",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/16/2018,11/21/2019,11/21/2019, , , , , , , , , 
3556,4969,6/15/1961,Male,176,91,Private,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/30/2018,2/6/2019,2/6/2019, , , , , , , , , 
3557,9542,6/15/1940,Male,176,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/1/2016,4/13/2017,4/13/2017,10/8/2018,3/24/2019,3/24/2019, , , , , , 
3558,1741,6/15/1938,Male,178,75,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,7/4/2016,12/18/2016,12/18/2016,5/21/2018,11/11/2018,11/11/2018, , , , , , 
3559,9236,6/15/1955,Female,165,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/29/2018,6/10/2019,6/10/2019, , , , , , , , , 
3560,4184,6/15/1952,Female,162,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,113,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/20/2018,6/18/2019,6/18/2019,5/4/2020,6/30/2020, , , , , , , 
3561,6973,6/15/1947,Male,170,72,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,115,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/11/2018,8/15/2019,8/15/2019, , , , , , , , , 
3562,6939,6/15/1935,Male,162,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,165,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/19/2018,5/20/2019,5/20/2019, , , , , , , , , 
3563,7336,6/15/1951,Female,167,65,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,R-X,No CTx,R-X,V-X,11/26/2018,2/28/2019,2/28/2019,3/6/2019,4/23/2019,4/23/2019, , , ,1/15/2020,5/12/2020,5/12/2020
3564,8924,6/15/1958,Male,180,87,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"999999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,DAR-X,DAR-X,V-X,V-X,10/11/2018,7/17/2019,7/17/2019,8/19/2019,6/25/2020,6/25/2020,9/24/2020,6/24/2021,6/24/2021,8/2/2021,10/11/2021,10/11/2021
3565,9566,6/15/1940,Female,165,62,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L", ,V-X,DAR-X,No CTx,No CTx, , , ,1/15/2017,9/15/2017,9/15/2017,10/31/2018,3/31/2020, , , , 
3566,1522,6/15/1943,Male,173,82,Compulsory health insurance CHI,Yes, , , ,Yes,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,7",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,10/16/2018,12/18/2018,12/18/2018,1/14/2019,6/20/2019,6/20/2019,3/12/2020,4/28/2021,4/28/2021, , , 
3567,1301,6/15/1938,Female,162,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"4,3",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,R-X,No CTx,No CTx,R-X,11/6/2018,1/8/2020,1/8/2020,3/17/2020,6/30/2020, , , , , , , 
3568,7924,6/15/1969,Male,172,90,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,",44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/26/2018,12/17/2018,12/17/2018, , , , , , , , , 
3569,6424,6/15/1954,Male,172,80,Compulsory health insurance CHI,No, ,Yes, ,Yes,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,EMP-X,R-X,No CTx,Other, , , ,11/6/2018,3/19/2019,3/19/2019,6/15/2020,10/19/2020,10/19/2020, , , 
3570,9901,6/15/1937,Male,180,73,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,No, , , , , ,unbekannt,Unbekannt,Ja,Nein, , , , , ,R-X,No CTx,No CTx,V-X,5/24/2013,2/14/2017,2/14/2017,11/22/2018,2/7/2019,2/7/2019, , , , , , 
3571,8706,6/15/1936,Male,175,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,R-X,DAR-X,R-X,V-X,7/2/2010,11/10/2015,11/10/2015,1/7/2016,7/1/2016,7/1/2016,10/22/2018,10/22/2018,10/22/2018,2/6/2020,11/20/2020,11/20/2020
3572,1128,6/15/1939,Male,165,70,Private,Yes, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,188,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,11/26/2018,6/30/2019, , , , , , , , , , 
3573,6099,6/15/1942,Female,160,63,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,R-X,7/11/2016,12/25/2016,12/25/2016,10/15/2018,3/31/2019,3/31/2019, , , , , , 
3574,2745,6/15/1946,Male,177,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,77,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/12/2016,4/9/2017,4/9/2017,10/15/2018,6/23/2019,6/23/2019, , , , , , 
3575,1835,6/15/1939,Male,175,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,58,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/6/2016,6/18/2017,6/18/2017,10/31/2018,4/16/2019,4/16/2019, , , , , , 
3576,7896,6/15/1947,Male,179,73,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,80,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/18/2016,3/5/2017,3/5/2017,6/4/2018,11/25/2018,11/25/2018, , , , , , 
3577,9774,6/15/1937,Male,175,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,85,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/21/2016,5/7/2017,5/7/2017,5/28/2018,11/11/2018,11/11/2018, , , , , , 
3578,2478,6/15/1935,Female,158,62,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,LEV-X,1/16/2017,9/24/2017,9/24/2017,11/5/2018,4/21/2019,4/21/2019, , , , , , 
3579,1640,6/15/1940,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,55,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,Other,12/1/2016,1/14/2018,1/14/2018,11/8/2018,4/24/2019,4/24/2019, , , , , , 
3580,5329,6/15/1950,Male,179,83,Private,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,86,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,1/16/2017,1/28/2018,1/28/2018,11/13/2018,4/29/2019,4/29/2019, , , , , , 
3581,6244,6/15/1945,Male,176,83,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,90,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/17/2016,6/4/2017,6/4/2017,11/15/2018,5/1/2019,5/1/2019, , , , , , 
3582,8177,6/15/1947,Male,177,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,63,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,4/6/2015,11/1/2015,11/1/2015,2/6/2017,7/23/2017,7/23/2017,11/20/2018,6/3/2019,6/3/2019,8/26/2019,12/15/2019,12/15/2019
3583,3595,6/15/1938,Female,163,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,78,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,Other,2/13/2017,2/25/2018,2/25/2018,11/28/2018,5/14/2019,5/14/2019,9/30/2019,12/22/2019,12/22/2019,2/3/2020,6/30/2020,10/14/1582
3584,4163,6/15/1945,Male,175,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/20/2017,7/30/2017,7/30/2017,11/30/2018,5/31/2019,5/31/2019, , , , , , 
3585,3403,6/15/1940,Male,180,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,88,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,NIN-X,DAR-X,V-X,11/7/2016,6/10/2017,6/10/2017,12/12/2018,5/21/2019,5/21/2019,9/30/2019,12/22/2019,12/22/2019,2/10/2020,6/30/2020,10/14/1582
3586,3076,6/15/1949,Male,176,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,12/28/2017,2/23/2018,2/23/2018, , , , , , , , , 
3587,2966,6/15/1939,Female,160,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,R-X,12/1/2016,5/31/2017,5/31/2017,12/20/2018,6/5/2019,6/5/2019,9/30/2019,12/20/2019,12/20/2019,2/10/2020,6/30/2020,10/14/1582
3588,5713,6/15/1941,Male,178,73,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,99,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/6/2017,10/22/2017,10/22/2017,12/28/2018,6/28/2019,6/28/2019, , , , , , 
3589,5773,6/15/1938,Female,160,57,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,66,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,2/2/2015,7/19/2015,7/19/2015,7/1/2016,12/31/2016,12/31/2016,7/9/2018,12/23/2018,12/23/2018, , , 
3590,3471,6/15/1985,Female,168,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"53,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/29/2018,4/16/2018,4/16/2018, , , , , , , , , 
3591,4801,6/15/1945,Male,176,72,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,NIN-X,No CTx,V-X,5/4/2015,11/29/2015,11/29/2015,1/2/2017,6/18/2017,6/18/2017,7/16/2018,12/30/2018,12/30/2018, , , 
3592,8434,6/15/1959,Female,168,70,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,3975,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/20/2018,3/14/2019,3/14/2019, , , , , , , , , 
3593,7906,6/15/1961,Male,186,93,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,83,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/15/2018,2/21/2019,2/21/2019, , , , , , , , , 
3594,9986,6/15/1932,Female,160,54,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,4100,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/2/2018,3/12/2019,3/12/2019, , , , , , , , , 
3595,9549,6/15/1960,Male,173,78,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,Unknown,IgG,"7,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/4/2018,12/7/2018,12/7/2018, , , , , , , , , 
3596,4970,6/15/1941,Male,174,65,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/5/2018,6/30/2019,10/14/1582, , , , , , , , , 
3597,2619,6/15/1950,Male,178,72,Private,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,98,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,2/2/2015,8/30/2015,8/30/2015,2/1/2017,7/31/2017,7/31/2017,12/28/2018,8/23/2019,8/23/2019,9/2/2019,12/22/2019,12/22/2019
3598,9167,6/15/1940,Female,166,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,4/6/2015,11/1/2015,11/1/2015,2/6/2017,7/23/2017,7/23/2017,12/27/2018,8/22/2019,8/22/2019,9/2/2019,12/20/2019,12/20/2019
3599,5509,6/15/1945,Male,177,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,70,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,Other,1/1/2016,1/15/2017,1/15/2017,6/1/2017,11/30/2017,11/30/2017,12/27/2018,8/22/2019,8/22/2019,9/2/2019,12/22/2019,12/22/2019
3600,6780,6/15/1941,Female,163,66,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"24,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,12/27/2018,1/9/2020,1/9/2020,8/26/2020,9/16/2020,9/16/2020,10/5/2020,1/25/2021,1/25/2021, , , 
3601,9229,6/15/1945,Female,164,74,Compulsory health insurance CHI,Unknown, , ,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,38",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/19/2018,2/13/2019,2/13/2019, , , , , , , , , 
3602,1289,6/15/1949,Male,160,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"24,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,NIN-X,V-X,R-X,6/19/2017,12/18/2017,12/18/2017,1/10/2018,7/2/2018,7/2/2018,7/19/2018,12/6/2018,12/6/2018,2/28/2019,10/3/2019,10/3/2019
3603,7337,6/15/1945,Male,176,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"31,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,4/2/2018,9/18/2018,9/18/2018,10/8/2018,4/22/2019,4/22/2019, , , , , , 
3604,5174,6/15/1967,Female,154,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"20,71","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,DAR-X,V-X,9/5/2016,11/28/2016,11/28/2016,6/29/2017,6/11/2018,6/11/2018,10/10/2018,12/27/2018,12/27/2018,2/4/2019,8/19/2019,8/19/2019
3605,2572,6/15/1973,Female,178,83,Private,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"24,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,NIN-X,POM-X,R-X,11/14/2017,5/8/2018,5/8/2018,5/23/2018,11/21/2018,11/21/2018,12/14/2018,5/29/2019,5/29/2019,7/9/2019,1/29/2020,1/29/2020
3606,4571,6/15/1936,Female,162,69,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,3/13/2017,9/5/2017,9/5/2017,9/15/2018,10/25/2018,10/25/2018,3/25/2019,9/30/2021, , , , 
3607,7634,6/15/1935,Female,157,55,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,76,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,Other,3/1/2016,3/12/2017,3/12/2017,10/16/2018,3/31/2019,3/31/2019, , , , , , 
3608,5934,6/15/1943,Male,175,70,Private,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,60,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,11/2/2015,1/24/2016,1/24/2016,11/28/2018,12/31/2018, , , , , , , 
3609,8570,6/15/1968,Male,174,70,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,1",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/1/2009,9/1/2009,9/1/2009,10/22/2018,12/31/2019,10/14/1582, , , , , , 
3610,1243,6/15/1945,Female,161,56,Private,No, , ,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,51",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,4/5/2018,10/4/2018,10/4/2018,10/16/2018,1/5/2022,1/5/2022,1/20/2022,3/31/2022,10/14/1582, , , 
3611,5066,6/15/1947,Male,189,86,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"24,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,DAR-X,R-X,5/4/2017,10/19/2017,10/19/2017,11/13/2017,10/26/2018,10/26/2018,11/6/2018,5/10/2021,5/10/2021,5/19/2021,8/13/2021,8/13/2021
3612,6657,6/15/1946,Female,160,48,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"22,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,NIN-X,KYP-X,R-X,11/30/2017,5/21/2018,5/21/2018,6/4/2018,11/26/2018,11/26/2018,12/6/2018,1/7/2019,1/7/2019,3/21/2019,1/20/2021,1/20/2021
3613,7785,6/15/1966,Female,166,70,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"33,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,V-X,R-X,3/31/2017,9/20/2017,9/20/2017,10/16/2017,9/20/2018,9/20/2018,10/8/2018,6/3/2019,6/3/2019,7/11/2019,6/22/2020,6/22/2020
3614,3019,6/15/1951,Male,177,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"7,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,4/24/2017,10/9/2017,10/9/2017,2/8/2018,8/9/2018,8/9/2018,8/31/2018,10/10/2018,10/10/2018,1/3/2019,10/26/2020,10/26/2020
3615,6573,6/15/1951,Female,165,77,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"34,33","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,V-X,V-X,4/9/2018,7/11/2018,7/11/2018,10/11/2018,1/16/2021,1/16/2021,2/3/2021,8/12/2021,8/12/2021,8/30/2021,3/31/2022, 
3616,8758,6/15/1943,Male,181,93,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/18/2018,7/4/2019,7/4/2019, , , , , , , , , 
3617,2924,6/15/1969,Male,183,81,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"7,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/11/2018,3/11/2019,3/11/2019, , , , , , , , , 
3618,1979,6/15/1940,Male,182,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/10/2018,3/31/2019, , , , , , , , , , 
3619,1530,6/15/1938,Female,158,54,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,81,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,LEV-X,12/14/2018,5/30/2019,5/30/2019,9/19/2019,3/4/2020,3/4/2020,3/23/2020,6/30/2020,10/14/1582, , , 
3620,7215,6/15/1937,Male,161,96,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,999,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,V-X,DAR-X,No CTx,No CTx, , , ,10/27/2016,10/20/2017,10/20/2017,10/11/2018,9/30/2019,10/14/1582, , , 
3621,8122,6/15/1944,Female,165,71,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"2,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/18/2018,6/30/2021,10/14/1582, , , , , , , , , 
3622,9526,6/15/1957,Female,162,74,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,999,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/27/2018,1/18/2019,1/18/2019, , , , , , , , , 
3623,7437,6/15/1937,Male,177,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,R-X,12/17/2018,6/2/2019,6/2/2019,9/16/2019,3/1/2020,3/1/2020,3/16/2020,6/8/2020,6/8/2020, , , 
3624,9100,6/15/1940,Female,160,63,Private,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,69,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,Other,12/13/2018,6/14/2019,6/14/2019,9/26/2019,3/11/2020,3/11/2020,3/23/2020,6/16/2020,6/16/2020, , , 
3625,2675,6/15/1942,Male,180,75,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,999,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/23/2018,6/30/2019,10/14/1582, , , , , , , , , 
3626,7905,6/15/1953,Male,177,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,83",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,DAR-X,NIN-X,V-X,11/23/2018,5/10/2019,5/10/2019,7/17/2020,3/2/2021,3/2/2021,3/26/2021,3/30/2021,3/30/2021,4/6/2021,7/28/2021,7/28/2021
3627,1967,6/15/1956,Female,163,88,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,9/26/2017,3/22/2018,3/22/2018,10/1/2018,12/23/2020,12/23/2020,1/11/2021,3/31/2022,10/14/1582, , , 
3628,4687,6/15/1950,Male,183,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,NIN-X,DAR-X,R-X,7/20/2017,1/15/2018,1/15/2018,1/30/2018,7/23/2018,7/23/2018,8/14/2018,12/5/2018,12/5/2018,12/18/2018,4/16/2019,4/16/2019
3629,9179,6/15/1947,Male,182,57,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,NIN-X,POM-X,V-X,9/20/2017,1/10/2018,1/10/2018,4/9/2018,9/25/2018,9/25/2018,10/9/2018,12/13/2019,12/13/2019,12/23/2019,12/23/2019,12/23/2019
3630,3469,6/15/1953,Male,162,55,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"19,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,5/15/2017,8/14/2017,8/14/2017,12/15/2017,11/20/2018,11/20/2018,11/29/2018,2/13/2019,2/13/2019,2/25/2019,12/16/2019,12/16/2019
3631,3548,6/15/1950,Male,172,102,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"6,61","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,6/23/2017,9/28/2017,9/28/2017,3/5/2018,8/20/2018,8/20/2018,9/10/2018,12/6/2018,12/6/2018,12/19/2018,8/8/2020,8/8/2020
3632,3579,6/15/1951,Male,176,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"32,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,NIN-X,POM-X,V-X,8/8/2017,12/8/2017,12/8/2017,5/24/2018,11/15/2018,11/15/2018,12/3/2018,5/13/2019,5/13/2019,7/3/2019,8/2/2020,8/2/2020
3633,1995,6/15/1950,Female,155,46,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"25,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,4/4/2018,7/5/2018,7/5/2018,10/8/2018,1/29/2019,1/29/2019,2/18/2019,2/19/2020,2/19/2020,3/12/2020,7/7/2020,7/7/2020
3634,3142,6/15/1961,Male,175,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"12,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,6/5/2017,9/7/2017,9/7/2017,3/12/2018,9/6/2018,9/6/2018,10/2/2018,6/4/2019,6/4/2019,6/18/2019,11/16/2020,11/16/2020
3635,7630,6/15/1950,Male,172,53,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"33,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,V-X,V-X,4/27/2017,7/25/2017,7/25/2017,2/6/2018,7/30/2018,7/30/2018,8/17/2018,11/14/2018,11/14/2018,12/27/2018,1/7/2019,1/7/2019
3636,5392,6/15/1945,Female,170,62,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/29/2018,12/12/2019,12/12/2019, , , , , , , , , 
3637,9928,6/15/1963,Female,173,74,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"11,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,12/13/2017,3/12/2018,3/12/2018,10/4/2018,11/7/2020,11/7/2020,11/26/2020,3/31/2022,10/14/1582, , , 
3638,6586,6/15/1950,Male,182,84,Private,No, , , , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"30,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,V-X,3/12/2018,6/7/2018,6/7/2018,10/2/2018,5/23/2019,5/23/2019,7/4/2019,1/28/2020,1/28/2020,2/6/2020,10/4/2020,10/4/2020
3639,5364,6/15/1949,Female,155,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,02",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,10/18/2018,12/17/2019,12/17/2019,3/10/2022,3/31/2022, , , , , , , 
3640,4087,6/15/1931,Male,160,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,V-X,R-X,V-X,4/20/2017,10/5/2017,10/5/2017,10/26/2017,10/3/2018,10/3/2018,12/6/2018,6/5/2019,6/5/2019,5/1/2020,9/20/2020,9/20/2020
3641,4382,6/15/1948,Male,174,70,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,999,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,DAR-X,12/14/2018,3/15/2019,3/15/2019,8/15/2019,11/14/2019,11/14/2019,1/16/2020,9/30/2020, , , , 
3642,6467,6/15/1959,Female,163,58,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,7",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L", ,R-X,DAR-X,No CTx,V-X,8/1/2016,1/1/2017,1/1/2017,11/5/2018,11/18/2020,11/18/2020,12/7/2020,12/31/2020, , , , 
3643,3717,6/15/1957,Female,160,51,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,65,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/9/2018,12/19/2018,12/19/2018, , , , , , , , , 
3644,5226,6/15/1940,Male,172,80,Compulsory health insurance CHI,No, ,Yes, , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,69,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,V-X,POM-X,No CTx,V-X,6/4/2018,10/15/2018,10/15/2018,12/6/2018,2/10/2021,2/10/2021,3/10/2021,3/31/2022, , , , 
3645,9268,6/15/1944,Female,168,72,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,2,III: one or more criteria are fulfilled,Other type,199,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,11/9/2018,4/4/2021,4/4/2021,5/26/2021,3/31/2022, , , , , , , 
3646,4322,6/15/1933,Female,160,80,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,Other type,11396,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , , ,Nein,R-X,No CTx,No CTx,V-X,10/9/2018,1/21/2019,1/21/2019,1/28/2019,2/15/2020,2/15/2020, , , , , , 
3647,2747,6/15/1947,Male,160,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,28,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Nein,R-X,No CTx,No CTx,V-X,7/13/2018,11/20/2018,11/20/2018,11/20/2018,6/30/2019, , , , , , , 
3648,6778,6/15/1951,Female,162,54,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"4,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,DAR-X,POM-X,No CTx,V-X,7/1/2017,10/1/2017,10/1/2017,3/18/2019,6/10/2019,6/10/2019,7/22/2019,9/9/2019,9/9/2019, , , 
3649,6525,6/15/1950,Female,158,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,95",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/7/2018,12/31/2021, ,11/27/2019,12/31/2021,10/14/1582, , , , , , 
3650,9750,6/15/1949,Male,167,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,14",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/14/2018,11/27/2019,11/27/2019, , , , , , , , , 
3651,7170,6/15/1954,Female,178,85,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"19,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,2/6/2017,7/24/2017,7/24/2017,12/15/2017,6/4/2018,6/4/2018,6/21/2018,6/30/2019,10/14/1582, , , 
3652,2759,6/15/1952,Female,153,66,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"23,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,4/4/2018,9/24/2018,9/24/2018,10/17/2018,1/10/2022,1/10/2022,1/24/2022,3/31/2022,10/14/1582, , , 
3653,7606,6/15/1969,Female,170,103,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"31,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,10/13/2016,1/16/2017,1/16/2017,7/6/2017,11/2/2018,11/2/2018,11/8/2018,5/22/2019,5/22/2019,8/31/2019,12/18/2019,12/18/2019
3654,1625,6/15/1947,Female,169,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"26,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,V-X,10/10/2016,1/16/2017,1/16/2017,7/6/2017,9/12/2017,9/12/2017,10/15/2018,3/18/2019,3/18/2019,3/27/2019,3/28/2019,3/28/2019
3655,5608,6/15/1948,Male,176,94,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,33","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,V-X,V-X,1/16/2017,5/22/2017,5/22/2017,11/1/2017,10/3/2018,10/3/2018,10/24/2018,7/5/2021,7/5/2021,7/20/2021,3/31/2022, 
3656,5898,6/15/1946,Male,178,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"9,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/12/2017,8/4/2017,8/4/2017,1/8/2018,6/28/2018,6/28/2018,7/24/2018,10/30/2018,10/30/2018, , , 
3657,5795,6/15/1945,Female,183,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,69",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,3/19/2018,9/14/2018,9/14/2018,10/10/2018,6/28/2021,6/28/2021,7/15/2021,3/31/2022,10/14/1582, , , 
3658,7723,6/15/1950,Female,178,70,Private,No, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"20,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,10/17/2018,12/17/2018,12/17/2018,3/10/2021,3/31/2022,10/14/1582, , , , , , 
3659,9759,6/15/1945,Female,165,71,Private,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgA,"1,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/15/2018,5/22/2019,5/22/2019, , , , , , , , , 
3660,3010,6/15/1950,Female,175,93,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,DAR-X,V-X,12/27/2017,6/21/2018,6/21/2018,10/8/2018,5/20/2019,5/20/2019,6/27/2019,7/31/2019,7/31/2019,9/18/2019,1/7/2021,1/7/2021
3661,4457,6/15/1950,Female,166,86,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,4,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,6/19/2017,9/21/2017,9/21/2017,12/21/2017,11/28/2018,11/28/2018,12/10/2018,1/30/2019,1/30/2019,3/8/2019,3/26/2019,3/26/2019
3662,2128,6/15/1943,Male,167,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"18,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,NIN-X,V-X,11/14/2016,2/13/2017,2/13/2017,6/20/2017,5/25/2018,5/25/2018,10/4/2018,3/12/2019,3/12/2019,3/19/2019,6/6/2019,6/6/2019
3663,1831,6/15/1946,Female,156,54,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,67",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/19/2018,6/15/2018,6/15/2018,10/19/2018,6/17/2020,6/17/2020, , , , , , 
3664,9389,6/15/1952,Male,161,53,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"23,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,8/7/2017,1/25/2018,1/25/2018,2/15/2018,8/15/2018,8/15/2018,8/23/2018,3/19/2019,3/19/2019, , , 
3665,4777,6/15/1941,Male,177,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"11,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,NIN-X,POM-X,V-X,8/2/2017,12/1/2017,12/1/2017,4/5/2018,9/24/2018,9/24/2018,10/11/2018,3/7/2019,3/7/2019,3/26/2019,3/26/2019,3/26/2019
3666,8517,6/15/1933,Male,162,69,Compulsory health insurance CHI,Unknown, ,Yes,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"13,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,V-X,NIN-X,V-X,11/17/2016,5/4/2017,5/4/2017,11/16/2017,10/30/2018,10/30/2018,1/31/2019,10/25/2019,10/25/2019,7/3/2020,5/6/2021,5/6/2021
3667,3835,6/15/1940,Female,163,53,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,96",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/26/2018,11/19/2019,11/19/2019, , , , , , , , , 
3668,4805,6/15/1954,Male,183,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"16,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/13/2018,11/6/2019,11/6/2019,11/26/2020,3/31/2022,10/14/1582, , , , , , 
3669,2591,6/15/1968,Female,158,57,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,DAR-X,POM-X,R-X,3/30/2017,9/21/2017,9/21/2017,10/17/2017,4/10/2018,4/10/2018,10/9/2018,2/3/2021,2/3/2021,2/22/2021,6/30/2021, 
3670,9488,6/15/1941,Female,162,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"28,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,5/26/2017,8/25/2017,8/25/2017,12/28/2017,6/21/2018,6/21/2018,7/6/2018,10/17/2018,10/17/2018,11/20/2018,8/31/2020,8/31/2020
3671,8883,6/15/1946,Male,171,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"25,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,R-X,3/19/2018,9/13/2018,9/13/2018,10/4/2018,12/30/2019,12/30/2019,2/12/2020,12/31/2021, , , , 
3672,3405,6/15/1947,Male,183,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,01",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/24/2018,7/19/2018,7/19/2018,10/8/2018,12/31/2021,10/14/1582, , , , , , 
3673,6002,6/15/1948,Female,168,75,Private,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,24",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,3/1/2018,6/7/2018,6/7/2018,10/19/2018,8/19/2020,8/19/2020,8/31/2020,12/21/2021,12/21/2021, , , 
3674,7582,6/15/1952,Female,166,55,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,13","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,4/19/2017,7/14/2017,7/14/2017,2/19/2018,8/20/2018,8/20/2018,9/6/2018,9/27/2018,9/27/2018,10/4/2018,2/13/2019,2/13/2019
3675,5434,6/15/1952,Male,176,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"16,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,NIN-X,DAR-X,R-X,10/30/2017,4/19/2018,4/19/2018,5/2/2018,10/19/2018,10/19/2018,11/2/2018,4/15/2019,4/15/2019,6/27/2019,6/20/2020,6/20/2020
3676,3973,6/15/1944,Male,172,61,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"22,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,NIN-X,No CTx,R-X,10/3/2017,3/22/2018,3/22/2018,4/12/2018,10/8/2018,10/8/2018,10/22/2018,6/30/2021, , , , 
3677,1488,6/15/1948,Female,164,62,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"33,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/25/2018,7/10/2019,7/10/2019, , , , , , , , , 
3678,9601,6/15/1944,Male,166,55,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"8,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,6/22/2017,9/26/2017,9/26/2017,4/19/2018,10/8/2018,10/8/2018,10/19/2018,1/2/2019,1/2/2019,1/23/2019,8/13/2019,8/13/2019
3679,5406,6/15/1953,Male,177,54,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,Other,V-X,4/24/2017,7/24/2017,7/24/2017,11/3/2017,4/23/2018,4/23/2018,5/15/2018,12/20/2018,12/20/2018,1/17/2019,1/24/2019,1/24/2019
3680,9959,6/15/1951,Female,164,82,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,61",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,NIN-X,V-X,1/2/2018,4/2/2018,4/2/2018,10/23/2018,1/2/2020,1/2/2020,1/23/2020,1/4/2021,1/4/2021,2/17/2022,3/31/2022, 
3681,7140,6/15/1953,Male,187,87,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,16",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,DAR-X,POM-X,R-X,4/5/2018,9/20/2018,9/20/2018,10/5/2018,4/17/2019,4/17/2019,6/19/2019,1/2/2020,1/2/2020,3/15/2020,9/3/2020,9/3/2020
3682,5570,6/15/1953,Male,166,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"15,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,DAR-X,V-X,7/11/2017,10/5/2017,10/5/2017,1/11/2018,7/5/2018,7/5/2018,7/23/2018,12/3/2018,12/3/2018,12/6/2018,12/7/2018,12/7/2018
3683,8046,6/15/1953,Male,183,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,NIN-X,V-X,R-X,3/19/2018,9/12/2018,9/12/2018,10/2/2018,1/24/2019,1/24/2019,3/20/2019,1/2/2020,1/2/2020,1/5/2020,4/14/2020,4/14/2020
3684,3894,6/15/1954,Female,174,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,8/28/2017,12/25/2017,12/25/2017,5/29/2018,11/22/2018,11/22/2018,12/20/2018,5/16/2019,5/16/2019,6/12/2019,8/19/2020,8/19/2020
3685,4318,6/15/1939,Female,173,69,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,42",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,8/21/2017,11/16/2017,11/16/2017,5/23/2018,11/12/2018,11/12/2018,12/6/2018,1/31/2019,1/31/2019,3/1/2019,4/16/2019,4/16/2019
3686,7296,6/15/1952,Female,174,72,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"24,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/24/2017,9/18/2017,9/18/2017,10/20/2018,12/31/2020, , , , , , , 
3687,2706,6/15/1950,Female,174,75,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/23/2018,10/29/2019,10/29/2019, , , , , , , , , 
3688,8584,6/15/1948,Male,176,55,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,29",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,11/2/2017,4/25/2018,4/25/2018,11/29/2018,6/28/2019,6/28/2019,8/12/2019,7/15/2020,7/15/2020, , , 
3689,2434,6/15/1952,Male,175,60,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"30,02","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,V-X,V-X,4/13/2017,7/20/2017,7/20/2017,10/16/2017,4/16/2018,4/16/2018,5/9/2018,9/27/2018,9/27/2018,12/13/2018,4/12/2019,4/12/2019
3690,4187,6/15/1957,Male,187,83,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,08",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/12/2018,11/18/2019,11/18/2019, , , , , , , , , 
3691,1489,6/15/1949,Male,171,72,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,6",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/14/2018,5/29/2019,5/29/2019,1/17/2020,12/31/2020,10/14/1582, , , , , , 
3692,4507,6/15/1944,Female,163,49,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,36",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,12/11/2017,6/6/2018,6/6/2018,11/1/2018,1/3/2019,1/3/2019,1/15/2019,2/18/2019,2/18/2019, , , 
3693,9052,6/15/1945,Male,176,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"24,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/4/2017,7/4/2017,7/4/2017,10/17/2018,12/31/2020, , , , , , , 
3694,7452,6/15/1946,Male,181,90,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/26/2018,11/1/2019,11/1/2019,9/20/2021,3/31/2022,10/14/1582, , , , , , 
3695,1701,6/15/1994,Female,166,76,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/25/2018,10/31/2019,10/31/2019,2/24/2022,3/31/2022, , , , , , , 
3696,6034,6/15/1945,Male,199,106,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,5",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/19/2018,11/25/2019,11/25/2019, , , , , , , , , 
3697,3633,6/15/1952,Male,185,70,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,7/25/2017,1/11/2018,1/11/2018,2/1/2018,7/23/2018,7/23/2018,8/1/2018,10/30/2018,10/30/2018,11/8/2018,5/28/2020,5/28/2020
3698,2606,6/15/1947,Male,181,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,V-X,V-X,9/11/2017,3/5/2018,3/5/2018,5/15/2018,11/8/2018,11/8/2018,3/18/2019,8/5/2019,8/5/2019,9/26/2019,9/18/2020,9/18/2020
3699,6797,6/15/1948,Male,170,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"22,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,6/27/2017,10/18/2017,10/18/2017,2/22/2018,8/21/2018,8/21/2018,9/14/2018,11/20/2018,11/20/2018,12/5/2018,6/24/2021,6/24/2021
3700,6242,6/15/1946,Female,169,49,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,26",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,2/16/2018,8/10/2018,8/10/2018,11/8/2018,11/1/2019,11/1/2019, , , , , , 
3701,8650,6/15/1944,Male,176,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,73",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,POM-X,V-X,2/26/2018,8/20/2018,8/20/2018,11/15/2018,11/8/2019,11/8/2019,3/1/2021,8/27/2021,8/27/2021,11/18/2021,3/31/2022, 
3702,2040,6/15/1931,Male,180,62,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"18,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,6/8/2017,11/27/2017,11/27/2017,10/15/2018,5/29/2019,5/29/2019,6/27/2019,12/31/2021, , , , 
3703,9138,6/15/1931,Male,180,62,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"18,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,6/8/2017,11/27/2017,11/27/2017,3/23/2018,9/19/2018,9/19/2018,10/4/2018,7/12/2021,7/12/2021,7/30/2021,3/31/2022,10/14/1582
3704,2241,6/15/1968,Female,163,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"17,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,V-X,KYP-X,No CTx,R-X,10/4/2018,11/6/2020,11/6/2020,11/20/2020,6/4/2021,6/4/2021,10/7/2021,3/31/2022,10/14/1582, , , 
3705,4512,6/15/1946,Female,168,76,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,12",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,12/18/2018,2/17/2019,2/17/2019,7/29/2021,3/31/2022,10/14/1582, , , , , , 
3706,5339,6/15/1954,Female,151,57,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"14,95","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,NIN-X,V-X,5/18/2017,8/10/2017,8/10/2017,12/18/2017,6/5/2018,6/5/2018,6/22/2018,12/6/2018,12/6/2018,1/2/2019,11/28/2019,11/28/2019
3707,1057,6/15/1945,Male,188,81,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"15,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,12/27/2016,4/25/2017,4/25/2017,10/16/2017,4/3/2018,4/3/2018,4/19/2018,9/20/2018,9/20/2018,1/21/2019,4/24/2019,4/24/2019
3708,8950,6/15/1966,Male,181,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,56",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,KYP-X,R-X,3/22/2018,9/20/2018,9/20/2018,10/8/2018,2/26/2021,2/26/2021,3/9/2021,7/27/2021,7/27/2021,7/28/2021,12/9/2021,12/9/2021
3709,2943,6/15/1932,Female,167,55,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,7/13/2017,10/11/2017,10/11/2017,4/17/2018,10/10/2018,10/10/2018,10/26/2018,5/14/2019,5/14/2019,7/4/2019,11/22/2020,11/22/2020
3710,4310,6/15/1952,Female,162,74,Private,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,4/12/2018,7/17/2018,7/17/2018,10/1/2018,1/2/2019,1/2/2019,2/19/2020,3/31/2022,10/14/1582, , , 
3711,6870,6/15/1944,Female,166,89,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,15",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/4/2018,9/27/2019,9/27/2019, , , , , , , , , 
3712,9892,6/15/1947,Female,172,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/30/2018,11/23/2019,11/23/2019, , , , , , , , , 
3713,6447,6/15/1950,Female,165,75,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"9,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,V-X,V-X,2/6/2017,5/10/2017,5/10/2017,11/10/2017,5/7/2018,5/7/2018,5/21/2018,10/25/2020,10/25/2020,11/17/2020,5/27/2021,5/27/2021
3714,8854,6/15/1968,Female,151,55,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"27,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,Other,V-X,3/6/2017,6/5/2017,6/5/2017,11/8/2017,4/25/2018,4/25/2018,5/21/2018,11/19/2018,11/19/2018,3/29/2019,6/12/2019,6/12/2019
3715,7667,6/15/1943,Female,151,69,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"30,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,7/18/2017,10/18/2017,10/18/2017,11/19/2018,11/30/2018,11/30/2018,12/4/2018,12/31/2021,10/14/1582, , , 
3716,1502,6/15/1953,Male,175,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,V-X,V-X,5/30/2017,8/24/2017,8/24/2017,1/3/2018,9/26/2018,9/26/2018,10/22/2018,4/29/2019,4/29/2019,7/9/2019,12/30/2019,12/30/2019
3717,3352,6/15/1925,Male,171,77,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"26,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,POM-X,R-X,4/12/2018,10/8/2018,10/8/2018,10/19/2018,6/2/2019,6/2/2019,6/3/2019,3/17/2021,3/17/2021,3/24/2021,8/10/2021,8/10/2021
3718,1062,6/15/1950,Male,175,89,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"18,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,KYP-X,NIN-X,EMP-X,DAR-X,4/30/2018,7/31/2018,7/31/2018,10/22/2018,2/1/2021,2/1/2021,2/14/2021,12/13/2021,12/13/2021,2/21/2022,3/31/2022, 
3719,2858,6/15/1945,Male,179,115,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"21,86","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,Other,V-X,3/27/2017,6/21/2017,6/21/2017,10/24/2017,4/23/2018,4/23/2018,5/10/2018,2/11/2019,2/11/2019,3/1/2019,3/19/2019,3/19/2019
3720,3887,6/15/1964,Female,154,43,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,47",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/4/2018,9/27/2019,9/27/2019, , , , , , , , , 
3721,8944,6/15/1944,Male,187,123,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"27,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/7/2018,4/2/2020,4/2/2020, , , , , , , , , 
3722,5367,6/15/1934,Female,162,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,01",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/22/2018,4/19/2018,4/19/2018,10/3/2018,6/28/2021,6/28/2021,8/4/2021,3/31/2022,10/14/1582, , , 
3723,3234,6/15/1953,Female,159,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"9,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,KYP-X,V-X,3/1/2017,6/5/2017,6/5/2017,8/1/2017,7/3/2018,7/3/2018,7/26/2018,5/6/2019,5/6/2019,6/27/2019,11/7/2019,11/7/2019
3724,6623,6/15/1950,Male,176,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"18,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,6/5/2017,8/31/2017,8/31/2017,10/17/2017,11/27/2017,11/27/2017,6/8/2018,12/6/2018,12/6/2018,3/6/2019,11/29/2019,11/29/2019
3725,4124,6/15/1951,Male,182,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"23,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,V-X,V-X,7/25/2016,10/31/2016,10/31/2016,10/17/2017,4/25/2018,4/25/2018,5/1/2018,12/19/2018,12/19/2018,4/5/2019,4/25/2019,4/25/2019
3726,7033,6/15/1953,Male,176,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"22,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,Other,R-X,12/22/2016,6/13/2017,6/13/2017,7/6/2017,6/14/2018,6/14/2018,6/28/2018,1/22/2019,1/22/2019,3/6/2019,5/1/2020,5/1/2020
3727,6113,6/15/1945,Male,181,82,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,64",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,2/22/2017,5/22/2017,5/22/2017,11/20/2017,5/11/2018,5/11/2018,5/30/2018,12/31/2021,10/14/1582, , , 
3728,7593,6/15/1951,Male,187,124,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"11,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,Other,R-X,11/9/2016,5/3/2017,5/3/2017,5/18/2017,5/2/2018,5/2/2018,5/28/2018,4/12/2019,4/12/2019,5/29/2019,6/10/2019,6/10/2019
3729,9663,6/15/1951,Female,162,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"29,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,3/26/2018,9/18/2018,9/18/2018,10/9/2018,3/31/2022,10/14/1582, , , , , , 
3730,8917,6/15/1950,Male,189,69,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,6/22/2017,9/19/2017,9/19/2017,2/7/2018,9/18/2018,9/18/2018,10/8/2018,5/12/2020,5/12/2020, , , 
3731,6501,6/15/1952,Male,173,54,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,9/19/2017,12/25/2017,12/25/2017,1/11/2018,11/5/2018,11/5/2018,11/22/2018,12/23/2019,12/23/2019,1/4/2020,10/11/2020,10/11/2020
3732,4031,6/15/1964,Male,176,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"23,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,10/18/2017,4/16/2018,4/16/2018,4/26/2018,10/11/2018,10/11/2018,12/17/2018,5/13/2019,5/13/2019,6/12/2019,7/28/2021,7/28/2021
3733,2742,6/15/1921,Female,155,69,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgM,"4,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/9/2018,12/31/2018, , , , , , , , , , 
3734,2913,6/15/1936,Male,180,80,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,45,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/6/2018,8/8/2019,8/8/2019, , , , , , , , , 
3735,5470,6/15/1929,Male,173,71,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"47,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,1/3/2018,9/10/2018,9/10/2018,12/10/2018,12/31/2019,10/14/1582, , , , , , 
3736,6218,6/15/1943,Female,165,63,Compulsory health insurance CHI,Yes, , , , , , , , , , ,3,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/31/2017,10/24/2018,10/24/2018, , , , , , , , , 
3737,3728,6/15/1965,Male,174,93,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"1,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/11/2014,2/24/2015,2/24/2015,10/30/2018,1/31/2019,1/31/2019, , , , , , 
3738,3259,6/15/1944,Female,165,82,Private,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"24,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,10/23/2018,11/6/2020,11/6/2020,11/13/2020,3/31/2022,10/14/1582, , , , , , 
3739,3880,6/15/1944,Female,171,49,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,9",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,1/23/2018,4/19/2018,4/19/2018,10/11/2018,9/10/2021,9/10/2021,10/18/2021,3/31/2022, , , , 
3740,7057,6/15/1946,Female,163,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"24,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,5/23/2017,8/17/2017,8/17/2017,11/8/2017,10/19/2018,10/19/2018,3/27/2019,6/6/2019,6/6/2019,6/13/2019,12/27/2019,12/27/2019
3741,8315,6/15/1934,Female,167,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,NIN-X,V-X,8/2/2017,11/2/2017,11/2/2017,2/16/2018,8/10/2018,8/10/2018,8/20/2018,12/31/2018,12/31/2018,3/4/2019,4/1/2019,4/1/2019
3742,2022,6/15/1973,Female,173,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"17,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,EMP-X,POM-X,V-X,9/1/2016,12/27/2016,12/27/2016,7/11/2017,6/13/2018,6/13/2018,7/9/2018,5/9/2019,5/9/2019,6/20/2019,8/11/2020,8/11/2020
3743,7715,6/15/1934,Female,167,66,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"16,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,8/3/2017,10/31/2017,10/31/2017,3/6/2018,9/4/2018,9/4/2018,9/25/2018,2/11/2019,2/11/2019,3/28/2019,4/23/2020,4/23/2020
3744,5432,6/15/1938,Female,170,80,Private,No, , , ,Yes,Yes,Yes, ,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/5/2018,12/31/2018, , , , , , , , , , 
3745,7315,6/15/1955,Male,174,60,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"4,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,POM-X,EMP-X,11/5/2016,2/10/2017,2/10/2017,7/5/2018,9/25/2018,9/25/2018,10/16/2018,1/9/2020,1/9/2020,1/31/2020,2/15/2020,2/15/2020
3746,2665,6/15/1948,Male,175,70,Private,No, , ,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,Other,KYP-X,EMP-X,V-X,10/20/2017,1/3/2018,1/3/2018,1/8/2018,3/26/2018,3/26/2018,8/20/2020,9/23/2020,9/23/2020,10/15/2020,1/25/2021,1/25/2021
3747,5192,6/15/1950,Female,170,55,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,1220,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,V-X,R-X,DAR-X,Other,1/15/2003,3/15/2003,3/15/2003,2/15/2009,9/15/2009,9/15/2009,6/6/2011,5/15/2016,5/15/2016,6/15/2016,9/15/2018,9/15/2018
3748,4896,6/15/1960,Female,160,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"9,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/9/2018,1/2/2019,1/2/2019, , , , , , , , , 
3749,1224,6/15/1951,Female,163,63,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,74",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/26/2018,3/26/2019,3/26/2019, , , , , , , , , 
3750,3332,6/15/1956,Female,167,78,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,65,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,R-X,KYP-X,No CTx,V-X,5/2/2013,8/15/2013,8/15/2013,5/15/2015,3/15/2017,3/15/2017,4/15/2017,11/21/2018,11/21/2018, , , 
3751,6426,6/15/1940,Male,999,80,Compulsory health insurance CHI,Unknown, , , , ,Yes, ,Yes, , , ,0,I: fulfilling all 4 criteria,IgA,"5,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,R-X,12/26/2018,2/1/2020,2/1/2020,6/30/2020,6/30/2020, , , , , , , 
3752,9592,6/15/1959,Male,174,76,Private,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,51,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,V-X,DAR-X,No CTx,Other,11/1/2006,2/1/2007,2/1/2007,3/1/2014,5/15/2014,5/15/2014,1/5/2018,12/15/2018,12/15/2018, , , 
3753,5063,6/15/1950,Male,180,90,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,6,ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,R-X,10/22/2018,6/24/2020,6/24/2020,9/28/2020,12/31/2020, , , , , , , 
3754,4128,6/15/1940,Female,158,73,Compulsory health insurance CHI,Unknown, , ,Yes, , ,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"28,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/4/2018,6/30/2019, , , , , , , , , , 
3755,8124,6/15/1957,Male,191,96,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgD,"9999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,12/20/2018,12/31/2018, , , , , , , , , , 
3756,2521,6/15/1952,Female,163,70,Compulsory health insurance CHI,Unknown, , , , , , , , ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"45,8",ISS stage II (neither stage I nor stage III),9,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Unbekannt,R-X,No CTx,No CTx,Other,11/15/2018,12/19/2018,12/19/2018,6/10/2019,6/30/2019, , , , , , , 
3757,5019,6/15/1941,Male,185,95,Private,No, , , , , ,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,LEV-X,7/7/2015,1/15/2016,1/15/2016,10/22/2018,12/31/2019, , , , , , , 
3758,3863,6/15/1949,Female,167,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,6,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/15/2018,6/3/2019,6/3/2019, , , , , , , , , 
3759,9166,6/15/1940,Male,185,95,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes, ,Yes,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"23,6",ISS stage II (neither stage I nor stage III),9,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/30/2018,6/30/2019, , , , , , , , , , 
3760,7094,6/15/1954,Male,999,80,Compulsory health insurance CHI,Unknown, , ,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,43,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/30/2018,1/1/2019,1/1/2019, , , , , , , , , 
3761,9769,6/15/1958,Female,162,86,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"28,8",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,No CTx, , , ,12/10/2018,6/30/2019, , , , , , , 
3762,2925,6/15/1946,Male,172,69,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"51,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/13/2018,12/31/2018, , , , , , , , , , 
3763,3420,6/15/1936,Male,178,75,Compulsory health insurance CHI,Unknown, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,34,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,8/11/2017,8/9/2018,8/9/2018,12/21/2018,6/30/2019, , , , , , , 
3764,5678,6/15/1938,Female,168,88,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,6200,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/5/2018,12/31/2018, , , , , , , , , , 
3765,8458,6/15/1959,Male,180,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/4/2018,3/10/2019,3/10/2019, , , , , , , , , 
3766,4528,6/15/1967,Male,184,75,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/5/2018,2/19/2019,2/19/2019, , , , , , , , , 
3767,8597,6/15/1957,Female,162,74,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/27/2018,2/9/2019,2/9/2019, , , , , , , , , 
3768,7040,6/15/1954,Male,172,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"24,14",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/1/2018,12/23/2018,12/23/2018,2/11/2020,7/1/2020,7/1/2020, , , , , , 
3769,5122,6/15/1946,Female,165,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,32,ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/4/2018,11/16/2018,11/16/2018, , , , , , , , , 
3770,7015,6/15/1955,Male,185,87,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,22,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Unbekannt, , , , ,Nein,KYP-X,POM-X,No CTx,V-X,7/18/2018,9/10/2018,9/10/2018,9/17/2018,12/7/2018,12/7/2018,4/24/2019,7/10/2019,7/10/2019, , , 
3771,8806,6/15/1946,Female,162,72,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"24,95","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,3/23/2017,6/15/2017,6/15/2017,10/23/2017,4/12/2018,4/12/2018,4/30/2018,9/20/2018,9/20/2018,10/9/2018,1/19/2021,1/19/2021
3772,7849,6/15/1949,Female,165,56,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,",44",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/20/2018,6/2/2018,6/2/2018,10/6/2021,12/2/2021,12/2/2021, , , , , , 
3773,2991,6/15/1946,Male,176,80,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,7",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,10/9/2018,2/14/2019,2/14/2019,9/16/2019,11/12/2020,11/12/2020,11/30/2020,12/2/2021,12/2/2021,12/13/2021,3/31/2022, 
3774,9977,6/15/1962,Female,165,59,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/5/2018,5/12/2018,5/12/2018, , , , , , , , , 
3775,2917,6/15/1940,Female,168,85,Compulsory health insurance CHI,Yes, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/4/2017,3/19/2018,3/19/2018,12/12/2018,3/31/2022, , , , , , , 
3776,5505,6/15/1946,Female,157,47,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"22,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Unbekannt,DAR-X,EMP-X,No CTx,V-X,9/14/2018,11/27/2018,11/27/2018,2/21/2020,3/28/2020,3/28/2020,3/31/2020,4/14/2020,4/14/2020, , , 
3777,3225,6/15/1961,Male,193,110,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"66,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/14/2018,1/31/2019,1/31/2019, , , , , , , , , 
3778,5816,6/15/1940,Female,163,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,6400,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/26/2018,12/31/2018, , , , , , , , , , 
3779,1285,6/15/1967,Male,182,102,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,40,unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/17/2018,1/7/2019,1/7/2019, , , , , , , , , 
3780,2287,6/15/1963,Male,180,92,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,10000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/26/2018,12/31/2018, , , , , , , , , , 
3781,1706,6/15/1941,Female,165,58,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes, , , ,Yes,2,III: one or more criteria are fulfilled,IgG,7220,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/6/2018,12/31/2018, , , , , , , , , , 
3782,7656,6/15/1944,Male,182,79,Compulsory health insurance CHI,Yes, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,6330,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/12/2018,12/31/2018, , , , , , , , , , 
3783,1799,6/15/1940,Female,156,57,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,3/29/2019,6/15/2019,6/15/2019,6/18/2020,9/25/2020,9/25/2020, , , , , , 
3784,8029,6/15/1943,Female,158,57,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"61,5",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,1/15/2019,6/11/2019,6/11/2019,9/27/2021,3/31/2022,10/14/1582, , , , , , 
3785,3549,6/15/1959,Male,183,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"44,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/21/2019,4/8/2019,4/8/2019, , , , , , , , , 
3786,8514,6/15/1950,Male,182,81,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Nein,DAR-X,NIN-X,EMP-X,V-X,3/21/2012,6/17/2012,6/17/2012,1/23/2019,10/15/2020,10/15/2020,10/19/2020,5/21/2021,5/21/2021,6/7/2021,3/1/2022,3/1/2022
3787,8377,6/15/1939,Female,160,41,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"2,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"<3,5 mg/L",Ja,V-X,DAR-X,No CTx,R-X,10/27/2015,3/16/2016,3/16/2016,6/14/2016,11/16/2016,11/16/2016,1/21/2019,3/31/2022,10/14/1582, , , 
3788,8563,6/15/1941,Male,179,76,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,No CTx,No CTx,R-X,2/18/2019,9/16/2019,9/16/2019,9/23/2019,12/31/2020, , , , , , , 
3789,9686,6/15/1957,Female,168,59,Private,No, , , , , ,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"7,6",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,1/6/2015,3/20/2015,3/20/2015,3/4/2019,6/23/2019,6/23/2019, , , , , , 
3790,1937,6/15/1949,Female,163,70,Self-Payer,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,DAR-X,EMP-X,R-X,4/14/2016,6/15/2017,6/15/2017,3/7/2019,10/29/2019,10/29/2019,12/3/2019,8/27/2020,8/27/2020,9/28/2020,7/18/2021,7/18/2021
3791,7019,6/15/1943,Male,180,84,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,43,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,KYP-X,NIN-X,V-X,7/23/2018,1/19/2019,1/19/2019,3/19/2019,2/25/2020,2/25/2020,3/27/2020,9/20/2020,9/20/2020,11/3/2020,11/5/2021,11/5/2021
3792,9452,6/15/1944,Male,185,90,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,29,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,DAR-X,V-X,3/9/2019,3/13/2020,3/13/2020,3/27/2020,11/23/2020,11/23/2020,12/17/2020,2/17/2022,2/17/2022,3/20/2022,3/31/2022, 
3793,1676,6/15/1937,Male,182,100,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,R-X,R-X,V-X,4/29/2011,9/16/2011,9/16/2011,6/16/2012,2/11/2013,2/11/2013,12/11/2015,5/30/2016,5/30/2016,2/17/2019,7/29/2019,7/29/2019
3794,2373,6/15/1946,Male,184,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , ,Yes,1,Unknown,IgA,611,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/15/2010,5/2/2010,5/2/2010,2/7/2019,12/31/2019,10/14/1582, , , , , , 
3795,7689,6/15/1960,Male,183,83,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/6/2019,4/21/2019,4/21/2019, , , , , , , , , 
3796,7777,6/15/1931,Female,160,58,Compulsory health insurance CHI,No, , , , , , , , , , ,3,III: one or more criteria are fulfilled,IgG,120,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,Other,2/8/2019,3/11/2019,3/11/2019, , , , , , , , , 
3797,1367,6/15/1954,Male,172,108,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"21,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/4/2019,6/27/2019,6/27/2019, , , , , , , , , 
3798,6704,6/15/1935,Male,175,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Other type,120,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,1/22/2019,2/19/2019,2/19/2019, , , , , , , , , 
3799,4822,6/15/1938,Male,180,76,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,Unknown,IgA,59,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,V-X,1/21/2019,6/11/2019,6/11/2019,7/19/2021,2/14/2022,2/14/2022, , , , , , 
3800,7730,6/15/1936,Female,164,75,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgD,"1,9",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/14/2019,5/2/2019,5/2/2019,12/19/2019,4/29/2021,4/29/2021, , , , , , 
3801,5821,6/15/1929,Male,167,66,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,3,III: one or more criteria are fulfilled,IgG,"3,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,R-X,No CTx,R-X,2/2/2019,1/20/2020,1/20/2020,5/29/2020,6/19/2020,6/19/2020,6/23/2020,5/20/2021,5/20/2021, , , 
3802,3566,6/15/1941,Female,156,53,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/3/2019,11/19/2019,11/19/2019,11/25/2019,3/31/2022, , , , , , , 
3803,5551,6/15/1928,Female,170,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"22,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,No CTx, , , ,3/26/2019,4/16/2019,4/16/2019, , , , , , 
3804,2480,6/15/1936,Male,178,82,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,I: fulfilling all 4 criteria,IgA,"5,17",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , ,Nein,DAR-X,No CTx,No CTx,R-X,2/12/2019,8/7/2019,8/7/2019,8/7/2019,10/7/2020,10/7/2020, , , , , , 
3805,4899,6/15/1934,Male,183,82,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"9,45",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/18/2019,3/2/2020,3/2/2020, , , , , , , , , 
3806,7912,6/15/1933,Female,165,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"44,81",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/27/2019,4/11/2019,4/11/2019, , , , , , , , , 
3807,1370,6/15/1950,Male,185,80,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"106,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/26/2019,7/5/2019,7/5/2019,9/5/2019,11/26/2019,11/26/2019, , , , , , 
3808,6882,6/15/1938,Female,162,64,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"35,64",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,1/30/2019,4/8/2020,4/8/2020, , , , , , , , , 
3809,5020,6/15/1939,Female,165,66,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"33,2",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Ja,No CTx,No CTx,No CTx,R-X,1/4/2019,6/8/2019,6/8/2019, , , , , , , , , 
3810,9066,6/15/1955,Female,163,72,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"36,6",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , , ,V-X,V-X,R-X,V-X,7/27/2009,1/14/2010,1/14/2010,12/20/2010,5/16/2011,5/16/2011,11/5/2012,1/4/2013,1/4/2013,2/5/2019,7/15/2019,7/15/2019
3811,4181,6/15/1950,Male,180,91,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"3,8",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/1/2019,7/5/2019,7/5/2019,8/21/2019,8/21/2019,8/21/2019, , , , , , 
3812,2564,6/15/1938,Male,167,66,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,2,ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,2/26/2019,11/25/2019,11/25/2019,12/9/2019,8/2/2020,8/2/2020, , , , , , 
3813,7559,6/15/1939,Female,165,78,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,Unknown,Other type,"2,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/12/2019,12/31/2021,10/14/1582, , , , , , , , , 
3814,3727,6/15/1951,Female,168,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"47,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,9,9,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,3/20/2012,5/15/2012,5/15/2012,3/4/2019,10/12/2021,10/12/2021, , , , , , 
3815,4888,6/15/1947,Female,166,71,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"15,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,POM-X,V-X,10/20/2016,4/17/2017,4/17/2017,5/2/2018,2/4/2019,2/4/2019,2/25/2019,6/14/2019,6/14/2019,6/20/2019,3/10/2020,3/10/2020
3816,6825,6/15/1954,Female,163,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"14,06","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,7/24/2017,1/12/2018,1/12/2018,7/30/2018,1/21/2019,1/21/2019,4/9/2019,5/10/2020,5/10/2020, , , 
3817,7492,6/15/1954,Male,169,66,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/28/2019,1/4/2021,1/4/2021,1/20/2021,3/31/2022, , , , , , , 
3818,1153,6/15/1941,Male,183,96,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/22/2019,3/31/2022,10/14/1582, , , , , , , , , 
3819,5360,6/15/1951,Male,177,84,Compulsory health insurance CHI,No, , , , , , , , ,Yes,Yes,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/22/2019,4/26/2019,4/26/2019, , , , , , , , , 
3820,2540,6/15/1956,Male,999,80,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,Unknown,IgG,99,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Nein,DAR-X,No CTx,No CTx,V-X,8/28/2015,12/11/2015,12/11/2015,1/9/2019,2/6/2020,2/6/2020, , , , , , 
3821,4937,6/15/1947,Female,160,93,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"23,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,11/22/2017,5/16/2018,5/16/2018,7/31/2018,1/17/2019,1/17/2019,2/1/2019,12/18/2020,12/18/2020, , , 
3822,3936,6/15/1945,Female,160,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,88",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/6/2016,9/5/2016,9/5/2016,3/5/2019,3/31/2022,10/14/1582, , , , , , 
3823,2883,6/15/1963,Female,172,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,36",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/5/2017,9/19/2017,9/19/2017,3/4/2019,3/31/2022,10/14/1582, , , , , , 
3824,1715,6/15/1945,Male,187,90,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"18,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,9/28/2017,12/22/2017,12/22/2017,2/7/2019,11/3/2021,11/3/2021,12/9/2021,3/31/2022, , , , 
3825,1944,6/15/1945,Female,160,71,Private,No, , , , ,Yes,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,25",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/1/2017,8/24/2017,8/24/2017,3/14/2019,3/31/2022,10/14/1582, , , , , , 
3826,4193,6/15/1954,Female,188,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/5/2017,11/20/2017,11/20/2017,2/6/2019,12/31/2021,10/14/1582, , , , , , 
3827,8831,6/15/1944,Female,173,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,2/23/2017,8/23/2017,8/23/2017,2/7/2019,3/13/2020,3/13/2020, , , , , , 
3828,8646,6/15/1950,Female,156,57,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/19/2019,6/14/2019,6/14/2019, , , , , , , , , 
3829,5129,6/15/1947,Female,170,51,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,42",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,3/15/2019,6/26/2019,6/26/2019,10/16/2019,6/11/2020,6/11/2020,8/12/2021,12/16/2021,12/16/2021, , , 
3830,1203,6/15/1963,Male,183,115,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"2,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,V-X,ISA-X,1/15/2019,5/10/2019,5/10/2019,11/19/2020,1/28/2021,1/28/2021,2/4/2021,3/5/2021,3/5/2021,3/15/2021,3/25/2021,3/25/2021
3831,7784,6/15/1941,Male,180,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,36",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/4/2019,2/10/2020,2/10/2020, , , , , , , , , 
3832,9614,6/15/1946,Female,150,52,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,39","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/11/2019,12/19/2019,12/19/2019, , , , , , , , , 
3833,1960,6/15/1946,Female,150,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/6/2019,5/22/2020,5/22/2020, , , , , , , , , 
3834,1746,6/15/1947,Female,170,51,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,81",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/11/2019,4/13/2019,4/13/2019, , , , , , , , , 
3835,7124,6/15/1950,Female,171,58,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,72",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/4/2019,8/12/2019,8/12/2019, , , , , , , , , 
3836,9912,6/15/1952,Female,176,82,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"32,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,7/19/2017,1/8/2018,1/8/2018,1/11/2018,9/18/2018,9/18/2018,2/4/2019,12/9/2019,12/9/2019,2/12/2021,5/1/2021,5/1/2021
3837,6021,6/15/1946,Male,173,85,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"26,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,11/28/2017,5/24/2018,5/24/2018,8/10/2018,2/8/2019,2/8/2019,2/19/2019,4/29/2019,4/29/2019,5/21/2019,11/5/2019,11/5/2019
3838,2486,6/15/1945,Female,165,71,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"14,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,POM-X,NIN-X,V-X,10/5/2017,3/22/2018,3/22/2018,8/14/2018,2/5/2019,2/5/2019,3/5/2019,5/3/2019,5/3/2019,5/28/2019,6/26/2019,6/26/2019
3839,1176,6/15/1931,Female,163,53,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"22,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,EMP-X,R-X,8/15/2018,3/14/2019,3/14/2019,3/26/2019,4/28/2020,4/28/2020,5/12/2020,10/19/2021,10/19/2021,11/16/2021,3/31/2022, 
3840,7483,6/15/1944,Male,174,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,05",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,5/10/2018,1/31/2019,1/31/2019,2/12/2019,11/29/2021,11/29/2021,12/13/2021,3/31/2022,10/14/1582, , , 
3841,5541,6/15/1937,Male,167,60,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/22/2018,9/6/2018,9/6/2018,3/7/2019,3/31/2022,10/14/1582, , , , , , 
3842,2031,6/15/1947,Male,172,65,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,31",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/5/2019,2/11/2020,2/11/2020,3/14/2022,3/31/2022, , , , , , , 
3843,4958,6/15/1953,Male,197,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,78",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/7/2019,1/31/2020,1/31/2020, , , , , , , , , 
3844,8880,6/15/1970,Male,200,143,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,11",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/4/2019,2/25/2020,2/25/2020, , , , , , , , , 
3845,7164,6/15/1935,Male,169,91,Compulsory health insurance CHI,Yes, , , , ,Yes,Unknown,Yes,Unknown,Yes,Unknown,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/9/2019,6/30/2020, , , , , , , , , , 
3846,8525,6/15/1946,Male,193,94,Private,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,1/15/2018,4/16/2018,4/16/2018,7/30/2018,1/21/2019,1/21/2019,3/20/2019,5/6/2019,5/6/2019,8/6/2019,9/18/2019,9/18/2019
3847,7962,6/15/1952,Female,169,75,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,41",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,6/12/2018,9/13/2018,9/13/2018,2/7/2019,7/23/2021,7/23/2021,8/17/2021,3/31/2022, , , , 
3848,8094,6/15/1954,Male,187,90,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"10,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,12/25/2017,6/18/2018,6/18/2018,9/3/2018,2/21/2019,2/21/2019,3/7/2019,12/5/2019,12/5/2019, , , 
3849,7200,6/15/1952,Female,167,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/15/2018,8/2/2018,8/2/2018,2/28/2019,3/31/2022,10/14/1582, , , , , , 
3850,8755,6/15/1962,Male,171,94,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,44",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,V-X,R-X,8/6/2018,1/22/2019,1/22/2019,2/1/2019,4/1/2019,4/1/2019,5/16/2019,6/21/2021,6/21/2021,7/14/2021,3/31/2022, 
3851,2427,6/15/1949,Female,165,71,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,13",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,DAR-X,R-X,5/2/2018,2/20/2019,2/20/2019,3/11/2019,1/2/2020,1/2/2020,5/28/2020,10/5/2020,10/5/2020,10/23/2020,3/31/2022,10/14/1582
3852,9146,6/15/1948,Female,166,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,76",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,5/17/2018,11/15/2018,11/15/2018,2/13/2019,3/7/2022,3/7/2022,3/17/2022,3/31/2022, , , , 
3853,3805,6/15/1952,Female,167,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"24,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,5/29/2018,11/19/2018,11/19/2018,3/1/2019,6/13/2021,6/13/2021,7/9/2021,3/31/2022,10/14/1582, , , 
3854,7626,6/15/1969,Male,201,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,64",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/4/2019,3/9/2020,3/9/2020,3/16/2021,3/31/2022,10/14/1582, , , , , , 
3855,6272,6/15/1947,Male,174,74,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"19,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,3/1/2019,5/1/2019,5/1/2019,2/3/2021,6/1/2021,6/1/2021,6/11/2021,3/31/2022, , , , 
3856,6945,6/15/1941,Male,172,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,LEV-X,No CTx,No CTx,V-X,3/25/2019,6/16/2019,6/16/2019,2/15/2021,6/27/2021,6/27/2021, , , , , , 
3857,5935,6/15/1955,Male,187,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,9,III: one or more criteria are fulfilled,IgG,50,unknown/ISS-Criteria not used for prognostics,9,9,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , ,Nein,No CTx,DAR-X,No CTx,V-X,12/21/2018,4/15/2019,4/15/2019, , , ,12/18/2019,3/31/2022,10/14/1582, , , 
3858,7461,6/15/1950,Female,160,63,Compulsory health insurance CHI,Unknown, , ,Yes,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"999,9",ISS stage II (neither stage I nor stage III),9,9,Yes,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/19/2019,4/26/2019,4/26/2019, , , , , , , , , 
3859,8425,6/15/1949,Female,169,78,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,25",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,1/29/2018,7/27/2018,7/27/2018,2/8/2019,5/21/2019,5/21/2019,7/11/2019,1/1/2020,1/1/2020,8/21/2020,8/5/2021,8/5/2021
3860,6406,6/15/1944,Female,176,57,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,87",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,4/23/2018,10/9/2018,10/9/2018,3/7/2019,1/10/2022,1/10/2022,2/3/2022,3/31/2022, , , , 
3861,4637,6/15/1954,Male,188,80,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,15",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,2/22/2018,8/16/2018,8/16/2018,3/4/2019,9/17/2021,9/17/2021,10/14/2021,3/31/2022, , , , 
3862,9506,6/15/1970,Male,186,68,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,R-X,9/25/2017,3/26/2018,3/26/2018,4/16/2018,3/18/2019,3/18/2019,4/15/2019,1/2/2020,1/2/2020,5/10/2020,8/5/2020,8/5/2020
3863,3140,6/15/1972,Female,161,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"3,22",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,4/30/2018,8/6/2018,8/6/2018,3/11/2019,11/27/2019,11/27/2019,12/12/2019,12/31/2021, , , , 
3864,1144,6/15/1945,Male,171,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,86",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,4/27/2018,7/20/2018,7/20/2018,2/12/2019,8/6/2021,8/6/2021,9/2/2021,3/31/2022,10/14/1582, , , 
3865,2761,6/15/1936,Male,184,81,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"11,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,V-X,R-X,8/16/2018,2/11/2019,2/11/2019,3/8/2019,3/5/2020,3/5/2020,3/23/2020,1/27/2022,1/27/2022,3/17/2022,3/31/2022, 
3866,5580,6/15/1951,Male,179,74,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,59",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,KYP-X,NIN-X,No CTx,R-X,7/27/2018,1/17/2019,1/17/2019,2/11/2019,8/26/2021,8/26/2021,9/17/2021,3/31/2022, , , , 
3867,7612,6/15/1962,Female,164,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/18/2019,5/19/2019,5/19/2019, , , , , , , , , 
3868,8526,6/15/1954,Female,163,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"14,06","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,V-X,V-X,7/24/2017,1/12/2018,1/12/2018,7/30/2018,1/21/2019,1/21/2019,2/1/2019,11/20/2019,11/20/2019,12/11/2019,12/24/2019,12/24/2019
3869,1556,6/15/1964,Male,184,89,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/4/2019,5/12/2019,5/12/2019, , , , , , , , , 
3870,3597,6/15/1964,Female,162,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"7,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,3/18/2019,4/28/2019,4/28/2019,9/6/2021,12/31/2021, , , , , , , 
3871,3383,6/15/1937,Female,158,56,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,LEV-X,No CTx,No CTx,LEV-X,3/11/2019,9/8/2019,9/8/2019,9/28/2020,3/21/2021,3/21/2021, , , , , , 
3872,1965,6/15/1948,Male,176,72,Compulsory health insurance CHI,No, , , , , , , ,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"9,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,EMP-X,V-X,5/5/2017,11/2/2017,11/2/2017,5/2/2018,10/23/2018,10/23/2018,11/2/2018,3/27/2019,3/27/2019,4/10/2019,1/2/2020,1/2/2020
3873,6274,6/15/1932,Female,167,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,08",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,R-X,POM-X,R-X,7/25/2018,1/15/2019,1/15/2019,2/6/2019,2/27/2020,2/27/2020,3/13/2020,7/14/2021,7/14/2021,8/9/2021,3/31/2022, 
3874,8174,6/15/1946,Female,175,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,98",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,3/21/2018,9/17/2018,9/17/2018,3/14/2019,12/9/2021,12/9/2021,1/19/2022,3/31/2022,10/14/1582, , , 
3875,8060,6/15/1951,Male,200,94,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"11,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,R-X,No CTx,R-X,8/23/2018,2/11/2019,2/11/2019,3/4/2019,7/16/2020,7/16/2020,7/28/2020,3/31/2022, , , , 
3876,8024,6/15/1949,Male,194,96,Private,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"17,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/31/2019,7/16/2019,7/16/2019, , , , , , , , , 
3877,4772,6/15/1954,Male,180,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/25/2019,6/24/2019,6/24/2019,5/4/2020,9/30/2021,10/14/1582, , , , , , 
3878,1042,6/15/1949,Male,175,59,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,42","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,2/14/2019,3/20/2020,3/20/2020,1/20/2022,3/31/2022,10/14/1582, , , , , , 
3879,7828,6/15/1945,Female,164,52,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,81",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/25/2019,3/5/2020,3/5/2020, , , , , , , , , 
3880,5070,6/15/1939,Female,162,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,1/30/2019,12/5/2019,12/5/2019, , , , , , , , , 
3881,9349,6/15/1962,Male,175,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,4930,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/29/2019,2/1/2019,2/1/2019, , , , , , , , , 
3882,8282,6/15/1939,Female,160,75,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/8/2019,3/31/2020, , , , , , , , , , 
3883,3009,6/15/1951,Male,173,73,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,999,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,9,9,9,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,R-X,DAR-X,KYP-X,V-X,4/15/2010,6/15/2010,6/15/2010,7/15/2017,8/15/2018,8/15/2018,1/22/2019,1/16/2020,1/16/2020,3/10/2020,5/12/2020,5/12/2020
3884,2657,6/15/1948,Male,180,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,2222,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,11/13/2018,11/23/2018,11/23/2018,1/29/2019,8/15/2019,8/15/2019, , , , , , 
3885,4297,6/15/1937,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,9,Unknown,IgG,1718,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,2/25/2019,8/22/2019,8/22/2019, , , , , , , , , 
3886,5892,6/15/1953,Female,162,69,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,Other type,999,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/25/2019,5/9/2019,5/9/2019, , , , , , , , , 
3887,8910,6/15/1941,Female,163,71,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,3463,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/28/2019,12/23/2019,12/23/2019, , , , , , , , , 
3888,1217,6/15/1952,Male,186,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,999,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,No CTx,No CTx,V-X,7/12/2012,9/6/2012,9/6/2012,1/29/2019,2/24/2020,2/24/2020, , , , , , 
3889,1263,6/15/1945,Male,168,70,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"13,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,11/14/2017,2/9/2018,2/9/2018,7/31/2018,1/28/2019,1/28/2019,2/14/2019,6/7/2021,6/7/2021,6/14/2021,8/28/2021,8/28/2021
3890,5310,6/15/1947,Male,170,78,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"30,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,7/31/2017,1/26/2018,1/26/2018,8/20/2018,2/7/2019,2/7/2019,2/25/2019,11/20/2019,11/20/2019,11/27/2019,9/23/2020,9/23/2020
3891,8366,6/15/1936,Male,162,68,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,15,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,3/6/2019,12/3/2019,12/3/2019,12/18/2019,7/16/2020,7/16/2020, , , , , , 
3892,7637,6/15/1953,Male,170,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,16,ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/6/2019,6/12/2019,6/12/2019, , , , , , , , , 
3893,1872,6/15/1945,Male,162,94,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"14,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,V-X,NIN-X,V-X,12/1/2017,5/25/2018,5/25/2018,8/15/2018,1/31/2019,1/31/2019,2/25/2019,5/27/2019,5/27/2019,7/17/2019,10/21/2020,10/21/2020
3894,9615,6/15/1953,Male,187,59,Private,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,32",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,2/15/2018,8/15/2018,8/15/2018,3/14/2019,7/23/2021,7/23/2021,8/12/2021,3/31/2022, , , , 
3895,2072,6/15/1954,Male,171,53,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"15,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,R-X,V-X,9/29/2017,3/16/2018,3/16/2018,7/23/2018,1/18/2019,1/18/2019,2/11/2019,7/14/2020,7/14/2020,8/3/2020,3/31/2021,3/31/2021
3896,4255,6/15/1938,Male,177,88,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"29,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/30/2018,2/21/2019,2/21/2019,3/12/2019,1/4/2021,1/4/2021, , , , , , 
3897,3698,6/15/1964,Female,160,89,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,61",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,No CTx,V-X,4/3/2018,9/18/2018,9/18/2018,3/18/2019,1/15/2021,1/15/2021,1/18/2022,3/31/2022, , , , 
3898,1790,6/15/1938,Male,177,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"24,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,NIN-X,POM-X,R-X,7/30/2018,1/24/2019,1/24/2019,2/11/2019,1/2/2020,1/2/2020,2/11/2020,6/24/2020,6/24/2020,7/2/2020,12/8/2020,12/8/2020
3899,3896,6/15/1949,Male,177,55,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,3/9/2018,8/27/2018,8/27/2018,3/11/2019,8/30/2020,8/30/2020,9/12/2020,1/7/2021,1/7/2021, , , 
3900,1833,6/15/1949,Male,173,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,64",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/28/2018,2/20/2019,2/20/2019,3/5/2019,3/31/2022,10/14/1582, , , , , , 
3901,9481,6/15/1953,Male,179,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,15",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,7/26/2018,1/16/2019,1/16/2019,2/1/2019,8/11/2021,8/11/2021,8/28/2021,10/13/2021,10/13/2021, , , 
3902,5728,6/15/1954,Male,184,63,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,34",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/30/2018,7/30/2018,7/30/2018,3/4/2019,8/19/2021,8/19/2021, , , , , , 
3903,1047,6/15/1954,Male,182,113,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,55",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/22/2019,11/1/2019,11/1/2019, , , , , , , , , 
3904,7472,6/15/1954,Female,156,62,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,39",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/14/2019,2/5/2020,2/5/2020, , , , , , , , , 
3905,7073,6/15/1945,Male,171,63,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,9",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/28/2019,11/21/2019,11/21/2019,12/29/2021,3/31/2022, , , , , , , 
3906,7273,6/15/1942,Male,177,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,11/1/2016,5/29/2017,5/29/2017,1/2/2019,6/18/2019,6/18/2019,3/16/2020,2/19/2021,2/19/2021,3/1/2021,12/17/2021,12/17/2021
3907,6615,6/15/1929,Female,174,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,47",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/7/2019,8/20/2019,8/20/2019, , , , , , , , , 
3908,6153,6/15/1946,Female,160,51,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"30,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,6/13/2017,12/8/2017,12/8/2017,3/27/2018,12/27/2018,12/27/2018,1/10/2019,7/9/2021,7/9/2021,8/3/2021,3/31/2022,10/14/1582
3909,7619,6/15/1955,Female,170,77,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/21/2019,4/9/2019,4/9/2019,9/12/2019,6/10/2021,6/10/2021, , , , , , 
3910,4561,6/15/1946,Female,164,66,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,V-X,7/1/2016,7/14/2017,7/14/2017,1/2/2019,6/18/2019,6/18/2019,2/28/2020,2/11/2021,2/11/2021,2/22/2021,12/21/2021,12/21/2021
3911,3764,6/15/1944,Female,159,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/12/2018,11/5/2018,11/5/2018,2/14/2019,6/3/2020,6/3/2020, , , , , , 
3912,5785,6/15/1945,Female,164,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"11,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,8/10/2018,11/2/2018,11/2/2018,2/28/2019,2/3/2022,2/3/2022,2/24/2022,3/31/2022, , , , 
3913,2773,6/15/1944,Female,179,60,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"22,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,7/3/2018,9/27/2018,9/27/2018,2/1/2019,1/2/2020,1/2/2020,5/4/2020,1/26/2022,1/26/2022,2/14/2022,3/31/2022, 
3914,5334,6/15/1948,Male,176,74,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"2,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/28/2019,3/5/2020,3/5/2020, , , , , , , , , 
3915,1081,6/15/1954,Female,168,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,10/9/2017,3/29/2018,3/29/2018,8/6/2018,1/28/2019,1/28/2019,2/21/2019,1/2/2020,1/2/2020,1/31/2020,1/10/2021,1/10/2021
3916,3856,6/15/1945,Female,167,72,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,48",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/19/2019,4/21/2019,4/21/2019, , , , , , , , , 
3917,7633,6/15/1948,Female,173,54,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,98",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/14/2019,7/24/2019,7/24/2019, , , , , , , , , 
3918,9483,6/15/1956,Female,175,71,Private,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,11",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,R-X,V-X,8/17/2017,11/23/2017,11/23/2017,4/5/2018,3/20/2019,3/20/2019,5/15/2019,1/2/2020,1/2/2020,1/19/2020,2/2/2020,2/2/2020
3919,2156,6/15/1940,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,POM-X,R-X,10/3/2016,3/19/2017,3/19/2017,1/4/2019,6/20/2019,6/20/2019,3/30/2020,3/18/2021,3/18/2021,3/29/2021,12/22/2021,12/22/2021
3920,7165,6/15/1949,Male,180,72,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,POM-X,R-X,8/17/2018,2/7/2019,2/7/2019,2/21/2019,5/7/2019,5/7/2019,7/8/2019,4/28/2021,4/28/2021,7/12/2021,11/23/2021,11/23/2021
3921,9556,6/15/1946,Male,183,120,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,1",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/13/2019,2/19/2020,2/19/2020, , , , , , , , , 
3922,4715,6/15/1945,Female,170,78,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"23,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,3/7/2019,2/28/2020,2/28/2020,10/27/2021,3/31/2022,10/14/1582, , , , , , 
3923,8141,6/15/1935,Female,155,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/7/2019,11/30/2019,11/30/2019,10/18/2020,3/31/2022,10/14/1582, , , , , , 
3924,7191,6/15/1948,Male,168,75,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,53",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/5/2019,10/23/2019,10/23/2019,8/3/2021,3/31/2022, , , , , , , 
3925,3665,6/15/1939,Male,175,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,10/1/2016,4/30/2017,4/30/2017,1/7/2019,6/28/2019,6/28/2019, , , , , , 
3926,5804,6/15/1967,Female,175,65,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"9999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,11/15/2015,12/15/2015,12/15/2015,3/8/2019,8/13/2020,8/13/2020, , , , , , 
3927,6092,6/15/1944,Male,178,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,POM-X,V-X,10/1/2016,10/15/2017,10/15/2017,1/7/2019,6/23/2019,6/23/2019,12/30/2019,12/18/2020,12/18/2020,1/4/2021,12/30/2021,12/30/2021
3928,7052,6/15/1953,Male,167,88,Compulsory health insurance CHI,No, , , , ,Yes,Unknown,Unknown,Unknown,Yes,Yes,2,I: fulfilling all 4 criteria,IgM,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/8/2019,6/28/2019,6/28/2019,7/11/2019,9/26/2019,9/26/2019, , , , , , 
3929,1617,6/15/1948,Female,165,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/13/2019,3/31/2019, , , , , , , , , , 
3930,5016,6/15/1928,Female,155,53,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,3,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,02",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/7/2019,9/18/2019,9/18/2019, , , , , , , , , 
3931,3119,6/15/1935,Male,170,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,V-X,No CTx,Other,6/8/2011,3/22/2012,3/22/2012,4/16/2012,11/19/2012,11/19/2012,3/14/2019,5/23/2019,5/23/2019, , , 
3932,2546,6/15/1933,Male,157,58,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/21/2019,7/23/2019,7/23/2019,10/28/2019,3/14/2021,3/14/2021, , , , , , 
3933,2965,6/15/1957,Female,166,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"31,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,DAR-X,V-X,4/16/2018,10/5/2018,10/5/2018,3/14/2019,8/5/2020,8/5/2020,8/31/2020,2/23/2021,2/23/2021,3/19/2021,6/21/2021,6/21/2021
3934,4797,6/15/1953,Male,187,59,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,56",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,6/4/2018,11/22/2018,11/22/2018,2/18/2019,12/8/2021,12/8/2021,1/13/2022,3/31/2022,10/14/1582, , , 
3935,4395,6/15/1952,Female,151,43,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,27",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,No CTx,R-X,8/27/2018,2/15/2019,2/15/2019,3/5/2019,1/2/2020,1/2/2020,5/28/2020,3/31/2022, , , , 
3936,3660,6/15/1952,Male,180,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,KYP-X,V-X,2/6/2018,7/30/2018,7/30/2018,2/14/2019,7/30/2019,7/30/2019,8/19/2019,7/29/2020,7/29/2020,8/11/2020,9/20/2020,9/20/2020
3937,6711,6/15/1947,Female,166,78,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,9/1/2016,9/17/2017,9/17/2017,1/11/2019,6/27/2019,6/27/2019, , , , , , 
3938,5028,6/15/1952,Female,162,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/12/2019,4/14/2019,4/14/2019, , , , , , , , , 
3939,4455,6/15/1948,Male,177,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/1/2016,2/22/2017,2/22/2017,1/16/2019,6/30/2019,10/14/1582, , , , , , 
3940,4144,6/15/1947,Male,175,101,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/19/2019,4/21/2019,4/21/2019,12/2/2021,3/31/2022, , , , , , , 
3941,4331,6/15/1947,Female,171,80,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,45",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/21/2019,3/13/2020,3/13/2020, , , , , , , , , 
3942,5588,6/15/1945,Female,171,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,75",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/5/2019,7/16/2020,7/16/2020,2/21/2022,3/31/2022, , , , , , , 
3943,3919,6/15/1950,Male,170,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,3/2/2018,8/20/2018,8/20/2018,2/4/2019,6/10/2021,6/10/2021,7/8/2021,3/31/2022, , , , 
3944,2897,6/15/1941,Female,164,67,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/1/2017,4/25/2017,4/25/2017,1/18/2019,11/28/2019,11/28/2019, , , , , , 
3945,7974,6/15/1933,Female,166,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,NIN-X,EMP-X,V-X,2/22/2018,8/16/2018,8/16/2018,2/28/2019,9/8/2020,9/8/2020,10/1/2020,11/12/2021,11/12/2021,2/10/2022,3/31/2022, 
3946,2199,6/15/1955,Male,178,68,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,63",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,KYP-X,V-X,4/30/2018,10/18/2018,10/18/2018,3/4/2019,4/3/2021,4/3/2021,4/21/2021,9/2/2021,9/2/2021,9/21/2021,3/31/2022,10/14/1582
3947,6044,6/15/1952,Male,171,79,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"12,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,NIN-X,No CTx,R-X,7/27/2018,1/24/2019,1/24/2019,2/4/2019,5/27/2021,5/27/2021,6/3/2021,8/24/2021,8/24/2021, , , 
3948,5464,6/15/1934,Female,164,47,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,9",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/21/2019,6/20/2019,6/20/2019, , , , , , , , , 
3949,6829,6/15/1950,Male,180,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/1/2016,2/22/2017,2/22/2017,1/18/2019,12/5/2019,12/5/2019, , , , , , 
3950,6608,6/15/1950,Female,150,57,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,I: fulfilling all 4 criteria,IgG,"1,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/20/2018,12/21/2018,12/21/2018,1/9/2019,11/19/2019,11/19/2019, , , , , , 
3951,6717,6/15/1957,Male,176,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"1,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,FAR-X,POM-X,V-X,9/27/2016,12/2/2016,12/2/2016,1/4/2018,3/15/2018,3/15/2018,4/10/2018,12/5/2018,12/5/2018,1/17/2019,10/23/2019,10/23/2019
3952,3231,6/15/1951,Male,178,78,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/29/2019,6/6/2019,6/6/2019, , , , , , , , , 
3953,4971,6/15/1959,Male,194,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,1/15/2019,5/17/2019,5/17/2019, , , , , , , , , 
3954,5253,6/15/1943,Male,183,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,KYP-X,Other,No CTx,V-X,6/11/2014,8/26/2014,8/26/2014,5/20/2016,9/2/2017,9/2/2017,1/9/2019,3/31/2022,10/14/1582, , , 
3955,4488,6/15/1942,Male,183,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,8/21/2015,3/10/2016,3/10/2016,6/7/2016,4/11/2018,4/11/2018,4/15/2018,12/1/2018,12/1/2018,1/29/2019,4/30/2019,4/30/2019
3956,9946,6/15/1958,Female,165,65,Private,Yes, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/18/2019,5/27/2019,5/27/2019, , , , , , , , , 
3957,1394,6/15/1961,Female,160,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,Unknown,IgG,"12,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , , , ,KYP-X,POM-X,DAR-X,KYP-X,4/17/2017,12/6/2017,12/6/2017,8/22/2018,1/10/2019,1/10/2019,1/14/2019,2/27/2019,2/27/2019,10/22/2019,10/29/2019,10/29/2019
3958,3464,6/15/1988,Male,183,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"28,9",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,1/21/2019,6/30/2019, , , , , , , , , , 
3959,9951,6/15/1969,Male,180,81,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,2427,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,2/25/2019,6/30/2019, , , , , , , , , , 
3960,7922,6/15/1947,Male,158,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,664,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/15/2019,6/3/2019,6/3/2019, , , , , , , , , 
3961,8983,6/15/1951,Male,166,77,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,25",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/15/2019,7/5/2019,7/5/2019, , , , , , , , , 
3962,3855,6/15/1952,Male,184,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,33",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/19/2019,6/27/2019,6/27/2019,2/18/2022,3/31/2022, , , , , , , 
3963,7346,6/15/1966,Female,164,70,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"14,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/31/2019,10/22/2019,10/22/2019,2/17/2022,3/31/2022, , , , , , , 
3964,5202,6/15/1951,Female,169,63,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,38",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/18/2019,6/19/2019,6/19/2019, , , , , , , , , 
3965,3422,6/15/1950,Male,181,77,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"20,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,NIN-X,V-X,10/23/2017,4/10/2018,4/10/2018,8/6/2018,1/21/2019,1/21/2019,2/8/2019,4/3/2019,4/3/2019,5/2/2019,8/16/2019,8/16/2019
3966,9191,6/15/1954,Male,200,143,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,56",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/23/2018,10/10/2018,10/10/2018,3/11/2019,12/31/2020,10/14/1582, , , , , , 
3967,1863,6/15/1950,Female,161,46,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,4",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,8/7/2017,1/29/2018,1/29/2018,7/20/2018,3/4/2019,3/4/2019,6/5/2019,12/31/2020, , , , 
3968,1208,6/15/1970,Male,185,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"7,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/9/2018,9/26/2018,9/26/2018,2/21/2019,12/31/2020,10/14/1582, , , , , , 
3969,3755,6/15/1947,Male,169,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/1/2018,1/17/2019,1/17/2019,1/31/2020,12/31/2020,10/14/1582, , , , , , 
3970,3169,6/15/1948,Female,166,60,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,"9,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/25/2019,3/2/2020,3/2/2020, , , , , , , , , 
3971,4221,6/15/1951,Male,179,91,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,01",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/6/2019,12/31/2020, , , , , , , , , , 
3972,1725,6/15/1935,Male,176,84,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,37",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/20/2019,4/17/2019,4/17/2019, , , , , , , , , 
3973,2846,6/15/1946,Female,162,51,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"20,61","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/5/2019,12/31/2020, , , , , , , , , , 
3974,3312,6/15/1936,Female,164,54,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,47",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/11/2019,12/31/2020, , , , , , , , , , 
3975,4962,6/15/1988,Male,183,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,1/21/2019,5/21/2019,5/21/2019, , , , , , , , , 
3976,2186,6/15/1969,Male,180,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99",ISS stage II (neither stage I nor stage III),9,No,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,12/1/2015,3/3/2016,3/3/2016,2/12/2019,6/30/2019, , , , , , , 
3977,3756,6/15/1947,Female,158,66,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,1,Unknown,IgG,"999,99",ISS stage II (neither stage I nor stage III),9,Yes,No,No,Unknown,Unknown, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Unbekannt,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,3/15/2019,7/4/2019,7/4/2019, , , , , , , , , 
3978,7533,6/15/1945,Male,177,73,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,ISA-X,V-X,12/1/2016,6/28/2017,6/28/2017,1/20/2019,7/6/2019,7/6/2019,12/27/2019,12/30/2020,12/30/2020,1/11/2021,6/30/2021,10/14/1582
3979,4116,6/15/1939,Female,157,55,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/1/2017,7/29/2017,7/29/2017,1/23/2019,6/27/2019,6/27/2019, , , , , , 
3980,6976,6/15/1947,Male,183,76,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,NIN-X,V-X,2/1/2017,4/25/2017,4/25/2017,1/26/2019,12/13/2019,12/13/2019,2/3/2020,12/22/2020,12/22/2020,1/4/2021,12/17/2021,12/17/2021
3981,3151,6/15/1950,Male,177,74,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,EMP-X,V-X,3/1/2017,5/23/2017,5/23/2017,1/28/2019,12/29/2019,12/29/2019,3/23/2020,1/15/2021,1/15/2021,2/8/2021,12/17/2021,12/17/2021
3982,5873,6/15/1951,Female,160,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgM,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,NIN-X,DAR-X,POM-X,V-X,2/1/2017,4/25/2017,4/25/2017,2/1/2019,7/18/2019,7/18/2019,3/3/2020,2/19/2021,2/19/2021,3/1/2021,9/10/2021,9/10/2021
3983,5516,6/15/1941,Male,176,72,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,3/1/2017,8/25/2017,8/25/2017,2/4/2019,6/27/2019,6/27/2019, , , , , , 
3984,4623,6/15/1938,Female,157,53,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,2/6/2017,4/30/2017,4/30/2017,2/11/2019,12/8/2019,12/8/2019,1/6/2020,6/22/2020,6/22/2020, , , 
3985,5805,6/15/1945,Male,175,81,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"10,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,POM-X,NIN-X,V-X,12/4/2017,5/30/2018,5/30/2018,8/21/2018,2/7/2019,2/7/2019,2/28/2019,5/9/2019,5/9/2019,5/10/2019,5/24/2019,5/24/2019
3986,9979,6/15/1943,Female,165,59,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,3/1/2017,5/23/2017,5/23/2017,2/20/2019,12/10/2019,12/10/2019,2/10/2020,6/30/2020,10/14/1582, , , 
3987,2035,6/15/1951,Male,175,92,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"31,22","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,11/30/2017,5/28/2018,5/28/2018,1/10/2019,1/3/2020,1/3/2020, , , , , , 
3988,1318,6/15/1942,Male,174,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"17,6",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,10/14/2015,3/9/2016,3/9/2016,2/19/2019,10/17/2020,10/17/2020,10/24/2020,2/11/2022,2/11/2022,2/16/2022,3/31/2022, 
3989,4760,6/15/1945,Male,191,125,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"18,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/22/2018,7/9/2018,7/9/2018,1/8/2019,1/1/2020,1/1/2020, , , , , , 
3990,3116,6/15/1942,Male,178,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/1/2017,9/26/2017,9/26/2017,2/20/2019,8/6/2019,8/6/2019, , , , , , 
3991,5404,6/15/1944,Male,178,80,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,36",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,1/24/2018,7/19/2018,7/19/2018,1/18/2019,1/2/2020,1/2/2020,4/4/2020,6/30/2020, , , , 
3992,9508,6/15/1949,Male,170,57,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,26",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,9/28/2017,3/23/2018,3/23/2018,10/18/2018,2/21/2019,2/21/2019,3/5/2019,6/11/2019,6/11/2019,6/25/2019,12/31/2021, 
3993,1571,6/15/1945,Female,172,81,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,58",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/13/2019,7/3/2019,7/3/2019,2/8/2021,3/31/2022, , , , , , , 
3994,4682,6/15/1954,Male,188,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,63","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/20/2019,7/3/2019,7/3/2019,3/10/2022,3/31/2022, , , , , , , 
3995,2602,6/15/1937,Male,170,74,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,LEV-X,4/1/2017,12/31/2017,12/31/2017,2/27/2019,6/28/2019,6/28/2019, , , , , , 
3996,2343,6/15/1950,Male,180,76,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,78",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/18/2019,7/1/2019,7/1/2019, , , , , , , , , 
3997,5033,6/15/1945,Female,157,64,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,NIN-X,V-X,1/1/2017,3/27/2017,3/27/2017,3/2/2019,12/20/2019,12/20/2019,2/10/2020,12/30/2020,12/30/2020,1/11/2021,9/8/2021,9/8/2021
3998,4486,6/15/1947,Male,181,70,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,25",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,2/18/2019,8/14/2020,8/14/2020,11/10/2021,3/31/2022,10/14/1582, , , , , , 
3999,6998,6/15/1952,Male,187,89,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,87",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/31/2019,11/21/2019,11/21/2019,12/23/2019,3/31/2022,10/14/1582, , , , , , 
4000,1028,6/15/1933,Male,184,80,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"25,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/8/2019,4/23/2020,4/23/2020, , , , , , , , , 
4001,7466,6/15/1948,Male,179,113,Private,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"21,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,Other,V-X,2/1/2018,5/7/2018,5/7/2018,8/16/2018,2/8/2019,2/8/2019,3/5/2019,6/17/2020,6/17/2020,12/5/2020,7/5/2021,7/5/2021
4002,7100,6/15/1935,Male,165,64,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"30,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/9/2018,11/5/2018,11/5/2018,2/19/2019,3/31/2022,10/14/1582, , , , , , 
4003,1990,6/15/1934,Female,169,76,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,73",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,3/19/2018,9/6/2018,9/6/2018,3/21/2019,6/30/2021,10/14/1582, , , , , , 
4004,2508,6/15/1953,Female,162,68,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,31",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,POM-X,R-X,3/5/2018,8/24/2018,8/24/2018,3/18/2019,4/12/2021,4/12/2021,4/23/2021,9/2/2021,9/2/2021,10/7/2021,3/31/2022, 
4005,9599,6/15/1948,Female,166,72,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,37",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,9/6/2018,11/30/2018,11/30/2018,2/22/2019,4/10/2021,4/10/2021,4/17/2021,6/30/2021, , , , 
4006,3872,6/15/1955,Male,167,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,Unknown,IgG,"3,39",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/11/2019,4/13/2019,4/13/2019, , , , , , , , , 
4007,2821,6/15/1936,Female,161,68,Compulsory health insurance CHI,Yes, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,24,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/6/2019,5/6/2021,5/6/2021, , , , , , , , , 
4008,7130,6/15/1946,Male,178,93,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,22,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,DAR-X,2/18/2019,9/23/2019,9/23/2019,10/14/2019,3/31/2022, , , , , , , 
4009,9438,6/15/1937,Male,183,86,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/19/2019,2/15/2020,2/15/2020, , , , , , , , , 
4010,3644,6/15/1941,Female,165,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/5/2017,12/15/2017,12/15/2017,3/12/2019,12/31/2019,10/14/1582, , , , , , 
4011,3346,6/15/1950,Male,170,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/21/2019,6/30/2019, , , , , , , , , , 
4012,9873,6/15/1949,Male,165,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,2/12/2019,12/9/2019,12/9/2019,6/15/2020,12/20/2020,12/20/2020,6/2/2021,6/30/2021,10/14/1582, , , 
4013,1447,6/15/1952,Female,158,65,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,165,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,Other,2/25/2019,6/30/2019, , , , , , , , , , 
4014,4599,6/15/1957,Female,166,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/6/2019,10/23/2019,10/23/2019, , , , , , , , , 
4015,5949,6/15/1952,Female,164,62,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/26/2019,11/18/2019,11/18/2019,6/9/2020,9/30/2020, , , , , , , 
4016,3014,6/15/1946,Female,164,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,No CTx,V-X,9/1/2014,1/1/2015,1/1/2015,1/14/2019,3/11/2021,3/11/2021,3/15/2021,3/31/2021, , , , 
4017,1724,6/15/1955,Male,163,60,Private,No, ,Yes, ,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,115,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/18/2019,10/24/2019,10/24/2019, , , , , , , , , 
4018,9218,6/15/1940,Female,163,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/19/2019,9/16/2019,9/16/2019, , , , , , , , , 
4019,8085,6/15/1938,Female,162,78,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes,Yes,2,III: one or more criteria are fulfilled,IgA,4470,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/25/2019,3/31/2019, , , , , , , , , , 
4020,6793,6/15/1932,Male,172,88,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,4420,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,Other,3/11/2019,3/31/2019, , , , , , , , , , 
4021,6728,6/15/1951,Female,160,77,Private,No, , , , , , , , , , ,1,Unknown,IgA,21,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , , ,KYP-X,POM-X,DAR-X,R-X,9/21/2017,12/20/2018,12/20/2018,3/28/2019,7/8/2020,7/8/2020,7/22/2020,1/26/2021,1/26/2021,2/1/2021,3/31/2022,10/14/1582
4022,7742,6/15/1947,Female,169,70,Private,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,45,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,R-X,11/5/2018,1/21/2019,1/21/2019,3/26/2019,1/28/2020,1/28/2020,3/4/2020,5/13/2021,5/13/2021,9/3/2021,12/31/2021,10/14/1582
4023,9966,6/15/1939,Male,180,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,R-X,KYP-X,No CTx,V-X,5/22/2016,9/1/2017,9/1/2017,10/10/2017,11/30/2018,11/30/2018,1/10/2019,6/30/2019,10/14/1582, , , 
4024,7122,6/15/1937,Female,159,63,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"5,6",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,3/26/2019,10/27/2020,10/27/2020, , , , , , , , , 
4025,6225,6/15/1942,Male,174,71,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,61,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,1/15/2018,3/15/2019,3/15/2019,3/15/2019,6/30/2019,10/14/1582, , , , , , 
4026,5311,6/15/1958,Male,174,92,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"2,3",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/22/2019,5/14/2019,5/14/2019, , , , , , , , , 
4027,7758,6/15/1956,Female,164,62,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,Other type,",21","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,R-X,No CTx,KYP-X,V-X,10/13/2015,1/12/2016,1/12/2016,1/18/2017,2/20/2019,2/20/2019, , , ,8/7/2019,9/3/2020,9/3/2020
4028,6487,6/15/1957,Female,163,52,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,57,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,KYP-X,No CTx,DAR-X,1/15/2019,6/15/2019,6/15/2019,9/1/2019,2/1/2020,2/1/2020,3/1/2020,6/30/2020, , , , 
4029,2052,6/15/1941,Female,167,62,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,72,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,R-X,3/15/2019,6/15/2019,6/15/2019,9/1/2019,2/1/2020,2/1/2020,3/1/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, 
4030,4205,6/15/1939,Male,169,63,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,62,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,1/15/2019,6/15/2019,6/15/2019,9/1/2019,2/1/2020,2/1/2020,3/1/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, 
4031,3948,6/15/1943,Female,169,55,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,59,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,KYP-X,POM-X,DAR-X,2/15/2019,6/15/2019,6/15/2019,7/1/2019,1/1/2020,1/1/2020,2/1/2020,5/15/2020,5/15/2020,5/15/2020,6/30/2020, 
4032,3578,6/15/1972,Male,188,73,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes,Yes, ,3,III: one or more criteria are fulfilled,IgG,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/4/2019,8/10/2019,8/10/2019,5/26/2021,12/31/2021,10/14/1582, , , , , , 
4033,8493,6/15/1962,Female,170,79,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , ,0,III: one or more criteria are fulfilled,IgA,5300,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,3/11/2019,6/11/2019,6/11/2019,8/25/2021,12/31/2021, , , , , , , 
4034,2354,6/15/1949,Male,176,104,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/28/2019,7/8/2019,7/8/2019,7/25/2019,6/24/2020,6/24/2020,4/20/2021,12/31/2021,10/14/1582, , , 
4035,5295,6/15/1945,Male,179,91,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,35",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,DAR-X,R-X,8/17/2018,2/7/2019,2/7/2019,3/7/2019,1/2/2020,1/2/2020,1/27/2020,10/10/2020,10/10/2020,10/25/2020,6/9/2021,6/9/2021
4036,3625,6/15/1949,Male,174,100,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,31",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/30/2018,7/25/2018,7/25/2018,2/21/2019,8/5/2021,8/5/2021, , , , , , 
4037,4722,6/15/1934,Male,179,103,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,41","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,NIN-X,V-X,4/20/2018,7/27/2018,7/27/2018,2/7/2019,10/9/2019,10/9/2019,10/31/2019,4/8/2020,4/8/2020,5/20/2020,1/6/2022,1/6/2022
4038,2398,6/15/1944,Female,162,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,86",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/21/2018,10/11/2018,10/11/2018,2/28/2019,3/31/2022,10/14/1582, , , , , , 
4039,9369,6/15/1952,Female,169,79,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,29",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,6/4/2018,9/5/2018,9/5/2018,2/6/2019,1/2/2020,1/2/2020,2/18/2020,3/31/2022,10/14/1582, , , 
4040,8711,6/15/1944,Female,162,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,29",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,8/18/2017,12/19/2017,12/19/2017,3/27/2018,3/5/2019,3/5/2019,5/20/2019,7/5/2021,7/5/2021, , , 
4041,8539,6/15/1945,Female,162,71,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,"29,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,6/25/2018,9/26/2018,9/26/2018,2/25/2019,7/30/2020,7/30/2020,8/16/2020,7/7/2021,7/7/2021,9/7/2021,3/31/2022, 
4042,2556,6/15/1948,Male,172,101,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,22",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/20/2018,11/15/2018,11/15/2018,3/11/2019,3/31/2022,10/14/1582, , , , , , 
4043,6536,6/15/1952,Female,169,79,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,83",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,2/26/2019,6/25/2019,6/25/2019,11/8/2019,11/28/2020,11/28/2020,12/15/2020,1/15/2021,1/15/2021, , , 
4044,6802,6/15/1939,Male,175,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"27,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,No CTx,R-X,8/15/2018,2/11/2019,2/11/2019,2/20/2019,5/27/2019,5/27/2019,6/18/2019,8/6/2021,8/6/2021, , , 
4045,7749,6/15/1939,Male,175,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"24,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,8/30/2018,3/1/2019,3/1/2019,3/14/2019,12/16/2021,12/16/2021, , , , , , 
4046,9296,6/15/1948,Female,171,113,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,R-X,DAR-X,No CTx,V-X,12/19/2014,2/14/2015,2/14/2015,3/18/2015,12/28/2016,12/28/2016,2/6/2019,6/30/2019, , , , 
4047,6868,6/15/1938,Female,169,70,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,55",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"<3,5 mg/L", ,V-X,KYP-X,No CTx,V-X,4/18/2016,1/9/2017,1/9/2017,11/13/2017,9/3/2018,9/3/2018,1/30/2019,5/23/2019,5/23/2019, , , 
4048,2714,6/15/1950,Male,172,150,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,2,III: one or more criteria are fulfilled,IgG,32,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/31/2019,7/12/2019,7/12/2019,9/20/2019,12/31/2020, , , , , , , 
4049,9309,6/15/1959,Female,168,70,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,3975,ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/2/2019,6/30/2019, , , , , , , , , , 
4050,6775,6/15/1940,Female,168,80,Compulsory health insurance CHI,Yes,Yes, , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,35,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/21/2019,6/27/2019,6/27/2019, , , , , , , , , 
4051,5059,6/15/1936,Male,174,80,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,15,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/27/2019,3/31/2022, , , , , , , , , , 
4052,3364,6/15/1953,Female,172,85,Compulsory health insurance CHI,Yes,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,79,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,ISA-X,V-X,3/26/2019,7/30/2019,7/30/2019,8/1/2019,8/9/2020,8/9/2020,8/26/2020,7/7/2021,7/7/2021,8/5/2021,3/31/2022,10/14/1582
4053,4367,6/15/1928,Male,190,90,Private,No, , , ,Yes,Yes, ,Yes, , , ,1,Unknown,IgG,999,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,V-X,No CTx,No CTx, , , ,11/16/2015,11/16/2017,11/16/2017,3/6/2019,3/31/2019, , , , 
4054,8241,6/15/1947,Male,180,80,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"4,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/1/2016,12/11/2018,12/11/2018,2/19/2019,9/30/2019, , , , , , , 
4055,4829,6/15/1946,Male,173,90,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,10/10/2010,3/1/2011,3/1/2011,2/10/2012,4/27/2012,4/27/2012,2/25/2019,2/14/2022,2/14/2022,2/21/2022,3/31/2022, 
4056,7624,6/15/1949,Male,175,62,Private,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,1200,ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/7/2019,3/7/2019,3/7/2019, , , , , , , , , 
4057,8814,6/15/1944,Female,167,97,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,DAR-X,1/11/2019,7/31/2020,7/31/2020,9/14/2020,9/30/2021,10/14/1582, , , , , , 
4058,6248,6/15/1958,Male,180,168,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,DAR-X,3/1/2019,2/28/2020,2/28/2020, , , , , , , , , 
4059,3121,6/15/1951,Female,168,76,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,9/25/2017,3/1/2018,3/1/2018,5/15/2018,11/15/2018,11/15/2018, , , , , , 
4060,7222,6/15/1935,Male,170,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,28,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,R-X,1/15/2019,3/31/2022, , , , , , , , , , 
4061,2921,6/15/1936,Male,180,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,1/10/2017,7/21/2017,7/21/2017,8/11/2017,7/22/2018,7/22/2018,3/5/2019,3/31/2022, , , , 
4062,8986,6/15/1951,Male,188,90,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,15000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/23/2017,1/15/2018,1/15/2018,3/11/2019,5/29/2019,5/29/2019, , , , , , 
4063,5480,6/15/1946,Male,173,90,Compulsory health insurance CHI,Yes,Yes, ,Yes, ,Yes, , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,No CTx,V-X,11/3/2010,4/4/2011,4/4/2011,2/10/2012,4/23/2012,4/23/2012,2/25/2019,12/31/2021,10/14/1582, , , 
4064,2291,6/15/1942,Male,182,83,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/1/2019,12/1/2019,12/1/2019,3/1/2020,12/31/2021,10/14/1582, , , , , , 
4065,5637,6/15/1955,Male,187,90,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,26,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,3/1/2019,6/1/2019,6/1/2019,3/1/2020,3/1/2021,3/1/2021,3/1/2021,6/30/2021, , , , 
4066,3130,6/15/1946,Male,170,79,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,69,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/28/2019,12/31/2019, , , , , , , , , , 
4067,7597,6/15/1963,Female,158,55,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"101,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/3/2019,9/30/2019, , , , , , , , , , 
4068,9500,6/15/1946,Female,155,53,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,48,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Ja,R-X,No CTx,No CTx,V-X,12/15/2014,3/10/2015,3/10/2015,3/11/2019,3/31/2022,10/14/1582, , , , , , 
4069,6806,6/15/1935,Female,168,83,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,7",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,Other,7/11/2017,7/11/2018,7/11/2018,6/18/2019,12/31/2019, , , , , , , 
4070,2345,6/15/1936,Female,165,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"4,74",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,Other,5/10/2006,8/27/2006,8/27/2006,6/18/2019,12/31/2019, , , , , , , 
4071,9918,6/15/1936,Female,160,44,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, ,Yes, ,1,Unknown,IgG,263,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,5/3/2019,6/30/2019, , , , , , , , , , 
4072,5333,6/15/1942,Male,169,83,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/28/2019,3/31/2022,10/14/1582, , , , , , , , , 
4073,2069,6/15/1941,Male,172,61,Compulsory health insurance CHI,No, , ,Yes,Yes,Unknown,Unknown,Unknown, , , ,9,III: one or more criteria are fulfilled,IgA,24,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , , ,R-X,No CTx,No CTx,V-X,3/20/2018,1/16/2019,1/16/2019,6/18/2019,3/31/2020,10/14/1582, , , , , , 
4074,7625,6/15/1944,Male,178,68,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"999,99",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/12/2018,5/22/2019,5/22/2019, , , , , , , , , 
4075,2332,6/15/1956,Male,180,87,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , ,Yes,0,I: fulfilling all 4 criteria,IgG,"3,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/14/2018,9/28/2018,9/28/2018, , , , , , , , , 
4076,2702,6/15/1937,Female,160,58,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Unknown, , , ,9,III: one or more criteria are fulfilled,IgA,"4,8",ISS stage II (neither stage I nor stage III),9,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,No CTx,V-X,4/19/2017,12/14/2017,12/14/2017,6/13/2019,9/3/2020,9/3/2020,9/8/2020,9/30/2020, , , , 
4077,4557,6/15/1933,Male,173,93,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Unknown,Yes, ,Yes,Unknown,9,III: one or more criteria are fulfilled,IgA,"13,88","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/15/2019,9/30/2020, , , , , , , , , , 
4078,9796,6/15/1944,Female,164,56,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,DAR-X,4/3/2019,10/18/2021,10/18/2021,11/17/2021,3/31/2022, , , , , , , 
4079,7799,6/15/1962,Female,166,87,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"2,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/6/2019,9/9/2019,9/9/2019, , , , , , , , , 
4080,5338,6/15/1954,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,99999999,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,LEV-X,V-X,11/1/2013,1/1/2014,1/1/2014,10/15/2017,6/15/2018,6/15/2018,12/1/2018,4/1/2019,4/1/2019,4/6/2019,8/2/2019,8/2/2019
4081,1390,6/15/1959,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , , ,DAR-X,No CTx,No CTx,V-X,8/19/2013,12/18/2013,12/18/2013,4/26/2019,8/20/2019,8/20/2019, , , , , , 
4082,7435,6/15/1954,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"5,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,Other,No CTx,No CTx,V-X,4/24/2006,7/23/2006,7/23/2006,10/15/2013,4/9/2019,4/9/2019, , , , , , 
4083,7585,6/15/1954,Male,999,80,Private,Yes, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"2,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,3/14/2014,5/22/2014,5/22/2014,4/24/2019,7/24/2019,7/24/2019, , , , , , 
4084,5770,6/15/1951,Male,178,68,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, ,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgA,"47,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/26/2019,7/29/2019,7/29/2019, , , , , , , , , 
4085,8587,6/15/1934,Female,158,55,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"29,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/22/2019,10/13/2020,10/13/2020,3/12/2021,3/31/2022, , , , , , , 
4086,1687,6/15/1943,Female,170,70,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,22,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,DAR-X,KYP-X,V-X,4/23/2018,7/19/2018,7/19/2018,6/12/2019,6/27/2020,6/27/2020,6/30/2020,6/3/2021,6/3/2021,6/17/2021,3/31/2022,10/14/1582
4087,9950,6/15/1945,Male,186,87,Compulsory health insurance CHI,Yes, , , ,Yes,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,32,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,EMP-X,EMP-X,KYP-X,V-X,3/12/2018,7/17/2018,7/17/2018,6/20/2019,6/26/2020,6/26/2020,7/23/2020,6/20/2021,6/20/2021,6/22/2021,3/23/2022,3/23/2022
4088,5113,6/15/1947,Male,189,89,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,27,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,EMP-X,NIN-X,V-X,5/23/2017,8/9/2018,8/9/2018,6/17/2019,10/9/2019,10/9/2019,12/11/2019,10/29/2020,10/29/2020,11/4/2020,8/20/2021,8/20/2021
4089,7357,6/15/1946,Female,165,77,Private,No,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,19,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,DAR-X,No CTx,V-X,12/12/2016,2/9/2018,2/9/2018,6/24/2019,10/23/2019,10/23/2019,12/19/2019,11/17/2020,11/17/2020, , , 
4090,9522,6/15/1949,Female,170,76,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,KYP-X,EMP-X,V-X,3/22/2016,7/17/2017,7/17/2017,5/23/2019,9/19/2019,9/19/2019,9/25/2019,7/20/2020,7/20/2020,7/25/2020,6/1/2021,6/1/2021
4091,4680,6/15/1950,Male,190,89,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,25,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,5/14/2016,6/3/2017,6/3/2017,6/21/2019,10/1/2019,10/1/2019,12/18/2019,12/2/2020,12/2/2020,12/31/2020,9/6/2021,9/6/2021
4092,1404,6/15/1948,Male,186,87,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,25,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,FAR-X,EMP-X,V-X,11/2/2016,3/19/2017,3/19/2017,3/28/2019,2/11/2020,2/11/2020,3/27/2020,3/6/2021,3/6/2021,3/26/2021,3/3/2022,3/3/2022
4093,9578,6/15/1950,Male,189,98,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,25,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,V-X,V-X,6/9/2017,11/3/2017,11/3/2017,6/18/2019,10/9/2019,10/9/2019,12/13/2019,11/13/2020,11/13/2020,12/19/2020,11/30/2021,11/30/2021
4094,2728,6/15/1943,Male,175,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,2",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,DAR-X,5/7/2019,4/15/2021,4/15/2021,5/19/2021,9/30/2021, , , , , , , 
4095,3386,6/15/1937,Female,172,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,695,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Unbekannt, , , ,"<3,5 mg/L", ,V-X,No CTx,No CTx,V-X,12/18/2012,2/5/2013,2/5/2013,5/21/2019,6/30/2019, , , , , , , 
4096,3102,6/15/1951,Female,168,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgD,600,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , , , ,V-X,No CTx,No CTx,Other,10/22/2007,2/11/2008,2/11/2008,4/1/2019,8/15/2019,8/15/2019, , , , , , 
4097,5370,6/15/1940,Female,170,69,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/14/2019,8/25/2019,8/25/2019, , , , , , , , , 
4098,8803,6/15/1951,Female,174,88,Self-Payer,No,Yes, , , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,17,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,6/21/2019,6/23/2020,6/23/2020,9/11/2020,8/17/2021,8/17/2021,9/21/2021,3/31/2022,10/14/1582, , , 
4099,5158,6/15/1946,Female,168,88,Private,No, , , , ,Yes,Yes,Yes, , ,Yes,0,III: one or more criteria are fulfilled,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,EMP-X,NIN-X,EMP-X,V-X,6/24/2019,11/18/2019,11/18/2019,12/17/2019,9/23/2020,9/23/2020,11/6/2020,9/6/2021,9/6/2021,9/28/2021,3/31/2022,10/14/1582
4100,2217,6/15/1958,Male,180,78,Compulsory health insurance CHI,No, , , ,Yes, , , ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,7436,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/29/2019,7/11/2019,7/11/2019, , , , , , , , , 
4101,2120,6/15/1937,Female,160,64,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , ,Yes, ,9,III: one or more criteria are fulfilled,IgG,3592,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/27/2019,11/26/2019,11/26/2019, , , , , , , , , 
4102,7398,6/15/1949,Female,175,99,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,2476,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/27/2019,8/8/2019,8/8/2019, , , , , , , , , 
4103,5218,6/15/1944,Female,155,55,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"2,06","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,EMP-X,No CTx,No CTx,V-X,6/25/2018,8/30/2018,8/30/2018,9/28/2020,3/31/2022, , , , , , , 
4104,8230,6/15/1937,Male,168,78,Compulsory health insurance CHI,Yes, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/16/2012,9/18/2013,9/18/2013,5/2/2019,1/30/2020,1/30/2020, , , , , , 
4105,8033,6/15/1939,Female,158,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,6021,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Unbekannt,Nein,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,6/13/2018,8/7/2018,8/7/2018, , , , , , , , , 
4106,2420,6/15/1954,Male,170,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,5474,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Unbekannt,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/16/2019,6/30/2019, , , , , , , , , , 
4107,8359,6/15/1952,Female,153,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,1414,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,4/1/2019,6/30/2019, , , , , , , , , , 
4108,8898,6/15/1947,Male,176,93,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,Other type,407,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,Other,7/15/2019, , , , , , , , , , , 
4109,1453,6/15/1927,Male,163,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,4850,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,4/9/2019,6/4/2019,6/4/2019, , , , , , , , , 
4110,6692,6/15/1968,Female,182,62,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,2348,unknown/ISS-Criteria not used for prognostics,No,No,Yes,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,5/16/2019,6/30/2019, , , , , , , , , , 
4111,3766,6/15/1942,Female,160,90,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,2388,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/7/2019,6/30/2019, , , , , , , , , , 
4112,3818,6/15/1951,Male,168,67,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgM,19,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/6/2019,6/30/2019, , , , , , , , , , 
4113,5094,6/15/1938,Male,170,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,2310,unknown/ISS-Criteria not used for prognostics,No,No,No,9,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,6/4/2019,6/30/2019, , , , , , , , , , 
4114,8990,6/15/1961,Female,165,64,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,6/10/2019,8/25/2019,8/25/2019,7/19/2021,12/31/2021, , , , , , , 
4115,7861,6/15/1958,Male,181,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/28/2019,8/11/2019,8/11/2019, , , , , , , , , 
4116,9727,6/15/1938,Male,174,81,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,3",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,6/24/2019,12/15/2019,12/15/2019,3/30/2021,6/27/2021,6/27/2021, , , , , , 
4117,6144,6/15/1947,Female,164,55,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"9999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/11/2019,7/30/2020,7/30/2020, , , , , , , , , 
4118,6389,6/15/1946,Male,172,72,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1, ,IgG,"56,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/5/2019,5/24/2019,5/24/2019, , , , , , , , , 
4119,7436,6/15/1983,Female,160,60,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"56,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,1/15/2018,5/28/2019,5/28/2019,6/14/2019,9/5/2019,9/5/2019, , , , , , 
4120,7932,6/15/1937,Male,170,88,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2, ,IgG,4522,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/28/2018,9/8/2018,9/8/2018,5/8/2019,6/27/2019,6/27/2019, , , , , , 
4121,7921,6/15/1942,Female,153,49,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"31,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/24/2019,4/11/2019,4/11/2019, , , , , , , , , 
4122,1123,6/15/1949,Male,179,80,Private,No, , , , , , , , , , ,3,III: one or more criteria are fulfilled,IgG,"7,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,EMP-X,R-X,4/24/2019,3/10/2020,3/10/2020,3/23/2020,2/4/2021,2/4/2021,2/15/2021,2/8/2022,2/8/2022,2/14/2022,3/31/2022, 
4123,4840,6/15/1950,Male,185,80,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"5,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,DAR-X,EMP-X,V-X,12/6/2016,9/28/2017,9/28/2017,5/13/2019,8/26/2020,8/26/2020,9/2/2020,7/28/2021,7/28/2021,8/25/2021,3/31/2022,10/14/1582
4124,9830,6/15/1940,Female,162,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"376,3",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,5/24/2019,5/31/2019,5/31/2019,9/23/2019,12/31/2019, , , , , , , 
4125,9673,6/15/1961,Female,164,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,280,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,8/18/2015,11/9/2015,11/9/2015, , , , , , , , , 
4126,7930,6/15/1940,Female,160,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/2/2015,6/4/2019,6/4/2019,7/12/2021,10/11/2021,10/11/2021, , , , , , 
4127,7567,6/15/1952,Male,165,80,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"72,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,9,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/24/2019,9/7/2019,9/7/2019,12/23/2020,2/5/2021,2/5/2021, , , , , , 
4128,3232,6/15/1949,Male,176,82,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes,Yes, ,1,I: fulfilling all 4 criteria,IgG,"2,72",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/17/2019,12/17/2019,12/17/2019,3/3/2020,10/29/2020,10/29/2020, , , , , , 
4129,2106,6/15/1945,Female,161,48,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"20,16","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/22/2019,7/22/2019,7/22/2019,11/22/2021,3/31/2022, , , , , , , 
4130,8774,6/15/1947,Male,186,98,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,07",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/25/2019,8/25/2019,8/25/2019, , , , , , , , , 
4131,1327,6/15/1950,Male,199,98,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,59",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,4/5/2019,10/11/2019,10/11/2019,7/29/2021,3/31/2022, , , , , , , 
4132,3088,6/15/1952,Female,166,73,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,12",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/30/2019,6/4/2020,6/4/2020, , , , , , , , , 
4133,1585,6/15/1957,Male,181,58,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/11/2019,6/11/2019,6/11/2019, , , , , , , , , 
4134,3649,6/15/1950,Male,186,82,Private,No,Yes, ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"5,4",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/11/2019,9/26/2019,9/26/2019,9/9/2020,6/21/2021,6/21/2021, , , , , , 
4135,5282,6/15/1945,Male,170,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,12",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/3/2019,5/26/2020,5/26/2020, , , , , , , , , 
4136,7704,6/15/1952,Female,169,86,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,31",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/1/2019,6/22/2020,6/22/2020, , , , , , , , , 
4137,1843,6/15/1952,Female,169,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,84",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/31/2019,11/28/2019,11/28/2019,10/10/2020,3/31/2022,10/14/1582, , , , , , 
4138,6675,6/15/1931,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/15/2019,9/30/2019, , , , , , , , , , 
4139,8358,6/15/1953,Female,155,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,76",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/14/2019,8/14/2019,8/14/2019,8/18/2021,3/31/2022, , , , , , , 
4140,5543,6/15/1953,Female,155,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,21",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/11/2019,8/11/2019,8/11/2019, , , , , , , , , 
4141,6098,6/15/1944,Male,168,48,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,DAR-X,No CTx,R-X,6/3/2019,1/16/2021,1/16/2021,2/7/2021,7/28/2021,7/28/2021,8/12/2021,3/31/2022,10/14/1582, , , 
4142,2817,6/15/1954,Female,166,49,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,99",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,6/6/2019,1/27/2021,1/27/2021,2/8/2021,8/16/2021,8/16/2021, , , , , , 
4143,3970,6/15/1963,Male,183,79,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/28/2019,8/30/2019,8/30/2019, , , , , , , , , 
4144,3131,6/15/1946,Male,176,79,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,56",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/28/2019,1/3/2020,1/3/2020, , , , , , , , , 
4145,6420,6/15/1938,Female,179,82,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,84",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/16/2019,9/12/2019,9/12/2019,3/17/2022,3/31/2022, , , , , , , 
4146,8062,6/15/1952,Female,156,62,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,67",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,KYP-X,POM-X,R-X,3/28/2019,4/29/2019,4/29/2019,5/2/2019,10/29/2019,10/29/2019,12/17/2020,4/8/2021,4/8/2021,4/17/2021,1/5/2022,1/5/2022
4147,1331,6/15/1951,Male,175,81,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,06",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/2/2019,8/29/2019,8/29/2019, , , , , , , , , 
4148,2327,6/15/1951,Male,177,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,71",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,5/20/2019,5/12/2020,5/12/2020,12/6/2020,7/27/2021,7/27/2021,8/16/2021,3/31/2022,10/14/1582, , , 
4149,7706,6/15/1951,Male,193,91,Private,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"24,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/12/2019,8/12/2019,8/12/2019, , , , , , , , , 
4150,5504,6/15/1940,Male,189,92,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"21,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/30/2019,5/22/2020,5/22/2020, , , , , , , , , 
4151,6270,6/15/1953,Male,172,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"7,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,5/6/2019,7/30/2020,7/30/2020,8/19/2020,7/2/2021,7/2/2021,8/13/2021,3/31/2022,10/14/1582, , , 
4152,4630,6/15/1932,Male,184,91,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/6/2019,5/11/2020,5/11/2020, , , , , , , , , 
4153,6053,6/15/1945,Male,180,77,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,56",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/7/2019,5/30/2020,5/30/2020, , , , , , , , , 
4154,4646,6/15/1930,Male,183,82,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"14,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/1/2019,4/23/2020,4/23/2020, , , , , , , , , 
4155,4877,6/15/1950,Male,178,75,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"15,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/6/2019,5/29/2020,5/29/2020, , , , , , , , , 
4156,7067,6/15/1961,Male,172,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/9/2019,7/30/2019,7/30/2019,2/8/2022,3/31/2022, , , , , , , 
4157,1919,6/15/1952,Female,168,80,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,35",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/11/2019,8/11/2019,8/11/2019,12/6/2021,3/31/2022, , , , , , , 
4158,7129,6/15/1946,Male,166,88,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,8",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/30/2019,7/30/2019,7/30/2019, , , , , , , , , 
4159,9434,6/15/1965,Male,176,88,Compulsory health insurance CHI,No, , , ,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"7,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/12/2019,9/7/2019,9/7/2019, , , , , , , , , 
4160,6734,6/15/1949,Male,190,90,Private,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,ISA-X,V-X,3/11/2016,2/10/2017,2/10/2017,5/24/2019,3/5/2020,3/5/2020,3/12/2020,3/16/2021,3/16/2021,3/24/2021,7/14/2021,7/14/2021
4161,7407,6/15/1962,Female,160,62,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,6/7/2019,9/17/2019,9/17/2019,10/12/2021,12/8/2021,12/8/2021, , , , , , 
4162,3006,6/15/1943,Male,185,88,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,DAR-X,POM-X,KYP-X,R-X,11/20/2017,2/21/2019,2/21/2019,5/22/2019,7/13/2020,7/13/2020,9/16/2020,10/22/2020,10/22/2020,11/17/2020,8/3/2021,8/3/2021
4163,9060,6/15/1952,Male,185,73,Compulsory health insurance CHI,Unknown, , , , ,Yes, , , ,Yes, ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,KYP-X,DAR-X,V-X,10/8/2011,11/3/2011,11/3/2011,12/1/2013,11/1/2015,11/1/2015,4/6/2016,9/14/2016,9/14/2016,12/14/2016,4/10/2019,4/10/2019
4164,4114,6/15/1946,Male,190,90,Compulsory health insurance CHI,No,Yes,Unknown,Yes,Unknown,Unknown,Unknown, , , ,Yes,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,4/2/2019,4/11/2019,4/11/2019,4/25/2019,6/17/2021,6/17/2021,6/30/2021,3/31/2022, , , , 
4165,5358,6/15/1939,Female,158,72,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/24/2019,3/31/2021,10/14/1582, , , , , , , , , 
4166,6919,6/15/1948,Female,158,72,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,5222,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,Other,No CTx,No CTx,V-X,3/6/2017,8/14/2017,8/14/2017,6/3/2019,8/1/2019,8/1/2019, , , , , , 
4167,4517,6/15/1954,Male,170,72,Private,Unknown, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,5/16/2019,8/22/2019,8/22/2019,9/30/2019,11/19/2019,11/19/2019, , , , , , 
4168,2006,6/15/1952,Female,153,60,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,No,No,Yes,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Ja,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,4/1/2019,9/18/2019,9/18/2019, , , , , , , , , 
4169,3392,6/15/1947,Male,176,93,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , , ,Other,No CTx,No CTx,V-X,10/27/2016,9/26/2017,9/26/2017,5/17/2019,10/7/2019,10/7/2019, , , , , , 
4170,9806,6/15/1927,Male,163,75,Private,Unknown,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,4628,unknown/ISS-Criteria not used for prognostics,9,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,3/13/2019,6/5/2019,6/5/2019, , , , , , , , , 
4171,4925,6/15/1968,Female,182,62,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,2305,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/16/2019,10/1/2019,10/1/2019, , , , , , , , , 
4172,8683,6/15/1942,Female,160,90,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/7/2019,9/11/2019,9/11/2019, , , , , , , , , 
4173,7794,6/15/1951,Male,168,68,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,Yes,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , , , ,V-X,R-X,No CTx,V-X,5/6/2019,9/4/2019,9/4/2019,9/28/2020,12/9/2020,12/9/2020,12/15/2020,3/31/2021, , , , 
4174,1039,6/15/1938,Male,170,82,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes, , , , , ,1,Unknown,IgG,1994,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,5/6/2019,1/10/2020,1/10/2020,2/6/2020,2/12/2020,2/12/2020, , , , , , 
4175,2790,6/15/1937,Male,176,71,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"17,35",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,Other,No CTx,No CTx,V-X,5/3/2019,8/21/2019,8/21/2019,3/16/2020,6/23/2020,6/23/2020, , , , , , 
4176,2976,6/15/1954,Female,168,77,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,35","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,6/6/2019,5/29/2020,5/29/2020,8/9/2021,3/31/2022, , , , , , , 
4177,3663,6/15/1953,Male,173,100,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,I: fulfilling all 4 criteria,IgA,"2,73",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,6/3/2019,8/3/2019,8/3/2019,12/21/2020,4/21/2021,4/21/2021,5/5/2021,12/31/2021, , , , 
4178,4416,6/15/1950,Female,157,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,48",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/24/2019,12/23/2019,12/23/2019, , , , , , , , , 
4179,9532,6/15/1942,Male,168,57,Private,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"2,4",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,V-X,DAR-X,DAR-X,V-X,4/23/2015,6/18/2015,6/18/2015,11/26/2018,1/17/2019,1/17/2019,6/11/2019,11/19/2019,11/19/2019,5/12/2021,10/6/2021,10/6/2021
4180,8117,6/15/1954,Male,175,134,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/28/2019,9/7/2019,9/7/2019, , , , , , , , , 
4181,6878,6/15/1945,Male,171,80,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,49",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/21/2019,6/13/2019,6/13/2019,6/24/2019,6/16/2020,6/16/2020, , , , , , 
4182,2949,6/15/1948,Female,153,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,5/16/2019,2/5/2020,2/5/2020,2/14/2020,4/2/2020,4/2/2020, , , , , , 
4183,3975,6/15/1945,Male,177,103,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"2,84",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/2/2019,7/2/2019,7/2/2019,11/22/2021,3/31/2022, , , , , , , 
4184,7266,6/15/1949,Female,165,90,Private,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/17/2019,5/22/2020,5/22/2020,2/26/2021,3/31/2022,10/14/1582, , , , , , 
4185,2233,6/15/1947,Male,192,99,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,28",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/3/2019,6/8/2020,6/8/2020,2/16/2022,3/31/2022,10/14/1582, , , , , , 
4186,2103,6/15/1953,Male,183,83,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,51",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/17/2019,7/17/2019,7/17/2019, , , , , , , , , 
4187,2223,6/15/1949,Female,158,62,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,35",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/6/2019,10/21/2019,10/21/2019,7/12/2020,12/31/2020,10/14/1582, , , , , , 
4188,5002,6/15/1948,Male,188,96,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,32",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/16/2019,6/26/2020,6/26/2020, , , , , , , , , 
4189,4366,6/15/1953,Male,188,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,82",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/11/2019,6/16/2020,6/16/2020, , , , , , , , , 
4190,5284,6/15/1945,Male,177,55,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"32,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/27/2019,12/31/2020, , , , , , , , , , 
4191,1298,6/15/1953,Male,184,70,Private,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"33,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,5/10/2019,7/22/2020,7/22/2020,8/2/2020,12/31/2020, , , , , , , 
4192,1860,6/15/1947,Female,155,54,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,83",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/22/2019,12/31/2020, , , , , , , , , , 
4193,4706,6/15/1945,Male,182,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"8,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,6/3/2019,7/2/2020,7/2/2020,1/25/2022,3/31/2022, , , , , , , 
4194,1021,6/15/1929,Female,162,48,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,78",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/7/2018,11/20/2018,11/20/2018,7/10/2019,1/8/2021,1/8/2021, , , , , , 
4195,7335,6/15/1945,Male,165,69,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,87",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,No CTx,V-X,6/14/2019,11/29/2019,11/29/2019,7/5/2021,12/7/2021,12/7/2021,12/16/2021,3/31/2022, , , , 
4196,6097,6/15/1952,Female,174,55,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"21,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/14/2019,12/18/2019,12/18/2019, , , , , , , , , 
4197,1147,6/15/1946,Female,174,56,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,6/13/2019,6/5/2020,6/5/2020,2/10/2022,3/31/2022, , , , , , , 
4198,6757,6/15/1944,Male,170,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/3/2019,4/8/2020,4/8/2020, , , , , , , , , 
4199,4344,6/15/1947,Male,172,73,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,27",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/19/2019,12/18/2019,12/18/2019, , , , , , , , , 
4200,1523,6/15/1936,Male,168,75,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,61,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Ja,No CTx,No CTx,No CTx,DAR-X,6/4/2019,3/31/2022, , , , , , , , , , 
4201,4454,6/15/1953,Male,165,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,60,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,ISA-X,No CTx,V-X,5/21/2019,7/30/2019,7/30/2019,8/8/2019,11/4/2019,11/4/2019,12/1/2021,3/31/2022,10/14/1582, , , 
4202,6570,6/15/1937,Female,163,84,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/21/2019,1/5/2022,1/5/2022, , , , , , , , , 
4203,9847,6/15/1934,Male,180,88,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,65,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,V-X,POM-X,DAR-X,R-X,5/16/2019,2/2/2020,2/2/2020,2/20/2020,11/2/2020,11/2/2020,11/21/2020,7/21/2021,7/21/2021,7/28/2021,10/28/2021,10/28/2021
4204,4795,6/15/1938,Female,163,70,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,54,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,6/15/2019,2/25/2021,2/25/2021,3/17/2021,3/31/2022, , , , , , , 
4205,3974,6/15/1967,Female,161,60,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"13,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,11/21/2018,2/14/2019,2/14/2019,6/3/2019,11/16/2020,11/16/2020,12/1/2020,3/31/2022,10/14/1582, , , 
4206,6875,6/15/1932,Male,169,51,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,66",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/17/2018,12/17/2018,12/17/2018,6/6/2019,5/29/2020,5/29/2020, , , , , , 
4207,9293,6/15/1944,Male,174,97,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,75",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,POM-X,R-X,11/26/2018,5/16/2019,5/16/2019,5/29/2019,10/11/2019,10/11/2019,12/10/2019,7/10/2020,7/10/2020,7/21/2020,8/2/2021,8/2/2021
4208,5623,6/15/1946,Male,189,94,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"11,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,11/2/2018,4/30/2019,4/30/2019,5/23/2019,7/23/2019,7/23/2019, , , , , , 
4209,6465,6/15/1947,Male,171,68,Private,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,32",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,EMP-X,No CTx,V-X,11/12/2018,3/7/2019,3/7/2019,5/23/2019,2/6/2020,2/6/2020,5/12/2020,3/31/2022,10/14/1582, , , 
4210,7989,6/15/1952,Male,181,120,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"21,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,R-X,11/7/2018,4/30/2019,4/30/2019,5/9/2019,2/12/2021,2/12/2021,2/28/2021,7/28/2021,7/28/2021,9/2/2021,1/25/2022,1/25/2022
4211,3409,6/15/1949,Male,181,84,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,11",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,11/15/2018,5/6/2019,5/6/2019,5/23/2019,10/12/2021,10/12/2021, , , , , , 
4212,3600,6/15/1958,Male,186,124,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,R-X,No CTx,R-X,11/20/2018,5/7/2019,5/7/2019,6/2/2019,11/27/2019,11/27/2019,5/30/2020,3/16/2021,3/16/2021, , , 
4213,5403,6/15/1929,Male,180,84,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,5,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,10/22/2018,1/23/2019,1/23/2019,5/10/2019,1/27/2021,1/27/2021,2/15/2021,5/27/2021,5/27/2021, , , 
4214,4063,6/15/1964,Male,180,75,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,NIN-X,POM-X,R-X,11/1/2018,4/23/2019,4/23/2019,5/9/2019,1/2/2020,1/2/2020,5/8/2020,10/23/2020,10/23/2020,11/17/2020,1/23/2021,1/23/2021
4215,2996,6/15/1939,Male,185,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,89",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,11/29/2018,5/21/2019,5/21/2019,6/3/2019,1/2/2020,1/2/2020,4/25/2020,6/30/2021,10/14/1582, , , 
4216,5642,6/15/1947,Female,153,53,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"30,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,LEV-X,No CTx,No CTx,R-X,12/14/2018,6/3/2019,6/3/2019,6/17/2019,4/14/2020,4/14/2020, , , , , , 
4217,5719,6/15/1954,Male,174,53,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"22,95","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,11/21/2017,5/17/2018,5/17/2018,11/27/2018,5/23/2019,5/23/2019,6/4/2019,6/22/2019,6/22/2019,7/24/2019,3/23/2020,3/23/2020
4218,7219,6/15/1946,Female,176,76,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,38",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,10/12/2018,1/11/2019,1/11/2019,6/10/2019,10/5/2021,10/5/2021, , , , , , 
4219,9243,6/15/1949,Female,174,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"12,95","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,12/4/2017,5/22/2018,5/22/2018,12/20/2018,6/6/2019,6/6/2019,6/24/2019,1/4/2021,1/4/2021,9/2/2021,3/31/2022,10/14/1582
4220,1222,6/15/1931,Female,162,97,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,POM-X,R-X,11/20/2018,5/15/2019,5/15/2019,6/3/2019,7/9/2021,7/9/2021,7/21/2021,12/9/2021,12/9/2021,1/20/2022,3/31/2022, 
4221,3186,6/15/1954,Male,162,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,11/1/2018,3/4/2019,3/4/2019,5/14/2019,12/2/2020,12/2/2020,12/13/2020,12/31/2020, , , , 
4222,8644,6/15/1951,Female,170,65,Private,No, , , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"27,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,11/19/2018,5/14/2019,5/14/2019,6/3/2019,1/20/2022,1/20/2022,2/16/2022,3/31/2022, , , , 
4223,1574,6/15/1954,Male,162,64,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"30,43","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,8/28/2018,12/24/2018,12/24/2018,5/24/2019,2/3/2020,2/3/2020,2/4/2020,12/31/2020, , , , 
4224,1287,6/15/1945,Male,195,126,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"7,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,10/12/2018,1/14/2019,1/14/2019,6/10/2019,7/26/2021,7/26/2021, , , , , , 
4225,4598,6/15/1934,Male,173,79,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,27",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/28/2017,1/4/2018,1/4/2018,7/11/2018,12/31/2020,10/14/1582, , , , , , 
4226,2655,6/15/1968,Male,185,79,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/12/2018,1/14/2019,1/14/2019,6/10/2019,3/31/2022,10/14/1582, , , , , , 
4227,4595,6/15/1945,Male,176,62,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,75",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/30/2018,12/5/2018,12/5/2018,6/6/2019,3/31/2022,10/14/1582, , , , , , 
4228,8948,6/15/1941,Male,170,63,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,04",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/9/2018,1/15/2019,1/15/2019,5/17/2019,5/9/2020,5/9/2020, , , , , , 
4229,8628,6/15/1948,Female,168,63,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes, , ,1,I: fulfilling all 4 criteria,IgG,"4,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,1/4/2019,3/28/2019,3/28/2019,6/13/2019,3/31/2022,10/14/1582, , , , , , 
4230,8660,6/15/1954,Female,163,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/19/2017,1/23/2018,1/23/2018,6/21/2018,12/31/2020,10/14/1582, , , , , , 
4231,5351,6/15/1954,Female,155,76,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,17",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,10/25/2018,2/18/2019,2/18/2019,6/10/2019,9/7/2021,9/7/2021,10/5/2021,3/31/2022,10/14/1582, , , 
4232,3610,6/15/1944,Female,172,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,97",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,12/11/2017,3/16/2018,3/16/2018,6/26/2019,2/9/2022,2/9/2022,2/16/2022,3/31/2022, , , , 
4233,5436,6/15/1946,Female,167,60,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"10,69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,10/25/2017,4/23/2018,4/23/2018,10/22/2018,4/22/2019,4/22/2019,5/9/2019,12/31/2020, , , , 
4234,5101,6/15/1954,Female,155,43,Private,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,24",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,KYP-X,POM-X,V-X,7/26/2018,11/16/2018,11/16/2018,6/19/2019,1/2/2020,1/2/2020,4/20/2020,1/18/2022,1/18/2022,1/25/2022,3/31/2022, 
4235,2989,6/15/1952,Female,166,75,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,4",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,V-X,10/17/2018,1/21/2019,1/21/2019,6/5/2019,12/23/2019,12/23/2019,1/2/2020,12/19/2020,12/19/2020,1/11/2021,12/15/2021,12/15/2021
4236,6015,6/15/1945,Male,170,61,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"12,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,2/15/2018,8/6/2018,8/6/2018,10/29/2018,4/22/2019,4/22/2019,5/3/2019,4/25/2020,4/25/2020, , , 
4237,7552,6/15/1944,Female,170,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,31",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,NIN-X,V-X,R-X,11/28/2018,5/23/2019,5/23/2019,6/7/2019,12/5/2019,12/5/2019,5/5/2020,4/20/2021,4/20/2021,5/3/2021,9/8/2021,9/8/2021
4238,3885,6/15/1944,Female,170,60,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,88",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,12/17/2018,6/10/2019,6/10/2019,6/24/2019,12/23/2019,12/23/2019,1/22/2020,9/3/2021,9/3/2021, , , 
4239,2570,6/15/1935,Male,168,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,NIN-X,No CTx,R-X,11/30/2018,5/27/2019,5/27/2019,6/13/2019,1/8/2021,1/8/2021,7/29/2021,3/31/2022, , , , 
4240,8100,6/15/1946,Female,167,60,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"12,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,V-X,V-X,2/27/2018,8/16/2018,8/16/2018,11/8/2018,5/8/2019,5/8/2019,5/28/2019,6/26/2019,6/26/2019,7/29/2019,9/4/2019,9/4/2019
4241,6262,6/15/1935,Male,168,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"10,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,R-X,11/20/2018,5/16/2019,5/16/2019,6/3/2019,9/16/2020,9/16/2020,6/22/2021,7/28/2021,7/28/2021, , , 
4242,7565,6/15/1947,Female,169,58,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,2/28/2018,8/22/2018,8/22/2018,12/5/2018,6/4/2019,6/4/2019,6/19/2019,7/7/2019,7/7/2019,7/17/2019,8/25/2020,8/25/2020
4243,1618,6/15/1944,Male,189,121,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,5,ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,11/15/2018,2/20/2019,2/20/2019,6/17/2019,2/8/2022,2/8/2022,3/9/2022,3/31/2022, , , , 
4244,7872,6/15/1950,Female,156,64,Private,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,57",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,V-X,NIN-X,V-X,12/28/2018,4/1/2019,4/1/2019,6/20/2019,9/11/2019,9/11/2019,10/9/2019,4/22/2020,4/22/2020,12/17/2020,2/5/2021,2/5/2021
4245,4710,6/15/1946,Female,160,68,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"10,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,POM-X,V-X,1/9/2018,6/28/2018,6/28/2018,11/29/2018,5/30/2019,5/30/2019,6/12/2019,7/2/2021,7/2/2021,7/19/2021,3/31/2022, 
4246,9855,6/15/1949,Male,178,58,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"33,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,12/22/2017,6/11/2018,6/11/2018,11/26/2018,5/15/2019,5/15/2019,6/3/2019,12/31/2021, , , , 
4247,8704,6/15/1951,Male,172,54,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"31,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,10/25/2017,4/24/2018,4/24/2018,10/25/2018,4/22/2019,4/22/2019,5/13/2019,8/19/2019,8/19/2019,2/21/2020,4/17/2020,4/17/2020
4248,8391,6/15/1946,Male,184,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"14,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,11/13/2017,5/1/2018,5/1/2018,11/5/2018,4/29/2019,4/29/2019,5/17/2019,10/30/2019,10/30/2019,12/30/2019,7/6/2021,7/6/2021
4249,4624,6/15/1948,Female,161,88,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"11,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,KYP-X,V-X,11/20/2017,5/7/2018,5/7/2018,12/5/2018,6/3/2019,6/3/2019,6/17/2019,4/14/2021,4/14/2021,5/13/2021,6/23/2021,6/23/2021
4250,9944,6/15/1953,Male,174,53,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,R-X,V-X,1/1/2018,6/28/2018,6/28/2018,11/28/2018,5/21/2019,5/21/2019,6/10/2019,1/2/2020,1/2/2020,1/3/2020,10/22/2020,10/22/2020
4251,9318,6/15/1950,Female,175,104,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"18,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,4/12/2018,10/9/2018,10/9/2018,12/24/2018,6/10/2019,6/10/2019,6/25/2019,3/31/2022,10/14/1582, , , 
4252,2224,6/15/1948,Male,197,118,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,Other,V-X,12/19/2017,6/19/2018,6/19/2018,11/26/2018,5/16/2019,5/16/2019,5/28/2019,6/4/2019,6/4/2019,6/12/2019,6/25/2019,6/25/2019
4253,8529,6/15/1945,Female,166,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,07",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,1/3/2018,6/21/2018,6/21/2018,11/15/2018,5/13/2019,5/13/2019,6/7/2019,1/2/2020,1/2/2020,4/27/2020,12/18/2020,12/18/2020
4254,3354,6/15/1952,Male,178,62,Private,No,Yes,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"24,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,1/8/2018,7/2/2018,7/2/2018,12/10/2018,5/30/2019,5/30/2019,6/12/2019,8/15/2020,8/15/2020,9/10/2020,1/24/2021,1/24/2021
4255,6024,6/15/1937,Female,164,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,96",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/13/2019,4/16/2020,4/16/2020, , , , , , , , , 
4256,3229,6/15/1948,Male,175,66,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"11,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,3/20/2018,9/7/2018,9/7/2018,11/29/2018,5/23/2019,5/23/2019,7/3/2019,12/17/2019,12/17/2019, , , 
4257,6953,6/15/1947,Male,172,103,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"24,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,12/19/2017,6/18/2018,6/18/2018,12/10/2018,6/3/2019,6/3/2019,6/17/2019,10/21/2020,10/21/2020,11/16/2020,1/24/2021,1/24/2021
4258,8429,6/15/1948,Male,181,85,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,12/14/2017,6/12/2018,6/12/2018,11/22/2018,5/23/2019,5/23/2019,6/4/2019,12/7/2020,12/7/2020,12/14/2020,12/8/2021,12/8/2021
4259,8352,6/15/1947,Female,170,75,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, ,Yes, , , , ,1,I: fulfilling all 4 criteria,Other type,"8,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/25/2019,8/18/2019,8/18/2019, , , , , , , , , 
4260,1769,6/15/1954,Female,161,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"11,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,2/19/2018,8/20/2018,8/20/2018,11/27/2018,5/23/2019,5/23/2019,6/5/2019,8/3/2020,8/3/2020,8/12/2020,11/5/2021,11/5/2021
4261,8456,6/15/1951,Male,192,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/7/2018,3/7/2019,3/7/2019,6/3/2019,8/24/2021,8/24/2021, , , , , , 
4262,5744,6/15/1974,Male,179,84,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"15,17","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,11/28/2018,5/22/2019,5/22/2019,6/6/2019,8/6/2019,8/6/2019,4/14/2021,3/31/2022, , , , 
4263,3950,6/15/1947,Male,180,99,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,4",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/14/2019,12/31/2019,10/14/1582, , , , , , , , , 
4264,1455,6/15/1933,Male,173,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"17,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,10/31/2018,1/31/2019,1/31/2019,6/10/2019,1/20/2022,1/20/2022,2/16/2022,3/31/2022, , , , 
4265,1675,6/15/1947,Male,186,123,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"19,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,10/31/2018,4/17/2019,4/17/2019,5/3/2019,8/16/2019,8/16/2019, , , , , , 
4266,5440,6/15/1932,Male,183,86,Private,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,69",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,V-X,R-X,11/19/2018,5/14/2019,5/14/2019,6/4/2019,11/19/2019,11/19/2019,5/10/2020,8/13/2021,8/13/2021,8/24/2021,3/31/2022, 
4267,8422,6/15/1953,Male,182,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"27,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,POM-X,V-X,9/10/2018,12/13/2018,12/13/2018,6/5/2019,6/30/2019,6/30/2019,7/10/2019,1/2/2020,1/2/2020,4/12/2020,4/13/2020,4/13/2020
4268,7522,6/15/1949,Female,165,74,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,34",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,12/17/2018,6/6/2019,6/6/2019,6/24/2019,12/31/2021,10/14/1582, , , , , , 
4269,2280,6/15/1950,Male,181,104,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"20,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/13/2018,11/12/2018,11/12/2018,5/15/2019,1/5/2021,1/5/2021, , , , , , 
4270,4738,6/15/1950,Female,168,72,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,6",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,12/17/2018,6/6/2019,6/6/2019,6/19/2019,6/11/2020,6/11/2020, , , , , , 
4271,8204,6/15/1956,Male,182,108,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,I: fulfilling all 4 criteria,IgG,"3,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,unbekannt,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,6/17/2019,11/8/2019,11/8/2019,11/9/2020,12/31/2020, , , , , , , 
4272,4018,6/15/1932,Male,179,68,Private,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,7",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,4/24/2019,11/28/2019,11/28/2019, , , , , , , , , 
4273,5430,6/15/1969,Male,186,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,8,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/4/2019,9/10/2019,9/10/2019, , , , , , , , , 
4274,3808,6/15/1945,Male,175,79,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/6/2019,12/10/2019,12/10/2019, , , , , , , , , 
4275,9933,6/15/1938,Female,166,74,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,6350,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/6/2019,6/30/2019, , , , , , , , , , 
4276,5471,6/15/1973,Male,181,79,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,9000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/17/2019,6/30/2019, , , , , , , , , , 
4277,3893,6/15/1929,Male,165,71,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,8400,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,Other,6/3/2019,12/3/2019,12/3/2019,12/2/2021,12/31/2021, , , , , , , 
4278,6449,6/15/1947,Female,160,82,Compulsory health insurance CHI,Yes, , ,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,7000,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,4/22/2019,12/20/2019,12/20/2019,11/17/2021,12/31/2021, , , , , , , 
4279,1942,6/15/1970,Female,165,58,Private,No, ,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,11000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/3/2019,6/30/2019, , , , , , , , , , 
4280,2805,6/15/1935,Female,165,62,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,8600,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/5/2019,12/20/2019,12/20/2019,9/6/2021,12/31/2021, , , , , , , 
4281,6397,6/15/1963,Male,191,88,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,9700,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/27/2019,6/30/2019, , , , , , , , , , 
4282,2309,6/15/1946,Female,158,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"4,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,POM-X,V-X,9/26/2016,1/23/2017,1/23/2017,4/1/2019,5/19/2020,5/19/2020,6/9/2020,8/4/2020,8/4/2020,8/19/2020,12/16/2020,12/16/2020
4283,6006,6/15/1955,Female,162,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,135,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,DAR-X,6/24/2019,3/16/2020,3/16/2020,9/15/2020,4/13/2021,4/13/2021, , , , , , 
4284,9734,6/15/1944,Male,178,79,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,"10,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,12/6/2018,5/29/2019,5/29/2019,6/15/2019,6/7/2020,6/7/2020, , , , , , 
4285,9893,6/15/1941,Male,183,59,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,4/29/2014,11/18/2014,11/18/2014,11/15/2016,9/7/2017,9/7/2017,9/26/2017,4/10/2019,4/10/2019,5/21/2019,6/8/2020,6/8/2020
4286,6751,6/15/1961,Male,175,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"12,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,10/28/2015,7/5/2016,7/5/2016,5/16/2017,8/28/2018,8/28/2018,7/12/2019,10/30/2019,10/30/2019,11/12/2019,12/31/2021, 
4287,3806,6/15/1951,Male,182,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"6,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,8/18/2015,3/21/2016,3/21/2016,4/17/2018,1/22/2019,1/22/2019,1/30/2019,5/14/2019,5/14/2019,6/5/2019,7/29/2021,7/29/2021
4288,3750,6/15/1948,Female,172,59,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"8,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,KYP-X,V-X,V-X,8/11/2015,2/24/2016,2/24/2016,1/17/2017,10/26/2017,10/26/2017,11/28/2017,5/14/2019,5/14/2019,7/9/2019,9/8/2019,9/8/2019
4289,7880,6/15/1953,Male,184,88,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"16,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,V-X,11/11/2015,7/26/2016,7/26/2016,5/23/2017,10/29/2018,10/29/2018,12/5/2018,5/22/2019,5/22/2019,6/18/2019,1/2/2020,1/2/2020
4290,6989,6/15/1952,Male,171,110,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"15,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,5/7/2019,4/9/2020,4/9/2020,1/13/2022,3/31/2022,10/14/1582, , , , , , 
4291,5532,6/15/1948,Female,165,62,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,44",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/2/2019,1/29/2020,1/29/2020, , , , , , , , , 
4292,2881,6/15/1952,Male,171,110,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,5/3/2019,4/25/2020,4/25/2020,3/8/2022,3/31/2022, , , , , , , 
4293,8353,6/15/1947,Female,167,88,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,5/13/2019,11/21/2019,11/21/2019,8/4/2020,3/31/2022,10/14/1582, , , , , , 
4294,1344,6/15/1944,Female,178,94,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,24",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,11/1/2018,4/29/2019,4/29/2019,5/10/2019,3/31/2022,10/14/1582, , , , , , 
4295,8781,6/15/1948,Male,164,69,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,10/18/2018,4/12/2019,4/12/2019,5/1/2019,9/4/2019,9/4/2019,5/17/2020,3/31/2022, , , , 
4296,5707,6/15/1953,Male,165,56,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,39",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/2/2019,4/24/2020,4/24/2020, , , , , , , , , 
4297,2957,6/15/1953,Male,187,90,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"22,43","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/6/2019,1/7/2020,1/7/2020, , , , , , , , , 
4298,2697,6/15/1951,Female,161,67,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , ,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,86",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/24/2019,5/16/2020,5/16/2020, , , , , , , , , 
4299,7474,6/15/1974,Male,187,74,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,49",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/15/2018,2/14/2019,2/14/2019,5/7/2019,7/16/2021,7/16/2021,8/24/2021,3/31/2022,10/14/1582, , , 
4300,6885,6/15/1951,Male,176,92,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/8/2019,11/13/2019,11/13/2019, , , , , , , , , 
4301,1450,6/15/1952,Male,180,78,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"3,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,6/11/2018,10/4/2018,10/4/2018,5/3/2019,6/30/2021,10/14/1582, , , , , , 
4302,3967,6/15/1945,Male,183,96,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,4",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,5/6/2019,1/2/2020,1/2/2020,5/16/2020,2/3/2022,2/3/2022,3/7/2022,3/31/2022, , , , 
4303,8569,6/15/1947,Female,155,70,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"27,24","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/2/2019,4/24/2020,4/24/2020, , , , , , , , , 
4304,1077,6/15/1952,Male,171,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/13/2019,7/5/2021,7/5/2021, , , , , , , , , 
4305,3843,6/15/1947,Male,176,83,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,28",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,DAR-X,No CTx,R-X,10/22/2018,4/15/2019,4/15/2019,5/3/2019,1/4/2022,1/4/2022,1/18/2022,3/31/2022,10/14/1582, , , 
4306,4869,6/15/1947,Male,176,83,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,23",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/5/2018,4/29/2019,4/29/2019,5/13/2019,8/17/2021,8/17/2021, , , , , , 
4307,8261,6/15/1953,Female,171,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"11,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,NIN-X,V-X,6/27/2018,9/28/2018,9/28/2018,5/1/2019,6/13/2019,6/13/2019,7/10/2019,10/12/2020,10/12/2020,10/20/2020,6/30/2021, 
4308,4385,6/15/1951,Female,163,65,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/9/2019,5/14/2020,5/14/2020,12/7/2021,3/31/2022, , , , , , , 
4309,4586,6/15/1944,Female,168,54,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,57",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,5/20/2019,5/12/2020,5/12/2020,2/17/2022,3/31/2022, , , , , , , 
4310,3573,6/15/1954,Female,166,63,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,18",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/13/2019,7/13/2019,7/13/2019, , , , , , , , , 
4311,8176,6/15/1945,Female,167,74,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,11",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,11/6/2018,2/5/2019,2/5/2019,5/1/2019,12/18/2019,12/18/2019,5/14/2020,12/29/2020,12/29/2020,1/13/2021,11/25/2021,11/25/2021
4312,8380,6/15/1953,Male,160,58,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"19,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/7/2018,12/10/2018,12/10/2018,5/16/2019,12/31/2021, , , , , , , 
4313,5483,6/15/1945,Female,165,78,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"23,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/7/2019,5/12/2020,5/12/2020,10/22/2020,3/31/2022,10/14/1582, , , , , , 
4314,9068,6/15/1952,Female,164,54,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,15",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/2/2019,11/20/2019,11/20/2019,12/8/2020,3/31/2022, , , , , , , 
4315,9494,6/15/1952,Male,171,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/10/2019,5/2/2020,5/2/2020, , , , , , , , , 
4316,8205,6/15/1948,Male,187,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,32",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/1/2018,12/28/2018,12/28/2018,5/1/2019,4/23/2020,4/23/2020, , , , , , 
4317,6145,6/15/1942,Male,173,73,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,19",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/19/2018,2/12/2019,2/12/2019,5/2/2019,4/24/2020,4/24/2020, , , , , , 
4318,1087,6/15/1948,Female,177,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/13/2019,11/11/2019,11/11/2019,11/10/2020,5/25/2021,5/25/2021, , , , , , 
4319,5484,6/15/1944,Female,168,51,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,95",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/10/2019,1/3/2020,1/3/2020,8/19/2019,3/29/2021,3/29/2021, , , , , , 
4320,7537,6/15/1947,Female,172,61,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,66",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/30/2018,10/31/2018,10/31/2018,5/27/2019,2/8/2021,2/8/2021, , , , , , 
4321,4802,6/15/1947,Male,175,70,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"7,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,Other,DAR-X,R-X,10/30/2018,4/25/2019,4/25/2019,5/6/2019,2/19/2020,2/19/2020,4/22/2020,8/31/2020,8/31/2020,9/23/2020,4/7/2021,4/7/2021
4322,1748,6/15/1947,Female,171,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,71",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/7/2019,10/22/2019,10/22/2019, , , , , , , , , 
4323,7274,6/15/1952,Female,166,71,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,71",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/6/2019,3/26/2020,3/26/2020, , , , , , , , , 
4324,1078,6/15/1949,Male,167,53,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,38",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,DAR-X,No CTx,V-X,5/9/2019,10/21/2019,10/21/2019,12/12/2019,1/19/2021,1/19/2021,12/7/2021,3/31/2022, , , , 
4325,4393,6/15/1943,Male,186,62,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"27,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,8/24/2018,11/19/2018,11/19/2018,5/23/2019,1/7/2021,1/7/2021,7/5/2021,3/31/2022,10/14/1582, , , 
4326,1055,6/15/1945,Male,178,74,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,1775,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/19/2018,12/14/2018,12/14/2018,5/3/2019,1/14/2021,1/14/2021, , , , , , 
4327,8052,6/15/1951,Female,167,66,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,68",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/24/2019,5/16/2020,5/16/2020, , , , , , , , , 
4328,6033,6/15/1961,Male,189,93,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,6",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/9/2019,7/9/2019,7/9/2019,10/5/2021,3/31/2022,10/14/1582, , , , , , 
4329,6731,6/15/1951,Male,186,116,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,82","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/6/2019,5/11/2020,5/11/2020,11/18/2021,3/31/2022, , , , , , , 
4330,5043,6/15/1950,Male,187,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"14,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/26/2018,2/22/2019,2/22/2019,5/9/2019,3/31/2022,10/14/1582, , , , , , 
4331,3572,6/15/1946,Female,174,103,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"18,17","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,7/26/2018,11/21/2018,11/21/2018,5/2/2019,7/5/2021,7/5/2021,7/15/2021,3/31/2022,10/14/1582, , , 
4332,2841,6/15/1951,Male,175,73,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"5,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/2/2019,4/24/2020,4/24/2020, , , , , , , , , 
4333,4534,6/15/1953,Male,172,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"18,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/6/2019,7/6/2019,7/6/2019,3/28/2022,3/31/2022, , , , , , , 
4334,7717,6/15/1929,Female,169,56,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"9,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/27/2019,6/1/2020,6/1/2020, , , , , , , , , 
4335,6453,6/15/1952,Female,167,73,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,"18,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,10/11/2018,4/8/2019,4/8/2019,5/1/2019,4/23/2020,4/23/2020, , , , , , 
4336,6763,6/15/1949,Female,163,51,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,39",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,8/1/2018,10/26/2018,10/26/2018,5/20/2019,2/18/2021,2/18/2021,2/26/2021,3/31/2022,10/14/1582, , , 
4337,3502,6/15/1946,Female,165,64,Compulsory health insurance CHI,No, ,Yes, ,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,115,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,6/17/2019,3/23/2020,3/23/2020, , , , , , , , , 
4338,3041,6/15/1950,Male,167,70,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,4/15/2019,12/31/2019,10/14/1582, , , , , , , , , 
4339,6579,6/15/1955,Male,162,65,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,135,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,4/15/2019,9/30/2019,10/14/1582, , , , , , , , , 
4340,1012,6/15/1938,Male,172,65,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,155,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,R-X,4/29/2019,10/11/2019,10/11/2019,6/22/2020,12/31/2020, , , , , , , 
4341,8042,6/15/1937,Female,162,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,5/6/2019,6/30/2019, , , , , , , , , , 
4342,4943,6/15/1939,Male,180,90,Private,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
4343,6628,6/15/1941,Male,190,89,Private,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/27/2019,9/30/2019, , , , , , , , , , 
4344,8322,6/15/1936,Male,172,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/3/2019,6/30/2019, , , , , , , , , , 
4345,8108,6/15/1938,Female,169,75,Compulsory health insurance CHI,Yes,Yes, , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,7/15/2019, , , , , , , , , , , 
4346,9559,6/15/1954,Male,175,134,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/25/2019,9/7/2019,9/7/2019, , , , , , , , , 
4347,2588,6/15/1954,Male,172,90,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"39,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/21/2019,7/31/2019,7/31/2019, , , , , , , , , 
4348,9665,6/15/1948,Female,149,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"57,6",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,4/16/2019,6/14/2019,6/14/2019, , , , , , , , , 
4349,8954,6/15/1971,Male,183,71,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"70,9",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/10/2019,6/3/2019,6/3/2019,7/9/2019,3/2/2020,3/2/2020, , , , , , 
4350,5764,6/15/1939,Female,161,70,Self-Payer,No, ,Yes,Yes, ,Unknown,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"29,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,R-X,No CTx,No CTx,V-X,4/16/2019,7/24/2019,7/24/2019,7/29/2019,3/31/2022,10/14/1582, , , , , , 
4351,3555,6/15/1930,Male,176,55,Private,No, , ,Yes, , ,Yes, , , , ,0,I: fulfilling all 4 criteria,IgG,"4,69",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,11/1/2018,4/18/2019,4/18/2019,5/7/2019,1/5/2021,1/5/2021, , , , , , 
4352,6541,6/15/1948,Female,176,113,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,NIN-X,No CTx,R-X,12/17/2018,6/3/2019,6/3/2019,6/20/2019,5/25/2021,5/25/2021,6/11/2021,7/29/2021,7/29/2021, , , 
4353,8057,6/15/1954,Male,181,102,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,EMP-X,V-X,R-X,10/24/2018,4/11/2019,4/11/2019,5/2/2019,1/2/2020,1/2/2020,1/6/2020,4/21/2020,4/21/2020,5/31/2020,9/29/2020,9/29/2020
4354,4040,6/15/1949,Male,166,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,06",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,7/9/2018,11/1/2018,11/1/2018,5/9/2019,10/13/2021,10/13/2021,11/19/2021,3/31/2022, , , , 
4355,4088,6/15/1944,Male,177,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,72",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,8/23/2018,11/19/2018,11/19/2018,5/6/2019,1/5/2022,1/5/2022,1/25/2022,3/31/2022, , , , 
4356,1513,6/15/1958,Male,171,89,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"22,03","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/13/2018,3/20/2019,3/20/2019,5/31/2019,3/31/2022,10/14/1582, , , , , , 
4357,3819,6/15/1948,Female,177,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,9/26/2018,1/24/2019,1/24/2019,5/6/2019,3/17/2020,3/17/2020,4/22/2020,12/31/2021, , , , 
4358,8045,6/15/1947,Female,167,87,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,96",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,10/17/2018,2/14/2019,2/14/2019,5/7/2019,1/5/2022,1/5/2022,2/1/2022,3/31/2022, , , , 
4359,4007,6/15/1965,Male,180,86,Compulsory health insurance CHI,No,Yes, , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/11/2019,5/31/2019,5/31/2019,6/4/2020,3/31/2022, , , , , , , 
4360,7719,6/15/1940,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,4/2/2019,9/16/2019,9/16/2019,3/26/2020,12/30/2020,12/30/2020,2/1/2021,3/31/2022,10/14/1582, , , 
4361,9926,6/15/1967,Male,183,90,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/24/2019,6/30/2019, , , , , , , , , , 
4362,7399,6/15/1957,Male,185,74,Compulsory health insurance CHI,Unknown, , , ,Yes,Yes,Yes,Yes, ,Yes, ,0,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L", ,POM-X,No CTx,No CTx,V-X,11/2/2018,4/2/2019,4/2/2019,7/31/2019,3/31/2020, , , , , , , 
4363,6903,6/15/1967,Female,160,72,Compulsory health insurance CHI,Unknown,Yes, , , ,Yes,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/26/2019,3/31/2020, , , , , , , , , , 
4364,2874,6/15/1938,Male,176,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,90,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,4/5/2019,9/19/2019,9/19/2019,3/24/2020,6/24/2021,6/24/2021,7/12/2021,3/31/2022,10/14/1582, , , 
4365,4485,6/15/1949,Female,162,67,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"7,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,POM-X,EMP-X,V-X,4/9/2019,7/1/2019,7/1/2019,3/19/2020,3/5/2021,3/5/2021,3/8/2021,12/28/2021,12/28/2021,2/7/2022,3/31/2022, 
4366,5399,6/15/1945,Female,178,65,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/30/2019,6/30/2019, , , , , , , , , , 
4367,5093,6/15/1944,Female,166,69,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,EMP-X,Other,4/9/2019,12/16/2019,12/16/2019,3/23/2020,3/26/2021,3/26/2021,3/29/2021,12/22/2021,12/22/2021,2/7/2022,3/31/2022, 
4368,6840,6/15/1950,Male,179,75,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,4/11/2019,7/3/2019,7/3/2019,3/25/2020,6/27/2021,6/27/2021,7/12/2021,3/31/2022,10/14/1582, , , 
4369,2329,6/15/1941,Female,159,56,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,11,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/16/2019,6/30/2019, , , , , , , , , , 
4370,8480,6/15/1947,Male,177,86,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,4/18/2019,7/10/2019,7/10/2019,3/9/2020,1/21/2021,1/21/2021,2/8/2021,3/31/2022,10/14/1582, , , 
4371,1419,6/15/1950,Female,164,70,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,4/22/2019,7/14/2019,7/14/2019,3/6/2020,1/8/2021,1/8/2021,2/8/2021,3/31/2022,10/14/1582, , , 
4372,5426,6/15/1934,Male,188,76,Compulsory health insurance CHI,Unknown, , ,Yes, ,Yes,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,3/1/2018,4/4/2019,4/4/2019,4/10/2019,6/30/2019, , , , , , , 
4373,2076,6/15/1941,Male,180,77,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,DAR-X,6/1/2019,4/1/2021,4/1/2021,4/1/2021,12/31/2021,10/14/1582, , , , , , 
4374,8546,6/15/1956,Female,166,62,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/1/2019,10/1/2019,10/1/2019, , , , , , , , , 
4375,6195,6/15/1946,Male,176,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/26/2019,6/30/2019, , , , , , , , , , 
4376,8878,6/15/1937,Female,156,52,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,EMP-X,R-X,4/30/2019,10/14/2019,10/14/2019,3/18/2020,3/18/2021,3/18/2021,3/29/2021,12/17/2021,12/17/2021,2/4/2022,3/31/2022, 
4377,3118,6/15/1935,Female,161,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"8,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/7/2019,10/21/2019,10/21/2019, , , , , , , , , 
4378,7834,6/15/1943,Male,180,77,Private,No,Unknown,Unknown,Yes, ,Yes,Yes,Yes,Unknown,Yes, ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,1/30/2017,7/16/2017,7/16/2017,5/6/2019,5/4/2020,5/4/2020,5/11/2020,6/30/2020, , , , 
4379,5571,6/15/1940,Male,181,76,Compulsory health insurance CHI,No,Unknown,Unknown,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,5",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,1/23/2017,4/16/2017,4/16/2017,5/6/2019,5/6/2020,5/6/2020,5/18/2020,6/30/2020, , , , 
4380,9576,6/15/1950,Female,167,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/13/2017,5/7/2017,5/7/2017,5/13/2019,4/12/2020,4/12/2020, , , , , , 
4381,6340,6/15/1945,Male,174,77,Compulsory health insurance CHI,No,Unknown,Unknown,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,1/2/2017,3/26/2017,3/26/2017,5/20/2019,11/3/2019,11/3/2019,2/24/2020,12/30/2020,12/30/2020,2/1/2021,3/31/2022,10/14/1582
4382,2525,6/15/1959,Male,175,85,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"45,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,12/19/2014,2/17/2015,2/17/2015,6/20/2019,7/17/2019,7/17/2019, , , , , , 
4383,1870,6/15/1936,Female,160,54,Compulsory health insurance CHI,No,Unknown,Unknown,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,DAR-X,R-X,2/13/2017,7/30/2017,7/30/2017,5/13/2019,10/27/2019,10/27/2019,3/16/2020,12/22/2020,12/22/2020,2/1/2021,1/5/2022,1/5/2022
4384,9327,6/15/1947,Male,177,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,POM-X,DAR-X,Other,3/21/2016,2/19/2017,2/19/2017,5/20/2019,11/24/2019,11/24/2019,3/16/2020,12/28/2020,12/28/2020,1/28/2021,3/31/2022,10/14/1582
4385,8659,6/15/1945,Male,178,78,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"8,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,POM-X,FAR-X,V-X,10/17/2016,1/8/2017,1/8/2017,5/23/2019,3/8/2020,3/8/2020,3/9/2020,9/20/2020,9/20/2020,9/28/2020,12/28/2020,12/28/2020
4386,7547,6/15/1940,Female,157,54,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgM,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,FAR-X,V-X,7/10/2017,7/22/2018,7/22/2018,5/30/2019,3/18/2020,3/18/2020,3/19/2020,8/25/2020,8/25/2020,9/7/2020,7/9/2021,7/9/2021
4387,8648,6/15/1939,Female,164,76,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,FAR-X,R-X,1/16/2017,7/2/2017,7/2/2017,5/27/2019,11/10/2019,11/10/2019,3/23/2020,9/24/2020,9/24/2020,9/28/2020,7/19/2021,7/19/2021
4388,6543,6/15/1940,Male,182,81,Private,No, , , ,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"16,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/27/2017,11/21/2017,11/21/2017, , , , , , , , , 
4389,6025,6/15/1942,Male,180,89,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1, ,IgA,"12,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/17/2017,10/10/2017,10/10/2017, , , , , , , , , 
4390,6625,6/15/1966,Male,179,74,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,64,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,4/15/2019,7/15/2019,7/15/2019,8/1/2019,2/1/2020,2/1/2020,3/1/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, 
4391,6486,6/15/1943,Male,164,72,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,53,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,R-X,5/15/2019,8/15/2019,8/15/2019,9/1/2019,2/1/2020,2/1/2020,3/1/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, 
4392,7279,6/15/1954,Male,175,61,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,48,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,KYP-X,POM-X,DAR-X,6/15/2019,8/15/2019,8/15/2019,9/1/2019,2/1/2020,2/1/2020,3/1/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, 
4393,3387,6/15/1959,Male,166,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/20/2019,10/22/2019,10/22/2019, , , , , , , , , 
4394,1656,6/15/1949,Male,178,76,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgM,55,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,Other,No CTx,No CTx,V-X,9/3/2019,11/18/2019,11/18/2019,11/26/2019,11/29/2019,11/29/2019, , , , , , 
4395,7003,6/15/1933,Female,140,52,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgM,25,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,Other,9/5/2019,9/9/2019,9/9/2019, , , , , , , , , 
4396,1351,6/15/1940,Male,165,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/31/2012,5/29/2012,5/29/2012,7/9/2012,12/27/2012,12/27/2012,7/10/2019,11/18/2019,11/18/2019, , , 
4397,9696,6/15/1933,Male,173,60,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"4,4",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,7/5/2019,6/19/2020,6/19/2020,9/28/2020,8/4/2021,8/4/2021, , , , , , 
4398,9058,6/15/1937,Male,185,59,Private,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,3,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,7",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,7/22/2019,10/4/2019,10/4/2019,11/21/2019,2/19/2020,2/19/2020, , , , , , 
4399,8111,6/15/1952,Female,160,54,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,8",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,No,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,R-X,DAR-X,POM-X,V-X,6/14/2016,8/30/2016,8/30/2016,7/22/2019,8/19/2020,8/19/2020,8/21/2020,11/26/2021,11/26/2021,3/3/2022,3/31/2022, 
4400,9699,6/15/1950,Male,180,80,Private,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/14/2019,8/26/2021,8/26/2021,9/6/2021,3/31/2022,10/14/1582, , , , , , 
4401,9835,6/15/1952,Female,165,70,Private,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"5,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,NIN-X,DAR-X,EMP-X,V-X,11/1/2016,10/6/2017,10/6/2017,7/23/2019,6/25/2020,6/25/2020,6/29/2020,8/18/2021,8/18/2021,9/14/2021,3/31/2022,10/14/1582
4402,3998,6/15/1956,Male,185,80,Self-Payer,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,NIN-X,V-X,10/26/2015,1/22/2016,1/22/2016,9/2/2019,10/1/2020,10/1/2020,10/12/2020,6/17/2021,6/17/2021,7/20/2021,2/16/2022,2/16/2022
4403,2859,6/15/1938,Male,170,60,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/12/2019,3/31/2021, , , , , , , , , , 
4404,8835,6/15/1956,Male,182,100,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,",53",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/15/2019,9/27/2019,9/27/2019, , , , , , , , , 
4405,5074,6/15/1945,Male,185,90,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,41,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,EMP-X,DAR-X,DAR-X,V-X,6/2/2018,10/23/2018,10/23/2018,9/7/2019,9/20/2020,9/20/2020,11/9/2020,11/10/2021,11/10/2021,12/16/2021,3/31/2022,10/14/1582
4406,6209,6/15/1947,Male,184,94,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,32,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,NIN-X,V-X,V-X,4/19/2018,8/23/2018,8/23/2018,9/12/2019,9/20/2020,9/20/2020,11/4/2020,8/20/2021,8/20/2021,9/13/2021,3/31/2022,10/14/1582
4407,1898,6/15/1951,Female,168,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,37,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,EMP-X,KYP-X,V-X,6/3/2018,9/30/2018,9/30/2018,9/15/2019,10/15/2020,10/15/2020,11/6/2020,11/3/2021,11/3/2021,12/12/2021,3/31/2022,10/14/1582
4408,5938,6/15/1953,Female,172,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,41,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,KYP-X,V-X,2/28/2018,5/10/2019,5/10/2019,9/25/2019,2/10/2020,2/10/2020,3/24/2020,3/12/2021,3/12/2021,3/22/2021,2/19/2022,2/19/2022
4409,5838,6/15/1954,Male,184,98,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"144,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,KYP-X,V-X,7/23/2019,10/12/2019,10/12/2019,1/14/2021,1/3/2022,1/3/2022,1/27/2022,2/10/2022,2/10/2022,2/23/2022,3/31/2022,10/14/1582
4410,2770,6/15/1946,Male,999,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/1/2019,5/1/2019,5/1/2019, , , , , , , , , 
4411,8351,6/15/1953,Female,167,79,Compulsory health insurance CHI,Yes,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,29,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,2/1/2018,5/23/2018,5/23/2018,9/26/2019,6/26/2020,6/26/2020,7/25/2020,9/1/2021,9/1/2021,9/27/2021,3/31/2022,10/14/1582
4412,8638,6/15/1951,Male,184,93,Private,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,39,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,EMP-X,V-X,KYP-X,V-X,10/4/2017,1/9/2018,1/9/2018,9/25/2019,6/27/2020,6/27/2020,7/25/2020,8/25/2021,8/25/2021,9/19/2021,3/31/2022,10/14/1582
4413,2768,6/15/1954,Female,170,78,Private,No,Yes, ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,37,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,EMP-X,NIN-X,EMP-X,V-X,8/3/2018,12/28/2018,12/28/2018,8/19/2019,6/19/2020,6/19/2020,7/26/2020,3/19/2021,3/19/2021,3/30/2021,12/12/2021,12/12/2021
4414,8009,6/15/1955,Male,190,99,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,40,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,EMP-X,V-X,KYP-X,V-X,9/23/2017,2/4/2018,2/4/2018,8/13/2019,6/13/2020,6/13/2020,7/10/2020,5/10/2021,5/10/2021,6/22/2021,3/31/2022,10/14/1582
4415,7208,6/15/1938,Female,165,65,Compulsory health insurance CHI,No,Yes, , , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,37,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,KYP-X,V-X,6/1/2017,10/10/2017,10/10/2017,8/14/2019,6/27/2020,6/27/2020,7/27/2020,6/15/2021,6/15/2021,6/22/2021,3/31/2022,10/14/1582
4416,1950,6/15/1945,Male,186,95,Compulsory health insurance CHI,No,Yes, , , ,Yes, , ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,40,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,KYP-X,V-X,4/24/2018,8/26/2018,8/26/2018,9/1/2019,6/15/2020,6/15/2020,7/22/2020,6/12/2021,6/12/2021,6/20/2021,2/28/2022,2/28/2022
4417,3467,6/15/1952,Female,168,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,30,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,8/21/2019,11/29/2020,11/29/2020,12/29/2020,9/2/2021,9/2/2021,9/24/2021,3/31/2022,10/14/1582, , , 
4418,5452,6/15/1942,Male,185,95,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,10/8/2019,9/26/2020,9/26/2020,11/5/2020,9/5/2021,9/5/2021,9/19/2021,3/31/2022,10/14/1582, , , 
4419,8511,6/15/1945,Male,184,91,Private,No,Yes,Yes,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,42,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,EMP-X,V-X,No CTx,V-X,10/23/2019,9/28/2020,9/28/2020,11/9/2020,9/9/2021,9/9/2021,9/28/2021,3/31/2022,10/14/1582, , , 
4420,7080,6/15/1947,Female,172,70,Private,No,Yes, , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,39,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,V-X,V-X,9/20/2019,12/12/2019,12/12/2019,12/27/2019,9/20/2020,9/20/2020,12/30/2020,12/9/2021,12/9/2021,12/22/2021,3/31/2022,10/14/1582
4421,5651,6/15/1948,Male,183,96,Private,No, ,Yes, ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,EMP-X,V-X,No CTx,V-X,10/8/2019,9/26/2020,9/26/2020,11/6/2020,8/9/2021,8/9/2021,9/20/2021,3/31/2022,10/14/1582, , , 
4422,7086,6/15/1950,Female,152,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/13/2019,11/25/2019,11/25/2019, , , , , , , , , 
4423,7759,6/15/1949,Male,180,89,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"4,4",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,9/3/2019,10/30/2020,10/30/2020,10/27/2020,3/31/2022,10/14/1582, , , , , , 
4424,4523,6/15/1960,Male,177,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,10/18/2011,1/2/2012,1/2/2012,9/19/2019,7/22/2020,7/22/2020,8/31/2020,2/11/2021,2/11/2021,2/13/2021,6/30/2021, 
4425,2058,6/15/1946,Male,178,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,NIN-X,DAR-X,No CTx,R-X,6/14/2016,3/7/2019,3/7/2019,6/19/2019,10/20/2020,10/20/2020,11/5/2020,12/31/2020, , , , 
4426,9823,6/15/1940,Female,162,81,Private,Yes, ,Yes, , , , , , , , ,1,Unknown,IgG,32,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,9/10/2019,10/20/2020,10/20/2020,3/5/2021,3/31/2022,10/14/1582, , , , , , 
4427,1220,6/15/1937,Female,160,55,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,99999999,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,9,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,R-X,7/25/2019,9/2/2019,9/2/2019, , , , , , , , , 
4428,2324,6/15/1954,Female,172,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"58,4",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,9/16/2019,11/7/2019,11/7/2019, , , , , , , , , 
4429,4383,6/15/1946,Female,164,66,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,Unknown,IgG,"41,7",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/30/2019,12/31/2021,10/14/1582, , , , , , , , , 
4430,9827,6/15/1941,Female,165,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"178,2",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,7/2/2019,12/23/2019,12/23/2019, , , , , , , , , 
4431,4446,6/15/1950,Female,154,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,133,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/22/2019,9/30/2019,9/30/2019, , , , , , , , , 
4432,4043,6/15/1949,Male,180,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,194,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,7/8/2019,11/25/2019,11/25/2019, , , , , , , , , 
4433,5159,6/15/1961,Male,171,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,548,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/19/2018,3/18/2019,3/18/2019, , , , , , , , , 
4434,6546,6/15/1947,Male,179,85,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,Unknown,IgG,245,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/2/2019,12/2/2019,12/2/2019, , , , , , , , , 
4435,8812,6/15/1952,Female,170,77,Compulsory health insurance CHI,No, , , ,Yes,Yes, ,Yes, , , ,2,Unknown,Other type,"65,3",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/1/2019,6/1/2019,6/1/2019, , , , , , , , , 
4436,3614,6/15/1943,Female,158,51,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,2,III: one or more criteria are fulfilled,IgA,",56",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,4/10/2017,4/16/2018,4/16/2018,8/15/2018,10/11/2018,10/11/2018,11/8/2018,7/10/2019,7/10/2019,7/24/2019,3/5/2020,3/5/2020
4437,2039,6/15/1940,Male,999,80,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"1,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,KYP-X,R-X,2/23/2017,5/8/2019,5/8/2019,7/8/2019,6/10/2020,6/10/2020,6/26/2020,2/22/2021,2/22/2021,5/15/2021,6/30/2021,10/14/1582
4438,2755,6/15/1955,Male,166,84,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"1,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,R-X,EMP-X,KYP-X,Other,3/5/2004,5/27/2004,5/27/2004,9/1/2015,12/1/2015,12/1/2015,1/15/2018,7/14/2019,7/14/2019,7/15/2019,12/31/2020,10/14/1582
4439,3895,6/15/1954,Male,177,77,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,Other type,"99999999,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , ,Nein,R-X,DAR-X,No CTx,V-X,5/1/2013,7/31/2013,7/31/2013,9/21/2015,7/2/2019,7/2/2019,7/17/2019,9/30/2021,10/14/1582, , , 
4440,2694,6/15/1951,Male,173,93,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,2,III: one or more criteria are fulfilled,IgA,"3,15",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,KYP-X,7/4/2019,3/11/2020,3/11/2020, , , , , , , , , 
4441,8804,6/15/1940,Male,168,61,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/2/2019,12/31/2019,10/14/1582, , , , , , , , , 
4442,3853,6/15/1957,Male,180,111,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"4,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,ISA-X,7/15/2019,11/25/2019,11/25/2019, , , , , , , , , 
4443,3608,6/15/1957,Male,174,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,0,I: fulfilling all 4 criteria,IgA,",33","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/18/2019,11/25/2019,11/25/2019, , , , , , , , , 
4444,2809,6/15/1960,Male,176,85,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , ,Yes,9,III: one or more criteria are fulfilled,IgG,"6,63",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,ISA-X,7/25/2019,12/15/2019,12/15/2019,5/6/2020,8/18/2020,8/18/2020, , , , , , 
4445,1438,6/15/1936,Female,160,55,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,EMP-X,V-X,7/22/2019,2/5/2020,2/5/2020,2/19/2020,10/15/2020,10/15/2020,10/28/2020,2/15/2021,2/15/2021,2/17/2021,9/21/2021,9/21/2021
4446,2532,6/15/1954,Male,182,80,Compulsory health insurance CHI,Unknown, , , , ,Yes,Yes, , , ,Yes,9,III: one or more criteria are fulfilled,IgA,"58,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/23/2019,9/30/2019,9/30/2019,5/11/2021,3/31/2022, , , , , , , 
4447,5196,6/15/1946,Male,166,71,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"16,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/14/2019,8/26/2020,8/26/2020, , , , , , , , , 
4448,4211,6/15/1944,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,EMP-X,V-X,7/1/2019,9/22/2019,9/22/2019,3/30/2020,1/14/2021,1/14/2021,1/25/2021,9/2/2021,9/2/2021,9/27/2021,3/31/2022,10/14/1582
4449,9252,6/15/1938,Female,162,58,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,POM-X,KYP-X,R-X,7/4/2019,12/18/2019,12/18/2019,2/24/2020,8/9/2020,8/9/2020,8/10/2020,6/27/2021,6/27/2021,7/12/2021,3/31/2022,10/14/1582
4450,7228,6/15/1946,Female,165,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,No CTx,V-X,7/8/2019,7/19/2020,7/19/2020,7/20/2020,6/24/2021,6/24/2021,7/12/2021,3/31/2022,10/14/1582, , , 
4451,9604,6/15/1948,Male,178,76,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,No CTx,V-X,7/9/2019,9/30/2019,9/30/2019,3/30/2020,12/28/2020,12/28/2020,2/1/2021,3/31/2022,10/14/1582, , , 
4452,7782,6/15/1939,Male,177,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,7/15/2019,12/29/2019,12/29/2019,3/23/2020,3/18/2021,3/18/2021,3/29/2021,12/20/2021,12/20/2021, , , 
4453,4530,6/15/1949,Male,180,83,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,7/17/2019,10/8/2019,10/8/2019,8/24/2020,8/27/2021,8/27/2021,9/13/2021,3/31/2022,10/14/1582, , , 
4454,3441,6/15/1950,Female,159,56,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,7/29/2019,10/20/2019,10/20/2019,8/31/2020,9/14/2021,9/14/2021,9/27/2021,3/31/2022, , , , 
4455,5362,6/15/1937,Male,175,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgM,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/2/2019,1/16/2020,1/16/2020, , , , , , , , , 
4456,5843,6/15/1949,Male,181,86,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,8/5/2019,8/16/2020,8/16/2020,3/27/2021,3/4/2022,3/4/2022,3/28/2022,3/31/2022, , , , 
4457,8132,6/15/1951,Female,166,75,Private,Yes, ,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,POM-X,V-X,8/8/2019,10/30/2019,10/30/2019,3/23/2020,9/8/2020,9/8/2020,9/14/2020,9/3/2021,9/3/2021,9/16/2021,3/31/2022, 
4458,8768,6/15/1940,Male,177,88,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"11,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,No CTx,V-X,8/12/2019,1/26/2020,1/26/2020,8/3/2020,8/31/2021,8/31/2021,9/13/2021,3/31/2022,10/14/1582, , , 
4459,9819,6/15/1942,Male,175,70,Private,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"11,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,ISA-X,V-X,8/15/2019,11/6/2019,11/6/2019,3/9/2020,9/20/2020,9/20/2020,9/28/2020,9/15/2021,9/15/2021,9/27/2021,3/31/2022,10/14/1582
4460,2852,6/15/1937,Female,160,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,R-X,8/19/2019,2/2/2020,2/2/2020,7/13/2020,6/23/2021,6/23/2021,7/5/2021,3/31/2022,10/14/1582, , , 
4461,7649,6/15/1950,Male,180,76,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"11,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,EMP-X,V-X,8/19/2019,11/10/2019,11/10/2019,3/20/2020,9/21/2020,9/21/2020,9/28/2020,6/30/2021,6/30/2021,7/12/2021,1/6/2022,1/6/2022
4462,3729,6/15/1945,Male,175,72,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"11,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,8/23/2019,3/19/2020,3/19/2020,9/28/2020,9/3/2021,9/3/2021,9/16/2021,3/31/2022,10/14/1582, , , 
4463,2066,6/15/1937,Female,158,54,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,8/29/2019,2/12/2020,2/12/2020,9/28/2020,9/14/2021,9/14/2021,9/27/2021,3/31/2022,10/14/1582, , , 
4464,9654,6/15/1935,Male,176,83,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,9/2/2019,12/22/2019,12/22/2019, , , , , , , , , 
4465,1126,6/15/1952,Female,165,69,Private,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,No CTx,V-X,9/4/2019,11/26/2019,11/26/2019,3/23/2020,7/20/2021,7/20/2021,8/2/2021,3/31/2022,10/14/1582, , , 
4466,2205,6/15/1943,Male,181,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,ISA-X,V-X,9/9/2019,12/1/2019,12/1/2019,6/22/2020,1/12/2021,1/12/2021,2/8/2021,2/21/2022,2/21/2022,3/21/2022,3/31/2022, 
4467,5013,6/15/1949,Male,179,75,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgD,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,9/9/2019,12/1/2019,12/1/2019,3/26/2020,3/5/2021,3/5/2021,3/22/2021,3/31/2022,10/14/1582, , , 
4468,7885,6/15/1950,Female,165,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"10,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,9/11/2019,2/25/2020,2/25/2020,8/3/2020,9/10/2021,9/10/2021,9/27/2021,3/31/2022,10/14/1582, , , 
4469,3433,6/15/1940,Male,173,79,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"8,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,9/17/2019,3/1/2020,3/1/2020,9/28/2020,8/20/2021,8/20/2021,9/6/2021,3/31/2022,10/14/1582, , , 
4470,7556,6/15/1951,Male,179,75,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,ISA-X,EMP-X,V-X,9/20/2019,12/12/2019,12/12/2019,3/30/2020,3/4/2021,3/4/2021,3/22/2021,12/22/2021,12/22/2021,2/7/2022,3/31/2022, 
4471,9017,6/15/1937,Female,159,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/24/2019,3/8/2020,3/8/2020, , , , , , , , , 
4472,6305,6/15/1942,Male,177,83,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"9,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,9/24/2019,3/8/2020,3/8/2020,9/14/2020,3/15/2021,3/15/2021,3/29/2021,1/28/2022,1/28/2022,2/28/2022,3/31/2022, 
4473,5858,6/15/1953,Female,167,75,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"11,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,POM-X,V-X,9/25/2019,12/17/2019,12/17/2019,3/26/2020,2/16/2021,2/16/2021,3/8/2021,3/10/2022,3/10/2022,3/30/2022,3/31/2022, 
4474,7313,6/15/1936,Male,173,69,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,9/25/2019,3/9/2020,3/9/2020,9/28/2020,7/21/2021,7/21/2021,8/2/2021,3/31/2022,10/14/1582, , , 
4475,7510,6/15/1953,Male,178,74,Private,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"9,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,9/26/2019,3/10/2020,3/10/2020,8/17/2020,3/10/2021,3/10/2021,3/29/2021,1/31/2022,1/31/2022,2/20/2022,3/31/2022, 
4476,7664,6/15/1939,Female,157,55,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"9,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/27/2019,12/31/2019, , , , , , , , , , 
4477,4037,6/15/1962,Male,182,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,",3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/2/2019,10/19/2019,10/19/2019,9/21/2021,3/31/2022,10/14/1582, , , , , , 
4478,5610,6/15/1967,Female,168,82,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"4,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/30/2019,11/10/2019,11/10/2019, , , , , , , , , 
4479,8754,6/15/1939,Male,180,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,3,III: one or more criteria are fulfilled,IgG,"7,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,LEV-X,No CTx,No CTx,LEV-X,9/23/2019,2/16/2020,2/16/2020,3/30/2021,10/3/2021,10/3/2021, , , , , , 
4480,9610,6/15/1959,Male,174,82,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"2,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/9/2019,11/10/2019,11/10/2019, , , , , , , , , 
4481,9657,6/15/1941,Male,169,74,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,9/2/2019,11/3/2019,11/3/2019,6/14/2021,11/28/2021,11/28/2021, , , , , , 
4482,9133,6/15/1957,Female,164,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/19/2019,11/3/2019,11/3/2019, , , , , , , , , 
4483,6588,6/15/1960,Male,179,82,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,9/27/2019,11/10/2019,11/10/2019,8/16/2021,12/31/2021, , , , , , , 
4484,5977,6/15/1937,Male,168,72,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,9/16/2019,3/8/2020,3/8/2020,9/6/2021,12/31/2021, , , , , , , 
4485,6341,6/15/1939,Male,190,90,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/26/2019,12/31/2019, , , , , , , , , , 
4486,1282,6/15/1945,Female,167,69,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,4250,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/16/2019,3/31/2020, , , , , , , , , , 
4487,9648,6/15/1928,Female,160,80,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgE,3200,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,V-X,8/5/2019,12/31/2019, , , , , , , , , , 
4488,8234,6/15/1940,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,Unknown,IgG,"10,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,9/30/2019,3/14/2020,3/14/2020,3/30/2020,9/10/2021,9/10/2021,9/27/2021,3/31/2022,10/14/1582, , , 
4489,6106,6/15/1940,Female,164,81,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,1646,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,8/27/2019,10/14/2019,10/14/2019, , , , , , , , , 
4490,1723,6/15/1937,Female,165,80,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,9,III: one or more criteria are fulfilled,IgG,375,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,9/17/2019,9/22/2020,9/22/2020,9/30/2020,5/5/2021,5/5/2021, , , , , , 
4491,6499,6/15/1950,Male,176,74,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , , ,KYP-X,EMP-X,DAR-X,V-X,9/15/2014,11/16/2014,11/16/2014,9/7/2016,7/5/2017,7/5/2017,9/26/2019,12/19/2019,12/19/2019,1/28/2020,7/17/2020,7/17/2020
4492,7368,6/15/1968,Male,158,76,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,1906,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/16/2019,3/31/2020,10/14/1582, , , , , , , , , 
4493,8197,6/15/1953,Male,188,93,Private,No,Yes,Yes,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , , ,R-X,KYP-X,EMP-X,V-X,10/15/2014,12/15/2014,12/15/2014,3/15/2016,7/15/2019,7/15/2019,8/20/2019,4/14/2020,4/14/2020,5/20/2020,5/15/2021,5/15/2021
4494,5701,6/15/1966,Male,196,78,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,1570,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,V-X,8/31/2019,11/21/2019,11/21/2019,2/17/2020,3/31/2021, , , , , , , 
4495,1016,6/15/1945,Male,190,93,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,281,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,EMP-X,DAR-X,No CTx,V-X,9/26/2019,12/19/2019,12/19/2019,12/9/2020,9/15/2021,9/15/2021,11/18/2021,3/31/2022, , , , 
4496,6619,6/15/1937,Male,174,96,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,3589,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,R-X,KYP-X,DAR-X,V-X,5/18/2015,10/29/2015,10/29/2015,4/1/2016,8/15/2016,8/15/2016,1/23/2017,4/25/2017,4/25/2017,8/24/2019,12/23/2020,12/23/2020
4497,4989,6/15/1936,Female,165,65,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"35,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/14/2019,12/28/2019,12/28/2019,1/6/2020,1/29/2020,1/29/2020, , , , , , 
4498,2184,6/15/1947,Female,173,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,58",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,12/7/2018,3/7/2019,3/7/2019,7/15/2019,1/2/2020,1/2/2020,4/12/2020,2/15/2022,2/15/2022,3/10/2022,3/31/2022, 
4499,4626,6/15/1948,Male,170,79,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"19,39","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,2/4/2019,7/25/2019,7/25/2019,8/8/2019,4/4/2020,4/4/2020, , , , , , 
4500,1019,6/15/1945,Male,183,77,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,14",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/17/2018,3/18/2019,3/18/2019,8/12/2019,3/31/2022,10/14/1582, , , , , , 
4501,3481,6/15/1947,Male,186,110,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,13",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,3/15/2019,9/9/2019,9/9/2019,9/19/2019,9/11/2020,9/11/2020, , , , , , 
4502,9801,6/15/1954,Male,182,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/31/2018,1/25/2019,1/25/2019,8/7/2019,3/31/2022,10/14/1582, , , , , , 
4503,6622,6/15/1946,Female,167,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,94",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,2/25/2019,8/12/2019,8/12/2019,8/26/2019,3/18/2020,3/18/2020,4/8/2020,6/30/2021,10/14/1582, , , 
4504,3524,6/15/1950,Male,174,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,72",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/6/2018,1/31/2019,1/31/2019,8/23/2019,3/31/2022,10/14/1582, , , , , , 
4505,3550,6/15/1955,Male,185,126,Private,No, , , , ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,95",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,1/2/2019,4/8/2019,4/8/2019,10/24/2019,3/31/2022,10/14/1582, , , , , , 
4506,8272,6/15/1946,Male,177,63,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"10,82","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,2/11/2019,5/13/2019,5/13/2019,9/19/2019,2/2/2021,2/2/2021,2/28/2021,8/24/2021,8/24/2021, , , 
4507,4713,6/15/1945,Male,184,87,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,11/19/2018,2/12/2019,2/12/2019,8/19/2019,6/3/2020,6/3/2020,8/5/2021,3/31/2022, , , , 
4508,8172,6/15/1954,Male,184,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,14",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/3/2018,4/1/2019,4/1/2019,9/16/2019,12/31/2019,10/14/1582, , , , , , 
4509,3451,6/15/1952,Male,185,73,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"21,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,9/13/2018,3/12/2019,3/12/2019,9/19/2019,9/11/2020,9/11/2020, , , , , , 
4510,4947,6/15/1948,Female,164,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,11/28/2018,2/27/2019,2/27/2019,8/6/2019,9/15/2021,9/15/2021,10/19/2021,3/31/2022, , , , 
4511,5417,6/15/1947,Male,183,94,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,1/11/2019,7/1/2019,7/1/2019,8/8/2019,1/18/2022,1/18/2022,2/4/2022,3/31/2022, , , , 
4512,4303,6/15/1944,Female,164,75,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,8",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,DAR-X,V-X,10/18/2018,4/19/2019,4/19/2019,9/5/2019,1/2/2020,1/2/2020,2/10/2020,2/2/2021,2/2/2021,9/13/2021,3/31/2022,10/14/1582
4513,2530,6/15/1944,Female,164,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"3,47","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,DAR-X,No CTx,V-X,8/13/2018,1/28/2019,1/28/2019,8/12/2019,9/16/2021,9/16/2021,10/4/2021,3/31/2022,10/14/1582, , , 
4514,7621,6/15/1951,Male,176,99,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,18,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/13/2018,9/11/2018,9/11/2018,9/26/2019,8/19/2020,8/19/2020, , , , , , 
4515,1059,6/15/1950,Male,169,70,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,54",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,DAR-X,No CTx,V-X,1/11/2019,7/4/2019,7/4/2019,7/23/2019,10/7/2020,10/7/2020,10/28/2020,12/31/2020,10/14/1582, , , 
4516,8710,6/15/1942,Male,176,76,Compulsory health insurance CHI,No, , ,Unknown, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"35,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/4/2019,11/4/2019,11/4/2019, , , , , , , , , 
4517,8573,6/15/1948,Female,169,79,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"11,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,2/12/2019,8/12/2019,8/12/2019,8/26/2019,12/31/2020,10/14/1582, , , , , , 
4518,3474,6/15/1946,Male,188,83,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,43",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,8/23/2018,2/11/2019,2/11/2019,3/7/2019,9/6/2019,9/6/2019,9/16/2019,9/27/2019,9/27/2019, , , 
4519,8853,6/15/1950,Female,168,58,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,61",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/17/2019,4/16/2019,4/16/2019,8/2/2019,9/23/2020,9/23/2020,10/11/2020,3/31/2022,10/14/1582, , , 
4520,4119,6/15/1972,Male,185,86,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"32,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/25/2018,1/22/2019,1/22/2019,8/12/2019,3/31/2022,10/14/1582, , , , , , 
4521,6690,6/15/1956,Female,155,52,Private,No, , , , ,Yes, ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"15,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/17/2018,4/3/2019,4/3/2019,8/5/2019,3/31/2022,10/14/1582, , , , , , 
4522,4098,6/15/1941,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,Other type,"4,1",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,8/7/2019,12/31/2020, , , , , , , , , , 
4523,6068,6/15/1931,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"379,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/10/2019,8/1/2019,8/1/2019, , , , , , , , , 
4524,6576,6/15/1933,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgM,"537,8",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,9/30/2019,3/31/2020, , , , , , , , , , 
4525,7393,6/15/1948,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"124,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,8/9/2019,9/30/2019,9/30/2019,1/14/2020,5/6/2020,5/6/2020,5/19/2020,6/30/2020, , , , 
4526,9026,6/15/1951,Male,181,103,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,2/13/2019,8/1/2019,8/1/2019,8/27/2019,12/10/2019,12/10/2019,12/27/2019,12/27/2019,12/27/2019, , , 
4527,1313,6/15/1946,Male,180,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/4/2019,8/2/2019,8/2/2019,8/12/2019,1/7/2021,1/7/2021, , , , , , 
4528,3873,6/15/1946,Male,180,69,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,33,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/28/2019,8/19/2019,8/19/2019,9/5/2019,8/18/2020,8/18/2020, , , , , , 
4529,2014,6/15/1945,Female,156,68,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,13",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/25/2019,8/22/2019,8/22/2019,9/6/2019,1/11/2021,1/11/2021, , , , , , 
4530,3771,6/15/1946,Female,164,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , , , ,KYP-X,No CTx,No CTx,V-X,7/8/2019,11/20/2019,11/20/2019,1/6/2020,2/28/2020,2/28/2020, , , , , , 
4531,6627,6/15/1948,Male,168,51,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,88",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,2/5/2019,8/2/2019,8/2/2019,8/26/2019,8/18/2020,8/18/2020, , , , , , 
4532,9125,6/15/1950,Male,179,108,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,16",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,NIN-X,No CTx,V-X,1/11/2019,4/17/2019,4/17/2019,9/24/2019,9/16/2020,9/16/2020,2/17/2022,3/31/2022, , , , 
4533,8421,6/15/1929,Female,161,63,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,6",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/26/2018,4/15/2019,4/15/2019,8/6/2019,3/31/2022,10/14/1582, , , , , , 
4534,6087,6/15/1951,Male,176,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/16/2018,5/23/2018,5/23/2018,9/10/2019,7/9/2020,7/9/2020,7/24/2020,5/5/2021,5/5/2021, , , 
4535,1270,6/15/1947,Female,168,55,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"20,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,POM-X,DAR-X,R-X,2/26/2019,8/15/2019,8/15/2019,9/10/2019,2/6/2020,2/6/2020,2/25/2020,5/22/2020,5/22/2020,6/1/2020,12/6/2020,12/6/2020
4536,9204,6/15/1945,Female,164,70,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,07",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,12/6/2018,3/4/2019,3/4/2019,8/19/2019,3/3/2020,3/3/2020,3/12/2020,12/31/2021, , , , 
4537,4689,6/15/1939,Male,180,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,54",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/15/2018,4/2/2019,4/2/2019,8/15/2019,11/6/2021,11/6/2021, , , , , , 
4538,4820,6/15/1952,Male,167,73,Private,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,78",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,8/2/2018,1/23/2019,1/23/2019,8/22/2019,8/19/2020,8/19/2020,6/10/2021,3/31/2022, , , , 
4539,3265,6/15/1946,Female,163,88,Private,No, ,Yes,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"15,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/4/2019,8/27/2019,8/27/2019,9/16/2019,6/26/2020,6/26/2020, , , , , , 
4540,9284,6/15/1944,Male,176,60,Private,No, , ,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,5,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,11/15/2018,2/18/2019,2/18/2019,8/13/2019,8/7/2020,8/7/2020,8/31/2020,6/30/2021, , , , 
4541,4237,6/15/1954,Female,181,61,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,96",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,DAR-X,V-X,2/28/2019,8/20/2019,8/20/2019,9/12/2019,3/9/2020,3/9/2020,3/30/2020,5/30/2020,5/30/2020,12/18/2020,4/15/2021,4/15/2021
4542,5233,6/15/1951,Female,162,66,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,33",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/20/2018,2/12/2019,2/12/2019,8/13/2019,6/11/2020,6/11/2020, , , , , , 
4543,9998,6/15/1945,Male,176,61,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"7,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/3/2018,11/5/2018,11/5/2018,9/21/2019,9/13/2020,9/13/2020, , , , , , 
4544,8999,6/15/1946,Female,162,68,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"17,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,10/18/2018,4/17/2019,4/17/2019,9/13/2019,6/14/2020,6/14/2020,7/8/2020,3/31/2022,10/14/1582, , , 
4545,6380,6/15/1945,Male,179,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,32",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,1/21/2019,7/15/2019,7/15/2019,8/1/2019,2/6/2020,2/6/2020, , , , , , 
4546,8051,6/15/1953,Male,177,101,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,29",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,1/31/2019,7/29/2019,7/29/2019,8/27/2019,4/28/2020,4/28/2020, , , , , , 
4547,2469,6/15/1942,Male,170,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,V-X,5/4/2017,9/6/2017,9/6/2017,8/21/2019,3/11/2020,3/11/2020,5/6/2020,9/22/2020,9/22/2020,10/4/2020,7/26/2021,7/26/2021
4548,2849,6/15/1971,Female,161,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"33,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,KYP-X,V-X,1/18/2018,7/13/2018,7/13/2018,1/28/2019,9/9/2019,9/9/2019,9/24/2019,9/9/2021,9/9/2021,9/21/2021,3/31/2022,10/14/1582
4549,6597,6/15/1947,Male,183,76,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,97",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,9/17/2018,3/5/2019,3/5/2019,9/20/2019,5/22/2020,5/22/2020, , , , , , 
4550,9842,6/15/1953,Female,165,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"15,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,2/15/2019,8/13/2019,8/13/2019,9/9/2019,3/31/2022,10/14/1582, , , , , , 
4551,1686,6/15/1953,Female,172,64,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,04",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,2/8/2019,8/6/2019,8/6/2019,8/15/2019,12/31/2021, , , , , , , 
4552,4285,6/15/1949,Male,187,91,Private,No, , , , , ,Yes, , , , ,0,I: fulfilling all 4 criteria,IgG,"4,51",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,12/25/2018,6/13/2019,6/13/2019,9/13/2019,1/12/2022,1/12/2022,2/2/2022,3/31/2022,10/14/1582, , , 
4553,7820,6/15/1966,Male,170,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,83",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/13/2018,6/4/2019,6/4/2019,9/13/2019,3/31/2022,10/14/1582, , , , , , 
4554,9936,6/15/1945,Female,164,64,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,27",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/6/2018,2/28/2019,2/28/2019,8/26/2019,8/18/2020,8/18/2020, , , , , , 
4555,7641,6/15/1966,Male,170,67,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,83",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,DAR-X,No CTx,V-X,8/1/2018,1/25/2019,1/25/2019,8/1/2019,7/24/2020,7/24/2020,8/4/2020,7/7/2021,7/7/2021, , , 
4556,3960,6/15/1931,Male,180,88,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,R-X,12/15/2019, , , , , , , , , , , 
4557,3933,6/15/1968,Male,170,72,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"16,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/5/2019,7/18/2019,7/18/2019,2/28/2020,9/11/2020,9/11/2020, , , , , , 
4558,9668,6/15/1970,Female,168,61,Private,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/29/2019,10/30/2019,10/30/2019, , , , , , , , , 
4559,9782,6/15/1940,Female,156,78,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"3,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Unknown,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,DAR-X,No CTx,R-X,9/4/2019,2/4/2020,2/4/2020,3/25/2020,11/12/2020,11/12/2020,8/5/2021,3/31/2022,10/14/1582, , , 
4560,9416,6/15/1940,Female,168,64,Compulsory health insurance CHI,Yes, , , , , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"4,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/30/2019,10/22/2019,10/22/2019, , , , , , , , , 
4561,4264,6/15/1936,Male,176,79,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Unknown,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,R-X,8/15/2019,2/5/2020,2/5/2020,3/4/2020,11/26/2020,11/26/2020, , , , , , 
4562,9351,6/15/1959,Female,165,62,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,140,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/23/2019,6/5/2020,6/5/2020, , , , , , , , , 
4563,9822,6/15/1949,Male,165,60,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,135,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/25/2019,3/24/2020,3/24/2020, , , , , , , , , 
4564,5813,6/15/1950,Male,170,66,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/17/2019,3/3/2020,3/3/2020, , , , , , , , , 
4565,9131,6/15/1937,Male,172,68,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/15/2019,12/16/2019,12/16/2019, , , , , , , , , 
4566,8401,6/15/1935,Male,175,62,Compulsory health insurance CHI,No, ,Yes, ,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,130,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/5/2019,6/23/2020,6/23/2020,8/25/2020,5/10/2021,5/10/2021, , , , , , 
4567,6866,6/15/1939,Female,165,60,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,130,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/19/2019,3/24/2020,3/24/2020, , , , , , , , , 
4568,9294,6/15/1949,Female,164,55,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,135,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/17/2019,3/31/2020, , , , , , , , , , 
4569,2750,6/15/1951,Male,162,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes,Yes,1,III: one or more criteria are fulfilled,IgA,"3,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,2/1/2017,4/19/2017,4/19/2017,9/25/2019,7/12/2021,7/12/2021,8/16/2021,12/31/2021,10/14/1582, , , 
4570,2105,6/15/1937,Male,183,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,45",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/26/2019,8/31/2020,8/31/2020, , , , , , , , , 
4571,7301,6/15/1945,Male,182,100,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"30,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/13/2019,12/31/2020, , , , , , , , , , 
4572,4335,6/15/1941,Female,170,62,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,37",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/8/2019,7/31/2020,7/31/2020, , , , , , , , , 
4573,9473,6/15/1948,Male,178,55,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"17,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/5/2019,8/10/2020,8/10/2020, , , , , , , , , 
4574,9854,6/15/1947,Male,182,92,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"29,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/30/2019,8/22/2020,8/22/2020,12/13/2020,12/31/2020, , , , , , , 
4575,9843,6/15/1932,Male,177,82,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,52",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/22/2019,5/9/2020,5/9/2020, , , , , , , , , 
4576,3720,6/15/1943,Male,179,59,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"2,46","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/6/2019,8/11/2020,8/11/2020, , , , , , , , , 
4577,9333,6/15/1941,Male,172,65,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,44",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/16/2019,11/29/2019,11/29/2019, , , , , , , , , 
4578,6614,6/15/1941,Male,172,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,47",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,9/5/2019,12/19/2019,12/19/2019,10/7/2021,3/31/2022, , , , , , , 
4579,6390,6/15/1948,Female,164,68,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"29,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/6/2019,8/18/2020,8/18/2020,2/24/2022,3/31/2022, , , , , , , 
4580,2612,6/15/1942,Male,175,77,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"19,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/28/2019,6/10/2020,6/10/2020, , , , , , , , , 
4581,6083,6/15/1944,Female,175,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/16/2019,11/11/2019,11/11/2019, , , , , , , , , 
4582,8665,6/15/1940,Female,166,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,43",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/5/2019,2/21/2020,2/21/2020, , , , , , , , , 
4583,9045,6/15/1947,Male,178,67,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"24,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,V-X,No CTx,V-X,9/3/2019,1/2/2020,1/2/2020,1/29/2020,7/18/2020,7/18/2020,7/27/2020,1/5/2021,1/5/2021, , , 
4584,3585,6/15/1960,Male,166,69,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"20,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/21/2019,3/18/2020,3/18/2020,6/8/2021,3/31/2022,10/14/1582, , , , , , 
4585,2092,6/15/1947,Male,187,95,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,43",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/19/2019,1/11/2021,1/11/2021, , , , , , , , , 
4586,7752,6/15/1971,Female,172,98,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"48,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/20/2019,9/30/2019,9/30/2019, , , , , , , , , 
4587,2207,6/15/1953,Male,177,101,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,29",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,V-X,R-X,1/31/2019,7/29/2019,7/29/2019,8/22/2019,1/21/2020,1/21/2020,2/6/2020,5/26/2020,5/26/2020,6/9/2020,6/2/2021,6/2/2021
4588,8760,6/15/1948,Male,178,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,1",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/22/2017,4/25/2018,4/25/2018,9/10/2019,4/13/2021,4/13/2021, , , , , , 
4589,7433,6/15/1971,Female,161,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"33,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,1/18/2018,7/13/2018,7/13/2018,1/28/2019,9/9/2019,9/9/2019,9/24/2019,5/19/2020,5/19/2020, , , 
4590,2688,6/15/1947,Male,183,76,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,97",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,KYP-X,No CTx,R-X,9/17/2018,3/5/2019,3/5/2019,3/21/2019,9/20/2019,9/20/2019,9/23/2019,12/17/2021,12/17/2021, , , 
4591,3183,6/15/1939,Female,162,64,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,4",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/26/2019,12/31/2019, , , , , , , , , , 
4592,2712,6/15/1959,Female,158,65,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"3,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/15/2019,10/30/2019,10/30/2019,7/15/2020,9/30/2020, , , , , , , 
4593,5533,6/15/1939,Female,163,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,95",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,9/9/2019,3/18/2020,3/18/2020,9/10/2020,2/10/2022,2/10/2022,2/24/2022,3/31/2022, , , , 
4594,5782,6/15/1955,Male,184,90,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,41",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/20/2019,2/18/2020,2/18/2020,11/30/2020,3/31/2022,10/14/1582, , , , , , 
4595,4136,6/15/1956,Male,199,105,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,22",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/5/2019,2/3/2020,2/3/2020, , , , , , , , , 
4596,7428,6/15/1956,Male,199,105,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,8/26/2019,2/17/2020,2/17/2020,8/18/2020,12/11/2020,12/11/2020,12/19/2020,6/20/2021,6/20/2021, , , 
4597,6814,6/15/1947,Female,159,62,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,87",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/22/2019,2/27/2020,2/27/2020, , , , , , , , , 
4598,8932,6/15/1936,Male,169,74,Compulsory health insurance CHI,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,Other,9/9/2019,4/8/2020,4/8/2020,2/7/2022,3/31/2022, , , , , , , 
4599,1314,6/15/1937,Male,176,82,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,8",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/7/2019,7/22/2021,7/22/2021, , , , , , , , , 
4600,7739,6/15/1970,Female,162,56,Private,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/26/2019,10/31/2019,10/31/2019,6/10/2021,6/30/2021, , , , , , , 
4601,7042,6/15/1936,Male,183,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,24",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/30/2019,8/22/2020,8/22/2020, , , , , , , , , 
4602,2491,6/15/1939,Male,169,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,2,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/29/2019,12/12/2019,12/12/2019, , , , , , , , , 
4603,3589,6/15/1943,Female,164,51,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,66",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/9/2019,11/9/2019,11/9/2019,8/4/2021,3/31/2022,10/14/1582, , , , , , 
4604,8012,6/15/1958,Male,166,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,11,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/26/2019,9/30/2019, , , , , , , , , , 
4605,9739,6/15/1945,Female,163,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/26/2019,8/31/2020,8/31/2020,10/18/2020,3/31/2022,10/14/1582, , , , , , 
4606,5827,6/15/1949,Male,187,83,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,04",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/3/2019,5/20/2020,5/20/2020, , , , , , , , , 
4607,8500,6/15/1939,Female,155,60,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/17/2019,9/9/2020,9/9/2020,3/7/2022,3/31/2022, , , , , , , 
4608,3349,6/15/1942,Male,178,80,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"23,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/22/2019,9/29/2020,9/29/2020, , , , , , , , , 
4609,4542,6/15/1947,Female,177,111,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/29/2019,10/28/2019,10/28/2019, , , , , , , , , 
4610,3045,6/15/1941,Male,178,117,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"21,47","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/26/2019,10/26/2019,10/26/2019, , , , , , , , , 
4611,2118,6/15/1946,Female,152,57,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"33,05",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,KYP-X,No CTx,V-X,8/20/2019,8/12/2020,8/12/2020,8/12/2021,3/16/2022,3/16/2022,3/22/2022,3/31/2022,10/14/1582, , , 
4612,1709,6/15/1960,Female,174,62,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,46",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/26/2019,2/5/2020,2/5/2020, , , , , , , , , 
4613,8796,6/15/1941,Male,178,117,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/18/2019,11/18/2019,11/18/2019,3/14/2022,3/31/2022, , , , , , , 
4614,8091,6/15/1948,Male,200,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"31,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/18/2019,11/18/2019,11/18/2019, , , , , , , , , 
4615,1987,6/15/1945,Male,186,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/16/2019,11/16/2019,11/16/2019,1/28/2021,3/31/2022,10/14/1582, , , , , , 
4616,3240,6/15/1940,Male,173,102,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,51",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/22/2019,10/22/2019,10/22/2019, , , , , , , , , 
4617,1466,6/15/1949,Male,182,101,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/5/2019,12/19/2019,12/19/2019,1/26/2021,3/31/2022,10/14/1582, , , , , , 
4618,3416,6/15/1941,Male,173,65,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,09",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/9/2019,6/9/2020,6/9/2020,8/30/2020,3/31/2022,10/14/1582, , , , , , 
4619,3226,6/15/1939,Male,186,123,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/2/2019,12/16/2019,12/16/2019, , , , , , , , , 
4620,4908,6/15/1949,Male,184,96,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,96",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/12/2019,4/22/2020,4/22/2020,8/11/2021,3/31/2022, , , , , , , 
4621,1470,6/15/1939,Male,188,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,47","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/26/2019,1/20/2020,1/20/2020, , , , , , , , , 
4622,8933,6/15/1953,Female,161,73,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"17,63","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/21/2019,6/18/2019,6/18/2019,11/6/2019,8/12/2021,8/12/2021, , , , , , 
4623,2192,6/15/1959,Male,171,52,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"11,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/19/2019,9/24/2020,9/24/2020,12/2/2021,3/31/2022, , , , , , , 
4624,4090,6/15/1949,Male,184,96,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,4",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,V-X,V-X,9/19/2019,9/3/2020,9/3/2020,9/21/2020,11/9/2020,11/9/2020,12/5/2020,8/23/2021,8/23/2021,9/10/2021,3/31/2022, 
4625,2812,6/15/1952,Female,166,52,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,86",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/8/2019,3/31/2022,10/14/1582, , , , , , , , , 
4626,9591,6/15/1939,Male,177,70,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/19/2019,8/24/2020,8/24/2020, , , , , , , , , 
4627,8286,6/15/1937,Male,173,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,78",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/1/2019,1/30/2020,1/30/2020,8/29/2020,7/9/2021,7/9/2021, , , , , , 
4628,5520,6/15/1936,Male,172,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/2/2019,9/30/2019, , , , , , , , , , 
4629,4069,6/15/1947,Male,171,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/21/2019,8/13/2020,8/13/2020, , , , , , , , , 
4630,7948,6/15/1939,Female,161,67,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/20/2019,8/25/2020,8/25/2020, , , , , , , , , 
4631,1067,6/15/1939,Female,172,78,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,13",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/19/2019,3/31/2022,10/14/1582, , , , , , , , , 
4632,9825,6/15/1944,Male,180,92,Compulsory health insurance CHI,No,Yes, , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"28,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/2/2019,8/25/2020,8/25/2020, , , , , , , , , 
4633,5559,6/15/1943,Female,161,49,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,36",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/9/2019,8/21/2020,8/21/2020, , , , , , , , , 
4634,6642,6/15/1946,Female,174,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,4,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/26/2019,9/7/2020,9/7/2020,1/19/2022,3/31/2022, , , , , , , 
4635,8283,6/15/1947,Male,180,88,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"23,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,9/4/2019,1/6/2021,1/6/2021, , , , , , , , , 
4636,8621,6/15/1947,Male,177,90,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,72",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,V-X,8/27/2019,8/30/2020,8/30/2020,9/23/2020,2/15/2021,2/15/2021,3/2/2021,6/25/2021,6/25/2021,7/13/2021,3/31/2022,10/14/1582
4637,8397,6/15/1953,Female,174,82,Compulsory health insurance CHI,No,Yes, ,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"7,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/20/2019,10/28/2019,10/28/2019,11/6/2020,3/31/2022,10/14/1582, , , , , , 
4638,9789,6/15/1943,Male,179,74,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,47,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/1/2019,2/1/2020,2/1/2020,3/1/2020,3/31/2020, , , , , , , 
4639,2119,6/15/1939,Male,176,75,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/28/2019,9/2/2020,9/2/2020,10/12/2021,3/31/2022,10/14/1582, , , , , , 
4640,5375,6/15/1945,Male,179,76,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgA,"2,38",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/9/2019,11/9/2019,11/9/2019, , , , , , , , , 
4641,8491,6/15/1944,Female,164,59,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,52,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/1/2019,2/1/2020,2/1/2020,3/1/2020,6/30/2020, , , , , , , 
4642,5883,6/15/1942,Male,176,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,68,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/1/2019,1/1/2020,1/1/2020,2/1/2020,3/31/2020, , , , , , , 
4643,9193,6/15/1943,Female,158,59,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,46,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,7/1/2019,2/1/2020,2/1/2020,3/1/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, , , , 
4644,9980,6/15/1943,Female,152,57,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/15/2019,2/20/2020,2/20/2020, , , , , , , , , 
4645,2141,6/15/1948,Female,165,47,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"6,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/2/2019,8/25/2020,8/25/2020, , , , , , , , , 
4646,8775,6/15/1941,Male,176,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,I: fulfilling all 4 criteria,IgA,"2,59",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/2/2019,10/7/2020,10/7/2020,10/23/2020,3/31/2022,10/14/1582, , , , , , 
4647,9677,6/15/1944,Male,169,74,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"34,42","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/11/2019,12/4/2019,12/4/2019, , , , , , , , , 
4648,6000,6/15/1946,Female,161,66,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,"15,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/3/2019,9/15/2020,9/15/2020, , , , , , , , , 
4649,2902,6/15/1948,Female,167,75,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,83",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,R-X,8/29/2019,8/21/2020,8/21/2020,1/20/2022,3/31/2022, , , , , , , 
4650,3904,6/15/1954,Male,183,78,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"26,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/27/2019,9/30/2019, , , , , , , , , , 
4651,5139,6/15/1945,Male,170,101,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,17",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/29/2019,12/21/2020,12/21/2020, , , , , , , , , 
4652,7463,6/15/1947,Male,176,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"21,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/12/2019,9/17/2020,9/17/2020, , , , , , , , , 
4653,2660,6/15/1948,Male,177,76,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,68",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/19/2019,8/11/2020,8/11/2020, , , , , , , , , 
4654,1888,6/15/1939,Male,178,64,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,81",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/2/2019,11/26/2020,11/26/2020, , , , , , , , , 
4655,7410,6/15/1945,Male,179,76,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,28",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/26/2019,11/18/2019,11/18/2019,1/27/2022,3/31/2022, , , , , , , 
4656,5916,6/15/1954,Male,184,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,14",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/3/2018,4/1/2019,4/1/2019,9/16/2019,3/31/2022,10/14/1582, , , , , , 
4657,4610,6/15/1955,Male,176,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,82",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,9/13/2018,12/6/2018,12/6/2018,7/2/2019,2/11/2020,2/11/2020,2/26/2020,5/1/2020,5/1/2020,5/4/2020,12/12/2020,12/12/2020
4658,2222,6/15/1950,Female,159,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,47",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,DAR-X,R-X,12/14/2018,6/10/2019,6/10/2019,7/4/2019,12/30/2019,12/30/2019,1/21/2020,1/28/2021,1/28/2021,2/9/2021,3/31/2022,10/14/1582
4659,3535,6/15/1947,Male,189,81,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,I: fulfilling all 4 criteria,IgA,"2,45",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/12/2018,12/10/2018,12/10/2018,9/11/2019,5/2/2020,5/2/2020, , , , , , 
4660,3675,6/15/1948,Male,188,131,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,11/1/2018,4/26/2019,4/26/2019,7/10/2019,7/2/2020,7/2/2020, , , , , , 
4661,3575,6/15/1951,Male,178,89,Private,No,Yes,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"17,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,POM-X,V-X,11/29/2018,5/17/2019,5/17/2019,7/5/2019,2/24/2020,2/24/2020,3/6/2020,12/10/2020,12/10/2020,12/25/2020,8/16/2021,8/16/2021
4662,8162,6/15/1954,Female,167,101,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,97",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/26/2018,5/23/2019,5/23/2019,9/3/2019,12/31/2021, , , , , , , 
4663,3070,6/15/1944,Female,157,62,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,13",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,5/18/2018,11/7/2018,11/7/2018,8/7/2019,3/4/2021,3/4/2021,3/24/2021,8/19/2021,8/19/2021, , , 
4664,1397,6/15/1964,Male,172,85,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"22,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/15/2019,6/4/2019,6/4/2019,7/17/2019,10/8/2019,10/8/2019, , , , , , 
4665,6788,6/15/1966,Male,177,78,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"45,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,7/25/2019,9/16/2019,9/16/2019, , , , , , , , , 
4666,1395,6/15/1954,Female,161,58,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"4,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,7/30/2019,9/27/2019,9/27/2019,5/26/2020,8/25/2020,8/25/2020,9/3/2020,10/23/2020,10/23/2020,11/3/2020,1/19/2021,1/19/2021
4667,7696,6/15/1959,Female,168,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"91,4",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,7/31/2019,10/3/2019,10/3/2019, , , , , , , , , 
4668,6432,6/15/1953,Female,157,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,37",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,10/19/2018,4/18/2019,4/18/2019,8/7/2019,3/31/2022,10/14/1582, , , , , , 
4669,6862,6/15/1953,Male,178,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"7,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,10/8/2018,4/1/2019,4/1/2019,4/12/2019,9/10/2019,9/10/2019,9/26/2019,2/20/2020,2/20/2020,3/10/2020,4/7/2020,4/7/2020
4670,4349,6/15/1952,Male,188,116,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,04",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,12/28/2018,6/27/2019,6/27/2019,7/16/2019,1/20/2022,1/20/2022,2/8/2022,3/31/2022, , , , 
4671,7571,6/15/1953,Male,178,113,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,9,III: one or more criteria are fulfilled,IgA,",29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,">5,5 mg/L",Unbekannt,KYP-X,No CTx,No CTx,V-X,8/1/2019,9/27/2019,9/27/2019,9/6/2021,3/31/2022, , , , , , , 
4672,2172,6/15/1943,Male,168,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,83","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,1/10/2019,7/1/2019,7/1/2019,7/26/2019,3/2/2020,3/2/2020,3/12/2020,12/17/2021,12/17/2021,1/24/2022,3/31/2022, 
4673,8513,6/15/1951,Male,187,91,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,23",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,11/22/2018,3/1/2019,3/1/2019,9/9/2019,9/1/2020,9/1/2020,8/31/2021,3/31/2022, , , , 
4674,3553,6/15/1951,Male,187,91,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,86",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/5/2018,1/3/2019,1/3/2019,4/9/2019,4/1/2020,4/1/2020, , , , , , 
4675,6022,6/15/1950,Male,195,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,59",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/22/2019,6/16/2020,6/16/2020, , , , , , , , , 
4676,9366,6/15/1945,Female,163,92,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,7",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,V-X,V-X,12/17/2018,6/11/2019,6/11/2019,7/22/2019,7/14/2020,7/14/2020,1/15/2021,8/21/2021,8/21/2021,9/15/2021,12/22/2021,12/22/2021
4677,7583,6/15/1947,Female,168,67,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,01",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/14/2018,2/18/2019,2/18/2019,7/5/2019,3/31/2022,10/14/1582, , , , , , 
4678,2865,6/15/1948,Male,177,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,31",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/27/2018,12/19/2018,12/19/2018,8/19/2019,12/31/2020,10/14/1582, , , , , , 
4679,9175,6/15/1951,Male,189,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"12,41","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,12/20/2018,8/18/2019,8/18/2019,9/4/2019,12/31/2020,10/14/1582, , , , , , 
4680,3258,6/15/1946,Female,162,71,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,58",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,9/27/2018,3/27/2019,3/27/2019,9/17/2019,9/9/2020,9/9/2020, , , , , , 
4681,4907,6/15/1956,Male,175,82,Compulsory health insurance CHI,No, ,Yes, ,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"48,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/1/2019,1/1/2020,1/1/2020,9/1/2020,6/30/2021, , , , , , , 
4682,9221,6/15/1940,Female,168,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"29,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,9/1/2019,3/1/2021,3/1/2021,3/2/2021,6/30/2021, , , , , , , 
4683,8991,6/15/1945,Male,179,77,Private,No,Yes, ,Yes,Yes,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,77",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/23/2018,10/19/2018,10/19/2018,7/8/2019,3/31/2022,10/14/1582, , , , , , 
4684,2203,6/15/1945,Male,176,89,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,4/12/2017,11/10/2017,11/10/2017,7/22/2019,12/31/2019,10/14/1582, , , , , , 
4685,2971,6/15/1947,Male,178,84,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,9",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,10/17/2017,5/18/2018,5/18/2018,8/7/2019,12/31/2019,10/14/1582, , , , , , 
4686,6746,6/15/1947,Female,170,79,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"7,9",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,8/15/2019,2/19/2021,2/19/2021,3/4/2021,11/30/2021,11/30/2021,12/14/2021,3/31/2022, , , , 
4687,3511,6/15/1948,Female,168,80,Compulsory health insurance CHI,No, ,Yes, , ,Yes, ,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,8,ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/11/2019,2/11/2021,2/11/2021,2/25/2021,3/31/2022,10/14/1582, , , , , , 
4688,6434,6/15/1952,Female,170,77,Private,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgA,9999,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Unknown,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Nein, , , , ,Nein,No CTx,V-X,No CTx,No CTx, , , , , , ,7/23/2019,10/8/2019,10/8/2019, , , 
4689,1557,6/15/1949,Male,175,84,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes,Yes, , , ,Yes,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/21/2019,12/31/2019, , , , , , , , , , 
4690,5727,6/15/1941,Female,168,60,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,8",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Nein, , , , ,Nein,No CTx,No CTx,No CTx,R-X,11/9/2019,2/2/2020,2/2/2020, , , , , , , , , 
4691,7602,6/15/1942,Male,179,87,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,Unknown,IgG,"2,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,10/7/2019,8/25/2020,8/25/2020, , , , , , , , , 
4692,8443,6/15/1959,Female,151,91,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,1,Unknown,IgG,"511,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,9,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/10/2019,4/14/2020,4/14/2020, , , , , , , , , 
4693,9553,6/15/1939,Male,168,80,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,Other type,"23,3",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/26/2018,12/30/2019,12/30/2019, , , , , , , , , 
4694,9861,6/15/1944,Male,167,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,DAR-X,KYP-X,ISA-X,R-X,3/10/2017,9/2/2019,9/2/2019,11/6/2019,6/23/2021,6/23/2021,7/21/2021,12/15/2021,12/15/2021,3/8/2022,3/31/2022, 
4695,7047,6/15/1970,Female,160,65,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,9,Unknown,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,ISA-X,No CTx,V-X,2/14/2017,4/30/2017,4/30/2017,11/11/2019,3/22/2021,3/22/2021,8/17/2021,3/31/2022,10/14/1582, , , 
4696,8582,6/15/1948,Male,182,85,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,"29,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/18/2019,3/31/2022,10/14/1582, , , , , , , , , 
4697,9718,6/15/1963,Male,190,85,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,10/5/2018,1/8/2019,1/8/2019, , , , , , , , , 
4698,5032,6/15/1935,Female,160,76,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,21,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/20/2018,8/23/2018,8/23/2018, , , , , , , , , 
4699,6689,6/15/1943,Male,176,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"288,8",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,POM-X,No CTx,No CTx,V-X,5/4/2015,7/10/2019,7/10/2019,10/28/2019,4/23/2021,4/23/2021, , , , , , 
4700,2905,6/15/1967,Male,187,84,Private,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"5,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,BLEN-X,KYP-X,V-X,7/1/2019,10/24/2019,10/24/2019,12/30/2020,2/8/2021,2/8/2021,3/19/2021,3/19/2021,3/19/2021,4/15/2021,6/5/2021,6/5/2021
4701,8682,6/15/1940,Male,180,80,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/27/2019,12/31/2019, , , , , , , , , , 
4702,9884,6/15/1948,Male,180,90,Private,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/7/2019,12/14/2020,12/14/2020, , , , , , , , , 
4703,1099,6/15/1948,Male,178,76,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/7/2019,12/31/2019, , , , , , , , , , 
4704,9194,6/15/1932,Female,167,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/9/2019,9/30/2020, , , , , , , , , , 
4705,5863,6/15/1938,Male,180,80,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/17/2019,6/30/2020, , , , , , , , , , 
4706,6867,6/15/1937,Male,180,60,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/26/2019,2/26/2020,2/26/2020, , , , , , , , , 
4707,4848,6/15/1943,Female,170,50,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes,Yes,1,III: one or more criteria are fulfilled,Other type,450,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/19/2019,10/29/2019,10/29/2019,11/12/2019,12/31/2019, , , , , , , 
4708,6484,6/15/1935,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"32,17","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,V-X,R-X,No CTx,V-X,5/15/2015,1/15/2016,1/15/2016,12/23/2019,10/20/2020,10/20/2020,10/27/2020,12/21/2020,12/21/2020, , , 
4709,3074,6/15/1940,Female,155,82,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"69,02","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/20/2019,9/2/2020,9/2/2020,12/17/2020,11/16/2021,11/16/2021, , , , , , 
4710,7953,6/15/1951,Male,181,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"7,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/9/2019,10/5/2020,10/5/2020,9/13/2021,3/31/2022,10/14/1582, , , , , , 
4711,7997,6/15/1943,Male,168,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"53,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/22/2019,12/31/2019, , , , , , , , , , 
4712,9641,6/15/1939,Male,195,92,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"37,65",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,EMP-X,No CTx,DAR-X,10/9/2019,11/3/2020,11/3/2020,12/2/2020,1/19/2022,1/19/2022,1/25/2022,3/31/2022,10/14/1582, , , 
4713,8909,6/15/1939,Male,178,80,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"74,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,KYP-X,V-X,11/7/2019,3/6/2020,3/6/2020,6/24/2020,9/30/2020,9/30/2020,10/14/2020,2/28/2021,2/28/2021,3/8/2021,6/7/2021,6/7/2021
4714,5395,6/15/1956,Female,163,69,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"21,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/5/2019,6/5/2020,6/5/2020, , , , , , , , , 
4715,4714,6/15/1941,Male,170,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"6,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/3/2019,8/1/2019,8/1/2019, , , , , , , , , 
4716,3097,6/15/1960,Male,175,82,Private,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,25,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/9/2019,12/27/2019,12/27/2019,3/14/2022,3/31/2022,10/14/1582, , , , , , 
4717,3817,6/15/1942,Female,160,70,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,R-X,DAR-X,POM-X,V-X,2/23/2017,11/28/2017,11/28/2017,12/8/2019,3/18/2021,3/18/2021,3/18/2021,8/19/2021,8/19/2021,3/16/2022,3/31/2022, 
4718,8390,6/15/1955,Male,178,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,DAR-X,KYP-X,ISA-X,V-X,5/2/2011,6/14/2011,6/14/2011,12/13/2019,2/25/2021,2/25/2021,3/1/2021,9/3/2021,9/3/2021,9/6/2021,10/11/2021,10/11/2021
4719,8258,6/15/1940,Female,168,74,Compulsory health insurance CHI,Unknown, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"999,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , , , ,V-X,No CTx,No CTx,R-X,8/15/2018,9/4/2019,9/4/2019,12/20/2019,3/31/2021, , , , , , , 
4720,5131,6/15/1942,Male,183,98,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , , , ,Other,R-X,No CTx,V-X,10/1/2019,1/22/2020,1/22/2020,1/29/2020,2/25/2020,2/25/2020,8/27/2020,3/31/2021, , , , 
4721,7049,6/15/1944,Male,182,99,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Nein,R-X,No CTx,No CTx,R-X,9/14/2017,12/5/2017,12/5/2017,12/5/2019,3/31/2021, , , , , , , 
4722,6901,6/15/1956,Female,160,55,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"999,99",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , , ,DAR-X,EMP-X,No CTx,V-X,2/13/2017,4/28/2017,4/28/2017,12/2/2019,11/15/2020,11/15/2020,11/24/2020,3/31/2021, , , , 
4723,5888,6/15/1952,Female,153,60,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,4/1/2019,7/8/2019,7/8/2019, , , , , , , , , 
4724,7617,6/15/1934,Male,176,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Nein,R-X,DAR-X,No CTx,R-X,7/1/2018,11/14/2018,11/14/2018,10/16/2019,4/17/2020,4/17/2020,5/25/2020,9/21/2020,9/21/2020, , , 
4725,8984,6/15/1951,Male,175,60,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,Unknown,IgA,30,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/22/2019,3/5/2019,3/5/2019, , , , , , , , , 
4726,8306,6/15/1942,Female,165,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"189,8",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,R-X,DAR-X,No CTx,V-X,3/21/2011,6/27/2011,6/27/2011,2/11/2016,9/26/2017,9/26/2017,10/30/2018,3/31/2022,10/14/1582, , , 
4727,5189,6/15/1940,Male,182,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,251,ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,3/9/2018,8/27/2018,8/27/2018,11/18/2019,12/31/2021,10/14/1582, , , , , , 
4728,4438,6/15/1940,Male,160,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,368,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,unbekannt,Nein,Ja,Nein, , , ,"<3,5 mg/L", ,DAR-X,DAR-X,No CTx,V-X,3/26/2012,9/28/2015,9/28/2015,11/21/2016,7/25/2017,7/25/2017,12/17/2019,9/23/2020,9/23/2020, , , 
4729,7270,6/15/1954,Male,180,87,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"9,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,R-X,POM-X,KYP-X,V-X,2/4/2014,3/5/2014,3/5/2014,3/6/2014,6/4/2014,6/4/2014,2/15/2017,7/6/2017,7/6/2017,7/10/2017,9/9/2019,9/9/2019
4730,1974,6/15/1943,Male,167,80,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,LEV-X,Other,7/1/1999,9/1/1999,9/1/1999,3/9/2016,8/21/2017,8/21/2017, , , ,10/17/2019,5/26/2020,5/26/2020
4731,6064,6/15/1959,Female,999,65,Compulsory health insurance CHI,No, , , , ,Yes, , , , ,Yes,9,I: fulfilling all 4 criteria,IgG,"3,83","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,Other,7/6/2004,9/3/2004,9/3/2004,3/1/2019,7/31/2019,7/31/2019, , , , , , 
4732,8912,6/15/1964,Male,182,79,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/10/2019,1/3/2020,1/3/2020, , , , , , , , , 
4733,9731,6/15/1954,Female,155,55,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , ,Yes,9,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,KYP-X,10/9/2019,1/29/2020,1/29/2020, , , , , , , , , 
4734,5697,6/15/1950,Male,180,83,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/9/2019,3/31/2022,10/14/1582, , , , , , , , , 
4735,4171,6/15/1948,Female,165,63,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"4,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,EMP-X,DAR-X,V-X,1/9/2018,11/13/2018,11/13/2018,12/3/2019,1/8/2021,1/8/2021,1/25/2021,1/12/2022,1/12/2022,1/24/2022,3/31/2022,10/14/1582
4736,6458,6/15/1943,Male,175,95,Private,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"36,95",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/29/2019,1/20/2020,1/20/2020, , , , , , , , , 
4737,5654,6/15/1931,Male,170,75,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"46,57","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,11/21/2019,9/30/2020,10/14/1582, , , , , , , , , 
4738,1341,6/15/1943,Male,168,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"63,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,DAR-X,11/18/2019,9/30/2021,10/14/1582, , , , , , , , , 
4739,8897,6/15/1939,Female,168,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,LEV-X,12/9/2019,5/31/2020,5/31/2020,3/8/2021,12/31/2021,10/14/1582, , , , , , 
4740,6847,6/15/1945,Male,188,95,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,35,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,6/1/2017,9/5/2018,9/5/2018,12/13/2019,2/25/2020,2/25/2020,3/26/2020,3/15/2021,3/15/2021,3/24/2021,1/24/2022,1/24/2022
4741,2906,6/15/1949,Male,190,95,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,34,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,2/23/2017,9/22/2018,9/22/2018,12/5/2019,3/4/2020,3/4/2020,3/30/2020,3/17/2021,3/17/2021,3/29/2021,2/24/2022,2/24/2022
4742,9971,6/15/1948,Male,190,94,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,27,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,9/7/2017,3/12/2019,3/12/2019,12/13/2019,3/26/2020,3/26/2020,8/29/2020,8/23/2021,8/23/2021,9/15/2021,3/31/2022,10/14/1582
4743,7389,6/15/1939,Male,169,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"4,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/7/2019,5/28/2020,5/28/2020,8/18/2020,3/31/2022,10/14/1582, , , , , , 
4744,2306,6/15/1958,Male,180,82,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,Other type,"12,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/5/2019,1/19/2020,1/19/2020, , , , , , , , , 
4745,3874,6/15/1962,Female,171,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/30/2019,2/9/2020,2/9/2020, , , , , , , , , 
4746,7330,6/15/1944,Male,175,81,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,DAR-X,12/2/2019,3/28/2021,3/28/2021,8/30/2021,12/31/2021, , , , , , , 
4747,8293,6/15/1953,Female,168,90,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"29,22",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,V-X,DAR-X,No CTx,V-X,4/18/2016,8/6/2016,8/6/2016,9/12/2016,2/19/2017,2/19/2017,10/11/2019,9/30/2021,10/14/1582, , , 
4748,6192,6/15/1950,Female,172,79,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,23,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,EMP-X,KYP-X,V-X,6/5/2016,8/13/2017,8/13/2017,12/11/2019,3/18/2020,3/18/2020,3/26/2020,10/20/2020,10/20/2020,12/4/2020,9/6/2021,9/6/2021
4749,1529,6/15/1959,Male,179,83,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/12/2019,1/19/2020,1/19/2020, , , , , , , , , 
4750,6179,6/15/1947,Female,170,76,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,37,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,2/23/2017,5/18/2018,5/18/2018,12/18/2019,3/30/2020,3/30/2020,3/31/2020,3/2/2021,3/2/2021,3/29/2021,3/19/2022,3/19/2022
4751,3810,6/15/1935,Male,172,82,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,LEV-X,12/9/2019,6/7/2020,6/7/2020,9/20/2021,12/31/2021, , , , , , , 
4752,9629,6/15/1939,Female,167,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/5/2013,1/9/2014,1/9/2014,12/2/2019,3/31/2022,10/14/1582, , , , , , 
4753,9039,6/15/1949,Female,170,68,Private,Yes,Yes, , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,31,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,DAR-X,ISA-X,V-X,1/10/2017,10/19/2018,10/19/2018,12/5/2019,3/23/2020,3/23/2020,3/30/2020,3/16/2021,3/16/2021,3/25/2021,2/25/2022,2/25/2022
4754,8369,6/15/1948,Female,169,71,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,V-X,KYP-X,DAR-X,V-X,3/3/2017,10/12/2018,10/12/2018,11/9/2019,3/15/2020,3/15/2020,3/25/2020,9/27/2020,9/27/2020,10/25/2020,11/16/2021,11/16/2021
4755,7058,6/15/1946,Male,179,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,26,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,KYP-X,V-X,3/9/2016,6/25/2017,6/25/2017,12/9/2019,6/25/2020,6/25/2020,7/12/2020,6/2/2021,6/2/2021,6/17/2021,3/31/2022,10/14/1582
4756,7971,6/15/1950,Female,168,73,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,32,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/9/2019,12/1/2020,12/1/2020, , , , , , , , , 
4757,3287,6/15/1944,Male,191,99,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,EMP-X,V-X,10/24/2019,1/25/2020,1/25/2020,3/26/2020,11/19/2020,11/19/2020,12/7/2020,11/28/2021,11/28/2021,12/17/2021,3/31/2022,10/14/1582
4758,2167,6/15/1959,Male,177,72,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,1/14/2016,4/13/2016,4/13/2016,6/25/2019,9/6/2019,9/6/2019, , , , , , 
4759,4692,6/15/1961,Male,186,118,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,31",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,EMP-X,No CTx,V-X,5/8/2014,8/4/2014,8/4/2014,9/21/2015,2/1/2018,2/1/2018,2/21/2018,11/25/2019,11/25/2019, , , 
4760,2575,6/15/1939,Female,168,77,Compulsory health insurance CHI,Yes, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,31",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,KYP-X,V-X,9/24/2014,8/13/2015,8/13/2015,8/20/2015,7/14/2016,7/14/2016,8/10/2016,12/6/2016,12/6/2016,12/15/2016,6/22/2017,6/22/2017
4761,5051,6/15/1951,Male,169,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/21/2018,12/17/2018,12/17/2018,1/15/2019,4/18/2019,4/18/2019, , , , , , 
4762,9925,6/15/1965,Male,165,70,Compulsory health insurance CHI,No, , , ,Yes, , , , ,Yes, ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/15/2018,5/31/2019,5/31/2019,11/12/2019,12/31/2019, , , , , , , 
4763,1396,6/15/1958,Female,172,58,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgM,25,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/16/2019,12/17/2019,12/17/2019, , , , , , , , , 
4764,8622,6/15/1940,Male,171,76,Private,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,1888,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,No CTx, , , ,10/30/2019,12/31/2019, , , , , , , 
4765,5111,6/15/1945,Male,172,69,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/6/2019,2/20/2020,2/20/2020,5/28/2020,10/13/2020,10/13/2020, , , , , , 
4766,9991,6/15/1970,Male,181,85,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/15/2019,3/3/2020,3/3/2020, , , , , , , , , 
4767,9535,6/15/1941,Female,155,53,Compulsory health insurance CHI,No,Yes, , , ,Yes, ,Yes, , , ,2,Unknown,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , , , ,No CTx,No CTx,No CTx,DAR-X,11/18/2019,3/31/2022,10/14/1582, , , , , , , , , 
4768,1252,6/15/1946,Male,172,58,Compulsory health insurance CHI,Yes, , ,Yes,Yes,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/19/2019,6/18/2020,6/18/2020,4/21/2021,3/31/2022,10/14/1582, , , , , , 
4769,9203,6/15/1939,Female,162,68,Compulsory health insurance CHI,No, , ,Unknown, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/22/2019,7/8/2019,7/8/2019,10/30/2019,6/30/2020, , , , , , , 
4770,4614,6/15/1943,Female,174,54,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes,Yes,2,III: one or more criteria are fulfilled,Other type,45000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,7/19/2019,10/29/2019,10/29/2019,11/12/2019,3/3/2020,3/3/2020,3/12/2020,5/28/2020,5/28/2020,7/2/2020,10/12/2020,10/12/2020
4771,4879,6/15/1955,Female,168,61,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,"9,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,R-X,ISA-X,No CTx,V-X,11/18/2019,5/15/2020,5/15/2020,12/28/2020,3/5/2021,3/5/2021,3/18/2021,6/30/2021, , , , 
4772,1578,6/15/1941,Male,164,64,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"999,99",ISS stage II (neither stage I nor stage III),9,Yes,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,1/29/2019,7/29/2019,7/29/2019, , , , , , , , , 
4773,5613,6/15/1955,Male,182,75,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,No CTx,No CTx,V-X,1/25/2018,9/6/2018,9/6/2018,1/26/2019,7/7/2020,7/7/2020, , , , , , 
4774,1766,6/15/1960,Female,164,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,No,9,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/11/2019,6/3/2019,6/3/2019, , , , , , , , , 
4775,9121,6/15/1962,Male,172,72,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,3,III: one or more criteria are fulfilled,IgG,5824,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/4/2019,12/31/2019, , , , , , , , , , 
4776,1635,6/15/1948,Female,158,77,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"3,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L", ,R-X,DAR-X,Other,V-X,6/15/2015,10/15/2015,10/15/2015,11/15/2015,8/15/2019,8/15/2019,10/25/2019,6/30/2021,10/14/1582,6/14/2021,6/30/2021, 
4777,3210,6/15/1939,Male,186,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"6,3",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , , , ,V-X,No CTx,No CTx,V-X,2/25/2016,6/23/2016,6/23/2016,11/28/2019,2/27/2020,2/27/2020, , , , , , 
4778,9325,6/15/1951,Female,160,43,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , ,Yes,9,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/11/2019,3/31/2020,3/31/2020, , , , , , , , , 
4779,6459,6/15/1953,Male,183,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,11/4/2019,1/28/2020,1/28/2020,3/18/2020,3/31/2022, , , , , , , 
4780,6180,6/15/1956,Male,186,100,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,3356,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/4/2019,3/1/2020,3/1/2020, , , , , , , , , 
4781,7202,6/15/1954,Female,170,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,Unknown,IgG,999,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,12/17/2019,1/14/2020,1/14/2020, , , , , , , , , 
4782,6042,6/15/1931,Male,180,81,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"3,6",unknown/ISS-Criteria not used for prognostics,9,Yes,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,No CTx,No CTx,V-X,5/31/2016,9/6/2016,9/6/2016,9/24/2016,12/18/2019,12/18/2019, , , , , , 
4783,4228,6/15/1952,Male,176,103,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"2,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/4/2019,3/19/2020,3/19/2020, , , , , , , , , 
4784,6336,6/15/1951,Male,173,78,Private,No, ,Yes, , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgA,"1,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,R-X,R-X,V-X,Other,1/31/2006,4/8/2006,4/8/2006,8/31/2012,11/8/2012,11/8/2012,7/30/2014,12/16/2014,12/16/2014,12/17/2014,3/10/2015,3/10/2015
4785,4660,6/15/1935,Male,170,74,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,DAR-X,12/13/2019,1/24/2020,1/24/2020,2/3/2020,7/24/2020,7/24/2020, , , , , , 
4786,4095,6/15/1934,Male,173,93,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes,Unknown,9,I: fulfilling all 4 criteria,IgA,"13,88","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,11/15/2019,3/31/2020, , , , , , , , , , 
4787,9652,6/15/1968,Male,174,83,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgA,"2,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/18/2019,2/8/2020,2/8/2020, , , , , , , , , 
4788,3440,6/15/1941,Male,178,90,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,4,ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/6/2019,3/31/2022,10/14/1582, , , , , , , , , 
4789,2393,6/15/1951,Female,173,61,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/25/2019,12/11/2019,12/11/2019, , , , , , , , , 
4790,5739,6/15/1969,Female,168,65,Private,No,Yes, , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,",72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/5/2019,1/30/2020,1/30/2020, , , , , , , , , 
4791,2212,6/15/1935,Female,150,50,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,10/11/2019,3/26/2020,3/26/2020,3/26/2020,10/8/2020,10/8/2020,10/8/2020,10/8/2020,10/8/2020, , , 
4792,5582,6/15/1942,Female,160,70,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,3764,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,10/15/2019,12/10/2019,12/10/2019, , , , , , , , , 
4793,7862,6/15/1954,Male,165,65,Compulsory health insurance CHI,No,Yes,Yes,Unknown,Yes,Yes,Yes,Yes, , , ,9,Unknown,IgG,"32,7",ISS stage II (neither stage I nor stage III),No,9,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/17/2019,6/16/2020,6/16/2020, , , , , , , , , 
4794,4891,6/15/1941,Male,171,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,57","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/12/2019,11/4/2020,11/4/2020, , , , , , , , , 
4795,2861,6/15/1934,Male,161,81,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/5/2019,1/5/2020,1/5/2020,1/10/2021,3/31/2022,10/14/1582, , , , , , 
4796,2139,6/15/1944,Male,186,96,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,78",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/5/2019,6/11/2020,6/11/2020,2/14/2022,3/31/2022, , , , , , , 
4797,4494,6/15/1944,Male,186,96,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,71",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/9/2019,1/4/2021,1/4/2021, , , , , , , , , 
4798,7943,6/15/1941,Female,160,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"17,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/6/2019,12/11/2020,12/11/2020, , , , , , , , , 
4799,8406,6/15/1940,Male,165,67,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/15/2019,2/7/2020,2/7/2020, , , , , , , , , 
4800,2091,6/15/1940,Male,178,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,R-X,12/17/2019,2/10/2020,2/10/2020,1/18/2022,3/31/2022, , , , , , , 
4801,8495,6/15/1941,Male,174,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,98",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,11/14/2019,10/21/2020,10/21/2020,7/23/2021,3/31/2022, , , , , , , 
4802,9423,6/15/1942,Female,169,106,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,R-X,11/21/2019,12/22/2020,12/22/2020,3/2/2022,3/31/2022, , , , , , , 
4803,6769,6/15/1946,Female,163,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,72",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/28/2019,2/20/2020,2/20/2020,2/14/2022,3/31/2022, , , , , , , 
4804,1547,6/15/1941,Male,174,81,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,49",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/28/2019,12/3/2020,12/3/2020, , , , , , , , , 
4805,9462,6/15/1950,Male,182,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"21,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,11/21/2019,1/2/2020,1/2/2020,4/27/2020,7/5/2021,7/5/2021,9/6/2021,3/31/2022, , , , 
4806,9721,6/15/1959,Female,155,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,63",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,11/4/2019,3/5/2020,3/5/2020,9/21/2020,2/23/2022,2/23/2022,3/11/2022,3/31/2022, , , , 
4807,7311,6/15/1960,Female,169,70,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,93",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/5/2019,1/28/2020,1/28/2020, , , , , , , , , 
4808,7524,6/15/1942,Female,169,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/14/2019,5/20/2020,5/20/2020, , , , , , , , , 
4809,3243,6/15/1943,Male,188,63,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,96",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/30/2019,12/22/2020,12/22/2020, , , , , , , , , 
4810,3350,6/15/1953,Male,182,85,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"24,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/1/2019,4/1/2020,4/1/2020,9/1/2021,9/30/2021, , , , , , , 
4811,8263,6/15/1968,Female,160,64,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"35,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/15/2019,4/1/2020,4/1/2020,9/1/2021,12/31/2021,10/14/1582, , , , , , 
4812,3224,6/15/1943,Female,160,57,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,15",unknown/ISS-Criteria not used for prognostics,Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/14/2019,5/20/2020,5/20/2020, , , , , , , , , 
4813,5238,6/15/1940,Male,172,79,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/23/2019,2/5/2020,2/5/2020, , , , , , , , , 
4814,8326,6/15/1937,Male,170,68,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/18/2019,11/23/2020,11/23/2020, , , , , , , , , 
4815,6448,6/15/1932,Male,202,91,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,51",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/18/2019,11/23/2020,11/23/2020, , , , , , , , , 
4816,9581,6/15/1950,Male,183,71,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"24,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/4/2019,12/4/2019,12/4/2019, , , , , , , , , 
4817,2065,6/15/1947,Female,181,82,Private,No, ,Yes,Yes,Yes,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,85",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/21/2019,12/21/2019,12/21/2019,3/9/2022,3/31/2022, , , , , , , 
4818,1045,6/15/1948,Female,167,69,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"16,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/21/2019,11/13/2020,11/13/2020, , , , , , , , , 
4819,5542,6/15/1942,Female,165,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/8/2019,1/8/2020,1/8/2020, , , , , , , , , 
4820,8059,6/15/1945,Female,165,59,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"16,46","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,11/21/2019,5/28/2020,5/28/2020,6/3/2020,8/5/2020,8/5/2020,8/18/2020,12/31/2020,10/14/1582, , , 
4821,6181,6/15/1936,Male,172,91,Private,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"24,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/11/2019,2/10/2020,2/10/2020, , , , , , , , , 
4822,2648,6/15/1947,Female,159,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"23,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,10/4/2019,1/2/2020,1/2/2020,5/24/2020,4/28/2021,4/28/2021,9/13/2021,3/31/2022, , , , 
4823,8050,6/15/1947,Male,180,84,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/15/2019,11/4/2020,11/4/2020, , , , , , , , , 
4824,2995,6/15/1938,Male,184,119,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,22",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/10/2019,4/23/2020,4/23/2020, , , , , , , , , 
4825,9222,6/15/1956,Male,183,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,45",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/25/2019,1/4/2021,1/4/2021, , , , , , , , , 
4826,5572,6/15/1942,Male,188,102,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,32",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/1/2019,6/16/2020,6/16/2020, , , , , , , , , 
4827,3508,6/15/1935,Male,173,82,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,14",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/2/2019,1/5/2021,1/5/2021,11/3/2021,3/31/2022, , , , , , , 
4828,3012,6/15/1943,Male,202,137,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"12,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/7/2019,11/12/2020,11/12/2020,5/2/2021,3/31/2022,10/14/1582, , , , , , 
4829,5313,6/15/1943,Male,178,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/13/2019,6/12/2020,6/12/2020, , , , , , , , , 
4830,4495,6/15/1944,Male,180,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,72",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/21/2019,3/31/2020, , , , , , , , , , 
4831,3209,6/15/1930,Male,189,86,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,47",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/18/2019,3/31/2020, , , , , , , , , , 
4832,2350,6/15/1942,Male,174,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,6,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/6/2019,5/13/2020,5/13/2020, , , , , , , , , 
4833,6282,6/15/1938,Male,172,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"11,4",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,10/22/2019,3/31/2022,10/14/1582, , , , , , , , , 
4834,9593,6/15/1941,Male,161,47,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,33",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/12/2019,3/25/2020,3/25/2020,6/6/2021,3/31/2022,10/14/1582, , , , , , 
4835,9824,6/15/1940,Male,173,51,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"4,29",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/14/2019,5/1/2020,5/1/2020, , , , , , , , , 
4836,1007,6/15/1964,Female,167,70,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,93",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/10/2019,12/15/2020,12/15/2020, , , , , , , , , 
4837,2136,6/15/1944,Male,156,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,5",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,12/18/2019,12/10/2020,12/10/2020,10/19/2021,3/31/2022,10/14/1582, , , , , , 
4838,8482,6/15/1959,Female,167,54,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,39",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/3/2019,11/25/2020,11/25/2020, , , , , , , , , 
4839,1608,6/15/1944,Female,166,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,83",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/10/2019,12/2/2020,12/2/2020, , , , , , , , , 
4840,6096,6/15/1933,Male,180,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,3",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/7/2019,10/18/2020,10/18/2020, , , , , , , , , 
4841,1887,6/15/1943,Male,187,85,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgA,"1,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/5/2019,2/4/2020,2/4/2020,1/4/2021,3/31/2022,10/14/1582, , , , , , 
4842,6215,6/15/1944,Male,178,67,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,49",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/25/2019,4/30/2020,4/30/2020, , , , , , , , , 
4843,2807,6/15/1943,Male,170,55,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"24,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/25/2019,11/30/2020,11/30/2020, , , , , , , , , 
4844,3928,6/15/1943,Male,170,55,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/22/2019,11/27/2020,11/27/2020,12/7/2021,3/31/2022, , , , , , , 
4845,4325,6/15/1947,Male,171,66,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/25/2019,11/17/2020,11/17/2020, , , , , , , , , 
4846,1033,6/15/1938,Female,155,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,28",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/1/2019,12/31/2021, , , , , , , , , , 
4847,8040,6/15/1944,Female,165,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,No CTx,R-X,12/3/2019,1/9/2021,1/9/2021,1/22/2021,12/13/2021,12/13/2021,1/20/2022,3/31/2022, , , , 
4848,8031,6/15/1936,Male,165,52,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"21,06","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/19/2019,11/11/2020,11/11/2020,10/14/2021,3/31/2022,10/14/1582, , , , , , 
4849,4779,6/15/1950,Male,173,93,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,84",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/28/2019,9/1/2020,9/1/2020,3/21/2022,3/31/2022,10/14/1582, , , , , , 
4850,7113,6/15/1947,Male,183,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/14/2019,11/19/2020,11/19/2020, , , , , , , , , 
4851,8035,6/15/1945,Female,178,99,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,73",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/25/2019,3/9/2020,3/9/2020, , , , , , , , , 
4852,1142,6/15/1948,Female,171,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,12",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,2/18/2019,5/20/2019,5/20/2019,11/11/2019,1/17/2022,1/17/2022,3/11/2022,3/31/2022, , , , 
4853,3746,6/15/1954,Male,184,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"14,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,6/19/2019,9/23/2019,9/23/2019,12/16/2019,3/31/2022,10/14/1582, , , , , , 
4854,8149,6/15/1940,Female,162,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"25,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/12/2019,2/4/2020,2/4/2020, , , , , , , , , 
4855,4803,6/15/1961,Female,165,60,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,09",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,11/15/2019,11/7/2020,11/7/2020,1/21/2021,3/31/2022,10/14/1582, , , , , , 
4856,3052,6/15/1936,Female,161,91,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"32,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,4/11/2019,7/10/2019,7/10/2019,12/23/2019,1/6/2021,1/6/2021, , , , , , 
4857,3905,6/15/1958,Male,170,67,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,91",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/14/2019,1/14/2020,1/14/2020, , , , , , , , , 
4858,8021,6/15/1936,Female,161,91,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,EMP-X,KYP-X,No CTx,V-X,12/18/2018,3/21/2019,3/21/2019,11/21/2019,3/18/2022,3/18/2022,3/24/2022,3/31/2022,10/14/1582, , , 
4859,6524,6/15/1945,Male,171,55,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,08",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/10/2019,1/2/2020,1/2/2020, , , , , , , , , 
4860,5895,6/15/1945,Male,177,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,16",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/14/2019,12/3/2019,12/3/2019,12/19/2019,12/31/2021,10/14/1582, , , , , , 
4861,6413,6/15/1951,Male,176,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,44",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/29/2019,11/23/2020,11/23/2020, , , , , , , , , 
4862,6907,6/15/1941,Male,176,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/11/2019,5/18/2020,5/18/2020,9/18/2020,4/2/2021,4/2/2021, , , , , , 
4863,9331,6/15/1949,Male,178,75,Private,No, , , , ,Yes, , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,03",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/3/2019,11/25/2020,11/25/2020,1/6/2022,3/31/2022, , , , , , , 
4864,5435,6/15/1948,Male,173,69,Private,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"21,88","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,EMP-X,V-X,No CTx,V-X,3/27/2019,6/27/2019,6/27/2019,12/19/2019,8/6/2021,8/6/2021,8/31/2021,3/31/2022, , , , 
4865,1121,6/15/1943,Male,179,60,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,11/13/2019,7/20/2020,7/20/2020,8/12/2020,3/31/2021,3/31/2021, , , , , , 
4866,9598,6/15/1949,Female,159,52,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,5",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/3/2019,8/3/2021,8/3/2021, , , , , , , , , 
4867,9730,6/15/1947,Male,177,102,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,48",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,11/15/2019,9/30/2020,9/30/2020,10/20/2020,4/27/2021,4/27/2021, , , , , , 
4868,8600,6/15/1955,Female,163,64,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,4/22/2019,7/16/2019,7/16/2019,11/26/2019,9/23/2020,9/23/2020,10/1/2020,3/31/2022,10/14/1582, , , 
4869,5420,6/15/1942,Male,175,86,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,19",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/14/2019,5/7/2020,5/7/2020, , , , , , , , , 
4870,6935,6/15/1944,Female,165,71,Private,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,81",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/23/2019,7/26/2019,7/26/2019,12/12/2019,6/10/2020,6/10/2020, , , , , , 
4871,9985,6/15/1950,Male,174,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,33",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/7/2019,1/7/2020,1/7/2020,11/22/2021,3/31/2022, , , , , , , 
4872,8249,6/15/1940,Male,184,104,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,31",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,NIN-X,POM-X,R-X,11/5/2019,1/2/2020,1/2/2020,5/29/2020,1/3/2021,1/3/2021,1/14/2021,7/12/2021,7/12/2021,7/23/2021,12/16/2021,12/16/2021
4873,5573,6/15/1949,Female,163,62,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/25/2019,11/30/2020,11/30/2020,10/19/2021,3/31/2022,10/14/1582, , , , , , 
4874,2630,6/15/1943,Male,160,79,Private,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"23,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,R-X,11/28/2019,11/20/2020,11/20/2020,10/7/2021,3/31/2022, , , , , , , 
4875,6800,6/15/1950,Female,163,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,81",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,1/28/2019,4/29/2019,4/29/2019,12/2/2019,12/9/2021,12/9/2021, , , , , , 
4876,2114,6/15/1944,Male,201,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/28/2019,5/4/2020,5/4/2020, , , , , , , , , 
4877,2146,6/15/1940,Male,181,86,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"28,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/23/2019,2/22/2020,2/22/2020, , , , , , , , , 
4878,8595,6/15/1947,Male,182,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"14,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,5/9/2019,8/12/2019,8/12/2019,11/13/2019,7/6/2021,7/6/2021,7/19/2021,8/13/2021,8/13/2021, , , 
4879,8497,6/15/1949,Male,187,137,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,",38",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , ,Nein,KYP-X,DAR-X,No CTx,V-X,7/10/2019,10/22/2019,10/22/2019,1/14/2020,3/10/2020,3/10/2020,11/15/2021,3/31/2022, , , , 
4880,1440,6/15/1955,Male,183,83,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,97",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/4/2019,8/1/2019,8/1/2019,12/9/2019,7/5/2021,7/5/2021, , , , , , 
4881,7895,6/15/1944,Male,175,87,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"8,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,3/22/2019,6/21/2019,6/21/2019,12/19/2019,10/23/2020,10/23/2020,11/15/2020,7/12/2021,7/12/2021, , , 
4882,4516,6/15/1953,Male,174,85,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,71",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,1/9/2019,4/11/2019,4/11/2019,11/8/2019,12/16/2020,12/16/2020,8/25/2021,3/31/2022,10/14/1582, , , 
4883,8082,6/15/1950,Male,184,122,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"15,96","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/11/2019,9/11/2019,9/11/2019,11/22/2019,11/14/2020,11/14/2020, , , , , , 
4884,1659,6/15/1953,Female,168,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,POM-X,DAR-X,R-X,12/14/2018,6/6/2019,6/6/2019,10/3/2019,12/16/2019,12/16/2019,3/25/2020,5/1/2020,5/1/2020,5/3/2020,6/30/2021,10/14/1582
4885,3241,6/15/1955,Female,151,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,29",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,3/22/2019,7/26/2019,7/26/2019,11/28/2019,10/4/2021,10/4/2021,11/16/2021,3/31/2022, , , , 
4886,8044,6/15/1930,Female,159,64,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/31/2019,5/23/2019,5/23/2019,11/11/2019,12/31/2020, , , , , , , 
4887,9637,6/15/1950,Male,197,72,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,72",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,R-X,12/24/2018,6/21/2019,6/21/2019,7/3/2019,12/27/2019,12/27/2019,2/10/2020,12/31/2021, , , , 
4888,4847,6/15/1945,Female,176,81,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"12,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,EMP-X,POM-X,KYP-X,V-X,5/7/2019,8/9/2019,8/9/2019,12/19/2019,5/25/2021,5/25/2021,8/5/2021,12/9/2021,12/9/2021,1/10/2022,3/31/2022,10/14/1582
4889,5103,6/15/1975,Female,164,72,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,86",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/14/2017,4/4/2018,4/4/2018,12/9/2019,12/31/2020, , , , , , , 
4890,1973,6/15/1930,Female,162,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,R-X,3/18/2019,9/16/2019,9/16/2019,11/7/2019,2/2/2022,2/2/2022,3/22/2022,3/31/2022, , , , 
4891,3313,6/15/1946,Female,161,69,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,81",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,POM-X,R-X,5/30/2019,11/21/2019,11/21/2019,12/6/2019,1/2/2020,1/2/2020,6/10/2020,12/3/2021,12/3/2021,12/16/2021,3/31/2022, 
4892,4459,6/15/1954,Female,161,62,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"13,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,5/20/2019,8/12/2019,8/12/2019,11/25/2019,3/31/2022,10/14/1582, , , , , , 
4893,1945,6/15/1951,Female,156,52,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,7",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,6/10/2019,11/28/2019,11/28/2019,12/23/2019,6/24/2021,6/24/2021,2/28/2022,3/31/2022, , , , 
4894,1241,6/15/1951,Male,171,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/22/2019,7/25/2019,7/25/2019,11/21/2019,12/2/2020,12/2/2020, , , , , , 
4895,6996,6/15/1946,Male,183,77,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,3",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/1/2019,6/27/2019,6/27/2019,12/5/2019,11/27/2020,11/27/2020, , , , , , 
4896,1594,6/15/1946,Male,183,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,96",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,1/4/2019,4/5/2019,4/5/2019,12/17/2019,8/25/2021,8/25/2021,1/13/2022,3/31/2022, , , , 
4897,6511,6/15/1946,Male,186,120,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,93",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,4/3/2019,9/30/2019,9/30/2019,10/25/2019,2/7/2020,2/7/2020, , , , , , 
4898,2360,6/15/1952,Male,171,75,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,57",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,5/27/2019,8/23/2019,8/23/2019,12/2/2019,10/18/2021,10/18/2021,10/26/2021,3/31/2022,10/14/1582, , , 
4899,8095,6/15/1950,Female,164,60,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,39",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,11/28/2018,5/27/2019,5/27/2019,12/5/2019,3/19/2020,3/19/2020, , , , , , 
4900,7501,6/15/1966,Male,182,89,Private,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,35",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,5/9/2019,8/8/2019,8/8/2019,11/12/2019,2/3/2022,2/3/2022,2/28/2022,3/31/2022, , , , 
4901,8189,6/15/1953,Male,179,69,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/22/2019,6/14/2019,6/14/2019,11/12/2019,5/6/2020,5/6/2020, , , , , , 
4902,1573,6/15/1954,Male,177,85,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,84",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,3/12/2019,9/9/2019,9/9/2019,11/12/2019,7/2/2021,7/2/2021,10/6/2021,3/31/2022, , , , 
4903,4361,6/15/1947,Female,164,57,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,4",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,POM-X,No CTx,V-X,5/10/2019,8/12/2019,8/12/2019,11/11/2019,9/16/2021,9/16/2021,10/7/2021,3/31/2022, , , , 
4904,9634,6/15/1935,Male,166,71,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,21,ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/30/2019,6/30/2020, , , , , , , , , , 
4905,4179,6/15/1955,Female,163,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/11/2019,9/5/2019,9/5/2019,12/9/2019,12/1/2020,12/1/2020, , , , , , 
4906,8652,6/15/1951,Male,189,93,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,14",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,DAR-X,No CTx,V-X,4/15/2019,7/11/2019,7/11/2019,12/2/2019,5/20/2021,5/20/2021,6/8/2021,3/31/2022,10/14/1582, , , 
4907,9940,6/15/1951,Male,176,75,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,12/26/2018,3/28/2019,3/28/2019,12/10/2019,3/31/2022, , , , , , , 
4908,6438,6/15/1950,Female,158,47,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"32,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,4/1/2019,9/30/2019,9/30/2019,12/16/2019,12/8/2020,12/8/2020, , , , , , 
4909,2629,6/15/1962,Male,175,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"30,5",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/18/2019,8/20/2019,8/20/2019, , , , , , , , , 
4910,7573,6/15/1955,Male,197,77,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"22,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,4/4/2019,9/30/2019,9/30/2019,12/16/2019,12/8/2020,12/8/2020, , , , , , 
4911,7132,6/15/1947,Male,185,77,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,EMP-X,POM-X,KYP-X,V-X,4/4/2019,7/3/2019,7/3/2019,11/11/2019,1/6/2021,1/6/2021,1/30/2021,6/10/2021,6/10/2021,7/15/2021,3/31/2022,10/14/1582
4912,2689,6/15/1943,Male,178,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,10/10/2019,1/1/2020,1/1/2020,7/6/2020,9/15/2021,9/15/2021,9/27/2021,3/31/2022,10/14/1582, , , 
4913,6419,6/15/1941,Male,176,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,R-X,10/2/2019,3/17/2020,3/17/2020,8/24/2020,3/18/2021,3/18/2021,3/29/2021,1/28/2022,1/28/2022,3/14/2022,3/31/2022, 
4914,9816,6/15/1947,Female,173,88,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,6",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,2/15/2017,6/27/2017,6/27/2017,11/19/2019,11/11/2020,11/11/2020, , , , , , 
4915,8697,6/15/1974,Male,173,55,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,13",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/25/2019,10/24/2019,10/24/2019,11/14/2019,12/31/2020, , , , , , , 
4916,3255,6/15/1940,Female,164,73,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,DAR-X,EMP-X,R-X,10/14/2019,3/29/2020,3/29/2020,8/24/2020,11/15/2020,11/15/2020,3/29/2021,1/11/2022,1/11/2022,2/21/2022,3/31/2022, 
4917,9988,6/15/1949,Female,161,69,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,96",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/9/2019,8/9/2019,8/9/2019,11/14/2019,1/5/2021,1/5/2021, , , , , , 
4918,2356,6/15/1945,Female,169,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,87","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,10/22/2018,1/23/2019,1/23/2019,6/17/2019,12/9/2019,12/9/2019,2/6/2020,11/26/2020,11/26/2020,12/14/2020,12/31/2020, 
4919,8566,6/15/1946,Male,176,79,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/14/2019,10/25/2020,10/25/2020,3/22/2021,3/31/2022,10/14/1582, , , , , , 
4920,8586,6/15/1948,Female,161,66,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,10/15/2019,1/6/2020,1/6/2020,8/10/2020,12/27/2020,12/27/2020,9/20/2021,3/31/2022,10/14/1582, , , 
4921,1796,6/15/1950,Female,151,54,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,53",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,R-X,6/7/2019,11/22/2019,11/22/2019,12/6/2019,6/29/2021,6/29/2021, , , , , , 
4922,3664,6/15/1954,Female,159,45,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,46",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,12/18/2018,6/7/2019,6/7/2019,12/18/2019,1/7/2021,1/7/2021,2/10/2021,12/9/2021,12/9/2021, , , 
4923,2631,6/15/1952,Male,176,62,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"23,96","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,POM-X,DAR-X,R-X,4/18/2019,10/16/2019,10/16/2019,11/4/2019,10/27/2020,10/27/2020,12/7/2020,1/28/2021,1/28/2021,2/13/2021,12/13/2021,12/13/2021
4924,7160,6/15/1951,Male,179,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,10/18/2019,1/9/2020,1/9/2020,9/28/2020,8/31/2021,8/31/2021,9/13/2021,3/31/2022,10/14/1582, , , 
4925,6157,6/15/1944,Female,163,69,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,10/18/2019,4/2/2020,4/2/2020,12/28/2020,12/30/2021,12/30/2021,3/28/2022,3/31/2022, , , , 
4926,2504,6/15/1949,Male,178,83,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"14,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/14/2019,6/6/2019,6/6/2019,12/2/2019,11/24/2020,11/24/2020, , , , , , 
4927,6805,6/15/1947,Female,164,83,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/1/2019,3/24/2020,3/24/2020, , , , , , , , , 
4928,1677,6/15/1955,Female,165,73,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,31",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,3/28/2019,9/13/2019,9/13/2019,11/7/2019,10/30/2020,10/30/2020, , , , , , 
4929,5940,6/15/1939,Male,160,56,Private,No, ,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"51,8",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Ja,No CTx,No CTx,No CTx,R-X,12/18/2019,3/31/2022,10/14/1582, , , , , , , , , 
4930,3086,6/15/1957,Male,183,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes,2,III: one or more criteria are fulfilled,IgG,"62,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/4/2019,2/27/2020,2/27/2020,8/27/2020,9/30/2020, , , , , , , 
4931,9476,6/15/1952,Female,167,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"20,1",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,11/18/2019,3/3/2020,3/3/2020, , , , , , , , , 
4932,3714,6/15/1945,Male,177,82,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,2/26/2019,6/19/2019,6/19/2019,11/14/2019,7/16/2021,7/16/2021,8/11/2021,3/31/2022, , , , 
4933,1276,6/15/1947,Female,162,60,Private,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,41",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/15/2019,7/15/2019,7/15/2019,11/27/2019,2/1/2020,2/1/2020, , , , , , 
4934,4365,6/15/1945,Male,183,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,4/29/2019,7/25/2019,7/25/2019,12/19/2019,9/15/2020,9/15/2020,6/8/2021,6/30/2021, , , , 
4935,8721,6/15/1946,Female,163,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,5",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,7/12/2018,10/11/2018,10/11/2018,12/27/2019,10/22/2020,10/22/2020,5/17/2021,3/31/2022,10/14/1582, , , 
4936,8930,6/15/1960,Male,191,113,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,57","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,4/8/2019,9/30/2019,9/30/2019,11/13/2019,11/5/2020,11/5/2020, , , , , , 
4937,1195,6/15/1952,Female,157,43,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,11",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,1/2/2019,4/4/2019,4/4/2019,11/5/2019,3/31/2022,10/14/1582, , , , , , 
4938,3327,6/15/1938,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,10/21/2019,4/5/2020,4/5/2020,12/28/2020,12/22/2021,12/22/2021,3/21/2022,3/31/2022, , , , 
4939,8506,6/15/1947,Female,159,57,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,10/21/2019,1/12/2020,1/12/2020,9/28/2020,3/14/2021,3/14/2021,9/6/2021,3/31/2022,10/14/1582, , , 
4940,9478,6/15/1938,Male,177,72,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,10/28/2019,4/12/2020,4/12/2020,12/29/2020,12/28/2021,12/28/2021,3/24/2022,3/31/2022, , , , 
4941,7257,6/15/1950,Female,163,67,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"8,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,10/31/2019,9/6/2020,9/6/2020,9/7/2020,2/21/2021,2/21/2021,9/27/2021,3/31/2022,10/14/1582, , , 
4942,8528,6/15/1943,Male,185,90,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgD,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,11/5/2019,1/27/2020,1/27/2020,12/30/2020,12/20/2021,12/20/2021,2/28/2022,3/31/2022, , , , 
4943,3154,6/15/1936,Female,158,56,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"11,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,DAR-X,No CTx,R-X,11/8/2019,4/23/2020,4/23/2020,9/30/2020,12/22/2020,12/22/2020,9/6/2021,3/31/2022,10/14/1582, , , 
4944,3280,6/15/1941,Male,177,95,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,DAR-X,POM-X,No CTx,V-X,11/11/2019,4/26/2020,4/26/2020,12/21/2020,12/30/2021,12/30/2021,2/7/2022,3/31/2022, , , , 
4945,1634,6/15/1947,Male,175,80,Private,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,11/11/2019,2/2/2020,2/2/2020,9/28/2020,3/14/2021,3/14/2021,9/23/2021,3/31/2022,10/14/1582, , , 
4946,9286,6/15/1950,Female,167,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,Unknown,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,11/15/2019,2/6/2020,2/6/2020,9/21/2020,3/7/2021,3/7/2021,3/22/2021,1/14/2022,1/14/2022,2/28/2022,3/31/2022, 
4947,6618,6/15/1935,Male,174,70,Compulsory health insurance CHI,Yes, , ,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/15/2019,4/30/2020,4/30/2020,12/30/2020,6/30/2021,10/14/1582, , , , , , 
4948,7150,6/15/1952,Male,177,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,11/21/2019,2/12/2020,2/12/2020,9/28/2020,3/14/2021,3/14/2021,9/13/2021,3/31/2022,10/14/1582, , , 
4949,7116,6/15/1939,Female,162,59,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/28/2019,5/13/2020,5/13/2020,12/21/2020,12/22/2021,12/22/2021, , , , , , 
4950,2972,6/15/1952,Male,178,75,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,11/28/2019,2/19/2020,2/19/2020,9/9/2020,2/18/2021,2/18/2021,3/1/2021,3/31/2022,10/14/1582, , , 
4951,5475,6/15/1936,Female,157,55,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"9,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,DAR-X,No CTx,R-X,12/2/2019,5/17/2020,5/17/2020,9/20/2020,12/21/2020,12/21/2020,9/28/2021,3/31/2022,10/14/1582, , , 
4952,7340,6/15/1947,Female,163,66,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,DAR-X,No CTx,R-X,12/3/2019,5/18/2020,5/18/2020,9/30/2020,12/22/2020,12/22/2020,9/20/2021,3/31/2022,10/14/1582, , , 
4953,8150,6/15/1954,Male,177,86,Private,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"11,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,12/9/2019,3/1/2020,3/1/2020,9/28/2020,3/14/2021,3/14/2021,11/29/2021,3/31/2022, , , , 
4954,3917,6/15/1945,Male,178,72,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,12/19/2019,3/11/2020,3/11/2020,12/30/2020,9/10/2021,9/10/2021,9/27/2021,3/31/2022,10/14/1582, , , 
4955,6312,6/15/1950,Male,181,86,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/30/2019,3/22/2020,3/22/2020,12/14/2020,6/30/2021,10/14/1582, , , , , , 
4956,9269,6/15/1950,Male,185,79,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"9,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/6/2019,5/13/2020,5/13/2020, , , , , , , , , 
4957,8217,6/15/1946,Male,185,91,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"32,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/25/2019,8/1/2019,8/1/2019,12/12/2019,1/4/2021,1/4/2021, , , , , , 
4958,2719,6/15/1946,Female,164,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"20,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,5/21/2019,11/8/2019,11/8/2019,11/27/2019,11/19/2020,11/19/2020, , , , , , 
4959,9379,6/15/1946,Male,168,74,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/27/2019,7/1/2019,7/1/2019,11/7/2019,3/31/2022,10/14/1582, , , , , , 
4960,3021,6/15/1953,Male,177,84,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"28,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,5/7/2019,11/1/2019,11/1/2019,11/11/2019,4/27/2020,4/27/2020, , , , , , 
4961,3456,6/15/1955,Female,162,66,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,125,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,10/22/2019,6/24/2020,6/24/2020, , , , , , , , , 
4962,1838,6/15/1948,Female,167,65,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,150,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,10/8/2019,6/30/2020,10/14/1582, , , , , , , , , 
4963,8339,6/15/1950,Male,172,70,Compulsory health insurance CHI,No, , , ,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,260,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/19/2019,6/30/2020,10/14/1582, , , , , , , , , 
4964,2211,6/15/1948,Male,165,72,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,165,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/25/2019,6/23/2020,6/23/2020, , , , , , , , , 
4965,5371,6/15/1955,Male,168,72,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,225,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,DAR-X,12/16/2019,6/12/2020,6/12/2020,9/14/2020,12/15/2020,12/15/2020, , , , , , 
4966,2974,6/15/1957,Male,172,65,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,270,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,DAR-X,12/16/2019,6/16/2020,6/16/2020,9/22/2020,11/30/2020,11/30/2020, , , , , , 
4967,6893,6/15/1953,Female,162,60,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,350,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,DAR-X,11/25/2019,6/15/2020,6/15/2020,8/25/2020,6/14/2021,6/14/2021, , , , , , 
4968,1275,6/15/1955,Male,180,90,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,33,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/22/2019,6/30/2020, , , , , , , , , , 
4969,3697,6/15/1942,Male,173,70,Compulsory health insurance CHI,Yes, , , ,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,51,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , , ,Nein,R-X,V-X,R-X,V-X,11/26/2019,4/14/2020,4/14/2020,5/18/2020,3/25/2021,3/25/2021,5/3/2021,9/8/2021,9/8/2021,9/20/2021,3/31/2022, 
4970,2057,6/15/1949,Male,171,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,Other type,2700,ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,EMP-X,V-X,9/23/2019,1/8/2020,1/8/2020,1/14/2020,3/10/2020,3/10/2020,3/24/2020,6/22/2021,6/22/2021,7/6/2021,3/31/2022, 
4971,1061,6/15/1951,Male,178,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,55,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,8/2/2019,3/31/2020, , , , , , , , , , 
4972,6640,6/15/1968,Male,184,91,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,51,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,8/6/2019,12/16/2019,12/16/2019, , , , , , , , , 
4973,2154,6/15/1928,Male,172,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,42,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,R-X,V-X,DAR-X,V-X,10/16/2013,5/28/2014,5/28/2014,11/15/2018,8/1/2019,8/1/2019,11/12/2019,6/21/2021,6/21/2021,7/28/2021,10/5/2021,10/5/2021
4974,8324,6/15/1947,Female,165,75,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,Other type,6037,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,R-X,No CTx,No CTx,V-X,7/22/2019,4/20/2020,4/20/2020,3/1/2021,10/27/2021,10/27/2021, , , , , , 
4975,6571,6/15/1935,Female,161,51,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,47,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , , ,Ja,No CTx,No CTx,No CTx,R-X,12/18/2019,12/31/2019, , , , , , , , , , 
4976,8579,6/15/1972,Male,178,90,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,2,I: fulfilling all 4 criteria,Other type,660,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,R-X,7/24/2019,3/31/2022, , , , , , , , , , 
4977,5605,6/15/1942,Male,172,90,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,42,ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,7/31/2018,8/15/2019,8/15/2019,10/16/2019,6/15/2020,6/15/2020,5/27/2021,3/31/2022, , , , 
4978,9118,6/15/1964,Female,163,74,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,14,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,V-X,No CTx,No CTx,V-X,11/15/2013,1/15/2014,1/15/2014,12/9/2019,8/14/2020,8/14/2020, , , , , , 
4979,9791,6/15/1942,Female,165,78,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,71,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,R-X,DAR-X,FAR-X,V-X,1/15/2010,11/15/2010,11/15/2010,3/15/2016,4/15/2018,4/15/2018,5/15/2018,9/15/2019,9/15/2019,9/23/2019,12/31/2019, 
4980,9403,6/15/1945,Female,163,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,63,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/15/2019,4/15/2020,4/15/2020, , , , , , , , , 
4981,3937,6/15/1942,Male,184,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,58,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/15/2019,6/15/2020,6/15/2020, , , , , , , , , 
4982,6583,6/15/1948,Male,174,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,74,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/15/2019,6/15/2020,6/15/2020, , , , , , , , , 
4983,9949,6/15/1940,Female,164,73,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,62,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/15/2019,4/15/2020,4/15/2020, , , , , , , , , 
4984,8702,6/15/1941,Female,165,71,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,52,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,V-X,No CTx,R-X,11/15/2019,2/1/2020,2/1/2020,3/1/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, , , , 
4985,5474,6/15/1939,Male,171,75,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"12,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,11/27/2019,1/27/2020,1/27/2020,3/12/2021,3/31/2022, , , , , , , 
4986,2766,6/15/1948,Male,184,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"16,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/25/2019,1/25/2020,1/25/2020, , , , , , , , , 
4987,3923,6/15/1943,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"265,6",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,V-X,DAR-X,No CTx, , , ,2/14/2011,4/11/2011,4/11/2011,1/3/2017,3/20/2017,3/20/2017,1/14/2020,12/8/2020,12/8/2020
4988,8685,6/15/1935,Male,175,95,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Ja,No CTx,No CTx,No CTx,V-X,3/12/2020,3/19/2020,3/19/2020, , , , , , , , , 
4989,8993,6/15/1938,Female,158,62,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , , ,Ja,No CTx,No CTx,No CTx,DAR-X,3/2/2020,10/27/2020,10/27/2020, , , , , , , , , 
4990,8985,6/15/1940,Male,180,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/27/2020,12/21/2020,12/21/2020, , , , , , , , , 
4991,7079,6/15/1944,Male,184,81,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/20/2020,3/31/2022,10/14/1582, , , , , , , , , 
4992,8070,6/15/1934,Female,165,68,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"3,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/20/2020,3/31/2020, , , , , , , , , , 
4993,1592,6/15/1950,Male,176,84,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,KYP-X,V-X,7/29/2014,11/28/2014,11/28/2014,6/5/2019,12/16/2019,12/16/2019,1/16/2020,8/31/2020,8/31/2020,9/30/2020,6/25/2021,6/25/2021
4994,1179,6/15/1950,Female,160,68,Compulsory health insurance CHI,No, , , , ,Yes, , , , ,Yes,2,III: one or more criteria are fulfilled,IgG,",96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,Other,Other,Other,V-X,6/16/2018,1/2/2019,1/2/2019,11/22/2019,12/18/2019,12/18/2019,1/7/2020,5/28/2020,5/28/2020,5/29/2020,7/22/2020,7/22/2020
4995,9211,6/15/1944,Female,165,44,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"6,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,11/10/2016,12/28/2016,12/28/2016,1/2/2017,1/10/2018,1/10/2018,1/29/2020,3/31/2022,10/14/1582, , , 
4996,9480,6/15/1949,Female,160,60,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,Other,V-X,6/6/2017,1/2/2018,1/2/2018,1/15/2020,5/26/2020,5/26/2020,6/1/2020,7/9/2020,7/9/2020,7/10/2020,7/14/2020,7/14/2020
4997,6080,6/15/1959,Male,178,94,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,"1,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/15/2020,4/30/2020,4/30/2020, , , , , , , , , 
4998,3783,6/15/1933,Male,180,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/7/2020,3/31/2020, , , , , , , , , , 
4999,3709,6/15/1948,Male,167,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2020,3/31/2021, , , , , , , , , , 
5000,3737,6/15/1940,Female,153,58,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,EMP-X,No CTx,DAR-X,10/1/2018,12/1/2018,12/1/2018,1/4/2019,12/17/2019,12/17/2019,1/8/2020,3/31/2022,10/14/1582, , , 
5001,8329,6/15/1950,Male,190,104,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"78,6",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/20/2020,3/30/2020,3/30/2020, , , , , , , , , 
5002,3069,6/15/1960,Female,168,72,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,2046,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/10/2020,7/13/2020,7/13/2020, , , , , , , , , 
5003,4443,6/15/1953,Female,172,87,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,2170,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,2/17/2020,5/14/2020,5/14/2020,11/9/2020,8/15/2021,8/15/2021,9/7/2021,2/3/2022,2/3/2022,3/7/2022,3/31/2022, 
5004,3839,6/15/1947,Male,188,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"33,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/10/2020,3/31/2022,10/14/1582, , , , , , , , , 
5005,3093,6/15/1955,Male,174,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,50,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/6/2020,3/31/2022,10/14/1582, , , , , , , , , 
5006,9212,6/15/1943,Female,160,69,Private,Yes, , , , , , , , , , ,0,Unknown,IgG,65,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,DAR-X,No CTx,No CTx,R-X,2/17/2020,7/21/2021,7/21/2021,7/30/2021,3/31/2022,10/14/1582, , , , , , 
5007,1170,6/15/1960,Male,180,80,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"41,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2020,5/11/2020,5/11/2020, , , , , , , , , 
5008,3972,6/15/1969,Female,158,50,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/6/2020,4/16/2020,4/16/2020, , , , , , , , , 
5009,7561,6/15/1955,Male,179,75,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"42,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,V-X,DAR-X,POM-X,V-X,2/27/2017,2/20/2018,2/20/2018,3/3/2020,2/2/2021,2/2/2021,2/15/2021,11/22/2021,11/22/2021,2/9/2022,3/31/2022, 
5010,1777,6/15/1958,Male,160,65,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,KYP-X,DAR-X,No CTx,V-X,4/1/2014,5/30/2014,5/30/2014,3/2/2020,1/17/2022,1/17/2022,2/24/2022,3/31/2022, , , , 
5011,4262,6/15/1945,Female,168,77,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"38,75",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,11/15/2016,12/1/2017,12/1/2017,1/16/2020,7/28/2021,7/28/2021,8/18/2021,3/31/2022, , , , 
5012,2792,6/15/1939,Male,169,79,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,15,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,KYP-X,No CTx,R-X,2/27/2018,10/10/2019,10/10/2019,2/6/2020,1/21/2021,1/21/2021,9/15/2021,3/31/2022,10/14/1582, , , 
5013,5689,6/15/1942,Male,184,98,Private,Yes, , , , , , , , , , ,9,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , , ,R-X,DAR-X,POM-X,V-X,2/15/2012,1/31/2020,1/31/2020,2/7/2020,10/29/2021,10/29/2021,11/29/2021,2/21/2022,2/21/2022,2/28/2022,3/31/2022, 
5014,1991,6/15/1954,Male,183,83,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,1800,ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,1/10/2020,2/24/2020,2/24/2020,12/28/2021,3/31/2022,10/14/1582, , , , , , 
5015,6991,6/15/1933,Male,176,71,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,6659,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/6/2020,6/18/2020,6/18/2020, , , , , , , , , 
5016,4838,6/15/1964,Female,168,75,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"6,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/30/2020,5/10/2020,5/10/2020, , , , , , , , , 
5017,1387,6/15/1944,Male,178,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/16/2020,12/20/2020,12/20/2020, , , , , , , , , 
5018,1983,6/15/1958,Male,181,92,Private,No, , , , ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"2,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/2/2020,5/3/2020,5/3/2020, , , , , , , , , 
5019,8527,6/15/1935,Male,174,75,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,3/9/2020,8/30/2020,8/30/2020, , , , , , , , , 
5020,7081,6/15/1952,Male,179,89,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,KYP-X,EMP-X,V-X,7/23/2018,5/9/2019,5/9/2019,7/25/2019,11/15/2019,11/15/2019,3/20/2020,10/13/2020,10/13/2020,12/9/2020,11/9/2021,11/9/2021
5021,4846,6/15/1945,Female,172,78,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,31,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,ISA-X,V-X,4/2/2018,2/9/2019,2/9/2019,3/9/2020,11/13/2020,11/13/2020,12/29/2020,1/9/2022,1/9/2022,3/24/2022,3/31/2022,10/14/1582
5022,1411,6/15/1950,Male,187,93,Private,No,Yes, , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,26,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/23/2020,12/18/2020,12/18/2020, , , , , , , , , 
5023,9711,6/15/1953,Male,186,96,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/22/2020,6/6/2021,6/6/2021,6/11/2021,3/31/2022,10/14/1582, , , , , , 
5024,8735,6/15/1947,Female,163,66,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,1/2/2020,3/25/2020,3/25/2020,9/30/2020,3/16/2021,3/16/2021,9/13/2021,3/31/2022,10/14/1582, , , 
5025,7817,6/15/1940,Male,178,78,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,2/2/2020,6/17/2020,6/17/2020,2/22/2021,3/31/2022,10/14/1582, , , , , , 
5026,6620,6/15/1938,Female,158,55,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,1/6/2020,6/21/2020,6/21/2020,9/30/2020,8/27/2021,8/27/2021,9/6/2021,3/31/2022,10/14/1582, , , 
5027,9148,6/15/1950,Male,176,80,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,1/10/2020,4/2/2020,4/2/2020,2/8/2021,2/16/2022,2/16/2022,3/21/2022,3/31/2022, , , , 
5028,6428,6/15/1956,Female,160,57,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes,Yes,1,III: one or more criteria are fulfilled,IgG,670,unknown/ISS-Criteria not used for prognostics,Yes,Yes,No,Yes,No,No,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,1/10/2020,4/21/2020,4/21/2020, , , , , , , , , 
5029,7167,6/15/1960,Female,9,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,Other type,"999999,99",ISS stage II (neither stage I nor stage III),9,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L", ,KYP-X,KYP-X,No CTx,V-X,10/15/2013,12/15/2013,12/15/2013,3/15/2017,6/15/2017,6/15/2017,3/23/2020,4/28/2020,4/28/2020, , , 
5030,7319,6/15/1935,Male,9,80,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"620,6",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/2/2020,2/27/2020,2/27/2020, , , , , , , , , 
5031,8481,6/15/1955,Female,9,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,191,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , , , ,KYP-X,No CTx,No CTx,V-X,1/7/2020,3/16/2020,3/16/2020,4/29/2020,6/10/2020,6/10/2020, , , , , , 
5032,2340,6/15/1961,Female,166,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,325,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,KYP-X,No CTx,No CTx,V-X,12/17/2019,3/2/2020,3/2/2020,3/31/2020,5/12/2020,5/12/2020, , , , , , 
5033,1027,6/15/1951,Female,162,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,1/15/2020,4/7/2020,4/7/2020,2/8/2021,2/24/2022,2/24/2022,3/21/2022,3/31/2022, , , , 
5034,9072,6/15/1943,Male,178,74,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,1/15/2020,6/30/2020,6/30/2020,9/21/2020,12/28/2021,12/28/2021,2/7/2022,3/31/2022, , , , 
5035,1378,6/15/1959,Female,170,72,Private,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/2/2020,4/12/2020,4/12/2020, , , , , , , , , 
5036,1908,6/15/1934,Male,171,63,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"3,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,LEV-X,3/9/2020,8/30/2020,8/30/2020,3/29/2021,12/31/2021,10/14/1582, , , , , , 
5037,4046,6/15/1960,Male,172,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/10/2020,4/19/2020,4/19/2020, , , , , , , , , 
5038,6193,6/15/1958,Male,189,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"999,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,V-X,KYP-X,No CTx,V-X,12/23/2014,3/3/2015,3/3/2015,3/12/2020,5/14/2020,5/14/2020,2/23/2022,3/31/2022,10/14/1582, , , 
5039,9057,6/15/1942,Male,182,99,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,19,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,KYP-X,ISA-X,V-X,2/2/2018,7/6/2018,7/6/2018,2/3/2020,11/5/2020,11/5/2020,12/22/2020,10/30/2021,10/30/2021,12/27/2021,3/31/2022,10/14/1582
5040,2419,6/15/1940,Male,175,83,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Ja,KYP-X,NIN-X,No CTx,V-X,6/27/2016,8/28/2016,8/28/2016,3/16/2020,4/11/2021,4/11/2021,11/22/2021,12/31/2021, , , , 
5041,1818,6/15/1940,Male,181,87,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,27,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,EMP-X,DAR-X,V-X,3/9/2018,7/19/2018,7/19/2018,2/28/2020,12/13/2020,12/13/2020,12/29/2020,8/29/2021,8/29/2021,9/15/2021,3/31/2022,10/14/1582
5042,6205,6/15/1947,Male,179,96,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,29,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,V-X,V-X,4/7/2018,8/12/2018,8/12/2018,3/7/2020,11/19/2020,11/19/2020,12/14/2020,8/29/2021,8/29/2021,9/23/2021,3/31/2022,10/14/1582
5043,3135,6/15/1947,Female,168,70,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,3/15/2020,7/26/2020,7/26/2020,10/19/2020,8/17/2021,8/17/2021,9/22/2021,3/31/2022,10/14/1582, , , 
5044,7991,6/15/1937,Male,174,72,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"9,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,1/13/2020,11/16/2020,11/16/2020,11/30/2020,12/21/2021,12/21/2021,1/31/2022,3/31/2022, , , , 
5045,4024,6/15/1935,Male,172,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,1/21/2020,7/6/2020,7/6/2020,7/6/2020,2/11/2021,2/11/2021,2/22/2021,3/31/2022,10/14/1582, , , 
5046,7084,6/15/1947,Female,159,56,Private,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/27/2020,4/19/2020,4/19/2020,11/23/2020,6/30/2021,10/14/1582, , , , , , 
5047,2131,6/15/1963,Male,172,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"4,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/18/2020,6/4/2020,6/4/2020, , , , , , , , , 
5048,1219,6/15/1945,Male,163,66,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"12,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/19/2020,6/19/2020,6/19/2020, , , , , , , , , 
5049,7586,6/15/1951,Female,166,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,1/31/2020,4/23/2020,4/23/2020,2/15/2021,1/20/2022,1/20/2022,2/7/2022,3/31/2022, , , , 
5050,9874,6/15/1940,Male,178,81,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,4/16/2014,7/10/2014,7/10/2014,3/23/2020,5/31/2020,5/31/2020, , , , , , 
5051,6247,6/15/1943,Female,166,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/26/2017,9/17/2017,9/17/2017,3/16/2020,12/12/2021,12/12/2021, , , , , , 
5052,8720,6/15/1936,Female,164,59,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"4,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,LEV-X,LEV-X,No CTx,LEV-X,1/8/2018,7/1/2018,7/1/2018,3/9/2020,9/6/2020,9/6/2020,12/13/2021,12/31/2021, , , , 
5053,5992,6/15/1949,Male,175,89,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Ja,V-X,No CTx,No CTx,V-X,4/7/2010,7/15/2010,7/15/2010,2/3/2020,4/20/2020,4/20/2020, , , , , , 
5054,7631,6/15/1950,Male,165,61,Private,Unknown,Yes,Yes, , , , , , , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,Other type,",7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/18/2020,11/28/2021,11/28/2021, , , , , , , , , 
5055,3056,6/15/1941,Female,160,74,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,Other type,",5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,9,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/10/2020,2/29/2020,2/29/2020, , , , , , , , , 
5056,5476,6/15/1935,Female,168,59,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/8/2020,12/31/2020, , , , , , , , , , 
5057,4785,6/15/1950,Male,171,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,",7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/15/2020,3/30/2020,3/30/2020, , , , , , , , , 
5058,3275,6/15/1961,Male,181,89,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/22/2015,8/2/2015,8/2/2015,3/18/2020,12/31/2021,10/14/1582, , , , , , 
5059,2367,6/15/1943,Female,163,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/3/2020,7/19/2020,7/19/2020,2/22/2021,3/31/2022,10/14/1582, , , , , , 
5060,4669,6/15/1951,Female,155,58,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"9,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,2/7/2020,9/14/2021,9/14/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
5061,7448,6/15/1953,Male,177,79,Private,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,2/10/2020,5/3/2020,5/3/2020,3/16/2021,2/16/2022,2/16/2022,3/14/2022,3/31/2022, , , , 
5062,9050,6/15/1941,Male,175,73,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,ISA-X,No CTx,V-X,2/7/2020,4/30/2020,4/30/2020,9/28/2020,12/21/2021,12/21/2021,3/7/2022,3/31/2022, , , , 
5063,6073,6/15/1939,Female,166,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/13/2020,11/30/2021,11/30/2021, , , , , , , , , 
5064,7942,6/15/1936,Male,172,75,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,2/19/2020,8/4/2020,8/4/2020,3/29/2021,12/10/2021,12/10/2021, , , , , , 
5065,2305,6/15/1965,Male,178,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"4,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/30/2020,6/7/2020,6/7/2020, , , , , , , , , 
5066,6942,6/15/1942,Male,163,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,LEV-X,No CTx,LEV-X,8/28/2017,2/18/2018,2/18/2018,3/9/2020,5/9/2021,5/9/2021,8/23/2021,12/31/2021, , , , 
5067,5547,6/15/1944,Male,174,72,Private,Yes, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,2/20/2020,12/17/2021,12/17/2021,2/16/2022,3/31/2022,10/14/1582, , , , , , 
5068,5275,6/15/1947,Female,164,70,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,1/15/2018,7/1/2018,7/1/2018,2/27/2020,9/3/2021,9/3/2021,9/20/2021,3/31/2022,10/14/1582, , , 
5069,3279,6/15/1950,Female,168,63,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,2/28/2020,5/21/2020,5/21/2020,9/28/2020,6/25/2021,6/25/2021,9/27/2021,3/31/2022,10/14/1582, , , 
5070,4540,6/15/1952,Male,180,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,3/2/2020,9/14/2021,9/14/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
5071,5130,6/15/1951,Male,185,99,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,31,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,EMP-X,V-X,10/6/2017,4/5/2018,4/5/2018,2/29/2020,11/29/2020,11/29/2020,12/18/2020,2/18/2022,2/18/2022,3/27/2022,3/31/2022, 
5072,4424,6/15/1953,Male,187,97,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,45,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,KYP-X,V-X,3/3/2018,7/9/2018,7/9/2018,3/16/2020,10/19/2020,10/19/2020,12/13/2020,12/10/2021,12/10/2021,12/22/2021,3/31/2022,10/14/1582
5073,4244,6/15/1946,Male,181,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,3/3/2020,3/2/2022,3/2/2022,3/25/2022,3/31/2022, , , , , , , 
5074,1279,6/15/1937,Female,156,53,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"9,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/6/2020,8/20/2020,8/20/2020,3/1/2021,3/31/2022,10/14/1582, , , , , , 
5075,7387,6/15/1951,Male,178,85,Private,No, ,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,3/11/2020,6/2/2020,6/2/2020,9/30/2020,9/2/2021,9/2/2021,9/13/2021,3/31/2022,10/14/1582, , , 
5076,5039,6/15/1936,Female,161,66,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"11,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,3/18/2020,9/1/2020,9/1/2020,3/29/2021,12/20/2021,12/20/2021, , , , , , 
5077,7239,6/15/1945,Male,178,90,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,3/26/2020,6/17/2020,6/17/2020,12/28/2020,12/16/2021,12/16/2021,2/7/2022,3/31/2022, , , , 
5078,6264,6/15/1941,Male,174,73,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"12,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,3/30/2020,12/22/2021,12/22/2021,3/28/2022,3/31/2022, , , , , , , 
5079,7682,6/15/1937,Male,168,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"46,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/10/2020,3/31/2020, , , , , , , , , , 
5080,9768,6/15/1933,Male,174,77,Private,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"19,38",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,1/30/2020,2/21/2020,2/21/2020, , , , , , , , , 
5081,4214,6/15/1937,Male,177,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"42,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/26/2020,4/16/2020,4/16/2020, , , , , , , , , 
5082,1886,6/15/1959,Male,180,83,Private,No, , ,Yes, ,Yes, , , , , ,9,III: one or more criteria are fulfilled,IgA,"9999,99",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,DAR-X,No CTx,No CTx,V-X,8/1/2018,11/1/2018,11/1/2018,2/14/2020,2/2/2021,2/2/2021, , , , , , 
5083,7584,6/15/1932,Female,160,55,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"40,67",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/17/2020,10/15/2020,10/15/2020, , , , , , , , , 
5084,3361,6/15/1943,Male,177,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,EMP-X,V-X,1/15/2018,7/1/2018,7/1/2018,1/6/2020,6/21/2020,6/21/2020,12/28/2020,12/14/2021,12/14/2021,3/7/2022,3/31/2022, 
5085,5268,6/15/1948,Female,159,66,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"9,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/5/2020,3/31/2022,10/14/1582, , , , , , , , , 
5086,9742,6/15/1939,Female,165,70,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,12/4/2017,5/20/2018,5/20/2018,2/24/2020,6/28/2021,6/28/2021,8/2/2021,3/31/2022,10/14/1582, , , 
5087,5957,6/15/1949,Male,179,84,Private,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"13,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,2/5/2018,7/22/2018,7/22/2018,3/26/2020,12/30/2020,12/30/2020,2/1/2021,2/18/2022,2/18/2022,3/21/2022,3/31/2022, 
5088,9826,6/15/1952,Female,163,68,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"11,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,12/1/2017,2/22/2018,2/22/2018,2/24/2020,3/11/2021,3/11/2021,3/22/2021,3/31/2022,10/14/1582, , , 
5089,8615,6/15/1937,Male,174,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,3/1/2018,8/15/2018,8/15/2018,3/30/2020,9/13/2020,9/13/2020,9/14/2020,12/10/2021,12/10/2021, , , 
5090,7213,6/15/1949,Female,166,83,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgA,"1,46",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/10/2020,6/2/2020,6/2/2020, , , , , , , , , 
5091,7242,6/15/1943,Female,158,62,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,43",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/12/2020,4/13/2020,4/13/2020, , , , , , , , , 
5092,1992,6/15/1938,Male,179,88,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,37",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/1/2020,2/6/2021,2/6/2021, , , , , , , , , 
5093,3000,6/15/1944,Female,176,57,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,"24,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/8/2020,6/5/2020,6/5/2020, , , , , , , , , 
5094,4135,6/15/1936,Female,165,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,5",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/10/2020,8/25/2020,8/25/2020,9/11/2020,3/31/2022,10/14/1582, , , , , , 
5095,6860,6/15/1946,Male,184,121,Private,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"20,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/14/2020,1/6/2021,1/6/2021, , , , , , , , , 
5096,1591,6/15/1942,Male,182,120,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,92",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/3/2020,6/30/2020,6/30/2020,7/7/2020,3/31/2022,10/14/1582, , , , , , 
5097,9996,6/15/1950,Female,162,56,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,75",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,2/23/2020,6/23/2020,6/23/2020,1/29/2021,7/14/2021,7/14/2021,7/21/2021,3/31/2022, , , , 
5098,2595,6/15/1935,Female,166,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"20,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/17/2020,5/26/2020,5/26/2020, , , , , , , , , 
5099,2789,6/15/1949,Male,171,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,56",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,2/25/2020,9/16/2020,9/16/2020,11/24/2021,3/31/2022, , , , , , , 
5100,3802,6/15/1948,Male,164,61,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,48",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,1/26/2020,8/9/2020,8/9/2020,8/25/2020,3/31/2022,10/14/1582, , , , , , 
5101,7159,6/15/1948,Female,157,85,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,21",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/3/2020,3/12/2020,3/12/2020,4/22/2020,4/15/2021,4/15/2021, , , , , , 
5102,3607,6/15/1950,Male,188,89,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,65",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/1/2020,1/24/2021,1/24/2021, , , , , , , , , 
5103,6370,6/15/1946,Male,168,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"12,87","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/7/2020,12/4/2020,12/4/2020,12/16/2020,3/31/2022,10/14/1582, , , , , , 
5104,9029,6/15/1936,Male,173,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/4/2020,1/9/2021,1/9/2021, , , , , , , , , 
5105,2985,6/15/1948,Female,157,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,53",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/18/2020,8/12/2020,8/12/2020,4/28/2021,10/15/2021,10/15/2021, , , , , , 
5106,5865,6/15/1937,Male,167,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,54",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/20/2020,4/21/2020,4/21/2020, , , , , , , , , 
5107,8547,6/15/1950,Male,176,62,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,47",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/27/2020,2/8/2021,2/8/2021, , , , , , , , , 
5108,9857,6/15/1942,Male,175,89,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"7,9",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,1/27/2020,9/23/2020,9/23/2020,9/29/2020,3/21/2022,3/21/2022,3/28/2022,3/31/2022, , , , 
5109,8081,6/15/1941,Female,153,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/21/2020,7/28/2020,7/28/2020, , , , , , , , , 
5110,7807,6/15/1941,Female,153,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,I: fulfilling all 4 criteria,IgG,"3,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2020,3/2/2021,3/2/2021, , , , , , , , , 
5111,7722,6/15/1940,Male,172,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,03",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/5/2020,8/12/2020,8/12/2020, , , , , , , , , 
5112,7343,6/15/1938,Female,149,49,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"15,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/7/2020,1/19/2021,1/19/2021, , , , , , , , , 
5113,4707,6/15/1959,Female,160,80,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,9,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,V-X,DAR-X,KYP-X,V-X,7/15/2014,10/9/2014,10/9/2014,2/6/2017,3/31/2017,3/31/2017,1/8/2020,8/26/2020,8/26/2020,9/15/2020,3/31/2021,10/14/1582
5114,4408,6/15/1953,Female,162,59,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"9,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,2/19/2018,8/5/2018,8/5/2018,3/2/2020,8/16/2021,8/16/2021,8/30/2021,3/31/2022,10/14/1582, , , 
5115,2210,6/15/1946,Female,163,48,Private,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"16,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/25/2020,3/2/2021,3/2/2021,2/17/2022,3/31/2022, , , , , , , 
5116,5175,6/15/1935,Male,193,112,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,32",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/3/2020,3/27/2020,3/27/2020, , , , , , , , , 
5117,9182,6/15/1935,Female,156,52,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,6/11/2018,11/25/2018,11/25/2018,3/25/2020,9/8/2020,9/8/2020,9/9/2020,11/29/2021,11/29/2021, , , 
5118,2475,6/15/1944,Male,182,61,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"30,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/6/2020,2/11/2021,2/11/2021,2/11/2022,3/31/2022, , , , , , , 
5119,1970,6/15/1946,Male,179,69,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,09",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/26/2020,1/6/2021,1/6/2021,1/17/2021,6/28/2021,6/28/2021, , , , , , 
5120,9552,6/15/1945,Female,171,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,47",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/24/2020,5/18/2020,5/18/2020,3/7/2022,3/31/2022, , , , , , , 
5121,3363,6/15/1947,Male,179,104,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/20/2020,12/22/2020,12/22/2020, , , , , , , , , 
5122,4411,6/15/1940,Male,179,104,Private,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,17",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/5/2020,4/6/2020,4/6/2020, , , , , , , , , 
5123,2316,6/15/1943,Male,164,61,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,16",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/27/2020,3/4/2021,3/4/2021, , , , , , , , , 
5124,7844,6/15/1942,Male,172,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,48",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/3/2020,2/7/2021,2/7/2021,3/1/2021,3/31/2022,10/14/1582, , , , , , 
5125,5167,6/15/1950,Male,171,79,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,44",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,1/10/2020,4/24/2020,4/24/2020,8/13/2021,12/9/2021,12/9/2021,2/23/2022,3/31/2022, , , , 
5126,5389,6/15/1949,Female,179,61,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,95",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,POM-X,No CTx,V-X,1/23/2020,5/7/2020,5/7/2020,1/7/2021,2/3/2022,2/3/2022,2/25/2022,3/31/2022, , , , 
5127,8184,6/15/1930,Female,168,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,55",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,1/18/2020,3/19/2020,3/19/2020,10/12/2021,3/31/2022,10/14/1582, , , , , , 
5128,2942,6/15/1941,Male,188,63,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,18",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,2/9/2020,5/24/2020,5/24/2020,10/4/2021,3/31/2022, , , , , , , 
5129,3655,6/15/1936,Male,166,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,65",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/14/2020,1/19/2021,1/19/2021,3/9/2022,3/31/2022, , , , , , , 
5130,3793,6/15/1940,Male,174,84,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,94",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/23/2020,4/24/2020,4/24/2020, , , , , , , , , 
5131,3770,6/15/1970,Male,188,94,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,7000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/24/2020,3/31/2020, , , , , , , , , , 
5132,2801,6/15/1948,Male,182,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,1",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/17/2020,7/6/2020,7/6/2020,7/20/2020,3/31/2022,10/14/1582, , , , , , 
5133,9154,6/15/1944,Female,160,45,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,79",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,1/18/2020,1/10/2021,1/10/2021, , , , , , , , , 
5134,5824,6/15/1945,Male,172,81,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,02",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/19/2020,2/24/2021,2/24/2021, , , , , , , , , 
5135,4880,6/15/1950,Male,176,64,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"3,36",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,1/4/2020,7/21/2020,7/21/2020,5/25/2021,7/20/2021,7/20/2021, , , , , , 
5136,2520,6/15/1933,Female,164,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"30,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/10/2020,1/5/2021,1/5/2021, , , , , , , , , 
5137,1469,6/15/1949,Female,169,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"5,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/14/2020,4/7/2020,4/7/2020, , , , , , , , , 
5138,6102,6/15/1941,Female,167,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,48",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/10/2020,6/28/2021,6/28/2021, , , , , , , , , 
5139,5206,6/15/1942,Male,171,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,47",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/2/2020,3/15/2021,3/15/2021, , , , , , , , , 
5140,3248,6/15/1944,Male,175,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,81",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/5/2020,4/30/2020,4/30/2020,12/2/2021,3/31/2022, , , , , , , 
5141,6505,6/15/1945,Male,172,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"8,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/5/2020,12/31/2020,10/14/1582, , , , , , , , , 
5142,5677,6/15/1942,Female,167,97,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,38",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/26/2020,12/31/2020,10/14/1582, , , , , , , , , 
5143,8164,6/15/1938,Male,188,75,Private,No, ,Yes,Yes,Yes, ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,31",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/3/2020,12/31/2020,10/14/1582, , , , , , , , , 
5144,5472,6/15/1949,Female,160,78,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/12/2020,12/31/2020, , , , , , , , , , 
5145,2424,6/15/1943,Male,172,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,21","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/10/2020,5/10/2020,5/10/2020, , , , , , , , , 
5146,4384,6/15/1941,Male,198,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"34,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/12/2020,4/13/2020,4/13/2020, , , , , , , , , 
5147,1851,6/15/1934,Female,162,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,42",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,1/16/2020,9/17/2020,9/17/2020,10/5/2020,12/31/2020, , , , , , , 
5148,9515,6/15/1943,Male,179,75,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,NIN-X,DAR-X,EMP-X,V-X,12/1/2017,5/17/2018,5/17/2018,1/6/2020,6/21/2020,6/21/2020,9/21/2020,12/14/2021,12/14/2021,2/7/2022,3/31/2022, 
5149,3522,6/15/1959,Male,163,55,Other,No, ,Yes,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,10000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/9/2020,3/31/2020, , , , , , , , , , 
5150,2506,6/15/1933,Male,176,80,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes,Yes, , , ,2,Unknown,IgG,",42",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/25/2020,6/17/2020,6/17/2020, , , , , , , , , 
5151,9158,6/15/1946,Male,178,90,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,4/19/2018,8/30/2018,8/30/2018,3/10/2020,11/17/2021,11/17/2021,12/1/2021,3/31/2022, , , , 
5152,7726,6/15/1947,Female,171,82,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,7",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,12/4/2017,4/20/2018,4/20/2018,2/18/2020,10/29/2021,10/29/2021,11/17/2021,3/31/2022,10/14/1582, , , 
5153,5836,6/15/1947,Male,176,85,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,7",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/9/2020,10/12/2021,10/12/2021,10/27/2021,3/31/2022, , , , , , , 
5154,6200,6/15/1950,Female,171,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"16,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/29/2020,7/28/2020,7/28/2020,8/3/2020,3/31/2022,10/14/1582, , , , , , 
5155,2044,6/15/1950,Male,178,75,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,47",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,1/16/2020,10/2/2020,10/2/2020,10/22/2020,2/3/2021,2/3/2021,2/25/2021,12/31/2021, , , , 
5156,5962,6/15/1943,Male,173,76,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,24",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,1/7/2020,12/21/2020,12/21/2020,2/23/2022,3/31/2022, , , , , , , 
5157,9427,6/15/1943,Male,194,75,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,5,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/6/2020,2/27/2021,2/27/2021, , , , , , , , , 
5158,9647,6/15/1942,Male,178,107,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,1",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/15/2020,1/20/2021,1/20/2021, , , , , , , , , 
5159,5048,6/15/1944,Male,188,66,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,64",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,1/28/2020,12/18/2020,12/18/2020,8/25/2021,3/31/2022, , , , , , , 
5160,2576,6/15/1945,Female,162,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"29,17","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/20/2020,2/18/2021,2/18/2021, , , , , , , , , 
5161,5794,6/15/1940,Female,155,45,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"24,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/1/2020,2/22/2021,2/22/2021, , , , , , , , , 
5162,4006,6/15/1945,Female,162,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"31,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/7/2020,2/12/2021,2/12/2021,12/28/2021,3/31/2022, , , , , , , 
5163,1206,6/15/1940,Male,184,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,53",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/3/2020,1/26/2021,1/26/2021, , , , , , , , , 
5164,8690,6/15/1940,Female,166,85,Private,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgA,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,1/3/2020,8/18/2020,8/18/2020, , , , , , , , , 
5165,5229,6/15/1936,Female,158,80,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"12,5",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/24/2020,6/9/2020,6/9/2020,7/21/2020,4/23/2021,4/23/2021, , , , , , 
5166,9053,6/15/1945,Male,173,69,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"6,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/8/2018,12/5/2018,12/5/2018,2/28/2020,12/31/2021, , , , , , , 
5167,3342,6/15/1947,Male,167,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,6",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/12/2020,11/18/2020,11/18/2020,12/7/2020,3/31/2022,10/14/1582, , , , , , 
5168,1056,6/15/1948,Female,167,67,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"21,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/22/2020,1/27/2021,1/27/2021, , , , , , , , , 
5169,3177,6/15/1962,Female,176,81,Compulsory health insurance CHI,Yes, , ,Yes,Yes, ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,6720,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/23/2020,3/31/2020, , , , , , , , , , 
5170,7302,6/15/1933,Male,180,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/5/2020,3/31/2020, , , , , , , , , , 
5171,7409,6/15/1949,Male,172,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,71",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/12/2020,1/7/2021,1/7/2021, , , , , , , , , 
5172,9183,6/15/1948,Male,163,71,Private,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,66",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/4/2020,4/2/2020,4/2/2020,1/8/2021,3/31/2022,10/14/1582, , , , , , 
5173,7950,6/15/1933,Female,166,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"32,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,EMP-X,DAR-X,No CTx,V-X,5/7/2019,8/13/2019,8/13/2019,3/9/2020,2/21/2022,2/21/2022,2/28/2022,3/31/2022, , , , 
5174,7416,6/15/1933,Female,166,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"9,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,7/29/2019,10/28/2019,10/28/2019,2/20/2020,3/31/2022,10/14/1582, , , , , , 
5175,4287,6/15/1948,Female,167,69,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"15,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/25/2019,12/16/2019,12/16/2019,1/28/2020,3/31/2022,10/14/1582, , , , , , 
5176,7568,6/15/1948,Female,175,70,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"3,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/16/2019,12/19/2019,12/19/2019,3/30/2020,9/30/2021,9/30/2021, , , , , , 
5177,2477,6/15/1945,Female,172,78,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,32",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/5/2019,10/28/2019,10/28/2019,3/2/2020,3/31/2022,10/14/1582, , , , , , 
5178,3099,6/15/1950,Female,167,55,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"17,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,POM-X,No CTx,No CTx,R-X,7/19/2019,2/11/2020,2/11/2020,2/27/2020,3/31/2022, , , , , , , 
5179,2183,6/15/1949,Male,177,66,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"19,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,1/30/2019,5/7/2019,5/7/2019,8/6/2019,7/5/2021,7/5/2021,7/12/2021,12/17/2021,12/17/2021, , , 
5180,2621,6/15/1973,Male,200,79,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,3508,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/24/2020,6/2/2020,6/2/2020, , , , , , , , , 
5181,1596,6/15/1931,Female,166,66,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,55",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,POM-X,DAR-X,KYP-X,R-X,8/22/2019,2/26/2020,2/26/2020,2/27/2020,5/12/2020,5/12/2020,5/27/2020,7/8/2021,7/8/2021,7/29/2021,3/31/2022,10/14/1582
5182,1912,6/15/1945,Male,175,55,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/2/2019,7/23/2019,7/23/2019,2/27/2020,3/31/2022,10/14/1582, , , , , , 
5183,7879,6/15/1947,Male,178,96,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"29,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,NIN-X,V-X,R-X,8/29/2019,12/23/2019,12/23/2019,2/12/2020,9/19/2020,9/19/2020,10/14/2020,6/26/2021,6/26/2021,7/22/2021,3/31/2022, 
5184,8679,6/15/1959,Female,164,48,Private,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,7500,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,3/27/2020,6/30/2020, , , , , , , , , , 
5185,6398,6/15/1949,Female,162,67,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"13,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,6/25/2019,9/30/2019,9/30/2019,3/4/2020,7/1/2021,7/1/2021,7/13/2021,3/31/2022, , , , 
5186,4097,6/15/1940,Female,166,99,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"32,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,8/16/2019,11/11/2019,11/11/2019,3/26/2020,2/17/2022,2/17/2022,3/2/2022,3/31/2022, , , , 
5187,8395,6/15/1946,Male,178,63,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"20,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,7/9/2019,1/16/2020,1/16/2020,3/4/2020,9/16/2020,9/16/2020, , , , , , 
5188,9384,6/15/1950,Male,179,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,21",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,V-X,V-X,4/4/2019,7/2/2019,7/2/2019,1/2/2020,1/17/2021,1/17/2021,1/28/2021,7/26/2021,7/26/2021,8/19/2021,3/31/2022, 
5189,8192,6/15/1950,Male,180,94,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"1,9",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,2/11/2020,4/28/2020,4/28/2020, , , , , , , , , 
5190,5840,6/15/1945,Male,180,90,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/3/2020,9/28/2020,9/28/2020, , , , , , , , , 
5191,9428,6/15/1939,Male,175,76,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/16/2020,10/13/2020,10/13/2020, , , , , , , , , 
5192,8608,6/15/1949,Male,175,87,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,4,ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/17/2020,6/30/2020, , , , , , , , , , 
5193,3961,6/15/1949,Male,180,90,Private,No,Yes, ,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,5,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,1/13/2020,12/21/2020,12/21/2020, , , , , , , , , 
5194,8869,6/15/1945,Female,179,79,Private,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/30/2020,6/29/2020,6/29/2020, , , , , , , , , 
5195,1758,6/15/1948,Male,179,56,Private,No, , , , , , , , , , ,2,Unknown,IgG,"25,28","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/27/2020,4/28/2020,4/28/2020,2/3/2021,3/31/2022,10/14/1582, , , , , , 
5196,7111,6/15/1940,Female,166,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,1/11/2020,1/3/2021,1/3/2021, , , , , , , , , 
5197,1678,6/15/1944,Male,174,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"21,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/23/2020,3/4/2021,3/4/2021, , , , , , , , , 
5198,2460,6/15/1947,Male,167,95,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,Unknown,IgG,"6,78",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/14/2020,1/19/2021,1/19/2021,8/23/2021,3/31/2022,10/14/1582, , , , , , 
5199,8834,6/15/1943,Male,176,83,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"11,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/30/2020,6/19/2020,6/19/2020,2/24/2021,3/31/2022,10/14/1582, , , , , , 
5200,3497,6/15/1941,Male,173,75,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"13,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/16/2020,9/9/2020,9/9/2020, , , , , , , , , 
5201,1814,6/15/1970,Female,171,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,8400,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,1/13/2020,4/6/2020,4/6/2020, , , , , , , , , 
5202,6368,6/15/1954,Male,182,80,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,3/16/2020,3/3/2022,3/3/2022,3/7/2022,3/31/2022, , , , , , , 
5203,9590,6/15/1960,Male,172,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,1",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/13/2020,3/31/2020,10/14/1582, , , , , , , , , 
5204,2622,6/15/1955,Female,168,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,5",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/16/2020,3/31/2020, , , , , , , , , , 
5205,2220,6/15/1949,Male,179,81,Private,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,3/6/2017,8/14/2017,8/14/2017,3/3/2020,8/1/2021,8/1/2021,8/9/2021,3/31/2022,10/14/1582, , , 
5206,1338,6/15/1943,Male,186,117,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,75",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/1/2020,2/6/2021,2/6/2021, , , , , , , , , 
5207,2059,6/15/1944,Male,182,87,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,65",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/5/2020,4/29/2020,4/29/2020, , , , , , , , , 
5208,1762,6/15/1947,Female,182,89,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,42",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/14/2020,2/19/2021,2/19/2021, , , , , , , , , 
5209,6722,6/15/1946,Female,159,59,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,88",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/7/2020,1/19/2021,1/19/2021, , , , , , , , , 
5210,8510,6/15/1947,Male,177,110,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,35",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,KYP-X,V-X,1/14/2020,12/4/2020,12/4/2020,12/20/2020,7/9/2021,7/9/2021,7/29/2021,12/9/2021,12/9/2021,1/20/2022,3/31/2022,10/14/1582
5211,4068,6/15/1942,Male,164,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,Unknown,IgG,"4,29",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/7/2020,4/3/2020,4/3/2020,11/2/2020,3/31/2022,10/14/1582, , , , , , 
5212,6379,6/15/1942,Male,180,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,34",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,2/27/2020,3/4/2021,3/4/2021,4/21/2021,3/31/2022, , , , , , , 
5213,6490,6/15/1948,Female,169,53,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,75",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,2/19/2020,9/8/2020,9/8/2020,9/23/2020,1/11/2021,1/11/2021,1/29/2021,8/10/2021,8/10/2021, , , 
5214,6159,6/15/1941,Male,180,115,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,94",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/18/2020,11/20/2020,11/20/2020,12/5/2020,6/30/2021,10/14/1582, , , , , , 
5215,7716,6/15/1944,Male,177,67,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"20,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/12/2020,8/20/2020,8/20/2020, , , , , , , , , 
5216,7056,6/15/1936,Female,162,60,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,25",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/25/2020,4/20/2020,4/20/2020, , , , , , , , , 
5217,4491,6/15/1941,Female,161,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"21,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,1/10/2020,7/5/2020,7/5/2020,7/23/2020,2/4/2022,2/4/2022,2/21/2022,3/31/2022, , , , 
5218,5096,6/15/1950,Male,180,93,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,5320,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/24/2020,3/31/2020, , , , , , , , , , 
5219,4332,6/15/1953,Female,165,68,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"6,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/25/2020,3/31/2022,10/14/1582, , , , , , , , , 
5220,1926,6/15/1953,Male,181,102,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,1",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,6/17/2019,10/9/2019,10/9/2019,3/13/2020,10/4/2021,10/4/2021,11/8/2021,3/31/2022, , , , 
5221,6400,6/15/1945,Male,172,99,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"23,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,7/1/2019,10/4/2019,10/4/2019,3/5/2020,2/8/2022,2/8/2022,2/14/2022,3/31/2022, , , , 
5222,1165,6/15/1947,Male,182,63,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,02",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,R-X,9/16/2019,1/14/2020,1/14/2020,2/19/2020,1/13/2022,1/13/2022,1/25/2022,3/31/2022, , , , 
5223,2261,6/15/1946,Female,158,88,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,85",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/18/2019,7/11/2019,7/11/2019,2/18/2020,4/21/2020,4/21/2020, , , , , , 
5224,9732,6/15/1950,Male,179,114,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,31",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/7/2019,8/13/2019,8/13/2019,2/25/2020,3/31/2022,10/14/1582, , , , , , 
5225,8922,6/15/1970,Male,184,84,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,38",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,V-X,V-X,7/12/2019,11/6/2019,11/6/2019,3/9/2020,7/5/2020,7/5/2020,7/17/2020,3/4/2021,3/4/2021,7/12/2021,3/31/2022, 
5226,3149,6/15/1942,Female,162,53,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,23",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,V-X,V-X,9/2/2019,11/25/2019,11/25/2019,2/27/2020,3/12/2021,3/12/2021,3/26/2021,7/2/2021,7/2/2021,7/19/2021,12/20/2021,12/20/2021
5227,6886,6/15/1949,Male,181,90,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,67",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/23/2019,8/27/2019,8/27/2019,2/17/2020,6/15/2021,6/15/2021,10/27/2021,3/31/2022, , , , 
5228,3963,6/15/1947,Male,176,77,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,9/5/2019,12/9/2019,12/9/2019,3/12/2020,3/2/2022,3/2/2022,3/17/2022,3/31/2022, , , , 
5229,1347,6/15/1930,Female,169,95,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,7/1/2019,12/16/2019,12/16/2019,1/2/2020,12/8/2021,12/8/2021,2/25/2022,3/31/2022,10/14/1582, , , 
5230,7679,6/15/1952,Female,168,49,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"30,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,1/21/2020,1/26/2021,1/26/2021,11/23/2021,3/31/2022,10/14/1582, , , , , , 
5231,1773,6/15/1950,Female,161,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,89",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/15/2019,8/19/2019,8/19/2019,1/20/2020,3/15/2021,3/15/2021, , , , , , 
5232,4918,6/15/1952,Female,163,52,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"3,76",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/22/2019,11/21/2019,11/21/2019,1/6/2020,12/29/2020,12/29/2020, , , , , , 
5233,7441,6/15/1950,Female,152,58,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,77",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,8/12/2019,11/25/2019,11/25/2019,1/27/2020,2/11/2021,2/11/2021,3/6/2021,3/31/2022,10/14/1582, , , 
5234,6807,6/15/1947,Female,156,57,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,7/8/2019,1/2/2020,1/2/2020,2/24/2020,9/13/2021,9/13/2021, , , , , , 
5235,3809,6/15/1954,Male,180,93,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,33",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,POM-X,R-X,9/9/2019,1/2/2020,1/2/2020,2/20/2020,4/1/2020,4/1/2020,4/25/2020,12/13/2020,12/13/2020,12/20/2020,8/18/2021,8/18/2021
5236,8307,6/15/1952,Female,175,63,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,59",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/6/2019,8/8/2019,8/8/2019,1/6/2020,3/31/2022,10/14/1582, , , , , , 
5237,1929,6/15/1973,Male,179,91,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,28",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/6/2019,11/20/2019,11/20/2019,1/30/2020,9/29/2020,9/29/2020, , , , , , 
5238,8298,6/15/1952,Male,169,72,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"14,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/30/2020,3/17/2020,3/17/2020,2/2/2022,3/31/2022,10/14/1582, , , , , , 
5239,4773,6/15/1955,Female,162,88,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/1/2019,10/1/2019,10/1/2019,10/2/2019,3/5/2020,3/5/2020, , , , , , 
5240,5939,6/15/1946,Female,164,57,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"14,87","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/22/2019,2/27/2020,2/27/2020,1/20/2022,3/31/2022, , , , , , , 
5241,9429,6/15/1954,Male,198,97,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,2/11/2020,11/25/2020,11/25/2020,12/21/2020,3/31/2022,10/14/1582, , , , , , 
5242,8202,6/15/1952,Female,174,63,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,13",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/22/2019,7/29/2019,7/29/2019,1/13/2020,3/31/2022, , , , , , , 
5243,4115,6/15/1947,Female,161,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,94",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/12/2019,11/7/2019,11/7/2019,1/26/2020,5/4/2020,5/4/2020, , , , , , 
5244,3593,6/15/1945,Male,184,83,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"7,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/23/2019,1/19/2020,1/19/2020,1/30/2020,7/23/2021,7/23/2021, , , , , , 
5245,7102,6/15/1954,Male,173,56,Compulsory health insurance CHI,No, , , , , , , ,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,87",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,8/27/2019,2/14/2020,2/14/2020,2/24/2020,6/26/2020,6/26/2020,7/13/2020,12/31/2020, , , , 
5246,7243,6/15/1948,Female,158,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,76",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/15/2019,10/15/2019,10/15/2019,2/4/2020,12/31/2020, , , , , , , 
5247,8942,6/15/1949,Male,180,67,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,34",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/8/2019,12/31/2020, , , , , , , , , , 
5248,6985,6/15/1955,Male,188,94,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/14/2019,9/12/2019,9/12/2019,1/9/2020,12/31/2020,10/14/1582, , , , , , 
5249,8725,6/15/1945,Female,162,86,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"16,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,1/29/2018,7/24/2018,7/24/2018,2/20/2020,1/7/2021,1/7/2021,2/18/2021,7/8/2021,7/8/2021, , , 
5250,3602,6/15/1955,Male,172,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,13","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/15/2019,8/15/2019,8/15/2019,2/4/2020,12/22/2020,12/22/2020, , , , , , 
5251,2257,6/15/1955,Female,154,45,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,98",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,KYP-X,NIN-X,R-X,8/14/2019,2/8/2020,2/8/2020,2/20/2020,4/29/2020,4/29/2020,5/20/2020,6/10/2021,6/10/2021,10/13/2021,3/31/2022, 
5252,9108,6/15/1948,Female,157,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"9,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,6/19/2019,12/16/2019,12/16/2019,1/11/2020,1/7/2021,1/7/2021, , , , , , 
5253,2101,6/15/1949,Male,198,104,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,07",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,7/5/2019,10/10/2019,10/10/2019,10/11/2019,2/20/2020,2/20/2020,3/3/2020,3/31/2022, , , , 
5254,7549,6/15/1974,Male,172,104,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/11/2019,12/4/2019,12/4/2019,2/12/2020,1/5/2021,1/5/2021, , , , , , 
5255,3426,6/15/1932,Female,158,51,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,97",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/27/2019,6/20/2019,6/20/2019,1/2/2020,1/6/2021,1/6/2021, , , , , , 
5256,8344,6/15/1949,Male,198,104,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,81",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/18/2019,10/25/2019,10/25/2019,2/26/2020,3/31/2022,10/14/1582, , , , , , 
5257,7605,6/15/1969,Female,167,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,05",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,7/4/2019,12/30/2019,12/30/2019,1/6/2020,1/25/2022,1/25/2022,2/8/2022,3/31/2022,10/14/1582, , , 
5258,2847,6/15/1943,Male,180,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,22",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,DAR-X,EMP-X,V-X,6/18/2019,12/12/2019,12/12/2019,1/2/2020,9/25/2020,9/25/2020,10/19/2020,3/18/2021,3/18/2021,4/2/2021,1/19/2022,1/19/2022
5259,4804,6/15/1945,Female,170,60,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,43",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,V-X,8/26/2019,11/28/2019,11/28/2019,11/29/2019,1/2/2020,1/2/2020,5/5/2020,3/31/2022,10/14/1582, , , 
5260,3542,6/15/1955,Male,176,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"24,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/6/2019,6/25/2020,6/25/2020, , , , , , , , , 
5261,5686,6/15/1968,Male,175,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"16,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/24/2020,5/14/2020,5/14/2020, , , , , , , , , 
5262,4830,6/15/1964,Male,165,82,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"5,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/24/2020,11/11/2020,11/11/2020, , , , , , , , , 
5263,8727,6/15/1947,Female,165,70,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,999,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,3/30/2020,6/12/2020,6/12/2020, , , , , , , , , 
5264,5301,6/15/1955,Female,155,50,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,5",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/23/2019,8/26/2019,8/26/2019,1/2/2020,12/23/2020,12/23/2020, , , , , , 
5265,8588,6/15/1950,Male,180,57,Private,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,71",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/17/2019,12/2/2019,12/2/2019,1/8/2020,5/9/2020,5/9/2020, , , , , , 
5266,7192,6/15/1946,Female,168,71,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"6,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/13/2018,7/30/2018,7/30/2018,2/6/2020,2/24/2021,2/24/2021, , , , , , 
5267,8951,6/15/1952,Male,173,79,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"12,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,6/13/2019,9/9/2019,9/9/2019,12/17/2019,2/23/2022,2/23/2022,3/7/2022,3/31/2022, , , , 
5268,7245,6/15/1945,Male,175,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/30/2019,10/22/2019,10/22/2019,1/6/2020,3/31/2022,10/14/1582, , , , , , 
5269,7801,6/15/1959,Male,183,87,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,R-X,6/17/2019,12/13/2019,12/13/2019,12/27/2019,2/10/2022,2/10/2022,2/18/2022,3/31/2022, , , , 
5270,2472,6/15/1948,Male,182,63,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"28,43","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,NIN-X,No CTx,R-X,7/11/2019,1/2/2020,1/2/2020,1/26/2020,5/20/2020,5/20/2020,6/4/2020,7/19/2021,7/19/2021, , , 
5271,5045,6/15/1948,Male,178,92,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"2,79",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,POM-X,V-X,5/30/2019,8/22/2019,8/22/2019,1/8/2020,2/3/2021,2/3/2021,2/20/2021,9/9/2021,9/9/2021,9/28/2021,3/31/2022, 
5272,8645,6/15/1954,Male,160,75,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,75",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,5/23/2019,11/21/2019,11/21/2019,12/10/2019,2/17/2022,2/17/2022,3/8/2022,3/31/2022,10/14/1582, , , 
5273,4260,6/15/1951,Male,183,111,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"14,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,5/17/2019,8/19/2019,8/19/2019,1/16/2020,3/2/2020,3/2/2020,4/9/2020,10/22/2020,10/22/2020,11/2/2020,8/21/2021,8/21/2021
5274,1982,6/15/1953,Female,171,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,49",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,7/18/2019,1/16/2020,1/16/2020,1/30/2020,1/22/2021,1/22/2021, , , , , , 
5275,6504,6/15/1953,Male,182,85,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,66",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,DAR-X,R-X,6/6/2019,11/22/2019,11/22/2019,12/12/2019,9/27/2020,9/27/2020,10/22/2020,4/21/2021,4/21/2021,8/24/2021,3/31/2022,10/14/1582
5276,4912,6/15/1951,Male,184,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,79",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/29/2019,7/29/2019,7/29/2019,12/20/2019,3/31/2022,10/14/1582, , , , , , 
5277,6929,6/15/1960,Male,183,79,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,11/21/2018,2/15/2019,2/15/2019,7/16/2019,2/25/2020,2/25/2020,3/4/2020,3/31/2022, , , , 
5278,2492,6/15/1949,Male,192,91,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,82",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,7/22/2019,1/15/2020,1/15/2020,2/9/2020,1/5/2022,1/5/2022,1/18/2022,3/31/2022,10/14/1582, , , 
5279,7342,6/15/1958,Female,173,66,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,4/9/2019,7/16/2019,7/16/2019,1/6/2020,3/31/2022,10/14/1582, , , , , , 
5280,3430,6/15/1950,Male,191,96,Private,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/9/2019,10/3/2019,10/3/2019,12/16/2019,12/31/2020, , , , , , , 
5281,7939,6/15/1954,Female,178,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,59",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/11/2018,12/11/2018,12/11/2018,7/16/2019,2/24/2020,2/24/2020, , , , , , 
5282,3026,6/15/1952,Male,187,64,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,R-X,POM-X,DAR-X,R-X,5/16/2019,11/12/2019,11/12/2019,12/5/2019,2/10/2020,2/10/2020,2/27/2020,3/18/2020,3/18/2020,4/8/2020,12/3/2020,12/3/2020
5283,6977,6/15/1953,Male,186,89,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,19",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,3/13/2019,6/7/2019,6/7/2019,12/23/2019,3/9/2020,3/9/2020,3/23/2020,5/11/2020,5/11/2020,6/4/2020,1/11/2021,1/11/2021
5284,9197,6/15/1958,Male,179,108,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"23,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,DAR-X,KYP-X,V-X,6/10/2019,11/29/2019,11/29/2019,12/16/2019,2/27/2020,2/27/2020,3/11/2020,1/7/2021,1/7/2021,3/21/2022,3/31/2022,10/14/1582
5285,8227,6/15/1931,Male,184,58,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,75",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,2/15/2019,6/12/2019,6/12/2019,12/9/2019,2/19/2020,2/19/2020,3/3/2020,3/23/2021,3/23/2021,4/28/2021,8/22/2021,8/22/2021
5286,4621,6/15/1950,Male,170,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/12/2019,8/13/2019,8/13/2019,1/10/2020,5/28/2020,5/28/2020, , , , , , 
5287,3850,6/15/1960,Female,165,70,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,1230,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,ISA-X,2/3/2020,6/2/2020,6/2/2020, , , , , , , , , 
5288,5488,6/15/1940,Female,153,56,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,EMP-X,No CTx,No CTx,V-X,9/2/2018,12/17/2019,12/17/2019,1/8/2020,12/31/2021,10/14/1582, , , , , , 
5289,2935,6/15/1976,Female,175,110,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"2,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/17/2020,3/27/2020,3/27/2020, , , , , , , , , 
5290,7521,6/15/1957,Female,158,88,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/24/2020,7/7/2020,7/7/2020, , , , , , , , , 
5291,6617,6/15/1961,Male,180,78,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,41,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,2/4/2020,12/20/2021,12/20/2021, , , , , , , , , 
5292,1066,6/15/1953,Female,157,74,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,2237,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/17/2020,6/15/2020,6/15/2020, , , , , , , , , 
5293,4050,6/15/1971,Female,165,115,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,16,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/27/2020,4/2/2020,4/2/2020, , , , , , , , , 
5294,9407,6/15/1959,Male,169,98,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/28/2020,3/20/2020,3/20/2020, , , , , , , , , 
5295,7495,6/15/1967,Male,179,95,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,",7",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,1/31/2020,4/14/2020,4/14/2020, , , , , , , , , 
5296,2544,6/15/1963,Male,185,95,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,63,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/15/2020,3/15/2020,3/15/2020, , , , , , , , , 
5297,1272,6/15/1934,Female,165,58,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,41,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,R-X,1/24/2020,3/31/2022, , , , , , , , , , 
5298,1924,6/15/1952,Female,169,57,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,53,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/15/2020,6/30/2020, , , , , , , , , , 
5299,2117,6/15/1942,Female,164,68,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,53,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,3/10/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, , , , , , , 
5300,3643,6/15/1947,Male,172,79,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,63,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/1/2020,6/30/2020,10/14/1582, , , , , , , , , 
5301,4258,6/15/1945,Female,159,63,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,64,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/1/2020,6/30/2020, , , , , , , , , , 
5302,2042,6/15/1960,Male,188,98,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,",62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/3/2020,3/19/2020,3/19/2020,3/20/2020,9/4/2020,9/4/2020, , , , , , 
5303,9635,6/15/1956,Female,168,51,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,62,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/15/2020,6/15/2020,6/15/2020, , , , , , , , , 
5304,9272,6/15/1942,Male,184,94,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,59,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/15/2020,6/30/2020, , , , , , , , , , 
5305,7766,6/15/1940,Female,157,53,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,60,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,2/15/2020,6/15/2020,6/15/2020,6/15/2020,6/30/2020, , , , , , , 
5306,4813,6/15/1944,Male,177,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,73,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/15/2020,6/30/2020, , , , , , , , , , 
5307,6164,6/15/1947,Female,166,74,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,59,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/1/2020,6/30/2020, , , , , , , , , , 
5308,8976,6/15/1950,Male,165,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,250,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/2/2020,6/30/2020,10/14/1582, , , , , , , , , 
5309,8531,6/15/1937,Female,166,58,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,350,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/16/2020,6/30/2020, , , , , , , , , , 
5310,4435,6/15/1949,Male,170,65,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,165,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,1/20/2020,9/30/2020,10/14/1582, , , , , , , , , 
5311,7078,6/15/1945,Female,162,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,250,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/10/2020,10/15/2020,10/15/2020, , , , , , , , , 
5312,1989,6/15/1942,Male,172,66,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,180,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/24/2020,4/6/2020,4/6/2020, , , , , , , , , 
5313,3559,6/15/1935,Female,158,60,Private,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,220,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/23/2020,3/31/2020, , , , , , , , , , 
5314,4904,6/15/1936,Male,167,62,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,260,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/16/2020,10/22/2020,10/22/2020, , , , , , , , , 
5315,8127,6/15/1958,Male,174,126,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,9,III: one or more criteria are fulfilled,IgG,"2,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/25/2020,8/12/2020,8/12/2020, , , , , , , , , 
5316,8464,6/15/1934,Male,175,80,Compulsory health insurance CHI,No,Unknown,Unknown,Unknown,Yes,Yes,Yes,Yes,Yes,Yes, ,9,III: one or more criteria are fulfilled,Other type,",4",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,2/20/2020,4/15/2020,4/15/2020, , , , , , , , , 
5317,6360,6/15/1960,Female,160,47,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,",44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/3/2020,3/6/2020,3/6/2020, , , , , , , , , 
5318,1168,6/15/1960,Male,164,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,",31",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,EMP-X,KYP-X,V-X,12/5/2016,2/15/2017,2/15/2017,5/15/2018,1/14/2020,1/14/2020,1/21/2020,10/2/2020,10/2/2020,6/2/2021,3/31/2022,10/14/1582
5319,6201,6/15/1963,Male,178,91,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"30,8",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,NIN-X,NIN-X,No CTx,V-X,9/2/2014,10/30/2014,10/30/2014,3/10/2020,12/16/2020,12/16/2020,7/9/2021,3/31/2022, , , , 
5320,9412,6/15/1959,Male,180,81,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"50,7",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,ISA-X,2/13/2020,6/9/2020,6/9/2020, , , , , , , , , 
5321,5494,6/15/1939,Male,170,72,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Unknown,Unknown,Unknown, ,Yes,2,III: one or more criteria are fulfilled,Other type,",1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/12/2020,4/21/2020,4/21/2020, , , , , , , , , 
5322,9507,6/15/1940,Male,162,65,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , ,Unknown, ,1,III: one or more criteria are fulfilled,Other type,",1",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,DAR-X,1/23/2020,12/31/2021, , , , , , , , , , 
5323,4584,6/15/1958,Male,179,79,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/1/2020,6/15/2020,6/15/2020,4/1/2021,9/30/2021, , , , , , , 
5324,9460,6/15/1944,Male,175,74,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,20,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/1/2020,12/31/2021,10/14/1582, , , , , , , , , 
5325,2753,6/15/1959,Female,163,85,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,",42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/12/2020,5/7/2020,5/7/2020, , , , , , , , , 
5326,2777,6/15/1950,Female,164,64,Private,No, , , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,20,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/1/2019,9/1/2019,9/1/2019,3/1/2020,12/31/2021,10/14/1582, , , , , , 
5327,9622,6/15/1934,Male,185,95,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"49,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/12/2020,3/31/2020, , , , , , , , , , 
5328,4487,6/15/1952,Female,159,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,2890,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/13/2020,3/31/2020, , , , , , , , , , 
5329,6239,6/15/1936,Male,190,87,Compulsory health insurance CHI,Unknown,Yes, ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,1988,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/16/2020,3/31/2020, , , , , , , , , , 
5330,4673,6/15/1960,Male,162,82,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,890,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/17/2020,3/31/2020, , , , , , , , , , 
5331,6928,6/15/1973,Female,158,65,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/16/2020,3/31/2020, , , , , , , , , , 
5332,6904,6/15/1953,Male,177,89,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,"10,2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,7/2/2020,9/8/2020,9/8/2020,3/18/2022,3/31/2022, , , , , , , 
5333,7000,6/15/1959,Female,155,56,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,"18,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,54", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/17/2020,3/31/2022,10/14/1582, , , , , , , , , 
5334,3284,6/15/1943,Male,176,68,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/4/2020,8/30/2020,8/30/2020, , , , , , , , , 
5335,6241,6/15/1951,Male,180,89,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"1,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/3/2012,11/15/2012,11/15/2012,6/29/2020,10/5/2020,10/5/2020, , , , , , 
5336,2633,6/15/1944,Female,157,54,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"3,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,DAR-X,No CTx,Other,10/16/2006,12/31/2006,12/31/2006,5/18/2020,2/24/2021,2/24/2021,3/18/2021,3/31/2022, , , , 
5337,6741,6/15/1964,Female,172,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"2,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/26/2020,10/22/2020,10/22/2020, , , , , , , , , 
5338,1981,6/15/1962,Female,173,65,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,38,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/1/2020,7/3/2020,7/3/2020, , , , , , , , , 
5339,8789,6/15/1935,Female,162,55,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,Unknown,IgG,"4,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,5/11/2020,8/19/2020,8/19/2020, , , , , , , , , 
5340,3213,6/15/1940,Female,152,60,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,Unknown,IgG,"2,3",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,5/20/2020,11/25/2020,11/25/2020, , , , , , , , , 
5341,5193,6/15/1956,Female,162,64,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,"3,87",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,2/7/2020,4/27/2020,4/27/2020, , , , , , , , , 
5342,6874,6/15/1947,Male,173,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgA,"1,4",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/24/2020,6/18/2020,6/18/2020, , , , , , , , , 
5343,2490,6/15/1980,Female,158,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,6/3/2019,9/15/2019,9/15/2019, , , , , , , , , 
5344,5956,6/15/1940,Female,152,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,5/11/2020,9/1/2020,9/1/2020, , , , , , , , , 
5345,9033,6/15/1945,Female,153,67,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , ,Yes, ,2,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Ja,No CTx,No CTx,No CTx,V-X,6/2/2020,3/31/2021, , , , , , , , , , 
5346,7287,6/15/1950,Male,184,92,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,09",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/22/2020,2/1/2021,2/1/2021, , , , , , , , , 
5347,7750,6/15/1964,Female,168,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/29/2020,8/9/2020,8/9/2020, , , , , , , , , 
5348,3707,6/15/1959,Female,165,61,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/17/2020,8/24/2020,8/24/2020, , , , , , , , , 
5349,3042,6/15/1964,Male,182,71,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,Unknown,IgG,"2,66",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , , ,Nein,DAR-X,POM-X,V-X,V-X,1/15/2018,4/11/2018,4/11/2018,11/28/2019,1/23/2020,1/23/2020,3/7/2020,4/26/2020,4/26/2020,4/27/2020,5/24/2020,5/24/2020
5350,9024,6/15/1934,Female,157,50,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"3,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,BLEN-X,No CTx,DAR-X,6/23/2020,11/11/2020,11/11/2020,11/25/2020,1/20/2021,1/20/2021,2/12/2021,3/8/2021,3/8/2021, , , 
5351,1230,6/15/1938,Male,181,88,Compulsory health insurance CHI,Yes,Yes, ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"6,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,LEV-X,6/22/2020,12/13/2020,12/13/2020, , , , , , , , , 
5352,7037,6/15/1952,Female,170,82,Private,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,38,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,DAR-X,No CTx,No CTx,DAR-X,4/16/2020,4/1/2021,4/1/2021,8/25/2021,3/31/2022,10/14/1582, , , , , , 
5353,6072,6/15/1943,Male,180,87,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,36,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/29/2020,3/31/2022,10/14/1582, , , , , , , , , 
5354,9201,6/15/1940,Male,191,77,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,20,ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,4/9/2020,5/9/2020,5/9/2020, , , , , , , , , 
5355,9453,6/15/1967,Male,179,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/8/2020,8/9/2020,8/9/2020, , , , , , , , , 
5356,9805,6/15/1948,Male,168,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/22/2020,12/31/2021,10/14/1582, , , , , , , , , 
5357,9503,6/15/1950,Male,185,80,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,39,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,7/14/2016,12/17/2016,12/17/2016,6/23/2020,8/19/2021,8/19/2021,9/17/2021,3/31/2022,10/14/1582, , , 
5358,1075,6/15/1963,Male,174,93,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,16","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/23/2020,8/25/2020,8/25/2020,9/17/2020,12/15/2020,12/15/2020, , , , , , 
5359,7813,6/15/1944,Male,167,79,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/23/2020,9/29/2020,9/29/2020, , , , , , , , , 
5360,3695,6/15/1945,Male,190,83,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,33,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,KYP-X,V-X,4/14/2017,10/23/2017,10/23/2017,6/12/2020,10/5/2020,10/5/2020,12/22/2020,11/28/2021,11/28/2021,12/5/2021,3/31/2022,10/14/1582
5361,8137,6/15/1946,Female,170,81,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,25,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,FAR-X,V-X,V-X,6/16/2017,10/17/2017,10/17/2017,5/20/2020,9/10/2020,9/10/2020,9/29/2020,8/28/2021,8/28/2021,9/28/2021,3/31/2022, 
5362,9278,6/15/1943,Male,170,70,Private,No, , ,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"33,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,6/16/2020,3/31/2022,10/14/1582, , , , , , , , , 
5363,6556,6/15/1947,Male,182,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"50,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,5/27/2020,3/31/2022, , , , , , , , , , 
5364,3194,6/15/1963,Male,177,88,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"11,58",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,4/29/2020,7/15/2020,7/15/2020, , , , , , , , , 
5365,2609,6/15/1959,Male,188,100,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,Other type,"9,9",unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,DAR-X,KYP-X,No CTx,V-X,7/1/2017,9/1/2017,9/1/2017,6/9/2020,1/19/2021,1/19/2021,2/9/2021,3/31/2021,10/14/1582, , , 
5366,7780,6/15/1951,Male,180,80,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"33,73",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,KYP-X,No CTx,V-X,6/13/2017,8/25/2017,8/25/2017,4/23/2020,1/7/2021,1/7/2021,3/23/2021,10/5/2021,10/5/2021, , , 
5367,6510,6/15/1952,Female,160,48,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,2,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/15/2020,9/14/2020,9/14/2020, , , , , , , , , 
5368,3786,6/15/1931,Female,155,76,Compulsory health insurance CHI,Yes, , , , , , , ,Yes, ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/25/2020,12/28/2020,12/28/2020, , , , , , , , , 
5369,6381,6/15/1948,Female,165,87,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/20/2020,8/29/2020,8/29/2020, , , , , , , , , 
5370,3955,6/15/1951,Female,186,95,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,31,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,11/4/2017,3/7/2018,3/7/2018,6/9/2020,8/24/2021,8/24/2021,9/23/2021,3/31/2022,10/14/1582, , , 
5371,9111,6/15/1952,Male,190,89,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,8/8/2017,2/24/2018,2/24/2018,6/25/2020,5/13/2021,5/13/2021,6/15/2021,3/31/2022,10/14/1582, , , 
5372,3738,6/15/1968,Male,182,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"1,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/2/2020,7/19/2020,7/19/2020, , , , , , , , , 
5373,5528,6/15/1965,Male,166,72,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/29/2020,8/23/2020,8/23/2020, , , , , , , , , 
5374,5624,6/15/1944,Female,163,61,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes, ,Yes, , , ,2,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,3/20/2020,6/24/2020,6/24/2020, , , , , , , , , 
5375,2451,6/15/1939,Male,175,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,5,unknown/ISS-Criteria not used for prognostics,Yes,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/23/2019,3/5/2020,3/5/2020, , , , , , , , , 
5376,4373,6/15/1950,Female,165,75,Compulsory health insurance CHI,Yes,Yes, , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,35,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,DAR-X,5/25/2020,6/5/2021,6/5/2021,6/20/2021,3/31/2022,10/14/1582, , , , , , 
5377,4092,6/15/1951,Male,178,88,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,39,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,6/3/2020,2/23/2021,2/23/2021,6/18/2021,3/31/2022,10/14/1582, , , , , , 
5378,3294,6/15/1940,Female,164,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/8/2016,3/31/2016,3/31/2016,6/2/2020,10/12/2020,10/12/2020, , , , , , 
5379,3586,6/15/1942,Male,175,81,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,LEV-X,No CTx,LEV-X,2/12/2018,8/5/2018,8/5/2018,6/4/2020,6/20/2021,6/20/2021,9/6/2021,12/31/2021, , , , 
5380,9655,6/15/1964,Male,179,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/15/2020,7/26/2020,7/26/2020, , , , , , , , , 
5381,9003,6/15/1943,Female,165,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,LEV-X,No CTx,V-X,8/15/2016,11/6/2016,11/6/2016,6/29/2020,8/30/2020,8/30/2020,11/22/2021,12/31/2021, , , , 
5382,5722,6/15/1942,Male,175,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,LEV-X,No CTx,V-X,9/25/2017,12/17/2017,12/17/2017,6/22/2020,9/13/2020,9/13/2020,12/6/2021,12/31/2021, , , , 
5383,4605,6/15/1938,Female,163,74,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"3,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,2/12/2018,4/15/2018,4/15/2018,6/15/2020,6/6/2021,6/6/2021, , , , , , 
5384,9190,6/15/1952,Female,168,125,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,2763,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/9/2020,8/25/2020,8/25/2020, , , , , , , , , 
5385,9818,6/15/1954,Female,154,61,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,999,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,5/12/2020,7/23/2020,7/23/2020,9/14/2020,9/30/2020, , , , , , , 
5386,6489,6/15/1952,Male,176,81,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"16,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/2/2016,1/26/2017,1/26/2017,4/23/2020,10/6/2020,10/6/2020, , , , , , 
5387,9913,6/15/1959,Male,176,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/7/2020,8/5/2020,8/5/2020, , , , , , , , , 
5388,8719,6/15/1933,Female,168,69,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"4,6",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,5/6/2020,11/18/2020,11/18/2020,2/17/2021,3/31/2022,10/14/1582, , , , , , 
5389,7184,6/15/1930,Male,170,94,Compulsory health insurance CHI,Yes,Yes,Yes, , ,Yes, ,Yes, , , ,9,I: fulfilling all 4 criteria,IgG,1824,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/26/2020,6/30/2020, , , , , , , , , , 
5390,2436,6/15/1935,Male,165,68,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"6,2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/28/2020,5/17/2021,5/17/2021, , , , , , , , , 
5391,4936,6/15/1938,Female,170,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,6/30/2020,9/30/2021, , , , , , , , , , 
5392,5797,6/15/1939,Female,146,41,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,6/29/2020,7/22/2020,7/22/2020, , , , , , , , , 
5393,1599,6/15/1946,Male,168,82,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"11,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/14/2020,8/4/2020,8/4/2020, , , , , , , , , 
5394,2347,6/15/1954,Female,168,67,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/8/2020,3/31/2022,10/14/1582, , , , , , , , , 
5395,6538,6/15/1948,Male,175,81,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,R-X,No CTx,No CTx,Other,3/15/2020,5/13/2020,5/13/2020,6/22/2020,6/30/2020, , , , , , , 
5396,5277,6/15/1945,Male,180,79,Private,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgA,"5,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,R-X,2/12/2020,5/21/2021,5/21/2021,6/1/2021,3/31/2022, , , , , , , 
5397,8318,6/15/1952,Male,183,80,Compulsory health insurance CHI,Yes, , , , ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"66,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/2/2020,7/25/2020,7/25/2020, , , , , , , , , 
5398,3658,6/15/1946,Male,175,77,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"2,8",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,EMP-X,6/12/2020,1/18/2021,1/18/2021, , , , , , , , , 
5399,9514,6/15/1933,Male,168,60,Compulsory health insurance CHI,Yes, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/22/2020,9/30/2021, , , , , , , , , , 
5400,6771,6/15/1950,Male,180,74,Private,No, , , , ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,5/11/2020,9/30/2021,10/14/1582, , , , , , , , , 
5401,1141,6/15/1948,Male,178,78,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,NIN-X,BLEN-X,R-X,12/8/2018,3/5/2020,3/5/2020,3/16/2020,6/16/2021,6/16/2021,7/10/2021,3/11/2022,3/11/2022,3/21/2022,3/31/2022, 
5402,9626,6/15/1966,Male,175,72,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"1,8",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/7/2020,7/31/2020,7/31/2020, , , , , , , , , 
5403,5445,6/15/1952,Male,172,80,Private,No, , ,Yes, ,Yes, , ,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"16,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/15/2020,10/29/2020,10/29/2020,7/21/2021,11/3/2021,11/3/2021, , , , , , 
5404,4089,6/15/1947,Male,177,89,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,10/23/2018,3/28/2019,3/28/2019,6/12/2020,10/8/2021,10/8/2021,10/20/2021,3/31/2022, , , , 
5405,1231,6/15/1948,Male,174,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,3/14/2019,7/10/2019,7/10/2019,5/26/2020,7/24/2021,7/24/2021,8/3/2021,3/31/2022,10/14/1582, , , 
5406,3512,6/15/1946,Male,174,87,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,4",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,5/5/2020,9/14/2021,9/14/2021,9/21/2021,3/31/2022,10/14/1582, , , , , , 
5407,6845,6/15/1948,Male,168,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,5",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,4/4/2018,10/18/2018,10/18/2018,4/15/2020,2/24/2021,2/24/2021,3/10/2021,3/31/2022,10/14/1582, , , 
5408,1938,6/15/1949,Male,176,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"6,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,1/29/2019,2/13/2020,2/13/2020,6/18/2020,10/13/2021,10/13/2021,10/27/2021,3/31/2022, , , , 
5409,5262,6/15/1945,Female,179,106,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,01",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/1/2020,5/19/2021,5/19/2021, , , , , , , , , 
5410,6473,6/15/1947,Female,164,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,18",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/1/2020,8/1/2020,8/1/2020, , , , , , , , , 
5411,2121,6/15/1948,Male,188,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/1/2020,6/22/2021,6/22/2021, , , , , , , , , 
5412,4426,6/15/1943,Female,158,42,Private,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"3,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/28/2020,7/6/2020,7/6/2020, , , , , , , , , 
5413,4081,6/15/1949,Female,155,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"31,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/1/2020,8/1/2020,8/1/2020, , , , , , , , , 
5414,4235,6/15/1942,Male,175,94,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,31",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/6/2020,12/31/2020, , , , , , , , , , 
5415,2240,6/15/1943,Male,185,91,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,96",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/15/2020,7/15/2020,7/15/2020,10/11/2021,3/31/2022,10/14/1582, , , , , , 
5416,8453,6/15/1943,Male,185,91,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,44",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/1/2020,8/1/2020,8/1/2020, , , , , , , , , 
5417,6895,6/15/1942,Male,175,94,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/6/2020,12/31/2020, , , , , , , , , , 
5418,4675,6/15/1945,Male,167,64,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,48",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/1/2020,6/7/2021,6/7/2021,2/21/2022,3/31/2022, , , , , , , 
5419,6219,6/15/1942,Female,161,70,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"18,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/12/2020,5/5/2021,5/5/2021, , , , , , , , , 
5420,4030,6/15/1944,Male,171,72,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,32",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/18/2020,3/12/2021,3/12/2021,3/9/2022,3/31/2022, , , , , , , 
5421,8232,6/15/1930,Female,173,85,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,48",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/25/2020,7/20/2020,7/20/2020, , , , , , , , , 
5422,7386,6/15/1944,Male,177,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,08",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/1/2020,8/1/2020,8/1/2020,8/27/2021,3/31/2022,10/14/1582, , , , , , 
5423,2005,6/15/1942,Female,167,51,Private,No, , , , , ,Yes, , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,46",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/6/2020,4/28/2021,4/28/2021, , , , , , , , , 
5424,1030,6/15/1947,Female,175,60,Private,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"29,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/1/2020,5/25/2021,5/25/2021, , , , , , , , , 
5425,3058,6/15/1946,Female,156,44,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,37",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/16/2020,1/14/2021,1/14/2021,10/12/2021,3/31/2022, , , , , , , 
5426,4480,6/15/1947,Female,162,66,Private,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/1/2020,8/24/2020,8/24/2020, , , , , , , , , 
5427,4208,6/15/1959,Male,177,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,No CTx,V-X,6/1/2020,7/28/2020,7/28/2020,8/10/2020,9/10/2020,9/10/2020,10/4/2020,7/20/2021,7/20/2021, , , 
5428,1631,6/15/1944,Male,169,76,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/9/2020,6/2/2021,6/2/2021,3/3/2022,3/31/2022, , , , , , , 
5429,4746,6/15/1944,Male,183,110,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/18/2020,5/11/2021,5/11/2021,12/8/2021,3/31/2022, , , , , , , 
5430,4601,6/15/1942,Male,174,62,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"80,8",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
5431,8068,6/15/1949,Female,162,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,84",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/16/2020,6/22/2021,6/22/2021, , , , , , , , , 
5432,8589,6/15/1954,Male,178,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"64,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,11/18/2018,3/8/2019,3/8/2019, , , , , , , , , 
5433,3482,6/15/1949,Female,162,46,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,56",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/28/2020,7/28/2020,7/28/2020, , , , , , , , , 
5434,4759,6/15/1955,Male,167,68,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,73",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,10/16/2019,4/4/2020,4/4/2020,4/14/2020,3/31/2022,10/14/1582, , , , , , 
5435,2195,6/15/1945,Female,151,57,Private,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,17",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/6/2019,11/1/2019,11/1/2019,5/18/2020,3/31/2022,10/14/1582, , , , , , 
5436,3674,6/15/1953,Female,156,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,04",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,10/28/2019,4/25/2020,4/25/2020,5/21/2020,3/31/2022,10/14/1582, , , , , , 
5437,6302,6/15/1951,Male,177,74,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,7/8/2019,11/7/2019,11/7/2019,5/30/2020,9/10/2021,9/10/2021,10/7/2021,3/31/2022,10/14/1582, , , 
5438,9785,6/15/1966,Male,161,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,10/18/2019,4/15/2020,4/15/2020,5/11/2020,12/31/2020,10/14/1582, , , , , , 
5439,6090,6/15/1945,Female,157,62,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,29",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/1/2020,1/7/2021,1/7/2021, , , , , , , , , 
5440,4053,6/15/1955,Male,182,68,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,36",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/1/2020,8/1/2020,8/1/2020,9/28/2021,3/31/2022,10/14/1582, , , , , , 
5441,8614,6/15/1950,Female,174,95,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,88","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,5/15/2020,9/11/2020,9/11/2020,10/2/2020,2/16/2022,2/16/2022,2/23/2022,3/31/2022, , , , 
5442,7488,6/15/1940,Female,176,77,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"9,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/12/2020,6/12/2020,6/12/2020, , , , , , , , , 
5443,1200,6/15/1940,Female,166,66,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,96",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/4/2020,7/9/2020,7/9/2020,7/28/2020,4/6/2021,4/6/2021, , , , , , 
5444,8708,6/15/1943,Male,191,91,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/26/2020,6/1/2021,6/1/2021, , , , , , , , , 
5445,6268,6/15/1950,Male,196,101,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,6/15/2020,9/14/2020,9/14/2020,10/2/2020,2/24/2022,2/24/2022,3/17/2022,3/31/2022, , , , 
5446,2355,6/15/1957,Male,180,62,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,79",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/7/2020,11/24/2020,11/24/2020,12/4/2020,3/31/2022,10/14/1582, , , , , , 
5447,3022,6/15/1947,Male,193,86,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,02",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,KYP-X,V-X,6/3/2020,8/13/2020,8/13/2020,9/8/2020,10/24/2020,10/24/2020,10/31/2020,7/5/2021,7/5/2021,7/21/2021,3/31/2022,10/14/1582
5448,7443,6/15/1947,Male,168,54,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,03",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/21/2020,6/3/2021,6/3/2021, , , , , , , , , 
5449,5714,6/15/1941,Female,161,50,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"11,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/28/2020,8/13/2020,8/13/2020, , , , , , , , , 
5450,8777,6/15/1943,Male,164,63,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"32,16","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,DAR-X,6/22/2020,7/20/2021,7/20/2021,8/12/2021,3/31/2022,10/14/1582, , , , , , 
5451,7990,6/15/1948,Male,184,88,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,9,III: one or more criteria are fulfilled,IgA,"12,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/14/2019,2/12/2020,2/12/2020,5/18/2020,6/30/2021,6/30/2021,7/26/2021,3/31/2022,10/14/1582, , , 
5452,2553,6/15/1954,Male,171,74,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,96",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,11/8/2019,4/24/2020,4/24/2020,5/8/2020,3/31/2022,10/14/1582, , , , , , 
5453,4976,6/15/1946,Male,179,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,98",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,POM-X,No CTx,No CTx,R-X,10/3/2019,3/19/2020,3/19/2020,4/9/2020,3/31/2022, , , , , , , 
5454,4632,6/15/1954,Male,173,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,4",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,11/1/2019,2/5/2020,2/5/2020,5/8/2020,2/8/2022,2/8/2022,2/22/2022,3/31/2022, , , , 
5455,4717,6/15/1955,Male,170,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,22",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/11/2019,12/27/2019,12/27/2019,5/29/2020,3/31/2022,10/14/1582, , , , , , 
5456,7889,6/15/1955,Male,176,64,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"31,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,11/13/2019,5/2/2020,5/2/2020,5/12/2020,12/31/2021, , , , , , , 
5457,1337,6/15/1952,Male,179,62,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"24,24","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/26/2019,11/28/2019,11/28/2019,4/8/2020,3/31/2022,10/14/1582, , , , , , 
5458,5530,6/15/1949,Male,170,73,Private,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"13,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/22/2020,1/14/2021,1/14/2021,2/17/2022,3/31/2022, , , , , , , 
5459,7662,6/15/1943,Male,170,68,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"1,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/3/2020,5/18/2020,5/18/2020, , , , , , , , , 
5460,1169,6/15/1950,Male,180,79,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,0,I: fulfilling all 4 criteria,IgG,"3,21",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/2/2020,8/2/2020,8/2/2020,8/3/2021,3/31/2022,10/14/1582, , , , , , 
5461,4987,6/15/1946,Female,167,67,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,26",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/6/2020,4/29/2021,4/29/2021, , , , , , , , , 
5462,2012,6/15/1944,Female,157,64,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,33",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/26/2020,7/26/2020,7/26/2020, , , , , , , , , 
5463,3337,6/15/1950,Female,177,105,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,79",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/7/2020,7/2/2020,7/2/2020, , , , , , , , , 
5464,9756,6/15/1944,Male,178,107,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,3,III: one or more criteria are fulfilled,IgG,"13,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Unknown,Yes,"2,24", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,DAR-X,5/15/2020,12/31/2021,10/14/1582, , , , , , , , , 
5465,7231,6/15/1939,Male,169,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,2,III: one or more criteria are fulfilled,IgG,"1,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/19/2020,7/18/2021,7/18/2021, , , , , , , , , 
5466,3582,6/15/1961,Female,168,78,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,30,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/14/2020,3/31/2022, , , , , , , , , , 
5467,8678,6/15/1959,Female,159,73,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,21,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/13/2020,8/13/2020,8/13/2020, , , , , , , , , 
5468,1825,6/15/1945,Male,187,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/29/2019,12/5/2019,12/5/2019,5/14/2020,6/30/2021,10/14/1582, , , , , , 
5469,8533,6/15/1937,Male,180,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,62,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/18/2020,3/31/2022, , , , , , , , , , 
5470,7558,6/15/1939,Male,165,74,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"18,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/26/2020,9/23/2021,9/23/2021, , , , , , , , , 
5471,5244,6/15/1935,Male,180,68,Private,Yes, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,3000,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,3/9/2020,3/31/2021, , , , , , , , , , 
5472,4520,6/15/1961,Male,184,99,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,41,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,2/25/2020,3/31/2022, , , , , , , , , , 
5473,8780,6/15/1944,Male,178,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,33,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,DAR-X,6/29/2020,3/31/2022, , , , , , , , , , 
5474,1925,6/15/1934,Male,172,90,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,4",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,6/26/2020,6/29/2020,6/29/2020, , , , , , , , , 
5475,4921,6/15/1955,Male,168,61,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"29,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,12/2/2019,5/19/2020,5/19/2020,5/29/2020,5/23/2021,5/23/2021, , , , , , 
5476,6652,6/15/1955,Male,184,83,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,36",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,11/6/2019,5/3/2020,5/3/2020,5/25/2020,6/14/2021,6/14/2021, , , , , , 
5477,2315,6/15/1952,Female,182,79,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"25,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,10/3/2019,3/30/2020,3/30/2020,4/21/2020,3/31/2022,10/14/1582, , , , , , 
5478,2152,6/15/1932,Female,173,53,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"2,06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/15/2019,11/7/2019,11/7/2019,5/20/2020,7/26/2021,7/26/2021, , , , , , 
5479,9314,6/15/1932,Male,162,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,19",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,R-X,6/13/2019,12/2/2019,12/2/2019,12/12/2019,6/10/2020,6/10/2020,12/6/2020,3/31/2022, , , , 
5480,2098,6/15/1946,Female,165,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"10,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,R-X,10/17/2019,4/14/2020,4/14/2020,5/9/2020,1/6/2022,1/6/2022,2/11/2022,3/31/2022, , , , 
5481,3185,6/15/1972,Female,161,53,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,44",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,10/28/2019,2/2/2020,2/2/2020,5/13/2020,10/6/2021,10/6/2021,11/3/2021,3/31/2022,10/14/1582, , , 
5482,9611,6/15/1955,Male,186,92,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,27",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/11/2019,10/14/2019,10/14/2019,4/13/2020,3/31/2022,10/14/1582, , , , , , 
5483,3214,6/15/1951,Female,161,51,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,11/7/2019,5/8/2020,5/8/2020,5/21/2020,11/4/2021,11/4/2021,11/23/2021,3/31/2022,10/14/1582, , , 
5484,7063,6/15/1965,Female,163,59,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,12/23/2019,3/19/2020,3/19/2020,6/12/2020,2/9/2022,2/9/2022,3/4/2022,3/31/2022, , , , 
5485,1753,6/15/1949,Male,183,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/27/2019,5/23/2019,5/23/2019,10/28/2019,6/9/2020,6/9/2020, , , , , , 
5486,5774,6/15/1946,Female,169,61,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"22,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,NIN-X,POM-X,R-X,10/8/2019,4/8/2020,4/8/2020,4/19/2020,11/29/2020,11/29/2020,12/18/2020,5/19/2021,5/19/2021,6/10/2021,3/31/2022, 
5487,7609,6/15/1947,Female,162,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"9,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/15/2019,2/10/2020,2/10/2020,6/10/2020,3/31/2022,10/14/1582, , , , , , 
5488,8541,6/15/1969,Female,157,78,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,8/29/2019,12/30/2019,12/30/2019,5/24/2020,12/17/2021,12/17/2021,1/18/2022,3/31/2022, , , , 
5489,2733,6/15/1954,Male,181,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,65",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/25/2019,10/30/2019,10/30/2019,5/8/2020,6/30/2021,10/14/1582, , , , , , 
5490,6133,6/15/1949,Male,170,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,27",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/30/2019,2/1/2020,2/1/2020,4/20/2020,3/31/2022,10/14/1582, , , , , , 
5491,4302,6/15/1963,Female,174,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"20,57",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,9/16/2019,12/23/2019,12/23/2019,4/24/2020,7/13/2021,7/13/2021,8/5/2021,3/31/2022,10/14/1582, , , 
5492,7712,6/15/1967,Male,190,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"5,41",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L", ,ISA-X,No CTx,No CTx,V-X,4/17/2020,8/20/2020,8/20/2020,5/10/2021,3/31/2022, , , , , , , 
5493,1956,6/15/1945,Male,189,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,69,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/15/2020,6/30/2020, , , , , , , , , , 
5494,2175,6/15/1950,Female,168,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,54,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/15/2020,6/30/2020, , , , , , , , , , 
5495,5098,6/15/1942,Male,175,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,75,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/15/2020,6/30/2020, , , , , , , , , , 
5496,9472,6/15/1939,Female,174,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,84,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/15/2020,6/30/2020, , , , , , , , , , 
5497,8460,6/15/1941,Female,162,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,67,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/15/2020,6/30/2020, , , , , , , , , , 
5498,9040,6/15/1937,Male,176,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,65,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/15/2020,6/30/2020, , , , , , , , , , 
5499,1867,6/15/1942,Female,159,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,85,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/15/2020,6/30/2020, , , , , , , , , , 
5500,2981,6/15/1938,Male,174,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,72,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/15/2020,6/30/2020, , , , , , , , , , 
5501,1103,6/15/1946,Female,168,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,73,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/15/2020,6/30/2020, , , , , , , , , , 
5502,3784,6/15/1948,Male,180,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,64,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/15/2020,6/30/2020, , , , , , , , , , 
5503,5972,6/15/1952,Male,184,68,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,29",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,8/1/2019,10/24/2019,10/24/2019,5/20/2020,3/31/2022, , , , , , , 
5504,5670,6/15/1974,Male,180,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"13,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,10/31/2019,4/25/2020,4/25/2020,5/13/2020,3/31/2022, , , , , , , 
5505,5930,6/15/1952,Male,184,68,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,1",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,V-X,No CTx,V-X,11/4/2019,1/29/2020,1/29/2020,5/1/2020,7/31/2020,7/31/2020,8/9/2020,11/22/2020,11/22/2020, , , 
5506,4697,6/15/1950,Female,165,54,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,24",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,No CTx,R-X,10/9/2019,3/26/2020,3/26/2020,4/12/2020,7/26/2020,7/26/2020,2/24/2021,7/11/2021,7/11/2021, , , 
5507,5486,6/15/1964,Male,185,82,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,16",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,11/15/2019,5/1/2020,5/1/2020,5/28/2020,3/31/2022,10/14/1582,2/14/2022,3/31/2022, , , , 
5508,2639,6/15/1955,Male,178,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"30,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,7/5/2019,9/30/2019,9/30/2019,5/3/2020,10/31/2020,10/31/2020,11/11/2020,3/31/2022,10/14/1582, , , 
5509,3103,6/15/1949,Female,164,63,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,08","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,11/13/2018,5/9/2019,5/9/2019,11/5/2019,4/28/2020,4/28/2020,5/15/2020,1/7/2021,1/7/2021, , , 
5510,4379,6/15/1949,Female,159,70,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"23,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,10/24/2018,4/11/2019,4/11/2019,11/13/2019,5/4/2020,5/4/2020,5/25/2020,7/10/2020,7/10/2020,7/26/2020,4/6/2021,4/6/2021
5511,2279,6/15/1955,Female,174,110,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,01",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,2/14/2019,8/2/2019,8/2/2019,11/14/2019,5/16/2020,5/16/2020,6/3/2020,9/29/2021,9/29/2021,10/14/2021,3/31/2022,10/14/1582
5512,6407,6/15/1950,Male,179,84,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"20,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/24/2019,7/24/2019,7/24/2019,11/20/2019,5/12/2020,5/12/2020,6/2/2020,2/9/2022,2/9/2022, , , 
5513,1358,6/15/1945,Male,201,93,Private,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,13",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,10/16/2019,1/16/2020,1/16/2020,5/11/2020,10/6/2020,10/6/2020,10/27/2020,12/28/2021,12/28/2021, , , 
5514,4853,6/15/1945,Male,179,84,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,12/24/2018,6/17/2019,6/17/2019,11/6/2019,5/4/2020,5/4/2020,5/21/2020,9/11/2021,9/11/2021, , , 
5515,3282,6/15/1953,Female,174,106,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"25,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,10/23/2018,4/22/2019,4/22/2019,10/30/2019,4/28/2020,4/28/2020,5/22/2020,3/31/2022,10/14/1582, , , 
5516,6555,6/15/1954,Male,181,82,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,83",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,11/29/2019,3/2/2020,3/2/2020,5/12/2020,3/4/2022,3/4/2022,3/21/2022,3/31/2022, , , , 
5517,9931,6/15/1953,Male,181,76,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,POM-X,No CTx,No CTx,R-X,10/25/2019,4/28/2020,4/28/2020,5/14/2020,6/30/2021, , , , , , , 
5518,2181,6/15/1947,Female,166,101,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"31,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,1/7/2019,7/5/2019,7/5/2019,11/13/2019,5/13/2020,5/13/2020,5/27/2020,3/31/2022,10/14/1582, , , 
5519,8712,6/15/1952,Male,170,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,69",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,8/6/2019,11/7/2019,11/7/2019,4/18/2020,3/31/2022,10/14/1582, , , , , , 
5520,5178,6/15/1953,Male,168,75,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"16,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,2/6/2019,7/31/2019,7/31/2019,11/4/2019,5/1/2020,5/1/2020,5/16/2020,12/31/2021, , , , 
5521,7705,6/15/1947,Female,182,79,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,16",ISS stage II (neither stage I nor stage III),9,9,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,11/4/2019,4/30/2020,4/30/2020,5/19/2020,12/31/2020, , , , , , , 
5522,2662,6/15/1945,Male,179,83,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,54",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/4/2019,2/29/2020,2/29/2020,5/24/2020,12/31/2020, , , , , , , 
5523,7484,6/15/1953,Male,186,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,67",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,7/31/2019,11/6/2019,11/6/2019,5/10/2020,9/1/2020,9/1/2020,9/10/2020,12/31/2020, , , , 
5524,5600,6/15/1950,Male,176,56,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"11,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,9/27/2019,3/15/2020,3/15/2020,4/9/2020,6/4/2020,6/4/2020, , , , , , 
5525,7944,6/15/1947,Female,174,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,07",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,10/10/2019,1/6/2020,1/6/2020,4/11/2020,12/13/2020,12/13/2020,12/26/2020,12/31/2020, , , , 
5526,2171,6/15/1947,Male,180,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,27",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,10/28/2019,4/18/2020,4/18/2020,5/12/2020,9/1/2020,9/1/2020,9/9/2020,1/4/2021,1/4/2021, , , 
5527,7008,6/15/1951,Female,161,64,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,11",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/16/2019,12/13/2019,12/13/2019,5/22/2020,5/25/2021,5/25/2021, , , , , , 
5528,9459,6/15/1952,Male,173,75,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,55",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/7/2019,2/3/2020,2/3/2020,5/8/2020,1/15/2021,1/15/2021, , , , , , 
5529,6442,6/15/1966,Female,151,58,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"11,22","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/19/2017,9/28/2017,9/28/2017,4/1/2020,4/29/2020,4/29/2020, , , , , , 
5530,4562,6/15/1949,Male,169,75,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,56",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/14/2019,2/19/2020,2/19/2020,5/29/2020,6/30/2021,10/14/1582, , , , , , 
5531,4398,6/15/1972,Female,174,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Unbekannt,DAR-X,No CTx,No CTx,R-X,10/23/2019,4/20/2020,4/20/2020,5/9/2020,3/31/2022,10/14/1582, , , , , , 
5532,5550,6/15/1950,Male,184,77,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"32,66","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,12/10/2018,5/27/2019,5/27/2019,11/4/2019,5/3/2020,5/3/2020,5/19/2020,6/30/2021,10/14/1582, , , 
5533,4791,6/15/1950,Male,184,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"16,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,12/28/2018,6/13/2019,6/13/2019,11/26/2019,5/12/2020,5/12/2020,5/24/2020,8/6/2021,8/6/2021, , , 
5534,1029,6/15/1951,Male,170,67,Compulsory health insurance CHI,No, , , , , , , ,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgG,"13,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,2/8/2019,7/29/2019,7/29/2019,11/18/2019,5/17/2020,5/17/2020,5/31/2020,7/13/2021,7/13/2021,8/5/2021,3/31/2022,10/14/1582
5535,9889,6/15/1951,Male,170,67,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"17,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,2/15/2019,8/16/2019,8/16/2019,11/8/2019,5/3/2020,5/3/2020,5/21/2020,3/31/2022, , , , 
5536,4933,6/15/1946,Male,177,86,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,09",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,1/18/2019,7/8/2019,7/8/2019,11/27/2019,5/20/2020,5/20/2020,5/31/2020,3/31/2022,10/14/1582, , , 
5537,9139,6/15/1949,Male,174,70,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"15,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,12/5/2018,5/30/2019,5/30/2019,11/1/2019,4/27/2020,4/27/2020,5/21/2020,3/31/2022,10/14/1582, , , 
5538,3613,6/15/1945,Female,162,73,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,2/13/2019,8/9/2019,8/9/2019,11/14/2019,5/15/2020,5/15/2020,5/30/2020,3/31/2022, , , , 
5539,9012,6/15/1949,Female,169,64,Private,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,10/9/2018,4/4/2019,4/4/2019,10/3/2019,3/25/2020,3/25/2020,4/19/2020,8/24/2021,8/24/2021,9/9/2021,3/31/2022, 
5540,2292,6/15/1945,Female,173,80,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,NIN-X,V-X,11/26/2018,5/15/2019,5/15/2019,9/19/2019,3/19/2020,3/19/2020,4/1/2020,2/6/2021,2/6/2021,2/21/2021,3/31/2022, 
5541,1400,6/15/1955,Male,169,71,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"13,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,1/21/2019,7/15/2019,7/15/2019,11/14/2019,5/9/2020,5/9/2020,5/22/2020,7/7/2020,7/7/2020,7/26/2020,12/31/2020, 
5542,4020,6/15/1949,Female,170,51,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"23,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,12/10/2018,6/3/2019,6/3/2019,10/18/2019,4/7/2020,4/7/2020,4/29/2020,6/18/2020,6/18/2020,7/6/2020,12/31/2020,10/14/1582
5543,7421,6/15/1948,Male,173,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,1/28/2019,7/18/2019,7/18/2019,10/8/2019,4/7/2020,4/7/2020,5/3/2020,3/31/2022,10/14/1582, , , 
5544,7329,6/15/1950,Male,169,98,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"23,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,11/15/2018,5/6/2019,5/6/2019,11/8/2019,5/8/2020,5/8/2020,6/3/2020,6/30/2020,6/30/2020,7/24/2020,7/13/2021,7/13/2021
5545,2632,6/15/1949,Male,182,82,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"13,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,1/24/2019,7/19/2019,7/19/2019,11/4/2019,5/1/2020,5/1/2020,5/18/2020,7/22/2020,7/22/2020,8/6/2020,2/27/2021,2/27/2021
5546,5656,6/15/1955,Female,169,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,2/28/2019,8/29/2019,8/29/2019,11/19/2019,5/14/2020,5/14/2020,5/31/2020,11/24/2020,11/24/2020,12/9/2020,12/10/2021,12/10/2021
5547,1507,6/15/1948,Female,169,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,11/15/2018,5/13/2019,5/13/2019,11/25/2019,5/20/2020,5/20/2020,6/7/2020,3/11/2021,3/11/2021,4/1/2021,3/31/2022, 
5548,3667,6/15/1946,Male,174,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,9",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,5/14/2020,12/2/2021,12/2/2021,12/13/2021,3/31/2022,10/14/1582, , , , , , 
5549,2094,6/15/1957,Female,158,61,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,unbekannt,Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,12/1/2019,1/31/2020,1/31/2020, , , , , , , , , 
5550,7506,6/15/1945,Male,180,90,Private,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,2/2/2018,4/30/2020,4/30/2020,5/11/2020,11/2/2020,11/2/2020,11/16/2020,11/30/2020,11/30/2020, , , 
5551,4463,6/15/1927,Male,180,85,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Unknown, , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/13/2020,12/10/2020,12/10/2020, , , , , , , , , 
5552,4881,6/15/1939,Female,170,78,Private,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,LEV-X,R-X,12/4/2017,5/27/2020,5/27/2020,6/8/2020,6/3/2021,6/3/2021,6/28/2021,9/15/2021,9/15/2021,9/29/2021,12/18/2021,12/18/2021
5553,2586,6/15/1951,Female,175,89,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,4/29/2020,12/15/2020,12/15/2020, , , , , , , , , 
5554,3095,6/15/1945,Female,170,65,Private,No, , , , , , , , , , ,1,Unknown,IgA,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No,"1,75", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , , , ,R-X,No CTx,No CTx,DAR-X,6/1/2020,9/28/2020,9/28/2020,1/4/2021,3/8/2021,3/8/2021, , , , , , 
5555,9414,6/15/1939,Female,170,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/15/2020,6/2/2021,6/2/2021, , , , , , , , , 
5556,6855,6/15/1934,Male,177,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Nein, , , , , ,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
5557,4799,6/15/1943,Male,185,90,Compulsory health insurance CHI,No,Yes, , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,9,No,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,DAR-X,EMP-X,Other,1/16/2006,3/23/2006,3/23/2006,6/30/2010,10/21/2010,10/21/2010,9/11/2018,11/5/2019,11/5/2019,5/19/2020,8/18/2020,8/18/2020
5558,2891,6/15/1938,Female,161,66,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"8,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,4/2/2020,9/16/2020,9/16/2020,9/30/2020,3/31/2022,10/14/1582, , , , , , 
5559,5784,6/15/1936,Male,174,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,4/2/2020,9/16/2020,9/16/2020,9/29/2020,12/21/2021,12/21/2021, , , , , , 
5560,7349,6/15/1950,Female,166,58,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,4/9/2020,7/1/2020,7/1/2020,3/29/2021,9/12/2021,9/12/2021,3/28/2022,3/31/2022, , , , 
5561,9645,6/15/1939,Male,176,70,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/6/2020,4/18/2021,4/18/2021,8/2/2021,3/31/2022,10/14/1582, , , , , , 
5562,6221,6/15/1941,Female,158,55,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,4/9/2020,9/23/2020,9/23/2020,3/22/2021,9/10/2021,9/10/2021,9/22/2021,3/31/2022,10/14/1582, , , 
5563,2869,6/15/1952,Male,178,77,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,4/13/2020,9/27/2020,9/27/2020,3/29/2021,9/12/2021,9/12/2021,3/21/2022,3/31/2022, , , , 
5564,8279,6/15/1937,Male,180,87,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/26/2020,3/31/2022,10/14/1582, , , , , , , , , 
5565,5832,6/15/1940,Male,185,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,6,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/13/2020,3/31/2022,10/14/1582, , , , , , , , , 
5566,4170,6/15/1951,Male,166,73,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, ,Yes,9,III: one or more criteria are fulfilled,IgG,103,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , , ,Ja,V-X,KYP-X,DAR-X,V-X,7/21/2014,10/2/2014,10/2/2014,6/6/2016,8/15/2016,8/15/2016,5/23/2017,1/10/2018,1/10/2018,1/8/2019,9/8/2020,9/8/2020
5567,6723,6/15/1936,Male,175,150,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/27/2020,6/22/2020,6/22/2020, , , , , , , , , 
5568,4709,6/15/1935,Female,166,60,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgA,"2,6",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/1/2016,12/13/2016,12/13/2016,5/6/2020,11/16/2020,11/16/2020, , , , , , 
5569,8092,6/15/1944,Male,165,75,Private,No, ,Yes, , , , , , , , ,9,Unknown,IgG,"2,3",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/8/2012,1/10/2013,1/10/2013, , , , , , , , , 
5570,6476,6/15/1959,Male,178,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"1,89",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/23/2020,12/31/2020,10/14/1582, , , , , , , , , 
5571,3841,6/15/1965,Female,164,75,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"85,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,ISA-X,6/9/2020,8/27/2020,8/27/2020, , , , , , , , , 
5572,5156,6/15/1951,Female,153,63,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"17,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,4/14/2020,5/28/2020,5/28/2020,6/11/2020,10/8/2020,10/8/2020,4/19/2021,7/13/2021,7/13/2021, , , 
5573,1473,6/15/1948,Male,181,76,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/13/2020,9/27/2020,9/27/2020,3/15/2021,3/31/2022, , , , , , , 
5574,2797,6/15/1946,Male,178,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,4/13/2020,7/5/2020,7/5/2020,3/29/2021,9/12/2021,9/12/2021,3/28/2022,3/31/2022, , , , 
5575,6834,6/15/1938,Female,156,70,Compulsory health insurance CHI,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/20/2020,7/12/2020,7/12/2020,2/8/2021,1/5/2022,1/5/2022, , , , , , 
5576,3639,6/15/1944,Female,162,67,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"11,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,4/23/2020,7/15/2020,7/15/2020,3/8/2021,3/2/2022,3/2/2022,3/21/2022,3/31/2022, , , , 
5577,1281,6/15/1941,Male,176,71,Private,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,11,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,4/27/2020,10/11/2020,10/11/2020,3/15/2021,9/16/2021,9/16/2021,9/29/2021,3/31/2022,10/14/1582, , , 
5578,5599,6/15/1955,Male,179,75,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,4/28/2020,10/12/2020,10/12/2020,3/29/2021,3/31/2022,10/14/1582, , , , , , 
5579,8130,6/15/1951,Female,165,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,4/30/2020,7/22/2020,7/22/2020,9/28/2020,3/14/2021,3/14/2021,9/27/2021,3/31/2022,10/14/1582, , , 
5580,5225,6/15/1953,Male,176,79,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/7/2020,6/30/2021,10/14/1582, , , , , , , , , 
5581,1196,6/15/1950,Female,159,57,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"9,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/12/2020,11/26/2021,11/26/2021, , , , , , , , , 
5582,6273,6/15/1940,Female,167,64,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/14/2020,3/12/2021,3/12/2021,3/22/2021,3/31/2022,10/14/1582, , , , , , 
5583,7096,6/15/1946,Male,177,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,DAR-X,EMP-X,No CTx,V-X,5/15/2020,8/6/2020,8/6/2020,3/22/2021,2/24/2022,2/24/2022,3/14/2022,3/31/2022, , , , 
5584,3685,6/15/1939,Female,161,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/21/2020,12/13/2021,12/13/2021, , , , , , , , , 
5585,5850,6/15/1937,Male,171,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,DAR-X,No CTx,R-X,5/21/2020,11/4/2020,11/4/2020,3/29/2021,12/16/2021,12/16/2021,3/14/2022,3/31/2022, , , , 
5586,9909,6/15/1945,Male,177,79,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"9,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/25/2020,6/30/2021,10/14/1582, , , , , , , , , 
5587,8193,6/15/1949,Female,172,63,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,IgG,"1,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,4/24/2020,8/23/2020,8/23/2020, , , , , , , , , 
5588,1975,6/15/1946,Female,162,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,5/25/2020,11/8/2020,11/8/2020,3/15/2021,9/17/2021,9/17/2021,9/28/2021,3/31/2022,10/14/1582, , , 
5589,1164,6/15/1937,Male,178,85,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"11,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,5/28/2020,9/27/2020,9/27/2020,9/28/2020,12/21/2021,12/21/2021, , , , , , 
5590,6321,6/15/1966,Female,178,94,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,6420,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/22/2020,6/30/2020, , , , , , , , , , 
5591,1415,6/15/1939,Male,180,83,Compulsory health insurance CHI,No, , , ,Yes,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,4920,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/25/2020,6/30/2020, , , , , , , , , , 
5592,5467,6/15/1936,Female,160,64,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes, , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,5200,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,Other,6/9/2020,6/30/2020, , , , , , , , , , 
5593,4380,6/15/1943,Male,178,75,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/28/2020,11/11/2020,11/11/2020,8/2/2021,3/31/2022,10/14/1582, , , , , , 
5594,5271,6/15/1946,Male,180,75,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,6/1/2020,3/10/2022,3/10/2022,3/28/2022,3/31/2022, , , , , , , 
5595,6350,6/15/1938,Female,158,54,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"9,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/1/2020,12/10/2021,12/10/2021, , , , , , , , , 
5596,9745,6/15/1951,Male,182,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,6/3/2020,8/25/2020,8/25/2020,3/8/2021,3/2/2022,3/2/2022,3/28/2022,3/31/2022, , , , 
5597,3910,6/15/1944,Female,164,73,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/9/2020,6/30/2021,10/14/1582, , , , , , , , , 
5598,7460,6/15/1949,Male,177,89,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/15/2020,10/18/2020,10/18/2020,3/22/2021,3/31/2022,10/14/1582, , , , , , 
5599,1242,6/15/1955,Male,176,79,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/19/2020,10/22/2020,10/22/2020,8/2/2021,3/31/2022,10/14/1582, , , , , , 
5600,9456,6/15/1944,Female,163,66,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,6/24/2020,10/27/2020,10/27/2020,3/29/2021,2/24/2022,2/24/2022,3/21/2022,3/31/2022, , , , 
5601,7669,6/15/1975,Male,182,105,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,6580,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/4/2020,6/30/2020, , , , , , , , , , 
5602,5331,6/15/1940,Female,160,82,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,4990,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/8/2020,6/30/2020,10/14/1582, , , , , , , , , 
5603,4843,6/15/1956,Female,164,58,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,10/1/2019,6/3/2020,6/3/2020, , , , , , , , , 
5604,3443,6/15/1934,Male,178,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1565,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/6/2020,6/30/2020, , , , , , , , , , 
5605,8277,6/15/1944,Female,165,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"999,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,No CTx, , , ,6/13/2020,6/30/2020, , , , , , , 
5606,2517,6/15/1963,Female,160,111,Compulsory health insurance CHI,Unknown, , , , , , , ,Yes,Yes, ,0,III: one or more criteria are fulfilled,IgG,"999,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/30/2020,6/30/2020, , , , , , , , , , 
5607,3618,6/15/1952,Female,170,79,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"999,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/27/2020,6/30/2020, , , , , , , , , , 
5608,6086,6/15/1945,Female,170,65,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,180,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/2/2020,3/9/2021,3/9/2021,11/8/2021,12/31/2021, , , , , , , 
5609,6762,6/15/1950,Female,168,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,210,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/15/2020,9/30/2020, , , , , , , , , , 
5610,2607,6/15/1948,Female,167,63,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/5/2020,2/12/2021,2/12/2021, , , , , , , , , 
5611,2365,6/15/1949,Female,164,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,190,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/4/2020,12/31/2020, , , , , , , , , , 
5612,2983,6/15/1955,Male,177,64,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,325,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/13/2020,10/30/2020,10/30/2020, , , , , , , , , 
5613,1138,6/15/1942,Female,166,62,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/13/2020,6/30/2020, , , , , , , , , , 
5614,9004,6/15/1939,Female,164,69,Private,Yes,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,7020,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/11/2020,6/30/2020, , , , , , , , , , 
5615,4966,6/15/1949,Male,170,68,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,270,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/8/2020,12/31/2020, , , , , , , , , , 
5616,8392,6/15/1976,Male,165,59,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,4870,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/28/2020,6/30/2020, , , , , , , , , , 
5617,2934,6/15/1954,Male,180,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"999,9",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/4/2018,3/13/2020,3/13/2020,5/4/2020,6/30/2020, , , , , , , 
5618,9523,6/15/1940,Male,178,81,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,26,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,6/1/2020,9/1/2021,9/1/2021,9/1/2021,9/30/2021, , , , , , , 
5619,8055,6/15/1958,Female,166,67,Compulsory health insurance CHI,No, , , ,Yes, , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgG,30,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/1/2020,11/1/2020,11/1/2020, , , , , , , , , 
5620,6075,6/15/1964,Male,185,98,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,45,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/1/2020,10/1/2020,10/1/2020, , , , , , , , , 
5621,4267,6/15/1960,Male,176,91,Private,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,4720,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/22/2020,6/30/2020, , , , , , , , , , 
5622,1306,6/15/1937,Female,166,62,Private,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,4040,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/18/2020,6/30/2020, , , , , , , , , , 
5623,6824,6/15/1952,Male,176,87,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,999,unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,KYP-X,DAR-X,Other,10/15/2006,10/15/2007,10/15/2007,3/15/2018,8/15/2018,8/15/2018,8/15/2018,11/15/2019,11/15/2019,9/22/2020,1/25/2022,1/25/2022
5624,8402,6/15/1942,Male,170,64,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,IgG,3946,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,7/6/2020,6/30/2021, , , , , , , , , , 
5625,3838,6/15/1938,Female,156,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , ,Yes,2,III: one or more criteria are fulfilled,IgG,3774,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,7/8/2020,8/15/2020,8/15/2020, , , , , , , , , 
5626,4842,6/15/1934,Female,168,68,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,3336,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,7/29/2020,1/15/2021,1/15/2021, , , , , , , , , 
5627,6661,6/15/1943,Male,178,86,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgA,3828,ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,No, , , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,7/16/2020,3/31/2022, , , , , , , , , , 
5628,7904,6/15/1936,Male,180,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,R-X,No CTx,No CTx,V-X,6/28/2020,1/10/2021,1/10/2021,4/13/2021,5/10/2021,5/10/2021, , , , , , 
5629,5512,6/15/1955,Female,160,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,5500,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , , ,R-X,KYP-X,No CTx,V-X,8/30/2020,4/20/2021,4/20/2021,7/8/2021,10/10/2021,10/10/2021,3/24/2022,3/31/2022,10/14/1582, , , 
5630,2295,6/15/1946,Female,158,55,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,5700,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,R-X,6/3/2020,9/30/2020, , , , , , , , , , 
5631,3001,6/15/1950,Female,158,55,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,6500,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,8/20/2020,9/30/2020, , , , , , , , , , 
5632,5860,6/15/1961,Female,162,80,Private,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,9/17/2012,10/29/2012,10/29/2012,9/7/2020,2/4/2022,2/4/2022,2/17/2022,3/31/2022,10/14/1582, , , 
5633,1565,6/15/1948,Male,190,90,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,35,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,R-X,KYP-X,No CTx,V-X,10/7/2014,1/20/2015,1/20/2015,9/14/2020,3/21/2022,3/21/2022,3/23/2022,3/31/2022,10/14/1582, , , 
5634,5958,6/15/1952,Male,188,109,Private,No, , ,Yes, , , ,Yes, , , ,9,III: one or more criteria are fulfilled,IgG,"999,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/26/2015,10/29/2015,10/29/2015,7/16/2020,12/2/2021,12/2/2021, , , , , , 
5635,9703,6/15/1946,Female,174,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,KYP-X,R-X,12/6/2017,7/23/2020,7/23/2020,8/14/2020,2/26/2021,2/26/2021,9/21/2021,3/8/2022,3/8/2022,3/10/2022,3/31/2022,10/14/1582
5636,8581,6/15/1939,Female,148,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,",6",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Unknown,Unknown, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,7/13/2020,11/27/2020,11/27/2020,11/25/2021,3/31/2022, , , , , , , 
5637,2169,6/15/1946,Female,179,69,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,3,III: one or more criteria are fulfilled,IgG,"4,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/17/2020,3/31/2022,10/14/1582, , , , , , , , , 
5638,3003,6/15/1958,Male,183,77,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/29/2020,3/31/2022,10/14/1582, , , , , , , , , 
5639,1662,6/15/1961,Female,169,76,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,15,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,4/14/2017,6/16/2017,6/16/2017,9/8/2020,11/4/2020,11/4/2020, , , , , , 
5640,9811,6/15/1944,Male,193,91,Compulsory health insurance CHI,Unknown, , , , , , ,Yes, , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgA,16,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/21/2020,6/15/2021,6/15/2021,9/21/2021,3/31/2022,10/14/1582, , , , , , 
5641,6982,6/15/1960,Male,178,82,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,8,ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/1/2020,2/23/2021,2/23/2021, , , , , , , , , 
5642,3204,6/15/1943,Male,184,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"16,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,7/11/2020,9/16/2021,9/16/2021,9/28/2021,3/31/2022,10/14/1582, , , , , , 
5643,5902,6/15/1944,Female,158,99,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,2140,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,8/27/2020,9/15/2020,9/15/2020, , , , , , , , , 
5644,7973,6/15/1943,Male,180,78,Compulsory health insurance CHI,No,Yes, , , , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,48,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,5/5/2018,10/12/2018,10/12/2018,9/12/2020,9/7/2021,9/7/2021,9/28/2021,3/31/2022,10/14/1582, , , 
5645,8195,6/15/1946,Male,184,90,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,EMP-X,No CTx,V-X,7/9/2018,11/25/2018,11/25/2018,9/24/2020,6/3/2021,6/3/2021,6/24/2021,3/31/2022,10/14/1582, , , 
5646,3907,6/15/1944,Female,167,80,Private,No,Yes, , , , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,19,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,KYP-X,No CTx,DAR-X,9/6/2020,9/2/2021,9/2/2021,9/27/2021,3/27/2022,3/27/2022,3/30/2022,3/31/2022, , , , 
5647,8098,6/15/1945,Female,168,74,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,0,Unknown,IgG,41,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,9/19/2020,12/9/2021,12/9/2021,12/15/2021,3/31/2022,10/14/1582, , , , , , 
5648,5621,6/15/1935,Male,175,90,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,DAR-X,7/25/2020,2/25/2021,2/25/2021,3/31/2021,10/7/2021,10/7/2021, , , , , , 
5649,4405,6/15/1945,Male,182,75,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,3,III: one or more criteria are fulfilled,IgG,"6,05",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,DAR-X,8/11/2020,3/20/2021,3/20/2021,6/1/2021,3/31/2022, , , , , , , 
5650,8655,6/15/1953,Male,173,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/18/2020,12/5/2020,12/5/2020, , , , , , , , , 
5651,2625,6/15/1960,Female,160,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,3,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,DAR-X,No CTx,V-X,5/24/2013,7/13/2013,7/13/2013,5/17/2016,9/21/2016,9/21/2016,9/20/2020,3/31/2022,10/14/1582, , , 
5652,8605,6/15/1965,Female,168,52,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,1,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,No,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,DAR-X,8/18/2020,11/30/2020,11/30/2020, , , , , , , , , 
5653,4600,6/15/1943,Female,166,64,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,Unknown,Other type,"5,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/15/2020,11/16/2020,11/16/2020, , , , , , , , , 
5654,5553,6/15/1963,Male,173,70,Compulsory health insurance CHI,No, , , , , , , , ,Yes,Yes,2,Unknown,IgG,"8,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/10/2020,11/24/2020,11/24/2020, , , , , , , , , 
5655,5408,6/15/1944,Female,161,81,Compulsory health insurance CHI,No, , , , , , , , , , ,2,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,9,Yes,9,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,1/2/2017,1/2/2020,1/2/2020,8/18/2020,1/19/2022,1/19/2022, , , , , , 
5656,8596,6/15/1956,Female,156,44,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"3,66",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,EMP-X,No CTx,DAR-X,7/27/2020,10/26/2020,10/26/2020,11/11/2020,4/7/2021,4/7/2021,4/21/2021,7/7/2021,7/7/2021, , , 
5657,5000,6/15/1940,Male,182,78,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"4,24",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,9/30/2020,12/9/2020,12/9/2020, , , , , , , , , 
5658,2116,6/15/1948,Female,160,55,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,9/1/2020,11/20/2020,11/20/2020, , , , , , , , , 
5659,8907,6/15/1948,Male,165,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"7,5",unknown/ISS-Criteria not used for prognostics,9,9,9,Yes,No,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,8/31/2020,11/9/2020,11/9/2020, , , , , , , , , 
5660,2153,6/15/1952,Male,190,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"18,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/17/2020,3/31/2022,10/14/1582, , , , , , , , , 
5661,1719,6/15/1948,Male,172,110,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"2,6",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,9/8/2020,10/6/2020,10/6/2020, , , , , , , , , 
5662,7698,6/15/1943,Female,162,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,30,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,R-X,DAR-X,ISA-X,V-X,4/19/2012,4/2/2014,4/2/2014,8/10/2015,12/1/2019,12/1/2019,8/3/2020,2/17/2021,2/17/2021,3/9/2021,6/22/2021,6/22/2021
5663,8114,6/15/1940,Female,165,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,6",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,8/10/2020,11/30/2020,11/30/2020, , , , , , , , , 
5664,4189,6/15/1960,Male,179,100,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/11/2016,6/30/2016,6/30/2016,7/28/2020,11/25/2020,11/25/2020, , , , , , 
5665,5455,6/15/1955,Male,175,73,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,24","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,12/15/2017,4/18/2018,4/18/2018,7/8/2020,9/3/2020,9/3/2020,10/21/2021,3/31/2022,10/14/1582, , , 
5666,5433,6/15/1958,Male,174,85,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"3,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,10/26/2018,2/28/2019,2/28/2019,7/1/2020,9/7/2020,9/7/2020,9/22/2020,12/2/2020,12/2/2020, , , 
5667,4894,6/15/1975,Male,175,83,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , ,Yes,0,III: one or more criteria are fulfilled,IgG,"11,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,POM-X,KYP-X,No CTx,V-X,7/4/2018,11/13/2018,11/13/2018,4/18/2019,6/17/2019,6/17/2019,7/26/2019,12/23/2019,12/23/2019, , , 
5668,4541,6/15/1964,Female,172,54,Compulsory health insurance CHI,No,Yes, , , , , , , , ,Yes,9,III: one or more criteria are fulfilled,IgG,"3,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , , ,NIN-X,DAR-X,No CTx,V-X,6/1/2017,10/2/2017,10/2/2017,3/26/2020,7/20/2020,7/20/2020,7/27/2020,9/30/2021,10/14/1582, , , 
5669,9465,6/15/1951,Male,177,120,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"3,8",unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,No,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,9/1/2020,9/30/2020, , , , , , , , , , 
5670,4073,6/15/1933,Male,176,94,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,Unknown,IgA,"1,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,No, , , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Ja,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/28/2020,10/5/2020,10/5/2020, , , , , , , , , 
5671,9521,6/15/1948,Male,170,86,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/5/2020,9/15/2020,9/15/2020, , , , , , , , , 
5672,6930,6/15/1955,Female,164,93,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"64,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/28/2020,12/23/2020,12/23/2020,9/27/2021,10/27/2021,10/27/2021, , , , , , 
5673,3986,6/15/1954,Female,172,100,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"50,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/30/2020,11/30/2020,11/30/2020, , , , , , , , , 
5674,6471,6/15/1942,Male,175,64,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"50,59",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/2/2020,12/23/2020,12/23/2020,1/18/2021,3/15/2021,3/15/2021, , , , , , 
5675,7253,6/15/1958,Male,190,82,Private,No,Yes, , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,42,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/14/2020,12/6/2020,12/6/2020, , , , , , , , , 
5676,1798,6/15/1969,Female,176,72,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,45,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/13/2020,11/5/2020,11/5/2020, , , , , , , , , 
5677,1896,6/15/1958,Male,178,81,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,unbekannt,Ja,Unbekannt,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/1/2020,9/30/2020,10/14/1582, , , , , , , , , 
5678,2980,6/15/1966,Male,185,91,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/11/2019,8/27/2019,8/27/2019, , , , , , , , , 
5679,6320,6/15/1946,Male,180,93,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,"20,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,3/23/2015,5/26/2015,5/26/2015,8/10/2020,10/30/2020,10/30/2020, , , , , , 
5680,5871,6/15/1942,Female,150,58,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"21,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/23/2020,12/31/2020, , , , , , , , , , 
5681,2916,6/15/1949,Male,187,89,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/3/2020,3/31/2022, , , , , , , , , , 
5682,8083,6/15/1935,Male,170,63,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,"4,15",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/17/2020,2/16/2021,2/16/2021, , , , , , , , , 
5683,7855,6/15/1936,Female,160,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,84",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/20/2020,9/19/2020,9/19/2020,11/1/2020,12/31/2020,10/14/1582, , , , , , 
5684,3002,6/15/1949,Male,183,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"29,34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/11/2020,7/26/2021,7/26/2021, , , , , , , , , 
5685,1946,6/15/1940,Female,179,59,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,35",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/5/2020,12/31/2020, , , , , , , , , , 
5686,3763,6/15/1949,Male,183,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"25,77","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/7/2020,7/20/2021,7/20/2021, , , , , , , , , 
5687,4816,6/15/1969,Female,170,54,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/22/2020,12/14/2020,12/14/2020, , , , , , , , , 
5688,3834,6/15/1945,Female,159,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"10,88","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/10/2020,11/13/2020,11/13/2020,12/9/2020,12/31/2020, , , , , , , 
5689,8503,6/15/1937,Male,178,78,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,9,II: fullfilling neither criteria for I nor criteria for III,Other type,"3,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,9,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/28/2020,12/1/2020,12/1/2020, , , , , , , , , 
5690,8745,6/15/1960,Male,178,73,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , ,Yes,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/1/2020,9/11/2020,9/11/2020,3/11/2022,3/31/2022, , , , , , , 
5691,1154,6/15/1945,Male,169,89,Private,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"25,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/28/2020,7/7/2021,7/7/2021,10/12/2021,3/31/2022, , , , , , , 
5692,1558,6/15/1942,Male,169,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"17,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/6/2020,8/19/2021,8/19/2021, , , , , , , , , 
5693,4242,6/15/1937,Male,181,66,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"29,47","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/10/2020,10/10/2020,10/10/2020, , , , , , , , , 
5694,4304,6/15/1957,Female,166,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/11/2020,11/6/2020,11/6/2020, , , , , , , , , 
5695,8943,6/15/1945,Male,184,96,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"24,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,7/11/2020,11/30/2020,11/30/2020,12/9/2020,12/31/2020, , , , , , , 
5696,3943,6/15/1943,Female,167,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"32,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,8/2/2020,11/2/2020,11/2/2020,11/20/2020,12/31/2020, , , , , , , 
5697,8729,6/15/1937,Female,164,96,Compulsory health insurance CHI,No,Yes, ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"24,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/12/2020,8/25/2021,8/25/2021, , , , , , , , , 
5698,4924,6/15/1946,Male,181,90,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,74",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,9/7/2020,8/19/2021,8/19/2021,9/9/2021,3/31/2022, , , , , , , 
5699,7327,6/15/1954,Male,172,73,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"10,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/24/2020,10/24/2020,10/24/2020, , , , , , , , , 
5700,9163,6/15/1941,Female,156,58,Private,No, , ,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,43",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/15/2020,6/23/2021,6/23/2021, , , , , , , , , 
5701,3321,6/15/1942,Male,185,79,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,02",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/21/2020,3/11/2021,3/11/2021, , , , , , , , , 
5702,5231,6/15/1940,Male,189,86,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,6",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/16/2020,11/16/2020,11/16/2020, , , , , , , , , 
5703,3554,6/15/1940,Female,176,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,93",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/30/2020,8/5/2021,8/5/2021, , , , , , , , , 
5704,7732,6/15/1940,Female,169,79,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,51",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/22/2020,10/5/2021,10/5/2021, , , , , , , , , 
5705,8915,6/15/1947,Male,177,81,Private,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,5,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/3/2020,11/16/2020,11/16/2020, , , , , , , , , 
5706,8142,6/15/1950,Female,167,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"19,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,9/7/2020,11/7/2020,11/7/2020,9/6/2021,3/31/2022, , , , , , , 
5707,8728,6/15/1948,Male,191,92,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/28/2020,6/25/2021,6/25/2021, , , , , , , , , 
5708,3898,6/15/1946,Female,164,73,Private,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,41",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/22/2020,4/14/2021,4/14/2021,4/26/2021,3/31/2022,10/14/1582, , , , , , 
5709,5288,6/15/1938,Female,149,56,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,26",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/18/2020,11/10/2020,11/10/2020, , , , , , , , , 
5710,1836,6/15/1949,Female,164,53,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,92",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/24/2020,7/6/2021,7/6/2021, , , , , , , , , 
5711,2048,6/15/1945,Male,178,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,94",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,8/5/2020,10/3/2020,10/3/2020,10/23/2020,2/23/2022,2/23/2022,3/9/2022,3/31/2022, , , , 
5712,8015,6/15/1945,Female,163,80,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/18/2020,12/5/2020,12/5/2020,12/14/2020,3/31/2022,10/14/1582, , , , , , 
5713,7793,6/15/1940,Male,173,76,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/15/2020,9/16/2020,9/16/2020,2/14/2022,3/31/2022, , , , , , , 
5714,1131,6/15/1949,Female,171,105,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,91",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/29/2020,1/7/2021,1/7/2021, , , , , , , , , 
5715,9632,6/15/1950,Male,181,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,9/9/2020,11/9/2020,11/9/2020,1/26/2022,3/31/2022,10/14/1582, , , , , , 
5716,8417,6/15/1932,Male,177,65,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"28,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,7/15/2020,6/21/2021,6/21/2021,8/6/2021,3/31/2022,10/14/1582, , , , , , 
5717,2358,6/15/1944,Female,161,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"28,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/19/2020,2/3/2021,2/3/2021, , , , , , , , , 
5718,9675,6/15/1941,Male,180,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,96",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/19/2020,7/12/2021,7/12/2021, , , , , , , , , 
5719,3627,6/15/1948,Female,163,69,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/7/2020,11/20/2020,11/20/2020, , , , , , , , , 
5720,4274,6/15/1946,Female,172,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,79",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/17/2020,11/17/2020,11/17/2020, , , , , , , , , 
5721,5165,6/15/1946,Male,180,56,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"15,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/2/2020,12/11/2020,12/11/2020,12/22/2020,3/31/2022,10/14/1582, , , , , , 
5722,2414,6/15/1949,Male,176,54,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,99",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/30/2020,12/1/2020,12/1/2020,12/26/2020,3/31/2022,10/14/1582, , , , , , 
5723,3304,6/15/1950,Male,175,76,Compulsory health insurance CHI,No,Yes, ,Yes, , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,17",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,7/24/2020,9/25/2020,9/25/2020,10/14/2020,12/2/2021,12/2/2021,1/19/2022,3/31/2022, , , , 
5724,2894,6/15/1950,Female,193,115,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"26,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/11/2020,11/3/2020,11/3/2020, , , , , , , , , 
5725,6927,6/15/1942,Female,154,50,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"15,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,9/21/2020,10/21/2020,10/21/2020,11/4/2020,9/7/2021,9/7/2021, , , , , , 
5726,5207,6/15/1938,Female,163,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,16",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/16/2020,6/30/2021, , , , , , , , , , 
5727,4865,6/15/1965,Male,177,63,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/11/2020,5/3/2021,5/3/2021, , , , , , , , , 
5728,3821,6/15/1948,Male,177,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"13,03","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/10/2020,1/21/2021,1/21/2021, , , , , , , , , 
5729,1266,6/15/1943,Male,186,76,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,61",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/31/2020,10/16/2020,10/16/2020,10/31/2020,3/31/2022,10/14/1582, , , , , , 
5730,8294,6/15/1942,Male,183,93,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"16,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,7/7/2020,9/6/2020,9/6/2020,6/23/2021,1/26/2022,1/26/2022,3/8/2022,3/31/2022, , , , 
5731,4658,6/15/1946,Female,165,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,POM-X,No CTx,No CTx,R-X,7/29/2020,7/22/2021,7/22/2021,7/5/2021,3/31/2022, , , , , , , 
5732,5886,6/15/1950,Female,175,81,Private,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,37",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/17/2020,9/15/2020,9/15/2020,11/12/2020,3/31/2022,10/14/1582, , , , , , 
5733,5507,6/15/1950,Female,159,51,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,65",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/17/2020,3/31/2022, , , , , , , , , , 
5734,6781,6/15/1941,Male,198,117,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,15",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/31/2020,10/6/2020,10/6/2020,10/17/2020,3/31/2022,10/14/1582, , , , , , 
5735,8262,6/15/1947,Male,171,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,25",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/31/2020,2/17/2021,2/17/2021, , , , , , , , , 
5736,1191,6/15/1946,Male,180,87,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,16",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/16/2020,10/16/2020,10/16/2020, , , , , , , , , 
5737,9678,6/15/1944,Male,179,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,8/2/2020,9/21/2020,9/21/2020,10/10/2020,8/25/2021,8/25/2021,9/13/2021,3/31/2022, , , , 
5738,1240,6/15/1942,Female,156,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/2/2020,12/16/2020,12/16/2020,2/8/2022,3/31/2022, , , , , , , 
5739,5261,6/15/1942,Male,194,98,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"32,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,8/13/2020,10/13/2020,10/13/2020,1/20/2022,3/31/2022,10/14/1582, , , , , , 
5740,3519,6/15/1945,Male,173,78,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/17/2020,8/30/2021,8/30/2021, , , , , , , , , 
5741,2238,6/15/1941,Female,165,56,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,89",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/13/2020,2/25/2021,2/25/2021, , , , , , , , , 
5742,3298,6/15/1940,Female,177,64,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,78",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/20/2020,11/20/2020,11/20/2020, , , , , , , , , 
5743,4493,6/15/1940,Male,176,82,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"19,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/4/2020,11/16/2020,11/16/2020,11/30/2020,3/31/2022,10/14/1582, , , , , , 
5744,4251,6/15/1938,Female,170,57,Private,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,94",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/4/2020,10/27/2020,10/27/2020, , , , , , , , , 
5745,5373,6/15/1946,Male,182,58,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/18/2020,3/26/2021,3/26/2021, , , , , , , , , 
5746,4011,6/15/1947,Male,187,87,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/7/2020,7/20/2021,7/20/2021,2/24/2022,3/31/2022, , , , , , , 
5747,1082,6/15/1961,Male,186,90,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"22,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/26/2020,1/9/2021,1/9/2021, , , , , , , , , 
5748,2348,6/15/1944,Female,165,66,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/21/2020,8/3/2021,8/3/2021,3/24/2022,3/31/2022, , , , , , , 
5749,3166,6/15/1959,Female,166,68,Private,No,Yes, ,Yes, , ,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"29,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/28/2020,11/13/2020,11/13/2020, , , , , , , , , 
5750,1964,6/15/1942,Male,178,77,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,63",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/24/2020,6/17/2021,6/17/2021, , , , , , , , , 
5751,4057,6/15/1941,Male,184,92,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,03",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/27/2020,4/21/2021,4/21/2021, , , , , , , , , 
5752,7016,6/15/1953,Male,182,104,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,1730,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/22/2020,12/4/2020,12/4/2020, , , , , , , , , 
5753,4245,6/15/1948,Male,202,96,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,43",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/11/2020,7/7/2021,7/7/2021, , , , , , , , , 
5754,4232,6/15/1948,Female,157,92,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,8/22/2020,9/22/2020,9/22/2020,10/13/2020,2/23/2022,2/23/2022,3/3/2022,3/31/2022, , , , 
5755,5932,6/15/1944,Male,187,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"10,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/24/2020,6/23/2021,6/23/2021,9/23/2021,3/31/2022, , , , , , , 
5756,9864,6/15/1942,Male,177,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,83",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/19/2020,11/19/2020,11/19/2020, , , , , , , , , 
5757,1680,6/15/1943,Male,189,98,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/6/2020,6/10/2021,6/10/2021, , , , , , , , , 
5758,3004,6/15/1943,Male,179,86,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"21,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/10/2020,7/6/2021,7/6/2021, , , , , , , , , 
5759,4930,6/15/1941,Male,181,101,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"9,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/28/2020,3/31/2022, , , , , , , , , , 
5760,2884,6/15/1946,Male,184,80,Private,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"31,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,7/10/2020,12/7/2020,12/7/2020,12/26/2020,7/5/2021,7/5/2021, , , , , , 
5761,6403,6/15/1942,Female,161,68,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,13",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/20/2020,9/19/2020,9/19/2020, , , , , , , , , 
5762,1988,6/15/1950,Male,178,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,01",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/8/2020,7/6/2021,7/6/2021, , , , , , , , , 
5763,2166,6/15/1945,Male,171,60,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"15,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/10/2020,3/31/2022,10/14/1582, , , , , , , , , 
5764,6294,6/15/1970,Male,180,79,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"6,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/21/2020,11/8/2020,11/8/2020, , , , , , , , , 
5765,3362,6/15/1949,Female,188,61,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,78",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/1/2020,6/17/2021,6/17/2021,10/18/2021,3/31/2022, , , , , , , 
5766,4497,6/15/1941,Female,160,47,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,74",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,7/29/2020,5/20/2021,5/20/2021,6/3/2021,8/28/2021,8/28/2021,9/8/2021,3/31/2022, , , , 
5767,1817,6/15/1940,Female,167,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"3,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/4/2020,12/17/2020,12/17/2020, , , , , , , , , 
5768,4458,6/15/1942,Male,171,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,9/16/2020,11/16/2020,11/16/2020,12/14/2020,12/21/2021,12/21/2021,1/18/2022,3/31/2022, , , , 
5769,3181,6/15/1959,Female,160,48,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"65,08",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/27/2020,9/26/2020,9/26/2020, , , , , , , , , 
5770,9866,6/15/1950,Female,179,75,Private,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"14,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/16/2020,7/6/2021,7/6/2021, , , , , , , , , 
5771,3773,6/15/1946,Male,180,84,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,91",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,7/3/2020,2/25/2021,2/25/2021,3/19/2021,1/17/2022,1/17/2022,2/24/2022,3/31/2022, , , , 
5772,3878,6/15/1945,Male,177,54,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,74",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/7/2020,7/20/2021,7/20/2021, , , , , , , , , 
5773,3560,6/15/1943,Male,175,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/15/2017,11/17/2017,11/17/2017,9/28/2020,12/31/2021,10/14/1582, , , , , , 
5774,3096,6/15/1945,Male,179,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"7,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/9/2018,3/11/2018,3/11/2018,9/7/2020,12/31/2021,10/14/1582, , , , , , 
5775,9336,6/15/1946,Female,170,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,7/31/2015,9/24/2015,9/24/2015,9/14/2020,11/28/2021,11/28/2021, , , , , , 
5776,8148,6/15/1950,Male,173,97,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,31",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,R-X,No CTx,R-X,1/25/2020,7/17/2020,7/17/2020,7/29/2020,10/19/2021,10/19/2021,11/17/2021,3/31/2022, , , , 
5777,7419,6/15/1945,Female,167,58,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,42,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/13/2019,7/13/2020,7/13/2020, , , , , , , , , 
5778,1810,6/15/1945,Female,161,63,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"15,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,1/13/2020,4/13/2020,4/13/2020,7/3/2020,1/5/2022,1/5/2022,1/18/2022,3/31/2022, , , , 
5779,5862,6/15/1947,Male,178,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"29,24",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,R-X,POM-X,R-X,1/5/2020,6/22/2020,6/22/2020,7/8/2020,10/13/2020,10/13/2020,11/7/2020,8/31/2021,8/31/2021,9/17/2021,3/31/2022, 
5780,5899,6/15/1937,Male,179,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"49,98",unknown/ISS-Criteria not used for prognostics,9,No,Yes,Yes,No,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Ja, , , , ,Ja,No CTx,No CTx,No CTx,V-X,7/2/2020,7/23/2020,7/23/2020, , , , , , , , , 
5781,8688,6/15/1944,Female,158,70,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"9,9",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,8/28/2020,3/31/2021,10/14/1582, , , , , , , , , 
5782,6995,6/15/1953,Male,188,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"12,16","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,1/4/2020,3/21/2020,3/21/2020,7/23/2020,1/26/2021,1/26/2021,2/10/2021,9/2/2021,9/2/2021, , , 
5783,4959,6/15/1949,Male,183,86,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,67",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/20/2019,1/29/2020,1/29/2020,8/21/2020,3/31/2022,10/14/1582, , , , , , 
5784,2757,6/15/1947,Female,166,73,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,02",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/14/2019,1/19/2020,1/19/2020,7/13/2020,10/27/2020,10/27/2020,11/12/2020,8/23/2021,8/23/2021, , , 
5785,6716,6/15/1945,Female,167,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,68",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,1/31/2020,7/23/2020,7/23/2020,8/12/2020,11/14/2020,11/14/2020,11/23/2020,3/31/2022,10/14/1582, , , 
5786,8084,6/15/1953,Female,155,62,Private,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,65",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,NIN-X,V-X,4/18/2020,6/20/2020,6/20/2020,9/12/2020,10/10/2020,10/10/2020,10/29/2020,9/1/2021,9/1/2021,9/24/2021,3/31/2022, 
5787,2458,6/15/1953,Female,158,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,24",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,2/8/2020,4/23/2020,4/23/2020,7/3/2020,11/29/2020,11/29/2020,12/6/2020,6/30/2021,10/14/1582, , , 
5788,4423,6/15/1950,Female,195,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,37",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/5/2020,5/18/2020,5/18/2020,9/15/2020,7/28/2021,7/28/2021, , , , , , 
5789,8360,6/15/1953,Female,158,58,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,06",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,10/21/2019,1/2/2020,1/2/2020,3/19/2020,9/11/2020,9/11/2020, , , , , , 
5790,1336,6/15/1972,Male,180,66,Private,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"18,83","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,12/23/2019,2/28/2020,2/28/2020,8/23/2020,3/21/2022,3/21/2022,3/29/2022,3/31/2022, , , , 
5791,9983,6/15/1950,Male,175,79,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,09",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,1/31/2020,7/18/2020,7/18/2020,8/7/2020,11/3/2021,11/3/2021, , , , , , 
5792,6062,6/15/1951,Male,191,93,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/19/2019,2/29/2020,2/29/2020,7/20/2020,2/9/2021,2/9/2021, , , , , , 
5793,3574,6/15/1955,Female,160,49,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,19",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,POM-X,DAR-X,No CTx,R-X,2/20/2020,8/13/2020,8/13/2020,9/5/2020,8/11/2021,8/11/2021,8/18/2021,9/8/2021,9/8/2021, , , 
5794,1984,6/15/1947,Female,163,51,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,0,I: fulfilling all 4 criteria,IgG,"3,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,2/18/2020,8/12/2020,8/12/2020,9/7/2020,3/2/2021,3/2/2021, , , , , , 
5795,6327,6/15/1948,Female,163,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,5/20/2019,9/11/2019,9/11/2019,1/24/2020,1/28/2022,1/28/2022,2/8/2022,3/31/2022, , , , 
5796,5217,6/15/1952,Male,166,69,Private,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"24,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/28/2019,1/11/2020,1/11/2020,7/3/2020,6/29/2021,6/29/2021, , , , , , 
5797,7141,6/15/1951,Female,171,98,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,62",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/29/2019,12/30/2019,12/30/2019,7/13/2020,4/2/2021,4/2/2021, , , , , , 
5798,8206,6/15/1952,Female,167,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,43",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/5/2019,1/2/2020,1/2/2020,7/4/2020,3/31/2022,10/14/1582, , , , , , 
5799,9938,6/15/1946,Male,168,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,84",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,EMP-X,No CTx,V-X,12/2/2019,3/2/2020,3/2/2020,8/2/2020,6/9/2021,6/9/2021,8/11/2021,3/31/2022,10/14/1582, , , 
5800,2806,6/15/1951,Female,171,98,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,76",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,V-X,V-X,11/14/2019,1/15/2020,1/15/2020,7/7/2020,9/25/2020,9/25/2020,10/9/2020,8/6/2021,8/6/2021,8/23/2021,3/31/2022, 
5801,7038,6/15/1955,Male,182,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"23,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,R-X,3/1/2020,8/16/2020,8/16/2020,9/8/2020,12/2/2021,12/2/2021,1/13/2022,3/31/2022, , , , 
5802,3111,6/15/1962,Male,180,109,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/3/2020,4/20/2020,4/20/2020,9/1/2020,7/21/2021,7/21/2021, , , , , , 
5803,1280,6/15/1948,Male,182,58,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"26,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,1/12/2020,7/9/2020,7/9/2020,11/10/2021,3/31/2022, , , , , , , 
5804,9661,6/15/1953,Male,183,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,48",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,2/15/2020,8/6/2020,8/6/2020,8/24/2020,2/10/2021,2/10/2021,11/3/2021,3/31/2022, , , , 
5805,4883,6/15/1946,Male,181,88,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"28,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,12/19/2019,3/25/2020,3/25/2020,9/8/2020,1/27/2022,1/27/2022,2/17/2022,3/31/2022, , , , 
5806,7454,6/15/1945,Male,166,49,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,1/19/2020,7/12/2020,7/12/2020,7/22/2020,12/30/2020,12/30/2020, , , , , , 
5807,7288,6/15/1947,Female,152,54,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,No CTx,R-X,1/16/2020,7/12/2020,7/12/2020,7/31/2020,1/24/2021,1/24/2021,2/14/2021,3/31/2022, , , , 
5808,3256,6/15/1953,Female,179,111,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,69",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,POM-X,No CTx,No CTx,R-X,10/7/2019,4/2/2020,4/2/2020,4/24/2020,9/11/2020,9/11/2020, , , , , , 
5809,1827,6/15/1945,Male,176,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,75",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/4/2019,6/27/2019,6/27/2019,1/30/2020,9/22/2020,9/22/2020, , , , , , 
5810,1743,6/15/1955,Female,166,54,Private,No, , , , , ,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"2,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,NIN-X,No CTx,R-X,1/12/2020,7/3/2020,7/3/2020,7/28/2020,8/19/2021,8/19/2021,9/7/2021,3/31/2022, , , , 
5811,1899,6/15/1951,Female,156,43,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,35",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/20/2019,7/23/2019,7/23/2019,1/26/2020,9/15/2020,9/15/2020, , , , , , 
5812,3439,6/15/1966,Male,193,101,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,35",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/19/2019,4/18/2020,4/18/2020,7/21/2020,3/31/2022,10/14/1582, , , , , , 
5813,4034,6/15/1966,Male,193,101,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/20/2020,5/24/2020,5/24/2020,8/28/2020,3/31/2022,10/14/1582, , , , , , 
5814,3792,6/15/1948,Male,178,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,11/4/2019,1/9/2020,1/9/2020,7/7/2020,2/19/2021,2/19/2021, , , , , , 
5815,8388,6/15/1956,Female,173,89,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,07",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,V-X,No CTx,V-X,2/28/2020,5/21/2020,5/21/2020,9/18/2020,12/9/2021,12/9/2021,1/18/2022,3/31/2022, , , , 
5816,8336,6/15/1956,Female,173,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,29",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/25/2020,4/4/2020,4/4/2020,7/13/2020,9/4/2021,9/4/2021, , , , , , 
5817,8680,6/15/1938,Male,174,73,Compulsory health insurance CHI,Yes, ,Yes, ,Yes, ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,5400,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/24/2020,9/30/2020, , , , , , , , , , 
5818,9084,6/15/1945,Male,178,82,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"9,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/29/2020,3/17/2021,3/17/2021, , , , , , , , , 
5819,6283,6/15/1941,Female,168,72,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"11,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/28/2020,12/16/2020,12/16/2020, , , , , , , , , 
5820,6071,6/15/1945,Male,174,83,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,17,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,4/1/2019,9/13/2019,9/13/2019,1/4/2020,6/20/2020,6/20/2020,7/7/2020,3/31/2022,10/14/1582, , , 
5821,9489,6/15/1945,Female,174,98,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,51",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,6/20/2019,12/5/2019,12/5/2019,2/27/2020,8/26/2020,8/26/2020,9/11/2020,3/31/2022,10/14/1582, , , 
5822,1643,6/15/1950,Male,174,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,EMP-X,V-X,No CTx,V-X,12/26/2019,3/3/2020,3/3/2020,7/11/2020,1/8/2021,1/8/2021,8/5/2021,12/19/2021,12/19/2021, , , 
5823,8813,6/15/1952,Female,168,76,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, ,Yes, , ,2,I: fulfilling all 4 criteria,IgG,"3,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,10/17/2019,1/11/2020,1/11/2020,7/28/2020,10/6/2021,10/6/2021,1/6/2022,3/31/2022, , , , 
5824,2603,6/15/1947,Female,163,51,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,11",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,9/23/2019,3/10/2020,3/10/2020,3/31/2020,1/4/2021,1/4/2021, , , , , , 
5825,8347,6/15/1955,Male,163,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,74",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,NIN-X,EMP-X,R-X,8/28/2019,2/24/2020,2/24/2020,3/15/2020,9/5/2020,9/5/2020,10/16/2020,2/2/2022,2/2/2022,3/9/2022,3/31/2022, 
5826,1271,6/15/1948,Female,157,81,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,V-X,V-X,2/11/2019,7/29/2019,7/29/2019,1/8/2020,6/30/2020,6/30/2020,7/12/2020,6/15/2021,6/15/2021,7/10/2021,3/31/2022, 
5827,1290,6/15/1954,Male,175,76,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,32",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,5/16/2019,11/12/2019,11/12/2019,1/24/2020,7/12/2020,7/12/2020,7/25/2020,6/30/2021,10/14/1582, , , 
5828,9714,6/15/1948,Female,160,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,2/12/2019,8/5/2019,8/5/2019,2/8/2020,7/27/2020,7/27/2020,8/20/2020,3/31/2022,10/14/1582, , , 
5829,9849,6/15/1948,Female,160,61,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,25","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,6/13/2019,12/5/2019,12/5/2019,2/26/2020,8/14/2020,8/14/2020,9/2/2020,3/31/2022,10/14/1582, , , 
5830,4293,6/15/1952,Male,187,94,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"24,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,5/2/2019,10/29/2019,10/29/2019,2/1/2020,7/28/2020,7/28/2020,8/8/2020,3/31/2022,10/14/1582, , , 
5831,2395,6/15/1945,Female,162,51,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"20,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,2/20/2019,8/8/2019,8/8/2019,1/12/2020,7/3/2020,7/3/2020,7/18/2020,6/21/2021,6/21/2021,7/15/2021,3/31/2022,10/14/1582
5832,4125,6/15/1945,Female,162,51,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"20,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,3/28/2019,9/29/2019,9/29/2019,2/2/2020,7/25/2020,7/25/2020,8/9/2020,12/17/2020,12/17/2020, , , 
5833,8784,6/15/1954,Male,189,63,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"20,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,6/13/2019,12/5/2019,12/5/2019,2/19/2020,8/12/2020,8/12/2020,8/26/2020,9/30/2021, , , , 
5834,5681,6/15/1937,Male,191,86,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,No CTx,R-X,1/19/2020,7/17/2020,7/17/2020,8/6/2020,1/17/2022,1/17/2022,2/25/2022,3/31/2022, , , , 
5835,7131,6/15/1955,Male,187,121,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"7,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/23/2020,4/4/2020,4/4/2020,7/28/2020,3/3/2022,3/3/2022,3/10/2022,3/31/2022, , , , 
5836,6702,6/15/1945,Female,165,66,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/27/2019,2/4/2020,2/4/2020,8/31/2020,3/31/2022,10/14/1582, , , , , , 
5837,7199,6/15/1955,Female,170,72,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,33",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/26/2019,2/1/2020,2/1/2020,8/16/2020,3/31/2022,10/14/1582, , , , , , 
5838,1354,6/15/1945,Male,176,81,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"19,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,POM-X,LEV-X,V-X,4/30/2018,7/4/2018,7/4/2018,9/21/2020,11/20/2020,11/20/2020,11/29/2020,8/2/2021,8/2/2021,8/12/2021,1/6/2022,1/6/2022
5839,3722,6/15/1945,Male,187,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,21,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,9/13/2017,2/20/2018,2/20/2018,9/4/2020,10/26/2020,10/26/2020,11/14/2020,12/28/2021,12/28/2021, , , 
5840,2701,6/15/1955,Female,162,54,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,12/30/2019,5/3/2020,5/3/2020,8/10/2020,3/31/2022,10/14/1582, , , , , , 
5841,8432,6/15/1945,Female,165,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,01",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/18/2020,5/1/2020,5/1/2020,7/13/2020,3/31/2022,10/14/1582, , , , , , 
5842,6188,6/15/1961,Female,178,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,12/19/2019,2/22/2020,2/22/2020,7/7/2020,12/14/2020,12/14/2020,12/25/2020,7/23/2021,7/23/2021, , , 
5843,8843,6/15/1962,Male,172,93,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,IgG,4780,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/1/2020,9/30/2020, , , , , , , , , , 
5844,6983,6/15/1938,Female,165,75,Private,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,6800,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/21/2020,9/30/2020, , , , , , , , , , 
5845,2245,6/15/1945,Male,180,76,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,3920,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/10/2020,9/30/2020, , , , , , , , , , 
5846,2249,6/15/1953,Female,164,73,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/3/2020,9/30/2020, , , , , , , , , , 
5847,2024,6/15/1956,Male,165,70,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"8,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,6/6/2017,8/22/2017,8/22/2017,8/14/2020,5/28/2021,5/28/2021,2/2/2022,3/31/2022, , , , 
5848,9524,6/15/1941,Male,178,110,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,",5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,27", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/27/2020,5/20/2021,5/20/2021, , , , , , , , , 
5849,9669,6/15/1953,Male,187,97,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,03",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/28/2019,3/2/2020,3/2/2020,8/8/2020,3/31/2022, , , , , , , 
5850,9941,6/15/1949,Male,165,64,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"26,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,POM-X,KYP-X,V-X,11/11/2019,2/4/2020,2/4/2020,8/28/2020,10/20/2020,10/20/2020,11/13/2020,12/3/2021,12/3/2021,1/20/2022,3/31/2022,10/14/1582
5851,6293,6/15/1949,Male,176,55,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,55",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,DAR-X,V-X,1/15/2020,5/8/2020,5/8/2020,8/26/2020,12/8/2020,12/8/2020,12/20/2020,7/29/2021,7/29/2021,8/10/2021,3/31/2022,10/14/1582
5852,4837,6/15/1949,Male,169,69,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,EMP-X,V-X,3/5/2020,5/9/2020,5/9/2020,9/10/2020,10/30/2020,10/30/2020,11/8/2020,2/3/2022,2/3/2022,2/24/2022,3/31/2022, 
5853,5921,6/15/1933,Male,183,106,Private,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,52",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,No CTx,R-X,1/13/2020,7/12/2020,7/12/2020,8/2/2020,11/22/2020,11/22/2020,12/15/2020,3/31/2022, , , , 
5854,9487,6/15/1933,Male,183,106,Private,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,02",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,R-X,12/26/2019,6/20/2020,6/20/2020,7/3/2020,10/7/2020,10/7/2020,10/22/2020,3/31/2022, , , , 
5855,1593,6/15/1946,Female,155,56,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"3,12",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/28/2019,3/5/2020,3/5/2020,7/3/2020,6/22/2021,6/22/2021, , , , , , 
5856,4514,6/15/1949,Male,169,69,Private,No, ,Yes,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,12/11/2019,2/24/2020,2/24/2020,8/28/2020,11/9/2020,11/9/2020,11/30/2020,7/6/2021,7/6/2021,8/2/2021,1/18/2022,1/18/2022
5857,3136,6/15/1949,Male,181,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,22",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,1/12/2020,7/2/2020,7/2/2020,7/28/2020,1/20/2022,1/20/2022,2/14/2022,3/31/2022, , , , 
5858,2547,6/15/1943,Male,172,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/5/2020,6/23/2021,6/23/2021,2/22/2022,3/31/2022, , , , , , , 
5859,5694,6/15/1938,Female,162,70,Compulsory health insurance CHI,Yes, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,7/22/2020,12/2/2020,12/2/2020,1/29/2021,9/14/2021,9/14/2021,10/13/2021,3/31/2022, , , , 
5860,1605,6/15/1951,Female,163,70,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/27/2020,3/31/2022,10/14/1582, , , , , , , , , 
5861,7490,6/15/1954,Female,165,100,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"5,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,6/3/2019,11/19/2019,11/19/2019,2/1/2020,8/1/2020,8/1/2020,8/17/2020,2/16/2021,2/16/2021,3/10/2021,6/29/2021,6/29/2021
5862,4734,6/15/1953,Female,159,57,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,15",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,1/22/2019,7/23/2019,7/23/2019,1/26/2020,7/22/2020,7/22/2020,8/6/2020,10/2/2020,10/2/2020,10/9/2020,12/20/2021,12/20/2021
5863,4818,6/15/1946,Female,152,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,9",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,4/3/2019,9/30/2019,9/30/2019,2/16/2020,8/2/2020,8/2/2020,8/17/2020,4/5/2021,4/5/2021, , , 
5864,6527,6/15/1953,Female,159,57,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,KYP-X,V-X,7/10/2019,1/2/2020,1/2/2020,3/22/2020,9/7/2020,9/7/2020,9/20/2020,10/7/2020,10/7/2020,10/20/2020,1/6/2021,1/6/2021
5865,1698,6/15/1941,Female,165,77,Compulsory health insurance CHI,Yes,Yes, , ,Yes, , , , , , ,0,Unknown,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,9/15/2020,12/31/2020, , , , , , , , , , 
5866,8372,6/15/1953,Female,159,57,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,76",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,KYP-X,V-X,4/18/2019,10/4/2019,10/4/2019,2/5/2020,7/31/2020,7/31/2020,8/17/2020,11/6/2020,11/6/2020,11/24/2020,5/14/2021,5/14/2021
5867,5107,6/15/1946,Female,152,56,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,12/28/2018,6/27/2019,6/27/2019,1/23/2020,7/21/2020,7/21/2020,8/5/2020,12/9/2021,12/9/2021, , , 
5868,1624,6/15/1952,Female,168,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"22,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,1/14/2019,7/15/2019,7/15/2019,1/1/2020,6/27/2020,6/27/2020,7/8/2020,7/28/2021,7/28/2021, , , 
5869,9454,6/15/1945,Male,179,54,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"23,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,2/21/2019,8/9/2019,8/9/2019,2/26/2020,8/18/2020,8/18/2020,9/13/2020,9/19/2020,9/19/2020,10/5/2020,12/31/2020,10/14/1582
5870,8485,6/15/1953,Male,176,84,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"16,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,7/4/2019,12/19/2019,12/19/2019,3/12/2020,9/3/2020,9/3/2020,9/17/2020,3/31/2022,10/14/1582, , , 
5871,2321,6/15/1952,Male,175,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"12,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,3/19/2019,9/11/2019,9/11/2019,1/11/2020,7/7/2020,7/7/2020,7/20/2020,12/31/2020,10/14/1582, , , 
5872,4559,6/15/1952,Female,165,54,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"34,05","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/17/2019,11/6/2019,11/6/2019,3/7/2020,8/29/2020,8/29/2020,9/14/2020,7/6/2021,7/6/2021, , , 
5873,6644,6/15/1948,Female,175,74,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"21,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,2/22/2019,8/22/2019,8/22/2019,1/15/2020,7/2/2020,7/2/2020,7/19/2020,10/28/2021,10/28/2021,12/2/2021,3/31/2022, 
5874,3564,6/15/1948,Male,188,95,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,4/25/2019,10/24/2019,10/24/2019,2/8/2020,7/26/2020,7/26/2020,8/10/2020,2/2/2021,2/2/2021,5/18/2021,11/2/2021,11/2/2021
5875,1192,6/15/1952,Female,165,54,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"21,34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,5/6/2019,10/25/2019,10/25/2019,2/6/2020,8/2/2020,8/2/2020,8/14/2020,3/7/2021,3/7/2021,3/14/2021,3/4/2022,3/4/2022
5876,9722,6/15/1955,Male,181,118,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,88",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,2/18/2019,8/14/2019,8/14/2019,1/6/2020,6/29/2020,6/29/2020,7/9/2020,2/4/2022,2/4/2022,2/14/2022,3/31/2022, 
5877,6853,6/15/1952,Female,162,51,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,4/19/2019,10/14/2019,10/14/2019,2/16/2020,8/12/2020,8/12/2020,8/27/2020,4/15/2021,4/15/2021, , , 
5878,2666,6/15/1952,Female,162,51,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"12,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,3/19/2019,9/4/2019,9/4/2019,3/8/2020,9/2/2020,9/2/2020,9/12/2020,1/5/2021,1/5/2021, , , 
5879,1651,6/15/1955,Female,175,108,Compulsory health insurance CHI,No, ,Yes,Yes, , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"7,16","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,LEV-X,V-X,12/27/2018,6/18/2019,6/18/2019,1/15/2020,7/9/2020,7/9/2020,7/26/2020,10/1/2020,10/1/2020,10/8/2020,3/18/2021,3/18/2021
5880,7710,6/15/1952,Male,169,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"15,75","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,EMP-X,V-X,3/20/2019,9/10/2019,9/10/2019,1/16/2020,7/9/2020,7/9/2020,7/23/2020,10/20/2020,10/20/2020,10/27/2020,12/6/2021,12/6/2021
5881,6656,6/15/1945,Male,175,61,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"24,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,1/29/2019,7/25/2019,7/25/2019,2/9/2020,7/29/2020,7/29/2020,8/12/2020,11/27/2020,11/27/2020,12/18/2020,4/8/2021,4/8/2021
5882,2855,6/15/1954,Female,165,69,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"6,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,6/4/2019,11/29/2019,11/29/2019,3/6/2020,8/21/2020,8/21/2020,9/13/2020,3/5/2021,3/5/2021,3/12/2021,5/14/2021,5/14/2021
5883,9922,6/15/1953,Female,167,60,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,5/14/2019,10/29/2019,10/29/2019,2/23/2020,8/22/2020,8/22/2020,9/15/2020,3/31/2022,10/14/1582, , , 
5884,9656,6/15/1955,Male,176,53,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"11,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,5/6/2019,10/28/2019,10/28/2019,2/6/2020,8/1/2020,8/1/2020,8/22/2020,5/3/2021,5/3/2021,7/19/2021,3/31/2022,10/14/1582
5885,5695,6/15/1943,Female,169,79,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,NIN-X,No CTx,R-X,2/10/2020,8/8/2020,8/8/2020,8/26/2020,4/21/2021,4/21/2021,5/11/2021,3/31/2022, , , , 
5886,4763,6/15/1948,Female,165,48,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"9,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,7/4/2019,12/25/2019,12/25/2019,3/8/2020,8/24/2020,8/24/2020,9/10/2020,8/11/2021,8/11/2021,9/10/2021,3/31/2022, 
5887,5772,6/15/1947,Female,165,68,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"19,32","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,1/3/2020,3/9/2020,3/9/2020,7/28/2020,2/16/2021,2/16/2021, , , , , , 
5888,4357,6/15/1966,Female,169,79,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,08","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,3/1/2020,8/18/2020,8/18/2020,9/6/2020,6/30/2021,10/14/1582, , , , , , 
5889,7534,6/15/1931,Male,178,73,Private,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"10,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,12/16/2019,6/12/2020,6/12/2020,7/3/2020,3/31/2022,10/14/1582, , , , , , 
5890,6469,6/15/1948,Female,163,79,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,12/9/2019,2/14/2020,2/14/2020,8/9/2020,3/31/2022,10/14/1582, , , , , , 
5891,6184,6/15/1946,Male,193,138,Private,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,53",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,2/10/2020,5/11/2020,5/11/2020,9/5/2020,9/21/2020,9/21/2020,10/17/2020,12/31/2020, , , , 
5892,2496,6/15/1955,Male,173,84,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,02",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/2/2020,5/4/2020,5/4/2020,7/31/2020,12/31/2020,10/14/1582, , , , , , 
5893,8724,6/15/1954,Male,170,53,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,33",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,9/23/2019,12/18/2019,12/18/2019,7/10/2020,12/31/2020, , , , , , , 
5894,6828,6/15/1936,Male,180,90,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/17/2020,12/7/2020,12/7/2020, , , , , , , , , 
5895,9862,6/15/1948,Female,170,67,Private,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,8,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,9/21/2020,9/30/2020, , , , , , , , , , 
5896,4225,6/15/1945,Male,176,74,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/21/2020,12/20/2020,12/20/2020, , , , , , , , , 
5897,6146,6/15/1950,Female,170,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/31/2020,9/30/2020, , , , , , , , , , 
5898,8331,6/15/1960,Male,180,90,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/28/2020,12/23/2020,12/23/2020, , , , , , , , , 
5899,6639,6/15/1942,Male,178,87,Private,Unknown,Unknown,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/27/2020,6/15/2021,6/15/2021, , , , , , , , , 
5900,3626,6/15/1952,Male,180,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"28,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,V-X,DAR-X,No CTx,R-X,3/1/2020,8/26/2020,8/26/2020,9/11/2020,10/12/2020,10/12/2020,10/19/2020,12/31/2020,10/14/1582, , , 
5901,4928,6/15/1954,Male,170,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"23,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,R-X,No CTx,R-X,1/19/2020,7/17/2020,7/17/2020,8/9/2020,11/24/2020,11/24/2020,12/8/2020,12/31/2020, , , , 
5902,5510,6/15/1954,Male,170,53,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,31",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/6/2019,2/3/2020,2/3/2020,7/18/2020,9/30/2020, , , , , , , 
5903,5279,6/15/1951,Male,189,81,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"19,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,10/2/2019,3/21/2020,3/21/2020,4/9/2020,9/26/2020,9/26/2020, , , , , , 
5904,4437,6/15/1954,Male,170,77,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"21,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,NIN-X,No CTx,R-X,1/29/2020,7/24/2020,7/24/2020,8/16/2020,11/11/2020,11/11/2020,11/23/2020,12/31/2020, , , , 
5905,1764,6/15/1945,Male,184,67,Private,No,Yes, ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,95",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/22/2020,4/24/2020,4/24/2020,9/5/2020,3/31/2022,10/14/1582, , , , , , 
5906,1422,6/15/1948,Male,169,89,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"17,27","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,NIN-X,No CTx,R-X,2/25/2020,8/12/2020,8/12/2020,8/28/2020,5/23/2021,5/23/2021,6/13/2021,3/31/2022, , , , 
5907,3450,6/15/1939,Female,166,48,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,21",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,NIN-X,No CTx,R-X,2/25/2020,8/20/2020,8/20/2020,9/5/2020,11/12/2020,11/12/2020,11/20/2020,3/31/2022, , , , 
5908,4702,6/15/1962,Female,162,57,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"500,8",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/21/2020,12/22/2020,12/22/2020, , , , , , , , , 
5909,6276,6/15/1955,Male,183,110,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/15/2019,2/15/2020,2/15/2020, , , , , , , , , 
5910,2717,6/15/1939,Female,171,69,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"47,1",ISS stage II (neither stage I nor stage III),No,No,No,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,1/30/2018,6/26/2020,6/26/2020,7/6/2020,7/28/2020,7/28/2020, , , , , , 
5911,6613,6/15/1954,Male,173,65,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"74,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,9,Yes,No, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L", ,DAR-X,POM-X,EMP-X,V-X,4/28/2016,7/11/2016,7/11/2016,1/29/2019,4/25/2019,4/25/2019,12/23/2019,8/10/2020,8/10/2020,8/13/2020,12/31/2020,10/14/1582
5912,5929,6/15/1946,Female,165,98,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"11,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/7/2019,1/13/2020,1/13/2020,8/8/2020,3/31/2022,10/14/1582, , , , , , 
5913,7246,6/15/1959,Female,181,81,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,2/28/2020,8/22/2020,8/22/2020,9/16/2020,12/10/2021,12/10/2021, , , , , , 
5914,8698,6/15/1943,Female,159,63,Private,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/27/2020,4/22/2021,4/22/2021, , , , , , , , , 
5915,1482,6/15/1950,Male,183,79,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,8",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/3/2020,3/31/2022,10/14/1582, , , , , , , , , 
5916,7432,6/15/1940,Male,183,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/30/2020,12/31/2021,10/14/1582, , , , , , , , , 
5917,8753,6/15/1943,Male,188,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/23/2020,3/31/2022,10/14/1582, , , , , , , , , 
5918,3295,6/15/1949,Female,166,75,Private,Yes, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,8/13/2020,10/28/2021,10/28/2021,11/1/2021,12/20/2021,12/20/2021, , , , , , 
5919,7209,6/15/1940,Male,180,78,Private,No,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,DAR-X,No CTx,R-X,9/21/2017,7/7/2020,7/7/2020,8/10/2020,7/7/2021,7/7/2021,7/13/2021,12/22/2021,12/22/2021, , , 
5920,4200,6/15/1949,Female,172,63,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"1,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,7/24/2020,11/13/2020,11/13/2020, , , , , , , , , 
5921,4620,6/15/1942,Female,152,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/5/2020,9/30/2020,9/30/2020, , , , , , , , , 
5922,3552,6/15/1939,Male,167,79,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"2,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,7/7/2020,3/31/2022,10/14/1582, , , , , , , , , 
5923,7045,6/15/2020,Male,169,81,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"17,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/13/2020,9/30/2020, , , , , , , , , , 
5924,6884,6/15/1954,Female,173,76,Private,Yes, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgM,24,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/13/2020,9/30/2020, , , , , , , , , , 
5925,3488,6/15/1965,Male,181,86,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes,Yes, ,0,III: one or more criteria are fulfilled,IgG,22,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/27/2020,9/30/2020, , , , , , , , , , 
5926,8742,6/15/1952,Male,165,89,Compulsory health insurance CHI,Yes,Yes, ,Yes, , ,Yes,Yes,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/1/2020,9/30/2020, , , , , , , , , , 
5927,5529,6/15/1961,Female,159,55,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgM,25,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/20/2020,9/30/2020, , , , , , , , , , 
5928,4199,6/15/1965,Male,170,99,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,65000,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/10/2020,9/28/2020,9/28/2020, , , , , , , , , 
5929,9274,6/15/1951,Male,174,86,Compulsory health insurance CHI,No,Yes, , ,Yes, ,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgM,22,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,10/17/2018,1/13/2019,1/13/2019,8/3/2020,9/30/2020, , , , , , , 
5930,9322,6/15/1948,Male,173,82,Compulsory health insurance CHI,Yes, , ,Yes,Yes, ,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,No CTx,No CTx,V-X,7/10/2017,9/30/2017,9/30/2017,8/4/2020,9/30/2020, , , , , , , 
5931,7098,6/15/1955,Female,169,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,19,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,Other,No CTx,No CTx,V-X,6/11/2019,8/31/2019,8/31/2019,7/17/2020,9/30/2020, , , , , , , 
5932,3290,6/15/1943,Female,152,48,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgM,24,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,V-X,6/8/2016,9/4/2016,9/4/2016,8/5/2020,9/30/2020, , , , , , , 
5933,3999,6/15/1938,Female,154,66,Private,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,Other,No CTx,No CTx,V-X,4/3/2018,6/24/2018,6/24/2018,8/12/2020,9/30/2020, , , , , , , 
5934,1809,6/15/1941,Male,172,69,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,24,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,Other,No CTx,No CTx,V-X,8/11/2015,10/31/2015,10/31/2015,8/20/2020,9/30/2020, , , , , , , 
5935,5964,6/15/1959,Female,159,74,Private,Yes, , ,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgM,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,Other,No CTx,No CTx,V-X,5/8/2018,7/29/2018,7/29/2018,8/25/2020,9/30/2020, , , , , , , 
5936,3693,6/15/1938,Male,180,92,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,",2",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Nein,No CTx,No CTx,No CTx,R-X,9/18/2020,3/31/2022,10/14/1582, , , , , , , , , 
5937,6290,6/15/1959,Male,180,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,Other type,",2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/3/2020,12/16/2020,12/16/2020,1/5/2021,3/31/2022,10/14/1582, , , , , , 
5938,1567,6/15/1960,Male,188,105,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/31/2020,9/30/2020, , , , , , , , , , 
5939,6004,6/15/1955,Female,160,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,",55",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,2/19/2019,2/26/2019,2/26/2019,9/9/2020,11/22/2021,11/22/2021,12/13/2021,3/31/2022,10/14/1582, , , 
5940,1009,6/15/1940,Female,160,58,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/10/2020,9/30/2020,10/14/1582, , , , , , , , , 
5941,4149,6/15/1968,Female,170,65,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"90,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/15/2019,1/17/2020,1/17/2020, , , , , , , , , 
5942,2045,6/15/1948,Male,166,168,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,Other type,",5",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,R-X,KYP-X,POM-X,V-X,8/8/2016,11/12/2016,11/12/2016,11/30/2016,5/26/2017,5/26/2017,6/20/2017,11/30/2017,11/30/2017,3/7/2018,7/20/2020,7/20/2020
5943,5540,6/15/1945,Male,177,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,68,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/15/2020,9/30/2020, , , , , , , , , , 
5944,4825,6/15/1948,Female,168,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,73,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/18/2020,9/30/2020, , , , , , , , , , 
5945,5487,6/15/1944,Male,170,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,59,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/15/2020,9/30/2020, , , , , , , , , , 
5946,9858,6/15/1938,Male,182,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,72,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/25/2020,9/30/2020, , , , , , , , , , 
5947,2004,6/15/1950,Female,172,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,64,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/27/2020,9/30/2020, , , , , , , , , , 
5948,3223,6/15/1950,Male,177,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/1/2020,3/31/2022,10/14/1582, , , , , , , , , 
5949,5348,6/15/1938,Female,159,56,Compulsory health insurance CHI,No,Unknown,Unknown,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"9,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,7/6/2020,12/20/2020,12/20/2020,3/29/2021,2/24/2022,2/24/2022,3/21/2022,3/31/2022, , , , 
5950,7095,6/15/1939,Male,176,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,7/6/2020,12/20/2020,12/20/2020,3/29/2021,12/17/2021,12/17/2021,2/7/2022,3/31/2022, , , , 
5951,9947,6/15/1951,Male,178,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/9/2020,12/23/2020,12/23/2020,8/2/2021,3/31/2022,10/14/1582, , , , , , 
5952,3743,6/15/1940,Male,179,75,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"10,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/13/2020,7/25/2021,7/25/2021,3/28/2022,3/31/2022, , , , , , , 
5953,3710,6/15/1945,Female,167,78,Private,Yes,Yes,Yes,Unknown, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,R-X,9/21/2020,6/5/2021,6/5/2021,6/21/2021,3/2/2022,3/2/2022,3/29/2022,3/31/2022, , , , 
5954,8553,6/15/1955,Male,167,59,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,270,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,7/20/2020,9/30/2020,10/14/1582, , , , , , , , , 
5955,1708,6/15/1949,Female,168,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,290,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/12/2020,12/31/2020,10/14/1582, , , , , , , , , 
5956,9380,6/15/1950,Female,163,65,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,350,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,DAR-X,9/14/2020,2/2/2021,2/2/2021,6/14/2021,12/31/2021,10/14/1582, , , , , , 
5957,4576,6/15/1942,Male,170,68,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,260,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/24/2020,4/15/2021,4/15/2021, , , , , , , , , 
5958,4291,6/15/1944,Female,170,65,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,270,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,9/14/2020,6/30/2021,10/14/1582, , , , , , , , , 
5959,4284,6/15/1942,Male,170,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,290,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,9/22/2020,10/12/2021,10/12/2021, , , , , , , , , 
5960,1641,6/15/1947,Male,165,60,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,280,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/7/2020,12/31/2020, , , , , , , , , , 
5961,3768,6/15/1985,Male,183,89,Compulsory health insurance CHI,No,Yes, , ,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,22,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/11/2020,4/16/2021,4/16/2021, , , , , , , , , 
5962,7713,6/15/1943,Female,157,53,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/16/2020,12/30/2020,12/30/2020,9/20/2021,3/31/2022, , , , , , , 
5963,5820,6/15/1940,Female,162,69,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/20/2020,6/30/2021,10/14/1582, , , , , , , , , 
5964,9474,6/15/1949,Female,166,79,Compulsory health insurance CHI,No,Unknown,Unknown,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"12,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/20/2020,1/3/2021,1/3/2021,8/2/2021,3/31/2022,10/14/1582, , , , , , 
5965,6256,6/15/1945,Male,179,74,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/27/2020,3/31/2022,10/14/1582, , , , , , , , , 
5966,2342,6/15/1936,Female,172,65,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/21/2020,3/31/2022,10/14/1582, , , , , , , , , 
5967,1829,6/15/1953,Male,181,77,Compulsory health insurance CHI,No,Unknown,Unknown,Yes, ,Yes,Yes,Yes,Yes, , ,0,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/27/2020,6/30/2021,10/14/1582, , , , , , , , , 
5968,8867,6/15/1948,Female,165,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/3/2020,1/17/2021,1/17/2021,9/20/2021,3/31/2022, , , , , , , 
5969,3286,6/15/1946,Female,158,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,DAR-X,8/7/2020,12/20/2021,12/20/2021,3/28/2022,3/31/2022, , , , , , , 
5970,8494,6/15/1943,Male,177,72,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Unknown, , ,1,III: one or more criteria are fulfilled,IgA,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/10/2020,1/24/2021,1/24/2021,8/9/2021,3/31/2022,10/14/1582, , , , , , 
5971,5598,6/15/1964,Male,178,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"6,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/7/2020,1/6/2021,1/6/2021, , , , , , , , , 
5972,1927,6/15/1957,Female,170,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/20/2020,10/19/2020,10/19/2020, , , , , , , , , 
5973,8556,6/15/1947,Female,170,87,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,4",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,ISA-X,No CTx,V-X,2/20/2018,6/29/2018,6/29/2018,9/18/2020,3/3/2022,3/3/2022,3/14/2022,3/31/2022,10/14/1582, , , 
5974,9353,6/15/1947,Male,176,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,4/17/2018,8/23/2018,8/23/2018,7/22/2020,11/4/2021,11/4/2021,11/16/2021,3/31/2022, , , , 
5975,8087,6/15/1948,Male,175,86,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,ISA-X,No CTx,V-X,10/17/2018,2/26/2019,2/26/2019,9/22/2020,3/10/2022,3/10/2022,3/17/2022,3/31/2022,10/14/1582, , , 
5976,1496,6/15/1941,Male,163,70,Private,No, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/28/2020,10/22/2020,10/22/2020, , , , , , , , , 
5977,2299,6/15/1944,Male,180,90,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,EMP-X,No CTx,R-X,11/5/2018,8/18/2020,8/18/2020,9/1/2020,12/14/2020,12/14/2020,1/11/2021,3/31/2021,10/14/1582, , , 
5978,1607,6/15/1938,Female,170,80,Private,No,Yes,Yes, , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,1/2/2018,7/14/2020,7/14/2020,8/3/2020,12/31/2020, , , , , , , 
5979,2593,6/15/1949,Male,183,89,Private,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,No,"2,11", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L", ,DAR-X,KYP-X,No CTx,R-X,1/22/2018,8/11/2020,8/11/2020,9/7/2020,9/6/2021,9/6/2021,9/27/2021,3/31/2022, , , , 
5980,5946,6/15/1949,Female,168,70,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,9/28/2020,9/30/2021, , , , , , , , , , 
5981,4588,6/15/1953,Male,176,73,Compulsory health insurance CHI,No,Unknown,Unknown,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,8/10/2020,1/24/2021,1/24/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
5982,2951,6/15/1949,Female,161,64,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/17/2020,1/31/2021,1/31/2021,3/21/2022,3/31/2022, , , , , , , 
5983,3509,6/15/1952,Male,180,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/17/2020,6/30/2021,10/14/1582, , , , , , , , , 
5984,7546,6/15/1941,Female,157,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"14,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/17/2020,1/31/2021,1/31/2021,8/30/2021,3/31/2022,10/14/1582, , , , , , 
5985,1866,6/15/1947,Female,167,70,Private,No,Unknown,Unknown,Yes, ,Yes,Yes,Yes, ,Yes, ,1,Unknown,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/24/2020,3/31/2022,10/14/1582, , , , , , , , , 
5986,1303,6/15/1938,Male,173,69,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,15,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,8/28/2020,2/11/2021,2/11/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
5987,3390,6/15/1945,Male,176,73,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,DAR-X,EMP-X,No CTx,V-X,8/24/2020,11/15/2020,11/15/2020,3/29/2021,3/3/2022,3/3/2022,3/28/2022,3/31/2022, , , , 
5988,9779,6/15/1939,Female,160,68,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,KYP-X,No CTx,No CTx,R-X,8/24/2020,2/7/2021,2/7/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
5989,2029,6/15/1942,Male,190,90,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgD,4,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L",Ja,NIN-X,DAR-X,KYP-X,R-X,3/3/2016,4/15/2017,4/15/2017,8/19/2018,3/17/2020,3/17/2020,8/3/2020,8/16/2021,8/16/2021,9/7/2021,3/7/2022,3/7/2022
5990,4563,6/15/1950,Female,167,95,Private,Yes,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,V-X,DAR-X,No CTx,R-X,6/1/2015,12/28/2016,12/28/2016,7/2/2018,1/21/2020,1/21/2020,9/28/2020,12/31/2020,10/14/1582, , , 
5991,9621,6/15/1960,Male,180,90,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/25/2020,12/8/2020,12/8/2020, , , , , , , , , 
5992,3977,6/15/1939,Female,166,59,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"26,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,9/1/2020,11/1/2021,11/1/2021,11/1/2021,12/31/2021, , , , , , , 
5993,8952,6/15/1962,Male,179,82,Private,No,Yes, ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"46,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/1/2020,12/1/2020,12/1/2020, , , , , , , , , 
5994,7054,6/15/1971,Female,158,95,Compulsory health insurance CHI,Unknown,Yes, , , ,Yes, ,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Unknown,Yes, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , , ,Nein,KYP-X,No CTx,No CTx,V-X,7/15/2018,1/15/2019,1/15/2019,4/27/2020,9/30/2020,10/14/1582, , , , , , 
5995,9910,6/15/1943,Female,170,75,Private,Yes,Yes,Yes,Unknown, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown, , , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,DAR-X,No CTx,No CTx,R-X,10/8/2018,8/31/2020,8/31/2020,9/14/2020,6/30/2021,10/14/1582, , , , , , 
5996,3712,6/15/1949,Male,174,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/16/2020,12/31/2020, , , , , , , , , , 
5997,3393,6/15/1951,Male,176,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,12/20/2019,4/14/2020,4/14/2020,11/24/2020,12/31/2020, , , , , , , 
5998,7802,6/15/1971,Female,170,60,Compulsory health insurance CHI,Unknown, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,45,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/18/2020,2/19/2021,2/19/2021, , , , , , , , , 
5999,9715,6/15/1946,Male,172,78,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"19,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,7/17/2020,10/9/2020,10/9/2020,10/13/2020,8/27/2021,8/27/2021,8/30/2021,3/31/2022,10/14/1582, , , 
6000,3038,6/15/1932,Female,160,64,Private,No,Yes, , , , , ,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,"4,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/7/2020,8/30/2021,8/30/2021, , , , , , , , , 
6001,5024,6/15/1951,Male,184,90,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,R-X,No CTx,V-X,2/1/2014,4/1/2014,4/1/2014,11/23/2020,7/20/2021,7/20/2021,8/3/2021,3/31/2022, , , , 
6002,9660,6/15/1945,Female,166,83,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,2864,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/18/2020,3/31/2022,10/14/1582, , , , , , , , , 
6003,4470,6/15/1935,Male,168,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"2,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/21/2020,3/31/2022,10/14/1582, , , , , , , , , 
6004,9280,6/15/1938,Male,175,82,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/24/2020,12/31/2020, , , , , , , , , , 
6005,1175,6/15/1946,Male,171,82,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,5/18/2020,12/11/2020,12/11/2020, , , , , , , , , 
6006,6095,6/15/1949,Female,166,75,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,644,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/3/2020,3/31/2022,10/14/1582, , , , , , , , , 
6007,4263,6/15/1939,Female,161,69,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,KYP-X,DAR-X,LEV-X,R-X,2/20/2018,9/30/2020,9/30/2020,12/3/2020,6/4/2021,6/4/2021,8/25/2021,2/3/2022,2/3/2022,2/23/2022,3/31/2022, 
6008,7061,6/15/1952,Female,163,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,11,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,POM-X,DAR-X,DAR-X,2/15/2020,10/9/2020,10/9/2020,10/13/2020,7/6/2021,7/6/2021,7/29/2021,1/27/2022,1/27/2022,1/28/2022,3/31/2022,10/14/1582
6009,2505,6/15/1958,Male,180,78,Private,No, , ,Yes, ,Yes,Yes, ,Yes,Yes,Yes,1,III: one or more criteria are fulfilled,IgA,"5,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,KYP-X,POM-X,V-X,12/15/2019,6/2/2020,6/2/2020,11/18/2020,9/21/2021,9/21/2021,9/23/2021,12/31/2021,12/31/2021,1/19/2022,3/1/2022,3/1/2022
6010,5942,6/15/1967,Male,188,92,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/30/2020,12/31/2020, , , , , , , , , , 
6011,6235,6/15/1955,Male,190,96,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"48,71","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,24", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/13/2020,12/29/2020,12/29/2020, , , , , , , , , 
6012,7735,6/15/1939,Female,176,100,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"45,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,11/26/2020,12/10/2020,12/10/2020, , , , , , , , , 
6013,6831,6/15/1948,Female,165,73,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"42,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,12/15/2020,5/3/2021,5/3/2021,8/23/2021,3/31/2022,10/14/1582, , , , , , 
6014,8633,6/15/1935,Male,175,68,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"39,96",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/10/2020,3/31/2022,10/14/1582, , , , , , , , , 
6015,4166,6/15/1964,Male,180,74,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"31,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/3/2020,2/15/2021,2/15/2021, , , , , , , , , 
6016,7881,6/15/1953,Male,176,88,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"27,64",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown,"2,04", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,12/4/2020,3/31/2022,10/14/1582, , , , , , , , , 
6017,3788,6/15/1950,Male,181,80,Private,Yes, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"6,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/23/2020,3/31/2022,10/14/1582, , , , , , , , , 
6018,4191,6/15/1954,Male,205,110,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"28,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,51", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/10/2020,5/14/2020,5/14/2020, , , , , , , , , 
6019,5337,6/15/1950,Female,165,60,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/10/2019,12/10/2019,12/10/2019,12/7/2020,3/31/2022,10/14/1582, , , , , , 
6020,4271,6/15/1945,Male,185,75,Private,Yes, , , , , , , , , , ,3,III: one or more criteria are fulfilled,IgG,"8,1",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,NIN-X,No CTx,No CTx,R-X,11/25/2020,12/20/2021,12/20/2021,12/21/2021,3/31/2022, , , , , , , 
6021,1778,6/15/1949,Female,170,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,55,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/10/2020,3/31/2022,10/14/1582, , , , , , , , , 
6022,1221,6/15/1959,Male,179,76,Private,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"61,5",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,10/13/2020,12/28/2020,12/28/2020, , , , , , , , , 
6023,9781,6/15/1944,Male,999,80,Private,No, , , , , ,Yes,Yes, , ,Yes,9,III: one or more criteria are fulfilled,IgG,"9999999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/27/2020,1/15/2021,1/15/2021, , , , , , , , , 
6024,9555,6/15/1947,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,260,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,11/10/2020,3/18/2021,3/18/2021, , , , , , , , , 
6025,7157,6/15/1947,Male,999,80,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,Unknown,IgG,227,unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,DAR-X,12/14/2020,3/31/2022, , , , , , , , , , 
6026,1889,6/15/1940,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,9,9,Yes,No,No,"20,21", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,DAR-X,12/30/2020,3/31/2022,10/14/1582, , , , , , , , , 
6027,5537,6/15/1951,Female,156,88,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/2/2020,1/14/2021,1/14/2021, , , , , , , , , 
6028,1915,6/15/1952,Male,999,80,Compulsory health insurance CHI,No,Yes, , , , , , , , ,Yes,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,Yes,9,Yes,No,"20,21", , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/5/2020,3/31/2021, , , , , , , , , , 
6029,5128,6/15/1971,Female,172,56,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,",46","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/25/2020,12/17/2020,12/17/2020, , , , , , , , , 
6030,4004,6/15/1947,Male,173,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/8/2019,11/27/2019,11/27/2019,11/17/2020,12/31/2020, , , , , , , 
6031,5478,6/15/1943,Male,162,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"13,2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/25/2020,12/6/2021,12/6/2021, , , , , , , , , 
6032,1949,6/15/1940,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,9,Unknown,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,10/20/2020,3/31/2021, , , , , , , , , , 
6033,8793,6/15/1941,Female,999,65,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,10/8/2020,3/31/2022, , , , , , , , , , 
6034,6117,6/15/1942,Female,162,70,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"11,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/10/2020,3/31/2022,10/14/1582, , , , , , , , , 
6035,7543,6/15/1965,Male,182,81,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/27/2020,2/25/2021,2/25/2021, , , , , , , , , 
6036,9346,6/15/1956,Male,169,61,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"8,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/2/2020,2/18/2021,2/18/2021, , , , , , , , , 
6037,7404,6/15/1943,Male,176,78,Private,No, , , , ,Yes,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/2/2020,3/31/2022,10/14/1582, , , , , , , , , 
6038,3677,6/15/1948,Male,169,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,DAR-X,12/2/2020,11/5/2021,11/5/2021,2/16/2022,3/31/2022, , , , , , , 
6039,9989,6/15/1965,Female,999,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/15/2020,3/11/2021,3/11/2021, , , , , , , , , 
6040,4172,6/15/1941,Male,183,90,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"26,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,1/3/2017,8/4/2017,8/4/2017,11/24/2020,11/21/2021,11/21/2021,12/21/2021,3/31/2022,10/14/1582, , , 
6041,4060,6/15/1940,Male,175,72,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/1/2020,3/31/2022,10/14/1582, , , , , , , , , 
6042,1471,6/15/1946,Female,165,57,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"14,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,10/1/2020,3/17/2021,3/17/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
6043,3615,6/15/1945,Male,178,83,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"15,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/2/2020,3/18/2021,3/18/2021,8/30/2021,3/31/2022,10/14/1582, , , , , , 
6044,5703,6/15/1940,Female,159,52,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,10/5/2020,3/18/2021,3/18/2021,3/29/2021,12/20/2021,12/20/2021,1/31/2022,3/31/2022, , , , 
6045,7174,6/15/1939,Male,175,79,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/5/2020,3/21/2021,3/21/2021,9/20/2021,3/31/2022, , , , , , , 
6046,1238,6/15/1937,Male,172,69,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"12,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,10/8/2020,3/17/2021,3/17/2021,3/29/2021,3/31/2022,10/14/1582, , , , , , 
6047,6028,6/15/1950,Female,166,76,Private,No, , ,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"15,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/12/2020,1/3/2021,1/3/2021,3/25/2021,3/31/2022,10/14/1582, , , , , , 
6048,8291,6/15/1943,Male,183,89,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,"17,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,11", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,DAR-X,11/9/2017,12/12/2018,12/12/2018,12/20/2020,11/30/2021,11/30/2021,12/19/2021,3/31/2022,10/14/1582, , , 
6049,9270,6/15/1952,Male,179,89,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/16/2020,4/1/2021,4/1/2021,3/14/2022,3/31/2022, , , , , , , 
6050,9482,6/15/1952,Male,165,82,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,R-X,No CTx,V-X,11/15/2013,1/15/2014,1/15/2014,11/19/2020,9/9/2021,9/9/2021,2/24/2022,3/31/2022, , , , 
6051,2877,6/15/1950,Female,171,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,12,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,10/27/2020,3/31/2022,10/14/1582, , , , , , , , , 
6052,1452,6/15/1957,Male,174,84,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,27,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/5/2020,4/2/2021,4/2/2021, , , , , , , , , 
6053,9178,6/15/1963,Female,161,75,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,3/15/2011,7/15/2011,7/15/2011,12/18/2020,2/19/2021,2/19/2021, , , , , , 
6054,8797,6/15/1966,Male,178,85,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"22,8",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,DAR-X,No CTx,No CTx,V-X,12/15/2016,3/15/2017,3/15/2017,12/1/2020,3/17/2021,3/17/2021, , , , , , 
6055,5777,6/15/1940,Female,167,75,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"34,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,5/14/2018,9/16/2018,9/16/2018,12/16/2020,11/13/2021,11/13/2021,12/27/2021,3/31/2022,10/14/1582, , , 
6056,1597,6/15/1944,Male,185,91,Compulsory health insurance CHI,No,Yes, , , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"29,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,5/8/2017,9/19/2017,9/19/2017,12/9/2020,12/7/2021,12/7/2021,12/20/2021,3/31/2022,10/14/1582, , , 
6057,6427,6/15/1941,Male,179,88,Private,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"31,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,V-X,6/16/2018,12/1/2018,12/1/2018,12/13/2020,11/28/2021,11/28/2021,12/16/2021,3/31/2022,10/14/1582, , , 
6058,7512,6/15/1944,Female,164,74,Compulsory health insurance CHI,Yes,Yes, , , , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"26,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,DAR-X,12/18/2020,3/21/2022,3/21/2022,3/30/2022,3/31/2022, , , , , , , 
6059,6801,6/15/1945,Female,159,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,19,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/14/2020,3/31/2022,10/14/1582, , , , , , , , , 
6060,3359,6/15/1936,Male,174,69,Compulsory health insurance CHI,Yes, , , , , , , , ,Yes, ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,9,No,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/7/2020,1/14/2021,1/14/2021, , , , , , , , , 
6061,9539,6/15/1954,Female,166,70,Private,No, , , ,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"17,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/26/2020,4/11/2021,4/11/2021,3/7/2022,3/31/2022, , , , , , , 
6062,9579,6/15/1945,Male,176,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"11,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/26/2020,4/11/2021,4/11/2021,9/13/2021,3/31/2022, , , , , , , 
6063,6003,6/15/1940,Female,157,66,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,10/30/2020,4/15/2021,4/15/2021,3/28/2022,3/31/2022, , , , , , , 
6064,8265,6/15/1946,Female,161,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,10/30/2020,4/15/2021,4/15/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
6065,8439,6/15/1947,Male,999,80,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,325,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/7/2014,6/24/2014,6/24/2014,10/21/2020,9/30/2021, , , , , , , 
6066,8027,6/15/1944,Male,177,73,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"14,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/3/2020,4/19/2021,4/19/2021,12/20/2021,3/31/2022, , , , , , , 
6067,1167,6/15/1945,Male,999,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,Unknown,IgA,170,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,9/22/2016,11/21/2016,11/21/2016,10/6/2020,3/31/2022,10/14/1582, , , , , , 
6068,4995,6/15/1942,Male,179,84,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"12,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/3/2020,4/19/2021,4/19/2021,9/23/2021,3/31/2022,10/14/1582, , , , , , 
6069,9097,6/15/1952,Female,159,66,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"12,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/9/2020,6/30/2021,10/14/1582, , , , , , , , , 
6070,5561,6/15/1948,Male,181,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,18,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/10/2020,3/31/2022,10/14/1582, , , , , , , , , 
6071,4323,6/15/1953,Female,165,57,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/16/2020,6/30/2021,10/14/1582, , , , , , , , , 
6072,6832,6/15/1952,Male,182,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,11/20/2020,5/6/2021,5/6/2021,3/7/2022,3/31/2022, , , , , , , 
6073,5810,6/15/1955,Female,167,62,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"16,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/23/2020,3/31/2022,10/14/1582, , , , , , , , , 
6074,5756,6/15/1946,Female,166,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"27,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/5/2020,3/31/2022,10/14/1582, , , , , , , , , 
6075,3507,6/15/1947,Male,176,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"14,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/30/2020,6/30/2021,10/14/1582, , , , , , , , , 
6076,8049,6/15/1957,Female,176,67,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,DAR-X,No CTx,No CTx,V-X,2/25/2014,4/29/2014,4/29/2014,11/6/2020,3/31/2022,10/14/1582, , , , , , 
6077,4337,6/15/1971,Male,187,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/10/2020,4/2/2021,4/2/2021, , , , , , , , , 
6078,8938,6/15/1956,Male,180,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"35,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/2/2020,2/22/2021,2/22/2021, , , , , , , , , 
6079,6089,6/15/1946,Male,174,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"12,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/24/2020,3/31/2022,10/14/1582, , , , , , , , , 
6080,5955,6/15/1943,Female,160,65,Compulsory health insurance CHI,Yes, , ,Yes,Yes, , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"13,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,11/27/2020,3/16/2021,3/16/2021,3/29/2021,2/28/2022,2/28/2022,3/28/2022,3/31/2022, , , , 
6081,2771,6/15/1938,Female,151,71,Compulsory health insurance CHI,Yes, , , ,Yes,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/26/2020,4/13/2021,4/13/2021, , , , , , , , , 
6082,6408,6/15/1944,Male,170,96,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Unknown,Unknown,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,V-X,V-X,No CTx,DAR-X,6/1/2016,2/1/2018,2/1/2018,5/22/2018,10/23/2018,10/23/2018,10/20/2020,7/13/2021,7/13/2021, , , 
6083,1997,6/15/1960,Male,179,100,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,Other type,"9999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,KYP-X,No CTx,V-X,4/11/2016,6/30/2016,6/30/2016,7/30/2020,11/25/2020,11/25/2020,3/10/2022,3/31/2022,10/14/1582, , , 
6084,7644,6/15/1946,Female,165,50,Compulsory health insurance CHI,No,Yes, , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,",63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,53", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/13/2020,1/28/2021,1/28/2021, , , , , , , , , 
6085,6761,6/15/1937,Female,136,34,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , ,Yes,2,III: one or more criteria are fulfilled,IgG,"3,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,10/16/2020,3/31/2022,10/14/1582, , , , , , , , , 
6086,7062,6/15/1954,Male,174,74,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,I: fulfilling all 4 criteria,IgA,",65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/4/2017,3/21/2018,3/21/2018,10/16/2020,3/31/2022,10/14/1582, , , , , , 
6087,1491,6/15/1958,Female,168,70,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,Other,No CTx,V-X,12/18/2014,3/31/2015,3/31/2015,9/12/2018,12/10/2018,12/10/2018,10/15/2020,11/12/2020,11/12/2020, , , 
6088,4347,6/15/1952,Male,178,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"1,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/12/2020,1/21/2021,1/21/2021, , , , , , , , , 
6089,3382,6/15/1948,Male,177,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Unknown,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,DAR-X,EMP-X,No CTx,V-X,1/1/2019,3/25/2019,3/25/2019,11/23/2020,12/16/2021,12/16/2021,2/21/2022,3/31/2022, , , , 
6090,7320,6/15/1950,Female,161,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,11,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Unknown,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,KYP-X,DAR-X,No CTx,R-X,11/5/2018,4/21/2019,4/21/2019,12/28/2020,9/20/2021,9/20/2021,9/30/2021,3/31/2022,10/14/1582, , , 
6091,3551,6/15/1939,Female,157,53,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Unknown,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,R-X,DAR-X,No CTx,V-X,1/1/2018,6/17/2018,6/17/2018,10/5/2020,3/21/2021,3/21/2021,9/24/2021,3/31/2022,10/14/1582, , , 
6092,8259,6/15/1947,Male,174,69,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,15,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Unknown,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,DAR-X,ISA-X,No CTx,V-X,1/1/2019,3/25/2019,3/25/2019,11/16/2020,11/22/2021,11/22/2021,12/6/2021,3/31/2022, , , , 
6093,2636,6/15/1942,Male,180,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Unknown,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,DAR-X,No CTx,No CTx,V-X,1/1/2018,1/13/2019,1/13/2019,11/23/2020,12/20/2021,12/20/2021, , , , , , 
6094,2535,6/15/1943,Female,163,54,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , ,Yes,1,Unknown,IgG,"4,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/5/2020,3/31/2022,10/14/1582, , , , , , , , , 
6095,8989,6/15/1951,Female,156,77,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"9999999,99",unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,Unknown,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,R-X,V-X,No CTx,No CTx, , , ,8/1/2017,11/1/2018,11/1/2018,10/15/2020,3/31/2021, , , , 
6096,7456,6/15/1949,Male,174,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,17","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Unknown,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,10/12/2020,3/31/2021, , , , , , , , , , 
6097,5386,6/15/1948,Male,169,87,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,Yes,Unknown,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/26/2020,3/31/2021, , , , , , , , , , 
6098,1427,6/15/1954,Female,167,91,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Unknown,Unknown,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,12/1/2020,3/31/2021, , , , , , , , , , 
6099,1841,6/15/1971,Male,186,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"5,6",unknown/ISS-Criteria not used for prognostics,No,9,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/25/2016,7/7/2016,7/7/2016, , , , , , , , , 
6100,7195,6/15/1951,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/22/2020,5/31/2021,5/31/2021, , , , , , , , , 
6101,8163,6/15/1958,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/16/2020,3/31/2021, , , , , , , , , , 
6102,5428,6/15/1950,Male,185,83,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,543,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,No,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/12/2020,1/28/2021,1/28/2021, , , , , , , , , 
6103,2259,6/15/1946,Male,179,79,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/2/2020,12/31/2021,10/14/1582, , , , , , , , , 
6104,5380,6/15/1967,Male,178,82,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"5,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/3/2020,1/17/2021,1/17/2021, , , , , , , , , 
6105,4161,6/15/1941,Female,999,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,7,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/7/2020,10/6/2021,10/6/2021, , , , , , , , , 
6106,3875,6/15/1945,Male,175,85,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,2,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,10/28/2020,12/31/2020, , , , , , , , , , 
6107,7969,6/15/1949,Female,170,80,Private,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,DAR-X,10/19/2020,12/1/2021,12/1/2021,12/14/2021,12/31/2021, , , , , , , 
6108,4360,6/15/1939,Male,178,80,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , , ,DAR-X,No CTx,No CTx,R-X,10/12/2020,2/26/2021,2/26/2021,3/9/2021,9/30/2021,10/14/1582, , , , , , 
6109,2130,6/15/1956,Male,180,90,Private,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/14/2020,3/15/2021,3/15/2021, , , , , , , , , 
6110,3753,6/15/1962,Female,164,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"1,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/7/2020,1/24/2021,1/24/2021, , , , , , , , , 
6111,7850,6/15/1936,Male,174,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"4,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,12/14/2020,6/6/2021,6/6/2021, , , , , , , , , 
6112,5286,6/15/1937,Male,171,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"5,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,8/14/2017,2/4/2018,2/4/2018,12/14/2020,6/6/2021,6/6/2021, , , , , , 
6113,1721,6/15/1943,Female,162,58,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"4,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,61", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/6/2018,11/28/2018,11/28/2018,12/15/2020,12/31/2021,10/14/1582, , , , , , 
6114,5903,6/15/1942,Female,167,73,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"5,37","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/7/2017,9/28/2017,9/28/2017,12/15/2020,12/31/2021,10/14/1582, , , , , , 
6115,6116,6/15/1945,Female,163,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,86","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/19/2017,9/10/2017,9/10/2017,12/21/2020,12/31/2021,10/14/1582, , , , , , 
6116,5556,6/15/1942,Female,170,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes,Yes,2,III: one or more criteria are fulfilled,Other type,131,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,DAR-X,11/17/2020,12/9/2020,12/9/2020,1/21/2021,12/31/2021,10/14/1582, , , , , , 
6117,2008,6/15/1938,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,Yes,"20,21", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/5/2020,5/20/2021,5/20/2021, , , , , , , , , 
6118,3736,6/15/1956,Male,172,68,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,Other type,420,unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,10/2/2020,12/15/2020,12/15/2020, , , , , , , , , 
6119,7977,6/15/1940,Male,180,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"2,85",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,LEV-X,No CTx,No CTx,V-X,9/6/2018,11/15/2018,11/15/2018,12/16/2020,12/31/2021,10/14/1582, , , , , , 
6120,5423,6/15/1969,Male,182,81,Compulsory health insurance CHI,No, ,Yes,Unknown,Yes,Unknown,Unknown,Unknown, ,Yes,Unknown,2,III: one or more criteria are fulfilled,IgG,"5,41","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/9/2020,12/31/2020, , , , , , , , , , 
6121,8967,6/15/1969,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,"9,9",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,10/26/2020,3/1/2021,3/1/2021, , , , , , , , , 
6122,1457,6/15/1961,Female,999,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,1,Unknown,Other type,488,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,11/23/2020,1/15/2021,1/15/2021, , , , , , , , , 
6123,9670,6/15/1943,Male,188,104,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,3", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,No CTx, , , ,11/20/2020,12/31/2020, , , , , , , 
6124,6567,6/15/1935,Male,164,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,24",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/27/2020,1/27/2021,1/27/2021,2/23/2021,6/30/2021,10/14/1582, , , , , , 
6125,1052,6/15/1941,Female,165,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,32",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,10/13/2020,2/7/2021,2/7/2021,2/19/2021,3/22/2021,3/22/2021, , , , , , 
6126,8557,6/15/1950,Male,181,73,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"32,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/17/2020,11/3/2021,11/3/2021, , , , , , , , , 
6127,8093,6/15/1941,Male,171,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,96",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/18/2020,12/17/2021,12/17/2021, , , , , , , , , 
6128,6647,6/15/1945,Male,166,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,69",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/6/2020,3/31/2022, , , , , , , , , , 
6129,3871,6/15/1935,Male,178,85,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,47,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,R-X,10/29/2020,3/31/2022, , , , , , , , , , 
6130,6266,6/15/1941,Male,171,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"28,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/25/2020,12/25/2020,12/25/2020, , , , , , , , , 
6131,3890,6/15/1939,Male,176,87,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,18,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,R-X,10/23/2020,3/31/2022, , , , , , , , , , 
6132,1254,6/15/1941,Male,171,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,96",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/15/2020,12/10/2020,12/10/2020, , , , , , , , , 
6133,1392,6/15/1951,Male,172,59,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/13/2020,1/13/2021,1/13/2021, , , , , , , , , 
6134,6786,6/15/1945,Male,165,99,Private,No, , , , ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"3,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/18/2020,1/7/2021,1/7/2021, , , , , , , , , 
6135,5273,6/15/1936,Female,159,94,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,33",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/4/2020,1/12/2021,1/12/2021, , , , , , , , , 
6136,4855,6/15/1941,Male,176,63,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/9/2020,10/22/2021,10/22/2021, , , , , , , , , 
6137,3869,6/15/1955,Female,167,67,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"20,33","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/19/2020,5/21/2021,5/21/2021, , , , , , , , , 
6138,3253,6/15/1945,Male,195,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/23/2020,3/31/2022, , , , , , , , , , 
6139,7075,6/15/1944,Male,174,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"9,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,11/9/2020,1/6/2021,1/6/2021,1/19/2021,4/8/2021,4/8/2021, , , , , , 
6140,9132,6/15/1950,Male,175,77,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,09",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/18/2020,1/18/2021,1/18/2021, , , , , , , , , 
6141,7852,6/15/1947,Male,175,73,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/9/2020,1/14/2021,1/14/2021,1/23/2021,3/31/2022,10/14/1582, , , , , , 
6142,9577,6/15/1951,Female,169,57,Private,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"14,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/8/2020,3/31/2022, , , , , , , , , , 
6143,8694,6/15/1949,Male,174,77,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/31/2020,3/31/2022, , , , , , , , , , 
6144,1437,6/15/1943,Female,163,95,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,12",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/4/2020,12/27/2020,12/27/2020, , , , , , , , , 
6145,4942,6/15/1936,Female,156,52,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"1,2",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Unknown,"1,5", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,11/20/2020,12/31/2020, , , , , , , , , , 
6146,8872,6/15/1951,Male,177,83,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,23",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/16/2020,1/14/2021,1/14/2021,1/31/2021,3/31/2022, , , , , , , 
6147,4281,6/15/1932,Female,157,61,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,58",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,61", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/11/2020,9/29/2021,9/29/2021, , , , , , , , , 
6148,3870,6/15/1936,Male,180,79,Private,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,4",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,R-X,11/9/2020,12/31/2020, , , , , , , , , , 
6149,7097,6/15/1943,Male,194,81,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,27",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/26/2020,8/7/2021,8/7/2021, , , , , , , , , 
6150,7221,6/15/1944,Female,169,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,51",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/19/2020,9/7/2021,9/7/2021, , , , , , , , , 
6151,8901,6/15/1942,Female,167,50,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,58",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/18/2020,1/4/2021,1/4/2021, , , , , , , , , 
6152,3400,6/15/1969,Male,178,72,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"6,9",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,Unknown,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/12/2020,12/31/2020, , , , , , , , , , 
6153,2896,6/15/1951,Female,168,79,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"13,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/24/2020,12/31/2021,12/31/2021, , , , , , , , , 
6154,7005,6/15/1949,Male,179,96,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,95",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,POM-X,V-X,No CTx,R-X,10/22/2020,7/5/2021,7/5/2021,8/19/2021,12/30/2021,12/30/2021,1/20/2022,3/31/2022, , , , 
6155,4104,6/15/1943,Female,155,57,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"13,31","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/18/2020,12/1/2021,12/1/2021, , , , , , , , , 
6156,2552,6/15/1950,Female,168,72,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/30/2020,7/27/2021,7/27/2021, , , , , , , , , 
6157,9704,6/15/1948,Female,174,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,6",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/27/2020,5/4/2021,5/4/2021, , , , , , , , , 
6158,6076,6/15/1949,Male,166,99,Private,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"31,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/27/2020,3/31/2022, , , , , , , , , , 
6159,3325,6/15/1949,Female,159,60,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,61", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/13/2020,9/28/2021,9/28/2021, , , , , , , , , 
6160,9554,6/15/1967,Male,174,85,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"28,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/27/2020,12/28/2020,12/28/2020, , , , , , , , , 
6161,2982,6/15/1949,Female,159,60,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,61", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/17/2020,9/15/2021,9/15/2021, , , , , , , , , 
6162,7513,6/15/1952,Male,167,59,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"1100,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,11/24/2020,2/5/2021,2/5/2021, , , , , , , , , 
6163,2919,6/15/1949,Male,169,59,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"6,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/2/2020,6/9/2021,6/9/2021, , , , , , , , , 
6164,7938,6/15/1951,Female,166,54,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"12,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/27/2020,6/4/2021,6/4/2021, , , , , , , , , 
6165,5459,6/15/1951,Female,167,50,Compulsory health insurance CHI,Yes,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"258,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,12/3/2020,3/31/2022,10/14/1582, , , , , , , , , 
6166,3245,6/15/1948,Female,162,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/13/2020,1/26/2021,1/26/2021, , , , , , , , , 
6167,8297,6/15/1952,Male,172,120,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,48,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes,"2,29", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Ja,V-X,No CTx,No CTx,V-X,11/19/2020,1/8/2021,1/8/2021,1/25/2021,11/21/2021,11/21/2021, , , , , , 
6168,7660,6/15/1943,Female,157,48,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,45", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/2/2020,12/17/2021,12/17/2021, , , , , , , , , 
6169,7388,6/15/1950,Male,187,110,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,35", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/2/2020,12/15/2021,12/15/2021, , , , , , , , , 
6170,4222,6/15/1968,Male,178,92,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,72,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/9/2020,1/12/2021,1/12/2021, , , , , , , , , 
6171,1598,6/15/1944,Male,171,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"19,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/1/2020,1/1/2021,1/1/2021, , , , , , , , , 
6172,5761,6/15/1950,Female,155,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/9/2020,4/14/2021,4/14/2021,10/26/2021,3/31/2022, , , , , , , 
6173,6610,6/15/1954,Female,169,78,Compulsory health insurance CHI,Yes, ,Yes, ,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,680,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/16/2020,3/31/2022, , , , , , , , , , 
6174,1637,6/15/1942,Male,181,65,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,77",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,11/20/2020,2/3/2021,2/3/2021,2/11/2021,7/6/2021,7/6/2021, , , , , , 
6175,9589,6/15/1941,Female,179,56,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,93",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/2/2020,11/11/2021,11/11/2021, , , , , , , , , 
6176,1528,6/15/1942,Male,187,88,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"13,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/30/2020,1/30/2021,1/30/2021, , , , , , , , , 
6177,7189,6/15/1952,Male,167,58,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,36",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/30/2020,3/15/2021,3/15/2021, , , , , , , , , 
6178,7334,6/15/1943,Male,182,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/17/2020,12/30/2021,12/30/2021, , , , , , , , , 
6179,9015,6/15/1947,Female,178,67,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"32,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/9/2020,2/3/2021,2/3/2021, , , , , , , , , 
6180,1343,6/15/1949,Male,192,82,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,83",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,11", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/5/2020,11/18/2021,11/18/2021, , , , , , , , , 
6181,2242,6/15/1942,Female,153,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,92",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,6", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/5/2020,1/28/2021,1/28/2021, , , , , , , , , 
6182,6036,6/15/1947,Female,162,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,41",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/15/2020,10/5/2021,10/5/2021, , , , , , , , , 
6183,3328,6/15/1947,Female,165,80,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"23,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/30/2020,5/4/2021,5/4/2021,5/21/2021,3/31/2022,10/14/1582, , , , , , 
6184,2185,6/15/1943,Male,182,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"13,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/17/2020,12/30/2021,12/30/2021, , , , , , , , , 
6185,8332,6/15/1949,Male,168,84,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/31/2020,10/24/2021,10/24/2021, , , , , , , , , 
6186,9074,6/15/1943,Female,167,69,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"22,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/23/2020,12/29/2021,12/29/2021, , , , , , , , , 
6187,9283,6/15/1950,Male,173,101,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,25",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/23/2020,7/15/2021,7/15/2021, , , , , , , , , 
6188,5297,6/15/1942,Male,188,84,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/22/2020,10/28/2021,10/28/2021, , , , , , , , , 
6189,5127,6/15/1944,Male,176,79,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,13",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/13/2020,10/6/2021,10/6/2021, , , , , , , , , 
6190,6399,6/15/1947,Male,180,103,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,91",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/1/2020,1/31/2021,1/31/2021, , , , , , , , , 
6191,1518,6/15/1933,Male,182,106,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,23",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,27", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/22/2020,11/4/2021,11/4/2021, , , , , , , , , 
6192,6278,6/15/1940,Female,160,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/22/2020,2/4/2021,2/4/2021, , , , , , , , , 
6193,9625,6/15/1941,Female,168,76,Private,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,49",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/27/2020,3/12/2021,3/12/2021, , , , , , , , , 
6194,4986,6/15/1942,Female,174,96,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,81",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/8/2020,1/21/2021,1/21/2021, , , , , , , , , 
6195,7378,6/15/1949,Male,184,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,26",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/27/2020,8/3/2021,8/3/2021, , , , , , , , , 
6196,8618,6/15/1949,Female,168,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"24,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/5/2020,7/14/2021,7/14/2021, , , , , , , , , 
6197,2944,6/15/1947,Female,159,83,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,51",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/13/2020,8/8/2021,8/8/2021, , , , , , , , , 
6198,7623,6/15/1947,Female,157,46,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"17,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,43", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/10/2020,5/24/2021,5/24/2021, , , , , , , , , 
6199,5631,6/15/1947,Female,159,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,31",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,10/9/2020,6/22/2021,6/22/2021,1/13/2022,3/31/2022, , , , , , , 
6200,9726,6/15/1936,Male,178,89,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,7962,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/28/2020,3/31/2022,10/14/1582, , , , , , , , , 
6201,7903,6/15/1943,Female,166,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,41,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/29/2020,3/1/2021,3/1/2021,3/29/2021,3/31/2022, , , , , , , 
6202,5188,6/15/1962,Male,185,95,Private,Yes, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,949,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/27/2020,12/28/2020,12/28/2020, , , , , , , , , 
6203,8005,6/15/1961,Male,166,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,4/29/2020,10/27/2020,10/27/2020,11/8/2020,3/31/2022,10/14/1582, , , , , , 
6204,5441,6/15/1976,Male,177,83,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,08",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,1/10/2020,3/19/2020,3/19/2020,10/10/2020,12/20/2020,12/20/2020,1/14/2021,3/31/2022,10/14/1582, , , 
6205,2070,6/15/1956,Male,196,137,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,0,I: fulfilling all 4 criteria,IgG,"3,02",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,5/9/2020,10/25/2020,10/25/2020,11/6/2020,3/31/2022,10/14/1582, , , , , , 
6206,9458,6/15/1954,Male,170,78,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,71",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,4/23/2020,10/22/2020,10/22/2020,11/10/2020,3/31/2022,10/14/1582, , , , , , 
6207,5947,6/15/1964,Male,174,83,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,01",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/21/2020,7/31/2020,7/31/2020,12/1/2020,3/31/2022,10/14/1582, , , , , , 
6208,4736,6/15/1950,Male,197,90,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,44",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,24", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/1/2020,6/3/2020,6/3/2020,10/6/2020,3/31/2022,10/14/1582, , , , , , 
6209,1388,6/15/1953,Female,162,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,82",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,4/28/2020,10/12/2020,10/12/2020,11/4/2020,12/24/2020,12/24/2020,1/13/2021,3/31/2022, , , , 
6210,1627,6/15/1954,Male,170,99,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,POM-X,No CTx,R-X,3/30/2020,9/27/2020,9/27/2020,10/22/2020,7/6/2021,7/6/2021,11/23/2021,3/31/2022, , , , 
6211,2467,6/15/1954,Female,164,92,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,27",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,1/4/2020,3/19/2020,3/19/2020,10/2/2020,3/31/2022,10/14/1582, , , , , , 
6212,7172,6/15/1948,Female,160,47,Compulsory health insurance CHI,No, , , , , , , ,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,15",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,"1,46", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,12/3/2019,5/21/2020,5/21/2020,6/13/2020,12/4/2020,12/4/2020, , , , , , 
6213,4430,6/15/1956,Male,174,111,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,24", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,R-X,5/30/2020,11/24/2020,11/24/2020,12/5/2020,1/17/2021,1/17/2021,1/29/2021,3/31/2022,10/14/1582, , , 
6214,8670,6/15/1948,Male,175,82,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,37",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,4/19/2020,10/5/2020,10/5/2020,10/30/2020,12/31/2020, , , , , , , 
6215,2236,6/15/1951,Male,178,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"3,83",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,3/12/2020,6/17/2020,6/17/2020,12/11/2020,12/31/2020, , , , , , , 
6216,5653,6/15/1954,Male,179,73,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,34",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/18/2020,7/18/2020,7/18/2020,11/14/2020,12/31/2020, , , , , , , 
6217,3418,6/15/1952,Female,165,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,83",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,12/20/2019,3/21/2020,3/21/2020,10/12/2020,12/31/2020, , , , , , , 
6218,4154,6/15/1947,Male,186,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,1/26/2020,5/20/2020,5/20/2020,11/16/2020,3/31/2022,10/14/1582, , , , , , 
6219,4477,6/15/1952,Male,193,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/2/2020,7/14/2020,7/14/2020,11/30/2020,12/31/2020, , , , , , , 
6220,8603,6/15/1948,Male,177,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,28",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,5/3/2020,10/21/2020,10/21/2020,11/4/2020,12/13/2021,12/13/2021,1/17/2022,3/31/2022,10/14/1582, , , 
6221,2229,6/15/1968,Male,173,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,47",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/2/2020,7/12/2020,7/12/2020,10/21/2020,3/31/2022,10/14/1582, , , , , , 
6222,7001,6/15/1936,Male,172,55,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,48",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/20/2020,5/20/2020,5/20/2020,10/12/2020,3/31/2022,10/14/1582, , , , , , 
6223,8741,6/15/1947,Female,155,59,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"9,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,4/30/2020,10/19/2020,10/19/2020,11/16/2020,3/31/2022,10/14/1582, , , , , , 
6224,8071,6/15/1953,Male,166,53,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"30,87","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,4/28/2020,6/28/2020,6/28/2020,10/12/2020,3/31/2022,10/14/1582, , , , , , 
6225,7076,6/15/1954,Male,168,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"27,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,5/21/2020,11/10/2020,11/10/2020,12/7/2020,12/8/2021,12/8/2021,1/13/2022,3/31/2022,10/14/1582, , , 
6226,6079,6/15/1964,Male,174,83,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,55",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/10/2019,8/22/2019,8/22/2019,1/23/2020,12/27/2020,12/27/2020, , , , , , 
6227,3657,6/15/1938,Female,159,66,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,96",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/13/2020,6/13/2020,6/13/2020,12/5/2020,3/31/2022,10/14/1582, , , , , , 
6228,7442,6/15/1949,Female,163,68,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"15,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,5/1/2020,10/16/2020,10/16/2020,11/10/2020,11/19/2021,11/19/2021, , , , , , 
6229,3742,6/15/1936,Male,167,70,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,5/25/2020,11/9/2020,11/9/2020,11/27/2020,3/31/2022,10/14/1582, , , , , , 
6230,1629,6/15/1955,Male,170,73,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"3,71",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/2/2020,6/12/2020,6/12/2020,12/6/2020,3/31/2022,10/14/1582, , , , , , 
6231,9028,6/15/1954,Male,168,69,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,4/5/2020,9/25/2020,9/25/2020,10/8/2020,3/31/2022,10/14/1582, , , , , , 
6232,8885,6/15/1956,Female,162,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,43",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,11/28/2019,4/2/2020,4/2/2020,10/25/2020,7/28/2021,7/28/2021,9/20/2021,3/31/2022,10/14/1582, , , 
6233,4964,6/15/1948,Male,173,53,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,17",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,2/18/2020,6/16/2020,6/16/2020,10/19/2020,12/7/2021,12/7/2021,12/21/2021,3/31/2022, , , , 
6234,8921,6/15/1952,Female,163,69,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"22,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,V-X,R-X,5/4/2020,10/19/2020,10/19/2020,10/31/2020,2/12/2021,2/12/2021,2/25/2021,9/9/2021,9/9/2021,9/28/2021,3/31/2022, 
6235,3057,6/15/1952,Male,170,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,02",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,No CTx,R-X,5/13/2020,10/28/2020,10/28/2020,11/11/2020,12/13/2021,12/13/2021,3/14/2022,3/31/2022, , , , 
6236,6253,6/15/1940,Male,185,59,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"29,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/18/2020,4/14/2020,4/14/2020,11/20/2020,3/31/2022, , , , , , , 
6237,6667,6/15/1949,Male,174,63,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/25/2019,2/21/2020,2/21/2020,6/17/2020,12/10/2020,12/10/2020, , , , , , 
6238,2518,6/15/1974,Female,169,101,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/23/2020,7/3/2020,7/3/2020,11/25/2020,3/31/2022,10/14/1582, , , , , , 
6239,5003,6/15/1956,Male,167,73,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"17,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,4/18/2020,10/1/2020,10/1/2020,10/25/2020,3/31/2022,10/14/1582, , , , , , 
6240,9126,6/15/1955,Male,180,86,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"34,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,R-X,3/25/2020,9/18/2020,9/18/2020,10/11/2020,2/4/2022,2/4/2022,2/21/2022,3/31/2022, , , , 
6241,9299,6/15/1937,Male,188,71,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,27",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,4/15/2020,9/30/2020,9/30/2020,10/22/2020,3/31/2022,10/14/1582, , , , , , 
6242,2781,6/15/1931,Male,173,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,68",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/22/2020,7/2/2020,7/2/2020,11/14/2020,12/13/2021,12/13/2021, , , , , , 
6243,9541,6/15/1953,Male,178,83,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"12,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/14/2020,6/22/2020,6/22/2020,11/10/2020,3/31/2022,10/14/1582, , , , , , 
6244,8507,6/15/1958,Male,176,81,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,72",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/11/2020,6/21/2020,6/21/2020,11/26/2020,3/31/2022,10/14/1582, , , , , , 
6245,9512,6/15/1953,Female,168,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,63",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/8/2020,6/10/2020,6/10/2020,10/1/2020,3/31/2022,10/14/1582, , , , , , 
6246,8356,6/15/1958,Male,175,83,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,8",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/10/2020,7/23/2020,7/23/2020,10/1/2020,3/31/2022,10/14/1582, , , , , , 
6247,3178,6/15/1941,Male,171,61,Private,No,Yes,Yes,Yes, ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"8,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,4/24/2020,10/11/2020,10/11/2020,10/28/2020,3/31/2022,10/14/1582, , , , , , 
6248,1251,6/15/1954,Female,150,56,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,5", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,2/28/2020,5/13/2020,5/13/2020,11/30/2020,3/31/2022,10/14/1582, , , , , , 
6249,5828,6/15/1963,Male,186,93,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,1",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,NIN-X,POM-X,R-X,12/6/2019,6/3/2020,6/3/2020,6/20/2020,2/5/2021,2/5/2021,2/26/2021,8/6/2021,8/6/2021,9/20/2021,12/13/2021,12/13/2021
6250,2592,6/15/1947,Female,166,48,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,65",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,51", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/2/2019,10/10/2019,10/10/2019,5/4/2020,12/17/2020,12/17/2020, , , , , , 
6251,8667,6/15/1954,Female,150,56,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"20,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,5", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,6/14/2019,8/26/2019,8/26/2019,1/16/2020,12/24/2020,12/24/2020, , , , , , 
6252,6466,6/15/1963,Male,186,93,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,01",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,KYP-X,No CTx,R-X,4/13/2020,10/5/2020,10/5/2020,10/30/2020,7/9/2021,7/9/2021,7/21/2021,10/6/2021,10/6/2021, , , 
6253,3525,6/15/1951,Female,163,70,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,41",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,4/3/2020,9/19/2020,9/19/2020,10/6/2020,2/3/2021,2/3/2021, , , , , , 
6254,9352,6/15/1943,Female,162,65,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,37",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/27/2020,6/10/2021,6/10/2021, , , , , , , , , 
6255,8626,6/15/1949,Male,163,52,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,27","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/6/2020,10/11/2021,10/11/2021, , , , , , , , , 
6256,6513,6/15/1953,Male,179,87,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, ,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,08",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/30/2020,9/2/2020,9/2/2020,11/24/2020,10/25/2021,10/25/2021, , , , , , 
6257,8438,6/15/1938,Female,162,44,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,43", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/1/2020,10/4/2021,10/4/2021, , , , , , , , , 
6258,9724,6/15/1943,Female,173,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,11",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/19/2020,12/31/2021, , , , , , , , , , 
6259,2416,6/15/1942,Female,161,45,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,77",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes,"1,44", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/7/2020,12/31/2021, , , , , , , , , , 
6260,4252,6/15/1969,Male,177,95,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,38",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,V-X,No CTx,V-X,2/1/2020,6/3/2020,6/3/2020,10/1/2020,2/16/2022,2/16/2022,2/24/2022,3/31/2022, , , , 
6261,9401,6/15/1950,Female,162,69,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,68",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/23/2020,12/31/2021,10/14/1582, , , , , , , , , 
6262,6307,6/15/1953,Male,179,87,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,87",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/15/2020,5/30/2020,5/30/2020,10/25/2020,3/31/2022,10/14/1582, , , , , , 
6263,1155,6/15/1949,Male,181,89,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,45",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/28/2020,8/1/2020,8/1/2020,12/6/2020,3/31/2022,10/14/1582, , , , , , 
6264,7693,6/15/1956,Female,160,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,81",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,2/19/2020,5/5/2020,5/5/2020,10/15/2020,8/12/2021,8/12/2021, , , , , , 
6265,4663,6/15/1941,Female,173,81,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/3/2020,8/8/2020,8/8/2020,11/10/2020,3/31/2022,10/14/1582, , , , , , 
6266,1234, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
6267,3939,6/15/1948,Male,178,78,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"27,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,3/31/2020,6/23/2020,6/23/2020,11/29/2020,3/31/2022, , , , , , , 
6268,9519,6/15/1956,Female,155,83,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,EMP-X,No CTx,R-X,4/24/2020,10/9/2020,10/9/2020,10/25/2020,10/18/2021,10/18/2021,3/3/2022,3/31/2022, , , , 
6269,6104,6/15/1938,Female,165,70,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,21",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,5/28/2020,11/10/2020,11/10/2020,12/4/2020,3/31/2022,10/14/1582, , , , , , 
6270,2948,6/15/1947,Female,184,89,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"25,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,V-X,No CTx,V-X,12/23/2019,4/14/2020,4/14/2020,10/9/2020,8/2/2021,8/2/2021,8/18/2021,3/31/2022, , , , 
6271,9607,6/15/1950,Male,169,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,4/4/2020,9/28/2020,9/28/2020,10/12/2020,3/31/2022, , , , , , , 
6272,6966,6/15/1953,Male,186,78,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,09",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,4/3/2020,9/30/2020,9/30/2020,10/17/2020,10/10/2021,10/10/2021,1/5/2022,3/31/2022, , , , 
6273,5145,6/15/1945,Male,175,81,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"34,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,5/19/2020,11/14/2020,11/14/2020,11/25/2020,12/31/2021,10/14/1582, , , , , , 
6274,2642,6/15/1945,Male,175,81,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"31,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,R-X,4/8/2020,10/5/2020,10/5/2020,10/26/2020,11/10/2021,11/10/2021,12/8/2021,12/31/2021, , , , 
6275,9383,6/15/1949,Female,162,93,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,51",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/14/2020,11/30/2020,11/30/2020,12/15/2020,12/31/2021,10/14/1582, , , , , , 
6276,7598,6/15/1945,Male,175,81,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"21,17","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,4/18/2020,10/5/2020,10/5/2020,10/30/2020,7/31/2021,7/31/2021, , , , , , 
6277,1847,6/15/1947,Female,157,64,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,59",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,64", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/14/2020,11/30/2020,11/30/2020,12/14/2020,6/30/2021,10/14/1582, , , , , , 
6278,1545,6/15/1937,Female,158,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,68,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/15/2020,12/31/2020, , , , , , , , , , 
6279,9916,6/15/1946,Male,188,123,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/22/2020,12/28/2020,12/28/2020,1/12/2021,3/31/2022,10/14/1582, , , , , , 
6280,7291,6/15/1946,Male,176,74,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,65",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/20/2020,10/6/2021,10/6/2021, , , , , , , , , 
6281,1868,6/15/1945,Male,172,94,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"32,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/11/2020,7/8/2021,7/8/2021, , , , , , , , , 
6282,6561,6/15/1942,Male,180,76,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/9/2020,5/20/2021,5/20/2021, , , , , , , , , 
6283,6562,6/15/1945,Male,172,94,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"22,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/1/2020,6/8/2021,6/8/2021, , , , , , , , , 
6284,7708,6/15/1946,Female,198,67,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"26,13","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/5/2020,11/18/2021,11/18/2021, , , , , , , , , 
6285,4744,6/15/1966,Male,177,89,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,62",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/17/2020,1/30/2021,1/30/2021, , , , , , , , , 
6286,2483,6/15/1942,Male,177,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,54",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/27/2020,5/19/2021,5/19/2021, , , , , , , , , 
6287,6165,6/15/1943,Male,178,83,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/8/2020,12/16/2021,12/16/2021, , , , , , , , , 
6288,1941,6/15/1966,Male,160,66,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,25",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/13/2020,11/26/2021,11/26/2021, , , , , , , , , 
6289,1494,6/15/1947,Female,163,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,66",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/1/2020,7/16/2021,7/16/2021,8/11/2021,12/31/2021,10/14/1582, , , , , , 
6290,1581,6/15/1948,Male,189,90,Private,No, , , , , ,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"9,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/13/2020,4/20/2021,4/20/2021, , , , , , , , , 
6291,2421,6/15/1966,Male,160,66,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,44",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/6/2020,3/11/2021,3/11/2021,3/26/2021,12/31/2021,10/14/1582, , , , , , 
6292,3281,6/15/1950,Male,173,76,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/24/2020,12/7/2021,12/7/2021, , , , , , , , , 
6293,4216,6/15/1944,Female,167,67,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,16",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/19/2020,10/11/2021,10/11/2021, , , , , , , , , 
6294,9869,6/15/1963,Female,160,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"34,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,61", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/23/2020,2/15/2021,2/15/2021, , , , , , , , , 
6295,4220,6/15/1943,Male,166,66,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,53",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,11/3/2020,7/5/2021,7/5/2021,2/10/2022,3/31/2022, , , , , , , 
6296,1135,6/15/1949,Male,176,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,89",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/10/2020,2/16/2021,2/16/2021, , , , , , , , , 
6297,7960,6/15/1950,Female,163,67,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"33,27","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/9/2020,1/2/2021,1/2/2021, , , , , , , , , 
6298,2142,6/15/1950,Female,163,67,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,56","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/3/2020,2/25/2021,2/25/2021, , , , , , , , , 
6299,4340,6/15/1951,Male,171,70,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"30,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/28/2020,12/28/2020,12/28/2020, , , , , , , , , 
6300,7351,6/15/1952,Female,165,69,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"21,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/19/2020,3/4/2021,3/4/2021, , , , , , , , , 
6301,2431,6/15/1952,Female,165,69,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"26,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/1/2020,2/14/2021,2/14/2021, , , , , , , , , 
6302,9217,6/15/1945,Female,168,51,Compulsory health insurance CHI,No,Yes, ,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"2,63",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/7/2020,10/20/2021,10/20/2021, , , , , , , , , 
6303,5839,6/15/1951,Male,184,78,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,57",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/18/2020,9/10/2021,9/10/2021, , , , , , , , , 
6304,7734,6/15/1951,Male,173,56,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,76",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/3/2020,7/3/2020,7/3/2020,12/1/2020,12/31/2021,10/14/1582, , , , , , 
6305,5006,6/15/1953,Male,179,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,16",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,DAR-X,No CTx,V-X,3/9/2020,5/23/2020,5/23/2020,10/31/2020,12/13/2021,12/13/2021,2/14/2022,3/31/2022, , , , 
6306,6789,6/15/1941,Male,174,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,06",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,5/30/2020,11/25/2020,11/25/2020,12/21/2021,3/31/2022,10/14/1582, , , , , , 
6307,6572,6/15/1950,Male,177,60,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,71",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,4/19/2020,7/2/2021,7/2/2021, , , , , , , , , 
6308,8734,6/15/1941,Male,174,58,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,9",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,6/7/2020,11/21/2020,11/21/2020,12/9/2020,4/2/2021,4/2/2021, , , , , , 
6309,8833,6/15/1950,Female,169,49,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,NIN-X,No CTx,R-X,4/13/2020,9/30/2020,9/30/2020,10/25/2020,6/21/2021,6/21/2021,7/8/2021,12/31/2021, , , , 
6310,7333,6/15/1950,Male,188,79,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,6/4/2019,8/8/2019,8/8/2019,1/12/2020,12/23/2020,12/23/2020,12/29/2020,6/30/2021, , , , 
6311,6032,6/15/1956,Male,166,71,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,77",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/17/2020,9/11/2020,9/11/2020,12/7/2020,12/31/2021, , , , , , , 
6312,2977,6/15/1950,Male,190,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/30/2020,2/11/2021,2/11/2021, , , , , , , , , 
6313,3319,6/15/1946,Female,164,88,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"18,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/30/2020,7/29/2020,7/29/2020,10/21/2020,12/31/2020, , , , , , , 
6314,7352,6/15/1961,Male,161,57,Compulsory health insurance CHI,No,Yes,Yes, , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"3,62","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/24/2020,1/18/2021,1/18/2021, , , , , , , , , 
6315,6758,6/15/1942,Male,167,75,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,147,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,EMP-X,No CTx,DAR-X,8/15/2019,10/24/2019,10/24/2019,11/5/2019,11/24/2020,11/24/2020,12/21/2020,6/30/2021,10/14/1582, , , 
6316,4636,6/15/1941,Male,170,81,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,04","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/27/2020,12/31/2020, , , , , , , , , , 
6317,1541,6/15/1944,Male,180,88,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,I: fulfilling all 4 criteria,IgA,"1,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/31/2020,12/31/2020, , , , , , , , , , 
6318,7964,6/15/1947,Male,177,74,Private,No, , ,Yes, , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/19/2020,12/31/2020, , , , , , , , , , 
6319,3345,6/15/1942,Male,185,64,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,48",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/9/2020,12/31/2020,10/14/1582, , , , , , , , , 
6320,9628,6/15/1943,Female,159,55,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,87",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/25/2020,12/31/2020, , , , , , , , , , 
6321,6078,6/15/1950,Male,183,82,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"15,96","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/23/2020,12/31/2020, , , , , , , , , , 
6322,7771,6/15/1945,Male,169,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,73",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/25/2020,12/31/2020, , , , , , , , , , 
6323,6141,6/15/1948,Female,173,66,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"22,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,6/27/2019,12/23/2019,12/23/2019,5/27/2020,11/12/2020,11/12/2020,12/4/2020,12/31/2020, , , , 
6324,4625,6/15/1948,Male,166,60,Private,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"18,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,6/20/2019,12/12/2019,12/12/2019,5/8/2020,11/5/2020,11/5/2020,11/19/2020,12/31/2020, , , , 
6325,9797,6/15/1956,Male,180,113,Private,No,Yes,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,36",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"2,31", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,7/4/2019,12/19/2019,12/19/2019,4/10/2020,10/2/2020,10/2/2020,10/12/2020,12/31/2021,10/14/1582, , , 
6326,2956,6/15/1950,Male,163,62,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"14,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,7/31/2019,1/24/2020,1/24/2020,5/4/2020,11/2/2020,11/2/2020,11/19/2020,6/22/2021,6/22/2021, , , 
6327,4627,6/15/1948,Female,179,78,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"13,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,5/13/2019,11/7/2019,11/7/2019,4/22/2020,10/15/2020,10/15/2020,10/25/2020,4/13/2021,4/13/2021, , , 
6328,9151,6/15/1953,Male,189,88,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,84",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,EMP-X,V-X,8/6/2019,1/22/2020,1/22/2020,5/25/2020,11/13/2020,11/13/2020,12/1/2020,2/15/2022,2/15/2022,3/3/2022,3/31/2022, 
6329,1842,6/15/1951,Male,186,60,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,17",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,6/19/2019,12/12/2019,12/12/2019,3/18/2020,9/9/2020,9/9/2020,10/5/2020,4/28/2021,4/28/2021,7/14/2021,11/24/2021,11/24/2021
6330,6972,6/15/1949,Male,161,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"15,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,7/1/2019,12/18/2019,12/18/2019,5/1/2020,10/26/2020,10/26/2020,11/13/2020,3/31/2022,10/14/1582, , , 
6331,8946,6/15/1952,Male,170,55,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,84","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,6/7/2019,11/21/2019,11/21/2019,5/28/2020,11/14/2020,11/14/2020,12/1/2020,8/12/2021,8/12/2021,9/10/2021,12/31/2021, 
6332,7721,6/15/1953,Male,190,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"29,69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,8/22/2019,2/16/2020,2/16/2020,5/10/2020,11/8/2020,11/8/2020,11/24/2020,12/31/2021,10/14/1582, , , 
6333,2303,6/15/1953,Female,152,45,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"10,06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,38", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,7/11/2019,1/7/2020,1/7/2020,5/8/2020,11/6/2020,11/6/2020,11/28/2020,7/6/2021,7/6/2021, , , 
6334,5228,6/15/1950,Female,162,67,Private,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,7/29/2019,1/21/2020,1/21/2020,5/28/2020,11/19/2020,11/19/2020,12/7/2020,12/1/2021,12/1/2021,1/13/2022,3/31/2022, 
6335,4543,6/15/1956,Female,161,55,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"34,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,LEV-X,V-X,7/5/2019,1/1/2020,1/1/2020,4/7/2020,9/23/2020,9/23/2020,10/11/2020,4/16/2021,4/16/2021,4/28/2021,10/5/2021,10/5/2021
6336,4195,6/15/1953,Male,202,109,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"11,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"2,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,6/7/2019,12/4/2019,12/4/2019,5/2/2020,10/18/2020,10/18/2020,10/30/2020,6/23/2021,6/23/2021, , , 
6337,4371,6/15/1951,Male,186,60,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,58",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,6/21/2019,12/20/2019,12/20/2019,4/25/2020,10/19/2020,10/19/2020,11/14/2020,5/31/2021,5/31/2021, , , 
6338,6285,6/15/1952,Male,181,101,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"21,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes,"2,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,8/29/2019,2/25/2020,2/25/2020,5/8/2020,10/30/2020,10/30/2020,11/13/2020,6/15/2021,6/15/2021, , , 
6339,2377,6/15/1951,Male,172,102,Private,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"5,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,6/20/2019,12/11/2019,12/11/2019,3/22/2020,9/19/2020,9/19/2020,10/4/2020,3/31/2022,10/14/1582, , , 
6340,4522,6/15/1952,Male,181,101,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,21","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"2,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,4/22/2019,10/17/2019,10/17/2019,4/12/2020,10/3/2020,10/3/2020,10/22/2020,3/31/2022, , , , 
6341,1830,6/15/1953,Female,164,48,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"16,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,5", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,7/11/2019,1/1/2020,1/1/2020,5/15/2020,11/7/2020,11/7/2020,11/28/2020,11/12/2021,11/12/2021,11/24/2021,3/31/2022, 
6342,9062,6/15/1948,Male,175,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"14,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,5/2/2019,10/25/2019,10/25/2019,4/22/2020,10/7/2020,10/7/2020,10/30/2020,5/17/2021,5/17/2021, , , 
6343,4109,6/15/1956,Female,166,66,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"17,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,4/4/2019,9/27/2019,9/27/2019,4/14/2020,10/2/2020,10/2/2020,10/25/2020,12/31/2021, , , , 
6344,4784,6/15/1950,Male,170,69,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"12,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,POM-X,V-X,6/24/2019,12/10/2019,12/10/2019,5/9/2020,11/3/2020,11/3/2020,11/23/2020,12/21/2020,12/21/2020,1/3/2021,5/5/2021,5/5/2021
6345,5835,6/15/1948,Female,160,63,Compulsory health insurance CHI,No, ,Yes,Yes,Yes,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"7,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,7/16/2019,1/9/2020,1/9/2020,5/22/2020,11/11/2020,11/11/2020,12/5/2020,9/2/2021,9/2/2021,9/9/2021,3/31/2022, 
6346,2352,6/15/1950,Male,170,69,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"28,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,7/25/2019,1/20/2020,1/20/2020,5/1/2020,10/18/2020,10/18/2020,11/10/2020,3/31/2022,10/14/1582, , , 
6347,6111,6/15/1955,Male,168,90,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"9,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,4/5/2019,9/26/2019,9/26/2019,3/25/2020,9/23/2020,9/23/2020,10/17/2020,7/9/2021,7/9/2021,9/13/2021,3/31/2022,10/14/1582
6348,1151,6/15/1953,Male,184,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"15,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,7/29/2019,1/21/2020,1/21/2020,5/5/2020,10/25/2020,10/25/2020,11/19/2020,3/31/2022,10/14/1582, , , 
6349,3060,6/15/1955,Female,168,72,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"9,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,5/7/2019,10/24/2019,10/24/2019,5/30/2020,11/19/2020,11/19/2020,12/7/2020,7/20/2021,7/20/2021, , , 
6350,9329,6/15/1947,Male,188,101,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"30,83","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,27", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,7/24/2019,1/13/2020,1/13/2020,5/8/2020,11/6/2020,11/6/2020,11/30/2020,12/26/2020,12/26/2020,1/18/2021,3/23/2021,3/23/2021
6351,2653,6/15/1948,Female,176,80,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"20,09","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,5/3/2019,10/17/2019,10/17/2019,4/21/2020,10/14/2020,10/14/2020,11/1/2020,2/24/2021,2/24/2021,3/17/2021,8/23/2021,8/23/2021
6352,9605,6/15/1946,Male,176,58,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"7,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,10/3/2019,3/25/2020,3/25/2020,6/14/2020,12/3/2020,12/3/2020,12/23/2020,6/15/2021,6/15/2021, , , 
6353,2691,6/15/1951,Male,185,81,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"16,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,7/11/2019,1/3/2020,1/3/2020,4/9/2020,10/4/2020,10/4/2020,10/9/2020,5/7/2021,5/7/2021, , , 
6354,4639,6/15/1950,Female,172,61,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,KYP-X,V-X,6/3/2019,11/18/2019,11/18/2019,4/27/2020,10/12/2020,10/12/2020,11/3/2020,4/4/2021,4/4/2021,4/26/2021,12/31/2021,10/14/1582
6355,6481,6/15/1950,Female,172,61,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"32,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,V-X,V-X,5/24/2019,11/22/2019,11/22/2019,3/25/2020,9/23/2020,9/23/2020,10/16/2020,3/21/2021,3/21/2021,4/12/2021,7/19/2021,7/19/2021
6356,4887,6/15/1950,Female,172,61,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"12,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,5/23/2019,11/20/2019,11/20/2019,5/19/2020,11/4/2020,11/4/2020,11/28/2020,4/11/2021,4/11/2021,5/7/2021,3/31/2022, 
6357,2102,6/15/1952,Female,158,88,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"21,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/15/2019,2/4/2020,2/4/2020,11/18/2020,6/30/2021,10/14/1582, , , , , , 
6358,6730,6/15/1951,Female,160,64,Compulsory health insurance CHI,No,Yes, ,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"14,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,POM-X,V-X,4/29/2019,10/24/2019,10/24/2019,3/22/2020,9/17/2020,9/17/2020,10/9/2020,12/25/2020,12/25/2020,1/4/2021,8/9/2021,8/9/2021
6359,3084,6/15/1953,Male,160,65,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"23,39","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,POM-X,V-X,3/27/2019,9/16/2019,9/16/2019,4/19/2020,10/12/2020,10/12/2020,10/22/2020,12/22/2021,12/22/2021,2/8/2022,3/31/2022, 
6360,6128,6/15/1951,Male,167,67,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"23,65","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,9/10/2019,3/5/2020,3/5/2020,6/15/2020,12/1/2020,12/1/2020,12/19/2020,12/29/2021,12/29/2021, , , 
6361,1652,6/15/1948,Male,174,62,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"20,18","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,4/11/2019,10/1/2019,10/1/2019,4/15/2020,10/4/2020,10/4/2020,10/21/2020,3/31/2022, , , , 
6362,6017,6/15/1954,Female,163,65,Private,No, , ,Yes, ,Yes,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"19,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,4/29/2019,10/21/2019,10/21/2019,4/30/2020,10/18/2020,10/18/2020,11/8/2020,3/31/2022,10/14/1582, , , 
6363,7402,6/15/1949,Male,174,80,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,65",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,7/5/2019,12/26/2019,12/26/2019,4/8/2020,9/30/2020,9/30/2020,10/23/2020,3/31/2022,10/14/1582, , , 
6364,6338,6/15/1967,Female,168,70,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"36,3",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,EMP-X,NIN-X,KYP-X,V-X,4/2/2013,6/18/2013,6/18/2013,5/9/2018,3/20/2019,3/20/2019,8/6/2019,8/20/2020,8/20/2020,12/2/2020,3/31/2022,10/14/1582
6365,4374,6/15/1952,Female,158,74,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,",46",unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,No,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,12/15/2020,3/12/2021,3/12/2021, , , , , , , , , 
6366,7832,6/15/1951,Female,164,60,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"42,1",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/12/2020,7/24/2020,7/24/2020, , , , , , , , , 
6367,1520,6/15/1945,Male,176,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,55,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/15/2020,12/31/2020, , , , , , , , , , 
6368,4618,6/15/1942,Female,168,53,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,62,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/15/2020,12/31/2020, , , , , , , , , , 
6369,7004,6/15/1942,Male,166,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,78,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/1/2020,12/31/2020, , , , , , , , , , 
6370,5077,6/15/1949,Female,167,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,75,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/15/2020,12/31/2020, , , , , , , , , , 
6371,1806,6/15/1936,Male,178,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,10/27/2020,12/31/2021,10/14/1582, , , , , , , , , 
6372,4608,6/15/1933,Male,182,81,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"7,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/24/2020,9/30/2021,10/14/1582, , , , , , , , , 
6373,8792,6/15/1952,Female,162,55,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,56",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/21/2020,12/17/2020,12/17/2020, , , , , , , , , 
6374,2886,6/15/1952,Male,177,84,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,"5,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/10/2020,1/12/2021,1/12/2021, , , , , , , , , 
6375,7910,6/15/1950,Female,168,72,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,125,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/16/2020,11/15/2021,11/15/2021, , , , , , , , , 
6376,9606,6/15/1955,Female,165,67,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,150,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/14/2020,5/17/2021,5/17/2021, , , , , , , , , 
6377,6908,6/15/1950,Male,168,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/18/2020,6/22/2021,6/22/2021, , , , , , , , , 
6378,6300,6/15/1948,Male,172,73,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,210,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/23/2020,6/7/2021,6/7/2021, , , , , , , , , 
6379,7177,6/15/1948,Male,175,69,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,210,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/14/2020,11/9/2021,11/9/2021, , , , , , , , , 
6380,9123,6/15/1952,Female,170,69,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"220,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,DAR-X,12/1/2020,11/15/2021,11/15/2021,12/6/2021,12/31/2021, , , , , , , 
6381,2914,6/15/1948,Male,165,68,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"190,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/23/2020,6/15/2021,6/15/2021, , , , , , , , , 
6382,3868,6/15/1944,Female,162,74,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"40,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,10/19/2020,12/31/2020, , , , , , , , , , 
6383,2739,6/15/1958,Female,158,65,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"20,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,11/16/2020,12/31/2020, , , , , , , , , , 
6384,7975,6/15/1948,Male,180,75,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"76,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,3/2/2018,10/4/2020,10/4/2020,10/4/2020,12/31/2020, , , , , , , 
6385,7251,6/15/1965,Male,182,78,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,"23,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/1/2020,3/1/2021,3/1/2021, , , , , , , , , 
6386,9954,6/15/1941,Female,166,61,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/1/2020,6/30/2021, , , , , , , , , , 
6387,2125,6/15/1940,Female,170,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,21,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,DAR-X,3/12/2021,1/11/2022,1/11/2022,1/14/2022,3/31/2022, , , , , , , 
6388,4433,6/15/1944,Female,150,55,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,13,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/26/2021,3/31/2022,10/14/1582, , , , , , , , , 
6389,3776,6/15/1945,Male,165,102,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,33,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,1/1/2020,11/6/2020,11/6/2020,1/28/2021,3/31/2022,10/14/1582, , , , , , 
6390,3460,6/15/1940,Female,166,79,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,Unknown,IgG,20,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,No,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,7/1/2019,7/13/2020,7/13/2020,3/19/2021,3/31/2022, , , , , , , 
6391,7635,6/15/1945,Female,175,82,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,2/4/2020,11/20/2020,11/20/2020,1/14/2021,9/30/2021,9/30/2021, , , , , , 
6392,7087,6/15/1968,Male,190,80,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,20,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/23/2021,5/17/2021,5/17/2021, , , , , , , , , 
6393,4327,6/15/1960,Female,161,60,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,"25,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/23/2021,3/31/2022,10/14/1582, , , , , , , , , 
6394,1703,6/15/1953,Female,164,81,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"9999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,DAR-X,4/30/2019,10/7/2020,10/7/2020,2/18/2021,3/31/2022,10/14/1582, , , , , , 
6395,2382,6/15/1953,Female,170,75,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,R-X,No CTx,No CTx,V-X,3/1/2016,4/5/2016,4/5/2016,1/28/2021,3/31/2022,10/14/1582, , , , , , 
6396,4248,6/15/1952,Female,168,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,48,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/9/2021,3/31/2022,10/14/1582, , , , , , , , , 
6397,8882,6/15/1936,Male,175,80,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,R-X,No CTx,No CTx,V-X,12/6/2019,12/21/2020,12/21/2020,1/18/2021,3/31/2022,10/14/1582, , , , , , 
6398,7599,6/15/1957,Female,160,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,21,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,1/4/2021,3/31/2022,10/14/1582, , , , , , , , , 
6399,6943,6/15/1952,Male,182,91,Private,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgA,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,No,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,10/9/2017,3/3/2019,3/3/2019,3/3/2021,3/31/2022,10/14/1582, , , , , , 
6400,5845,6/15/1948,Male,185,95,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"50,31",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/4/2021,3/23/2021,3/23/2021, , , , , , , , , 
6401,1728,6/15/1949,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes,Yes,Unknown,Unknown,Unknown,Unknown,Unknown,Yes,Unknown,9,III: one or more criteria are fulfilled,IgG,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/20/2021,4/22/2021,4/22/2021, , , , , , , , , 
6402,5766,6/15/1944,Male,178,75,Private,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/11/2021,3/31/2022,10/14/1582, , , , , , , , , 
6403,6061,6/15/1934,Male,178,77,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,9,III: one or more criteria are fulfilled,IgA,"15,6",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Nein,V-X,No CTx,No CTx,V-X,2/25/2021,4/9/2021,4/9/2021,1/14/2022,3/31/2022, , , , , , , 
6404,7369,6/15/1953,Male,170,74,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"34,79",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/25/2021,5/10/2021,5/10/2021,2/24/2022,3/31/2022, , , , , , , 
6405,5501,6/15/1949,Male,178,74,Private,No, , ,Yes, , , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgD,"88,2",unknown/ISS-Criteria not used for prognostics,Yes,Yes,No,Yes,No,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/16/2021,7/5/2021,7/5/2021, , , , , , , , , 
6406,8451,6/15/1948,Female,164,66,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,1/4/2021,6/20/2021,6/20/2021,9/29/2021,3/31/2022,10/14/1582, , , , , , 
6407,7142,6/15/1943,Male,179,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,11,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/4/2021,3/31/2022,10/14/1582, , , , , , , , , 
6408,9441,6/15/1937,Female,157,53,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,1/4/2021,6/20/2021,6/20/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
6409,9707,6/15/1939,Male,176,87,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,15,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/6/2021,6/22/2021,6/22/2021,9/13/2021,3/31/2022, , , , , , , 
6410,3588,6/15/1944,Female,161,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/6/2021,3/3/2022,3/3/2022,3/28/2022,3/31/2022, , , , , , , 
6411,6660,6/15/1944,Male,179,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"13,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/11/2021,5/16/2021,5/16/2021,9/20/2021,3/31/2022,10/14/1582, , , , , , 
6412,8743,6/15/1942,Male,177,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,1/11/2021,6/27/2021,6/27/2021,12/6/2021,3/31/2022, , , , , , , 
6413,5983,6/15/1946,Female,156,50,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,1/18/2021,6/30/2021,6/30/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
6414,5643,6/15/1951,Male,178,90,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"14,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/18/2021,5/23/2021,5/23/2021,3/24/2022,3/31/2022, , , , , , , 
6415,1774,6/15/1951,Female,166,68,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/25/2021,4/18/2021,4/18/2021,9/27/2021,3/31/2022,10/14/1582, , , , , , 
6416,9298,6/15/1938,Female,161,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,1/25/2021,9/16/2021,9/16/2021,9/30/2021,3/31/2022,10/14/1582, , , , , , 
6417,2134,6/15/1953,Male,178,92,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"11,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/1/2021,6/6/2021,6/6/2021,3/28/2022,3/31/2022, , , , , , , 
6418,4112,6/15/1952,Male,183,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,2/8/2021,3/31/2022,10/14/1582, , , , , , , , , 
6419,3642,6/15/1949,Male,177,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"17,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/8/2021,3/31/2022,10/14/1582, , , , , , , , , 
6420,2160,6/15/1944,Female,158,56,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/8/2021,6/13/2021,6/13/2021,12/7/2021,3/31/2022, , , , , , , 
6421,9013,6/15/1950,Male,180,87,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"14,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/8/2021,6/13/2021,6/13/2021,3/28/2022,3/31/2022, , , , , , , 
6422,5682,6/15/1953,Female,159,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Unknown,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,2/15/2021,3/31/2022,10/14/1582, , , , , , , , , 
6423,6186,6/15/1946,Male,176,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/15/2021,8/1/2021,8/1/2021,3/30/2022,3/31/2022, , , , , , , 
6424,7328,6/15/1943,Male,178,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"9,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/22/2021,8/8/2021,8/8/2021,2/28/2022,3/31/2022, , , , , , , 
6425,3622,6/15/1950,Female,164,61,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"16,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/1/2021,8/15/2021,8/15/2021,3/3/2022,3/31/2022, , , , , , , 
6426,6682,6/15/1954,Female,167,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/1/2021,3/31/2022,10/14/1582, , , , , , , , , 
6427,8751,6/15/1954,Male,181,88,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"18,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/8/2021,6/24/2021,6/24/2021,9/30/2021,3/31/2022,10/14/1582, , , , , , 
6428,6328,6/15/1940,Female,157,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"13,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No,"1,54", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,3/8/2021,8/22/2021,8/22/2021,3/28/2022,3/31/2022, , , , , , , 
6429,1439,6/15/1943,Female,180,90,Private,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/4/2021,6/30/2021, , , , , , , , , , 
6430,8904,6/15/1949,Male,178,80,Private,Yes,Yes,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,1/5/2021,11/11/2021,11/11/2021,12/1/2021,3/31/2022,10/14/1582, , , , , , 
6431,9153,6/15/1947,Male,180,89,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,9,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/1/2021,3/31/2021, , , , , , , , , , 
6432,3479,6/15/1949,Male,177,76,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,4102,ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/15/2021,3/31/2022,10/14/1582, , , , , , , , , 
6433,1324,6/15/1952,Male,172,78,Private,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,7,ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,DAR-X,10/19/2020,3/8/2021,3/8/2021,3/29/2021,3/31/2021, , , , , , , 
6434,6605,6/15/1949,Female,175,75,Private,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,DAR-X,KYP-X,No CTx,R-X,4/8/2019,2/26/2021,2/26/2021,3/8/2021,12/14/2021,12/14/2021,12/27/2021,12/31/2021, , , , 
6435,5717,6/15/1939,Male,178,80,Private,Yes,Yes,Yes, , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,No,Yes,No,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,1/11/2021,3/31/2021, , , , , , , , , , 
6436,7954,6/15/1959,Male,178,85,Private,No,Yes, , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/1/2021,6/30/2021, , , , , , , , , , 
6437,8016,6/15/1945,Male,180,83,Compulsory health insurance CHI,Yes,Yes, , , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,1/6/2020,2/22/2021,2/22/2021,3/2/2021,3/31/2022,10/14/1582, , , , , , 
6438,1391,6/15/1944,Female,160,67,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,2681,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/6/2021,3/31/2022,10/14/1582, , , , , , , , , 
6439,9185,6/15/1944,Male,178,82,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"29,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,EMP-X,No CTx,DAR-X,3/19/2019,7/17/2019,7/17/2019,3/18/2021,3/18/2022,3/18/2022,3/28/2022,3/31/2022, , , , 
6440,7308,6/15/1948,Male,174,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/8/2021,3/31/2021, , , , , , , , , , 
6441,7520,6/15/1947,Male,185,90,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"34,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,8/8/2019,11/17/2019,11/17/2019,3/16/2021,11/30/2021,11/30/2021,12/20/2021,3/31/2022,10/14/1582, , , 
6442,6681,6/15/1949,Male,182,85,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"36,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,11/29/2019,3/7/2020,3/7/2020,3/13/2021,2/24/2022,2/24/2022,3/14/2022,3/31/2022, , , , 
6443,6738,6/15/1939,Female,161,63,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,9,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/8/2021,8/22/2021,8/22/2021,3/17/2022,3/31/2022, , , , , , , 
6444,6479,6/15/1947,Male,186,92,Private,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,"22,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,No CTx,DAR-X,12/12/2019,4/5/2020,4/5/2020,3/22/2021,2/22/2022,2/22/2022,3/31/2022,3/31/2022, , , , 
6445,1914,6/15/1950,Female,167,65,Private,No,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,"28,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,ISA-X,No CTx,DAR-X,2/26/2018,6/25/2018,6/25/2018,3/17/2021,3/2/2022,3/2/2022,3/25/2022,3/31/2022, , , , 
6446,4282,6/15/1951,Female,168,77,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"39,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,ISA-X,No CTx,V-X,2/25/2018,5/2/2018,5/2/2018,3/16/2021,2/27/2022,2/27/2022,3/2/2022,3/31/2022,10/14/1582, , , 
6447,9009,6/15/1953,Female,171,71,Compulsory health insurance CHI,Yes,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"38,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,3/10/2021,3/4/2022,3/4/2022,3/20/2022,3/31/2022,10/14/1582, , , , , , 
6448,2133,6/15/1951,Male,184,90,Compulsory health insurance CHI,Yes,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"37,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,3/18/2021,2/23/2022,2/23/2022,3/29/2022,3/31/2022, , , , , , , 
6449,9701,6/15/1940,Female,166,74,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, ,Yes,Yes,2,III: one or more criteria are fulfilled,IgG,"8,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/1/2021,11/10/2021,11/10/2021, , , , , , , , , 
6450,4572,6/15/1947,Male,174,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,3",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,DAR-X,6/10/2019,12/10/2019,12/10/2019,2/9/2021,3/31/2021, , , , , , , 
6451,6115,6/15/1962,Male,183,88,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,3,III: one or more criteria are fulfilled,IgA,"7,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/8/2021,5/31/2021,5/31/2021, , , , , , , , , 
6452,8947,6/15/1955,Female,175,66,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/12/2021,4/14/2021,4/14/2021, , , , , , , , , 
6453,9320,6/15/1964,Male,187,96,Private,No, , , , , , , , , ,Yes,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,64",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/18/2021,8/15/2021,8/15/2021, , , , , , , , , 
6454,1614,6/15/1955,Female,158,79,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"2,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/4/2021,4/23/2021,4/23/2021, , , , , , , , , 
6455,9939,6/15/1939,Female,158,41,Compulsory health insurance CHI,Yes, , , , ,Yes, ,Yes, , ,Yes,2,Unknown,IgG,"5,06",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,37", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/15/2021,11/5/2021,11/5/2021,11/17/2021,3/31/2022,10/14/1582, , , , , , 
6456,1199,6/15/1969,Male,160,86,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"19,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/17/2021,7/7/2021,7/7/2021, , , , , , , , , 
6457,4992,6/15/1952,Male,174,63,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, ,Yes,1,III: one or more criteria are fulfilled,IgG,311,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/12/2021,5/16/2021,5/16/2021, , , , , , , , , 
6458,2808,6/15/1947,Female,158,68,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , ,Yes,1,Unknown,IgA,",13",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,DAR-X,LEV-X,V-X,1/13/2020,8/31/2020,8/31/2020,9/9/2020,2/4/2021,2/4/2021,2/24/2021,5/3/2021,5/3/2021,5/19/2021,7/7/2021,7/7/2021
6459,8669,6/15/1939,Male,178,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,187,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/18/2021,3/31/2021, , , , , , , , , , 
6460,9771,6/15/1944,Female,150,53,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,2/23/2021,12/10/2021,12/10/2021,12/14/2021,3/31/2022,10/14/1582, , , , , , 
6461,1193,6/15/1960,Male,193,120,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"3,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/29/2021,3/31/2021, , , , , , , , , , 
6462,6549,6/15/1966,Female,160,57,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes,Yes,2,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,No,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,2/20/2021,5/30/2021,5/30/2021, , , , , , , , , 
6463,8713,6/15/1948,Male,186,80,Private,No, ,Yes,Yes,Yes,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,"10,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/1/2021,3/31/2022, , , , , , , , , , 
6464,2371,6/15/1950,Female,170,71,Private,Yes, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/2/2021,3/31/2022,10/14/1582, , , , , , , , , 
6465,5290,6/15/1939,Female,158,64,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"36,72",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/25/2021,3/31/2022,10/14/1582, , , , , , , , , 
6466,2887,6/15/1946,Male,158,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"65,71","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,1/28/2021,3/31/2022, , , , , , , , , , 
6467,2281,6/15/1963,Male,196,100,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"33,2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,33", , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,Other,No CTx,No CTx,DAR-X,2/2/2021,7/6/2021,7/6/2021,3/3/2022,3/6/2022,3/6/2022, , , , , , 
6468,9106,6/15/1969,Female,168,73,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/8/2021,4/5/2021,4/5/2021, , , , , , , , , 
6469,9381,6/15/1959,Male,182,84,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, ,Yes, , ,Yes, ,3,III: one or more criteria are fulfilled,IgG,"7,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/22/2021,3/31/2021, , , , , , , , , , 
6470,1204,6/15/1938,Female,159,71,Compulsory health insurance CHI,Yes,Yes, , ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgA,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Unknown,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/25/2021,3/31/2021, , , , , , , , , , 
6471,5133,6/15/1944,Male,173,88,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , ,Yes,2,III: one or more criteria are fulfilled,IgG,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/8/2021,3/31/2021, , , , , , , , , , 
6472,7762,6/15/1940,Male,176,85,Private,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/1/2021,3/31/2021, , , , , , , , , , 
6473,9829,6/15/1953,Female,161,66,Private,Yes, ,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes,Yes,1,III: one or more criteria are fulfilled,IgA,"5,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/9/2021,3/31/2021, , , , , , , , , , 
6474,7864,6/15/1965,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L", ,R-X,KYP-X,No CTx,V-X,8/23/2010,10/11/2010,10/11/2010,2/8/2013,2/15/2021,2/15/2021,3/11/2021,11/3/2021,11/3/2021, , , 
6475,4209,6/15/1940,Male,162,50,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgG,110,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,51", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/9/2021,12/31/2021, , , , , , , , , , 
6476,9595,6/15/1936,Male,183,111,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , ,Yes,3,III: one or more criteria are fulfilled,IgG,685,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,32", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/9/2021,12/31/2021, , , , , , , , , , 
6477,9545,6/15/1943,Female,154,75,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes,"1,73", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , , ,Nein,DAR-X,No CTx,No CTx,V-X,8/28/2018,1/30/2019,1/30/2019,3/3/2021,3/31/2022,10/14/1582, , , , , , 
6478,8158,6/15/1957,Female,160,92,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,32,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/12/2021,6/3/2021,6/3/2021, , , , , , , , , 
6479,9870,6/15/1949,Male,999,80,Private,No,Yes,Yes,Yes,Yes, , , , , , ,9,III: one or more criteria are fulfilled,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,3/18/2021,3/31/2021, , , , , , , , , , 
6480,9527,6/15/1961,Female,172,64,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,3/23/2021,10/1/2021,10/1/2021,10/5/2021,12/31/2021,10/14/1582, , , , , , 
6481,5191,6/15/1941,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,216,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,3/22/2021,8/17/2021,8/17/2021, , , , , , , , , 
6482,4039,6/15/1954,Female,999,65,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"20,21", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Ja, , , , , ,No CTx,No CTx,No CTx,DAR-X,1/12/2021,3/23/2021,3/23/2021, , , , , , , , , 
6483,5251,6/15/1967,Female,999,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"20,21", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Ja, , , , , ,No CTx,No CTx,No CTx,V-X,2/1/2021,3/22/2021,3/22/2021, , , , , , , , , 
6484,4629,6/15/1951,Male,172,69,Compulsory health insurance CHI,Unknown, , , , , , , , , ,Yes,9,I: fulfilling all 4 criteria,IgA,11,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,Other,1/15/2021,2/24/2022,2/24/2022, , , , , , , , , 
6485,8243,6/15/1942,Male,999,80,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"11,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Unknown,Unknown,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,DAR-X,3/2/2021,1/6/2022,1/6/2022, , , , , , , , , 
6486,1512,6/15/1961,Female,172,75,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/18/2021,10/28/2021,10/28/2021,2/3/2022,3/31/2022, , , , , , , 
6487,3308,6/15/1940,Female,165,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,588,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Unknown,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,DAR-X,1/12/2021,4/15/2021,4/15/2021,8/3/2021,12/30/2021,12/30/2021, , , , , , 
6488,7023,6/15/1939,Female,157,46,Compulsory health insurance CHI,No, , , , , , , , , , ,1,Unknown,IgG,171,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Unknown,Unknown,"1,43", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,3/8/2021,11/15/2021,11/15/2021, , , , , , , , , 
6489,6052,6/15/1951,Female,152,51,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,200,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,46", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,8/8/2017,10/23/2017,10/23/2017,3/23/2021,6/30/2021,10/14/1582, , , , , , 
6490,2394,6/15/1952,Female,999,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,9,Unknown,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,12/2/2020,1/25/2021,1/25/2021,2/10/2021,12/31/2021,10/14/1582, , , , , , 
6491,6554,6/15/1952,Female,171,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/8/2021,6/4/2021,6/4/2021, , , , , , , , , 
6492,1250,6/15/1950,Male,179,81,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/1/2021,3/31/2022,10/14/1582, , , , , , , , , 
6493,3638,6/15/1949,Male,176,84,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"8,1",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/9/2021,3/31/2022,10/14/1582, , , , , , , , , 
6494,5179,6/15/1951,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,Yes,"20,21", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/14/2021,2/4/2021,2/4/2021,3/3/2021,4/21/2021,4/21/2021, , , , , , 
6495,9691,6/15/1946,Female,170,67,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"7,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,EMP-X,DAR-X,ISA-X,V-X,5/15/2017,12/18/2017,12/18/2017,7/15/2018,1/15/2019,1/15/2019,2/13/2019,12/15/2020,12/15/2020,2/15/2021,9/15/2021,9/15/2021
6496,1366,6/15/1963,Female,166,82,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"76,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,V-X,No CTx,V-X,11/29/2019,2/11/2020,2/11/2020,1/15/2021,2/12/2021,2/12/2021,2/23/2021,7/27/2021,7/27/2021, , , 
6497,2441,6/15/1931,Female,147,60,Compulsory health insurance CHI,Yes, , ,Yes,Yes,Yes,Yes,Yes, , , ,9,III: one or more criteria are fulfilled,IgG,"55,7",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/24/2021,3/31/2022, , , , , , , , , , 
6498,1493,6/15/1958,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/11/2021,4/26/2021,4/26/2021, , , , , , , , , 
6499,9967,6/15/1958,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,IgG,"9999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,3/29/2021,6/28/2021,6/28/2021, , , , , , , , , 
6500,1907,6/15/1952,Female,999,65,Compulsory health insurance CHI,No, , , , , , , , , , ,9,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown,"20,21", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Unbekannt,Ja,Unbekannt, , , , , ,R-X,KYP-X,No CTx,V-X,11/1/2011,12/1/2011,12/1/2011,2/20/2017,1/13/2020,1/13/2020,1/5/2021,9/6/2021,9/6/2021, , , 
6501,7294,6/15/1947,Male,174,59,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"7,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/3/2021,3/31/2022,10/14/1582, , , , , , , , , 
6502,3584,6/15/1944,Female,165,75,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,96",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/21/2021,3/23/2021,3/23/2021, , , , , , , , , 
6503,4084,6/15/1948,Female,175,72,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,01",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,1/28/2021,4/29/2021,4/29/2021,11/25/2021,3/31/2022, , , , , , , 
6504,4671,6/15/1951,Female,155,71,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,38",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/18/2021,3/31/2022,10/14/1582, , , , , , , , , 
6505,7755,6/15/1951,Male,183,72,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,89",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/19/2021,3/31/2022, , , , , , , , , , 
6506,9078,6/15/1942,Female,163,89,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,05",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/18/2021,3/31/2022,10/14/1582, , , , , , , , , 
6507,9952,6/15/1946,Male,172,58,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"16,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,1/4/2021,3/31/2022, , , , , , , , , , 
6508,9432,6/15/1945,Male,172,77,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"16,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/4/2021,3/31/2022, , , , , , , , , , 
6509,3851,6/15/1946,Male,173,75,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"14,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/4/2021,4/29/2021,4/29/2021, , , , , , , , , 
6510,8379,6/15/1961,Female,153,52,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,63",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,48", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/24/2021,12/30/2021,12/30/2021, , , , , , , , , 
6511,7169,6/15/1932,Male,175,57,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"31,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/26/2021,5/11/2021,5/11/2021, , , , , , , , , 
6512,9761,6/15/1946,Female,164,63,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"15,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/3/2021,3/31/2022, , , , , , , , , , 
6513,6744,6/15/1947,Female,163,79,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"18,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/18/2021,4/12/2021,4/12/2021, , , , , , , , , 
6514,5869,6/15/1950,Male,176,65,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"3,4",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Unbekannt,DAR-X,No CTx,No CTx,V-X,3/27/2017,6/10/2017,6/10/2017,2/26/2021,9/30/2021,10/14/1582, , , , , , 
6515,5698,6/15/1943,Female,153,53,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,1",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/5/2021,5/5/2021,5/5/2021, , , , , , , , , 
6516,6055,6/15/1949,Female,167,77,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/11/2021,4/13/2021,4/13/2021, , , , , , , , , 
6517,7453,6/15/1949,Male,176,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/21/2021,4/15/2021,4/15/2021, , , , , , , , , 
6518,6779,6/15/1941,Male,175,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,03",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/4/2021,3/31/2022,10/14/1582, , , , , , , , , 
6519,5757,6/15/1941,Female,150,82,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/19/2021,3/21/2021,3/21/2021, , , , , , , , , 
6520,9705,6/15/1944,Male,173,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,41","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/3/2021,3/31/2022,10/14/1582, , , , , , , , , 
6521,8794,6/15/1951,Female,163,54,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/29/2021,3/31/2022,10/14/1582, , , , , , , , , 
6522,3174,6/15/1949,Female,161,46,Private,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"22,55","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,45", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/3/2021,5/3/2021,5/3/2021, , , , , , , , , 
6523,7545,6/15/1948,Male,173,104,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,02",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/17/2021,12/31/2021,10/14/1582, , , , , , , , , 
6524,2511,6/15/1962,Male,177,84,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,76",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/2/2021,5/2/2021,5/2/2021, , , , , , , , , 
6525,3796,6/15/1951,Male,176,83,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,92",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,1/21/2021,12/15/2021,12/15/2021, , , , , , , , , 
6526,1881,6/15/1948,Female,179,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,26",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,1/14/2021,3/31/2022,10/14/1582, , , , , , , , , 
6527,6600,6/15/1962,Male,177,84,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,43",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/10/2021,4/12/2021,4/12/2021, , , , , , , , , 
6528,8815,6/15/1945,Female,174,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"27,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/22/2021,8/30/2021,8/30/2021, , , , , , , , , 
6529,3769,6/15/1949,Female,166,66,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"22,43","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/18/2021,6/30/2021,10/14/1582, , , , , , , , , 
6530,9753,6/15/1947,Female,177,83,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"6,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/7/2021,6/28/2021,6/28/2021, , , , , , , , , 
6531,4786,6/15/1960,Female,167,50,Private,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,8",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/16/2021,5/16/2021,5/16/2021, , , , , , , , , 
6532,5444,6/15/1941,Male,176,81,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,21",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/26/2021,3/31/2022,10/14/1582, , , , , , , , , 
6533,8811,6/15/1948,Female,165,57,Private,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,63",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/4/2021,3/6/2021,3/6/2021, , , , , , , , , 
6534,7161,6/15/1941,Male,164,126,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,09",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"2,26", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/2/2021,8/10/2021,8/10/2021, , , , , , , , , 
6535,5294,6/15/1949,Female,162,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,02",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/23/2021,7/7/2021,7/7/2021, , , , , , , , , 
6536,9321,6/15/1931,Female,164,65,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,83",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/11/2021,3/13/2021,3/13/2021, , , , , , , , , 
6537,3461,6/15/1959,Female,168,71,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"12,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/22/2021,3/31/2022,10/14/1582, , , , , , , , , 
6538,4831,6/15/1943,Female,169,73,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/15/2021,6/30/2021, , , , , , , , , , 
6539,7022,6/15/1941,Female,155,87,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"31,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/4/2021,5/4/2021,5/4/2021, , , , , , , , , 
6540,6154,6/15/1951,Female,160,47,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"16,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,46", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/3/2021,4/5/2021,4/5/2021, , , , , , , , , 
6541,2251,6/15/1944,Male,178,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,8",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/4/2021,3/31/2022, , , , , , , , , , 
6542,6171,6/15/1948,Male,189,101,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,7",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,28", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/19/2021,7/27/2021,7/27/2021, , , , , , , , , 
6543,4984,6/15/1950,Female,166,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,9",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/4/2021,3/29/2021,3/29/2021, , , , , , , , , 
6544,8810,6/15/1941,Male,187,124,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,76",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/16/2021,3/31/2022,10/14/1582, , , , , , , , , 
6545,6774,6/15/1946,Female,160,72,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"16,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/19/2021,5/14/2021,5/14/2021, , , , , , , , , 
6546,1720,6/15/1940,Female,161,70,Private,No, , ,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,7",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/29/2021,4/23/2021,4/23/2021, , , , , , , , , 
6547,6922,6/15/1944,Female,163,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"6,13","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/10/2021,4/12/2021,4/12/2021, , , , , , , , , 
6548,2435,6/15/1947,Female,160,45,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"12,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,43", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/2/2021,12/31/2021,10/14/1582, , , , , , , , , 
6549,4279,6/15/1947,Female,160,45,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"19,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,43", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/3/2021,12/31/2021,10/14/1582, , , , , , , , , 
6550,5322,6/15/1947,Male,175,64,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,51",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/28/2021,4/8/2021,4/8/2021, , , , , , , , , 
6551,5851,6/15/1951,Male,196,123,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"32,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"2,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/21/2021,12/20/2021,12/20/2021, , , , , , , , , 
6552,7773,6/15/1942,Male,173,89,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,83",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/27/2021,3/31/2022,10/14/1582, , , , , , , , , 
6553,2828,6/15/1947,Female,170,66,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"12,26","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/23/2021,3/31/2022, , , , , , , , , , 
6554,7014,6/15/1940,Female,150,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/5/2021,3/7/2021,3/7/2021, , , , , , , , , 
6555,7002,6/15/1941,Male,182,113,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,26",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,33", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/2/2021,5/25/2021,5/25/2021, , , , , , , , , 
6556,2860,6/15/1948,Male,177,74,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,26",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/17/2021,8/18/2021,8/18/2021, , , , , , , , , 
6557,1854,6/15/1944,Female,162,52,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,39","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,54", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/13/2021,7/21/2021,7/21/2021, , , , , , , , , 
6558,8233,6/15/1951,Female,158,47,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,45", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/26/2021,4/20/2021,4/20/2021, , , , , , , , , 
6559,7915,6/15/1947,Female,166,60,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,66",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/15/2021,12/21/2021,12/21/2021, , , , , , , , , 
6560,5500,6/15/1947,Female,156,43,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"2,14",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,38", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,2/9/2021,9/6/2021,9/6/2021,9/17/2021,3/31/2022,10/14/1582, , , , , , 
6561,6844,6/15/1944,Male,170,67,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,28",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/7/2021,3/31/2022,10/14/1582, , , , , , , , , 
6562,9032,6/15/1949,Male,169,72,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/23/2021,4/25/2021,4/25/2021, , , , , , , , , 
6563,7714,6/15/1950,Male,179,80,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"20,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/17/2021,6/18/2021,6/18/2021,7/7/2021,3/31/2022,10/14/1582, , , , , , 
6564,9841,6/15/1947,Male,186,119,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"19,33","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"2,42", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/16/2021,3/31/2022, , , , , , , , , , 
6565,7681,6/15/1947,Male,177,106,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"22,56","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/1/2021,4/3/2021,4/3/2021, , , , , , , , , 
6566,2097,6/15/1943,Female,165,76,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"15,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/4/2021,3/31/2022, , , , , , , , , , 
6567,8805,6/15/1949,Female,155,58,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"2,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/26/2021,8/6/2021,8/6/2021, , , , , , , , , 
6568,1476,6/15/1943,Female,177,82,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,73",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,2/23/2021,4/25/2021,4/25/2021,9/14/2021,3/31/2022, , , , , , , 
6569,6777,6/15/1942,Male,187,104,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,1",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,29", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/2/2021,4/4/2021,4/4/2021, , , , , , , , , 
6570,1902,6/15/1946,Male,177,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,25",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/9/2021,4/11/2021,4/11/2021, , , , , , , , , 
6571,2635,6/15/1935,Male,198,96,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"15,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,31", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/9/2021,5/25/2021,5/25/2021, , , , , , , , , 
6572,4218,6/15/1941,Male,184,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"3,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/15/2021,3/31/2022,10/14/1582, , , , , , , , , 
6573,9261,6/15/1945,Male,179,119,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes, , ,2,I: fulfilling all 4 criteria,IgG,"3,02",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,35", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/3/2021,8/26/2021,8/26/2021, , , , , , , , , 
6574,6474,6/15/1944,Female,168,75,Private,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"22,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/19/2021,3/21/2021,3/21/2021, , , , , , , , , 
6575,6557,6/15/1944,Female,171,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,76",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/9/2021,3/31/2022,10/14/1582, , , , , , , , , 
6576,6641,6/15/1941,Male,187,85,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"14,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/2/2021,7/6/2021,7/6/2021, , , , , , , , , 
6577,9834,6/15/1959,Male,182,93,Private,No,Yes, ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"23,06","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/20/2021,4/2/2021,4/2/2021, , , , , , , , , 
6578,6881,6/15/1948,Female,171,74,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,81",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/16/2021,5/4/2021,5/4/2021, , , , , , , , , 
6579,1735,6/15/1947,Male,165,71,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/1/2021,5/1/2021,5/1/2021, , , , , , , , , 
6580,8047,6/15/1943,Male,184,91,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,81",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/4/2021,3/31/2022,10/14/1582, , , , , , , , , 
6581,4647,6/15/1959,Female,163,65,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"28,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/21/2021,3/23/2021,3/23/2021, , , , , , , , , 
6582,5668,6/15/1949,Male,170,74,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,3,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/14/2021,3/31/2022,10/14/1582, , , , , , , , , 
6583,6659,6/15/1943,Male,180,68,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,57",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/21/2021,5/6/2021,5/6/2021, , , , , , , , , 
6584,4575,6/15/1945,Female,178,109,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"23,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,26", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/8/2021,8/30/2021,8/30/2021, , , , , , , , , 
6585,7527,6/15/1932,Male,176,66,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,68",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/4/2021,3/31/2022,10/14/1582, , , , , , , , , 
6586,3336,6/15/1951,Female,163,59,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,59",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/12/2021,11/18/2021,11/18/2021,11/23/2021,3/31/2022, , , , , , , 
6587,1323,6/15/1943,Male,177,83,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,55",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/9/2021,3/31/2022,10/14/1582, , , , , , , , , 
6588,6369,6/15/1941,Male,189,104,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"19,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,31", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/23/2021,4/25/2021,4/25/2021, , , , , , , , , 
6589,3073,6/15/1932,Female,173,103,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"1,32",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,POM-X,No CTx,V-X,7/1/2020,9/3/2020,9/3/2020,1/26/2021,7/19/2021,7/19/2021,8/1/2021,3/31/2022, , , , 
6590,5247,6/15/1971,Male,176,72,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"21,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/25/2020,8/6/2020,8/6/2020,1/25/2021,3/31/2022,10/14/1582, , , , , , 
6591,4198,6/15/1946,Male,188,97,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,08",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,23", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/18/2020,7/18/2020,7/18/2020,2/19/2021,3/31/2022,10/14/1582, , , , , , 
6592,6288,6/15/1945,Male,176,110,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"4,91",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"2,25", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,8/20/2020,10/26/2020,10/26/2020,2/16/2021,3/31/2022,10/14/1582, , , , , , 
6593,8228,6/15/1956,Male,178,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,97",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/19/2020,7/19/2020,7/19/2020,2/18/2021,3/31/2022,10/14/1582, , , , , , 
6594,4138,6/15/1952,Male,179,76,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,24",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/4/2020,11/4/2020,11/4/2020,3/3/2021,3/31/2022,10/14/1582, , , , , , 
6595,3501,6/15/1954,Male,180,90,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,7/3/2020,12/23/2020,12/23/2020,1/8/2021,3/31/2022,10/14/1582, , , , , , 
6596,2693,6/15/1951,Female,156,76,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,35","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,V-X,No CTx,V-X,11/15/2019,1/29/2020,1/29/2020,8/4/2020,3/26/2021,3/26/2021,8/31/2021,3/31/2022, , , , 
6597,4049,6/15/1948,Female,154,50,Private,No, , , , , , , ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"32,83","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,46", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,7/14/2020,1/11/2021,1/11/2021,2/3/2021,3/31/2022,10/14/1582, , , , , , 
6598,6409,6/15/1950,Female,169,57,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/17/2020,2/15/2021,2/15/2021,3/3/2021,3/31/2022,10/14/1582, , , , , , 
6599,1053,6/15/1949,Male,179,98,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,61,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/23/2021,6/30/2021, , , , , , , , , , 
6600,5014,6/15/1941,Female,164,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,1",unknown/ISS-Criteria not used for prognostics,Yes,No,No,No,No,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Nein,No CTx,No CTx,No CTx,R-X,3/19/2021,3/31/2022, , , , , , , , , , 
6601,2465,6/15/1965,Male,180,80,Private,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,45,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,2/23/2021,5/28/2021,5/28/2021, , , , , , , , , 
6602,1011,6/15/1950,Female,168,48,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,62",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,53", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/15/2020,9/28/2020,9/28/2020,1/4/2021,5/13/2021,5/13/2021, , , , , , 
6603,7778,6/15/1942,Male,999,80,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"9999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/3/2021,3/31/2022,10/14/1582, , , , , , , , , 
6604,2456,6/15/1956,Female,155,75,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"28,78","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,7/31/2020,1/28/2021,1/28/2021,2/16/2021,8/10/2021,8/10/2021, , , , , , 
6605,4597,6/15/1940,Male,177,87,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"25,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/26/2020,8/4/2020,8/4/2020,1/7/2021,3/31/2022,10/14/1582, , , , , , 
6606,9176,6/15/1952,Male,182,91,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/8/2020,7/7/2020,7/7/2020,2/4/2021,3/31/2022,10/14/1582, , , , , , 
6607,9784,6/15/1969,Male,999,80,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"12,3",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/24/2021,6/25/2021,6/25/2021, , , , , , , , , 
6608,1140,6/15/1950,Male,193,111,Private,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"3,47",ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"2,41", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,V-X,No CTx,V-X,4/30/2020,7/7/2020,7/7/2020,1/5/2021,6/9/2021,6/9/2021,8/17/2021,12/31/2021, , , , 
6609,7701,6/15/1949,Male,176,70,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,92",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,EMP-X,No CTx,V-X,3/2/2020,6/26/2020,6/26/2020,1/13/2021,2/18/2022,2/18/2022,3/9/2022,3/31/2022, , , , 
6610,2438,6/15/1962,Male,178,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,08",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/1/2020,9/1/2020,9/1/2020,2/19/2021,3/31/2022,10/14/1582, , , , , , 
6611,3449,6/15/1946,Male,188,100,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,98",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,26", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/30/2020,9/3/2020,9/3/2020,2/25/2021,3/31/2022,10/14/1582, , , , , , 
6612,7931,6/15/1932,Male,999,80,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,8",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/10/2021,3/31/2022,10/14/1582, , , , , , , , , 
6613,1288,6/15/1952,Male,183,87,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,87","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,8/11/2020,2/4/2021,2/4/2021,3/2/2021,3/31/2022,10/14/1582, , , , , , 
6614,3852,6/15/1956,Female,160,47,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,31",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,46", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/17/2020,8/26/2020,8/26/2020,2/5/2021,3/31/2022,10/14/1582, , , , , , 
6615,5155,6/15/1950,Male,193,111,Private,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,29",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,41", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,1/9/2020,3/16/2020,3/16/2020,10/1/2020,3/25/2021,3/25/2021, , , , , , 
6616,6412,6/15/1952,Female,166,66,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,32",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,7/30/2020,1/19/2021,1/19/2021,1/26/2021,3/31/2022,10/14/1582, , , , , , 
6617,4691,6/15/1951,Male,168,73,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"26,52","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,6/23/2020,12/25/2020,12/25/2020,1/13/2021,3/31/2022,10/14/1582, , , , , , 
6618,3916,6/15/1952,Female,169,64,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"11,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,4/6/2020,8/5/2020,8/5/2020,1/14/2021,3/31/2022,10/14/1582, , , , , , 
6619,1320,6/15/1953,Female,160,54,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,3/26/2020,6/11/2020,6/11/2020,1/19/2021,3/31/2022,10/14/1582, , , , , , 
6620,2990,6/15/1947,Male,198,117,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"12,39","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,51", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/19/2020,2/11/2021,2/11/2021,3/4/2021,3/31/2022,10/14/1582, , , , , , 
6621,2824,6/15/1950,Male,182,78,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,55",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/28/2020,7/10/2020,7/10/2020,1/12/2021,3/31/2022,10/14/1582, , , , , , 
6622,4634,6/15/1956,Female,170,75,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"3,69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,8/20/2020,2/5/2021,2/5/2021,2/25/2021,3/31/2022,10/14/1582, , , , , , 
6623,9425,6/15/1956,Male,171,63,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,47",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,9/8/2020,2/23/2021,2/23/2021,3/9/2021,12/31/2021,10/14/1582, , , , , , 
6624,4324,6/15/1960,Male,170,49,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"13,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,DAR-X,No CTx,R-X,8/5/2020,1/19/2021,1/19/2021,2/18/2021,11/9/2021,11/9/2021,12/7/2021,12/31/2021, , , , 
6625,1737,6/15/1948,Female,166,101,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"4,34",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,2/26/2020,5/6/2020,5/6/2020,10/2/2020,3/25/2021,3/25/2021,3/29/2021,3/31/2022, , , , 
6626,2399,6/15/1953,Female,166,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,7/30/2020,1/20/2021,1/20/2021,2/3/2021,3/17/2021,3/17/2021, , , , , , 
6627,5138,6/15/1952,Male,171,108,Compulsory health insurance CHI,No, , ,Yes, , , , ,Yes,Yes, ,2,III: one or more criteria are fulfilled,IgA,"17,04","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,8/6/2019,8/11/2020,8/11/2020,9/2/2020,12/23/2020,12/23/2020,1/11/2021,3/31/2022,10/14/1582, , , 
6628,8658,6/15/1948,Female,166,53,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,68","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,9/11/2019,9/16/2020,9/16/2020,9/20/2020,12/19/2020,12/19/2020,1/4/2021,8/5/2021,8/5/2021, , , 
6629,8224,6/15/1952,Male,171,108,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"34,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,9/23/2019,9/28/2020,9/28/2020,10/14/2020,2/5/2021,2/5/2021,2/16/2021,3/31/2022,10/14/1582, , , 
6630,3902,6/15/1956,Male,177,81,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"24,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,No CTx,V-X,11/14/2019,5/5/2020,5/5/2020,7/28/2020,1/22/2021,1/22/2021,2/16/2021,6/4/2021,6/4/2021, , , 
6631,1293,6/15/1948,Male,176,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,04",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,7/9/2020,1/4/2021,1/4/2021,1/26/2021,8/3/2021,8/3/2021, , , , , , 
6632,7227,6/15/1951,Male,185,99,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,4",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,23", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,7/8/2020,1/4/2021,1/4/2021,1/15/2021,8/19/2021,8/19/2021,9/16/2021,3/31/2022, , , , 
6633,3842,6/15/1952,Female,162,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,7/30/2020,1/26/2021,1/26/2021,2/17/2021,8/25/2021,8/25/2021, , , , , , 
6634,8671,6/15/1947,Male,173,59,Private,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"12,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,6/16/2020,8/31/2020,8/31/2020,3/11/2021,7/21/2021,7/21/2021, , , , , , 
6635,9192,6/15/1950,Male,180,116,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"9,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,34", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,10/22/2020,1/6/2021,1/6/2021,3/24/2021,1/20/2022,1/20/2022,2/11/2022,3/31/2022, , , , 
6636,7431,6/15/1955,Female,166,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,54",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/10/2020,8/20/2020,8/20/2020,3/2/2021,3/31/2022,10/14/1582, , , , , , 
6637,6355,6/15/1951,Female,159,45,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,03",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"1,43", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,7/2/2020,12/25/2020,12/25/2020,1/12/2021,3/31/2022, , , , , , , 
6638,2386,6/15/1965,Female,174,78,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,16",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/12/2020,8/11/2020,8/11/2020,3/5/2021,8/14/2021,8/14/2021, , , , , , 
6639,5163,6/15/1956,Female,160,61,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,0,I: fulfilling all 4 criteria,IgA,"1,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,8/11/2020,2/10/2021,2/10/2021,3/5/2021,9/10/2021,9/10/2021, , , , , , 
6640,6668,6/15/1954,Male,172,81,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"15,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,EMP-X,DAR-X,No CTx,V-X,7/2/2020,12/21/2020,12/21/2020,1/14/2021,12/2/2021,12/2/2021,12/10/2021,3/31/2022, , , , 
6641,8994,6/15/1955,Female,166,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,55",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/28/2020,10/12/2020,10/12/2020,2/26/2021,3/31/2022,10/14/1582, , , , , , 
6642,8285,6/15/1933,Male,178,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,38",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,8/19/2020,2/11/2021,2/11/2021,2/26/2021,9/7/2021,9/7/2021, , , , , , 
6643,4615,6/15/1952,Female,162,51,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"21,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,53", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,No CTx,V-X,4/13/2020,6/26/2020,6/26/2020,1/14/2021,7/24/2021,7/24/2021,8/5/2021,3/31/2022,10/14/1582, , , 
6644,7941,6/15/1956,Female,173,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"22,06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,8/29/2019,2/21/2020,2/21/2020,8/10/2020,1/31/2021,1/31/2021,2/18/2021,6/30/2021,10/14/1582, , , 
6645,7685,6/15/1976,Male,181,88,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"29,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,6/25/2020,12/2/2020,12/2/2020,1/21/2021,3/31/2022,10/14/1582, , , , , , 
6646,7244,6/15/1971,Male,187,94,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,95",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,7/8/2020,12/24/2020,12/24/2020,1/15/2021,7/12/2021,7/12/2021, , , , , , 
6647,4874,6/15/1946,Male,187,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,27","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,10/7/2019,3/30/2020,3/30/2020,7/13/2020,12/29/2020,12/29/2020,1/19/2021,9/29/2021,9/29/2021, , , 
6648,7361,6/15/1937,Male,172,68,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"51,7",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/12/2021,3/31/2022, , , , , , , , , , 
6649,1076,6/15/1947,Female,153,53,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"27,59","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,7/18/2019,7/23/2020,7/23/2020,7/28/2020,12/29/2020,12/29/2020,1/22/2021,12/31/2021,10/14/1582, , , 
6650,5276,6/15/1955,Male,165,72,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"26,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,9/10/2019,3/10/2020,3/10/2020,7/16/2020,1/1/2021,1/1/2021,1/22/2021,7/20/2021,7/20/2021, , , 
6651,9810,6/15/1949,Male,176,77,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,76",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,7/18/2019,7/16/2020,7/16/2020,7/21/2020,1/12/2021,1/12/2021,1/23/2021,7/6/2021,7/6/2021,7/19/2021,11/25/2021,11/25/2021
6652,8623,6/15/1952,Male,176,78,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,46",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,10/7/2019,7/22/2020,7/22/2020,8/15/2020,2/1/2021,2/1/2021,2/25/2021,7/6/2021,7/6/2021, , , 
6653,2522,6/15/1950,Female,170,78,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"17,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,DAR-X,V-X,10/7/2019,4/1/2020,4/1/2020,7/6/2020,12/24/2020,12/24/2020,1/4/2021,9/8/2021,9/8/2021,9/13/2021,3/31/2022,10/14/1582
6654,4070,6/15/1950,Male,189,78,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"12,66","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,V-X,No CTx,V-X,7/1/2019,12/30/2019,12/30/2019,6/30/2020,12/29/2020,12/29/2020,1/11/2021,7/19/2021,7/19/2021, , , 
6655,4782,6/15/1950,Male,189,78,Private,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"6,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,7/2/2019,12/25/2019,12/25/2019,7/9/2020,12/28/2020,12/28/2020,1/15/2021,8/4/2021,8/4/2021, , , 
6656,2954,6/15/1946,Male,167,65,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"11,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,KYP-X,V-X,10/23/2019,8/3/2020,8/3/2020,8/24/2020,2/18/2021,2/18/2021,3/8/2021,6/25/2021,6/25/2021,7/12/2021,3/31/2022,10/14/1582
6657,2923,6/15/1952,Female,169,76,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"16,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,12/17/2019,12/22/2020,12/22/2020,1/6/2021,2/23/2021,2/23/2021,3/13/2021,7/20/2021,7/20/2021,8/16/2021,3/31/2022,10/14/1582
6658,1953,6/15/1954,Male,184,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"12,43","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,V-X,DAR-X,No CTx,R-X,1/30/2020,7/30/2020,7/30/2020,8/23/2020,1/27/2021,1/27/2021,2/2/2021,3/31/2022,10/14/1582, , , 
6659,3659,6/15/1950,Male,181,74,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,12/10/2019,12/15/2020,12/15/2020,1/6/2021,2/13/2021,2/13/2021,3/1/2021,10/5/2021,10/5/2021,10/19/2021,3/31/2022,10/14/1582
6660,5923,6/15/1956,Female,168,68,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,39","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,10/24/2019,10/29/2020,10/29/2020,10/30/2020,3/1/2021,3/1/2021,3/15/2021,3/31/2022,10/14/1582, , , 
6661,7518,6/15/1946,Female,169,78,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"22,66","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,7/12/2019,7/17/2020,7/17/2020,7/27/2020,1/16/2021,1/16/2021,1/31/2021,10/6/2021,10/6/2021,10/27/2021,3/31/2022,10/14/1582
6662,7613,6/15/1946,Male,175,79,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"25,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,NIN-X,V-X,7/1/2019,12/26/2019,12/26/2019,7/20/2020,1/14/2021,1/14/2021,1/26/2021,9/1/2021,9/1/2021,9/20/2021,3/31/2022, 
6663,3370,6/15/1954,Female,161,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"20,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,POM-X,R-X,1/14/2020,7/12/2020,7/12/2020,7/27/2020,1/15/2021,1/15/2021,1/31/2021,7/1/2021,7/1/2021,7/21/2021,3/31/2022, 
6664,5117,6/15/1949,Male,173,51,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"32,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,6", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,8/26/2019,6/16/2020,6/16/2020,7/3/2020,12/20/2020,12/20/2020,1/13/2021,12/9/2021,12/9/2021, , , 
6665,2017,6/15/1949,Male,173,59,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"20,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,12/2/2019,7/21/2020,7/21/2020,8/11/2020,1/27/2021,1/27/2021,2/10/2021,3/31/2022,10/14/1582, , , 
6666,8311,6/15/1967,Male,186,92,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"2,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,2/22/2021,3/31/2021, , , , , , , , , , 
6667,5781,6/15/1954,Female,171,49,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"10,12","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,DAR-X,No CTx,V-X,9/12/2019,3/8/2020,3/8/2020,7/30/2020,1/22/2021,1/22/2021,2/5/2021,12/16/2021,12/16/2021, , , 
6668,6679,6/15/1950,Female,169,74,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"13,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,NIN-X,V-X,7/31/2019,1/18/2020,1/18/2020,8/6/2020,2/2/2021,2/2/2021,2/12/2021,1/10/2022,1/10/2022,1/26/2022,3/31/2022, 
6669,4506,6/15/1950,Female,177,60,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/3/2020,8/7/2020,8/7/2020,3/4/2021,3/31/2022,10/14/1582, , , , , , 
6670,9808,6/15/1970,Female,162,57,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,I: fulfilling all 4 criteria,IgA,"2,71",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,6", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,7/8/2020,12/24/2020,12/24/2020,1/11/2021,7/14/2021,7/14/2021, , , , , , 
6671,2147,6/15/1955,Female,174,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"23,48","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,12/17/2019,6/4/2020,6/4/2020,8/22/2020,2/11/2021,2/11/2021,2/24/2021,9/28/2021,9/28/2021,10/20/2021,3/31/2022,10/14/1582
6672,8661,6/15/1952,Female,164,77,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"17,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,LEV-X,V-X,8/13/2019,1/30/2020,1/30/2020,8/31/2020,2/25/2021,2/25/2021,3/12/2021,4/9/2021,4/9/2021,4/19/2021,8/30/2021,8/30/2021
6673,3134,6/15/1946,Male,175,68,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"9,04","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,9/13/2019,2/21/2020,2/21/2020,6/16/2020,12/8/2020,12/8/2020,1/1/2021,6/30/2021,10/14/1582, , , 
6674,9027,6/15/1939,Female,162,50,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"6,56","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"1,51", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/16/2021,3/31/2021, , , , , , , , , , 
6675,5910,6/15/1956,Male,167,91,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"23,97","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,">5,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,7/29/2019,1/17/2020,1/17/2020,7/1/2020,12/17/2020,12/17/2020,1/8/2021,8/3/2021,8/3/2021,8/17/2021,3/31/2022,10/14/1582
6676,9122,6/15/1958,Male,172,77,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,",6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/9/2021,7/2/2021,7/2/2021, , , , , , , , , 
6677,6745,6/15/1951,Male,177,90,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"21,7",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes,"2,07", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Nein, , , , ,Nein,R-X,DAR-X,No CTx,Other,12/11/2006,4/3/2007,4/3/2007,3/2/2016,9/21/2016,9/21/2016,3/9/2021,3/31/2022,10/14/1582, , , 
6678,9054,6/15/1955,Female,158,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"64,6",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,POM-X,No CTx,V-X,5/19/2020,7/21/2020,7/21/2020,8/3/2021,9/30/2021,9/30/2021,10/7/2021,12/10/2021,12/10/2021, , , 
6679,2312,6/15/1955,Female,160,61,Private,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"28,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/8/2021,6/9/2021,6/9/2021, , , , , , , , , 
6680,2711,6/15/1957,Male,172,92,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"6,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/1/2021,6/24/2021,6/24/2021, , , , , , , , , 
6681,2228,6/15/1950,Male,176,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"22,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/22/2021,3/31/2021, , , , , , , , , , 
6682,3636,6/15/1957,Female,159,96,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"27,2",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Unknown,"1,97", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L", ,V-X,No CTx,No CTx,V-X,12/30/2013,3/20/2014,3/20/2014,2/16/2021,3/31/2021, , , , , , , 
6683,5204,6/15/1951,Female,168,63,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,89",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/4/2021,3/29/2021,3/29/2021, , , , , , , , , 
6684,2628,6/15/1945,Female,168,55,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"14,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/22/2021,7/16/2021,7/16/2021,11/29/2021,3/31/2022, , , , , , , 
6685,6257,6/15/1942,Female,160,69,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/4/2021,4/19/2021,4/19/2021, , , , , , , , , 
6686,7201,6/15/1941,Male,179,114,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"22,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,31", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,1/27/2021,4/21/2021,4/21/2021, , , , , , , , , 
6687,1649,6/15/1955,Male,173,60,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,No CTx,R-X,7/16/2020,1/14/2021,1/14/2021,2/8/2021,8/16/2021,8/16/2021,12/28/2021,3/31/2022, , , , 
6688,1756,6/15/1948,Male,181,62,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,39",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,DAR-X,No CTx,R-X,7/30/2020,1/29/2021,1/29/2021,2/23/2021,9/14/2021,9/14/2021,11/3/2021,3/31/2022, , , , 
6689,7967,6/15/1946,Male,173,50,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,51",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,EMP-X,No CTx,R-X,8/25/2020,2/15/2021,2/15/2021,3/3/2021,9/1/2021,9/1/2021,11/29/2021,3/31/2022, , , , 
6690,1259,6/15/1955,Female,161,50,Compulsory health insurance CHI,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"29,09","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,51", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/20/2020,7/12/2020,7/12/2020,1/12/2021,3/31/2022, , , , , , , 
6691,6342,6/15/1951,Female,158,83,Compulsory health insurance CHI,No,Yes,Yes, ,Yes,Yes, , , ,Yes, ,9,III: one or more criteria are fulfilled,IgG,"4,54",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Unknown,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,2/12/2021,3/31/2022, , , , , , , , , , 
6692,6816,6/15/1952,Male,182,80,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"5,69","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/12/2021,4/12/2021,4/12/2021, , , , , , , , , 
6693,9155,6/15/1958,Male,186,67,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,"9,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/21/2021,6/24/2021,6/24/2021, , , , , , , , , 
6694,1600,6/15/1947,Female,163,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/12/2021,6/30/2021,10/14/1582, , , , , , , , , 
6695,5741,6/15/1961,Female,172,64,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,2/23/2021,6/15/2021,6/15/2021,9/7/2021,9/30/2021,10/14/1582, , , , , , 
6696,5465,6/15/1944,Female,150,53,Compulsory health insurance CHI,No, , , , ,Yes, , , , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"9999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/23/2021,12/31/2021,10/14/1582, , , , , , , , , 
6697,6123,6/15/1938,Female,164,87,Compulsory health insurance CHI,Yes, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/4/2021,3/31/2022,10/14/1582, , , , , , , , , 
6698,3523,6/15/1959,Male,187,92,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,11,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/4/2021,8/24/2021,8/24/2021, , , , , , , , , 
6699,3568,6/15/1945,Female,160,69,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"31,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/17/2021,7/22/2021,7/22/2021, , , , , , , , , 
6700,5691,6/15/1953,Male,191,98,Compulsory health insurance CHI,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,27", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/15/2012,5/15/2012,5/15/2012,5/5/2021,3/31/2022,10/14/1582, , , , , , 
6701,9743,6/15/1966,Female,168,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,Other type,"99999999,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,DAR-X,11/24/2020,1/19/2021,1/19/2021,5/28/2021,3/31/2022,10/14/1582, , , , , , 
6702,3155,6/15/1968,Female,158,70,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgG,15,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/18/2021,9/9/2021,9/9/2021, , , , , , , , , 
6703,5054,6/15/1957,Male,178,82,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,8",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/2/2021,3/31/2022,10/14/1582, , , , , , , , , 
6704,4464,6/15/1936,Male,162,62,Compulsory health insurance CHI,No, , , , , , ,Yes, , ,Yes,2,III: one or more criteria are fulfilled,IgA,26,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,4/1/2021,7/8/2021,7/8/2021, , , , , , , , , 
6705,9094,6/15/1939,Male,182,80,Private,No, , , , , , , , , , ,1,Unknown,IgG,18,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes,"2,01", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,DAR-X,5/26/2021,12/31/2021,10/14/1582, , , , , , , , , 
6706,2247,6/15/1953,Male,161,85,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,56,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,12/11/2018,4/7/2020,4/7/2020,6/11/2021,3/31/2022,10/14/1582, , , , , , 
6707,1815,6/15/1954,Female,166,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"22,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,6/18/2021,8/13/2021,8/13/2021,8/16/2021,3/31/2022,10/14/1582, , , , , , 
6708,4307,6/15/1969,Male,175,75,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,30,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/28/2021,10/18/2021,10/18/2021, , , , , , , , , 
6709,1403,6/15/1936,Male,181,80,Private,No,Yes,Yes, , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"10,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/9/2020,3/31/2022,10/14/1582, , , , , , , , , 
6710,2756,6/15/1954,Female,165,85,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"5,2",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Unknown,Unknown,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,V-X,No CTx,No CTx,V-X,2/7/2017,1/31/2018,1/31/2018,5/26/2021,3/31/2022,10/14/1582, , , , , , 
6711,3260,6/15/1969,Female,160,90,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,9",unknown/ISS-Criteria not used for prognostics,9,No,No,Yes,Unknown,Unknown,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,KYP-X,DAR-X,No CTx,V-X,4/4/2017,7/5/2017,7/5/2017,4/28/2021,11/18/2021,11/18/2021,12/1/2021,3/31/2022, , , , 
6712,3571,6/15/1947,Male,186,109,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,4",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,33", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/3/2021,3/31/2022,10/14/1582, , , , , , , , , 
6713,4849,6/15/1950,Male,175,81,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"6,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/25/2021,3/31/2022,10/14/1582, , , , , , , , , 
6714,2656,6/15/1941,Male,181,67,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, , ,Yes,0,III: one or more criteria are fulfilled,Other type,",06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/14/2021,3/31/2022,10/14/1582, , , , , , , , , 
6715,9924,6/15/1941,Female,154,56,Private,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"1,54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,53", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/14/2021,8/10/2021,8/10/2021, , , , , , , , , 
6716,1407,6/15/1940,Female,164,62,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Unknown,Unknown,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,DAR-X,1/23/2021,10/20/2021,10/20/2021, , , , , , , , , 
6717,7709,6/15/1970,Male,187,86,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"9,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/31/2021,6/30/2021, , , , , , , , , , 
6718,1393,6/15/1940,Female,160,68,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/19/2021,12/6/2021,12/6/2021, , , , , , , , , 
6719,8492,6/15/1957,Female,170,65,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , ,Yes,2,III: one or more criteria are fulfilled,IgG,368,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/9/2021,6/30/2021, , , , , , , , , , 
6720,2543,6/15/1960,Female,165,84,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,Other type,62,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,DAR-X,4/8/2021,6/24/2021,6/24/2021, , , , , , , , , 
6721,6114,6/15/1948,Male,189,95,Compulsory health insurance CHI,Yes,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,36,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,9,No,Yes,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,KYP-X,V-X,No CTx,DAR-X,6/9/2018,11/26/2020,11/26/2020,6/8/2021,2/21/2022,2/21/2022,3/20/2022,3/31/2022, , , , 
6722,9570,6/15/1949,Female,171,78,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,I: fulfilling all 4 criteria,IgG,36,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,DAR-X,7/12/2018,6/4/2019,6/4/2019,6/10/2021,3/31/2022,10/14/1582, , , , , , 
6723,5913,6/15/1950,Male,184,94,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,0, ,IgG,39,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,DAR-X,7/10/2018,11/15/2018,11/15/2018,6/16/2021,3/31/2022,10/14/1582, , , , , , 
6724,9697,6/15/1951,Female,170,87,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0, ,IgG,33,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,EMP-X,No CTx,No CTx,DAR-X,12/4/2018,4/9/2019,4/9/2019,6/20/2021,9/30/2021,10/14/1582, , , , , , 
6725,6563,6/15/1956,Female,168,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,999,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,9,9,9,Unknown,Unknown,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , , ,R-X,DAR-X,No CTx,V-X,5/15/2018,5/15/2019,5/15/2019,11/15/2019,6/15/2021,6/15/2021,6/22/2021,12/31/2021, , , , 
6726,2016,6/15/1964,Male,178,76,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,0,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"1,94", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Ja, , , , , ,V-X,DAR-X,DAR-X,V-X,9/17/2008,1/8/2009,1/8/2009,3/16/2015,5/29/2015,5/29/2015,6/25/2019,5/11/2021,5/11/2021,10/5/2021,2/2/2022,2/2/2022
6727,8157,6/15/1966,Male,181,82,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,Unknown,IgA,",58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,No,No,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,KYP-X,KYP-X,V-X,6/6/2017,11/1/2017,11/1/2017,7/27/2020,1/1/2021,1/1/2021,2/10/2021,3/30/2021,3/30/2021,5/6/2021,3/31/2022,10/14/1582
6728,4993,6/15/1959,Male,165,49,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,2,Unknown,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/26/2021,11/12/2021,11/12/2021, , , , , , , , , 
6729,8591,6/15/1958,Male,192,130,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,9,Unknown,IgG,5449,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No,"2,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/29/2021,9/13/2021,9/13/2021, , , , , , , , , 
6730,3747,6/15/1939,Male,168,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/14/2021,12/31/2021, , , , , , , , , , 
6731,3623,6/15/1948,Female,165,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,136,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Ja,No CTx,No CTx,No CTx,V-X,5/14/2021,8/4/2021,8/4/2021, , , , , , , , , 
6732,4628,6/15/1945,Female,170,73,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,4/5/2021,11/2/2021,11/2/2021,12/1/2021,3/31/2022, , , , , , , 
6733,3723,6/15/1949,Male,178,85,Private,Yes,Yes, , ,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/21/2021,3/31/2022, , , , , , , , , , 
6734,3640,6/15/1940,Female,167,80,Private,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/3/2021,6/30/2021, , , , , , , , , , 
6735,6876,6/15/1946,Male,180,86,Private,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/17/2021,12/31/2021, , , , , , , , , , 
6736,5201,6/15/1943,Male,178,96,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,13,unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,No,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Unbekannt,No CTx,No CTx,No CTx,DAR-X,5/26/2021,12/31/2021,10/14/1582, , , , , , , , , 
6737,7843,6/15/1972,Male,175,76,Private,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/3/2021,6/30/2021, , , , , , , , , , 
6738,4828,6/15/1943,Male,172,77,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, ,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgA,"6,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,4/13/2021,6/30/2021, , , , , , , , , , 
6739,6175,6/15/1939,Female,161,69,Compulsory health insurance CHI,Yes,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/14/2021,11/29/2021,11/29/2021, , , , , , , , , 
6740,2162,6/15/1969,Female,174,66,Other,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/14/2021,6/30/2021, , , , , , , , , , 
6741,5596,6/15/1950,Male,175,68,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,15,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,ISA-X,No CTx,R-X,3/20/2019,11/13/2019,11/13/2019,4/22/2020,6/10/2021,6/10/2021,6/17/2021,1/20/2022,1/20/2022, , , 
6742,9961,6/15/1946,Male,176,81,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,9,No,9,Yes,Unknown,Unknown,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,V-X,No CTx,No CTx,Other,5/1/2019,11/1/2019,11/1/2019,5/17/2021,6/30/2021, , , , , , , 
6743,4041,6/15/1943,Male,176,83,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,4128,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,6/8/2021,3/31/2022,10/14/1582, , , , , , , , , 
6744,4510,6/15/1972,Male,173,75,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,173,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/15/2020,8/26/2020,8/26/2020,4/14/2021,9/2/2021,9/2/2021, , , , , , 
6745,3725,6/15/1939,Male,164,90,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,128,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,V-X,KYP-X,EMP-X,No CTx, , , ,3/17/2014,10/14/2014,10/14/2014,8/5/2019,3/4/2021,3/4/2021,4/1/2021,6/30/2021,10/14/1582
6746,7196,6/15/1940,Female,164,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,9,Yes,9,9,Unknown,Unknown,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,KYP-X,KYP-X,No CTx,V-X,12/3/2019,12/6/2019,12/6/2019,4/29/2020,3/8/2021,3/8/2021,6/11/2021,6/30/2021,10/14/1582, , , 
6747,7639,6/15/1963,Male,170,72,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",9,Yes,No,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/23/2021,4/27/2021,4/27/2021, , , , , , , , , 
6748,8147,6/15/1938,Female,165,60,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"1,98",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,5/22/2021,6/29/2021,6/29/2021,7/15/2021,11/26/2021,11/26/2021, , , , , , 
6749,4698,6/15/1933,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,228,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L", ,R-X,No CTx,No CTx,V-X,9/2/2014,5/17/2016,5/17/2016,9/16/2016,4/12/2021,4/12/2021, , , , , , 
6750,7562,6/15/1951,Female,167,70,Private,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,7,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/10/2021,9/18/2021,9/18/2021, , , , , , , , , 
6751,5292,6/15/1947,Male,180,90,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,4/1/2019,4/12/2021,4/12/2021,5/17/2021,9/30/2021, , , , , , , 
6752,7306,6/15/1938,Male,178,85,Private,Yes, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,1/28/2019,6/1/2021,6/1/2021,6/21/2021,10/27/2021,10/27/2021, , , , , , 
6753,5737,6/15/1943,Male,181,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,9/3/2018,5/21/2021,5/21/2021,6/28/2021,1/11/2022,1/11/2022, , , , , , 
6754,4306,6/15/1946,Female,167,70,Compulsory health insurance CHI,No,Yes,Yes, , , ,Unknown,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,9,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,V-X,KYP-X,No CTx,R-X,6/19/2017,6/11/2019,6/11/2019,8/13/2019,5/5/2021,5/5/2021,6/7/2021,6/30/2021,10/14/1582, , , 
6755,4301,6/15/1947,Female,171,80,Private,Yes, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,7,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,12/10/2018,3/15/2021,3/15/2021,4/12/2021,12/31/2021, , , , , , , 
6756,5715,6/15/1946,Female,170,111,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,36,unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,Yes,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Ja,No CTx,No CTx,No CTx,DAR-X,6/23/2021,3/31/2022, , , , , , , , , , 
6757,9702,6/15/1940,Male,178,90,Compulsory health insurance CHI,Yes, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgA,23,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,No,No,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,R-X,5/3/2021,10/15/2021,10/15/2021, , , , , , , , , 
6758,2375,6/15/1940,Male,175,88,Compulsory health insurance CHI,Yes, , , , , ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,44,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/12/2021,3/31/2022, , , , , , , , , , 
6759,2596,6/15/1941,Male,170,65,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,24,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,5/27/2021,11/8/2021,11/8/2021,11/15/2021,3/31/2022, , , , , , , 
6760,5844,6/15/1969,Male,178,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,9,Unknown,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/27/2021,7/8/2021,7/8/2021, , , , , , , , , 
6761,4817,6/15/1945,Male,158,75,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/1/2021,6/30/2021, , , , , , , , , , 
6762,4132,6/15/1963,Female,170,71,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,"2,7",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Unknown,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/26/2021,6/30/2021, , , , , , , , , , 
6763,5724,6/15/1942,Male,180,95,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,No,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,4/5/2021,6/30/2021, , , , , , , , , , 
6764,9582,6/15/1959,Male,176,113,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"9,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Unknown,Unknown,"2,27", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,6/1/2018,8/1/2018,8/1/2018, , , , , , , , , 
6765,2213,6/15/1952,Male,175,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,4/5/2021,6/30/2021, , , , , , , , , , 
6766,1931,6/15/1941,Female,163,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,9",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/31/2021,6/30/2021, , , , , , , , , , 
6767,9464,6/15/1944,Female,162,61,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"1,65", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Ja, , , , , ,No CTx,No CTx,No CTx,DAR-X,1/14/2021,3/31/2022, , , , , , , , , , 
6768,1577,6/15/1941,Female,158,65,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"5,7",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/22/2021,9/3/2021,9/3/2021, , , , , , , , , 
6769,2692,6/15/1952,Female,170,70,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,9,Unknown,IgG,4410,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No,"1,81", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,4/19/2021,8/9/2021,8/9/2021,10/29/2021,3/31/2022, , , , , , , 
6770,4275,6/15/1948,Male,170,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,Unknown,IgG,"502,7",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,6/21/2021,3/31/2022,10/14/1582, , , , , , , , , 
6771,6512,6/15/1937,Female,150,70,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,Unknown,IgG,"322,8",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,V-X,V-X,No CTx,V-X,8/8/2011,4/24/2012,4/24/2012,11/2/2015,12/1/2016,12/1/2016,5/3/2021,5/25/2021,5/25/2021, , , 
6772,4503,6/15/1949,Male,174,91,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,NIN-X,No CTx,No CTx,R-X,2/18/2020,8/12/2020,8/12/2020,5/10/2021,6/30/2021, , , , , , , 
6773,9852,6/15/1946,Male,181,80,Private,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,3,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/5/2021,3/31/2022, , , , , , , , , , 
6774,8809,6/15/1949,Male,189,80,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"6,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,4/14/2021,3/31/2022,10/14/1582, , , , , , , , , 
6775,3912,6/15/1950,Female,166,65,Private,No, , , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,1/6/2020,5/24/2021,5/24/2021,5/31/2021,3/31/2022,10/14/1582, , , , , , 
6776,6238,6/15/1955,Male,178,93,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgA,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,No,No,"2,11", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Nein, , , , , ,KYP-X,DAR-X,POM-X,V-X,9/1/2016,1/15/2017,1/15/2017,11/15/2019,6/10/2020,6/10/2020,6/15/2020,1/12/2021,1/12/2021,1/15/2021,4/23/2021,4/23/2021
6777,9251,6/15/1941,Female,160,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,POM-X,POM-X,V-X,3/19/2015,1/14/2016,1/14/2016,6/15/2017,7/24/2018,7/24/2018,7/25/2018,3/24/2021,3/24/2021,4/12/2021,5/11/2021,5/11/2021
6778,8748,6/15/1951,Female,148,55,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"2,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,48", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/6/2021,6/9/2021,6/9/2021, , , , , , , , , 
6779,9449,6/15/1962,Male,178,82,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"5,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Nein,R-X,V-X,POM-X,Other,11/17/2008,2/13/2009,2/13/2009,9/1/2011,3/2/2012,3/2/2012,3/6/2012,5/14/2012,5/14/2012,10/15/2013,10/18/2018,10/18/2018
6780,3480,6/15/1954,Male,182,81,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,24","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,6/22/2021,12/6/2021,12/6/2021, , , , , , , , , 
6781,2741,6/15/1957,Male,178,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Unknown,Unknown,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,R-X,KYP-X,KYP-X,V-X,12/15/2011,1/30/2012,1/30/2012,6/15/2014,6/15/2015,6/15/2015,1/15/2016,3/14/2021,3/14/2021,3/15/2021,5/15/2021,5/15/2021
6782,8199,6/15/1943,Male,178,70,Private,No, , , , ,Yes, , ,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"4,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,9/13/2016,11/25/2016,11/25/2016,7/23/2021,12/31/2021,10/14/1582, , , , , , 
6783,9687,6/15/1938,Male,175,78,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,4/5/2021,9/19/2021,9/19/2021,3/28/2022,3/31/2022, , , , , , , 
6784,8488,6/15/1943,Female,163,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"12,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/5/2021,9/19/2021,9/19/2021,2/24/2022,3/31/2022, , , , , , , 
6785,7754,6/15/1949,Male,177,82,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgA,"11,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/12/2021,9/26/2021,9/26/2021, , , , , , , , , 
6786,9300,6/15/1951,Male,178,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,4/12/2021,3/31/2022,10/14/1582, , , , , , , , , 
6787,3865,6/15/1942,Female,164,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,1,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/12/2021,9/26/2021,9/26/2021,3/9/2022,3/31/2022, , , , , , , 
6788,2787,6/15/1938,Male,175,78,Compulsory health insurance CHI,Yes,Unknown,Unknown,Yes,Unknown,Unknown,Unknown,Unknown,Yes,Unknown,Unknown,1,III: one or more criteria are fulfilled,IgA,"8,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,4/19/2021,10/3/2021,10/3/2021,3/25/2022,3/31/2022, , , , , , , 
6789,5184,6/15/1953,Female,167,62,Compulsory health insurance CHI,No,Unknown,Unknown,Yes,Unknown,Yes,Yes,Yes,Unknown,Unknown,Unknown,1,III: one or more criteria are fulfilled,IgG,"10,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/26/2021,10/10/2021,10/10/2021, , , , , , , , , 
6790,4633,6/15/1948,Male,179,84,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"3,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/26/2021,10/10/2021,10/10/2021, , , , , , , , , 
6791,6784,6/15/1946,Female,161,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/3/2021,10/17/2021,10/17/2021,3/23/2022,3/31/2022, , , , , , , 
6792,4370,6/15/1952,Female,168,67,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,V-X,5/26/2021,7/15/2021,7/15/2021, , , , , , , , , 
6793,9793,6/15/1963,Female,158,52,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,0,Unknown,IgG,"17,2",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes,"1,51", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/4/2021,9/28/2021,9/28/2021, , , , , , , , , 
6794,7179,6/15/1947,Male,177,72,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/10/2021,10/24/2021,10/24/2021, , , , , , , , , 
6795,5361,6/15/1940,Female,158,55,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"11,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,5/10/2021,10/24/2021,10/24/2021,3/30/2022,3/31/2022, , , , , , , 
6796,8039,6/15/1939,Male,172,67,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"9,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/10/2021,10/24/2021,10/24/2021,3/17/2022,3/31/2022, , , , , , , 
6797,4141,6/15/1950,Female,165,67,Private,No, , , , ,Yes,Yes,Yes,Yes, ,Yes,1,III: one or more criteria are fulfilled,Other type,",9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/17/2021,3/31/2022,10/14/1582, , , , , , , , , 
6798,7118,6/15/1937,Male,176,86,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,5/24/2021,11/7/2021,11/7/2021,3/29/2022,3/31/2022, , , , , , , 
6799,8043,6/15/1954,Female,166,61,Compulsory health insurance CHI,No, , , ,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/24/2021,8/15/2021,8/15/2021, , , , , , , , , 
6800,2034,6/15/1954,Female,170,70,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,25,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,7/13/2021,9/28/2021,9/28/2021, , , , , , , , , 
6801,4533,6/15/1946,Female,165,66,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgA,"20,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,4/22/2021,3/31/2022,10/14/1582, , , , , , , , , 
6802,5168,6/15/1940,Female,155,48,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"31,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,44", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/27/2021,6/30/2021, , , , , , , , , , 
6803,3988,6/15/1939,Male,169,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes,Yes,1,Unknown,IgG,"1,4",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/1/2016,1/10/2017,1/10/2017,9/25/2018,7/29/2020,7/29/2020, , , , , , 
6804,4086,6/15/1943,Female,166,72,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,"1,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/31/2021,11/14/2021,11/14/2021, , , , , , , , , 
6805,4159,6/15/1939,Male,178,73,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/31/2021,11/14/2021,11/14/2021, , , , , , , , , 
6806,3429,6/15/1953,Male,184,99,Private,Yes, , , , ,Yes,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"48,22",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,5/18/2021,11/24/2021,11/24/2021, , , , , , , , , 
6807,7854,6/15/1938,Male,178,85,Private,No,Yes,Yes, , , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"64,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,4/29/2021,3/31/2022,10/14/1582, , , , , , , , , 
6808,8144,6/15/1940,Female,170,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"50,01",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Ja,No CTx,No CTx,No CTx,DAR-X,6/28/2021,8/30/2021,8/30/2021, , , , , , , , , 
6809,1702,6/15/1941,Female,164,66,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"51,07","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/11/2021,4/21/2021,4/21/2021,5/10/2021,6/2/2021,6/2/2021, , , , , , 
6810,2074,6/15/1943,Male,160,80,Private,No, , ,Yes, , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"99999999,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Unknown,Unknown,"5,36", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , , , ,R-X,DAR-X,No CTx,V-X,7/1/2017,12/1/2017,12/1/2017,8/1/2018,2/1/2021,2/1/2021,6/21/2021,6/30/2021, , , , 
6811,4700,6/15/1940,Male,160,67,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,9,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,Yes,No,No,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"<3,5 mg/L",Ja,V-X,No CTx,No CTx,V-X,1/28/2013,9/5/2013,9/5/2013,6/1/2021,11/18/2021,11/18/2021, , , , , , 
6812,7110,6/15/1945,Male,172,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,33",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/2/2021,3/31/2022,10/14/1582, , , , , , , , , 
6813,7103,6/15/1943,Male,177,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/13/2021,3/31/2022,10/14/1582, , , , , , , , , 
6814,1321,6/15/1932,Male,170,66,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,17",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/10/2021,3/31/2022,10/14/1582, , , , , , , , , 
6815,3334,6/15/1959,Female,173,69,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes,Yes, , ,3,III: one or more criteria are fulfilled,IgG,"8,87","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,No,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/4/2021,3/31/2022,10/14/1582, , , , , , , , , 
6816,9867,6/15/1942,Male,183,83,Compulsory health insurance CHI,No, , , , , , , ,Yes,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/25/2021,3/31/2022,10/14/1582, , , , , , , , , 
6817,1776,6/15/1963,Female,166,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/10/2021,8/25/2021,8/25/2021,9/13/2021,3/31/2022,10/14/1582, , , , , , 
6818,4901,6/15/1949,Male,174,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,No,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/13/2021,12/21/2021,12/21/2021, , , , , , , , , 
6819,2791,6/15/1944,Female,156,79,Compulsory health insurance CHI,No, , , ,Yes, ,Yes, , , , ,3,III: one or more criteria are fulfilled,IgG,"12,89",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/5/2021,3/31/2022, , , , , , , , , , 
6820,3458,6/15/1945,Female,164,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,76", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/17/2021,9/9/2021,9/9/2021, , , , , , , , , 
6821,5525,6/15/1968,Female,159,86,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/24/2021,3/31/2022,10/14/1582, , , , , , , , , 
6822,4407,6/15/1951,Male,177,78,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/19/2021,8/11/2021,8/11/2021, , , , , , , , , 
6823,3297,6/15/1942,Male,188,87,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,92",ISS stage II (neither stage I nor stage III),Yes,Yes,No,No,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/3/2021,3/31/2022,10/14/1582, , , , , , , , , 
6824,6651,6/15/1966,Male,174,61,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"24,81",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/26/2021,7/21/2021,7/21/2021, , , , , , , , , 
6825,3222,6/15/1948,Male,183,88,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,3,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/15/2021,3/31/2022, , , , , , , , , , 
6826,4150,6/15/1950,Female,161,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,3,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/4/2021,7/27/2021,7/27/2021, , , , , , , , , 
6827,5577,6/15/1970,Male,166,79,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/31/2021,8/23/2021,8/23/2021, , , , , , , , , 
6828,2650,6/15/1955,Female,166,68,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,76", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/20/2021,8/12/2021,8/12/2021, , , , , , , , , 
6829,9693,6/15/1945,Male,181,85,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"29,02",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/10/2021,3/31/2022, , , , , , , , , , 
6830,5034,6/15/1973,Male,168,81,Private,No,Yes, ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/3/2021,6/30/2021, , , , , , , , , , 
6831,4317,6/15/1943,Female,173,90,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,04", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/10/2021,9/2/2021,9/2/2021, , , , , , , , , 
6832,7970,6/15/1951,Male,182,77,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,81","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,4/25/2021,7/8/2021,7/8/2021,7/28/2021,9/23/2021,9/23/2021, , , , , , 
6833,3037,6/15/1950,Female,161,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,3,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,85", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/21/2021,7/14/2021,7/14/2021, , , , , , , , , 
6834,7071,6/15/1950,Male,180,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/7/2021,11/21/2021,11/21/2021, , , , , , , , , 
6835,1000,6/15/1943,Female,160,47,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"10,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,46", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/29/2021,9/21/2021,9/21/2021, , , , , , , , , 
6836,8474,6/15/1959,Male,175,82,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,98", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/2/2021,5/28/2021,5/28/2021, , , , , , , , , 
6837,1340,6/15/1948,Male,195,71,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/20/2021,3/31/2022, , , , , , , , , , 
6838,2554,6/15/1944,Female,154,46,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"17,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,41", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/7/2021,3/31/2022, , , , , , , , , , 
6839,9891,6/15/1973,Male,184,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/10/2021,3/31/2022, , , , , , , , , , 
6840,6147,6/15/1972,Male,176,98,Compulsory health insurance CHI,Yes, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,14", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/15/2021,9/7/2021,9/7/2021, , , , , , , , , 
6841,7233, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
6842,8860,6/15/1960,Female,161,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,71", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/4/2021,12/31/2021,10/14/1582, , , , , , , , , 
6843,5986,6/15/1953,Female,166,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"10,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/7/2021,11/21/2021,11/21/2021, , , , , , , , , 
6844,1732,6/15/1945,Male,175,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"7,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/14/2021,11/28/2021,11/28/2021, , , , , , , , , 
6845,1032,6/15/1941,Female,174,100,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/15/2021,3/31/2022, , , , , , , , , , 
6846,2548,6/15/1946,Male,176,109,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,",82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,24", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/25/2021,3/31/2022, , , , , , , , , , 
6847,4834,6/15/1961,Male,182,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/13/2021,3/31/2022,10/14/1582, , , , , , , , , 
6848,5097,6/15/1936,Female,162,87,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"4,18","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/27/2021,3/31/2022, , , , , , , , , , 
6849,2722,6/15/1944,Male,175,87,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/17/2021,8/25/2021,8/25/2021, , , , , , , , , 
6850,4686,6/15/1961,Male,170,75,Private,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgG,"1,63","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/29/2021,6/30/2021, , , , , , , , , , 
6851,4554,6/15/1944,Female,170,68,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,1",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/7/2021,3/31/2022, , , , , , , , , , 
6852,7788,6/15/1967,Male,177,100,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,17", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/6/2021,3/31/2022, , , , , , , , , , 
6853,7277,6/15/1961,Male,178,83,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/14/2021,7/30/2021,7/30/2021, , , , , , , , , 
6854,7193,6/15/1948,Male,172,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,No,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/10/2021,11/15/2021,11/15/2021, , , , , , , , , 
6855,4941,6/15/1964,Male,181,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/22/2021,10/5/2021,10/5/2021, , , , , , , , , 
6856,7144,6/15/1947,Male,184,83,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgG,"3,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/14/2021,3/31/2022, , , , , , , , , , 
6857,3741,6/15/1931,Female,173,70,Compulsory health insurance CHI,No,Yes, , , , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/25/2021,3/31/2022, , , , , , , , , , 
6858,1309,6/15/1955,Male,179,91,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,No,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/14/2021,6/30/2021, , , , , , , , , , 
6859,7694,6/15/1938,Male,179,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,",64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/31/2021,12/31/2021,12/31/2021, , , , , , , , , 
6860,8196,6/15/1935,Male,186,118,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,41", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/27/2021,11/2/2021,11/2/2021, , , , , , , , , 
6861,3944,6/15/1936,Female,172,84,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,3,III: one or more criteria are fulfilled,IgA,"18,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/6/2021,3/31/2022, , , , , , , , , , 
6862,1536,6/15/1933,Female,179,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/14/2021,3/31/2022,10/14/1582, , , , , , , , , 
6863,5933,6/15/1946,Male,182,81,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/25/2021,3/31/2022, , , , , , , , , , 
6864,7531,6/15/1961,Female,152,48,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,42", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/4/2021,7/27/2021,7/27/2021, , , , , , , , , 
6865,6726,6/15/1955,Female,156,63,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/11/2021,8/3/2021,8/3/2021, , , , , , , , , 
6866,9642,6/15/1946,Female,166,73,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,22","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,81", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/26/2021,3/31/2022, , , , , , , , , , 
6867,1922,6/15/1968,Male,193,77,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"1,89","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/2/2021,6/30/2021, , , , , , , , , , 
6868,5925,6/15/1963,Female,158,55,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,76","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/4/2021,6/29/2021,6/29/2021, , , , , , , , , 
6869,9518,6/15/1945,Female,172,56,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes,Yes, ,3,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,13",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/23/2021,3/31/2022,10/14/1582, , , , , , , , , 
6870,2599,6/15/1946,Female,172,59,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,3,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,No,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,R-X,POM-X,NIN-X,V-X,6/17/2019,10/14/2019,10/14/2019,6/9/2020,3/25/2021,3/25/2021,4/27/2021,11/18/2021,11/18/2021,1/19/2022,3/31/2022, 
6871,5230,6/15/1947,Male,182,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/12/2021,3/31/2022,10/14/1582, , , , , , , , , 
6872,6124,6/15/1950,Male,176,56,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,89","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/7/2021,3/31/2022,10/14/1582, , , , , , , , , 
6873,1436,6/15/1942,Male,185,64,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,85", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/19/2021,8/11/2021,8/11/2021, , , , , , , , , 
6874,8394,6/15/1946,Male,181,98,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/29/2021,3/31/2022,10/14/1582, , , , , , , , , 
6875,6211,6/15/1944,Female,160,59,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,61", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/29/2021,3/31/2022, , , , , , , , , , 
6876,1194,6/15/1953,Male,181,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,8/9/2018,10/4/2018,10/4/2018,5/31/2021,3/31/2022,10/14/1582, , , , , , 
6877,5340,6/15/1944,Male,177,70,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"12,63",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/21/2021,3/31/2022,10/14/1582, , , , , , , , , 
6878,9800,6/15/1970,Female,168,64,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/26/2021,8/18/2021,8/18/2021, , , , , , , , , 
6879,6839,6/15/1951,Male,184,84,Private,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,47","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/10/2021,8/2/2021,8/2/2021, , , , , , , , , 
6880,8995,6/15/1952,Female,172,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/4/2021,9/10/2021,9/10/2021, , , , , , , , , 
6881,7211,6/15/1950,Female,159,47,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"23,5",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,45", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/23/2021,3/31/2022,10/14/1582, , , , , , , , , 
6882,1511,6/15/1931,Female,162,48,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"1,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,49", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/24/2021,8/9/2021,8/9/2021, , , , , , , , , 
6883,2318,6/15/1949,Male,167,67,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,75", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/13/2021,8/5/2021,8/5/2021, , , , , , , , , 
6884,1401,6/15/1961,Male,176,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,6",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,5/7/2020,7/2/2020,7/2/2020,6/8/2021,3/31/2022,10/14/1582, , , , , , 
6885,1211,6/15/1936,Male,168,80,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgA,"18,04",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/27/2021,8/22/2021,8/22/2021, , , , , , , , , 
6886,8561,6/15/1956,Male,188,71,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/27/2021,8/19/2021,8/19/2021, , , , , , , , , 
6887,9762,6/15/1964,Female,159,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,",54","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/12/2017,9/6/2017,9/6/2017,5/13/2021,3/31/2022,10/14/1582, , , , , , 
6888,6906,6/15/1940,Female,174,65,Compulsory health insurance CHI,Yes,Yes,Yes, , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/9/2021,3/31/2022,10/14/1582, , , , , , , , , 
6889,6236,6/15/1949,Male,171,62,Private,No,Yes, ,Yes, ,Yes,Yes, ,Yes, , ,3,III: one or more criteria are fulfilled,IgG,"24,91",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/10/2021,11/15/2021,11/15/2021, , , , , , , , , 
6890,8178,6/15/1942,Male,181,83,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,3,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/24/2021,3/31/2022, , , , , , , , , , 
6891,6038,6/15/1954,Male,178,102,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,19", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,4/9/2021,12/31/2021, , , , , , , , , , 
6892,4106,6/15/1934,Female,168,76,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,"23,4",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/8/2021,7/19/2021,7/19/2021, , , , , , , , , 
6893,8078,6/15/1947,Female,174,76,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/24/2021,12/31/2021,10/14/1582, , , , , , , , , 
6894,5137,6/15/1947,Male,184,93,Private,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/28/2021,9/30/2021, , , , , , , , , , 
6895,4452,6/15/1929,Male,178,68,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes, ,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"15,97",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/17/2021,9/9/2021,9/9/2021,12/7/2021,12/31/2021,10/14/1582, , , , , , 
6896,9544,6/15/1967,Male,181,106,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,04","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,26", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/7/2021,8/30/2021,8/30/2021, , , , , , , , , 
6897,5385,6/15/1938,Female,169,72,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"19,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/28/2021,3/31/2022, , , , , , , , , , 
6898,6785,6/15/1965,Female,167,67,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,3,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,No,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,6/11/2021,8/24/2021,8/24/2021,9/10/2021,3/31/2022, , , , , , , 
6899,2997,6/15/1957,Female,166,64,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"8,87",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/28/2021,7/21/2021,7/21/2021, , , , , , , , , 
6900,8978,6/15/1945,Male,174,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,87", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/9/2021,3/31/2022, , , , , , , , , , 
6901,1464,6/15/1944,Male,182,98,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,No,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,5/10/2021,7/26/2021,7/26/2021, , , , , , , , , 
6902,4755,6/15/1930,Male,184,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,5",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,5/17/2021,3/31/2022, , , , , , , , , , 
6903,7996,6/15/1938,Female,168,86,Private,No, , , , ,Yes, ,Yes,Yes, , ,3,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/14/2021,3/31/2022, , , , , , , , , , 
6904,7264,6/15/1980,Female,168,64,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"25,91",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/22/2021,9/14/2021,9/14/2021, , , , , , , , , 
6905,2851,6/15/1952,Female,168,50,Compulsory health insurance CHI,No, , , ,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,5/15/2019,9/11/2019,9/11/2019,4/20/2021,12/8/2021,12/8/2021,12/29/2021,3/31/2022, , , , 
6906,5369,6/15/1954,Female,166,63,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,5/26/2021,12/1/2021,12/1/2021, , , , , , , , , 
6907,4701,6/15/1939,Female,157,66,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,",93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,67", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/18/2017,9/12/2017,9/12/2017,5/19/2021,7/21/2021,7/21/2021, , , , , , 
6908,5519,6/15/1929,Male,195,87,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,48","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/10/2021,12/16/2021,12/16/2021,1/13/2022,3/31/2022, , , , , , , 
6909,2580,6/15/1957,Male,179,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,04", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/19/2021,8/11/2021,8/11/2021,9/1/2021,3/31/2022,10/14/1582, , , , , , 
6910,8612,6/15/1957,Male,183,80,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/29/2021,3/31/2022, , , , , , , , , , 
6911,4859,6/15/1939,Male,179,87,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,",96",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/9/2021,11/24/2021,11/24/2021, , , , , , , , , 
6912,5535,6/15/1954,Female,176,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,",93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,95", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/27/2021,7/22/2021,7/22/2021, , , , , , , , , 
6913,4016,6/15/1967,Female,170,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,92", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/13/2021,8/5/2021,8/5/2021, , , , , , , , , 
6914,1108,6/15/1941,Female,161,81,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"15,33",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/10/2021,6/30/2021, , , , , , , , , , 
6915,8418,6/15/1941,Female,157,48,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"16,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,45", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/2/2021,3/31/2022,10/14/1582, , , , , , , , , 
6916,1283,6/15/1952,Male,178,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,96", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/20/2013,5/15/2013,5/15/2013,6/11/2021,3/31/2022,10/14/1582, , , , , , 
6917,9255,6/15/1930,Male,191,97,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,26", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,NIN-X,V-X,4/19/2016,3/22/2017,3/22/2017,5/19/2020,3/23/2021,3/23/2021,5/25/2021,7/19/2021,7/19/2021,8/9/2021,3/31/2022, 
6918,3758,6/15/1954,Female,170,78,Compulsory health insurance CHI,No,Yes, , , , ,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"8,25",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,4/23/2019,4/10/2020,4/10/2020,4/2/2021,10/8/2021,10/8/2021,1/13/2022,3/31/2022, , , , 
6919,2700,6/15/1950,Male,181,83,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgM,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,03", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/3/2021,6/30/2021, , , , , , , , , , 
6920,1812,6/15/1933,Female,169,53,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"21,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,Yes,Yes,"1,6", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,6/12/2019,5/28/2020,5/28/2020,6/14/2021,6/30/2021, , , , , , , 
6921,1036,6/15/1946,Male,182,95,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/20/2021,3/31/2022,10/14/1582, , , , , , , , , 
6922,5604,6/15/1956,Female,159,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,73", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,KYP-X,DAR-X,No CTx,V-X,7/5/2018,8/29/2018,8/29/2018,2/13/2020,2/4/2021,2/4/2021,5/13/2021,6/30/2021, , , , 
6923,1405,6/15/1948,Female,168,95,Compulsory health insurance CHI,Unknown,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,32",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/17/2021,9/9/2021,9/9/2021, , , , , , , , , 
6924,7039,6/15/1939,Male,178,84,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"21,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,8/2/2019,8/11/2020,8/11/2020,5/27/2021,3/31/2022,10/14/1582, , , , , , 
6925,5900,6/15/1959,Male,171,62,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,73", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/18/2014,4/15/2014,4/15/2014,5/17/2021,8/5/2021,8/5/2021, , , , , , 
6926,9424,6/15/1959,Male,171,62,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,73", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/17/2014,8/12/2014,8/12/2014,6/29/2021,8/3/2021,8/3/2021, , , , , , 
6927,4028,6/15/1947,Female,166,95,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,02", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,4/6/2021,3/31/2022, , , , , , , , , , 
6928,5197,6/15/1941,Male,175,63,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,77", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,POM-X,V-X,3/22/2017,5/17/2017,5/17/2017,7/15/2020,4/20/2021,4/20/2021,5/19/2021,8/25/2021,8/25/2021,9/15/2021,3/31/2022, 
6929,4368,6/15/1955,Male,189,125,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,5", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,EMP-X,No CTx,V-X,11/25/2015,1/20/2016,1/20/2016,4/6/2021,10/6/2021,10/6/2021,10/20/2021,3/31/2022,10/14/1582, , , 
6930,9289,6/15/1951,Male,174,66,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,06","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,4/18/2019,4/9/2020,4/9/2020,4/2/2021,3/31/2022,10/14/1582, , , , , , 
6931,4631,6/15/1941,Male,181,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,68","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,No,Yes,Yes,No,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,5/28/2019,11/12/2019,11/12/2019,4/28/2021,3/31/2022, , , , , , , 
6932,9023,6/15/1947,Male,188,92,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,7/16/2019,6/29/2020,6/29/2020,5/6/2021,6/30/2021, , , , , , , 
6933,9728,6/15/1959,Male,167,49,Compulsory health insurance CHI,Yes, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,19","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,53", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,8/21/2019,8/13/2020,8/13/2020,5/11/2021,6/30/2021, , , , , , , 
6934,9597,6/15/1962,Female,163,69,Compulsory health insurance CHI,Unknown, ,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"17,78",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/5/2019,8/30/2019,8/30/2019,4/28/2021,3/31/2022,10/14/1582, , , , , , 
6935,6182,6/15/1971,Female,165,58,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,63", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,4/15/2015,8/19/2015,8/19/2015,8/5/2020,4/27/2021,4/27/2021,6/28/2021,3/31/2022, , , , 
6936,5387,6/15/1943,Male,173,58,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,76","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,R-X,DAR-X,No CTx,V-X,4/17/2019,6/12/2019,6/12/2019,7/15/2020,4/12/2021,4/12/2021,5/11/2021,6/30/2021, , , , 
6937,6718,6/15/1940,Female,159,73,Private,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,6/21/2016,6/6/2017,6/6/2017,6/3/2020,4/6/2021,4/6/2021,5/13/2021,8/24/2021,8/24/2021,9/13/2021,3/31/2022,10/14/1582
6938,2509,6/15/1953,Male,191,69,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,3,III: one or more criteria are fulfilled,IgA,"5,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,7/2/2019,6/23/2020,6/23/2020,4/6/2021,3/31/2022,10/14/1582, , , , , , 
6939,3437,6/15/1967,Male,170,84,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,75","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,95", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/13/2014,7/8/2014,7/8/2014,5/20/2021,3/31/2022,10/14/1582, , , , , , 
6940,7377,6/15/1952,Male,183,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,06","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,V-X,No CTx,R-X,11/14/2018,11/5/2019,11/5/2019,6/10/2021,9/8/2021,9/8/2021,9/28/2021,3/31/2022, , , , 
6941,2587,6/15/1949,Male,169,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,96","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/18/2021,3/31/2022,10/14/1582, , , , , , , , , 
6942,6483,6/15/1961,Male,170,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,66","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/21/2021,8/18/2021,8/18/2021,9/2/2021,3/31/2022,10/14/1582, , , , , , 
6943,6933,6/15/1960,Male,174,73,Compulsory health insurance CHI,Yes, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/14/2021,9/6/2021,9/6/2021, , , , , , , , , 
6944,3127,6/15/1959,Male,175,89,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,05", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/19/2017,12/14/2017,12/14/2017,5/17/2021,12/31/2021,10/14/1582, , , , , , 
6945,3445,6/15/1931,Female,165,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,71","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,6", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,7/18/2017,9/12/2017,9/12/2017,2/5/2020,9/23/2020,9/23/2020,4/11/2021,12/31/2021,10/14/1582, , , 
6946,3303,6/15/1956,Female,162,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,65", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,NIN-X,V-X,2/10/2015,5/6/2015,5/6/2015,3/3/2020,8/26/2020,8/26/2020,6/17/2021,9/7/2021,9/7/2021,9/21/2021,12/31/2021, 
6947,1976,6/15/1959,Male,171,72,Compulsory health insurance CHI,Yes, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,33","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,84", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,R-X,EMP-X,No CTx,V-X,2/14/2018,4/11/2018,4/11/2018,5/27/2021,12/3/2021,12/3/2021,12/20/2021,12/31/2021, , , , 
6948,6401,6/15/1943,Male,175,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,43","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,KYP-X,R-X,2/7/2018,8/9/2018,8/9/2018,6/7/2021,9/20/2021,9/20/2021,9/28/2021,12/20/2021,12/20/2021,12/27/2021,12/31/2021, 
6949,9899,6/15/1953,Male,178,105,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/18/2019,8/13/2019,8/13/2019,5/6/2021,3/31/2022,10/14/1582, , , , , , 
6950,3927,6/15/1949,Female,168,97,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,KYP-X,V-X,11/28/2017,11/13/2018,11/13/2018,8/18/2020,1/21/2021,1/21/2021,4/20/2021,8/18/2021,8/18/2021,9/2/2021,3/31/2022,10/14/1582
6951,3795,6/15/1976,Female,167,79,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,5/7/2019,11/26/2019,11/26/2019,4/21/2021,3/31/2022,10/14/1582, , , , , , 
6952,9804,6/15/1949,Female,168,97,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/13/2018,11/8/2018,11/8/2018,11/22/2021,3/31/2022, , , , , , , 
6953,4102,6/15/1968,Male,183,81,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,91","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/22/2019,9/30/2019,9/30/2019,4/9/2021,3/31/2022, , , , , , , 
6954,7175,6/15/1971,Male,181,86,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,54","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/6/2019,8/1/2019,8/1/2019,5/13/2021,12/15/2021,12/15/2021, , , , , , 
6955,5515,6/15/1950,Male,181,87,Compulsory health insurance CHI,Yes, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgA,"1,31","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,08", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,5/20/2015,10/14/2015,10/14/2015,5/6/2020,4/7/2021,4/7/2021,5/4/2021,2/10/2022,2/10/2022,3/22/2022,3/31/2022, 
6956,5118,6/15/1946,Female,160,47,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,47","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,46", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/12/2017,3/9/2017,3/9/2017,6/9/2021,3/31/2022,10/14/1582, , , , , , 
6957,3079,6/15/1944,Male,173,92,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,3,III: one or more criteria are fulfilled,IgG,"8,73",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Ja,R-X,POM-X,DAR-X,V-X,6/4/2019,11/12/2019,11/12/2019,6/9/2021,8/9/2021,8/9/2021,8/31/2021,12/10/2021,12/10/2021,2/21/2022,3/31/2022, 
6958,8155,6/15/1959,Female,173,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,37","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/19/2017,7/14/2017,7/14/2017,6/7/2021,3/31/2022,10/14/1582, , , , , , 
6959,5177,6/15/1953,Male,181,64,Compulsory health insurance CHI,No, ,Yes, ,Yes, ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/18/2019,6/13/2019,6/13/2019,5/18/2021,3/31/2022,10/14/1582, , , , , , 
6960,3326,6/15/1955,Male,173,82,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"1,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,96", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/5/2015,4/2/2015,4/2/2015,6/10/2021,3/31/2022,10/14/1582, , , , , , 
6961,4266,6/15/1936,Male,175,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,89", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,3/13/2013,2/25/2014,2/25/2014,1/8/2020,3/29/2021,3/29/2021,4/20/2021,11/3/2021,11/3/2021, , , 
6962,5825,6/15/1944,Female,168,84,Compulsory health insurance CHI,Yes, , ,Yes, , ,Yes, , ,Yes, ,3,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,79","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,NIN-X,No CTx,R-X,7/23/2019,6/16/2020,6/16/2020,4/8/2021,10/14/2021,10/14/2021,2/3/2022,3/31/2022, , , , 
6963,9674,6/15/1954,Male,186,106,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,3", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,4/9/2019,6/4/2019,6/4/2019,6/17/2021,3/31/2022, , , , , , , 
6964,2652,6/15/1939,Male,177,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,9/7/2016,8/21/2017,8/21/2017,3/13/2019,5/10/2021,5/10/2021,6/2/2021,12/13/2021,12/13/2021, , , 
6965,5012,6/15/1937,Male,180,79,Private,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgA,"12,37",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,4/3/2019,3/25/2020,3/25/2020,5/11/2021,11/23/2021,11/23/2021, , , , , , 
6966,7106,6/15/1938,Female,163,54,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,10/10/2018,4/3/2019,4/3/2019,5/6/2021,12/28/2021,12/28/2021,2/9/2022,3/31/2022, , , , 
6967,9729,6/15/1937,Male,178,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,2, , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,EMP-X,V-X,6/3/2015,5/10/2016,5/10/2016,3/4/2020,4/28/2021,4/28/2021,5/6/2021,6/29/2021,6/29/2021,7/22/2021,3/31/2022,10/14/1582
6968,1156,6/15/1973,Male,189,89,Private,Unknown,Yes,Yes, , , ,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,51","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/23/2019,7/18/2019,7/18/2019,6/8/2021,3/31/2022,10/14/1582, , , , , , 
6969,6849,6/15/1937,Male,187,67,Compulsory health insurance CHI,Unknown,Yes, , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/3/2019,11/27/2019,11/27/2019,5/24/2021,3/31/2022,10/14/1582, , , , , , 
6970,3196,6/15/1935,Female,158,53,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,52", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,1/20/2016,3/16/2016,3/16/2016,2/18/2020,2/8/2021,2/8/2021,5/6/2021,3/31/2022,10/14/1582, , , 
6971,4578,6/15/1936,Female,167,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,88", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,1/13/2016,3/9/2016,3/9/2016,4/22/2021,3/31/2022,10/14/1582, , , , , , 
6972,1070,6/15/1929,Male,176,56,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,69", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,POM-X,No CTx,V-X,11/4/2015,12/30/2015,12/30/2015,2/13/2020,3/11/2021,3/11/2021,4/12/2021,12/8/2021,12/8/2021, , , 
6973,3901,6/15/1937,Male,175,83,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"13,01","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,5/30/2021,3/31/2022, , , , , , , , , , 
6974,9356,6/15/1948,Female,163,58,Compulsory health insurance CHI,No,Yes, , , ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,6/11/2019,5/27/2020,5/27/2020,4/14/2021,3/31/2022,10/14/1582, , , , , , 
6975,6070,6/15/1935,Female,158,53,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"1,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,52", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/16/2016,7/11/2016,7/11/2016,6/8/2021,6/30/2021, , , , , , , 
6976,7318,6/15/1937,Male,183,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,01", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/18/2018,6/13/2018,6/13/2018,6/9/2021,7/22/2021,7/22/2021, , , , , , 
6977,7099,6/15/1980,Male,188,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,13","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,12", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,3/2/2017,4/27/2017,4/27/2017,6/17/2021,3/31/2022,10/14/1582, , , , , , 
6978,1765,6/15/1947,Male,165,85,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgD,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/18/2019,8/13/2019,8/13/2019,6/15/2021,3/31/2022,10/14/1582, , , , , , 
6979,7616,6/15/1955,Male,174,87,Private,No, ,Yes,Yes, , ,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,4/3/2019,3/24/2020,3/24/2020,9/8/2020,5/25/2021,5/25/2021,6/28/2021,12/2/2021,12/2/2021,12/21/2021,3/31/2022, 
6980,5497,6/15/1952,Male,193,86,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , ,Yes, ,3,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,POM-X,No CTx,R-X,4/4/2019,3/26/2020,3/26/2020,6/3/2021,12/9/2021,12/9/2021,2/28/2022,3/31/2022, , , , 
6981,5987,6/15/1960,Female,166,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,KYP-X,No CTx,R-X,8/29/2019,9/3/2020,9/3/2020,4/19/2021,10/25/2021,10/25/2021,3/18/2022,3/31/2022,10/14/1582, , , 
6982,1958,6/15/1959,Male,188,99,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,35","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,25", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/7/2017,4/4/2017,4/4/2017,6/24/2021,3/31/2022,10/14/1582, , , , , , 
6983,2708,6/15/1931,Female,161,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,71", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,8/21/2018,6/19/2019,6/19/2019,5/19/2021,11/24/2021,11/24/2021, , , , , , 
6984,7085,6/15/1939,Female,170,93,Private,No, ,Yes, , , ,Yes,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,1",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/20/2019,8/15/2019,8/15/2019,5/24/2021,3/31/2022,10/14/1582, , , , , , 
6985,7936,6/15/1949,Female,159,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,",61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/12/2018,6/7/2018,6/7/2018,6/21/2021,6/30/2021, , , , , , , 
6986,1284,6/15/1946,Male,179,108,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,26", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/22/2017,1/17/2018,1/17/2018,6/3/2021,3/31/2022,10/14/1582, , , , , , 
6987,4442,6/15/1934,Male,173,73,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,12/20/2016,11/29/2017,11/29/2017,9/2/2020,5/17/2021,5/17/2021,6/3/2021,9/7/2021,9/7/2021,9/27/2021,3/31/2022,10/14/1582
6988,7238,6/15/1947,Male,174,71,Private,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"22,64","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,5/21/2019,4/28/2020,4/28/2020,5/24/2021,3/31/2022,10/14/1582, , , , , , 
6989,5574,6/15/1942,Female,174,58,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,5/8/2019,4/20/2020,4/20/2020,5/24/2021,3/31/2022,10/14/1582, , , , , , 
6990,4269,6/15/1969,Female,160,47,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,46", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,DAR-X,V-X,5/10/2017,4/17/2018,4/17/2018,12/18/2019,3/23/2021,3/23/2021,4/22/2021,8/20/2021,8/20/2021,9/14/2021,3/31/2022,10/14/1582
6991,1161,6/15/1953,Male,180,108,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,96","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,27", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,5/7/2014,7/2/2014,7/2/2014,5/12/2021,3/31/2022,10/14/1582, , , , , , 
6992,9312,6/15/1974,Male,180,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"11,93",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/3/2019,8/28/2019,8/28/2019,6/10/2021,3/31/2022,10/14/1582, , , , , , 
6993,9209,6/15/1969,Male,170,52,Private,No,Yes,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,6/10/2019,8/6/2019,8/6/2019,6/10/2020,3/30/2021,3/30/2021,4/21/2021,3/31/2022,10/14/1582, , , 
6994,7158,6/15/1944,Male,195,100,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,32", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,4/17/2018,3/25/2019,3/25/2019,5/4/2021,6/30/2021, , , , , , , 
6995,4852,6/15/1945,Female,168,72,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,81", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,No CTx,No CTx,R-X,3/19/2019,12/10/2019,12/10/2019,4/7/2021,10/6/2021,10/6/2021, , , , , , 
6996,7875,6/15/1954,Male,184,67,Private,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/6/2019,11/1/2019,11/1/2019,6/9/2021,11/24/2021,11/24/2021, , , , , , 
6997,1304,6/15/1949,Male,183,84,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,33","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,06", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,V-X,NIN-X,V-X,5/15/2018,5/7/2019,5/7/2019,6/14/2021,6/28/2021,6/28/2021,7/1/2021,1/13/2022,1/13/2022,1/26/2022,3/31/2022, 
6998,9011,6/15/1960,Male,186,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,",92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,11", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,3/10/2016,2/28/2017,2/28/2017,7/21/2020,4/6/2021,4/6/2021,5/18/2021,7/13/2021,7/13/2021, , , 
6999,6792,6/15/1946,Female,179,67,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,92","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/11/2019,8/6/2019,8/6/2019,4/8/2021,12/10/2021,12/10/2021, , , , , , 
7000,1487,6/15/1963,Male,186,104,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"21,72","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"2,28", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,4/3/2019,10/29/2019,10/29/2019,5/3/2021,3/31/2022,10/14/1582, , , , , , 
7001,2499,6/15/1939,Male,170,80,Private,Yes, , , , , , , , ,Yes,Yes,1,III: one or more criteria are fulfilled,IgA,"4,83",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,No,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,R-X,EMP-X,ISA-X,V-X,3/14/2014,7/30/2014,7/30/2014,8/18/2014,5/2/2016,5/2/2016,5/3/2018,3/19/2021,3/19/2021,4/7/2021,12/31/2021,10/14/1582
7002,6673,6/15/1951,Female,158,68,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,0,III: one or more criteria are fulfilled,IgG,10626,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,4/22/2021,6/21/2021,6/21/2021, , , , , , , , , 
7003,5264,6/15/1955,Male,180,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1085,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/15/2019,1/17/2020,1/17/2020, , , , , , , , , 
7004,4330,6/15/1948,Male,168,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes,Yes,3,III: one or more criteria are fulfilled,IgG,"9,7",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,5/31/2021,6/30/2021, , , , , , , , , , 
7005,4449,6/15/1957,Male,184,90,Compulsory health insurance CHI,No, , , , , ,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"2,9",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/7/2021,8/19/2021,8/19/2021, , , , , , , , , 
7006,2265,6/15/1959,Male,185,84,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,0,III: one or more criteria are fulfilled,IgG,29,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,6/1/2021,11/1/2021,11/1/2021, , , , , , , , , 
7007,2392,6/15/1943,Female,168,72,Compulsory health insurance CHI,No, , , ,Yes, , , ,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,31,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,6/1/2021,6/30/2021, , , , , , , , , , 
7008,6531,6/15/1955,Female,170,69,Private,No, , , ,Yes,Yes, , , ,Yes, ,0,III: one or more criteria are fulfilled,IgG,39,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,6/1/2021,11/1/2021,11/1/2021, , , , , , , , , 
7009,7173,6/15/1938,Male,172,65,Compulsory health insurance CHI,No, ,Yes, ,Yes,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,185,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,5/24/2021,11/15/2021,11/15/2021, , , , , , , , , 
7010,1650,6/15/1940,Female,196,61,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,220,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,4/22/2021,12/31/2021,10/14/1582, , , , , , , , , 
7011,7248,6/15/1937,Male,168,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,170,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,6/15/2021,10/12/2021,10/12/2021, , , , , , , , , 
7012,2641,6/15/1959,Male,189,96,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,3",unknown/ISS-Criteria not used for prognostics,No,No,Yes,9,No,Yes,"2,23", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Ja,DAR-X,No CTx,No CTx,V-X,9/27/2021,12/23/2021,12/23/2021,1/25/2022,3/31/2022, , , , , , , 
7013,9689,6/15/1945,Female,153,54,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"2,5",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,5", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/6/2021,3/31/2022,10/14/1582, , , , , , , , , 
7014,3840,6/15/1945,Female,170,75,Private,No,Yes, ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,42,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/9/2021,3/31/2022,10/14/1582, , , , , , , , , 
7015,6057,6/15/1968,Male,178,75,Private,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,Unknown,IgG,"28,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/29/2021,10/21/2021,10/21/2021, , , , , , , , , 
7016,6934,6/15/1958,Female,157,78,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"9,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/21/2021,3/31/2022,10/14/1582, , , , , , , , , 
7017,2466,6/15/1948,Female,160,70,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,23,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/27/2021,12/17/2021,12/17/2021, , , , , , , , , 
7018,2513,6/15/1970,Male,176,74,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,Unknown,IgG,47,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/23/2021,3/31/2022,10/14/1582, , , , , , , , , 
7019,9584,6/15/1944,Female,160,67,Private,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"27,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/1/2021,3/31/2022,10/14/1582, , , , , , , , , 
7020,5416,6/15/1951,Male,188,90,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,34,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/17/2017,12/20/2018,12/20/2018,9/23/2021,3/31/2022,10/14/1582, , , , , , 
7021,6376,6/15/1949,Male,185,90,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,32,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/20/2018,10/25/2019,10/25/2019,9/16/2021,3/31/2022,10/14/1582, , , , , , 
7022,1691,6/15/1953,Male,179,85,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,Unknown,IgG,25,ISS stage II (neither stage I nor stage III),No,9,No,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/12/2021,3/31/2022,10/14/1582, , , , , , , , , 
7023,9516,6/15/1950,Male,168,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,Unknown,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/20/2021,3/31/2022,10/14/1582, , , , , , , , , 
7024,4025,6/15/1948,Female,157,59,Private,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,35,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/23/2021,3/31/2022,10/14/1582, , , , , , , , , 
7025,4649,6/15/1968,Female,175,75,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,Unknown,IgA,15,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/31/2021,12/21/2021,12/21/2021, , , , , , , , , 
7026,5995,6/15/1968,Male,174,66,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"33,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,9,No,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/26/2021,11/15/2021,11/15/2021, , , , , , , , , 
7027,5246,6/15/1979,Female,163,106,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , ,Yes,1,III: one or more criteria are fulfilled,Other type,"1,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/6/2021,11/25/2021,11/25/2021, , , , , , , , , 
7028,9036,6/15/1949,Female,170,77,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,"2,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/23/2021,12/31/2021,10/14/1582, , , , , , , , , 
7029,6540,6/15/1948,Female,171,68,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,",02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/13/2021,12/31/2021,10/14/1582, , , , , , , , , 
7030,6646,6/15/1936,Male,170,72,Compulsory health insurance CHI,No,Yes, , ,Yes, ,Yes,Yes, , ,Yes,9,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , , , ,R-X,DAR-X,No CTx,V-X,7/7/2014,10/11/2017,10/11/2017,8/13/2020,7/9/2021,7/9/2021,7/23/2021,9/2/2021,9/2/2021, , , 
7031,4447,6/15/1940,Female,160,60,Private,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"2,07",unknown/ISS-Criteria not used for prognostics,No,No,No,No,No,No,"1,62", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Unbekannt,Nein, , , , , ,R-X,V-X,No CTx,Other,5/14/2007,7/30/2007,7/30/2007,4/16/2014,7/22/2014,7/22/2014,7/7/2021,3/31/2022, , , , 
7032,8559,6/15/1955,Male,176,87,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,"2,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/21/2020,12/28/2020,12/28/2020, , , , , , , , , 
7033,9444,6/15/1958,Male,189,96,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgA,"5,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,23", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,ISA-X,V-X,V-X,2/24/2017,5/18/2017,5/18/2017,8/20/2021,11/17/2021,11/17/2021,11/18/2021,12/31/2021,12/31/2021,1/11/2022,3/31/2022, 
7034,3129,6/15/1939,Male,170,78,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/6/2021,9/30/2021, , , , , , , , , , 
7035,6838,6/15/1944,Male,176,82,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,6",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/20/2021,9/30/2021, , , , , , , , , , 
7036,4768,6/15/1952,Male,177,85,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,7",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/23/2021,9/30/2021, , , , , , , , , , 
7037,3133,6/15/1955,Male,172,79,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/30/2021,9/30/2021, , , , , , , , , , 
7038,3606,6/15/1944,Female,165,53,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,683,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,9/22/2021,9/30/2021, , , , , , , , , , 
7039,4975,6/15/1946,Male,181,80,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,"13,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/21/2021,3/31/2022, , , , , , , , , , 
7040,4871,6/15/1942,Female,167,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L", ,V-X,R-X,DAR-X,V-X,12/16/2009,3/15/2010,3/15/2010,3/15/2013,9/15/2013,9/15/2013,10/15/2013,6/15/2019,6/15/2019,9/21/2021,3/31/2022, 
7041,5976,6/15/1938,Male,175,74,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,3",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/16/2021,2/28/2022,2/28/2022, , , , , , , , , 
7042,4123,6/15/1945,Male,175,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Unknown,Unknown,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,R-X,DAR-X,No CTx,V-X,9/15/2014,11/15/2014,11/15/2014,12/9/2015,6/10/2020,6/10/2020,9/21/2021,3/31/2022, , , , 
7043,3700,6/15/1963,Male,187,92,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/26/2021,11/12/2021,11/12/2021, , , , , , , , , 
7044,1296,6/15/1946,Male,174,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"6,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,5/18/2020,2/10/2021,2/10/2021,9/13/2021,9/30/2021,10/14/1582, , , , , , 
7045,3533,6/15/1948,Male,184,90,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"57,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,9,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/2/2021,3/31/2022, , , , , , , , , , 
7046,9156,6/15/1946,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,01",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Nein,POM-X,KYP-X,EMP-X,V-X,4/15/2011,6/23/2011,6/23/2011,4/29/2015,9/20/2015,9/20/2015,7/10/2017,6/30/2020,6/30/2020,7/6/2020,6/8/2021,6/8/2021
7047,7271,6/15/1938,Male,180,80,Compulsory health insurance CHI,Yes,Yes, , , , , ,Yes, , , ,1,Unknown,IgG,",6",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/9/2021,10/28/2021,10/28/2021,11/3/2021,3/31/2022,10/14/1582, , , , , , 
7048,1380,6/15/1940,Male,170,116,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,Unknown,IgG,"3,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,24", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/6/2021,3/31/2022,10/14/1582, , , , , , , , , 
7049,8054,6/15/1945,Female,162,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/21/2020,11/24/2020,11/24/2020,9/22/2021,9/30/2021, , , , , , , 
7050,9751,6/15/1953,Female,180,82,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,Unknown,IgA,"65,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,7/26/2021,9/27/2021,9/27/2021, , , , , , , , , 
7051,8089,6/15/1952,Male,178,115,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,"430,8",unknown/ISS-Criteria not used for prognostics,No,Yes,No,Yes,No,No,"2,31", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Ja,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,7/24/2020,9/15/2020,9/15/2020, , , , , , , , , 
7052,4769,6/15/1959,Male,175,75,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,Unknown,IgG,210,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,7/13/2021,9/7/2021,9/7/2021, , , , , , , , , 
7053,3301,6/15/1951,Male,175,75,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No,"1,9", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Unbekannt,Unbekannt, , , , , ,No CTx,No CTx,No CTx,V-X,9/20/2021,9/23/2021,9/23/2021, , , , , , , , , 
7054,7458,6/15/1937,Female,148,61,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"1,54", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , , ,R-X,No CTx,No CTx,V-X,9/21/2021,1/25/2022,1/25/2022,2/4/2022,3/31/2022, , , , , , , 
7055,8328,6/15/1945,Male,175,90,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Yes,No,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,5/17/2021,3/31/2022, , , , , , , , , , 
7056,9288,6/15/1969,Male,167,108,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,0,I: fulfilling all 4 criteria,IgG,"234,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,No,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,8/9/2021,9/27/2021,9/27/2021, , , , , , , , , 
7057,2442,6/15/1946,Male,181,80,Private,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"8,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/18/2021,3/31/2022,10/14/1582, , , , , , , , , 
7058,2124,6/15/1950,Male,179,82,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/20/2021,3/31/2022, , , , , , , , , , 
7059,1377,6/15/1954,Male,186,83,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, ,Yes,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/14/2021,11/29/2021,11/29/2021, , , , , , , , , 
7060,6706,6/15/1936,Female,165,82,Private,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/19/2021,3/31/2022,10/14/1582, , , , , , , , , 
7061,6715,6/15/1940,Male,178,80,Private,Yes, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,9,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Unknown,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , ,Ja,DAR-X,No CTx,No CTx,R-X,9/20/2021,2/8/2022,2/8/2022,3/10/2022,3/31/2022, , , , , , , 
7062,3964,6/15/1957,Female,170,76,Private,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/6/2021,9/30/2021, , , , , , , , , , 
7063,4767,6/15/1943,Male,178,80,Private,Yes,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,9/6/2021,3/31/2022, , , , , , , , , , 
7064,6687,6/15/1937,Male,180,90,Compulsory health insurance CHI,Yes,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,9",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,No,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,DAR-X,No CTx,No CTx,R-X,7/1/2019,8/31/2021,8/31/2021,9/13/2021,3/31/2022, , , , , , , 
7065,7260,6/15/1963,Male,170,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,8/20/2019,9/13/2021,9/13/2021,9/20/2021,12/16/2021,12/16/2021, , , , , , 
7066,6372,6/15/1945,Female,167,80,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/13/2021,3/1/2022,3/1/2022, , , , , , , , , 
7067,5711,6/15/1938,Male,180,80,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/20/2021,9/30/2021, , , , , , , , , , 
7068,8945,6/15/1941,Male,180,90,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,9/27/2021,3/31/2022, , , , , , , , , , 
7069,1693,6/15/1949,Male,180,75,Compulsory health insurance CHI,Yes,Yes,Yes, , , , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"6,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,9/20/2021,12/8/2021,12/8/2021,2/2/2022,3/31/2022, , , , , , , 
7070,4981,6/15/1965,Male,177,81,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/15/2017,9/15/2017,9/15/2017,7/27/2021,3/31/2022,10/14/1582, , , , , , 
7071,4765,6/15/1959,Female,150,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"62,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/17/2021,11/11/2021,11/11/2021, , , , , , , , , 
7072,8346,6/15/1944,Female,160,67,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"123,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/24/2021,3/31/2022, , , , , , , , , , 
7073,5787,6/15/1973,Male,199,99,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),9,9,9,9,Unknown,Unknown,"2,35", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,KYP-X,No CTx,No CTx,V-X,6/15/2012,8/15/2012,8/15/2012,9/30/2021,3/31/2022,10/14/1582, , , , , , 
7074,1456,6/15/1949,Male,179,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"14,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/5/2021,12/19/2021,12/19/2021, , , , , , , , , 
7075,4696,6/15/1943,Female,162,77,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,2,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/5/2021,12/19/2021,12/19/2021,3/24/2022,3/31/2022, , , , , , , 
7076,7776,6/15/1947,Female,158,63,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,64", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/12/2021,12/26/2021,12/26/2021,3/28/2022,3/31/2022, , , , , , , 
7077,8756,6/15/1951,Male,178,74,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"11,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/12/2021,12/26/2021,12/26/2021, , , , , , , , , 
7078,5989,6/15/1948,Male,174,79,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"15,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,7/12/2021,12/26/2021,12/26/2021,3/30/2022,3/31/2022, , , , , , , 
7079,8166,6/15/1945,Female,160,68,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"10,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/19/2021,3/31/2022, , , , , , , , , , 
7080,6783,6/15/1939,Female,156,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"10,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,53", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/26/2021,3/31/2022, , , , , , , , , , 
7081,2788,6/15/1937,Male,176,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/26/2021,3/31/2022, , , , , , , , , , 
7082,4972,6/15/1953,Female,165,61,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"11,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/2/2021,3/31/2022, , , , , , , , , , 
7083,4927,6/15/1951,Male,181,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"11,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/9/2021,3/31/2022,10/14/1582, , , , , , , , , 
7084,2113,6/15/1949,Male,179,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"4,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/9/2021,3/31/2022, , , , , , , , , , 
7085,8449,6/15/1940,Male,174,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Unknown,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/16/2021,3/31/2022, , , , , , , , , , 
7086,3908,6/15/1932,Female,167,55,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"16,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes,"1,61", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/19/2021,9/13/2021,9/13/2021, , , , , , , , , 
7087,2067,6/15/1937,Male,175,84,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"14,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/16/2021,3/31/2022, , , , , , , , , , 
7088,8550,6/15/1933,Male,176,84,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,2, , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/19/2021,3/31/2022, , , , , , , , , , 
7089,6066,6/15/1969,Female,165,52,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,89",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,9/6/2021,3/31/2022,10/14/1582, , , , , , , , , 
7090,7575,6/15/1966,Male,180,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,Unknown,IgA,21,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,8/2/2021,10/25/2021,10/25/2021, , , , , , , , , 
7091,7297,6/15/1956,Female,153,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,74", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/13/2021,3/31/2022, , , , , , , , , , 
7092,1365,6/15/1941,Female,174,100,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/12/2021,3/31/2022, , , , , , , , , , 
7093,4418,6/15/1944,Male,181,101,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,21", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/1/2021,3/31/2022, , , , , , , , , , 
7094,4256,6/15/1937,Male,179,93,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/25/2021,3/31/2022, , , , , , , , , , 
7095,5539,6/15/1938,Male,179,60,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,",64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/4/2021,3/31/2022, , , , , , , , , , 
7096,2452,6/15/1955,Male,179,91,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,1,I: fulfilling all 4 criteria,IgG,"5,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,No,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/13/2021,10/5/2021,10/5/2021, , , , , , , , , 
7097,9880,6/15/1948,Female,157,51,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No,"1,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/9/2021,12/13/2021,12/13/2021, , , , , , , , , 
7098,1852,6/15/1960,Female,159,61,Private,No,Yes, ,Yes, , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,No,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,6/16/2021,8/11/2021,8/11/2021, , , , , , , , , 
7099,3699,6/15/1943,Male,184,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,56",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,96", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/4/2021,3/31/2022, , , , , , , , , , 
7100,6596,6/15/1948,Female,157,51,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No,"1,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/20/2021,3/31/2022, , , , , , , , , , 
7101,7420,6/15/1956,Male,171,80,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/10/2021,3/31/2022, , , , , , , , , , 
7102,3543,6/15/1938,Male,162,46,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"1,46", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/19/2021,3/31/2022, , , , , , , , , , 
7103,4661,6/15/1936,Female,165,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/13/2021,3/31/2022,10/14/1582, , , , , , , , , 
7104,1636,6/15/1949,Female,171,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/8/2021,3/31/2022,10/14/1582, , , , , , , , , 
7105,8820,6/15/1946,Male,177,63,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,78", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/17/2021,3/31/2022, , , , , , , , , , 
7106,4872,6/15/1959,Male,177,95,Compulsory health insurance CHI,No, , , , ,Yes, , ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"14,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/12/2021,3/31/2022, , , , , , , , , , 
7107,3947,6/15/1953,Male,169,73,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/22/2021,3/31/2022, , , , , , , , , , 
7108,7344,6/15/1955,Female,166,68,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,76", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/13/2021,7/6/2021,7/6/2021, , , , , , , , , 
7109,6558,6/15/1950,Female,161,64,Private,Yes, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgA,"2,64","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,67", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/15/2021,3/31/2022,10/14/1582, , , , , , , , , 
7110,5926,6/15/1948,Male,177,93,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"13,22","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/19/2021,3/31/2022,10/14/1582, , , , , , , , , 
7111,1348,6/15/1950,Male,187,109,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"29,67",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No,"2,34", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/13/2021,6/9/2021,6/9/2021, , , , , , , , , 
7112,4033,6/15/1936,Female,163,47,Compulsory health insurance CHI,No, ,Yes,Yes,Yes, , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,85",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,48", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/6/2021,3/31/2022,10/14/1582, , , , , , , , , 
7113,5889,6/15/1951,Male,176,94,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,53","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/3/2021,3/31/2022, , , , , , , , , , 
7114,9001,6/15/1961,Male,171,66,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,5/5/2021,6/30/2021,6/30/2021, , , , , , , , , 
7115,7550,6/15/1934,Male,182,113,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"8,88",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"2,33", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/21/2021,3/31/2022, , , , , , , , , , 
7116,9974,6/15/1954,Male,170,89,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,No,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,8/17/2021,3/31/2022,10/14/1582, , , , , , , , , 
7117,6630,6/15/1943,Male,184,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,56","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,96", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/19/2021,3/31/2022, , , , , , , , , , 
7118,7516,6/15/1944,Male,180,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,86","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/12/2021,9/6/2021,9/6/2021, , , , , , , , , 
7119,4044,6/15/1961,Male,182,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/2/2021,3/31/2022, , , , , , , , , , 
7120,9373,6/15/1956,Male,176,80,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/12/2021,10/4/2021,10/4/2021, , , , , , , , , 
7121,4253,6/15/1934,Male,175,91,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgG,"2,21","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,06", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,R-X,7/2/2021,3/31/2022, , , , , , , , , , 
7122,4740,6/15/1951,Male,174,107,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,2,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,2", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/4/2021,3/31/2022,10/14/1582, , , , , , , , , 
7123,6974,6/15/1942,Female,169,59,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,67", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/28/2021,12/31/2021,10/14/1582, , , , , , , , , 
7124,1010,6/15/1949,Male,183,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,94", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,8/23/2021,12/31/2021,10/14/1582, , , , , , , , , 
7125,9973,6/15/1940,Female,179,78,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/26/2021,12/31/2021,10/14/1582, , , , , , , , , 
7126,4606,6/15/1966,Male,188,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,99", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/13/2021,9/7/2021,9/7/2021, , , , , , , , , 
7127,7517,6/15/1930,Male,170,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,71", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/7/2021,12/31/2021,10/14/1582, , , , , , , , , 
7128,7999,6/15/1941,Male,177,104,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,8/31/2021,12/31/2021,10/14/1582, , , , , , , , , 
7129,7767,6/15/1932,Male,170,66,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/24/2021,12/31/2021, , , , , , , , , , 
7130,6518,6/15/1948,Male,198,99,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,1574,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,Yes,Unknown,Unknown,"2,34", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,R-X,7/15/2014,9/15/2014,9/15/2014,8/5/2021,3/31/2022, , , , , , , 
7131,6894,6/15/1939,Male,180,84,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"18,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/28/2021,3/31/2022, , , , , , , , , , 
7132,7668,6/15/1950,Female,166,64,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,42",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/1/2021,3/31/2022,10/14/1582, , , , , , , , , 
7133,3424,6/15/1967,Male,174,78,Compulsory health insurance CHI,Yes, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/7/2021,9/1/2021,9/1/2021, , , , , , , , , 
7134,7194,6/15/1958,Female,163,76,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,4/28/2021,6/23/2021,6/23/2021, , , , , , , , , 
7135,2687,6/15/1944,Male,190,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,V-X,7/29/2021,3/31/2022,10/14/1582, , , , , , , , , 
7136,8389,6/15/1961,Male,178,109,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,75","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,26", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/18/2021,3/31/2022, , , , , , , , , , 
7137,5037,6/15/1959,Female,172,84,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/28/2021,9/22/2021,9/22/2021, , , , , , , , , 
7138,7887,6/15/1949,Male,183,101,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"1,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,23", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/23/2021,12/16/2021,12/16/2021, , , , , , , , , 
7139,5973,6/15/1963,Female,163,71,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,77", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/14/2021,3/31/2022,10/14/1582, , , , , , , , , 
7140,3324,6/15/1975,Female,168,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,63","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,93", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,8/25/2021,3/31/2022,10/14/1582, , , , , , , , , 
7141,7765,6/15/1954,Male,178,88,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,72","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,06", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,9/22/2021,12/15/2021,12/15/2021, , , , , , , , , 
7142,1780,6/15/1941,Male,176,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,97", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/15/2021,3/31/2022,10/14/1582, , , , , , , , , 
7143,3830,6/15/1965,Male,186,117,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,4", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/17/2021,3/31/2022, , , , , , , , , , 
7144,3715,6/15/1961,Male,172,84,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"1,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,97", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/3/2021,3/31/2022, , , , , , , , , , 
7145,1096,6/15/1938,Male,171,67,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/5/2021,12/20/2021,12/20/2021, , , , , , , , , 
7146,1335,6/15/1942,Female,164,66,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,46",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/29/2021,3/31/2022, , , , , , , , , , 
7147,6139,6/15/1945,Male,172,71,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,3,I: fulfilling all 4 criteria,IgG,"2,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes,"1,84", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/20/2021,3/31/2022, , , , , , , , , , 
7148,1822,6/15/1946,Female,162,66,Compulsory health insurance CHI,No,Yes, , , , , , , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/18/2021,3/31/2022,10/14/1582, , , , , , , , , 
7149,9653,6/15/1937,Male,188,94,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"2,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/21/2021,3/31/2022, , , , , , , , , , 
7150,9777,6/15/1945,Male,180,66,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,84", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/13/2021,9/7/2021,9/7/2021, , , , , , , , , 
7151,8410,6/15/1967,Female,165,63,Compulsory health insurance CHI,No,Yes,Yes,Yes,Unknown,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"16,02","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/6/2021,8/31/2021,8/31/2021, , , , , , , , , 
7152,6488,6/15/1937,Male,179,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,05", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/13/2021,3/31/2022,10/14/1582, , , , , , , , , 
7153,1648,6/15/1931,Female,163,55,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),Yes,No,No,No,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/31/2021,3/31/2022,10/14/1582, , , , , , , , , 
7154,6534,6/15/1944,Male,179,77,Private,No, ,Yes,Yes, , , , ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,8/19/2021,3/31/2022,10/14/1582, , , , , , , , , 
7155,8788,6/15/1949,Female,164,66,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/16/2021,3/31/2022, , , , , , , , , , 
7156,2289,6/15/1963,Male,172,84,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,7/21/2021,12/29/2021,12/29/2021,3/18/2022,3/31/2022, , , , , , , 
7157,7995,6/15/1939,Male,184,81,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,9/8/2021,3/31/2022,10/14/1582, , , , , , , , , 
7158,7913,6/15/1941,Male,181,110,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , ,Yes, ,3,III: one or more criteria are fulfilled,Other type,"999,99",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"2,29", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/15/2021,3/31/2022, , , , , , , , , , 
7159,1025,6/15/1955,Male,175,86,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/20/2021,9/30/2021, , , , , , , , , , 
7160,1064,6/15/1952,Male,182,105,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"4,47",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,26", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/25/2021,12/31/2021, , , , , , , , , , 
7161,3468,6/15/1951,Female,165,63,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"3,82","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,KYP-X,V-X,No CTx,V-X,10/11/2019,2/14/2020,2/14/2020,3/21/2021,7/3/2021,7/3/2021,7/3/2021,10/16/2021,10/16/2021, , , 
7162,8852,6/15/1969,Male,175,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"18,45","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/12/2021,9/7/2021,9/7/2021, , , , , , , , , 
7163,5222,6/15/1941,Male,180,101,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,03",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/5/2021,3/31/2022,10/14/1582, , , , , , , , , 
7164,6081,6/15/1939,Male,179,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,77", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/26/2021,3/31/2022,10/14/1582, , , , , , , , , 
7165,7494,6/15/1944,Female,151,54,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,17",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No,"1,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,7/1/2021,3/31/2022, , , , , , , , , , 
7166,9747,6/15/1951,Male,177,73,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes,"1,9", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/26/2021,3/31/2022, , , , , , , , , , 
7167,7232,6/15/1940,Female,159,49,Compulsory health insurance CHI,No,Yes, , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,38",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,48", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/21/2021,3/31/2022, , , , , , , , , , 
7168,3124,6/15/1949,Female,165,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,85", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/2/2021,3/31/2022, , , , , , , , , , 
7169,7744,6/15/1946,Male,166,92,Compulsory health insurance CHI,No,Yes, , , , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,8/17/2021,3/31/2022, , , , , , , , , , 
7170,4434,6/15/1952,Male,170,73,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,57",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,4/2/2021,6/25/2021,6/25/2021, , , , , , , , , 
7171,2831,6/15/1941,Female,168,58,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,46","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,No,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,7/13/2021,3/31/2022, , , , , , , , , , 
7172,4121,6/15/1954,Female,170,97,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/16/2021,5/11/2021,5/11/2021, , , , , , , , , 
7173,1433,6/15/1944,Male,171,102,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/23/2021,3/31/2022,10/14/1582, , , , , , , , , 
7174,6067,6/15/1950,Male,179,82,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgG,"4,41","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,01", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/2/2021,3/31/2022, , , , , , , , , , 
7175,8116,6/15/1953,Male,169,79,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,9", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/29/2021,3/31/2022, , , , , , , , , , 
7176,5150,6/15/1949,Female,168,79,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgD,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,8/24/2021,3/31/2022, , , , , , , , , , 
7177,3168,6/15/1960,Male,170,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,87","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/18/2021,3/31/2022, , , , , , , , , , 
7178,7902,6/15/1964,Female,159,82,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,56","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/13/2021,12/6/2021,12/6/2021, , , , , , , , , 
7179,9765,6/15/1939,Female,173,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,91", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/17/2021,3/31/2022,10/14/1582, , , , , , , , , 
7180,9129,6/15/1938,Female,169,72,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"19,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/6/2021,3/31/2022, , , , , , , , , , 
7181,1022,6/15/1933,Male,173,71,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/3/2021,3/31/2022, , , , , , , , , , 
7182,6819,6/15/1961,Male,174,71,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,9/10/2021,12/3/2021,12/3/2021, , , , , , , , , 
7183,8609,6/15/1931,Male,175,69,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,",71",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/7/2021,3/31/2022, , , , , , , , , , 
7184,9713,6/15/1961,Male,174,71,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,14","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/6/2021,8/31/2021,8/31/2021, , , , , , , , , 
7185,7867,6/15/1936,Female,168,63,Compulsory health insurance CHI,No,Yes, , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"29,65",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,9/2/2021,3/31/2022,10/14/1582, , , , , , , , , 
7186,5870,6/15/1954,Male,178,103,Compulsory health insurance CHI,No,Yes, ,Yes, , , ,Yes, ,Yes, ,3,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,Yes,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,7/12/2021,3/31/2022, , , , , , , , , , 
7187,6516,6/15/1939,Female,160,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"8,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/23/2021,3/31/2022, , , , , , , , , , 
7188,1478,6/15/1952,Male,176,85,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"13,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/30/2021,3/31/2022, , , , , , , , , , 
7189,4585,6/15/1953,Female,163,50,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,68,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/19/2021,10/5/2021,10/5/2021, , , , , , , , , 
7190,4378,6/15/1951,Female,160,78,Compulsory health insurance CHI,No,Yes, , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,50,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/27/2021,3/9/2022,3/9/2022, , , , , , , , , 
7191,6739,6/15/1968,Female,170,85,Private,No, ,Yes, ,Yes, , , , , , ,2,III: one or more criteria are fulfilled,IgG,25,ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,7/5/2021,12/15/2021,12/15/2021, , , , , , , , , 
7192,5263,6/15/1946,Female,167,73,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,Other type,1100,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/18/2021,1/31/2022,1/31/2022,2/2/2022,3/31/2022,10/14/1582, , , , , , 
7193,6695,6/15/1945,Female,161,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"8,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/30/2021,3/31/2022, , , , , , , , , , 
7194,2589,6/15/1954,Male,178,76,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"15,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/6/2021,3/31/2022,10/14/1582, , , , , , , , , 
7195,9390,6/15/1950,Female,162,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,2,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/6/2021,3/31/2022,10/14/1582, , , , , , , , , 
7196,8320,6/15/1953,Male,181,87,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/6/2021,11/28/2021,11/28/2021,3/22/2022,3/31/2022, , , , , , , 
7197,4774,6/15/1949,Male,999,80,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"318,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Unknown,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,6/14/2021,7/12/2021,7/12/2021,7/26/2021,10/25/2021,10/25/2021, , , , , , 
7198,3565,6/15/1949,Female,999,65,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"32,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Unknown,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,DAR-X,7/12/2021,3/31/2022,10/14/1582, , , , , , , , , 
7199,4695,6/15/1944,Female,173,83,Private,No,Yes, , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/17/2019,8/12/2019,8/12/2019,9/3/2021,3/31/2022,10/14/1582, , , , , , 
7200,3527,6/15/1948,Male,173,89,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,Yes,No,Yes,No,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,NIN-X,No CTx,No CTx,R-X,6/27/2019,12/19/2019,12/19/2019,7/20/2021,8/12/2021,8/12/2021, , , , , , 
7201,2061,6/15/1950,Female,165,72,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,79", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,R-X,No CTx,No CTx,V-X,4/10/2019,3/17/2020,3/17/2020,7/23/2021,3/31/2022, , , , , , , 
7202,1880,6/15/1940,Male,180,64,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"23,51",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/16/2019,9/10/2019,9/10/2019,7/27/2021,10/15/2021,10/15/2021, , , , , , 
7203,3462,6/15/1960,Male,183,103,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,25", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/10/2019,3/16/2020,3/16/2020,8/26/2021,3/31/2022, , , , , , , 
7204,4010,6/15/1940,Male,175,60,Compulsory health insurance CHI,No,Yes, , , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,23,ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,7/25/2019,4/22/2020,4/22/2020,9/13/2021,3/31/2022,10/14/1582, , , , , , 
7205,6422,6/15/1937,Male,168,97,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"14,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,8/21/2019,5/20/2020,5/20/2020,7/16/2021,3/31/2022, , , , , , , 
7206,1319,6/15/1948,Female,170,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,03", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/11/2015,5/6/2015,5/6/2015,8/30/2021,3/31/2022,10/14/1582, , , , , , 
7207,9667,6/15/1947,Male,175,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,92", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,4/12/2018,3/19/2019,3/19/2019,7/28/2021,3/31/2022,10/14/1582, , , , , , 
7208,5082,6/15/1946,Male,178,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,62","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,94", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/18/2018,3/13/2019,3/13/2019,9/14/2021,3/31/2022,10/14/1582, , , , , , 
7209,6224,6/15/1944,Male,175,88,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,3,I: fulfilling all 4 criteria,IgG,"1,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes,"2,04", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,2/11/2020,9/23/2020,9/23/2020,8/4/2021,3/31/2022,10/14/1582, , , , , , 
7210,3311,6/15/1956,Female,159,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"8,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,5/20/2019,7/15/2019,7/15/2019,7/2/2021,3/31/2022,10/14/1582, , , , , , 
7211,9575,6/15/1945,Female,160,86,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"1,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,89", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,2/8/2017,1/17/2018,1/17/2018,7/8/2021,3/31/2022, , , , , , , 
7212,3419,6/15/1960,Male,183,103,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,25", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/13/2019,3/19/2020,3/19/2020,8/17/2021,3/31/2022, , , , , , , 
7213,5893,6/15/1940,Male,175,60,Compulsory health insurance CHI,No,Yes, , , ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,23,ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/13/2019,6/3/2020,6/3/2020,8/26/2021,3/31/2022,10/14/1582, , , , , , 
7214,9883,6/15/1959,Female,152,82,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,2",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,6/20/2019,5/27/2020,5/27/2020,7/28/2021,3/31/2022, , , , , , , 
7215,9671,6/15/1940,Female,156,59,Private,No, , , , , ,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,R-X,9/25/2019,6/5/2020,6/5/2020,7/8/2021,3/31/2022, , , , , , , 
7216,7926,6/15/1937,Male,157,69,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,5/16/2019,4/14/2020,4/14/2020,9/8/2021,3/31/2022,10/14/1582, , , , , , 
7217,8112,6/15/1935,Male,177,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,97", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/13/2018,8/22/2019,8/22/2019,8/26/2021,3/31/2022,10/14/1582, , , , , , 
7218,4991,6/15/1954,Male,186,105,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,15","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,29", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/22/2019,6/17/2019,6/17/2019,8/9/2021,12/31/2021,10/14/1582, , , , , , 
7219,9733,6/15/1969,Male,188,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,2/7/2017,4/4/2017,4/4/2017,8/16/2021,12/31/2021,10/14/1582, , , , , , 
7220,8218,6/15/1955,Male,180,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/15/2018,10/15/2018,10/15/2018,8/25/2021,12/31/2021,10/14/1582, , , , , , 
7221,4277,6/15/1963,Female,156,55,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,41",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,53", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,6/19/2019,5/6/2020,5/6/2020,8/18/2021,3/31/2022, , , , , , , 
7222,2775,6/15/1948,Male,177,87,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,04", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,DAR-X,No CTx,R-X,7/17/2018,3/21/2019,3/21/2019,8/4/2021,11/23/2021,11/23/2021,12/9/2021,12/31/2021, , , , 
7223,1606,6/15/1970,Female,178,93,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,11", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,2/12/2019,4/9/2019,4/9/2019,9/9/2021,3/31/2022,10/14/1582, , , , , , 
7224,6905,6/15/1954,Female,171,81,Compulsory health insurance CHI,No,Yes,Unknown, , , , ,Yes, , , ,1, ,Other type, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,No,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,R-X,8/13/2019,6/18/2020,6/18/2020,8/2/2021,9/30/2021, , , , , , , 
7225,6245,6/15/1944,Female,173,83,Private,No,Yes, , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/29/2019,7/24/2019,7/24/2019,9/13/2021,3/31/2022,10/14/1582, , , , , , 
7226,1622,6/15/1942,Male,189,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,61",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No,2, , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,8/12/2019,7/28/2020,7/28/2020,7/7/2021,3/31/2022,10/14/1582, , , , , , 
7227,9533,6/15/1947,Male,173,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,78","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,11/8/2016,1/17/2017,1/17/2017,7/15/2021,3/31/2022,10/14/1582, , , , , , 
7228,6019,6/15/1944,Male,184,68,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,9",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/25/2019,8/18/2020,8/18/2020,7/5/2021,3/31/2022, , , , , , , 
7229,3144,6/15/1955,Male,180,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,6/27/2018,8/22/2018,8/22/2018,7/20/2021,3/31/2022,10/14/1582, , , , , , 
7230,1865,6/15/1958,Male,179,79,Private,No,Yes, , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"17,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,6/6/2019,8/2/2019,8/2/2019,7/5/2021,3/31/2022,10/14/1582, , , , , , 
7231,9051,6/15/1944,Male,184,68,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,9",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,8/13/2019,4/7/2020,4/7/2020,7/5/2021,3/31/2022, , , , , , , 
7232,5219,6/15/1946,Male,182,100,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"24,42",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/18/2019,8/13/2019,8/13/2019,9/16/2021,3/31/2022,10/14/1582, , , , , , 
7233,2819,6/15/1973,Male,193,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,1/8/2019,3/5/2019,3/5/2019,8/4/2021,3/31/2022,10/14/1582, , , , , , 
7234,7884,6/15/1958,Male,179,79,Private,No,Yes, , , ,Yes, ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"17,94","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,5/10/2019,7/5/2019,7/5/2019,7/9/2021,3/31/2022,10/14/1582, , , , , , 
7235,5017,6/15/1937,Male,179,68,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,3",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,3/12/2019,3/3/2020,3/3/2020,7/20/2021,3/31/2022,10/14/1582, , , , , , 
7236,6643,6/15/1938,Female,163,50,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,5/22/2019,4/21/2020,4/21/2020,8/4/2021,3/31/2022, , , , , , , 
7237,2285,6/15/1944,Male,164,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,7/15/2019,2/15/2020,2/15/2020,7/21/2021,3/31/2022, , , , , , , 
7238,4147,6/15/1930,Female,170,66,Compulsory health insurance CHI,Unknown,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,93","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/17/2019,6/12/2019,6/12/2019,8/19/2021,3/31/2022,10/14/1582, , , , , , 
7239,5747,6/15/1931,Male,188,113,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,45","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,38", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,6/25/2019,6/30/2020,6/30/2020,7/22/2021,3/31/2022, , , , , , , 
7240,6872,6/15/1949,Female,178,81,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,99", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,R-X,8/8/2018,5/21/2019,5/21/2019,7/9/2021,3/31/2022, , , , , , , 
7241,4863,6/15/1947,Male,175,77,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgG,"2,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,92", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/15/2018,12/15/2018,12/15/2018,9/9/2021,3/31/2022,10/14/1582, , , , , , 
7242,6830,6/15/1958,Female,170,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,32","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,03", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/15/2015,3/15/2015,3/15/2015,8/23/2021,3/31/2022,10/14/1582, , , , , , 
7243,9124,6/15/1937,Male,179,68,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,3",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,3/6/2019,5/2/2019,5/2/2019,8/23/2021,3/31/2022,10/14/1582, , , , , , 
7244,4638,6/15/1952,Male,175,83,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,87",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,4/15/2019,6/15/2019,6/15/2019,7/28/2021,3/31/2022,10/14/1582, , , , , , 
7245,4445,6/15/1937,Male,180,79,Private,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"12,37",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,4/16/2019,12/12/2019,12/12/2019,7/2/2021,3/31/2022, , , , , , , 
7246,1783,6/15/1956,Male,163,76,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgA,"1,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,9/15/2014,11/15/2014,11/15/2014,7/21/2021,3/31/2022,10/14/1582, , , , , , 
7247,5568,6/15/1935,Male,177,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,98", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/29/2019,7/24/2019,7/24/2019,9/29/2021,3/31/2022,10/14/1582, , , , , , 
7248,6295,6/15/1968,Female,164,54,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,14",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,POM-X,No CTx,No CTx,R-X,9/20/2019,4/29/2020,4/29/2020,7/8/2021,3/31/2022, , , , , , , 
7249,8925,6/15/1963,Male,170,69,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,58","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,8", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/9/2017,10/4/2017,10/4/2017,9/21/2021,3/31/2022,10/14/1582, , , , , , 
7250,5031,6/15/1937,Male,168,97,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"14,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,9,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,7/29/2019,11/11/2019,11/11/2019,9/20/2021,3/31/2022,10/14/1582, , , , , , 
7251,4122,6/15/1937,Male,179,68,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,3",ISS stage II (neither stage I nor stage III),Yes,9,Yes,Yes,Yes,No,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,5/27/2019,7/22/2019,7/22/2019,7/6/2021,3/31/2022,10/14/1582, , , , , , 
7252,2555,6/15/1950,Female,151,54,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,95","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,49", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,8/15/2015,10/15/2015,10/15/2015,8/11/2021,3/31/2022,10/14/1582, , , , , , 
7253,5413,6/15/1940,Male,174,84,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,55,unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , , ,No CTx,No CTx,No CTx,R-X,8/10/2021,3/31/2022, , , , , , , , , , 
7254,2026,6/15/1942,Female,166,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,Other type,1484,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,Unknown,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,R-X,7/15/2021,9/7/2021,9/7/2021, , , , , , , , , 
7255,1101,6/15/1956,Male,163,76,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,11/7/2018,10/16/2019,10/16/2019,8/4/2021,3/31/2022, , , , , , , 
7256,9853,6/15/1950,Female,165,72,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,79", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,V-X,No CTx,No CTx,V-X,9/6/2018,8/14/2019,8/14/2019,8/11/2021,3/31/2022, , , , , , , 
7257,6851,6/15/1964,Male,180,89,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"1,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,09", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,10/24/2017,12/19/2017,12/19/2017,8/3/2021,3/31/2022, , , , , , , 
7258,5400,6/15/1949,Female,178,81,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,15","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,99", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/9/2017,1/16/2018,1/16/2018,8/12/2021,3/31/2022, , , , , , , 
7259,6306,6/15/1949,Female,171,73,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"12,62",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/21/2019,7/16/2019,7/16/2019,7/26/2021,3/31/2022, , , , , , , 
7260,4065,6/15/1933,Male,178,68,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,82","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,85", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,6/11/2019,1/9/2020,1/9/2020,7/7/2021,12/8/2021,12/8/2021,1/10/2022,3/31/2022, , , , 
7261,4906,6/15/1973,Male,193,91,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,11","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,22", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,11/7/2018,1/9/2019,1/9/2019,9/22/2021,3/31/2022,10/14/1582, , , , , , 
7262,1172,6/15/1957,Female,152,80,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"2,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,77", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,11/15/2018,8/20/2019,8/20/2019,8/5/2021,3/31/2022, , , , , , , 
7263,8280,6/15/1962,Male,189,101,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"26,14",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,No,"2,28", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,R-X,5/28/2019,5/12/2020,5/12/2020,7/19/2021,3/31/2022, , , , , , , 
7264,3283,6/15/1940,Male,166,79,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,V-X,POM-X,No CTx,R-X,10/16/2019,8/17/2020,8/17/2020,7/21/2021,11/14/2021,11/14/2021,3/1/2022,3/31/2022, , , , 
7265,3646,6/15/1959,Male,177,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,03", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/7/2014,7/2/2014,7/2/2014,9/20/2021,3/31/2022,10/14/1582, , , , , , 
7266,1213,6/15/1939,Female,158,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,72", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/8/2018,4/16/2019,4/16/2019,9/14/2021,12/31/2021,10/14/1582, , , , , , 
7267,2815,6/15/1952,Male,174,58,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/8/2019,6/3/2019,6/3/2019,8/23/2021,12/31/2021,10/14/1582, , , , , , 
7268,6457,6/15/1948,Male,186,74,Compulsory health insurance CHI,No, , , , ,Yes, , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"29,22",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,2/26/2019,4/24/2019,4/24/2019,7/6/2021,12/31/2021,10/14/1582, , , , , , 
7269,5381,6/15/1937,Male,170,60,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,85",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,12/11/2019,10/15/2020,10/15/2020,9/2/2021,12/31/2021,10/14/1582, , , , , , 
7270,2193,6/15/1944,Male,164,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,7/10/2019,6/18/2020,6/18/2020,8/12/2021,12/31/2021,10/14/1582, , , , , , 
7271,4328,6/15/1953,Female,153,63,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,6", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,7/3/2019,8/28/2019,8/28/2019,7/13/2021,3/31/2022,10/14/1582, , , , , , 
7272,3476,6/15/1937,Male,178,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,2, , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/4/2018,3/19/2019,3/19/2019,7/5/2021,3/31/2022, , , , , , , 
7273,7415,6/15/1942,Male,189,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,61",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No,2, , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,7/29/2020,9/23/2020,9/23/2020,8/23/2021,3/31/2022,10/14/1582, , , , , , 
7274,1570,6/15/1967,Male,173,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,R-X,No CTx,V-X,6/15/2015,12/31/2016,12/31/2016,12/15/2017,2/15/2020,2/15/2020,7/15/2021,9/30/2021, , , , 
7275,1376,6/15/1973,Male,183,118,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,22","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,38", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/15/2014,1/15/2015,1/15/2015,8/18/2021,3/31/2022,10/14/1582, , , , , , 
7276,7857,6/15/1950,Female,160,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,63", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,POM-X,No CTx,V-X,3/10/2016,2/14/2017,2/14/2017,7/28/2021,12/20/2021,12/20/2021,1/13/2022,3/31/2022, , , , 
7277,9609,6/15/1951,Female,153,49,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,19","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,44", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,V-X,2/14/2018,1/16/2019,1/16/2019,8/25/2021,3/31/2022, , , , , , , 
7278,9397,6/15/1951,Female,178,70,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,6/12/2019,8/7/2019,8/7/2019,9/28/2021,3/31/2022,10/14/1582, , , , , , 
7279,7983,6/15/1950,Female,165,72,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,4/9/2019,3/10/2020,3/10/2020,8/30/2021,3/31/2022,10/14/1582, , , , , , 
7280,1458,6/15/1942,Male,189,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,61",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No,2, , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,12/17/2020,8/12/2021,8/12/2021,9/2/2021,3/31/2022,10/14/1582, , , , , , 
7281,1325,6/15/1955,Male,178,102,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,",63",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,POM-X,No CTx,No CTx,R-X,11/20/2019,7/14/2020,7/14/2020,7/20/2021,10/28/2021,10/28/2021, , , , , , 
7282,7963,6/15/1942,Male,164,70,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,V-X,POM-X,No CTx,R-X,3/21/2019,2/26/2020,2/26/2020,8/4/2021,12/2/2021,12/2/2021,12/14/2021,3/31/2022, , , , 
7283,2407,6/15/1956,Female,161,68,Compulsory health insurance CHI,No, , , ,Yes, ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,71",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/8/2019,1/20/2020,1/20/2020,8/11/2021,3/31/2022, , , , , , , 
7284,1105,6/15/1943,Female,167,51,Compulsory health insurance CHI,No,Yes, , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,NIN-X,No CTx,No CTx,R-X,4/9/2019,2/4/2020,2/4/2020,7/23/2021,3/31/2022, , , , , , , 
7285,3250,6/15/1942,Male,189,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,61",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No,2, , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,6/19/2019,5/13/2020,5/13/2020,8/25/2021,3/31/2022, , , , , , , 
7286,2929,6/15/1950,Female,160,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,63", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/16/2015,3/23/2016,3/23/2016,7/13/2021,3/31/2022, , , , , , , 
7287,9948,6/15/1940,Male,183,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,99", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/3/2017,4/25/2018,4/25/2018,9/13/2021,3/31/2022,10/14/1582, , , , , , 
7288,6446,6/15/1957,Female,163,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,71","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,89", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/16/2017,7/11/2017,7/11/2017,8/23/2021,3/31/2022,10/14/1582, , , , , , 
7289,8048,6/15/1938,Female,163,54,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,8/11/2021,3/31/2022, , , , , , , , , , 
7290,6129,6/15/1944,Male,164,95,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,7/24/2019,9/18/2019,9/18/2019,8/19/2021,3/31/2022,10/14/1582, , , , , , 
7291,1093,6/15/1960,Male,183,103,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,25", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/7/2017,8/9/2017,8/9/2017,9/20/2021,3/31/2022,10/14/1582, , , , , , 
7292,7536,6/15/1957,Male,189,93,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,91","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,2", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/5/2019,8/30/2019,8/30/2019,8/4/2021,3/31/2022,10/14/1582, , , , , , 
7293,5305,6/15/1940,Male,174,86,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,3,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,5/14/2019,11/26/2019,11/26/2019,8/5/2021,3/31/2022, , , , , , , 
7294,9048,6/15/1970,Female,160,77,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/20/2021,9/30/2021, , , , , , , , , , 
7295,3053,6/15/1959,Male,176,88,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"18,3",unknown/ISS-Criteria not used for prognostics,Yes,No,No,No,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/10/2020,2/2/2021,2/2/2021, , , , , , , , , 
7296,1122,6/15/1946,Male,186,72,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"9,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,DAR-X,8/26/2021,9/30/2021, , , , , , , , , , 
7297,8411,6/15/1953,Female,170,82,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/17/2021,9/30/2021, , , , , , , , , , 
7298,9279,6/15/1955,Male,170,68,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,999999,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Unknown,Unknown,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Ja, , , , , ,R-X,KYP-X,DAR-X,V-X,10/1/2012,3/13/2013,3/13/2013,4/1/2014,10/1/2014,10/1/2014,4/10/2021,8/20/2021,8/20/2021,9/1/2021,3/31/2022, 
7299,7034,6/15/1961,Male,180,92,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes,Yes, ,Yes, ,0,III: one or more criteria are fulfilled,IgG,"89,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,No,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,7/20/2021,9/30/2021, , , , , , , , , , 
7300,2046,6/15/1936,Male,174,102,Private,No, , ,Yes,Yes,Yes,Yes,Yes,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"10,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,7/26/2021,9/30/2021, , , , , , , , , , 
7301,6437,6/15/1970,Female,165,76,Private,Yes, ,Yes,Yes,Yes, , , , , , ,0,III: one or more criteria are fulfilled,IgA,"9,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/20/2021,9/30/2021, , , , , , , , , , 
7302,2322,6/15/1950,Male,185,89,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,12,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,9/23/2021,9/30/2021, , , , , , , , , , 
7303,7272,6/15/1931,Male,166,79,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,No,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,Other,8/2/2021,9/30/2021, , , , , , , , , , 
7304,9957,6/15/1959,Male,173,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,0,Unknown,IgG,21,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/7/2021,9/30/2021, , , , , , , , , , 
7305,8764,6/15/1954,Male,176,71,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,Other type,",17","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/3/2021,11/26/2021,11/26/2021, , , , , , , , , 
7306,3774,6/15/1958,Male,196,120,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"1,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/6/2021,11/29/2021,11/29/2021, , , , , , , , , 
7307,6810,6/15/1965,Male,189,98,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"18,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,25", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/1/2021,9/30/2021, , , , , , , , , , 
7308,1274,6/15/1942,Female,165,68,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"30,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,9/1/2021,9/30/2021, , , , , , , , , , 
7309,8413,6/15/1964,Male,189,98,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes, , , , , ,0,III: one or more criteria are fulfilled,IgG,16,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"2,25", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,9/1/2021,9/30/2021, , , , , , , , , , 
7310,2649,6/15/1946,Female,162,59,Private,No, , ,Yes,Yes,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,19,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/1/2020,9/1/2021,9/1/2021,9/2/2021,12/31/2021,10/14/1582, , , , , , 
7311,9297,6/15/1965,Female,173,70,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,9",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Unknown,Unknown,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,DAR-X,No CTx,No CTx,V-X,7/15/2020,9/15/2020,9/15/2020,2/11/2020,5/15/2020,5/15/2020, , , , , , 
7312,7988,6/15/1948,Male,172,70,Private,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgA,"2,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,7/6/2021,9/30/2021,10/14/1582, , , , , , , , , 
7313,5545,6/15/1966,Female,168,65,Private,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"7,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,8/17/2021,9/30/2021, , , , , , , , , , 
7314,9972,6/15/1943,Male,191,94,Compulsory health insurance CHI,Yes, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"5,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,23", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/25/2016,1/6/2017,1/6/2017,11/10/2021,3/31/2022, , , , , , , 
7315,5664,6/15/1965,Female,165,90,Private,No,Yes, ,Yes, , ,Yes, , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,Unknown,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , , ,Nein,No CTx,No CTx,No CTx,DAR-X,10/19/2021,1/13/2022,1/13/2022, , , , , , , , , 
7316,4938,6/15/1972,Female,161,55,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,36,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/29/2021,3/31/2022, , , , , , , , , , 
7317,1749,6/15/1971,Female,165,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"28,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/7/2021,3/31/2022, , , , , , , , , , 
7318,6395,6/15/1956,Male,184,95,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"41,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/29/2021,3/31/2022, , , , , , , , , , 
7319,9564,6/15/1947,Female,173,85,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,IgG,25,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/29/2021,3/31/2022, , , , , , , , , , 
7320,2209,6/15/1974,Male,190,105,Private,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,45,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,No,"2,33", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/8/2021,11/19/2021,11/19/2021, , , , , , , , , 
7321,4342,6/15/1957,Male,180,88,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,20,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/20/2021,3/31/2022, , , , , , , , , , 
7322,4870,6/15/1951,Female,160,83,Compulsory health insurance CHI,No, , , , , ,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"50,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/25/2021,12/9/2021,12/9/2021,12/14/2021,3/31/2022, , , , , , , 
7323,7392,6/15/1958,Male,177,81,Private,No, , , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,12/15/2018,12/15/2020,12/15/2020,12/13/2021,3/31/2022,10/14/1582, , , , , , 
7324,1602,6/15/1962,Male,165,75,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"29,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/7/2021,3/31/2022, , , , , , , , , , 
7325,2930,6/15/1950,Female,165,70,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,40,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/18/2021,3/31/2022, , , , , , , , , , 
7326,4401,6/15/1958,Male,176,89,Compulsory health insurance CHI,Yes, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,22,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/19/2021,3/31/2022, , , , , , , , , , 
7327,9813,6/15/1950,Female,158,51,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,I: fulfilling all 4 criteria,IgA,"14,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,5", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/25/2021,3/31/2022, , , , , , , , , , 
7328,4399,6/15/1962,Female,162,78,Compulsory health insurance CHI,No, , , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"30,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/19/2021,3/31/2022, , , , , , , , , , 
7329,9594,6/15/1940,Male,174,79,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/2/2021,12/31/2021, , , , , , , , , , 
7330,7956,6/15/1953,Male,178,94,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/23/2020,12/20/2021,12/20/2021,12/28/2021,12/31/2021, , , , , , , 
7331,6227,6/15/1938,Male,178,102,Compulsory health insurance CHI,No, ,Yes, , ,Yes, ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"5,61","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,No,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,10/28/2021,12/31/2021, , , , , , , , , , 
7332,6220,6/15/1940,Male,186,90,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,15", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,V-X,DAR-X,No CTx,V-X,10/12/2018,4/15/2019,4/15/2019,12/17/2021,3/17/2022,3/17/2022,3/30/2022,3/31/2022, , , , 
7333,2720,6/15/1942,Female,163,77,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,NIN-X,No CTx,No CTx,DAR-X,12/8/2020,8/16/2021,8/16/2021,11/29/2021,12/31/2021, , , , , , , 
7334,5663,6/15/1944,Male,172,83,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/22/2021,12/31/2021, , , , , , , , , , 
7335,8175,6/15/1948,Female,155,45,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"2,5",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,4", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/2/2021,3/31/2022,10/14/1582, , , , , , , , , 
7336,3953,6/15/1950,Female,156,57,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"3,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/27/2021,3/31/2022, , , , , , , , , , 
7337,1409,6/15/1942,Male,178,103,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,"5,6",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,Yes,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Ja,No CTx,No CTx,No CTx,V-X,11/22/2021,3/31/2022, , , , , , , , , , 
7338,8187,6/15/1943,Female,169,71,Compulsory health insurance CHI,Yes,Yes, , , ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,31,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,6/6/2019,12/8/2019,12/8/2019,12/3/2021,3/31/2022,10/14/1582, , , , , , 
7339,7504,6/15/1949,Male,176,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"6,1",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,10/11/2021,12/23/2021,12/23/2021, , , , , , , , , 
7340,1503,6/15/1937,Female,172,77,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,3,unknown/ISS-Criteria not used for prognostics,No,No,Yes,No,No,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , ,Nein,No CTx,No CTx,No CTx,R-X,10/8/2021,3/31/2022, , , , , , , , , , 
7341,4672,6/15/1958,Female,175,102,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,7",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Unknown,Unknown,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,5/16/2021,8/14/2021,8/14/2021,8/16/2021,3/31/2022,10/14/1582, , , , , , 
7342,2749,6/15/1951,Female,168,76,Private,No,Yes,Yes, , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,37,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/9/2019,1/21/2020,1/21/2020,12/15/2021,3/31/2022,10/14/1582, , , , , , 
7343,7262,6/15/1950,Male,172,93,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"5,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/19/2021,3/31/2022,10/14/1582, , , , , , , , , 
7344,7980,6/15/1941,Male,185,95,Compulsory health insurance CHI,Yes,Yes,Yes, , , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,29,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,12/28/2019,7/9/2020,7/9/2020,12/15/2021,3/31/2022, , , , , , , 
7345,1794,6/15/1945,Male,177,87,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"6,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,EMP-X,No CTx,No CTx,V-X,10/5/2020,11/29/2021,11/29/2021,12/13/2021,12/31/2021, , , , , , , 
7346,5657,6/15/1945,Male,186,90,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,28,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/20/2019,7/19/2019,7/19/2019,12/9/2021,3/31/2022,10/14/1582, , , , , , 
7347,1118,6/15/1956,Female,168,113,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"68,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,8/31/2015,12/3/2015,12/3/2015, , , , , , , , , 
7348,3499,6/15/1950,Female,167,69,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"8,9",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/6/2021,12/31/2021, , , , , , , , , , 
7349,2402,6/15/1936,Male,180,94,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,3,III: one or more criteria are fulfilled,IgA,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/24/2021,12/31/2021, , , , , , , , , , 
7350,1308,6/15/1943,Female,160,75,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,Unknown,IgG,"245,8",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,Yes,No,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,1/6/2020,12/22/2020,12/22/2020, , , , , , , , , 
7351,2173,6/15/1942,Female,167,84,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,6",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/13/2021,12/31/2021, , , , , , , , , , 
7352,2613,6/15/1945,Male,189,80,Private,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/1/2021,3/31/2022, , , , , , , , , , 
7353,5405,6/15/1950,Female,166,70,Private,Yes, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Nein,Nein,Nein,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/6/2021,3/31/2022, , , , , , , , , , 
7354,1060,6/15/1965,Male,194,100,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,",57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,32", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/20/2021,12/31/2021, , , , , , , , , , 
7355,9719,6/15/1944,Female,164,47,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,IgA,"6,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,10/25/2021,12/5/2021,12/5/2021, , , , , , , , , 
7356,9499,6/15/1955,Male,181,78,Private,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"9,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/30/2021,3/31/2022, , , , , , , , , , 
7357,9112,6/15/1959,Male,169,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Ja,Nein,Nein,Nein,Ja,Ja,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/11/2021,3/31/2022, , , , , , , , , , 
7358,6986,6/15/1946,Female,165,69,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/15/2021,12/31/2021, , , , , , , , , , 
7359,5025,6/15/1948,Male,170,73,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/4/2021,12/31/2021, , , , , , , , , , 
7360,7692,6/15/1945,Female,162,69,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,IgG,"11,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/1/2021,3/31/2022, , , , , , , , , , 
7361,3423,6/15/1939,Male,177,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/1/2021,3/31/2022, , , , , , , , , , 
7362,8918,6/15/1946,Female,159,57,Compulsory health insurance CHI,Yes, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"10,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/4/2021,3/31/2022, , , , , , , , , , 
7363,1115,6/15/1943,Female,166,61,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,1,III: one or more criteria are fulfilled,Other type,"1,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/4/2021,3/31/2022, , , , , , , , , , 
7364,5661,6/15/1966,Male,178,97,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,"5,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,11/4/2021,12/31/2021, , , , , , , , , , 
7365,8761,6/15/1956,Male,170,90,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgD,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/26/2021,12/10/2021,12/10/2021, , , , , , , , , 
7366,8153,6/15/1937,Male,174,81,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"12,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/11/2021,3/31/2022, , , , , , , , , , 
7367,7949,6/15/1947,Male,172,68,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"9,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Unknown,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,10/18/2021,3/31/2022, , , , , , , , , , 
7368,4897,6/15/1950,Male,188,88,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,27,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,10/12/2018,2/9/2019,2/9/2019,12/13/2021,3/31/2022,10/14/1582, , , , , , 
7369,2800,6/15/1951,Male,177,86,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,14,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/25/2021,3/31/2022, , , , , , , , , , 
7370,1357,6/15/1948,Female,165,67,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,83,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/1/2021,3/31/2022, , , , , , , , , , 
7371,2778,6/15/1972,Male,179,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/1/2021,3/31/2022, , , , , , , , , , 
7372,5950,6/15/1954,Male,180,78,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,23,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/8/2021,3/31/2022, , , , , , , , , , 
7373,7355,6/15/1956,Male,176,96,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,Other type,0,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/15/2021,3/31/2022, , , , , , , , , , 
7374,9065,6/15/1956,Female,154,55,Compulsory health insurance CHI,Yes, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"1,7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/15/2021,3/31/2022, , , , , , , , , , 
7375,1181,6/15/1941,Female,165,63,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgA,"7,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/13/2021,12/31/2021, , , , , , , , , , 
7376,9202,6/15/1964,Female,168,92,Compulsory health insurance CHI,No,Yes, , ,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgA,"9,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/22/2021,12/31/2021, , , , , , , , , , 
7377,4796,6/15/1950,Female,163,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,21,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/15/2021,3/31/2022, , , , , , , , , , 
7378,1232,6/15/1942,Male,175,76,Compulsory health insurance CHI,No, , , ,Yes, , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,34,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/22/2021,3/31/2022, , , , , , , , , , 
7379,6658,6/15/1962,Female,164,99,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,"3,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/29/2021,3/31/2022, , , , , , , , , , 
7380,7028,6/15/1949,Male,177,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,61,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/6/2021,3/31/2022, , , , , , , , , , 
7381,2871,6/15/1947,Female,152,75,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"10,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/6/2021,3/31/2022, , , , , , , , , , 
7382,5685,6/15/1954,Male,178,86,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,",21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/13/2021,3/31/2022, , , , , , , , , , 
7383,6911,6/15/1935,Female,167,79,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,49","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,88", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/28/2021,3/31/2022, , , , , , , , , , 
7384,4140,6/15/1947,Female,155,71,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,18","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/15/2021,3/31/2022, , , , , , , , , , 
7385,8520,6/15/1930,Female,161,47,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,73","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/8/2021,3/31/2022, , , , , , , , , , 
7386,6992,6/15/1955,Male,177,76,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,12","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,93", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/14/2021,3/31/2022, , , , , , , , , , 
7387,4617,6/15/1963,Male,173,81,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,53",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,10/20/2021,3/31/2022,10/14/1582, , , , , , , , , 
7388,8778,6/15/1939,Female,165,63,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,69", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/24/2021,3/31/2022, , , , , , , , , , 
7389,1876,6/15/1946,Male,173,85,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes, , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,89",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/4/2021,3/31/2022, , , , , , , , , , 
7390,6027,6/15/1970,Male,177,58,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,72", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/9/2021,3/31/2022, , , , , , , , , , 
7391,5368,6/15/1983,Male,177,67,Compulsory health insurance CHI,No,Yes, ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,",83","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/27/2021,12/22/2021,12/22/2021, , , , , , , , , 
7392,9019,6/15/1946,Male,183,76,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,",74","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/21/2021,3/31/2022, , , , , , , , , , 
7393,9646,6/15/1961,Male,170,104,Private,No,Yes, , , ,Yes, ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,01","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/9/2021,3/31/2022, , , , , , , , , , 
7394,2864,6/15/1972,Female,151,47,Compulsory health insurance CHI,No,Yes,Yes, , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,4", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/1/2021,3/31/2022, , , , , , , , , , 
7395,5522,6/15/1958,Male,178,59,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/9/2021,3/31/2022, , , , , , , , , , 
7396,7316,6/15/1948,Male,176,89,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/2/2021,3/31/2022, , , , , , , , , , 
7397,3091,6/15/1964,Male,177,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"16,79",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/29/2021,3/31/2022, , , , , , , , , , 
7398,7171,6/15/1960,Male,180,99,Private,No, , , , , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/8/2021,3/31/2022, , , , , , , , , , 
7399,4778,6/15/1970,Female,164,87,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , ,Yes, ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/7/2021,3/31/2022, , , , , , , , , , 
7400,6725,6/15/1948,Male,183,97,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"23,58","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,19", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/6/2021,3/31/2022, , , , , , , , , , 
7401,6767,6/15/1942,Male,180,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/7/2021,3/31/2022, , , , , , , , , , 
7402,4873,6/15/1944,Female,165,45,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,47", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/26/2021,3/31/2022, , , , , , , , , , 
7403,8371,6/15/1942,Male,179,102,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,25",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,No,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/4/2021,3/31/2022, , , , , , , , , , 
7404,2584,6/15/1942,Female,173,107,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,19", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/17/2021,3/31/2022, , , , , , , , , , 
7405,8673,6/15/1945,Male,184,63,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,34","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/27/2021,12/22/2021,12/22/2021, , , , , , , , , 
7406,9410,6/15/1954,Male,171,77,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,3,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,23",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/16/2021,3/31/2022, , , , , , , , , , 
7407,2095,6/15/1950,Female,156,50,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,47", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/16/2021,3/31/2022, , , , , , , , , , 
7408,5853,6/15/1962,Male,169,69,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/4/2021,3/31/2022, , , , , , , , , , 
7409,8578,6/15/1951,Male,182,89,Compulsory health insurance CHI,No,Yes, ,Yes, , , ,Yes, ,Yes, ,3,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/3/2021,3/31/2022, , , , , , , , , , 
7410,1722,6/15/1933,Male,173,62,Private,No, ,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"22,85","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/12/2021,12/8/2021,12/8/2021, , , , , , , , , 
7411,8037,6/15/1950,Male,179,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein,Ja,Nein,Nein,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/11/2021,12/6/2021,12/6/2021, , , , , , , , , 
7412,6742,6/15/1947,Female,167,83,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , ,Yes, ,3,III: one or more criteria are fulfilled,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,11/4/2021,3/31/2022, , , , , , , , , , 
7413,1418,6/15/1942,Male,174,77,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,92", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/16/2021,3/31/2022, , , , , , , , , , 
7414,1441,6/15/1951,Male,176,111,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,26", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/19/2021,3/31/2022, , , , , , , , , , 
7415,3017,6/15/1966,Male,182,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"5,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/2/2021,12/31/2021, , , , , , , , , , 
7416,1844,6/15/1945,Male,175,77,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"6,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/6/2021,12/31/2021, , , , , , , , , , 
7417,8020,6/15/1975,Male,161,69,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,",7","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,73", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,8/15/2016,10/15/2016,10/15/2016,11/1/2021,3/31/2022,10/14/1582, , , , , , 
7418,7951,6/15/1955,Male,182,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,09","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,83", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,7/15/2016,9/15/2016,9/15/2016,11/18/2021,3/31/2022,10/14/1582, , , , , , 
7419,3269,6/15/1949,Male,184,102,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,98","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,25", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/15/2019,4/15/2019,4/15/2019,11/22/2021,3/31/2022, , , , , , , 
7420,8845,6/15/1948,Male,162,67,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,71", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,9/15/2017,3/15/2018,3/15/2018,11/16/2021,3/31/2022, , , , , , , 
7421,6143,6/15/1945,Female,164,74,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,8", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,V-X,No CTx,No CTx,R-X,11/15/2017,6/15/2018,6/15/2018,10/6/2021,3/31/2022, , , , , , , 
7422,7092,6/15/1943,Female,163,61,Private,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,No,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,8/6/2020,4/21/2021,4/21/2021,10/28/2021,3/31/2022,10/14/1582, , , , , , 
7423,7497,6/15/1944,Female,178,86,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,39","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,8/15/2018,3/15/2019,3/15/2019,11/2/2021,3/31/2022,10/14/1582, , , , , , 
7424,1364,6/15/1947,Male,182,85,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/15/2017,9/15/2017,9/15/2017,10/28/2021,3/31/2022, , , , , , , 
7425,4145,6/15/1957,Male,171,61,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,71", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/15/2018,1/15/2019,1/15/2019,12/17/2021,3/31/2022, , , , , , , 
7426,6240,6/15/1948,Female,156,67,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"24,96","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,1/15/2019,3/15/2019,3/15/2019,10/13/2021,3/31/2022,10/14/1582, , , , , , 
7427,9368,6/15/1946,Female,167,84,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,87","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/13/2021,12/31/2021, , , , , , , , , , 
7428,3278,6/15/1944,Female,161,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"29,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/20/2021,3/31/2022, , , , , , , , , , 
7429,7652,6/15/1949,Male,181,94,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,8/15/2018,2/15/2019,2/15/2019,10/18/2021,3/31/2022,10/14/1582, , , , , , 
7430,8530,6/15/1947,Male,180,60,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"3,46","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,77", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,4/15/2020,6/15/2020,6/15/2020,10/4/2021,3/31/2022,10/14/1582, , , , , , 
7431,2410,6/15/1962,Male,180,83,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"3,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/20/2021,3/31/2022, , , , , , , , , , 
7432,3107,6/15/1939,Female,169,64,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,23","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,73", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,4/15/2018,12/15/2018,12/15/2018,12/6/2021,3/31/2022,10/14/1582, , , , , , 
7433,4776,6/15/1944,Male,176,63,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,8/15/2020,3/15/2021,3/15/2021,10/14/2021,3/31/2022,10/14/1582, , , , , , 
7434,9906,6/15/1947,Female,165,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,2/15/2018,9/15/2018,9/15/2018,10/14/2021,3/31/2022,10/14/1582, , , , , , 
7435,9308,6/15/1946,Female,166,56,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/15/2019,7/15/2019,7/15/2019,12/7/2021,3/31/2022, , , , , , , 
7436,7874,6/15/1943,Female,172,101,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,5","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,13", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,1/15/2018,10/15/2018,10/15/2018,11/2/2021,3/31/2022,10/14/1582, , , , , , 
7437,1966,6/15/1958,Male,166,76,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,10/15/2019,8/15/2020,8/15/2020,10/14/2021,3/31/2022,10/14/1582, , , , , , 
7438,5562,6/15/1948,Male,171,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,9/15/2019,4/15/2020,4/15/2020,10/12/2021,3/31/2022,10/14/1582, , , , , , 
7439,7680,6/15/1969,Female,173,64,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,13",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,8/15/2019,3/15/2020,3/15/2020,10/19/2021,3/31/2022,10/14/1582, , , , , , 
7440,7459,6/15/1940,Male,178,96,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,6/26/2019,12/3/2019,12/3/2019,10/8/2021,3/31/2022, , , , , , , 
7441,6039,6/15/1955,Male,183,92,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,14", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/15/2016,10/15/2016,10/15/2016,11/4/2021,3/31/2022, , , , , , , 
7442,3590,6/15/1950,Male,194,127,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,56", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/15/2018,4/15/2018,4/15/2018,10/8/2021,3/31/2022, , , , , , , 
7443,1472,6/15/1952,Male,175,81,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"1,92","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,97", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/15/2017,1/15/2018,1/15/2018,12/28/2021,3/31/2022, , , , , , , 
7444,9347,6/15/1949,Male,182,85,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"17,03","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,R-X,No CTx,No CTx,V-X,1/16/2018,3/13/2018,3/13/2018,12/9/2021,3/31/2022, , , , , , , 
7445,7570,6/15/1959,Male,184,88,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,63","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,11", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Nein,Unbekannt,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,10/23/2019,4/14/2020,4/14/2020,11/24/2021,3/31/2022, , , , , , , 
7446,8998,6/15/1968,Male,173,58,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,28","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/15/2019,6/15/2019,6/15/2019,10/6/2021,3/31/2022, , , , , , , 
7447,2028,6/15/1959,Female,171,52,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"1,79","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,6", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/15/2017,2/15/2018,2/15/2018,12/9/2021,3/31/2022, , , , , , , 
7448,4247,6/15/1948,Female,178,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,69","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,71", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/15/2013,11/15/2013,11/15/2013,12/29/2021,3/31/2022, , , , , , , 
7449,5575,6/15/1959,Male,179,94,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,13", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,1/15/2018,7/15/2018,7/15/2018,12/7/2021,3/31/2022, , , , , , , 
7450,8512,6/15/1962,Male,182,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,07", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,7/15/2014,10/15/2014,10/15/2014,12/17/2021,3/31/2022, , , , , , , 
7451,7046,6/15/1943,Female,178,68,Compulsory health insurance CHI,Yes,Yes, ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,3/19/2018,9/10/2018,9/10/2018,10/7/2021,3/31/2022,10/14/1582, , , , , , 
7452,9585,6/15/1965,Male,178,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,6/15/2019,8/15/2019,8/15/2019,10/18/2021,3/31/2022,10/14/1582, , , , , , 
7453,8138,6/15/1956,Female,159,47,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"2,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,45", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,11/24/2021,3/31/2022, , , , , , , , , , 
7454,7427,6/15/1952,Male,185,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,98", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,11/8/2018,7/25/2019,7/25/2019,11/8/2021,3/31/2022,10/14/1582, , , , , , 
7455,8765,6/15/1960,Female,165,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,72", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/15/2014,6/15/2014,6/15/2014,11/15/2021,3/31/2022, , , , , , , 
7456,5047,6/15/1938,Female,167,73,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,",84",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,10/27/2020,7/15/2021,7/15/2021,11/10/2021,3/31/2022,10/14/1582, , , , , , 
7457,4386,6/15/1937,Female,166,67,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,51","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,74", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/15/2017,3/15/2017,3/15/2017,10/26/2021,3/31/2022,10/14/1582, , , , , , 
7458,8032,6/15/1960,Female,169,62,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,11/15/2019,8/15/2020,8/15/2020,10/11/2021,3/31/2022,10/14/1582, , , , , , 
7459,3267,6/15/1954,Female,172,83,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,96", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/30/2016,10/25/2016,10/25/2016,11/18/2021,3/31/2022, , , , , , , 
7460,6110,6/15/1956,Female,164,53,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgM,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/12/2021,12/7/2021,12/7/2021, , , , , , , , , 
7461,8848,6/15/1958,Male,173,80,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,94", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,5/27/2014,7/22/2014,7/22/2014,12/6/2021,3/31/2022, , , , , , , 
7462,3495,6/15/1961,Male,181,89,Compulsory health insurance CHI,No, , ,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"10,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/11/2021,12/24/2021,12/24/2021, , , , , , , , , 
7463,3620,6/15/1947,Female,171,59,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,69", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/8/2021,3/31/2022, , , , , , , , , , 
7464,8296,6/15/1940,Male,177,76,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,36","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,93", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L", ,KYP-X,No CTx,No CTx,V-X,8/3/2016,9/28/2016,9/28/2016,11/3/2021,3/31/2022,10/14/1582, , , , , , 
7465,6271,6/15/1940,Male,175,62,Private,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,75", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/6/2021,12/2/2021,12/2/2021, , , , , , , , , 
7466,9200,6/15/1937,Female,170,65,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Nein,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/1/2021,12/31/2021, , , , , , , , , , 
7467,9157,6/15/1939,Male,177,78,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgA,"2,14","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,95", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/29/2021,3/31/2022, , , , , , , , , , 
7468,3261,6/15/1946,Male,180,75,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"3,97","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,94", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/10/2021,12/31/2021, , , , , , , , , , 
7469,6955,6/15/1970,Male,172,80,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, ,Yes, ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/13/2021,12/31/2021, , , , , , , , , , 
7470,1294,6/15/1939,Male,184,78,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,38","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/7/2021,12/2/2021,12/2/2021, , , , , , , , , 
7471,5352,6/15/1965,Female,163,73,Compulsory health insurance CHI,No, , , , , , , ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,3/15/2021,9/15/2021,9/15/2021,11/1/2021,12/31/2021,10/14/1582, , , , , , 
7472,7925,6/15/1934,Female,151,54,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, ,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,23","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,49", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/15/2019,10/10/2019,10/10/2019,10/19/2021,3/31/2022,10/14/1582, , , , , , 
7473,5649,6/15/1937,Male,172,93,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Nein,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,3/15/2020,9/15/2020,9/15/2020,10/19/2021,12/31/2021,10/14/1582, , , , , , 
7474,4432,6/15/1981,Male,181,86,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,4/5/2017,5/31/2017,5/31/2017,12/2/2021,3/31/2022, , , , , , , 
7475,1564,6/15/1945,Female,166,98,Compulsory health insurance CHI,No,Yes, ,Yes, , ,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,3/7/2019,5/2/2019,5/2/2019,10/7/2021,12/31/2021,10/14/1582, , , , , , 
7476,8594,6/15/1951,Female,165,96,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,59","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,02", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/12/2018,1/7/2019,1/7/2019,11/16/2021,3/31/2022, , , , , , , 
7477,6234,6/15/1945,Male,180,87,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,74","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,No,"2,07", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,12/5/2019,6/23/2020,6/23/2020,10/12/2021,3/31/2022,10/14/1582, , , , , , 
7478,4792,6/15/1974,Female,165,50,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,53", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/29/2021,3/31/2022, , , , , , , , , , 
7479,5720,6/15/1948,Male,177,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/15/2021,3/31/2022, , , , , , , , , , 
7480,8287,6/15/1967,Male,185,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,14", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/17/2019,8/12/2019,8/12/2019,12/7/2021,3/31/2022, , , , , , , 
7481,5055,6/15/1947,Male,174,101,Private,No, ,Yes, , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,49","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,No,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,R-X,11/12/2021,3/31/2022, , , , , , , , , , 
7482,3182,6/15/1946,Male,175,55,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,52","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,4/8/2020,12/17/2020,12/17/2020,11/4/2021,3/31/2022,10/14/1582, , , , , , 
7483,7121,6/15/1935,Female,167,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes, , , , ,3,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,17",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/8/2021,3/31/2022, , , , , , , , , , 
7484,4142,6/15/1932,Male,185,90,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,75","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,1/8/2020,3/11/2020,3/11/2020,10/12/2021,3/31/2022,10/14/1582, , , , , , 
7485,2337,6/15/1953,Female,165,91,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,44","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"1,98", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/9/2018,7/4/2018,7/4/2018,11/23/2021,3/31/2022, , , , , , , 
7486,2013,6/15/1950,Female,175,97,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,92",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Unbekannt,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,11/30/2021,3/31/2022, , , , , , , , , , 
7487,3291,6/15/1948,Female,163,72,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/6/2021,3/31/2022, , , , , , , , , , 
7488,4674,6/15/1980,Male,175,81,Compulsory health insurance CHI,No, ,Yes,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,",69",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/4/2020,12/30/2020,12/30/2020,11/10/2021,3/31/2022,10/14/1582, , , , , , 
7489,8829,6/15/1944,Male,189,97,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,24", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Unbekannt,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/30/2021,3/31/2022, , , , , , , , , , 
7490,7775,6/15/1962,Female,168,53,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,59", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/15/2015,8/15/2015,8/15/2015,12/27/2021,3/31/2022, , , , , , , 
7491,6979,6/15/1941,Female,171,80,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,81","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/18/2021,3/31/2022, , , , , , , , , , 
7492,5001,6/15/1937,Male,168,60,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , ,Yes, ,0,III: one or more criteria are fulfilled,IgG,"8,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,12/9/2020,9/28/2021,9/28/2021,10/12/2021,3/31/2022,10/14/1582, , , , , , 
7493,5798,6/15/1963,Male,160,47,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,46", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/27/2021,3/31/2022, , , , , , , , , , 
7494,1874,6/15/1944,Male,165,48,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,51", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/2/2021,3/31/2022, , , , , , , , , , 
7495,3470,6/15/1945,Male,179,87,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,07","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,12/14/2021,3/31/2022, , , , , , , , , , 
7496,4923,6/15/1965,Male,187,100,Private,No, , ,Yes, ,Yes, , , ,Yes, ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,No,Yes,Yes,Yes,"2,26", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/3/2021,3/31/2022, , , , , , , , , , 
7497,6216,6/15/1950,Female,155,45,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,4", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/24/2021,3/31/2022, , , , , , , , , , 
7498,1190,6/15/1967,Female,172,86,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/7/2021,3/31/2022, , , , , , , , , , 
7499,2758,6/15/1947,Female,170,65,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgA,"12,51",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,12/8/2021,3/31/2022, , , , , , , , , , 
7500,4935,6/15/1968,Male,186,93,Compulsory health insurance CHI,No, ,Yes,Yes, , , ,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/29/2021,3/31/2022, , , , , , , , , , 
7501,1539,6/15/1948,Female,160,79,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"999,99",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,No,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,3/5/2020,7/17/2020,7/17/2020,10/19/2021,3/31/2022,10/14/1582, , , , , , 
7502,6249,6/15/1942,Male,175,62,Private,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/28/2019,6/11/2020,6/11/2020,11/25/2021,3/31/2022, , , , , , , 
7503,9709,6/15/1946,Male,180,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,44",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,8/12/2019,2/6/2020,2/6/2020,12/3/2021,3/31/2022, , , , , , , 
7504,7493,6/15/1949,Female,166,75,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,83", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/15/2014,11/15/2014,11/15/2014,12/13/2021,3/31/2022, , , , , , , 
7505,8773,6/15/1964,Male,189,69,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgM,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,94", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,10/15/2015,1/15/2016,1/15/2016,10/20/2021,3/31/2022,10/14/1582, , , , , , 
7506,5374,6/15/1947,Male,183,77,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"2,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,99", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/29/2018,2/21/2019,2/21/2019,12/7/2021,3/31/2022, , , , , , , 
7507,4555,6/15/1960,Male,174,92,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,29","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,07", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,11/20/2019,11/3/2021,11/3/2021,11/22/2021,3/31/2022,10/14/1582, , , , , , 
7508,6632,6/15/1974,Female,165,50,Compulsory health insurance CHI,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,Other type,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,53", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/11/2021,3/31/2022, , , , , , , , , , 
7509,8476,6/15/1948,Male,177,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,"2,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/9/2021,3/31/2022, , , , , , , , , , 
7510,8289,6/15/1942,Male,174,79,Private,No,Yes,Yes,Yes, ,Yes,Unknown,Unknown,Unknown,Unknown,Unknown,9,III: one or more criteria are fulfilled,IgG,"8,9",unknown/ISS-Criteria not used for prognostics,No,No,Yes,Yes,No,No,"1,94", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Unbekannt,Unbekannt, , , , , ,NIN-X,No CTx,No CTx,V-X,6/15/2020,12/17/2020,12/17/2020,11/24/2021,12/31/2021, , , , , , , 
7511,9479,6/15/1936,Male,177,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,2,III: one or more criteria are fulfilled,Other type,"4,63","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,LEV-X,12/20/2021,12/31/2021, , , , , , , , , , 
7512,8927,6/15/1942,Male,178,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,36","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,LEV-X,No CTx,No CTx,LEV-X,7/1/2019,12/22/2019,12/22/2019,12/6/2021,12/31/2021, , , , , , , 
7513,8472,6/15/1942,Female,159,48,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/7/2021,3/31/2022, , , , , , , , , , 
7514,1444,6/15/1939,Male,176,81,Private,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,10/4/2021,3/31/2022, , , , , , , , , , 
7515,4134,6/15/1951,Male,185,62,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,5/15/2019,11/13/2019,11/13/2019,10/6/2021,12/31/2021, , , , , , , 
7516,1120,6/15/1944,Male,173,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,NIN-X,No CTx,No CTx,V-X,11/9/2020,12/16/2021,12/16/2021,12/20/2021,12/31/2021, , , , , , , 
7517,9981,6/15/1950,Male,170,91,Compulsory health insurance CHI,Yes, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,999,unknown/ISS-Criteria not used for prognostics,9,9,9,9,Unknown,No,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,DAR-X,No CTx,No CTx,V-X,7/15/2020,9/15/2020,9/15/2020,11/25/2021,3/31/2022, , , , , , , 
7518,1972,6/15/1953,Male,172,67,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,3,III: one or more criteria are fulfilled,IgG,"4,62",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,EMP-X,DAR-X,V-X,5/20/2015,9/2/2015,9/2/2015,10/20/2016,10/30/2017,10/30/2017,4/1/2018,6/25/2018,6/25/2018,7/17/2018,12/16/2020,12/16/2020
7519,4278,6/15/1954,Female,161,73,Private,No,Yes, , , , , , , , , ,9,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,98","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,KYP-X,10/28/2021,3/31/2022,10/14/1582, , , , , , , , , 
7520,2126,6/15/1956,Male,190,110,Private,No,Yes, , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"9,18",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,38", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,10/15/2021,3/31/2022,10/14/1582, , , , , , , , , 
7521,3242,6/15/1964,Male,178,81,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,5333,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/13/2021,2/24/2022,2/24/2022, , , , , , , , , 
7522,9056,6/15/1953,Female,159,52,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,409,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,12/20/2021,3/3/2022,3/3/2022, , , , , , , , , 
7523,6663,6/15/1951,Female,153,60,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,"2,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,KYP-X,12/21/2021,12/31/2021,10/14/1582, , , , , , , , , 
7524,3629,6/15/1955,Female,188,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,No,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,11/15/2021,2/24/2022,2/24/2022, , , , , , , , , 
7525,2604,6/15/1954,Male,167,71,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,0,III: one or more criteria are fulfilled,Other type,",02","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,8", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/15/2021,12/31/2021, , , , , , , , , , 
7526,4519,6/15/1940,Female,164,70,Compulsory health insurance CHI,No, , ,Yes,Yes,Yes,Yes,Yes, , ,Yes,3,III: one or more criteria are fulfilled,IgG,"5,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/22/2021,12/31/2021, , , , , , , , , , 
7527,7810,6/15/1961,Male,181,88,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,No,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,5/23/2016,7/18/2016,7/18/2016,11/4/2021,1/25/2022,1/25/2022, , , , , , 
7528,3891,6/15/1945,Female,168,83,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,35","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/20/2018,11/11/2018,11/11/2018,12/13/2021,12/31/2021, , , , , , , 
7529,7572,6/15/1936,Male,169,78,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"4,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,LEV-X,9/9/2019,3/1/2020,3/1/2020,12/27/2021,12/31/2021, , , , , , , 
7530,1024,6/15/1942,Female,158,74,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,9,Unknown,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/4/2021,3/31/2022, , , , , , , , , , 
7531,8426,6/15/1936,Female,165,78,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"3,1",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,R-X,No CTx,No CTx,DAR-X,3/25/2020,4/29/2021,4/29/2021,12/4/2021,12/31/2021, , , , , , , 
7532,5057,6/15/1974,Male,174,64,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , ,Yes,0,III: one or more criteria are fulfilled,Other type,",16",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,No,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Nein,DAR-X,No CTx,No CTx,V-X,1/23/2015,4/24/2015,4/24/2015,12/13/2021,12/31/2021, , , , , , , 
7533,7507,6/15/1971,Male,176,87,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"10,3",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Unknown,Unknown,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , , , ,No CTx,No CTx,No CTx,V-X,2/20/2018,3/12/2018,3/12/2018, , , , , , , , , 
7534,9898,6/15/1954,Male,185,96,Compulsory health insurance CHI,No, , , , , , , , ,Yes,Yes,1,Unknown,IgG,"4,6",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,No,No,Yes,"2,2", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,DAR-X,11/8/2021,3/31/2022, , , , , , , , , , 
7535,2198,6/15/1965,Female,163,73,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes, , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"3,44","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/19/2021,12/31/2021, , , , , , , , , , 
7536,8415,6/15/1937,Male,172,93,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Unbekannt,"<3,5 mg/L",Nein,NIN-X,No CTx,No CTx,R-X,2/6/2019,9/26/2019,9/26/2019,12/2/2021,12/31/2021, , , , , , , 
7537,2967,6/15/1950,Female,999,65,Compulsory health insurance CHI,Yes, ,Yes,Yes, ,Yes, , , , ,Yes,0,III: one or more criteria are fulfilled,Other type,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , , ,Nein,KYP-X,No CTx,No CTx,V-X,5/21/2012,6/5/2012,6/5/2012,10/14/2021,12/31/2021,10/14/1582, , , , , , 
7538,8461,6/15/1941,Female,176,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/16/2021,3/31/2022, , , , , , , , , , 
7539,9265,6/15/1950,Female,165,70,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,3,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/29/2021,3/31/2022, , , , , , , , , , 
7540,4952,6/15/1960,Female,165,64,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,EMP-X,11/7/2021,3/31/2022,10/14/1582, , , , , , , , , 
7541,9672,6/15/1954,Female,162,67,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgA,"41,95","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Unknown,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,DAR-X,No CTx,No CTx,EMP-X,6/1/2019,11/30/2019,11/30/2019,12/19/2021,3/31/2022, , , , , , , 
7542,2512,6/15/1962,Male,178,90,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"38,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/7/2014,3/10/2014,3/10/2014,11/15/2021,3/31/2022, , , , , , , 
7543,5116,6/15/1941,Female,160,74,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/6/2021,12/31/2021, , , , , , , , , , 
7544,4501,6/15/1947,Male,178,92,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,69,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,11/1/2021,3/31/2022, , , , , , , , , , 
7545,7947,6/15/1947,Female,170,58,Compulsory health insurance CHI,No,Yes, , ,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,63,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , , ,Nein,No CTx,No CTx,No CTx,DAR-X,10/7/2021,3/31/2022,10/14/1582, , , , , , , , , 
7546,9903,6/15/1964,Female,175,86,Compulsory health insurance CHI,No, , ,Yes, , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,9,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,No,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , ,Nein,R-X,No CTx,No CTx,DAR-X,12/9/2021,3/1/2022,3/1/2022,3/21/2022,3/31/2022, , , , , , , 
7547,6137,6/15/1946,Male,176,84,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"7,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,EMP-X,No CTx,No CTx,DAR-X,4/19/2021,10/8/2021,10/8/2021,12/13/2021,12/31/2021, , , , , , , 
7548,4711,6/15/1969,Male,178,88,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"12,8",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Unknown,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,11/22/2021,3/22/2022,3/22/2022, , , , , , , , , 
7549,5771,6/15/1931,Female,170,80,Private,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/16/2021,3/31/2022, , , , , , , , , , 
7550,1819,6/15/1952,Male,999,80,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , ,Yes, ,Yes,1,III: one or more criteria are fulfilled,IgG,"2,4",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"20,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/20/2015,8/14/2015,8/14/2015,10/19/2021,12/31/2021, , , , , , , 
7551,4515,6/15/1941,Male,168,79,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"26,1",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Nein,Ja,Nein,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,10/7/2021,11/3/2021,11/3/2021, , , , , , , , , 
7552,8483,6/15/1954,Male,180,90,Private,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/9/2021,12/31/2021, , , , , , , , , , 
7553,3228,6/15/1936,Male,178,75,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/8/2021,3/31/2022, , , , , , , , , , 
7554,5881,6/15/1955,Male,180,77,Compulsory health insurance CHI,Yes, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,",41",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/1/2021,3/31/2022, , , , , , , , , , 
7555,2331,6/15/1948,Female,160,60,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgG,"4,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,12/22/2021,3/31/2022, , , , , , , , , , 
7556,2577,6/15/1961,Male,176,82,Compulsory health insurance CHI,No,Yes,Yes,Yes, , ,Yes,Yes, ,Yes, ,9,III: one or more criteria are fulfilled,IgG,"9,1",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,11/15/2021,1/19/2022,1/19/2022, , , , , , , , , 
7557,3318,6/15/1955,Male,179,94,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"6,9",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/7/2021,3/1/2022,3/1/2022, , , , , , , , , 
7558,1800,6/15/1949,Male,176,87,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"8,8",ISS stage II (neither stage I nor stage III),No,Yes,Yes,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,11/24/2021,3/31/2022, , , , , , , , , , 
7559,9509,6/15/1961,Male,185,88,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , ,Yes, ,0,III: one or more criteria are fulfilled,IgG,"37,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/1/2021,12/31/2021, , , , , , , , , , 
7560,8903,6/15/1942,Female,163,62,Compulsory health insurance CHI,No, , , , , ,Yes, , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"17,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/1/2021,12/31/2021, , , , , , , , , , 
7561,5999,6/15/1932,Male,175,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"44,17",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/10/2014,6/17/2014,6/17/2014,10/22/2021,3/11/2022,3/11/2022, , , , , , 
7562,4305,6/15/1963,Female,164,50,Private,No, , , , ,Yes,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,Other type,"28,7","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,53", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/20/2021,3/31/2022, , , , , , , , , , 
7563,7757,6/15/1966,Female,170,100,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"9,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/2/2021,3/31/2022, , , , , , , , , , 
7564,2071,6/15/1956,Male,181,92,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,6,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"2,13", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/14/2021,3/31/2022, , , , , , , , , , 
7565,3785,6/15/1939,Female,160,70,Private,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,9,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/7/2021,3/31/2022,10/14/1582, , , , , , , , , 
7566,4893,6/15/1943,Male,180,85,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,10,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/13/2021,3/31/2022,10/14/1582, , , , , , , , , 
7567,6161,6/15/1968,Female,169,67,Compulsory health insurance CHI,No, , , , , , , , ,Yes, ,0,III: one or more criteria are fulfilled,IgA,"7,5",ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,12/8/2021,12/31/2021, , , , , , , , , , 
7568,4999,6/15/1953,Male,179,75,Private,No,Yes,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"23,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,POM-X,No CTx,V-X,10/4/2018,12/21/2018,12/21/2018,5/18/2021,12/2/2021,12/2/2021,12/6/2021,3/31/2022, , , , 
7569,3300,6/15/1936,Male,178,85,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes, ,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"19,7",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,V-X,DAR-X,No CTx,R-X,1/14/2020,2/16/2021,2/16/2021,2/23/2021,12/2/2021,12/2/2021,12/14/2021,3/31/2022, , , , 
7570,5324,6/15/1962,Female,162,79,Private,No, , ,Yes, ,Yes,Yes,Yes,Yes, , ,3,III: one or more criteria are fulfilled,Other type,"1,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Nein,V-X,KYP-X,No CTx,V-X,8/17/2017,12/14/2017,12/14/2017,3/14/2018,8/7/2019,8/7/2019,12/7/2021,3/10/2022,3/10/2022, , , 
7571,2457,6/15/1945,Male,174,82,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"6,4","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,12/20/2021,3/31/2022,10/14/1582, , , , , , , , , 
7572,2634,6/15/1928,Male,175,76,Private,Yes,Yes,Yes,Yes,Yes, , ,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"6,9",unknown/ISS-Criteria not used for prognostics,Yes,Yes,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,10/18/2021,12/31/2021, , , , , , , , , , 
7573,5518,6/15/1981,Male,187,99,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"2,25", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Unbekannt,No CTx,No CTx,No CTx,No CTx, , , , , , , , , , , , 
7574,8248,6/15/1950,Male,172,69,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,150,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,12/6/2021,12/31/2021, , , , , , , , , , 
7575,5185,6/15/1930,Female,165,58,Compulsory health insurance CHI,No, ,Yes,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,140,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,12/20/2021,12/31/2021, , , , , , , , , , 
7576,7423,6/15/1942,Male,167,62,Compulsory health insurance CHI,No,Yes, , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,120,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,10/18/2021,12/31/2021, , , , , , , , , , 
7577,4036,6/15/1953,Female,164,67,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,11,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,10/29/2021,2/21/2022,2/21/2022, , , , , , , , , 
7578,1262,6/15/1952,Female,164,55,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,"5,67","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/10/2022,3/26/2022,3/26/2022, , , , , , , , , 
7579,3032,6/15/1952,Male,186,83,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"4,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,3/11/2019,5/17/2019,5/17/2019,3/4/2022,3/31/2022,10/14/1582, , , , , , 
7580,4483,6/15/1943,Male,177,72,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Other type,",23",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"1,88", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,DAR-X,2/22/2022,3/31/2022,10/14/1582, , , , , , , , , 
7581,2696,6/15/1947,Male,176,83,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"2,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/30/2022,3/31/2022, , , , , , , , , , 
7582,7412,6/15/1944,Male,180,88,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"1,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,08", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,9/14/2016,3/7/2020,3/7/2020,3/29/2022,3/31/2022, , , , , , , 
7583,7821,6/15/1972,Female,159,66,Compulsory health insurance CHI,No, ,Yes, , , ,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/7/2022,3/31/2022, , , , , , , , , , 
7584,1920,6/15/1932,Male,171,84,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgA,"8,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/14/2022,3/31/2022, , , , , , , , , , 
7585,9895,6/15/1962,Male,175,86,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/21/2022,3/31/2022, , , , , , , , , , 
7586,4389,6/15/1950,Female,166,79,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/18/2022,3/31/2022, , , , , , , , , , 
7587,2734,6/15/1943,Female,171,73,Compulsory health insurance CHI,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"7,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/15/2022,3/31/2022, , , , , , , , , , 
7588,9372,6/15/1955,Male,181,106,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, ,Yes,Yes, , , ,3,III: one or more criteria are fulfilled,IgG,"8,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,26", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/14/2022,3/31/2022, , , , , , , , , , 
7589,7743,6/15/1962,Male,186,102,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,9,Yes,Yes,"2,27", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Unbekannt,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/6/2022,3/31/2022, , , , , , , , , , 
7590,3459,6/15/1954,Male,183,97,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,3798,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,No,"2,19", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Ja,Unbekannt,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/31/2022,3/31/2022, , , , , , , , , , 
7591,6393,6/15/1968,Male,189,105,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,Yes,No,No,Yes,Yes,Yes,"2,32", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,1/31/2022,3/31/2022, , , , , , , , , , 
7592,4591,6/15/1939,Male,173,88,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,3089,unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,No,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/29/2022,3/31/2022, , , , , , , , , , 
7593,8892,6/15/1959,Female,150,64,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"1,84",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/3/2022,3/31/2022, , , , , , , , , , 
7594,2736,6/15/1947,Male,170,70,Compulsory health insurance CHI,No, , , , , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,99,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",9,9,9,9,Unknown,Unknown,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,EMP-X,V-X,No CTx,V-X,4/15/2011,8/15/2011,8/15/2011,3/15/2020,12/15/2020,12/15/2020,3/28/2022,3/31/2022, , , , 
7595,2667,6/15/1953,Female,158,83,Compulsory health insurance CHI,No, , ,Yes, , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"3,48",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , ,Nein,No CTx,No CTx,No CTx,V-X,3/15/2022,3/31/2022, , , , , , , , , , 
7596,7901,6/15/1954,Female,154,66,Compulsory health insurance CHI,No, , , , , , , , , , ,9,III: one or more criteria are fulfilled,IgG,"125,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,64", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/14/2022,3/31/2022, , , , , , , , , , 
7597,5140,6/15/1949,Female,162,78,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"7,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/23/2022,3/31/2022, , , , , , , , , , 
7598,9127,6/15/1964,Male,175,78,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,8128,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/31/2022,3/31/2022, , , , , , , , , , 
7599,5979,6/15/1959,Female,166,79,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,7766,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/30/2022,3/31/2022, , , , , , , , , , 
7600,2214,6/15/1974,Female,172,76,Private,No, ,Yes, , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,20,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,1/18/2022,3/22/2022,3/22/2022, , , , , , , , , 
7601,4916,6/15/1955,Male,187,98,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,33,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,24", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/29/2022,3/31/2022, , , , , , , , , , 
7602,6386,6/15/1947,Male,187,102,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"24,85",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,No,"2,27", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/7/2022,3/31/2022, , , , , , , , , , 
7603,4508,6/15/1956,Female,160,82,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/31/2022,3/31/2022,10/14/1582, , , , , , , , , 
7604,7600,6/15/1956,Male,181,89,Compulsory health insurance CHI,No,Yes, , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,51,unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,Yes,No,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/4/2022,3/31/2022, , , , , , , , , , 
7605,8319,6/15/1961,Female,161,97,Compulsory health insurance CHI,Yes, , ,Yes, , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgA,"1,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,KYP-X,3/11/2022,3/31/2022,10/14/1582, , , , , , , , , 
7606,4699,6/15/1942,Female,160,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,I: fulfilling all 4 criteria,IgG,"4,22","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/11/2022,3/31/2022,10/14/1582, , , , , , , , , 
7607,1848,6/15/1939,Female,158,49,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,47", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/17/2022,3/31/2022, , , , , , , , , , 
7608,1900,6/15/1949,Male,183,84,Compulsory health insurance CHI,Unknown, , ,Yes, , , , , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgA,"45,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/24/2022,3/31/2022, , , , , , , , , , 
7609,6373,6/15/1958,Female,177,85,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,0,I: fulfilling all 4 criteria,IgG,"29,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/4/2022,3/31/2022,10/14/1582, , , , , , , , , 
7610,4878,6/15/1955,Female,171,65,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,40,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/10/2022,3/31/2022, , , , , , , , , , 
7611,4968,6/15/1941,Male,174,81,Compulsory health insurance CHI,No, , , , , , , , , , ,9,I: fulfilling all 4 criteria,IgG,"99999999,99",unknown/ISS-Criteria not used for prognostics,No,Yes,No,No,Unknown,Unknown,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , , , ,KYP-X,No CTx,No CTx,R-X,12/15/2018,11/15/2020,11/15/2020,2/16/2022,3/31/2022,10/14/1582, , , , , , 
7612,1933,6/15/1944,Female,175,80,Compulsory health insurance CHI,Yes, , , , , ,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,16,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/13/2022,3/31/2022, , , , , , , , , , 
7613,9418,6/15/1964,Female,164,68,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgG,"17,6",unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Nein,Nein,Nein,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/16/2022,3/31/2022, , , , , , , , , , 
7614,8545,6/15/1966,Female,178,78,Private,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,37,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/22/2022,3/31/2022, , , , , , , , , , 
7615,9666,6/15/1946,Male,174,87,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"9,2",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,2/2/2021,12/10/2021,12/10/2021,3/28/2022,3/31/2022, , , , , , , 
7616,5743,6/15/1951,Female,158,69,Compulsory health insurance CHI,Unknown, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"18,8","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Ja,Nein,Ja,Nein,Nein,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/10/2022,3/31/2022, , , , , , , , , , 
7617,9357,6/15/1939,Male,171,79,Compulsory health insurance CHI,No, , , ,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/28/2022,3/31/2022, , , , , , , , , , 
7618,1479,6/15/1940,Male,171,73,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"6,57",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,85", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,DAR-X,8/20/2020,12/25/2020,12/25/2020,1/11/2022,3/31/2022,10/14/1582, , , , , , 
7619,5937,6/15/1941,Male,182,85,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , ,Yes,1,III: one or more criteria are fulfilled,Other type,",18","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,NIN-X,No CTx,No CTx,DAR-X,11/18/2018,9/10/2019,9/10/2019,2/28/2021,3/21/2022,3/21/2022, , , , , , 
7620,3338,6/15/1940,Female,165,59,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"8,6",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,65", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/28/2022,3/31/2022, , , , , , , , , , 
7621,9358,6/15/1961,Female,168,120,Compulsory health insurance CHI,No, , , , , , , , , ,Yes,0,III: one or more criteria are fulfilled,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,No,Yes,Yes,"2,25", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,8/19/2021,11/25/2021,11/25/2021,2/28/2022,3/31/2022, , , , , , , 
7622,9219,6/15/1938,Female,165,52,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,4581,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,No,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,1/15/2021,3/15/2022,3/15/2022,3/16/2022,3/31/2022, , , , , , , 
7623,9365,6/15/1950,Female,159,60,Compulsory health insurance CHI,No,Yes, ,Yes, , , , , , ,Yes,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,6",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"1,61", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , , , ,No CTx,No CTx,No CTx,DAR-X,2/16/2022,3/31/2022, , , , , , , , , , 
7624,8011,6/15/1939,Female,161,78,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"8,8","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/21/2022,3/31/2022, , , , , , , , , , 
7625,9113,6/15/1949,Female,165,62,Private,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"10,1",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/28/2022,3/31/2022, , , , , , , , , , 
7626,2908,6/15/1942,Male,187,80,Private,No, , , , , , , , , , ,3,I: fulfilling all 4 criteria,IgG,"5,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Nein,Nein,Ja,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/1/2022,3/31/2022, , , , , , , , , , 
7627,8859,6/15/1950,Male,190,83,Private,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgA,"10,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,11", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/21/2022,3/31/2022, , , , , , , , , , 
7628,8887,6/15/1944,Male,173,84,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"7,3",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes,"1,98", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/28/2020,11/17/2021,11/17/2021,3/14/2022,3/31/2022, , , , , , , 
7629,7576,6/15/1955,Female,160,45,Private,No, , ,Yes, , , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"1,85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"1,43", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/10/2022,3/31/2022, , , , , , , , , , 
7630,4532,6/15/1964,Male,170,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Unknown/not measured, ,ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,No,"1,85", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,3/7/2022,3/31/2022, , , , , , , , , , 
7631,8786,6/15/1978,Male,178,108,Compulsory health insurance CHI,No, ,Yes, , , , , , , ,Yes,1,III: one or more criteria are fulfilled,IgG,"6,33","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,No,Yes,Yes,"2,25", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,11/5/2021,1/3/2022,1/3/2022,1/11/2022,3/31/2022,10/14/1582, , , , , , 
7632,2560,6/15/1963,Female,180,80,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,Unknown/not measured, ,unknown/ISS-Criteria not used for prognostics,No,No,No,9,Yes,Unknown,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,3/27/2022,3/31/2022, , , , , , , , , , 
7633,7187,6/15/1936,Female,162,64,Compulsory health insurance CHI,No, , , , , , , , , , ,0,Unknown,IgA,58,unknown/ISS-Criteria not used for prognostics,No,No,No,9,Yes,No,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,2/15/2022,3/31/2022, , , , , , , , , , 
7634,7688,6/15/1940,Female,158,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"7,3",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/5/2021,12/20/2021,12/20/2021,2/21/2022,3/31/2022, , , , , , , 
7635,7149,6/15/1954,Female,155,71,Compulsory health insurance CHI,No, ,Yes, , , , ,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"2,42","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,Yes,Yes,Yes,Yes,"1,7",Nein,Nein,Nein,Nein,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/14/2022,3/31/2022, , , , , , , , , , 
7636,7101,6/15/1940,Female,166,67,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,",12",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,KYP-X,12/9/2019,2/16/2020,2/16/2020,2/9/2022,3/31/2022, , , , , , , 
7637,8940,6/15/1960,Male,173,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"8,2",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/17/2022,3/31/2022, , , , , , , , , , 
7638,2854,6/15/1951,Female,162,63,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"25,25",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/28/2022,3/31/2022, , , , , , , , , , 
7639,2820,6/15/1944,Female,159,66,Compulsory health insurance CHI,No, , , , , , ,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"17,5",ISS stage II (neither stage I nor stage III),No,Yes,Yes,No,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/7/2022,3/31/2022, , , , , , , , , , 
7640,4298,6/15/1957,Female,176,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,99999999,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,94", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/11/2022,3/31/2022, , , , , , , , , , 
7641,7803,6/15/1960,Female,168,70,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/18/2022,3/31/2022, , , , , , , , , , 
7642,9137,6/15/1936,Male,179,64,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,24","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,81", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/21/2022,3/31/2022, , , , , , , , , , 
7643,4110,6/15/1953,Male,163,72,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, ,Yes, , ,2,III: one or more criteria are fulfilled,IgG,"18,21","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/4/2022,3/31/2022, , , , , , , , , , 
7644,7115,6/15/1934,Female,169,61,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,56",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Unbekannt,Unbekannt,Unbekannt,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/10/2022,3/31/2022, , , , , , , , , , 
7645,1897,6/15/1945,Male,187,91,Compulsory health insurance CHI,No,Yes,Yes, , , ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"6,24",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/4/2022,3/31/2022, , , , , , , , , , 
7646,6915,6/15/1957,Female,170,71,Compulsory health insurance CHI,No, , , , , ,Yes, ,Yes, , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,29","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/28/2022,3/31/2022, , , , , , , , , , 
7647,8714,6/15/1956,Male,170,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,05","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,2, , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/14/2022,3/31/2022, , , , , , , , , , 
7648,3513,6/15/1940,Male,179,72,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"4,57","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,9", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/9/2022,3/31/2022, , , , , , , , , , 
7649,1399,6/15/1942,Male,182,113,Private,No, ,Yes, , , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"28,08",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"2,33", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/17/2022,3/31/2022, , , , , , , , , , 
7650,9534,6/15/1978,Female,177,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"6,1","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Ja,Nein,Nein,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/10/2022,3/31/2022, , , , , , , , , , 
7651,8284,6/15/1938,Male,177,56,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Unknown/not measured, ,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,69", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/14/2022,3/31/2022, , , , , , , , , , 
7652,5754,6/15/1958,Female,166,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,5",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/17/2022,3/31/2022, , , , , , , , , , 
7653,1434,6/15/1937,Female,168,90,Compulsory health insurance CHI,No, , , , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,3,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,Yes,No,No,2, , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Unbekannt,Unbekannt,Unbekannt,Nein,Ja,Unbekannt, , ,No CTx,No CTx,No CTx,V-X,3/22/2022,3/31/2022, , , , , , , , , , 
7654,3036,6/15/1946,Male,177,92,Compulsory health insurance CHI,Yes,Yes, , ,Yes,Yes, , , , ,Yes,0,III: one or more criteria are fulfilled,IgG,"5,44",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,DAR-X,No CTx,V-X,6/19/2017,9/21/2017,9/21/2017,5/6/2021,10/21/2021,10/21/2021,3/17/2022,3/31/2022, , , , 
7655,2425,6/15/1941,Male,176,83,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"6,6",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,10/19/2020,11/19/2021,11/19/2021,2/7/2022,3/31/2022, , , , , , , 
7656,2009,6/15/1962,Female,170,70,Private,No,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/7/2022,3/31/2022, , , , , , , , , , 
7657,2018,6/15/1856,Female,156,58,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"5,1",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Nein,Nein,Nein,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/3/2022,3/31/2022, , , , , , , , , , 
7658,5071,6/15/1946,Male,172,80,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,5",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/28/2022,3/31/2022, , , , , , , , , , 
7659,1247,6/15/1940,Male,180,90,Private,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,9,ISS stage II (neither stage I nor stage III),No,Yes,No,No,Yes,No,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,DAR-X,3/30/2022,3/31/2022, , , , , , , , , , 
7660,1249,6/15/1949,Female,160,70,Private,No, , , , , ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"6,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,73", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/28/2022,3/31/2022, , , , , , , , , , 
7661,8521,6/15/1966,Female,170,115,Private,No, , ,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"9,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"2,23", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/11/2022,3/31/2022, , , , , , , , , , 
7662,2798,6/15/1957,Male,179,71,Private,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"8,5","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/3/2022,3/31/2022, , , , , , , , , , 
7663,4656,6/15/1945,Male,180,90,Compulsory health insurance CHI,No,Yes,Yes, , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,8,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/28/2022,3/31/2022, , , , , , , , , , 
7664,8348,6/15/1945,Female,160,75,Compulsory health insurance CHI,No, ,Yes, , ,Yes, ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,9",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/14/2022,3/31/2022, , , , , , , , , , 
7665,4609,6/15/1946,Female,159,57,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"27,3",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/3/2022,3/31/2022, , , , , , , , , , 
7666,3857,6/15/1949,Male,177,95,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"36,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/3/2022,3/31/2022, , , , , , , , , , 
7667,8106,6/15/1954,Male,179,86,Private,No, , , , , ,Yes,Yes, ,Yes,Yes,1,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/10/2022,3/31/2022, , , , , , , , , , 
7668,2726,6/15/1946,Male,178,87,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,Other type,"4,1",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/10/2022,3/31/2022, , , , , , , , , , 
7669,4730,6/15/1942,Female,164,76,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"23,6",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"1,82", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/17/2022,3/31/2022, , , , , , , , , , 
7670,8509,6/15/1953,Female,167,62,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgA,"18,4",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/17/2022,3/31/2022, , , , , , , , , , 
7671,5457,6/15/1941,Male,176,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes,Yes, , ,1,III: one or more criteria are fulfilled,IgG,"41,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/24/2022,3/31/2022, , , , , , , , , , 
7672,5581,6/15/1950,Female,160,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"3,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,75", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/17/2022,3/31/2022, , , , , , , , , , 
7673,3398,6/15/1961,Male,188,91,Private,No, ,Yes, ,Yes, ,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"7,3","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,"2,18", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,11/1/2021,1/18/2022,1/18/2022,2/7/2022,3/31/2022, , , , , , , 
7674,4404,6/15/1944,Male,176,79,Private,No, , ,Yes,Yes,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgG,"6,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,No,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,">5,5 mg/L", ,V-X,No CTx,No CTx,R-X,6/3/2019,6/30/2020,6/30/2020,3/8/2022,3/31/2022, , , , , , , 
7675,5725,6/15/1947,Male,174,77,Compulsory health insurance CHI,No, , ,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"27,5",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/31/2022,3/31/2022, , , , , , , , , , 
7676,6158,6/15/1954,Female,158,58,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgA,"26,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"1,58", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/4/2022,3/31/2022, , , , , , , , , , 
7677,8244,6/15/1938,Male,176,89,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes,Yes,Yes, ,2,III: one or more criteria are fulfilled,Other type,"3,5",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"2,05",Nein,Nein,Nein,Nein,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,2/7/2022,3/31/2022, , , , , , , , , , 
7678,3866,6/15/1963,Male,177,95,Compulsory health insurance CHI,No, , ,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgG,"38,3","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/15/2013,4/15/2013,4/15/2013,2/7/2022,3/31/2022, , , , , , , 
7679,6590,6/15/1947,Male,179,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"7,3",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/21/2022,3/31/2022, , , , , , , , , , 
7680,6204,6/15/1941,Male,170,66,Compulsory health insurance CHI,No,Yes, , ,Yes,Yes, ,Yes, ,Yes,Yes,2,III: one or more criteria are fulfilled,IgG,"2,9",unknown/ISS-Criteria not used for prognostics,No,Yes,Yes,Yes,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"<3,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/11/2022,3/31/2022,10/14/1582, , , , , , , , , 
7681,7607,6/15/1952,Male,178,116,Compulsory health insurance CHI,No, ,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,",73","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,32",Nein,Nein,Nein,Nein,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2022,3/31/2022, , , , , , , , , , 
7682,5576,6/15/1946,Male,180,104,Private,Yes, , ,Yes, , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"3,47",unknown/ISS-Criteria not used for prognostics,No,No,No,Yes,No,No,"2,23", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , , , ,No CTx,No CTx,No CTx,DAR-X,2/23/2022,3/31/2022, , , , , , , , , , 
7683,5265,6/15/1938,Female,157,73,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"5,9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,R-X,6/17/2021,3/1/2022,3/1/2022,3/21/2022,3/31/2022,10/14/1582, , , , , , 
7684,6898,6/15/1952,Male,183,88,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"5,4",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/14/2022,3/31/2022, , , , , , , , , , 
7685,3860,6/15/1955,Female,170,62,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,89,ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/10/2022,3/31/2022, , , , , , , , , , 
7686,5779,6/15/1933,Male,178,78,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,28,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,3/11/2022,3/31/2022, , , , , , , , , , 
7687,6587,6/15/1978,Male,176,74,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgA,12,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.3 Solitäres Plasmozytom,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/21/2022,3/31/2022, , , , , , , , , , 
7688,5089,6/15/1937,Male,189,95,Compulsory health insurance CHI,Yes,Yes, , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,38,ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"2,22", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/19/2022,3/31/2022, , , , , , , , , , 
7689,9868,6/15/1949,Male,186,109,Private,Yes, , , , ,Yes,Yes, , , ,Yes,1,II: fullfilling neither criteria for I nor criteria for III,Other type,",1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"2,33", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Unbekannt, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/4/2022,3/31/2022,10/14/1582, , , , , , , , , 
7690,7560,6/15/1950,Female,154,70,Compulsory health insurance CHI,Yes,Yes,Yes, ,Yes,Yes, , , , , ,2,III: one or more criteria are fulfilled,IgG,"39,7",unknown/ISS-Criteria not used for prognostics,Yes,No,Yes,Yes,Yes,Unknown,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Nein,Ja, , , ,"<3,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/4/2022,3/31/2022, , , , , , , , , , 
7691,6232,6/15/1942,Male,162,59,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,9",ISS stage II (neither stage I nor stage III),No,No,Yes,No,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/31/2022,3/31/2022, , , , , , , , , , 
7692,4475,6/15/1952,Male,180,124,Compulsory health insurance CHI,No, , , , , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"99999999,99",unknown/ISS-Criteria not used for prognostics,9,Yes,9,9,Unknown,Unknown,"2,4", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Unbekannt,Unbekannt,Unbekannt, , , , , ,KYP-X,No CTx,No CTx,V-X,1/15/2017,7/15/2017,7/15/2017,2/2/2022,3/31/2022,10/14/1582, , , , , , 
7693,5936,6/15/1935,Male,179,83,Compulsory health insurance CHI,No,Yes, , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/3/2022,3/31/2022, , , , , , , , , , 
7694,1416,6/15/1948,Male,172,64,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,26",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Ja,KYP-X,No CTx,No CTx,V-X,9/15/2018,10/15/2019,10/15/2019,3/8/2022,3/31/2022,10/14/1582, , , , , , 
7695,2524,6/15/1945,Male,162,74,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,8",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,8/15/2019,7/15/2020,7/15/2020,3/7/2022,3/31/2022,10/14/1582, , , , , , 
7696,3375,6/15/1943,Male,178,72,Private,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"4,4","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/13/2016,11/25/2016,11/25/2016,1/20/2022,3/31/2022,10/14/1582, , , , , , 
7697,2882,6/15/1955,Female,166,64,Compulsory health insurance CHI,No,Yes,Yes,Yes, , , , , ,Yes, ,1,III: one or more criteria are fulfilled,IgG,"37,1",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/14/2022,3/31/2022, , , , , , , , , , 
7698,8414,6/15/1939,Female,156,63,Compulsory health insurance CHI,Yes, , , , ,Yes,Yes,Yes, ,Yes, ,1,III: one or more criteria are fulfilled,Other type,",9","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,No,Yes,Yes,Yes,"1,63", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/21/2022,3/31/2022, , , , , , , , , , 
7699,7146,6/15/1952,Female,166,79,Compulsory health insurance CHI,No, , , ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,"2,6","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,87",Nein,Nein,Nein,Nein,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/21/2022,3/31/2022, , , , , , , , , , 
7700,1414,6/15/1961,Female,175,85,Compulsory health insurance CHI,No, , ,Yes, , , ,Yes,Yes,Yes, ,1,Unknown,Other type,"99999999,99","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,Yes,Yes,Yes,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,1/2/2022,3/31/2022,10/14/1582, , , , , , , , , 
7701,5618,6/15/1952,Male,170,84,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,5/15/2020,4/15/2021,4/15/2021,3/11/2022,3/31/2022, , , , , , , 
7702,6820,6/15/1959,Female,171,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,63",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No,"1,93", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,R-X,1/15/2020,11/15/2020,11/15/2020,2/11/2022,3/31/2022, , , , , , , 
7703,6136,6/15/1949,Female,161,65,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,68", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,3/15/2020,2/15/2021,2/15/2021,2/14/2022,3/31/2022, , , , , , , 
7704,3772,6/15/1954,Male,190,105,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"7,1",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,33", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,4/15/2018,8/15/2018,8/15/2018,2/28/2022,3/31/2022, , , , , , , 
7705,9863,6/15/1959,Male,169,53,Compulsory health insurance CHI,No, , , , , , ,Yes, , , ,2,I: fulfilling all 4 criteria,IgG,"5,11",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,6", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/18/2022,3/31/2022, , , , , , , , , , 
7706,1595,6/15/1965,Male,176,86,Compulsory health insurance CHI,No, , ,Yes, , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"12,42",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,02", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,2/7/2022,3/31/2022, , , , , , , , , , 
7707,3252,6/15/1955,Male,180,91,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,7",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,11", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,6/15/2019,9/15/2019,9/15/2019,2/9/2022,3/31/2022, , , , , , , 
7708,9492,6/15/1946,Male,161,51,Compulsory health insurance CHI,No, , , , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,42","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,Yes,Yes,Yes,Yes,Yes,"1,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,4/15/2021,1/15/2022,1/15/2022,3/21/2022,3/31/2022, , , , , , , 
7709,2748,6/15/1945,Female,167,56,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"1,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,62", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/2/2022,3/31/2022, , , , , , , , , , 
7710,5874,6/15/1955,Female,168,77,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,0,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,17","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/23/2022,3/31/2022, , , , , , , , , , 
7711,3068,6/15/1959,Male,173,92,Private,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"17,87",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/18/2022,3/31/2022, , , , , , , , , , 
7712,8929,6/15/1952,Male,178,66,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,03","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,82", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/10/2022,3/31/2022, , , , , , , , , , 
7713,8342,6/15/1950,Male,182,74,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"2,53","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,95", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/14/2022,3/31/2022, , , , , , , , , , 
7714,4974,6/15/1955,Male,183,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,92", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2022,3/31/2022, , , , , , , , , , 
7715,4387,6/15/1946,Male,181,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"1,94","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,02", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/10/2022,3/31/2022, , , , , , , , , , 
7716,5243,6/15/1955,Male,174,98,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,12", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/7/2022,3/31/2022, , , , , , , , , , 
7717,7314,6/15/1969,Male,189,66,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgD,"6,1",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,9", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/1/2022,3/31/2022, , , , , , , , , , 
7718,7025,6/15/1965,Male,167,51,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"3,1",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,56", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/21/2022,3/31/2022, , , , , , , , , , 
7719,8288,6/15/1955,Female,156,83,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"5,6",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/9/2022,3/31/2022, , , , , , , , , , 
7720,1446,6/15/1964,Female,160,57,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,59", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/8/2022,3/31/2022, , , , , , , , , , 
7721,7677,6/15/1949,Female,156,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,2,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,73", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/6/2022,3/31/2022, , , , , , , , , , 
7722,6101,6/15/1947,Female,167,80,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,93","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,89", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/21/2022,3/31/2022, , , , , , , , , , 
7723,2362,6/15/1948,Male,179,68,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,",85","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,85", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/27/2022,3/31/2022, , , , , , , , , , 
7724,6410,6/15/1953,Female,163,58,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"3,02","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,No,Yes,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,V-X,3/23/2022,3/31/2022, , , , , , , , , , 
7725,6391,6/15/1940,Male,189,119,Compulsory health insurance CHI,No, , ,Yes,Yes, , ,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,29",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,45", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/11/2022,3/31/2022, , , , , , , , , , 
7726,8271,6/15/1942,Male,167,78,Compulsory health insurance CHI,No, , , , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,67","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes,"1,87", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Ja,Nein,Nein,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/25/2022,3/31/2022, , , , , , , , , , 
7727,9720,6/15/1976,Male,168,76,Compulsory health insurance CHI,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,Other type,99999999,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,86", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/9/2022,3/31/2022, , , , , , , , , , 
7728,1311,6/15/1942,Male,179,80,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,4",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes,"1,99", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/23/2022,3/31/2022, , , , , , , , , , 
7729,8386,6/15/1943,Male,188,72,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"8,22",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,R-X,1/14/2022,3/31/2022, , , , , , , , , , 
7730,2578,6/15/1947,Male,183,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/18/2022,3/31/2022, , , , , , , , , , 
7731,6335,6/15/1945,Male,176,85,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,23",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,No,"2,01", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,3/1/2022,3/31/2022, , , , , , , , , , 
7732,8583,6/15/1957,Male,182,71,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"4,2",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,No,"1,91", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L", ,No CTx,No CTx,No CTx,V-X,2/24/2022,3/31/2022, , , , , , , , , , 
7733,2782,6/15/1975,Male,169,51,Compulsory health insurance CHI,No, , , , , , ,Yes,Yes, , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/23/2022,3/31/2022, , , , , , , , , , 
7734,7945,6/15/1946,Male,183,64,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,I: fulfilling all 4 criteria,IgG,"2,84","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,84", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/1/2022,3/31/2022, , , , , , , , , , 
7735,3556,6/15/1940,Female,168,50,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,29",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,55", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/21/2022,3/31/2022, , , , , , , , , , 
7736,8657,6/15/1973,Male,162,66,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,51",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,7", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/28/2022,3/31/2022, , , , , , , , , , 
7737,5917,6/15/1965,Male,176,75,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"56,2",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Ja,EMP-X,No CTx,No CTx,V-X,8/15/2020,12/15/2020,12/15/2020,3/7/2022,3/31/2022, , , , , , , 
7738,7548,6/15/1961,Female,168,69,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"8,22","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,No,"1,78", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L", ,DAR-X,EMP-X,No CTx,V-X,3/15/2020,5/15/2020,5/15/2020,2/15/2022,2/15/2022,2/15/2022,3/28/2022,3/31/2022, , , , 
7739,4602,6/15/1962,Female,166,69,Compulsory health insurance CHI,No, , ,Yes,Yes, , , , , , ,1,III: one or more criteria are fulfilled,Other type,"67,1","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Unknown,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,">5,5 mg/L", ,DAR-X,ISA-X,No CTx,V-X,2/15/2018,4/15/2018,4/15/2018,9/15/2020,12/15/2020,12/15/2020,3/21/2022,3/31/2022, , , , 
7740,4505,6/15/1965,Male,175,94,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgA,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,09", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/17/2022,3/31/2022, , , , , , , , , , 
7741,9586,6/15/1964,Male,172,66,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes,Yes, ,Yes, ,2,III: one or more criteria are fulfilled,IgA,"30,38","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,Yes,No,Yes,Yes,Yes,"1,78", , , , ,ICD-10 C90.1 Plasmazell-Leukämie,Ja,Ja,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,2/21/2022,3/31/2022, , , , , , , , , , 
7742,1037,6/15/1967,Female,175,87,Compulsory health insurance CHI,Yes,Yes,Yes,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,Other type,"1,2","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,9/1/2021,11/24/2021,11/24/2021, , , , , , , , , 
7743,6981,6/15/1962,Male,184,112,Compulsory health insurance CHI,No,Yes, ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"42,3",ISS stage II (neither stage I nor stage III),No,No,No,Yes,Yes,Yes,"2,34", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,3/15/2022,3/31/2022, , , , , , , , , , 
7744,2085,6/15/1948,Male,189,89,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,Other type,99999999,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"2,16", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/18/2022,3/31/2022, , , , , , , , , , 
7745,4468,6/15/1975,Female,161,48,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"1,61","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,48", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/22/2022,3/31/2022, , , , , , , , , , 
7746,5451,6/15/1949,Male,161,82,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/25/2022,3/31/2022, , , , , , , , , , 
7747,5008,6/15/1950,Male,169,59,Compulsory health insurance CHI,No, , , ,Yes,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,75",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,67", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/3/2022,3/31/2022, , , , , , , , , , 
7748,4665,6/15/1938,Female,160,53,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,6",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,54", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/18/2022,3/31/2022, , , , , , , , , , 
7749,2075,6/15/1968,Male,177,125,Compulsory health insurance CHI,No,Yes, ,Yes,Yes,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"34,9","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,38", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,8/5/2021,10/25/2021,10/25/2021, , , , , , , , , 
7750,6835,6/15/1944,Male,173,79,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,98",ISS stage II (neither stage I nor stage III),No,No,No,No,Yes,Yes,"1,93", , , , ,ICD-10 C90.0 Smouldering Myeloma (asymptomatisch),Nein,Nein,Nein,Nein,Nein,Nein,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,1/27/2022,3/31/2022, , , , , , , , , , 
7751,1849,6/15/1951,Female,155,53,Private,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,",99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,Yes,No,No,Yes,Yes,"1,5", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/9/2022,3/31/2022, , , , , , , , , , 
7752,9188,6/15/1948,Male,184,83,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"2,66",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,06", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/14/2022,3/31/2022, , , , , , , , , , 
7753,7745,6/15/1948,Male,160,78,Compulsory health insurance CHI,No,Yes, , ,Yes,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,35",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,81", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/3/2022,3/31/2022, , , , , , , , , , 
7754,5760,6/15/1952,Female,154,55,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgG,"2,88","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,52", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/10/2022,3/31/2022, , , , , , , , , , 
7755,1534,6/15/1952,Male,172,73,Compulsory health insurance CHI,No, , , , , , , , , , ,1,I: fulfilling all 4 criteria,IgA,"1,55","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/2/2022,3/31/2022, , , , , , , , , , 
7756,5894,6/15/1943,Male,180,82,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgG,"4,26","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,Yes,Yes,Yes,"2,02", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,3/8/2022,3/31/2022, , , , , , , , , , 
7757,1639,6/15/1950,Male,184,103,Compulsory health insurance CHI,No, , , , ,Yes, , , , , ,1,III: one or more criteria are fulfilled,IgA,"15,81",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"2,26", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/14/2022,3/31/2022, , , , , , , , , , 
7758,2638,6/15/1940,Male,163,51,Compulsory health insurance CHI,No, , , , , , , , , , ,2,I: fulfilling all 4 criteria,IgA,"1,25","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,53", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,1/6/2022,3/31/2022, , , , , , , , , , 
7759,1668,6/15/1955,Male,188,94,Compulsory health insurance CHI,No, ,Yes,Yes, , , , , , , ,0,III: one or more criteria are fulfilled,IgA,"8,11","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"2,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,DAR-X,No CTx,No CTx,R-X,3/15/2020,2/15/2021,2/15/2021,3/4/2022,3/31/2022, , , , , , , 
7760,9690,6/15/1951,Male,181,65,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"4,41",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No,"1,83", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,DAR-X,No CTx,No CTx,V-X,11/15/2019,10/15/2020,10/15/2020,3/7/2020,3/31/2022, , , , , , , 
7761,6821,6/15/1941,Male,184,98,Compulsory health insurance CHI,No, , , , , ,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"2,51",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,21", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/15/2020,7/15/2021,7/15/2021,3/10/2022,3/31/2022, , , , , , , 
7762,5448,6/15/1943,Male,171,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"12,47","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,No,Yes,Yes,"1,91", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,2/15/2020,9/15/2020,9/15/2020,2/17/2022,3/31/2022,10/14/1582, , , , , , 
7763,1442,6/15/1953,Male,151,63,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",Yes,No,Yes,No,Yes,Yes,"1,59", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,7/15/2021,12/15/2021,12/15/2021,2/8/2022,3/31/2022, , , , , , , 
7764,5808,6/15/1940,Female,164,61,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"5,81",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,R-X,No CTx,No CTx,V-X,12/15/2020,5/15/2021,5/15/2021,2/24/2022,3/31/2022, , , , , , , 
7765,7267,6/15/1946,Female,172,79,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"23,32",ISS stage II (neither stage I nor stage III),Yes,Yes,No,Yes,Yes,No,"1,92", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,V-X,No CTx,No CTx,R-X,1/15/2021,12/15/2021,12/15/2021,2/7/2022,3/31/2022, , , , , , , 
7766,4009,6/15/1940,Male,185,91,Compulsory health insurance CHI,No, , ,Yes, ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,",97",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,No,"2,15", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L", ,KYP-X,No CTx,No CTx,R-X,1/15/2021,11/15/2021,11/15/2021,2/21/2022,3/31/2022,10/14/1582, , , , , , 
7767,1339,6/15/1946,Female,175,95,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,I: fulfilling all 4 criteria,IgG,"4,56",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,1", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,4/15/2017,3/15/2018,3/15/2018,2/7/2022,3/31/2022, , , , , , , 
7768,4390,6/15/1948,Female,161,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,86", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/15/2021,12/15/2021,12/15/2021,3/4/2022,3/31/2022, , , , , , , 
7769,7672,6/15/1944,Female,150,65,Compulsory health insurance CHI,No,Yes,Yes, , ,Yes,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgA,"1,94",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,6", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,12/15/2019,11/15/2020,11/15/2020,2/10/2022,3/31/2022, , , , , , , 
7770,5802,6/15/1956,Male,180,77,Compulsory health insurance CHI,No, ,Yes, , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgD,"4,1",ISS stage II (neither stage I nor stage III),Yes,No,Yes,Yes,Yes,Yes,"1,96", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,V-X,No CTx,No CTx,V-X,1/15/2021,4/15/2021,4/15/2021,3/9/2022,3/31/2022, , , , , , , 
7771,9245,6/15/1953,Female,168,65,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"65,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,74", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Ja,V-X,No CTx,No CTx,R-X,10/15/2020,9/15/2021,9/15/2021,2/22/2022,3/31/2022, , , , , , , 
7772,9495,6/15/1952,Female,172,56,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,55",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,66", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,2/15/2019,5/15/2019,5/15/2019,2/18/2022,3/31/2022, , , , , , , 
7773,8772,6/15/1943,Male,173,99,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"9,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,12", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,12/15/2018,5/15/2019,5/15/2019,2/10/2022,3/31/2022, , , , , , , 
7774,2187,6/15/1954,Female,153,54,Private,No, , , , , ,Yes,Yes, , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"4,61",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,5", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,8/15/2017,7/15/2018,7/15/2018,2/21/2022,3/31/2022, , , , , , , 
7775,8447,6/15/1945,Male,177,86,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"2,03", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,3/15/2019,2/15/2020,2/15/2020,1/17/2022,3/31/2022, , , , , , , 
7776,8468,6/15/1946,Female,166,65,Compulsory health insurance CHI,No,Yes, ,Yes,Yes, ,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,92",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,72", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/15/2020,12/15/2020,12/15/2020,3/9/2022,3/31/2022, , , , , , , 
7777,1286,6/15/1938,Male,187,91,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"22,41",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,No,Yes,Yes,"2,17", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/15/2019,9/15/2020,9/15/2020,3/2/2022,3/31/2022, , , , , , , 
7778,1582,6/15/1961,Female,172,82,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"2,74",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,V-X,3/15/2017,6/15/2017,6/15/2017,2/1/2022,3/31/2022,10/14/1582, , , , , , 
7779,9638,6/15/1942,Female,173,81,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"3,32",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,95", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,3/15/2020,2/15/2021,2/15/2021,3/14/2022,3/31/2022, , , , , , , 
7780,1811,6/15/1940,Female,168,55,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,Other type,"99999999,99",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,62", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,10/15/2020,8/15/2021,8/15/2021,2/17/2022,3/31/2022,10/14/1582, , , , , , 
7781,9528,6/15/1944,Male,180,78,Compulsory health insurance CHI,No, ,Yes, , ,Yes, , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"10,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,97", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,KYP-X,No CTx,No CTx,R-X,6/15/2019,4/15/2020,4/15/2020,3/7/2022,3/31/2022,10/14/1582, , , , , , 
7782,3721,6/15/1962,Male,189,128,Compulsory health insurance CHI,No, ,Yes, , , ,Yes, , , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgG,"6,2",ISS stage II (neither stage I nor stage III),Yes,Yes,Yes,Yes,Yes,Yes,"2,52", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,5/15/2019,3/15/2020,3/15/2020,3/17/2022,3/31/2022, , , , , , , 
7783,2850,6/15/1942,Female,168,68,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgA,"26,02",ISS stage II (neither stage I nor stage III),Yes,No,No,Yes,Yes,Yes,"1,77", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Unbekannt, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,2/24/2022,3/31/2022, , , , , , , , , , 
7784,8799,6/15/1974,Male,182,79,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,1,III: one or more criteria are fulfilled,IgG,"88,35","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",Yes,No,Yes,Yes,Yes,Yes,2, , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,">5,5 mg/L",Ja,No CTx,No CTx,No CTx,DAR-X,1/27/2022,2/3/2022,2/3/2022, , , , , , , , , 
7785,9795,6/15/1960,Male,166,64,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes, , , , , ,1,III: one or more criteria are fulfilled,Other type,6,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"1,71", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Nein,No CTx,No CTx,No CTx,V-X,2/24/2022,3/31/2022, , , , , , , , , , 
7786,3541,6/15/1953,Male,180,85,Compulsory health insurance CHI,No, ,Yes, , , , , , , , ,1,II: fullfilling neither criteria for I nor criteria for III,IgG,"21,77","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"2,05", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,R-X,11/28/2019,7/2/2020,7/2/2020,1/10/2022,3/31/2022,10/14/1582, , , , , , 
7787,6030,6/15/1951,Female,170,67,Private,No, , , , , , , , , , ,0,I: fulfilling all 4 criteria,IgG,"15,65","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,78", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/6/2022,3/31/2022,10/14/1582, , , , , , , , , 
7788,6964,6/15/1943,Male,174,100,Compulsory health insurance CHI,No, , , , ,Yes,Yes,Yes, , , ,2,II: fullfilling neither criteria for I nor criteria for III,IgA,"33,34","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,Yes,Yes,No,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Nein,Nein, , , ,">5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,9/5/2019,9/6/2020,9/6/2020,1/19/2022,3/31/2022, , , , , , , 
7789,1969,6/15/1935,Male,174,70,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes,Yes, , , ,2,III: one or more criteria are fulfilled,IgG,"47,51",ISS stage II (neither stage I nor stage III),No,No,Yes,Yes,Yes,Yes,"1,84", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Nein,Ja, , , ,"3,5 - 5,5 mg/L",Ja,DAR-X,No CTx,No CTx,V-X,5/9/2018,9/11/2020,9/11/2020,2/4/2022,3/31/2022, , , , , , , 
7790,8135,6/15/1938,Male,170,68,Compulsory health insurance CHI,No, , ,Yes, ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"71,18","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Nein, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,11/14/2014,1/20/2017,1/20/2017,1/5/2022,3/31/2022,10/14/1582, , , , , , 
7791,4372,6/15/1959,Female,156,57,Compulsory health insurance CHI,No,Yes,Yes, ,Yes, , , , , , ,1,III: one or more criteria are fulfilled,IgG,"51,6","ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,56", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,3/7/2022,3/31/2022, , , , , , , , , , 
7792,7772,6/15/1935,Male,160,47,Compulsory health insurance CHI,No, , , , , , , , , , ,1,III: one or more criteria are fulfilled,IgG,"13,95","ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,No,Yes,Yes,"1,46", , , , ,ICD-10 D47.2 MGUS - monoklonale Gammopathie unklarer Signifikanz,Nein,Nein,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,DAR-X,1/13/2022,3/31/2022,10/14/1582, , , , , , , , , 
7793,8752,6/15/1943,Female,153,60,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgG,"15,2",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,57", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,2/9/2022,3/31/2022, , , , , , , , , , 
7794,3120,6/15/1963,Male,162,71,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,1,III: one or more criteria are fulfilled,IgG,"9,1",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,76", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,DAR-X,No CTx,No CTx,V-X,1/15/2021,3/15/2021,3/15/2021,3/10/2022,3/31/2022, , , , , , , 
7795,8470,6/15/1944,Female,174,66,Compulsory health insurance CHI,No, , , , ,Yes,Yes, , , , ,2,III: one or more criteria are fulfilled,IgA,"8,1",ISS stage II (neither stage I nor stage III),Yes,No,Yes,No,Yes,Yes,"1,79", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"3,5 - 5,5 mg/L",Nein,R-X,No CTx,No CTx,V-X,1/15/2021,6/15/2021,6/15/2021,3/9/2022,3/31/2022, , , , , , , 
7796,4351,6/15/1943,Female,167,55,Private,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,43,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,No,Yes,Yes,Yes,"1,61", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"<3,5 mg/L",Nein,DAR-X,No CTx,No CTx,DAR-X,9/9/2019,1/17/2021,1/17/2021,3/20/2022,3/31/2022, , , , , , , 
7797,3935,6/15/1946,Male,185,90,Compulsory health insurance CHI,Yes,Yes,Yes, , , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgA,25,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,No,Yes,Yes,Yes,"2,14", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Ja, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,DAR-X,7/19/2019,1/25/2021,1/25/2021,3/19/2022,3/31/2022,10/14/1582, , , , , , 
7798,2302,6/15/1948,Male,184,93,Compulsory health insurance CHI,No,Yes,Yes,Yes, ,Yes,Yes, , , , ,0,III: one or more criteria are fulfilled,IgG,38,"ISS stage III (β 2-mikroglobulin > 5,5 mg/l)",No,No,Yes,Yes,Yes,Yes,"2,16", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,">5,5 mg/L",Ja,KYP-X,No CTx,No CTx,DAR-X,4/23/2020,10/23/2021,10/23/2021,3/14/2022,3/31/2022,10/14/1582, , , , , , 
7799,6950,6/15/1949,Male,190,95,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , ,Yes,Yes, , , ,0,III: one or more criteria are fulfilled,IgG,41,"ISS stage I (β 2-mikroglobulin < 3,5 mg/l and albumine > 3,5 g/dl)",No,No,Yes,Yes,Yes,Yes,"2,23", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Nein,Ja,Nein, , , ,"<3,5 mg/L",Nein,KYP-X,No CTx,No CTx,DAR-X,4/23/2020,12/13/2021,12/13/2021,3/1/2022,3/31/2022,10/14/1582, , , , , , 
7800,6429,6/15/1942,Male,175,88,Compulsory health insurance CHI,Yes,Yes,Yes,Yes, , , , , , , ,2,III: one or more criteria are fulfilled,IgG,"33,7",ISS stage II (neither stage I nor stage III),No,Yes,No,Yes,Yes,Yes,"2,04", , , , ,ICD-10 C90.0 Multiples Myelom (symptomatisch),Ja,Ja,Ja, , , ,"3,5 - 5,5 mg/L",Nein,No CTx,No CTx,No CTx,R-X,3/21/2022,3/31/2022, , , , , , , , , , 
